PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sawa, T; Zaki, MH; Okamoto, T; Akuta, T; Tokutomi, Y; Kim-Mitsuyama, S; Ihara, H; Kobayashi, A; Yamamoto, M; Fujii, S; Arimoto, H; Akaike, T				Sawa, Tomohiro; Zaki, Mohammad Hasan; Okamoto, Tatsuya; Akuta, Teruo; Tokutomi, Yoshiko; Kim-Mitsuyama, Shokei; Ihara, Hideshi; Kobayashi, Akira; Yamamoto, Masayuki; Fujii, Shigemoto; Arimoto, Hirokazu; Akaike, Takaaki			Protein S-guanylation by the biological signal 8-nitroguanosine 3 ',5 '-cyclic monophosphate	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE; TYROSINE NITRATION; CYCLIC-GMP; NITROSYLATION; INHIBITOR; SUPEROXIDE; TRANSDUCTION; PATHOGENESIS; INVOLVEMENT; MECHANISMS	The signaling pathway of nitric oxide (NO) depends mainly on guanosine 3',5'-cyclic monophosphate (cGMP, 1). Here we report the formation and chemical biology of a nitrated derivative of cGMP, 8-nitroguanosine 3', 5'- cyclic monophosphate (8-nitro-cGMP, 2), in NO-mediated signal transduction. Immunocytochemistry demonstrated marked 8-nitro-cGMP production in various cultured cells in an NO-dependent manner. This finding was confirmed by HPLC plus electrochemical detection and tandem mass spectrometry. 8-Nitro-cGMP activated cGMP-dependent protein kinase and showed unique redox-active properties independent of cGMP activity. Formation of protein Cys-cGMP adducts by 8-nitro-cGMP was identified as a new post-translational modification, which we call protein S-guanylation. 8-Nitro-cGMP seems to regulate the redox-sensor signaling protein Keap1, via S-guanylation of the highly nucleophilic cysteine sulfhydryls of Keap1. This study reveals 8-nitro-cGMP to be a second messenger of NO and sheds light on new areas of the physiology and chemical biology of signal transduction by NO.	Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan; Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan; Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; Univ Tsukuba, JST ERATO Environm Response Project, Tsukuba, Ibaraki 3058577, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Chem, Sendai, Miyagi 9818555, Japan	Kumamoto University; Osaka Metropolitan University; Tohoku University; Japan Science & Technology Agency (JST); University of Tsukuba; Tohoku University	Akaike, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Dept Pharmacol & Mol Therapeut, 1-1-1 Honjo, Kumamoto 8608556, Japan.	takakaik@gpo.kumamoto-u.ac.jp	Kobayashi, Akira/AAN-8003-2020; Arimoto, Hirokazu/E-9414-2010; Arimoto, Hirokazu/S-6793-2019; Yamamoto, Masayuki/A-4873-2010	Arimoto, Hirokazu/0000-0002-0086-6117; Arimoto, Hirokazu/0000-0002-0086-6117; Yamamoto, Masayuki/0000-0002-9073-9436; Kobayashi, Akira/0000-0001-9727-1218; Zaki, Hasan/0000-0001-9002-5399				Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Alam MS, 2006, MICROB PATHOGENESIS, V40, P116, DOI 10.1016/j.micpath.2005.11.007; ASHMAN DF, 1963, BIOCHEM BIOPH RES CO, V11, P330, DOI 10.1016/0006-291X(63)90566-7; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1979, J BIOL CHEM, V254, P1205; HARDMAN JG, 1966, J BIOL CHEM, V241, P4812; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Lucas KA, 2000, PHARMACOL REV, V52, P375; Marcondes S, 2006, P NATL ACAD SCI USA, V103, P3434, DOI 10.1073/pnas.0509397103; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Miyamoto Y, 2000, BIOCHEM BIOPH RES CO, V267, P918, DOI 10.1006/bbrc.1999.2046; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Sawa T, 2006, FREE RADICAL BIO MED, V40, P711, DOI 10.1016/j.freeradbiomed.2005.09.035; Sawa T, 2003, BIOCHEM BIOPH RES CO, V311, P300, DOI 10.1016/j.bbrc.2003.10.003; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Terasaki Y, 2006, AM J RESP CRIT CARE, V174, P665, DOI 10.1164/rccm.200510-1580OC; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004	37	190	195	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					727	735		10.1038/nchembio.2007.33	http://dx.doi.org/10.1038/nchembio.2007.33			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17906641				2022-12-25	WOS:000250311500015
J	Dixon, AL; Liang, L; Moffatt, MF; Chen, W; Heath, S; Wong, KCC; Taylor, J; Burnett, E; Gut, I; Farrall, M; Lathrop, GM; Abecasis, GR; Cookson, WOC				Dixon, Anna L.; Liang, Liming; Moffatt, Miriam F.; Chen, Wei; Heath, Simon; Wong, Kenny C. C.; Taylor, Jenny; Burnett, Edward; Gut, Ivo; Farrall, Martin; Lathrop, G. Mark; Abecasis, Goncalo R.; Cookson, William O. C.			A genome-wide association study of global gene expression	NATURE GENETICS			English	Article							NORMALIZATION; VARIANTS; RISK	We have created a global map of the effects of polymorphism on gene expression in 400 children from families recruited through a proband with asthma. We genotyped 408,273 SNPs and identified expression quantitative trait loci from measurements of 54,675 transcripts representing 20,599 genes in Epstein-Barr virus-transformed lymphoblastoid cell lines. We found that 15,084 transcripts (28%) representing 6,660 genes had narrow-sense heritabilities (H-2) > 0.3. We executed genome-wide association scans for these traits and found peak lod scores between 3.68 and 59.1. The most highly heritable traits were markedly enriched in Gene Ontology descriptors for response to unfolded protein (chaperonins and heat shock proteins), regulation of progression through the cell cycle, RNA processing, DNA repair, immune responses and apoptosis. SNPs that regulate expression of these genes are candidates in the study of degenerative diseases, malignancy, infection and inflammation. We have created a downloadable database to facilitate use of our findings in the mapping of complex disease loci.	Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Ctr Stat Genet, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91057 Evry, France; European Collect Cell Cultures, Salisbury SP4 0JG, Wilts, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Universite Paris Saclay	Cookson, WOC (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Chen, Wei/AAX-5994-2020; Taylor, Jennifer M/A-1686-2010; Cookson, William/HHC-1790-2022; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012; Abecasis, Goncalo R/B-7840-2010	Chen, Wei/0000-0001-7196-8703; Taylor, Jennifer M/0000-0003-4231-0181; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; Abecasis, Goncalo/0000-0003-1509-1825	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEATY JS, 1995, MOL CELL BIOL, V15, P4771; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; *BRIT THOR SOC, 2003, THORAX S1, V58, pI1; Cardon LR, 1999, AM J HUM GENET, V65, pA245; CHEN WM, IN PRESS AM J HUM GE; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	26	769	804	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1202	1207		10.1038/ng2109	http://dx.doi.org/10.1038/ng2109			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873877				2022-12-25	WOS:000249737400015
J	Matsuzaka, T; Shimano, H; Yahagi, N; Kato, T; Atsumi, A; Yamamoto, T; Inoue, N; Ishikawa, M; Okada, S; Ishigaki, N; Iwasaki, H; Iwasaki, Y; Karasawa, T; Kumadaki, S; Matsui, T; Sekiya, M; Ohashi, K; Hasty, AH; Nakagawa, Y; Takahashi, A; Suzuki, H; Yatoh, S; Sone, H; Toyoshima, H; Osuga, JI; Yamada, N				Matsuzaka, Takashi; Shimano, Hitoshi; Yahagi, Naoya; Kato, Toyonori; Atsumi, Ayaka; Yamamoto, Takashi; Inoue, Noriyuki; Ishikawa, Mayumi; Okada, Sumiyo; Ishigaki, Naomi; Iwasaki, Hitoshi; Iwasaki, Yuko; Karasawa, Tadayoshi; Kumadaki, Shin; Matsui, Toshiyuki; Sekiya, Motohiro; Ohashi, Ken; Hasty, Alyssa H.; Nakagawa, Yoshimi; Takahashi, Akimitsu; Suzuki, Hiroaki; Yatoh, Sigeru; Sone, Hirohito; Toyoshima, Hideo; Osuga, Jun-ichi; Yamada, Nobuhiro			Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance	NATURE MEDICINE			English	Article							STEAROYL-COA DESATURASE-1; ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEINS; MICE LACKING; TRANSCRIPTION FACTOR; METABOLIC SYNDROME; LIPID-METABOLISM; LIVER-DISEASE; IKK-BETA; SENSITIVITY	Insulin resistance is often associated with obesity and can precipitate type 2 diabetes. To date, most known approaches that improve insulin resistance must be preceded by the amelioration of obesity and hepatosteatosis. Here, we show that this provision is not mandatory; insulin resistance and hyperglycemia are improved by the modification of hepatic fatty acid composition, even in the presence of persistent obesity and hepatosteatosis. Mice deficient for Elovl6, the gene encoding the elongase that catalyzes the conversion of palmitate to stearate, were generated and shown to become obese and develop hepatosteatosis when fed a high- fat diet or mated to leptin- deficient ob/ ob mice. However, they showed marked protection from hyperinsulinemia, hyperglycemia and hyperleptinemia. Amelioration of insulin resistance was associated with restoration of hepatic insulin receptor substrate- 2 and suppression of hepatic protein kinase C e activity resulting in restoration of Akt phosphorylation. Collectively, these data show that hepatic fatty acid composition is a new determinant for insulin sensitivity that acts independently of cellular energy balance and stress. Inhibition of this elongase could be a new therapeutic approach for ameliorating insulin resistance, diabetes and cardiovascular risks, even in the presence of a continuing state of obesity.	Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Tsukuba; University of Tsukuba; University of Tokyo; Vanderbilt University	Shimano, H (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shimano-tky@umin.ac.jp	Sone, Hirohito/ABC-9346-2021; Shimano, Hitoshi/V-1761-2019; Hasty, Alyssa/AAA-2757-2020; Shimano, Hitoshi/AAI-5648-2020; Yahagi, Naoya/D-2360-2014	Sone, Hirohito/0000-0003-1263-2817; Shimano, Hitoshi/0000-0002-5562-5572; Hasty, Alyssa/0000-0001-7302-8045; Yahagi, Naoya/0000-0002-1823-1865; Karasawa, Tadayoshi/0000-0002-6738-2360				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hiraoka-Yamamoto J, 2004, CLIN EXP PHARMACOL P, V31, P107, DOI 10.1111/j.1440-1681.2004.04121.x; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Matsuzaka T, 2002, J LIPID RES, V43, P911; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Neumann-Haefelin C, 2004, DIABETES, V53, P528, DOI 10.2337/diabetes.53.3.528; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	376	395	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1193	1202		10.1038/nm1662	http://dx.doi.org/10.1038/nm1662			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17906635				2022-12-25	WOS:000249980200035
J	Tarpey, PS; Raymond, FL; Nguyen, LS; Rodriguez, J; Hackett, A; Vandeleur, L; Smith, R; Shoubridge, C; Edkins, S; Stevens, C; O'Meara, S; Tofts, C; Barthorpe, S; Buck, G; Cole, J; Halliday, K; Hills, K; Jones, D; Mironenko, T; Perry, J; Varian, J; West, S; Widaa, S; Teague, J; Dicks, E; Butler, A; Menzies, A; Richardson, D; Jenkinson, A; Shepherd, R; Raine, K; Moon, J; Luo, Y; Parnau, J; Bhat, SS; Gardner, A; Corbett, M; Brooks, D; Thomas, P; Parkinson-Lawrence, E; Porteous, ME; Warner, JP; Sanderson, T; Pearson, P; Simensen, RJ; Skinner, C; Hoganson, G; Superneau, D; Wooster, R; Bobrow, M; Turner, G; Stevenson, RE; Schwartz, CE; Futreal, PA; Srivastava, AK; Stratton, MR; Gecz, J				Tarpey, Patrick S.; Raymond, F. Lucy; Nguyen, Lam S.; Rodriguez, Jayson; Hackett, Anna; Vandeleur, Lucianne; Smith, Raffaella; Shoubridge, Cheryl; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Hills, Katy; Jones, David; Mironenko, Tatiana; Perry, Janet; Varian, Jennifer; West, Sofie; Widaa, Sara; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Richardson, David; Jenkinson, Andrew; Shepherd, Rebecca; Raine, Keiran; Moon, Jenny; Luo, Yin; Parnau, Josep; Bhat, Shambhu S.; Gardner, Alison; Corbett, Mark; Brooks, Doug; Thomas, Paul; Parkinson-Lawrence, Emma; Porteous, Mary E.; Warner, John P.; Sanderson, Tracy; Pearson, Pauline; Simensen, Richard J.; Skinner, Cindy; Hoganson, George; Superneau, Duane; Wooster, Richard; Bobrow, Martin; Turner, Gillian; Stevenson, Roger E.; Schwartz, Charles E.; Futreal, P. Andrew; Srivastava, Anand K.; Stratton, Michael R.; Gecz, Jozef			Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation	NATURE GENETICS			English	Article							EXON-JUNCTION COMPLEX; MARFANOID HABITUS; FG SYNDROME; SURVEILLANCE; TRANSLATION; ELEGANS; HUPF3B; GENE; FORM	Nonsense- mediated mRNA decay ( NMD) is of universal biological significance(1-3). It has emerged as an important global RNA, DNA and translation regulatory pathway(4). By systematically sequencing 737 genes ( annotated in the Vertebrate Genome Annotation database) on the human X chromosome in 250 families with X- linked mental retardation, we identified mutations in the UPF3 regulator of nonsense transcripts homolog B ( yeast) ( UPF3B) leading to protein truncations in three families: two with the Lujan- Fryns phenotype5,6 and one with the FG phenotype7. We also identified a missense mutation in another family with nonsyndromic mental retardation. Three mutations lead to the introduction of a premature termination codon and subsequent NMD of mutant UPF3B mRNA. Protein blot analysis using lymphoblastoid cell lines from affected individuals showed an absence of the UPF3B protein in two families. The UPF3B protein is an important component of the NMD surveillance machinery(8,9). Our results directly implicate abnormalities of NMD in human disease and suggest at least partial redundancy of NMD pathways.	Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Cambridge Inst Med Res, Cambridge CB2 2XY, England; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; GOLD Serv, Waratah, NSW 2298, Australia; Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5001, Australia; SE Scotland Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Rockford Mem Hosp, Rockford, IL 61103 USA; Genet Serv Louisiana, Baton Rouge, LA 70884 USA; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ Adelaide, Dept Paediat, Adelaide, SA 5001, Australia	Womens & Childrens Hospital Australia; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Greenwood Genetic Center; University of South Australia; University of Adelaide; University of London; Institute of Cancer Research - UK; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Parkinson-Lawrence, Emma/F-4085-2013; Thomas, Paul Q/K-4497-2012; Brooks, Doug A/K-6714-2012; Corbett, Mark/A-8063-2010; Shoubridge, Cheryl/A-1571-2016; Gecz, Jozef/X-3469-2019	Corbett, Mark/0000-0001-9298-3072; Shoubridge, Cheryl/0000-0002-0157-3084; Gecz, Jozef/0000-0002-7884-6861; Buck, Gemma/0000-0001-5289-1050; Richardson, David/0000-0003-0247-9118; Parkinson-Lawrence, Emma/0000-0002-3845-4847; Nguyen, Lam Son/0000-0002-0114-1222; Raine, Keiran/0000-0002-5634-1539; Brooks, Doug/0000-0001-9098-3626; Jenkinson, Andrew/0000-0002-0703-6984; warner, jonathan peter/0000-0001-5301-675X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; Wellcome Trust [077012] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DeHert M, 1996, AM J MED GENET, V67, P212; FRYNS JP, 1987, AM J MED GENET, V28, P267, DOI 10.1002/ajmg.1320280202; Gecz J, 2000, GENOME RES, V10, P157, DOI 10.1101/gr.10.2.157; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Graham JM, 1998, AM J MED GENET, V80, P145; Kadlec J, 2004, NAT STRUCT MOL BIOL, V11, P330, DOI 10.1038/nsmb741; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; LeBlanc JJ, 2004, J VIROL, V78, P5139, DOI 10.1128/JVI.78.10.5139-5146.2004; LUJAN JE, 1984, AM J MED GENET, V17, P311, DOI 10.1002/ajmg.1320170124; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mitrovich QM, 2005, CURR BIOL, V15, P963, DOI 10.1016/j.cub.2005.04.055; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Van Buggenhout G, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-26; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002	29	180	184	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1127	1133		10.1038/ng2100	http://dx.doi.org/10.1038/ng2100			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704778	Green Accepted			2022-12-25	WOS:000249122400023
J	Buch, S; Schafmayer, C; Volzke, H; Becker, C; Franke, A; von Eller-Eberstein, H; Kluck, C; Bassmann, I; Brosch, M; Lammert, F; Miquel, JF; Nervi, F; Wittig, M; Rosskopf, D; Timm, B; Holl, C; Seeger, M; ElSharawy, A; Lu, T; Egberts, J; Fandrich, F; Folsch, UR; Krawczak, M; Schreiber, S; Nurnberg, P; Tepel, J; Hampe, J				Buch, Stephan; Schafmayer, Clemens; Volzke, Henry; Becker, Christian; Franke, Andre; von Eller-Eberstein, Huberta; Kluck, Christian; Bassmann, Ingelore; Brosch, Mario; Lammert, Frank; Miquel, Juan Francisco; Nervi, Flavio; Wittig, Michael; Rosskopf, Dieter; Timm, Birgit; Holl, Christine; Seeger, Marcus; ElSharawy, Abdou; Lu, Tim; Egberts, Jan; Fandrich, Fred; Folsch, Ulrich R.; Krawczak, Michael; Schreiber, Stefan; Nurnberg, Peter; Tepel, Jurgen; Hampe, Jochen			A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease	NATURE GENETICS			English	Article							GALLBLADDER-DISEASE; MICE; POLYMORPHISMS; ABCG5/ABCG8; SITOSTEROLEMIA; DETERMINANTS; ACCUMULATION; POPULATION; PREVALENCE; STEROLS	With an overall prevalence of 10-20%, gallstone disease (cholelithiasis) represents one of the most frequent and economically relevant health problems of industrialized countries1,2. We performed an association scan of 4500,000 SNPs in 280 individuals with gallstones and 360 controls. A follow-up study of the 235 most significant SNPs in 1,105 affected individuals and 873 controls replicated the disease association of SNP A-1791411 in ABCG8 (allelic P value P-CCA = 4.1 x 10(-9)), which was subsequently attributed to coding variant rs11887534 (D19H). Additional replication was achieved in 728 German (P = 2.8 x 10(-7)) and 167 Chilean subjects (P = 0.02). The overall odds ratio for D19H carriership was 2.2 (95% confidence interval: 1.8-2.6, P = 1.4 x 10(-14)) in the full German sample. Association was stronger in subjects with cholesterol gallstones (odds ratio = 3.3), suggesting that His19 might be associated with a more efficient transport of cholesterol into the bile.	Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; Univ Hosp Greifswald, Inst Community Med, D-17487 Greifswald, Germany; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD German Resource Ctr Genome Res, D-14059 Berlin, Germany; Univ Hosp Bonn, Dept Internal Med 1, D-53105 Bonn, Germany; Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; Univ Greifswald, Inst Pharmacol, D-17487 Greifswald, Germany; Univ Hosp Schleswig Holstein, Inst Med Stat & Informat, D-24105 Kiel, Germany; Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Bonn; Pontificia Universidad Catolica de Chile; Ernst Moritz Arndt Universitat Greifswald; University of Kiel; Schleswig Holstein University Hospital; University of Cologne	Hampe, J (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany.	jhampe@1med.uni-kiel.de	Faendrich, Fred/B-1705-2010; Egberts, Jan-Hendrik/E-3211-2015; Franke, Andre/B-2151-2010; Hampe, Jochen/A-2555-2010; Buch, Stephan/AAV-5028-2021; Elsharawy, Abdou/C-9848-2010; Krawczak, Michael/A-8964-2010	Franke, Andre/0000-0003-1530-5811; Hampe, Jochen/0000-0002-2421-6127; Krawczak, Michael/0000-0003-2603-1502; Brosch, Mario/0000-0001-8983-6557				Acalovschi M, 2006, EUR J INTERN MED, V17, P490, DOI 10.1016/j.ejim.2006.04.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Berge KE, 2002, J LIPID RES, V43, P486; DUBDRIDGE F, 2003, EPIDEMIOLOGY, V25, P115; Duggirala R, 1999, GENET EPIDEMIOL, V16, P191, DOI 10.1002/(SICI)1098-2272(1999)16:2<191::AID-GEPI6>3.0.CO;2-6; Franke A, 2006, HUM MUTAT, V27, P583, DOI 10.1002/humu.20306; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; Hubacek J A, 2001, Hum Mutat, V18, P359, DOI 10.1002/humu.1206; Iida A, 2002, J HUM GENET, V47, P285, DOI 10.1007/s100380200041; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729; KORNER G, 1937, Z MENSCHLICHE VERERB, V20, P528; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert F, 2002, HEPATOLOGY, V36, P1145, DOI 10.1053/jhep.2002.36821; Nakeeb A, 2002, ANN SURG, V235, P842, DOI 10.1097/00000658-200206000-00012; NURNBERG D, 1989, DEUT MED WOCHENSCHR, V114, P1059, DOI 10.1055/s-2008-1066716; Paigen B, 2000, PHYSIOL GENOMICS, V4, P59, DOI 10.1152/physiolgenomics.2000.4.1.59; Puppala S, 2006, AM J HUM GENET, V78, P377, DOI 10.1086/500274; SALEN G, 1992, J LIPID RES, V33, P945; SARIN SK, 1995, HEPATOLOGY, V22, P138; SCHAFMAYER C, IN PRESS LIVER INT; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Schafmayer C, 2006, HEPATOLOGY, V44, P650, DOI 10.1002/hep.21289; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; Wittenburg H, 2005, MAMM GENOME, V16, P495, DOI 10.1007/s00335-005-0006-2; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Wittenburg H, 2002, J CLIN INVEST, V110, P605, DOI 10.1172/JCI200216548	30	243	255	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					995	999		10.1038/ng2101	http://dx.doi.org/10.1038/ng2101			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632509				2022-12-25	WOS:000248446900017
J	Hunter, DJ; Kraft, P; Jacobs, KB; Cox, DG; Yeager, M; Hankinson, SE; Wacholder, S; Wang, ZM; Welch, R; Hutchinson, A; Wang, JW; Yu, K; Chatterjee, N; Orr, N; Willett, WC; Colditz, GA; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Hayes, RB; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, RN; Thomas, G; Chanock, SJ				Hunter, David J.; Kraft, Peter; Jacobs, Kevin B.; Cox, David G.; Yeager, Meredith; Hankinson, Susan E.; Wacholder, Sholom; Wang, Zhaoming; Welch, Robert; Hutchinson, Amy; Wang, Junwen; Yu, Kai; Chatterjee, Nilanjan; Orr, Nick; Willett, Walter C.; Colditz, Graham A.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Hayes, Richard B.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Thomas, Gilles; Chanock, Stephen J.			A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer	NATURE GENETICS			English	Article							LOCI; PREMENOPAUSAL; BRCA1	We conducted a genome- wide association study ( GWAS) of breast cancer by genotyping 528,173 SNPs in 1,145 postmenopausal women of European ancestry with invasive breast cancer and 1,142 controls. We identified four SNPs in intron 2 of FGFR2 ( which encodes a receptor tyrosine kinase and is amplified or overexpressed in some breast cancers) that were highly associated with breast cancer and confirmed this association in 1,776 affected individuals and 2,072 controls from three additional studies. Across the four studies, the association with all four SNPs was highly statistically significant ( P-trend for the most strongly associated SNP ( rs1219648) = 1.1 x 10(-10); population attributable risk = 16%). Four SNPs at other loci most strongly associated with breast cancer in the initial GWAS were not associated in the replication studies. Our summary results from the GWAS are available online in a form that should speed the identification of additional risk loci.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; SAIC Frederick, NCI FCRDC, Frederick, MD 21702 USA; NCI, Pediat Oncol Branch, Canc Res Ctr, NIH,DHHS, Bethesda, MD USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; NCI, Div Canc Prevent, NIH, DHHS, Bethesda, MD 20892 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI 54449 USA; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Marshfield Clinic; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Hunter, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 75 Francis St, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu	Yeager, Meredith/AAA-5322-2020; Cox, David/ABA-7454-2020; Wang, Junwen/D-3700-2011; Colditz, Graham/A-3963-2009; Tucker, Margaret A/B-4297-2015; Wang, Zhaoming/R-5527-2018; Cox, David G/A-2023-2009; Wang, Junwen/C-4432-2009	Wang, Junwen/0000-0002-4432-4707; Colditz, Graham/0000-0002-7307-0291; Wang, Zhaoming/0000-0001-7556-3869; Cox, David G/0000-0002-2152-9259; McCarty, Catherine/0000-0003-1089-0142; Jacobs, Kevin/0000-0002-4657-6473; Cox, David/0000-0003-2047-4687; Hayes, Richard/0000-0002-0918-661X; Edsall, Lee Elizabeth/0000-0002-0326-2829	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [U01 CA098233, U01 CA098710, R01 CA067262, U01 CA049449, R01 CA049449, R01 CA050385, 5U01CA098233, CA87969, U01 CA067262, R01 CA065725, P01 CA087969, CA67262, CA50385, CA49449, CA65725] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049449, U01CA098710, Z01SC010083, U01CA067262, U01CA098233, R01CA050385, R01CA067262, U01CA049449, P01CA087969, R01CA065725] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; CHANOCK SJ, IN PRESS NATURE; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Falush D, 2003, GENETICS, V164, P1567; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stevens VL, 2006, CANCER EPIDEM BIOMAR, V15, P1226, DOI 10.1158/1055-9965.EPI-05-0930; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	23	1172	1225	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					870	874		10.1038/ng2075	http://dx.doi.org/10.1038/ng2075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17529973	Green Accepted			2022-12-25	WOS:000247619800017
J	Radzishevsky, IS; Rotem, S; Bourdetsky, D; Navon-Venezia, S; Carmeli, Y; Mor, A				Radzishevsky, Inna S.; Rotem, Shahar; Bourdetsky, Dmitry; Navon-Venezia, Shiri; Carmeli, Yehuda; Mor, Amram			Improved antimicrobial peptides based on acyl-lysine oligomers	NATURE BIOTECHNOLOGY			English	Article							DERMASEPTIN S4 DERIVATIVES; ANTIBACTERIAL PROPERTIES	We describe peptidomimetic oligomers that show rapid, nonhemolytic, broad-spectrum bactericidal properties in mice and do not induce the emergence of resistance. The oligomers contain acyl chains, which prevent the formation of stable secondary structure. This design appears advantageous over conventional antimicrobial peptides with respect to in vivo efficacy and safety, and may provide a convenient platform for the development of peptide antibiotics.	Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-64239 Tel Aviv, Israel	Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	amor@tx.technion.ac.il		Navon-Venezia, Shiri/0000-0002-4916-110X; Radzishevsky, Inna/0000-0001-7748-7599				Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Marynka K, 2007, CHEM BIOL, V14, P75, DOI 10.1016/j.chembiol.2006.11.009; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Navon-Venezia S, 2002, ANTIMICROB AGENTS CH, V46, P689, DOI 10.1128/AAC.46.3.689-694.2002; Rotem S, 2006, ANTIMICROB AGENTS CH, V50, P2666, DOI 10.1128/AAC.00030-06; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	15	214	224	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					657	659		10.1038/nbt1309	http://dx.doi.org/10.1038/nbt1309			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17529972				2022-12-25	WOS:000247077500021
J	Liang, JY; Shao, SH; Xu, ZX; Hennessy, B; Ding, ZY; Larrea, M; Kondo, S; Dumont, DJ; Gutterman, JU; Walker, CL; Slingerland, JM; Mills, GB				Liang, Jiyong; Shao, Shan H.; Xu, Zhi-Xiang; Hennessy, Bryan; Ding, Zhiyong; Larrea, Michelle; Kondo, Seiji; Dumont, Dan J.; Gutterman, Jordan U.; Walker, Cheryl L.; Slingerland, Joyce M.; Mills, Gordon B.			The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis	NATURE CELL BIOLOGY			English	Article							KINASE INHIBITOR P27(KIP1); PROTEIN-KINASE; CELL-SURVIVAL; CANCER; GROWTH; LOCALIZATION; DOWNSTREAM; STABILITY; RAPAMYCIN; UPSTREAM	Nutrients and bioenergetics are prerequisites for proliferation and survival of mammalian cells(1,2). We present evidence that the cyclin-dependent kinase inhibitor p27(Kip1), is phosphorylated at Thr 198 downstream of the Peutz-Jeghers syndrome protein-AMP-activated protein kinase (LKB1-AMPK) energy-sensing pathway, thereby increasing p27 stability and directly linking sensing of nutrient concentration and bioenergetics to cell-cycle progression. Ectopic expression of wild-type and phosphomimetic Thr 198 to Asp 198 (T198D), but not unstable Thr 198 to Ala 198 (p27(T198A)) is sufficient to induce autophagy. Under stress conditions that activate the LKB1-AMPK pathway with subsequent induction of autophagy, p27 knockdown results in apoptosis. Thus LKB1-AMPK pathway-dependent phosphorylation of p27 at Thr 198 stabilizes p27 and permits cells to survive growth factor withdrawal and metabolic stress through autophagy. This may contribute to tumour-cell survival under conditions of growth factor deprivation, disrupted nutrient and energy metabolism, or during stress of chemotherapy.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Texas, MD Anderson Hosp & Tumor Inst, Dept Carcinogenesis, Smithville, TX 78957 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Miami	Mills, GB (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gmills@mdanderson.org		Hennessy, Bryan/0000-0002-7871-6477	NCI NIH HHS [P30 CA16672, P01CA099031, P01 CA64602, CA63613, P50-CA83639] Funding Source: Medline; NICHD NIH HHS [HD046282] Funding Source: Medline; NIEHS NIH HHS [ES08263] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046282] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA063613, P50CA083639, P30CA016672, P01CA099031, P01CA064602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008263] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Motti ML, 2004, CELL CYCLE, V3, P1074; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	35	695	723	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					218	U125		10.1038/ncb1537	http://dx.doi.org/10.1038/ncb1537			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237771				2022-12-25	WOS:000243903000015
J	Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, DG; Eccles, D; Easton, DF; Stratton, MR				Rahman, Nazneen; Seal, Sheila; Thompson, Deborah; Kelly, Patrick; Renwick, Anthony; Elliott, Anna; Reid, Sarah; Spanova, Katarina; Barfoot, Rita; Chagtai, Tasnim; Jayatilake, Hiran; McGuffog, Lesley; Hanks, Sandra; Evans, D. Gareth; Eccles, Diana; Easton, Douglas F.; Stratton, Michael R.		Breast Canc Susceptibility Collabo	PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene	NATURE GENETICS			English	Article							FANCONI-ANEMIA; HELICASE BRIP1; BRCA2; MUTATIONS	PALB2 interacts with BRCA2, and biallelic mutations in PALB2 ( also known as FANCN), similar to biallelic BRCA2 mutations, cause Fanconi anemia. We identified monoallelic truncating PALB2 mutations in 10/ 923 individuals with familial breast cancer compared with 0/1,084 controls ( P= 0.0004) and show that such mutations confer a 2.3- fold higher risk of breast cancer ( 95% confidence interval (c.i.) 1.4 - 3.9, P =0.0025). The results show that PALB2 is a breast cancer susceptibility gene and further demonstrate the close relationship of the Fanconi anemia - DNA repair pathway and breast cancer predisposition.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Strangeways Res Lab, Cambridge, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YA, Hants, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; University of Cambridge; University of Manchester; Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Evans, D Gareth/AAB-4308-2022; Eccles, Diana/K-6327-2019; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Rahman, Nazneen/0000-0003-4376-0440	Wellcome Trust [077012, 068545/Z/02] Funding Source: Medline; Breast Cancer Now [2005NOV53, 2003:592] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	699	709	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					165	167		10.1038/ng1959	http://dx.doi.org/10.1038/ng1959			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200668	Green Accepted			2022-12-25	WOS:000244063900013
J	Cheung, N; Chan, LC; Thompson, A; Cleary, ML; So, CWE				Cheung, Ngai; Chan, Li Chong; Thompson, Alex; Cleary, Michael L.; So, Chi Wai Eric			Protein arginine-methyltransferase-dependent oncogenesis	NATURE CELL BIOLOGY			English	Article							MYELOID PROGENITORS; TRANSCRIPTIONAL ACTIVATION; HEMATOPOIETIC PROGENITORS; HISTONE H4; IN-VIVO; METHYLATION; MLL; LEUKEMIA; TRANSFORMATION; GENE	Enzymes that mediate reversible epigenetic modifications have not only been recognized as key in regulating gene expression(1) and oncogenesis(2,3), but also provide potential targets for molecular therapy(4). Although the methylation of arginine 3 of histone 4 ( H4R3) by protein arginine methyltransferase 1 ( PRMT1) is a critical modification for active chromatin(5,6) and prevention of heterochromatin spread(7), there has been no direct evidence of any role of PRMTs in cancer. Here, we show that PRMT1 is an essential component of a novel Mixed Lineage Leukaemia ( MLL) oncogenic transcriptional complex with both histone acetylation and H4R3 methylation activities, which also correlate with the expression of critical MLL downstream targets. Direct fusion of MLL with PRMT1 or Sam68, a bridging molecule in the complex for PRMT1 interaction, could enhance self-renewal of primary haematopoietic cells. Conversely, specific knockdown of PRMT1 or Sam68 expression suppressed MLL-mediated transformation. This study not only functionally dissects the oncogenic transcriptional machinery associated with an MLL fusion complex, but also uncovers-for the first time-an essential function of PRMTs in oncogenesis and reveals their potential as novel therapeutic targets in human cancer.	Inst Canc Res, Hematol Oncol Sect, Sutton SM2 5NG, Surrey, England; Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; Queens Univ Belfast, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	University of London; Institute of Cancer Research - UK; University of Hong Kong; Queens University Belfast; Stanford University	So, CWE (corresponding author), Inst Canc Res, Hematol Oncol Sect, Sutton SM2 5NG, Surrey, England.	eric.so@icr.ac.uk		Thompson, Alex/0000-0002-9315-5321	Worldwide Cancer Research [04-0916] Funding Source: Medline	Worldwide Cancer Research		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cheung N, 2004, BIOCHEM J, V383, P27, DOI 10.1042/BJ20040041; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; So CW, 1997, P NATL ACAD SCI USA, V94, P2563, DOI 10.1073/pnas.94.6.2563; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	35	234	258	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1208	1215		10.1038/ncb1642	http://dx.doi.org/10.1038/ncb1642			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891136				2022-12-25	WOS:000249882300017
J	Kebir, H; Kreymborg, K; Ifergan, I; Dodelet-Devillers, A; Cayrol, R; Bernard, M; Giuliani, F; Arbour, N; Becher, B; Prat, A				Kebir, Hania; Kreymborg, Katharina; Ifergan, Igal; Dodelet-Devillers, Aurore; Cayrol, Romain; Bernard, Monique; Giuliani, Fabrizio; Arbour, Nathalie; Becher, Burkhard; Prat, Alexandre			Human T(H)17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; EXPRESSION; MIGRATION; CYTOKINE; IL-17; CELLS; TH1	T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL- 17 and IL- 22 receptors on blood- brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL- 17 and IL- 22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4(+) lymphocyte recruitment.	Univ Montreal, Notre Dame Hosp, Ctr Hosp, Ctr Study Brain Dis,Neuroimmunol Unit, Montreal, PQ H2L 4M1, Canada; Univ Zurich, Dept Neurol, Div Neuroimmunol, CH-8057 Zurich, Switzerland; Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2G3, Canada	Universite de Montreal; University of Zurich; University of Alberta	Prat, A (corresponding author), Univ Montreal, Notre Dame Hosp, Ctr Hosp, Ctr Study Brain Dis,Neuroimmunol Unit, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	a.prat@umontreal.ca	Becher, Burkhard/ABE-4225-2020; Ifergan, Igal/AAI-9734-2020; Ifergan, Igal/AAR-7849-2021	Becher, Burkhard/0000-0002-1541-7867; Ifergan, Igal/0000-0003-2945-2580; Kebir, Hania/0000-0001-6174-8846; Arbour, Nathalie/0000-0002-3718-1584; Prat, Alexandre/0000-0001-6188-0580	Canadian Institutes of Health Research [79785-1] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Biernacki K, 2001, J NEUROPATH EXP NEUR, V60, P1127, DOI 10.1093/jnen/60.12.1127; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Prat A, 2005, J AUTOIMMUN, V24, P119, DOI 10.1016/j.jaut.2005.01.004; RENNO T, 1994, INT IMMUNOL, V6, P347, DOI 10.1093/intimm/6.3.347; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	14	1143	1192	1	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2007	13	10					1173	1175		10.1038/nm1651	http://dx.doi.org/10.1038/nm1651			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17828272	Green Accepted			2022-12-25	WOS:000249980200032
J	Kim, KD; Zhao, J; Auh, S; Yang, XM; Du, PS; Tang, H; Fu, YX				Kim, Kwang Dong; Zhao, Jie; Auh, Sogyong; Yang, Xuanming; Du, Peishuang; Tang, Hong; Fu, Yang-Xin			Adaptive immune cells temper initial innate responses	NATURE MEDICINE			English	Article							DENDRITIC CELLS; ANTIVIRAL IMMUNITY; RECEPTOR; MICE; INFECTION; MATURATION; NECROSIS; SHOCK	Toll- like receptors ( TLRs) recognize conserved microbial structures called pathogen- associated molecular patterns. Signaling from TLRs leads to upregulation of co- stimulatory molecules for better priming of T cells and secretion of inflammatory cytokines by innate immune cells(1-4). Lymphocyte-deficient hosts often die of acute infection, presumably owing to their lack of an adaptive immune response to effectively clear pathogens. However, we show here that an unleashed innate immune response due to the absence of residential T cells can also be a direct cause of death. Viral infection or administration of poly(I:C), a ligand for TLR3, led to cytokine storm in T-cell- or lymphocyte- deficient mice in a fashion dependent on NK cells and tumor necrosis factor. We have further shown, through the depletion of CD4(+) and CD8(+) cells in wild- type mice and the transfer of T lymphocytes into Rag- 1 deficient mice, respectively, that T cells are both necessary and sufficient to temper the early innate response. In addition to the effects of natural regulatory T cells, close contact of resting CD4(+)CD25(-)Foxp3(-) or CD8(+) T cells with innate cells could also suppress the cytokine surge by various innate cells in an antigen- independent fashion. Therefore, adaptive immune cells have an unexpected role in tempering initial innate responses.	Chinese Acad Sci, Ctr Infect & Immun, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chicago	Fu, YX (corresponding author), Chinese Acad Sci, Ctr Infect & Immun, 15 Da Tun Rd, Beijing 100101, Peoples R China.	yfu@uchicago.edu		Yang, Xuanming/0000-0002-3261-8206; fu, yang-xin/0000-0001-8441-6617	NCI NIH HHS [R01 CA115540, R01 CA115540-03, CA115540] Funding Source: Medline; NIAID NIH HHS [R01 AI062026-08, R01 AI062026, R01 AI062026-07, AI062026, R01 AI062026-06] Funding Source: Medline; NIDDK NIH HHS [R01 DK058897-05, R01 DK058897, R01 DK058891, DK58891, R01 DK058897-06, R01 DK058897-07] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07281, T32 GM007281] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA115540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891, R01DK058897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; El-Sawy T, 2004, AM J PATHOL, V165, P147, DOI 10.1016/S0002-9440(10)63283-X; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; Haring J, 2001, CURR OPIN MICROBIOL, V4, P462, DOI 10.1016/S1369-5274(00)00236-8; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; LAVI E, 1984, J VIROL, V51, P563, DOI 10.1128/JVI.51.2.563-566.1984; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035	19	272	288	4	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1248	1252		10.1038/nm1633	http://dx.doi.org/10.1038/nm1633			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17891146	Bronze, Green Published, Green Accepted			2022-12-25	WOS:000249980200042
J	Zhou, WL; Lin, LZ; Majumdar, A; Li, X; Zhang, XX; Liu, W; Etheridge, L; Shi, YQ; Martin, J; Van de Ven, W; Kaartinen, V; Wynshaw-Boris, A; McMahon, AP; Rosenfeld, MG; Evans, SM				Zhou, Wenlai; Lin, Lizhu; Majumdar, Arindam; Li, Xue; Zhang, Xiaoxue; Liu, Wei; Etheridge, Leah; Shi, Yunqing; Martin, James; Van de Ven, Wim; Kaartinen, Vesa; Wynshaw-Boris, Anthony; McMahon, Andrew P.; Rosenfeld, Michael G.; Evans, Sylvia M.			Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGF beta 2	NATURE GENETICS			English	Article							BETA-CATENIN; TRANSFORMING GROWTH-FACTOR-BETA-2; OUTFLOW TRACT; EXPRESSION; HEART; GENE; MOUSE; MICE; ATF-2; PITX2	Transcriptional readout downstream of canonical Wnt signaling is known to be mediated by beta-catenin activation of well-described targets, but potential transcriptional readout in response to noncanonical Wnt signaling remains poorly understood. Here, we define a transcriptional pathway important in noncanonical Wnt signaling. We have found that Wnt11 is a direct target of a canonical beta-catenin pathway in developing heart and that Wnt11 mutants show cardiac outflow tract defects. We provide genetic and biochemical evidence that Wnt11 signaling affects extracellular matrix composition, cytoskeletal rearrangements and polarized cell movement required for morphogenesis of the cardiac outflow tract. Notably, transforming growth factor beta 2 (TGF beta 2), a key effector of organ morphogenesis, is regulated by Wnt11- mediated noncanonical signaling in developing heart and somites via one or more activating transcription factor (ATF)/cyclic AMP response element binding protein ( CREB) family members. Thus, we propose that transcriptional readout mediated at least in part by a Wnt11 -> ATF/CREB -> TGF beta 2 pathway is critical in regulating morphogenesis in response to noncanonical Wnt signaling.	Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Med, La Jolla, CA 92093 USA; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; Texas A&M Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Univ Calif San Diego, Ctr Comprehens Canc, Dept Pediat, La Jolla, CA 92093 USA; Katholieke Univ Leuven, Dept Human Genet, Lab Mol Oncol, B-3000 Louvain, Belgium; Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; KU Leuven; University of Southern California; Harvard University	Evans, SM (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu; syevans@ucsd.edu	Evans, Sylvia/G-1980-2015; McMahon, Andrew P/ABE-7520-2020; Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, R01HL074066, R01HL070867, R01HL066276, DP1HL117649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064744, R01DK054364, R37DK054364, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL066276, HL66276, R01 HL065445, HL74066, DP1 HL117649, HL65445, HL70867, R01 HL070867, R01 HL074066] Funding Source: Medline; NIDDK NIH HHS [DK054364, R01 DK054364, DK18477, DK 064744, R37 DK054364, R01 DK018477, K01 DK064744] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alward WLM, 2000, AM J OPHTHALMOL, V130, P107, DOI 10.1016/S0002-9394(00)00525-0; Bartram U, 2001, CIRCULATION, V103, P2745; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Campione M, 1999, DEVELOPMENT, V126, P1225; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chien KR, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.19892; CHRISTIANSEN JH, 1995, MECH DEVELOP, V51, P341, DOI 10.1016/0925-4773(95)00383-5; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Henderson DJ, 2001, CIRC RES, V89, P6, DOI 10.1161/hh1301.092497; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; JAKOWLEW SB, 1994, DIFFERENTIATION, V55, P105, DOI 10.1046/j.1432-0436.1994.5520105.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kelly RG, 2000, MICROSC RES TECHNIQ, V50, P510, DOI 10.1002/1097-0029(20000915)50:6<510::AID-JEMT8>3.0.CO;2-1; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Li H, 2001, ARCH BIOCHEM BIOPHYS, V394, P1, DOI 10.1006/abbi.2001.2518; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu CY, 2002, DEVELOPMENT, V129, P5081; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moon RT, 2005, SCI STKE; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	50	134	139	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1225	1234		10.1038/ng2112	http://dx.doi.org/10.1038/ng2112			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767158	Green Accepted			2022-12-25	WOS:000249737400018
J	Lundmark, F; Duvefelt, K; Iacobaeus, E; Kockum, I; Wallstrom, E; Khademi, M; Oturai, A; Ryder, LP; Saarela, J; Harbo, HF; Celius, EG; Salter, H; Olsson, T; Hillert, J				Lundmark, Frida; Duvefelt, Kristina; Iacobaeus, Ellen; Kockum, Ingrid; Wallstroem, Erik; Khademi, Mohsen; Oturai, Annette; Ryder, Lars P.; Saarela, Janna; Harbo, Hanne F.; Celius, Elisabeth G.; Salter, Hugh; Olsson, Tomas; Hillert, Jan			Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE; GENE; SUSCEPTIBILITY; DISEASE; POLYMORPHISMS; ASSOCIATIONS; EXPRESSION; LOCUS	Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of multiple sclerosis show autoimmune features and depend partly on genetic factors. Of these genetic factors, only the HLA gene complex has been repeatedly confirmed to be associated with multiple sclerosis, despite considerable efforts. Polymorphisms in a number of non- HLA genes have been reported to be associated with multiple sclerosis, but so far confirmation has been difficult. Here, we report compelling evidence that polymorphisms in IL7R, which encodes the interleukin 7 receptor a chain ( IL7R alpha), indeed contribute to the non- HLA genetic risk in multiple sclerosis, demonstrating a role for this pathway in the pathophysiology of this disease. In addition, we report altered expression of the genes encoding IL7R alpha and its ligand, IL7, in the cerebrospinal fluid compartment of individuals with multiple sclerosis.	Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden; Karolinska Univ Hosp, Clin Res Ctr, Mutat Anal Facil, SE-14186 Huddinge, Sweden; Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, SE-17176 Stockholm, Sweden; Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Oslo, Inst Immunol, N-0027 Oslo, Norway; Ulleval Hosp, Dept Neurol, N-0407 Oslo, Norway; AstraZeneca R&D, Dept Dis Biol, Pharmacogenom Sect, SE-15185 Sodertalje, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Finland National Institute for Health & Welfare; University of Oslo; University of Oslo; AstraZeneca	Hillert, J (corresponding author), Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden.	jan.hillert@ki.se	ryder, lars p/Q-2060-2015; Celius, Elisabeth Gulowsen/S-1387-2019; Saarela, Janna S/E-5369-2014; Kockum, Ingrid/O-8781-2018	ryder, lars p/0000-0002-4744-3496; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Kockum, Ingrid/0000-0002-0867-4726; Saarela, Janna/0000-0002-0853-6219; Khademi, Mohsen/0000-0003-0801-1444; Olsson, Tomas/0000-0002-2938-1877				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OGUA Y, 2001, NATURE, V411, P603; Roxburgh RH, 2006, J NEUROIMMUNOL, V171, P193, DOI 10.1016/j.jneuroim.2005.10.006; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	23	363	374	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1108	1113		10.1038/ng2106	http://dx.doi.org/10.1038/ng2106			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660816				2022-12-25	WOS:000249122400020
J	Attanasio, M; Uhlenhaut, NH; Sousa, VH; O'Toole, JF; Otto, E; Anlag, K; Klugmann, C; Treier, AC; Helou, J; Sayer, JA; Seelow, D; Nurnberg, G; Becker, C; Chudley, AE; Nurnberg, P; Hildebrandt, F; Treier, M				Attanasio, Massimo; Uhlenhaut, N. Henriette; Sousa, Vitor H.; O'Toole, John F.; Otto, Edgar; Anlag, Katrin; Klugmann, Claudia; Treier, Anna-Corina; Helou, Juliana; Sayer, John A.; Seelow, Dominik; Nurnberg, Gudrun; Becker, Christian; Chudley, Albert E.; Nurnberg, Peter; Hildebrandt, Friedhelm; Treier, Mathias			Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLYCYSTIC KIDNEY-DISEASE; TISSUE GROWTH-FACTOR; RENAL FIBROSIS; TRANSCRIPTION FACTOR; CYSTIC-DISEASE; PRIMARY CILIA; TGF-BETA; PROGRESSION; PROTEIN	Nephronophthisis (NPHP), an autosomal recessive kidney disease, is the most frequent genetic cause of end-stage renal failure in the first three decades of life. Positional cloning of the six known NPHP genes1-4 has linked its pathogenesis to primary cilia function3,5. Here we identify mutation of GLIS2 as causing an NPHP-like phenotype in humans and mice, using positional cloning and mouse transgenics, respectively. Kidneys of Glis2 mutant mice show severe renal atrophy and fibrosis starting at 8 weeks of age. Differential gene expression studies on Glis2 mutant kidneys demonstrate that genes promoting epithelial-to-mesenchymal transition and fibrosis are upregulated in the absence of Glis2. Thus, we identify Glis2 as a transcription factor mutated in NPHP and demonstrate its essential role for the maintenance of renal tissue architecture through prevention of apoptosis and fibrosis.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD Deutsches Ressourcenzentrum Genomforsch GmbH, D-14059 Berlin, Germany; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E3P4, Canada; Univ Manitoba, Dept Biochem, Winnipeg, MB R3E3P4, Canada; Univ Manitoba, Dept Med Genet, Winnipeg, MB R3E3P4, Canada; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; European Molecular Biology Laboratory (EMBL); University of Cologne; University of Manitoba; University of Manitoba; University of Manitoba; University of Cologne	Treier, M (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	treier@embl.de	Sousa, Vitor/E-3679-2016; Uhlenhaut, Henriette/AFR-1141-2022; Treier, Mathias/AAD-6388-2021; Seelow, Dominik/HGB-3124-2022; Sayer, John A./AAN-2729-2020; Uhlenhaut, Nina Henriette/C-6288-2014; Uhlenhaut, Henriette/AAP-5400-2020	Sousa, Vitor/0000-0001-8768-2742; Seelow, Dominik/0000-0002-9746-4412; Sayer, John A./0000-0003-1881-3782; Otto, Edgar/0000-0002-2387-9973; Attanasio, Massimo/0000-0002-1278-3650; Uhlenhaut, Henriette/0000-0002-4220-4779	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069274, R01DK068306, K08DK071108, R01DK064614] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK064614, DK068306, DK069274, DK071108] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Louro ID, 2002, CANCER RES, V62, P5867; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8; Zhang M, 2005, NEPHRON EXP NEPHROL, V99, P68, DOI 10.1159/000083414; ZOLLINGER HU, 1980, HELV PAEDIATR ACTA, V35, P509	30	165	168	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1018	1024		10.1038/ng2072	http://dx.doi.org/10.1038/ng2072			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618285				2022-12-25	WOS:000248446900021
J	d'Abbadie, M; Hofreiter, M; Vaisman, A; Loakes, D; Gasparutto, D; Cadet, J; Woodgate, R; Paabo, S; Holliger, P				d'Abbadie, Marc; Hofreiter, Michael; Vaisman, Alexandra; Loakes, David; Gasparutto, Didier; Cadet, Jean; Woodgate, Roger; Paeaebo, Svante; Holliger, Philipp			Molecular breeding of polymerases for amplification of ancient DNA	NATURE BIOTECHNOLOGY			English	Article							COMPARTMENTALIZED SELF-REPLICATION; DIRECTED-EVOLUTION; DEOXYRIBONUCLEIC ACID; NEANDERTHAL DNA; EXTENSION; SEQUENCES; TEMPLATE; PROTEIN; ORIGIN; FAMILY	In the absence of repair, lesions accumulate in DNA. Thus, DNA persisting in specimens of paleontological, archaeological or forensic interest is inevitably damaged(1). We describe a strategy for the recovery of genetic information from damaged DNA. By molecular breeding(2) of polymerase genes from the genus Thermus ( Taq ( Thermus aquaticus), Tth ( Thermus thermophilus) and Tfl ( Thermus flavus)) and compartmentalized self-replication(3,4) selection, we have evolved polymerases that can extend single, double and even quadruple mismatches, process non-canonical primer-template duplexes and bypass lesions found in ancient DNA, such as hydantoins and abasic sites. Applied to the PCR amplification of 47,000-60,000-year-old cave bear DNA, these outperformed Taq DNA polymerase by up to 150% and yielded amplification products at sample dilutions at which Taq did not. Our results demonstrate that engineered polymerases can expand the recovery of genetic information from Pleistocene specimens and may benefit genetic analysis in paleontology, archeology and forensic medicine.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Max Planck Inst Mol Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; NICHHD, NIH, Sect DNA Replicat Repair & Mutagenesis, Bethesda, MD 20892 USA; CEA Grenoble, Commiss Energia Atom, Dept Rech Fondamentale Mat Condensee, Lab Lesions Acides Nucl,SCIB UMR 3,CEA UJF, F-38054 Grenoble 9, France	MRC Laboratory Molecular Biology; Max Planck Society; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ph1@mrc-lmb.cam.ac.uk	Cadet, Jean/M-2971-2018; Vaisman, Alexandra/C-3766-2013; Hofreiter, Michael/A-3996-2017	Cadet, Jean/0000-0003-2594-9485; Vaisman, Alexandra/0000-0002-2521-1467; Woodgate, Roger/0000-0001-5581-4616; Hofreiter, Michael/0000-0003-0441-4705	Intramural NIH HHS Funding Source: Medline; Medical Research Council [U.1051.03.006(78804), MC_U105178804] Funding Source: Medline; MRC [MC_U105178804] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderung C, 2005, P NATL ACAD SCI USA, V102, P8431, DOI 10.1073/pnas.0503396102; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Debbie P, 1997, NUCLEIC ACIDS RES, V25, P4825, DOI 10.1093/nar/25.23.4825; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Geigl EM, 2001, AM J HUM GENET, V68, P287, DOI 10.1086/316948; Ghadessy FJ, 2007, METH MOL B, V352, P237; Ghadessy FJ, 2004, NAT BIOTECHNOL, V22, P755, DOI 10.1038/nbt974; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; Hofreiter M, 2004, CURR BIOL, V14, P40, DOI 10.1016/j.cub.2003.12.035; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; LINDAHL T, 1973, BIOCHEMISTRY-US, V12, P5151, DOI 10.1021/bi00749a020; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; McDonald JP, 2006, NUCLEIC ACIDS RES, V34, P1102, DOI 10.1093/nar/gkj512; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; Ong JL, 2006, J MOL BIOL, V361, P537, DOI 10.1016/j.jmb.2006.06.050; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Suzuki M, 1996, P NATL ACAD SCI USA, V93, P9670, DOI 10.1073/pnas.93.18.9670; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Xia G, 2002, P NATL ACAD SCI USA, V99, P6597, DOI 10.1073/pnas.102577799; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	30	95	108	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					939	943		10.1038/nbt1321	http://dx.doi.org/10.1038/nbt1321			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17632524	Green Accepted			2022-12-25	WOS:000248725800033
J	Connor, KM; SanGiovanni, JP; Lofqvist, C; Aderman, CM; Chen, J; Higuchi, A; Hong, S; Pravda, EA; Majchrzak, S; Carper, D; Hellstrom, A; Kang, JX; Chew, EY; Salem, N; Serhan, CN; Smith, LEH				Connor, Kip M.; SanGiovanni, John Paul; Lofqvist, Chatarina; Aderman, Christopher M.; Chen, Jing; Higuchi, Akiko; Hong, Song; Pravda, Elke A.; Majchrzak, Sharon; Carper, Deborah; Hellstrom, Ann; Kang, Jing X.; Chew, Emily Y.; Salem, Norman, Jr.; Serhan, Charles N.; Smith, Lois E. H.			Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis	NATURE MEDICINE			English	Article							NF-KAPPA-B; DOCOSAHEXAENOIC ACID; ISCHEMIC RETINOPATHY; RESOLVIN E1; IN-VIVO; INFLAMMATION; RECEPTOR; NEOVASCULARIZATION; INHIBITION; PROLIFERATION	Many sight-threatening diseases have two critical phases, vessel loss followed by hypoxia-driven destructive neovascularization. These diseases include retinopathy of prematurity and diabetic retinopathy, leading causes of blindness in childhood and middle age affecting over 4 million people in the United States. We studied the influence of omega-3- and omega-6-polyunsaturated fatty acids (PUFAs) on vascular loss, vascular regrowth after injury, and hypoxia-induced pathological neovascularization in a mouse model of oxygen-induced retinopathy. We show that increasing omega-3-PUFA tissue levels by dietary or genetic means decreased the avascular area of the retina by increasing vessel regrowth after injury, thereby reducing the hypoxic stimulus for neovascularization. The bioactive omega-3-PUFA-derived mediators neuroprotectinD1, resolvinD1 and resolvinE1 also potently protected against neovascularization. The protective effect of omega-3-PUFAs and their bioactive metabolites was mediated, in part, through suppression of tumor necrosis factor-alpha. This inflammatory cytokine was found in a subset of microglia that was closely associated with retinal vessels. These findings indicate that increasing the sources of omega-3-PUFA or their bioactive products reduces pathological angiogenesis. Western diets are often deficient in omega-3-PUFA, and premature infants lack the important transfer from the mother to the infant of omega-3-PUFA that normally occurs in the third trimester of pregnancy. Supplementing omega-3-PUFA intake may be of benefit in preventing retinopathy.	Harvard Univ, Sch Med, Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; NEI, Div Epidemiol & Clin Res, Bethesda, MD 20892 USA; Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, Boston, MA 02115 USA; NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA; NEI, Off Director, Bethesda, MD 20892 USA; Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci, Gothenburg, Sweden; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Gothenburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Gothenburg; Harvard University; Harvard Medical School; Massachusetts General Hospital	Smith, LEH (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	lois.smith@childrens.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020; Yan, Shuo/B-8381-2009; Majchrzak, Sharon/F-1830-2013; SanGiovanni, John Paul/A-7605-2008; Akın, Mustafa Senol/F-5143-2017	Majchrzak, Sharon/0000-0001-8934-7294; Akın, Mustafa Senol/0000-0003-0055-8277; Hellstrom, Ann/0000-0002-9259-1244; Lofqvist, Chatarina/0000-0003-4371-5164; Connor, Kip/0000-0002-2048-9080; SanGiovanni, John Paul/0000-0001-7199-7053	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY017789, R01EY008670, T32EY007145, R01EY017017, R21EY014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R29GM038765, R37GM038765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000235] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 EY999999] Funding Source: Medline; NEI NIH HHS [EY14811, R01 EY008670, EY017017, T32 EY007145, R21 EY014811, 5 T32 EY07145, R01 EY017017, EY008670, 1F32 EY017789, F32 EY017789] Funding Source: Medline; NICHD NIH HHS [P01 HD18655, P30 HD018655] Funding Source: Medline; NIDCR NIH HHS [P50-DE016191, P50 DE016191] Funding Source: Medline; NIGMS NIH HHS [GM38765, R37 GM038765, R01 GM038765] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Fierro IM, 2002, J PHARMACOL EXP THER, V300, P385, DOI 10.1124/jpet.300.2.385; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Grounds MD, 2005, CELL TISSUE RES, V320, P509, DOI 10.1007/s00441-005-1102-z; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Millet I, 2000, J BIOL CHEM, V275, P15114, DOI 10.1074/jbc.275.20.15114; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087-JLR200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211	30	516	556	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					868	873		10.1038/nm1591	http://dx.doi.org/10.1038/nm1591			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17589522	Green Accepted			2022-12-25	WOS:000247902800035
J	Fischbach, MA; Clardy, J				Fischbach, Michael A.; Clardy, Jon			One pathway, many products	NATURE CHEMICAL BIOLOGY			English	Editorial Material							METABOLITES NATURAL-PRODUCTS; GIBBERELLIN BIOSYNTHESIS; EVOLUTION; DIVERSITY; PLANTS; FUNGI; MODEL	Biosynthetic pathways for secondary metabolites usually make many products, not just one. In this Commentary, we consider why molecular promiscuity might be an evolutionarily advantageous feature of these pathways.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu	Jansen, Nils/G-1835-2011	Fischbach, Michael/0000-0003-3079-8247	NCI NIH HHS [CA59021, CA24487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA059021, R01CA024487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brady SF, 2001, J AM CHEM SOC, V123, P9900, DOI 10.1021/ja016176y; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Firn RD, 2006, TRENDS PLANT SCI, V11, P112, DOI 10.1016/j.tplants.2006.01.001; Firn RD, 2003, NAT PROD REP, V20, P382, DOI 10.1039/b208815k; Firn RD, 2000, MOL MICROBIOL, V37, P989, DOI 10.1046/j.1365-2958.2000.02098.x; Hedden P, 2001, J PLANT GROWTH REGUL, V20, P319, DOI 10.1007/s003440010037; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; STONE MJ, 1992, MOL MICROBIOL, V6, P29, DOI 10.1111/j.1365-2958.1992.tb00834.x; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; WILLIAMS DH, 1989, J NAT PROD, V52, P1189, DOI 10.1021/np50066a001; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zhang H, 2003, BIOL PHARM BULL, V26, P642, DOI 10.1248/bpb.26.642	15	136	138	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					353	355		10.1038/nchembio0707-353	http://dx.doi.org/10.1038/nchembio0707-353			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17576415				2022-12-25	WOS:000247462800003
J	Grzeschik, KH; Bornholdt, D; Oeffner, F; Konig, A; Boente, MD; Enders, H; Fritz, B; Hertl, M; Grasshoff, U; Hofling, K; Oji, V; Paradisi, M; Schuchardt, C; Szalai, Z; Tadini, G; Traupe, H; Happle, R				Grzeschik, Karl-Heinz; Bornholdt, Dorothea; Oeffner, Frank; Koenig, Arne; del Carmen Boente, Maria; Enders, Herbert; Fritz, Barbara; Hertl, Michael; Grasshoff, Ute; Hoefling, Katja; Oji, Vinzenz; Paradisi, Mauro; Schuchardt, Christian; Szalai, Zsuzsanna; Tadini, Gianluca; Traupe, Heiko; Happle, Rudolf			Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia	NATURE GENETICS			English	Article							GENE; MUTATIONS	Focal dermal hypoplasia ( FDH) is an X- linked dominant multisystem birth defect affecting tissues of ectodermal and mesodermal origin. Using a stepwise approach of ( i) genetic mapping of FDH, ( ii) high- resolution comparative genome hybridization to seek deletions in candidate chromosome areas and ( iii) point mutation analysis in candidate genes, we identified PORCN, encoding a putative O- acyltransferase and potentially crucial for cellular export of Wnt signaling proteins, as the gene mutated in FDH. The findings implicate FDH as a developmental disorder caused by a deficiency in PORCN.	Univ Marburg, Dept Human Genet, D-35033 Marburg, Germany; Univ Marburg, Dept Dermatol, D-35033 Marburg, Germany; Hosp Nino Jesus, Dept Dermatol, RA-4000 San Miguel De Tucuman, Argentina; Univ Tubingen, Dept Human Genet, D-72076 Tubingen, Germany; Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany; Univ Munster, Dept Dermatol, D-48149 Munster, Germany; Ist Dermopat Immacolata, Div Pediat Dermatol, I-00167 Rome, Italy; Klin Pieper, D-79837 St Blasien Menzenschwand, Germany; Heim Pal Childrens Hosp, Dept Pediat Dermatol, H-1089 Budapest, Hungary; Univ Milan, Ist Sci Dermatol, Ctr Hereditary Skin Dis, I-20122 Milan, Italy	Philipps University Marburg; Philipps University Marburg; Eberhard Karls University of Tubingen; University of Bonn; University of Munster; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Milan	Grzeschik, KH (corresponding author), Univ Marburg, Dept Human Genet, Bahnhofstr 7, D-35033 Marburg, Germany.	grzeschi@staff.uni-marburg.de		Oji, Vinzenz/0000-0003-1380-4828				Behninger C, 2000, GENET COUNSEL, V11, P157; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GORLIN RJ, 2001, OXFORD MONOGRAPHS ME, V42, P571; Hancock S, 2002, AM J MED GENET, V110, P370, DOI 10.1002/ajmg.10456; HAPPLE R, 1977, BRIT J DERMATOL, V96, P133, DOI 10.1111/j.1365-2133.1977.tb12534.x; He X, 2006, DEVELOPMENT, V133, P2597, DOI 10.1242/dev.02452; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380511; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	15	185	199	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					833	835		10.1038/ng2052	http://dx.doi.org/10.1038/ng2052			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546031				2022-12-25	WOS:000247619800011
J	Wang, GG; Cai, L; Pasillas, MP; Kamps, MP				Wang, Gang G.; Cai, Ling; Pasillas, Martina P.; Kamps, Mark P.			NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis	NATURE CELL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW-CELLS; HISTONE METHYLTRANSFERASE; HOMEOBOX GENES; X-CHROMOSOMES; GERM-LINE; C-ELEGANS; MEIS1; TRANSCRIPTION; MLL	Nuclear receptor-binding SET domain protein 1 (NSD1) prototype is a family of mammalian histone methyltransferases ( NSD1, NSD2/MMSET/WHSC1, NSD3/WHSC1L1) that are essential in development and are mutated in human acute myeloid leukemia ( AML) 1,2, overgrowth syndromes(3), multiple myeloma(4) and lung cancers(5). In AML, the recurring t( 5; 11)( q35; p15.5) translocation fuses NSD1 to nucleoporin-98 ( NUP98)(6). Here, we present the first characterization of the transforming properties and molecular mechanisms of NUP98-NSD1. We demonstrate that NUP98-NSD1 induces AML in vivo, sustains self-renewal of myeloid stem cells in vitro, and enforces expression of the HoxA7, HoxA9, HoxA10 and Meis1 proto-oncogenes. Mechanistically, NUP98-NSD1 binds genomic elements adjacent to HoxA7 and HoxA9, maintains histone H3 Lys 36 (H3K36) methylation and histone acetylation, and prevents EZH2-mediated transcriptional repression of the Hox-A locus during differentiation. Deletion of the NUP98 FG-repeat domain, or mutations in NSD1 that inactivate the H3K36 methyltransferase activity or that prevent binding of NUP98-NSD1 to the Hox-A locus precluded both Hox-A gene activation and myeloid progenitor immortalization. We propose that NUP98-NSD1 prevents EZH2-mediated repression of Hox-A locus genes by colocalizing H3K36 methylation and histone acetylation at regulatory DNA elements. This report is the first to link deregulated H3K36 methylation to tumorigenesis and to link NSD1 to transcriptional regulation of the Hox- A locus.	Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kamps, MP (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mkamps@ucsd.edu	Wang, G Greg/L-6666-2014	Wang, G Greg/0000-0002-7210-9940	NATIONAL CANCER INSTITUTE [R01CA056876] Funding Source: NIH RePORTER; NCI NIH HHS [CA56876] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afonja O, 2000, LEUKEMIA RES, V24, P849, DOI 10.1016/S0145-2126(00)00059-X; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; La Starza R, 2004, GENE CHROMOSOME CANC, V41, P395, DOI 10.1002/gcc.20103; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tompa R, 2007, GENETICS, V175, P585, DOI 10.1534/genetics.106.067751; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	35	288	303	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					804	U134		10.1038/ncb1608	http://dx.doi.org/10.1038/ncb1608			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17589499				2022-12-25	WOS:000247760700016
J	Yuan, JP; Zeng, WZ; Huang, GN; Worley, PF; Muallem, S				Yuan, Joseph P.; Zeng, Weizhong; Huang, Guo N.; Worley, Paul F.; Muallem, Shmuel			STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels	NATURE CELL BIOLOGY			English	Article							CA2+ ENTRY; TRANSIENT RECEPTOR; CATION CHANNELS; CRAC CHANNEL; ORAI1; DEPLETION; RELEASE; ACTIVATION; MECHANISM; TERMINUS	Stromal interacting molecule 1 (STIM1) is a Ca2+ sensor that conveys the Ca2+ load of the endoplasmic reticulum to store-operated channels (SOCs) at the plasma membrane. Here, we report that STIM1 binds TRPC1, TRPC4 and TRPC5 and determines their function as SOCs. Inhibition of STIM1 function inhibits activation of TRPC5 by receptor stimulation, but not by La3+, suggesting that STIM1 is obligatory for activation of TRPC channels by agonists, but STIM1 is not essential for channel function. Through a distinct mechanism, STIM1 also regulates TRPC3 and TRPC6. STIM1 does not bind TRPC3 and TRPC6, and regulates their function indirectly by mediating the heteromultimerization of TRPC3 with TRPC1 and TRPC6 with TRPC4. TRPC7 is not regulated by STIM1. We propose a new definition of SOCs, as channels that are regulated by STIM1 and require the store depletion-mediated clustering of STIM1. By this definition, all TRPC channels, except TRPC7, function as SOCs.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Worley, PF (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu			NIDA NIH HHS [R01 DA010309-08, DA00266, R01 DA010309, R01 DA010309-07, P50 DA000266-310015, R37 DA010309, R01 DA010309-09, P50 DA000266-370017, R01 DA010309-06, R01 DA010309-04, P50 DA000266-360017, P50 DA000266, DA10309, R01 DA010309-05] Funding Source: Medline; NIDCR NIH HHS [R01 DE012309-10, R01 DE012309-03, R01 DE012309-11, DE12309, R01 DE012309-05, R01 DE012309-08, R01 DE012309-06, R01 DE012309-07, R01 DE012309-12, R01 DE012309-09, R01 DE012309, R01 DE012309-04] Funding Source: Medline; NIDDK NIH HHS [R01 DK038938-17, R01 DK038938-23, R01 DK038938-18, R01 DK038938-24, R01 DK038938-21, R01 DK038938, DK38938, R01 DK038938-16, R01 DK038938-15, R01 DK038938-14, R01 DK038938-19, R01 DK038938-22, R01 DK038938-20] Funding Source: Medline; NIMH NIH HHS [P50 MH068830-010002, P50 MH068830-040002, P50 MH068830-030002, P50 MH068830-050002, P50 MH068830, MH068830, P50 MH068830-020002] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010309, R01DA010309, P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2006, PHARMACOL THERAPEUT, V112, P744, DOI 10.1016/j.pharmthera.2006.05.013; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Lievremont JP, 2004, AM J PHYSIOL-CELL PH, V287, pC1709, DOI 10.1152/ajpcell.00350.2004; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; LOESSBERG PA, 1991, J BIOL CHEM, V266, P1363; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Vazquez G, 2006, J BIOL CHEM, V281, P25250, DOI 10.1074/jbc.M604994200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	44	398	408	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					636	U38		10.1038/ncb1590	http://dx.doi.org/10.1038/ncb1590			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486119	Green Accepted			2022-12-25	WOS:000246922700008
J	Ravid, T; Hochstrasser, M				Ravid, Tommer; Hochstrasser, Mark			Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue	NATURE CELL BIOLOGY			English	Article							N-TERMINAL UBIQUITINATION; CONJUGATING ENZYME; IN-VIVO; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; QUALITY-CONTROL; ER MEMBRANE; DEGRADATION; RETICULUM; COMPLEX	Cells have quality-control mechanisms to recognize non-native protein structures and either help the proteins fold or promote their degradation(1,2). Ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) work together to assemble polyubiquitin chains on misfolded or misassembled proteins, which are then degraded by the proteasome(3,4). Here, we find that Ubc7, a yeast E2, can itself undergo degradation when its levels exceed that of its binding partner Cue1, a transmembrane protein that tethers Ubc7 to the endoplasmic reticulum(5-6). Unassembled, and thus mislocalized, Ubc7 is targeted to the proteasome by Ufd4, a homologous to E6-AP C-terminus (HECT)-class E3. Ubc7 is autoubiquitinated by a novel mechanism wherein the catalytic cysteine, instead of a lysine residue, provides the polyubiquitin chain acceptor site, and this cysteine-linked chain functions as a degradation signal. The polyubiquitin chain can also be transferred to a lysine side chain, suggesting a mechanism for polyubiquitin chain assembly that precedes substrate modification.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	NIGMS NIH HHS [GM046904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046904, R01GM046904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821	33	130	134	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					422	U109		10.1038/ncb1558	http://dx.doi.org/10.1038/ncb1558			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17310239				2022-12-25	WOS:000245359400013
J	Cox, A; Dunning, AM; Garcia-Closas, M; Balasubramanian, S; Reed, MWR; Pooley, KA; Scollen, S; Baynes, C; Ponder, BAJ; Chanock, S; Lissowska, J; Brinton, L; Peplonska, B; Southey, MC; Hopper, JL; McCredie, MRE; Giles, GG; Fletcher, O; Johnson, N; Silva, ID; Gibson, L; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Torres, D; Hamann, U; Justenhoven, C; Brauch, H; Chang-Claude, J; Kropp, S; Risch, A; Wang-Gohrke, S; Schurmann, P; Bogdanova, N; Dork, T; Fagerholm, R; Aaltonen, K; Blomqvist, C; Nevanlinna, H; Seal, S; Renwick, A; Stratton, MR; Rahman, N; Sangrajrang, S; Hughes, D; Odefrey, F; Brennan, P; Spurdle, AB; Chenevix-Trench, G; Beesley, J; Mannermaa, A; Hartikainen, J; Kataja, V; Kosma, VM; Couch, FJ; Olson, JE; Goode, EL; Broeks, A; Schmidt, MK; Hogervorst, FBL; Van't Veer, LJ; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Wedren, S; Hall, P; Low, YL; Liu, JJ; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Sigurdson, AJ; Stredrick, DL; Alexander, BH; Struewing, JP; Pharoah, PDP; Easton, DF				Cox, Angela; Dunning, Alison M.; Garcia-Closas, Montserrat; Balasubramanian, Sabapathy; Reed, Malcolm W. R.; Pooley, Karen A.; Scollen, Serena; Baynes, Caroline; Ponder, Bruce A. J.; Chanock, Stephen; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Southey, Melissa C.; Hopper, John L.; McCredie, Margaret R. E.; Giles, Graham G.; Fletcher, Olivia; Johnson, Nichola; dos Santos Silva, Isabel; Gibson, Lorna; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Torres, Diana; Hamann, Ute; Justenhoven, Christina; Brauch, Hiltrud; Chang-Claude, Jenny; Kropp, Silke; Risch, Angela; Wang-Gohrke, Shan; Schuermann, Peter; Bogdanova, Natalia; Doerk, Thilo; Fagerholm, Rainer; Aaltonen, Kirsimari; Blomqvist, Carl; Nevanlinna, Heli; Seal, Sheila; Renwick, Anthony; Stratton, Michael R.; Rahman, Nazneen; Sangrajrang, Suleeporn; Hughes, David; Odefrey, Fabrice; Brennan, Paul; Spurdle, Amanda B.; Chenevix-Trench, Georgia; Beesley, Jonathan; Mannermaa, Arto; Hartikainen, Jaana; Kataja, Vesa; Kosma, Veli-Matti; Couch, Fergus J.; Olson, Janet E.; Goode, Ellen L.; Broeks, Annegien; Schmidt, Marjanka K.; Hogervorst, Frans B. L.; Van't Veer, Laura J.; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Wedren, Sara; Hall, Per; Low, Yen-Ling; Liu, Jianjun; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Sigurdson, Alice J.; Stredrick, Denise L.; Alexander, Bruce H.; Struewing, Jeffery P.; Pharoah, Paul D. P.; Easton, Douglas F.		Kathleen Cunningham Fdn Consortium; Breast Canc Assoc Consortium	A common coding variant in CASP8 is associated with breast cancer risk	NATURE GENETICS			English	Article							TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; ATAXIA-TELANGIECTASIA; REDUCED RISK; TGF-BETA; SUSCEPTIBILITY; POLYMORPHISMS; WOMEN; IGFBP3; REGION; LOCUS	The Breast Cancer Association Consortium (BCAC) has been established to conduct combined case-control analyses with augmented statistical power to try to confirm putative genetic associations with breast cancer. We genotyped nine SNPs for which there was some prior evidence of an association with breast cancer: CASP8 D302H (rs1045485), IGFBP3-202 C -> A (rs2854744), SOD2 V16A (rs1799725), TGFB1 L10P (rs1982073), ATM S49C (rs1800054), ADH1B 3' UTR A -> G (rs1042026), CDKN1A S31R (rs1801270), ICAM5 V301I (rs1056538) and NUMA1 A794G (rs3750913). We included data from 9-15 studies, comprising 11,391-18,290 cases and 14,753-22,670 controls. We found evidence of an association with breast cancer for CASP8 D302H (with odds ratios (OR) of 0.89 (95% confidence interval (c.i.): 0.85-0.94) and 0.74 (95% c.i.: 0.62-0.87) for heterozygotes and rare homozygotes, respectively, compared with common homozygotes; P(trend) = 1.1 x 10(-7)) and weaker evidence for TGFB1 L10P (OR = 1.07 (95% c.i.: 1.02-1.13) and 1.16 (95% c.i.: 1.08-1.25), respectively; P(trend) = 2.8 x 10(-5)). These results demonstrate that common breast cancer susceptibility alleles with small effects on risk can be identified, given sufficiently powerful studies.	Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England; Univ Cambridge, Dept Oncol, Cambridge CB2 1TN, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; NCI, Core Genotyping Facil, Ctr Adv Technol, Bethesda, MD 20892 USA; Ctr Canc, PL-02781 Warsaw, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; Univ Melbourne, Melbourne, Vic 3010, Australia; Univ Otago, Dunedin, New Zealand; Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Univ Tubingen, D-72074 Tubingen, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Ulm, D-89069 Ulm, Germany; Hannover Med Sch, Dept Gynecol & Obstet, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00290 Helsinki, Finland; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Natl Canc Inst, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69372 Lyon, France; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Oncol, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FI-70211 Kuopio, Finland; Mayo Clin Coll Med, Rochester, MN 55905 USA; Netherlands Canc Inst, Dept Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol & Mol Pathol, NL-1066 CX Amsterdam, Netherlands; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Ulsan, Coll Med, Dept Surg, Ulsan 680749, South Korea; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Genome Inst Singapore, Singapore 138672, Singapore; CNIO, Spanish Natl Canc Res Ctr, E-28049 Madrid, Spain; NCI, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA	University of Sheffield; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Melbourne; University of Otago; Cancer Council Victoria; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Hannover Medical School; Hannover Medical School; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of London; Institute of Cancer Research - UK; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); QIMR Berghofer Medical Research Institute; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Mayo Clinic; Netherlands Cancer Institute; Netherlands Cancer Institute; Seoul National University (SNU); University of Ulsan; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Cox, A (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.	a.cox@shef.ac.uk	Garcia-Closas, Montserrat/F-3871-2015; Struewing, Jeffery P/I-7502-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Pharoah, Paul/V-6658-2019; Spurdle, Amanda B/A-4978-2011; Noh, Dong-Young/G-5531-2011; Reed, Malcolm Walter/AAG-9219-2020; Gonzalez-Neira, Anna/C-5791-2015; Lissowska, Jolanta/AAH-3252-2020; Liu, Jianjun/AAK-4989-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; balasubramanian, saba prakash/H-2830-2019; Rahman, Nazneen/B-8890-2012; Peplonska, Beata/F-6004-2010; Nordestgaard, Borge Gronne/ABF-1310-2020; Yoo, Keun-Young/J-5548-2012; Brinton, Louise A/G-7486-2015; Dörk, Thilo/J-8620-2012; Schmidt, Marjanka K/G-9058-2011; Hartikainen, Jaana M/E-6256-2015; Ribas-Despuig, Gloria/M-6190-2017; Kang, Dae Hee/E-8631-2012; Bogdanova, Natalia V./Y-2205-2019; Peplonska, Beata/AAO-1265-2020; Risch, Angela/H-2669-2013; Ribas, Gloria/K-3379-2013; Rahman, Nazneen/D-2802-2013	Garcia-Closas, Montserrat/0000-0003-1033-2650; Struewing, Jeffery P/0000-0002-4848-3334; Chenevix-Trench, Georgia/0000-0002-1878-2587; Pharoah, Paul/0000-0001-8494-732X; Spurdle, Amanda B/0000-0003-1337-7897; Reed, Malcolm Walter/0000-0001-7442-2132; Gonzalez-Neira, Anna/0000-0002-5421-2020; Lissowska, Jolanta/0000-0003-2695-5799; Liu, Jianjun/0000-0002-3255-3019; Garcia-Closas, Montserrat/0000-0003-1033-2650; balasubramanian, saba prakash/0000-0001-5953-2843; Brinton, Louise A/0000-0003-3853-8562; Dörk, Thilo/0000-0002-9458-0282; Schmidt, Marjanka K/0000-0002-2228-429X; Hartikainen, Jaana M/0000-0001-8267-1905; Peplonska, Beata/0000-0003-3915-2872; Risch, Angela/0000-0002-8026-5505; Blomqvist, Carl/0000-0003-3041-1938; Nevanlinna, Heli/0000-0002-0916-2976; Bowcock, Anne/0000-0001-8691-9090; Beesley, Jonathan/0000-0003-1942-325X; Ribas, Gloria/0000-0001-6883-4130; Kataja, Vesa/0000-0003-4846-4843; Fletcher, Olivia/0000-0001-9387-7116; Rahman, Nazneen/0000-0003-4376-0440; Scollen, Serena/0000-0002-9311-1337; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Southey, Melissa/0000-0002-6313-9005; Brauch, Hiltrud/0000-0001-7531-2736; Hughes, David John/0000-0003-1668-8770; dos Santos Silva, Isabel/0000-0002-6596-8798; Kang, Daehee/0000-0003-4031-5878; Cox, Angela/0000-0002-5138-1099; Giles, Graham/0000-0003-4946-9099; Dunning, Alison Margaret/0000-0001-6651-7166	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA82267, CA-95-003] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2004NOV49, BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095003, P01CA082267, Z01CP010126, Z01SC010083] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buchholz TA, 2004, CANCER, V100, P1345, DOI 10.1002/cncr.20133; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunning AM, 2003, CANCER RES, V63, P2610; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kammerer S, 2005, P NATL ACAD SCI USA, V102, P2004, DOI 10.1073/pnas.0409806102; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Krippl P, 2003, CANCER LETT, V201, P181, DOI 10.1016/S0304-3835(03)00468-3; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P412; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohrbacher M, 2005, CANCER EPIDEM BIOMAR, V14, P289; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Shin AS, 2005, CANCER EPIDEM BIOMAR, V14, P1567, DOI 10.1158/1055-9965.EPI-05-0078; Stredrick DL, 2006, HUM MUTAT, V27, P538, DOI 10.1002/humu.20323; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	30	429	445	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					352	358		10.1038/ng1981	http://dx.doi.org/10.1038/ng1981			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293864				2022-12-25	WOS:000244480000017
J	Fox, RJ; Davis, SC; Mundorff, EC; Newman, LM; Gavrilovic, V; Ma, SK; Chung, LM; Ching, C; Tam, S; Muley, S; Grate, J; Gruber, J; Whitman, JC; Sheldon, RA; Huisman, GW				Fox, Richard J.; Davis, S. Christopher; Mundorff, Emily C.; Newman, Lisa M.; Gavrilovic, Vesna; Ma, Steven K.; Chung, Loleta M.; Ching, Charlene; Tam, Sarena; Muley, Sheela; Grate, John; Gruber, John; Whitman, John C.; Sheldon, Roger A.; Huisman, Gjalt W.			Improving catalytic function by ProSAR-driven enzyme evolution	NATURE BIOTECHNOLOGY			English	Article							DIRECTED EVOLUTION; HALOALCOHOL DEHALOGENASE; MOLECULAR EVOLUTION; SEARCH ALGORITHM; IN-VITRO; PROTEIN; BIOCATALYSIS; PROGRAM; DESIGN; FAMILY	We describe a directed evolution approach that should find broad application in generating enzymes that meet predefined process-design criteria. It augments recombination-based directed evolution by incorporating a strategy for statistical analysis of protein sequence activity relationships (ProSAR). This combination facilitates mutation-oriented enzyme optimization by permitting the capture of additional information contained in the sequence-activity data. The method thus enables identification of beneficial mutations even in variants with reduced function. We use this hybrid approach to evolve a bacterial halohydrin dehalogenase that improves the volumetric productivity of a cyanation process B4,000-fold. This improvement was required to meet the practical design criteria for a commercially relevant biocatalytic process involved in the synthesis of a cholesterol-lowering drug, atorvastatin (Lipitor), and was obtained by variants that had at least 35 mutations.	Codexis Inc, Redwood City, CA 94063 USA; Delft Univ Technol, Dept Organ Chem, NL-2628 BL Delft, Netherlands	Delft University of Technology	Huisman, GW (corresponding author), Codexis Inc, 200 Penobscot Dr, Redwood City, CA 94063 USA.	gjalt.huisman@codexis.com	Sheldon, Roger Arthur/ADM-3421-2022	Huisman, Gjalt/0000-0003-1955-1120				Bennett K. P., 2003, NATO SCI SERIES, V190, P227; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; de Jong RM, 2003, EMBO J, V22, P4933, DOI 10.1093/emboj/cdg479; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; EROSHKIN AM, 1995, COMPUT APPL BIOSCI, V11, P39; EROSHKIN AM, 1993, COMPUT APPL BIOSCI, V9, P491; Fox R, 2005, J THEOR BIOL, V234, P187, DOI 10.1016/j.jtbi.2004.11.031; Fox R, 2003, PROTEIN ENG, V16, P589, DOI 10.1093/protein/gzg077; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; HELLBERG S, 1986, ACTA CHEM SCAND B, V40, P135, DOI 10.3891/acta.chem.scand.40b-0135; Hibbert EG, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-29; Kauffman S. A., 1993, ORIGINS ORDER; Kubinyi H, 1997, DRUG DISCOV TODAY, V2, P457, DOI 10.1016/S1359-6446(97)01079-9; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Matsuda H, 1999, Method for producing (R)-4-cyano-3-hydroxybutyric acid lower alkyl ester, Patent No. [US 5908953, 5908953]; Mee RP, 1997, J PEPT RES, V49, P89; NAKAMURA T, 1991, BIOCHEM BIOPH RES CO, V180, P124, DOI 10.1016/S0006-291X(05)81264-1; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; SANDBERG WS, 1993, P NATL ACAD SCI USA, V90, P8367, DOI 10.1073/pnas.90.18.8367; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stutzman-Engwall K, 2005, METAB ENG, V7, P27, DOI 10.1016/j.ymben.2004.07.003; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Thayer AM, 2006, CHEM ENG NEWS, V84, P26, DOI 10.1021/cen-v084n033.p026; VANDENWIJNGAARD AJ, 1991, J BACTERIOL, V173, P124, DOI 10.1128/jb.173.1.124-129.1991; Vlieg JETV, 2001, J BACTERIOL, V183, P5058, DOI 10.1128/JB.183.17.5058-5066.2001; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504	34	329	375	14	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					338	344		10.1038/nbt1286	http://dx.doi.org/10.1038/nbt1286			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17322872				2022-12-25	WOS:000244748300026
J	Nathan, C				Nathan, Carl			Aligning pharmaceutical innovation with medical need	NATURE MEDICINE			English	Editorial Material							DRUG DISCOVERY; GLOBAL HEALTH; ANTIBIOTICS; FRAMEWORK; BUSINESS; ACCESS; CANCER		Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, 1300 York Ave, New York, NY 10021 USA.	cnathan@med.cornell.edu						Abramowicz M, 2003, VANDERBILT LAW REV, V56, P115; Barton JH, 2005, JAMA-J AM MED ASSOC, V294, P2075, DOI 10.1001/jama.294.16.2075; Check E, 2006, NATURE, V444, P412, DOI 10.1038/444412b; Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Cuatrecasas P, 2006, J CLIN INVEST, V116, P2837, DOI 10.1172/JCI29999; Danzon Patricia M, 2003, Int J Health Care Finance Econ, V3, P183, DOI 10.1023/A:1025384819575; DUGGER C, 2006, NY TIMES        1201, pA9; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Fox JL, 2006, NAT BIOTECHNOL, V24, P1521, DOI 10.1038/nbt1206-1521; Hubbard T, 2004, PLOS BIOL, V2, P147, DOI 10.1371/journal.pbio.0020052; Katz ML, 2006, NAT BIOTECHNOL, V24, P1529, DOI 10.1038/nbt1206-1529; Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865; KREMER M, 2004, STRONG MED CREATING, P55; LANJOUW J, 2006, INNOVATIONS, V1, P108; Leaf C, 2004, FORTUNE, V149, P76; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Love JP, 2006, B WORLD HEALTH ORGAN, V84, P408; MacCoss M, 2004, SCIENCE, V303, P1810, DOI 10.1126/science.1096800; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Nathan C, 2005, NAT REV DRUG DISCOV, V4, P887, DOI 10.1038/nrd1878; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Outterson Kevin, 2005, Yale J Health Policy Law Ethics, V5, P193; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Pisano GP, 2006, HARVARD BUS REV, V84, P114; Pogge TW, 2005, METAPHILOSOPHY, V36, P182, DOI 10.1111/j.1467-9973.2005.00362.x; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Sporn MB, 2006, NAT CLIN PRACT ONCOL, V3, P364, DOI 10.1038/ncponc0536; Walsh C. T., 2005, TREATING INFECT DIS, P1	32	37	39	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2007	13	3					304	308		10.1038/nm0307-304	http://dx.doi.org/10.1038/nm0307-304			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17342145				2022-12-25	WOS:000244715700042
J	Turner, BM				Turner, Bryan M.			Defining an epigenetic code	NATURE CELL BIOLOGY			English	Article							HISTONE H3; CHROMATIN-STRUCTURE; METHYLATION; ACETYLATION; EXPRESSION; PROTEINS; NUCLEUS; MEMORY	The nucleosome surface is decorated with an array of enzyme-catalysed modifications on histone tails. These modifications have well-defined roles in a variety of ongoing chromatin functions, often by acting as receptors for non-histone proteins, but their longer-term effects are less clear. Here, an attempt is made to define how histone modifications operate as part of a predictive and heritable epigenetic code that specifies patterns of gene expression through differentiation and development.	Univ Birmingham, Sch Med, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Turner, BM (corresponding author), Univ Birmingham, Sch Med, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England.	b.m.turner@bham.ac.uk			Biotechnology and Biological Sciences Research Council [G18987] Funding Source: Medline; Medical Research Council [G0300332] Funding Source: Medline; MRC [G0300332] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barbieri Marcello, 2003, ORGANIC CODES INTRO; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CRICK FHC, 1963, SCIENCE, V139, P461, DOI 10.1126/science.139.3554.461; CRICK FHC, 1963, PROG NUCLEIC ACID RE, V1, P163, DOI 10.1016/S0079-6603(08)60642-X; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gilbert N, 2005, INT REV CYTOL, V242, P283; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	30	267	282	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					2	6		10.1038/ncb0107-2	http://dx.doi.org/10.1038/ncb0107-2			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17199124				2022-12-25	WOS:000243255100002
J	Takahashi, Y; Coppola, D; Matsushita, N; Cualing, HD; Sun, M; Sato, Y; Liang, C; Jung, JU; Cheng, JQ; Mule, JJ; Pledger, WJ; Wang, HG				Takahashi, Yoshinori; Coppola, Domenico; Matsushita, Norimasa; Cualing, Hernani D.; Sun, Mei; Sato, Yuya; Liang, Chengyu; Jung, Jae U.; Cheng, Jin Q.; Mule, James J.; Pledger, W. Jack; Wang, Hong-Gang			Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR; MEMBRANE CURVATURE; MAMMALIAN-CELLS; PROTEIN; DOMAIN; GENE; BCL-2; MACROAUTOPHAGY; MECHANISMS	Autophagy is an evolutionarily conserved 'self-eating' process. Although the genes essential for autophagy ( named Atg) have been identified in yeast, the molecular mechanism of how Atg proteins control autophagosome formation in mammalian cells remains to be elucidated. Here, we demonstrate that Bif-1 ( also known as Endophilin B1) interacts with Beclin 1 through ultraviolet irradiation resistance-associated gene ( UVRAG) and functions as a positive mediator of the class III PI( 3) kinase ( PI( 3) KC3). In response to nutrient deprivation, Bif-1 localizes to autophagosomes where it colocalizes with Atg5, as well as microtubule-associated protein light chain 3 (LC3). Furthermore, loss of Bif-1 suppresses autophagosome formation. Although the SH3 domain of Bif-1 is sufficient for binding to UVRAG, both the BAR and SH3 domains are required for Bif-1 to activate PI( 3) KC3 and induce autophagosome formation. We also observed that Bif-1 ablation prolongs cell survival under starvation conditions. Moreover, knockout of Bif-1 significantly enhances the development of spontaneous tumours in mice. These findings suggest that Bif-1 joins the UVRAG-Beclin 1 complex as a potential activator of autophagy and tumour suppressor.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Harvard Univ, Sch Med, Southborough, MA 01772 USA	H Lee Moffitt Cancer Center & Research Institute; Harvard University	Wang, HG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Hong-Gang.Wang@moffitt.org	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817; LIANG, CHENGYU/0000-0001-6082-2143	NCI NIH HHS [R01 CA082197-08, R01 CA082197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082197] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakrishnan A, 2006, GENE CHROMOSOME CANC, V45, P883, DOI 10.1002/gcc.20352; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KISEN GO, 1993, CARCINOGENESIS, V14, P2501, DOI 10.1093/carcin/14.12.2501; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JW, 2006, PATHOLOGY, V38, P312, DOI 10.1080/00313020600820880; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mathew R, 2007, AUTOPHAGY, V3, P502, DOI 10.4161/auto.4605; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; SCHWARZE PE, 1985, EXP CELL RES, V157, P15, DOI 10.1016/0014-4827(85)90148-X; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Toth S, 2002, CELL TISSUE RES, V309, P409, DOI 10.1007/s00441-001-0506-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	46	669	722	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1142	1151		10.1038/ncb1634	http://dx.doi.org/10.1038/ncb1634			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891140	Green Accepted			2022-12-25	WOS:000249882300009
J	Laflamme, MA; Chen, KY; Naumova, AV; Muskheli, V; Fugate, JA; Dupras, SK; Reinecke, H; Xu, CH; Hassanipour, M; Police, S; O'Sullivan, C; Collins, L; Chen, YH; Minami, E; Gill, EA; Ueno, S; Yuan, C; Gold, J; Murry, CE				Laflamme, Michael A.; Chen, Kent Y.; Naumova, Anna V.; Muskheli, Veronica; Fugate, James A.; Dupras, Sarah K.; Reinecke, Hans; Xu, Chunhui; Hassanipour, Mohammad; Police, Shailaja; O'Sullivan, Chris; Collins, Lila; Chen, Yinhong; Minami, Elina; Gill, Edward A.; Ueno, Shuichi; Yuan, Chun; Gold, Joseph; Murry, Charles E.			Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts	NATURE BIOTECHNOLOGY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; IN-VIVO; CARDIAC MYOGENESIS; CYCLOSPORINE-A; APOPTOSIS; MYOCYTES; DEATH; PROTECTION; CULTURE; GROWTH	Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation of hES cells into cardiomyocytes, insufficient purity of cardiomyocyte preparations and poor survival of hES cell-derived myocytes after transplantation. Seeking to overcome these challenges, we generated highly purified human cardiomyocytes using a readily scalable system for directed differentiation that relies on activin A and BMP4. We then identified a cocktail of pro-survival factors that limits cardiomyocyte death after transplantation. These techniques enabled consistent formation of myocardial grafts in the infarcted rat heart. The engrafted human myocardium attenuated ventricular dilation and preserved regional and global contractile function after myocardial infarction compared with controls receiving noncardiac hES cell derivatives or vehicle. The ability of hES cell derived cardiomyocytes to partially remuscularize myocardial infarcts and attenuate heart failure encourages their study under conditions that closely match human disease.	Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; Univ Washington, Dept Pathol, Seattle, WA 98109 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Radiol, Seattle, WA 98109 USA; Geron Corp, Menlo Pk, CA 94025 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geron Corporation	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, 815 Mercer St, Seattle, WA 98109 USA.	murry@u.washington.edu	Laflamme, Michael/AAV-6791-2021	Laflamme, Michael/0000-0001-5908-880X	NHLBI NIH HHS [R24 HL 064387, T32 HL 07828, R01 HL 061553, P01 HL 03174, R01 HL 084642, K08 HL 080431] Funding Source: Medline; NIBIB NIH HHS [T32 EB 001650] Funding Source: Medline; NIGMS NIH HHS [P20 GM 069983] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, P01HL003174, R24HL064387, R01HL084642, K08HL080431, R01HL061553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069983] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akao M, 2003, CIRC RES, V92, P195, DOI 10.1161/01.RES.0000051862.16691.F9; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Cao GD, 2002, J NEUROSCI, V22, P5423; CONTRERAS JL, 2002, KIDNEY INT S1, V61, P79; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Emgard M, 2003, J NEUROCHEM, V86, P1223, DOI 10.1046/j.1471-4159.2003.01931.x; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gold J, 2005, CIRCULATION, V112, pU62; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Guerette B, 1997, J IMMUNOL, V159, P2522; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mallory GK, 1939, AM HEART J, V18, P647; MEDEVITT TC, 2005, J MOL CELL CARDIOL, V39, P865; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Montolio M, 2005, CELL TRANSPLANT, V14, P59, DOI 10.3727/000000005783983269; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakajima Y, 2002, DEV BIOL, V245, P291, DOI 10.1006/dbio.2002.0637; Nakano M, 2004, PANCREAS, V29, P104, DOI 10.1097/00006676-200408000-00004; Nicklas JA, 2003, J FORENSIC SCI, V48, P936; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001; Reinecke Hans, 2003, Methods Mol Biol, V219, P97; Reiss K, 1997, EXP CELL RES, V235, P198, DOI 10.1006/excr.1997.3669; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; RUMIANTSEV P, 1991, GROWTH HYPERPLASIS; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Skuk D, 2003, J NEUROPATH EXP NEUR, V62, P951, DOI 10.1093/jnen/62.9.951; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; SUGI Y, 1995, DEV BIOL, V168, P567, DOI 10.1006/dbio.1995.1102; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van den Berg A, 2000, INT J CANCER, V86, P548, DOI 10.1002/(SICI)1097-0215(20000515)86:4<548::AID-IJC17>3.0.CO;2-A; WEIER HUG, 1991, CHROMOSOMA, V100, P371, DOI 10.1007/BF00337515; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2006, STEM CELLS DEV, V15, P631, DOI 10.1089/scd.2006.15.631; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194; Zvibel I, 2002, CELL TRANSPLANT, V11, P621, DOI 10.3727/000000002783985404	73	1597	1727	3	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1015	1024		10.1038/nbt1327	http://dx.doi.org/10.1038/nbt1327			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17721512				2022-12-25	WOS:000249444200025
J	Richards, A; van den Maagdenberg, AMJM; Jen, JC; Kavanagh, D; Bertram, P; Spitzer, D; Liszewski, MK; Barilla-LaBarca, ML; Terwindt, GM; Kasai, Y; McLellan, M; Grand, MG; Vanmolkot, KRJ; de Vries, B; Wan, J; Kane, MJ; Mamsa, H; Schafer, R; Stam, AH; Haan, J; Paulus, TVMDJ; Storimans, CW; van Schooneveld, MJ; Oosterhuis, JA; Gschwendter, A; Dichgans, M; Kotschet, KE; Hodgkinson, S; Hardy, TA; Delatycki, MB; Hajj-Ali, RA; Kothari, PH; Nelson, SF; Frants, RR; Baloh, RW; Ferrari, MD; Atkinson, JP				Richards, Anna; van den Maagdenberg, Arn M. J. M.; Jen, Joanna C.; Kavanagh, David; Bertram, Paula; Spitzer, Dirk; Liszewski, M. Kathryn; Barilla-LaBarca, Maria-Louise; Terwindt, Gisela M.; Kasai, Yumi; McLellan, Mike; Grand, Mark Gilbert; Vanmolkot, Kaate R. J.; de Vries, Boukje; Wan, Jijun; Kane, Michael J.; Mamsa, Hafsa; Schaefer, Ruth; Stam, Anine H.; Haan, Joost; Paulus, T. V. M. de Jong; Storimans, Caroline W.; van Schooneveld, Mary J.; Oosterhuis, Jendo A.; Gschwendter, Andreas; Dichgans, Martin; Kotschet, Katya E.; Hodgkinson, Suzanne; Hardy, Todd A.; Delatycki, Martin B.; Hajj-Ali, Rula A.; Kothari, Parul H.; Nelson, Stanley F.; Frants, Rune R.; Baloh, Robert W.; Ferrari, Michel D.; Atkinson, John P.			C-terminal truncations in human 3 '-5 ' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy	NATURE GENETICS			English	Article							CEREBRORETINAL VASCULOPATHY; HEREDITARY ENDOTHELIOPATHY; VASCULAR RETINOPATHY; NEPHROPATHY	Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle- age onset. In nine families, we identified heterozygous C- terminal frameshift mutations in TREX1, which encodes a 3'-5' exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.	Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; N Shore Long Isl Jewish Hlth Syst, Dept Med, Div Rheumatol, Manhasset, NY 11030 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA; Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1000 GC Amsterdam, Netherlands; Acad Med Ctr, Dept Ophthalmol, NL-1100 DD Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Meander Med Ctr, NL-3800 BM Amersfoort, Netherlands; Univ Med Ctr, Dept Ophthalmol, NL-3508 GA Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2300 RC Leiden, Netherlands; Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia; Liverpool Hosp, Dept Neurol, Liverpool, NSW 2170, Australia; Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia; Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; Northwell Health; Washington University (WUSTL); Washington University (WUSTL); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munich; Monash University; Liverpool Hospital; Concord Repatriation General Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Cleveland Clinic Foundation; University of California System; University of California Los Angeles	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	jatkinso@im.wustl.edu	Barillla-LaBarca, Maria Louise/AAR-9207-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Dichgans, Martin/HCH-3247-2022; Richards, Anna/E-8337-2013; Nelson, Stanley F/D-4771-2009; Ferrari, Michel D./ABE-3758-2021; Delatycki, Martin B/A-5409-2013; Kavanagh, David/E-8498-2011	Dichgans, Martin/0000-0002-0654-387X; Nelson, Stanley F/0000-0002-2082-3114; Ferrari, Michel D./0000-0001-9691-9449; Kavanagh, David/0000-0003-4718-0072; MCLELLAN, MICHAEL/0000-0002-2703-8784; Atkinson, John/0000-0002-2514-3441; Hardy, Todd/0000-0003-4145-3172; Schafer, Ruth Christine/0000-0002-4324-1854; Hodgkinson, Suzanne/0000-0002-9029-6663	NATIONAL EYE INSTITUTE [R01EY015311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002952] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY15311] Funding Source: Medline; NIDCD NIH HHS [P50 DC02952] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohn AC, 2005, CLIN EXP OPHTHALMOL, V33, P181, DOI 10.1111/j.1442-9071.2005.00976.x; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; GRAND MG, 1988, OPHTHALMOLOGY, V95, P649, DOI 10.1016/s0161-6420(88)33131-3; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Storimans C W, 1991, Eur J Ophthalmol, V1, P73; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; Weil S, 1999, NEUROLOGY, V53, P629, DOI 10.1212/WNL.53.3.629	15	279	296	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1068	1070		10.1038/ng2082	http://dx.doi.org/10.1038/ng2082			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660820				2022-12-25	WOS:000249122400014
J	Kuhn, B; del Monte, F; Hajjar, RJ; Chang, YS; Lebeche, D; Arab, S; Keating, MT				Kuhn, Bernhard; del Monte, Federica; Hajjar, Roger J.; Chang, Yuh-Shin; Lebeche, Djamel; Arab, Shima; Keating, Mark T.			Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair	NATURE MEDICINE			English	Article							MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; DNA-SYNTHESIS; HEART; KINASE; GROWTH; BINUCLEATION; INHIBITION; PROTEIN	Adult mammalian hearts respond to injury with scar formation and not with cardiomyocyte proliferation, the cellular basis of regeneration. Although cardiogenic progenitor cells may maintain myocardial turnover, they do not give rise to a robust regenerative response. Here we show that extracellular periostin induced reentry of differentiated mammalian cardiomyocytes into the cell cycle. Periostin stimulated mononucleated cardiomyocytes to go through the full mitotic cell cycle. Periostin activated alpha(V), beta(1), beta(3) and beta(5) integrins located in the cardiomyocyte cell membrane. Activation of phosphatidylinositol-3-OH kinase was required for periostin-induced reentry of cardiomyocytes into the cell cycle and was sufficient for cell-cycle reentry in the absence of periostin. After myocardial infarction, periostin-induced cardiomyocyte cell-cycle reentry and mitosis were associated with improved ventricular remodeling and myocardial function, reduced fibrosis and infarct size, and increased angiogenesis. Thus, periostin and the pathway that it regulates may provide a target for innovative strategies to treat heart failure.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kuhn, B (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	bernhard.kuhn@cardio.chboston.org; mark.keating@novartis.com	del Monte, Federica/AAB-3982-2019; del Monte, Federica/AAF-3961-2020	del Monte, Federica/0000-0001-9506-9665	NHLBI NIH HHS [HL080498, R01 HL078691, K08 HL085143, HL071763, HL057263, K01 HL076659, HL083156, K08 HL069842] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057263, R01HL078691, R01HL083156, R01HL080498, R01HL071763, K08HL069842, R29HL057263, K01HL076659] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Gilbert ME, 2005, TOXICOL SCI, V86, P365, DOI 10.1093/toxsci/kfi156; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; KATZ EB, 1992, AM J PHYSIOL, V262, pH1867, DOI 10.1152/ajpheart.1992.262.6.H1867; KATZBERG AA, 1977, AM J ANAT, V149, P489, DOI 10.1002/aja.1001490406; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lebeche D, 2001, J RENIN-ANGIO-ALDO S, V2, pS154, DOI 10.1177/14703203010020012701; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Litvin J, 2006, CARDIOVASC PATHOL, V15, P24, DOI 10.1016/j.carpath.2005.09.001; Litvin J, 2005, ANAT REC PART A, V287A, P1205, DOI 10.1002/ar.a.20237; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Ma HL, 2004, AM J PHYSIOL-CELL PH, V286, pC556, DOI 10.1152/ajpcell.00328.2003; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Prunier F, 2007, AM J PHYSIOL-HEART C, V292, pH522, DOI 10.1152/ajpheart.00357.2006; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Sun M, 2003, CIRCULATION, V107, P1046, DOI 10.1161/01.CIR.0000051363.86009.3C; Tai IT, 2005, CARCINOGENESIS, V26, P908, DOI 10.1093/carcin/bgi034; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tatsuka M, 1998, CANCER RES, V58, P4811; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455; Yoshioka N, 2002, EXP CELL RES, V279, P91, DOI 10.1006/excr.2002.5590; ZarainHerzberg A, 1996, MOL CELL BIOCHEM, V164, P285, DOI 10.1007/BF00408669	48	492	528	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					962	969		10.1038/nm1619	http://dx.doi.org/10.1038/nm1619			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17632525				2022-12-25	WOS:000248674600027
J	Wang, XL; Sutton, VR; Peraza-Llanes, JO; Yu, ZY; Rosetta, R; Kou, YC; Eble, TN; Patel, A; Thaller, C; Fang, P; Van den Veyver, IB				Wang, Xiaoling; Sutton, V. Reid; Peraza-Llanes, J. Omar; Yu, Zhiyin; Rosetta, Rebecca; Kou, Ying-Chuck; Eble, Tanya N.; Patel, Ankita; Thaller, Christina; Fang, Ping; Van den Veyver, Ignatia B.			Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia	NATURE GENETICS			English	Article							DOMINANT CHONDRODYSPLASIA PUNCTATA; PORCUPINE; GENE; INACTIVATION; DISORDERS; FAMILY	Focal dermal hypoplasia is an X- linked dominant disorder characterized by patchy hypoplastic skin and digital, ocular and dental malformations. We used array comparative genomic hybridization to identify a 219- kb deletion in Xp11.23 in two affected females. We sequenced genes in this region and found heterozygous and mosaic mutations in PORCN in other affected females and males, respectively. PORCN encodes the human homolog of Drosophila melanogaster porcupine, an endoplasmic reticulum protein involved in secretion of Wnt proteins.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; IMSS, Dept Pediat, Merida 97109, Mexico; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	iveyver@bcm.edu	Patel, Ankita/D-3247-2013; Van den Veyver, Ignatia B/AAF-4510-2021	Van den Veyver, Ignatia B/0000-0002-0651-5924	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD051805] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064, HD051805] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Froyen G, 2007, HUM GENET, V121, P539, DOI 10.1007/s00439-007-0343-1; GOLTZ RW, 1992, ARCH DERMATOL, V128, P1108; GORSKI JL, 1991, AM J MED GENET, V40, P332, DOI 10.1002/ajmg.1320400317; HALL EH, 1983, J AM ACAD DERMATOL, V9, P443, DOI 10.1016/S0190-9622(83)70157-X; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Shirahama S, 2003, HUM GENET, V112, P78, DOI 10.1007/s00439-002-0844-x; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; TSUJI T, 1982, J CUTAN PATHOL, V9, P271, DOI 10.1111/j.1600-0560.1982.tb01063.x; Van den Veyver IB, 2002, CYTOGENET GENOME RES, V99, P289, DOI 10.1159/000071606; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	15	180	224	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					836	838		10.1038/ng2057	http://dx.doi.org/10.1038/ng2057			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546030				2022-12-25	WOS:000247619800012
J	Dupuy, D; Bertin, N; Hidalgo, CA; Venkatesan, K; Tu, D; Lee, D; Rosenberg, J; Svrzikapa, N; Blanc, A; Carnec, A; Carvunis, AR; Pulak, R; Shingles, J; Reece-Hoyes, J; Hunt-Newbury, R; Viveiros, R; Mohler, WA; Tasan, M; Roth, FP; Le Peuch, C; Hope, IA; Johnsen, R; Moerman, DG; Barabasi, AL; Baillie, D; Vidal, M				Dupuy, Denis; Bertin, Nicolas; Hidalgo, Cesar A.; Venkatesan, Kavitha; Tu, Domena; Lee, David; Rosenberg, Jennifer; Svrzikapa, Nenad; Blanc, Aurelie; Carnec, Alain; Carvunis, Anne-Ruxandra; Pulak, Rock; Shingles, Jane; Reece-Hoyes, John; Hunt-Newbury, Rebecca; Viveiros, Ryan; Mohler, William A.; Tasan, Murat; Roth, Frederick P.; Le Peuch, Christian; Hope, Ian A.; Johnsen, Robert; Moerman, Donald G.; Barabasi, Albert-Laszlo; Baillie, David; Vidal, Marc			Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC CELL LINEAGES; C-ELEGANS; GENE-EXPRESSION; UNC-52 TRANSCRIPTS; NETWORK; PROTEIN; RNA; NEMATODE; HERMAPHRODITE; MAP	Differential regulation of gene expression is essential for cell fate specification in metazoans. Characterizing the transcriptional activity of gene promoters, in time and in space, is therefore a critical step toward understanding complex biological systems. Here we present an in vivo spatiotemporal analysis for similar to B900 predicted C. elegans promoters (similar to 5% of the predicted protein-coding genes), each driving the expression of green fluorescent protein (GFP). Using a flow-cytometer adapted for nematode profiling, we generated 'chronograms', two-dimensional representations of fluorescence intensity along the body axis and throughout development from early larvae to adults. Automated comparison and clustering of the obtained in vivo expression patterns show that genes coexpressed in space and time tend to belong to common functional categories. Moreover, integration of this data set with C. elegans protein-protein interactome data sets enables prediction of anatomical and temporal interaction territories between protein partners.	Harvard Univ, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; CNRS, Ctr Rech Biochim Macromol, FRE 2593, F-34293 Montpellier 5, France; Univ Notre Dame, Dept Phys, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Union Biometr, Holliston, MA 01746 USA; Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; Harvard Univ, Sch Med, Ctr Canc Syst Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Notre Dame; Simon Fraser University; University of Leeds; University of British Columbia; University of Connecticut; University of Connecticut; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Vidal, M (corresponding author), Harvard Univ, Sch Med, Ctr Canc Syst Biol, 44 Binney St, Boston, MA 02115 USA.	alb@nd.edu; baillie@sfu.ca; marc_vidal@dfci.harvard.edu	Dupuy, Denis/M-7299-2014; Bertin, Nicolas/O-9602-2019; Roth, Frederick P/H-6308-2011; Barabasi, Albert-Laszlo/S-6474-2017; Reece-Hoyes, John/B-2321-2008; Hope, Ian/M-4186-2018; Hidalgo, Cesar A./B-5155-2009; Bertin, Nicolas/C-3025-2008	Hope, Ian/0000-0002-8990-3163; Hidalgo, Cesar A./0000-0002-6977-9492; Reece-Hoyes, John/0000-0001-5251-5813; SVRZIKAPA, NENAD/0000-0003-2065-1794; Roth, Frederick/0000-0002-6628-649X; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Dupuy, Denis/0000-0002-4781-5595; Bertin, Nicolas/0000-0002-9835-9606; /0000-0002-6031-5982; Barabasi, Albert/0000-0002-4028-3522	NATIONAL CANCER INSTITUTE [R33CA097516] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224, F32HG004098] Funding Source: NIH RePORTER; NCI NIH HHS [4 R33 CA097516-02, 1 P20 CA11300-01] Funding Source: Medline; NHGRI NIH HHS [HG003224, HG004098] Funding Source: Medline; NICHD NIH HHS [HD43156] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fujita M, 2003, DEV BIOL, V256, P290, DOI 10.1016/S0012-1606(03)00040-X; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Inoue T, 2005, P NATL ACAD SCI USA, V102, P4972, DOI 10.1073/pnas.0408122102; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim S, 2000, SCIENCE, V288, P150, DOI 10.1126/science.288.5463.150; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kostic I, 2002, DEVELOPMENT, V129, P2155; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Loria PM, 2003, CURR BIOL, V13, P1317, DOI 10.1016/S0960-9822(03)00532-3; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Spike CA, 2002, DEVELOPMENT, V129, P4999; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; Toms N, 2001, BMC Dev Biol, V1, P2, DOI 10.1186/1471-213X-1-2; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5	42	243	250	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					663	668		10.1038/nbt1305	http://dx.doi.org/10.1038/nbt1305			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17486083				2022-12-25	WOS:000247077500023
J	Draviam, VM; Stegmeier, F; Nalepa, G; Sowa, ME; Chen, J; Liang, A; Hannon, GJ; Sorger, PK; Harper, JW; Elledge, SJ				Draviam, Viji M.; Stegmeier, Frank; Nalepa, Grzegorz; Sowa, Mathew E.; Chen, Jing; Liang, Anthony; Hannon, Gregory J.; Sorger, Peter K.; Harper, J. Wade; Elledge, Stephen J.			A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling	NATURE CELL BIOLOGY			English	Article							KINETOCHORE LOCALIZATION; CHROMOSOME CONGRESSION; MAMMALIAN-CELLS; PROTEIN-KINASE; CENP-E; MAD2; MITOSIS; BUB1; P38; ACTIVATION	Defects in chromosome-microtubule attachment trigger spindle-checkpoint activation and delay mitotic progression(1,2). How microtubule attachment is sensed and integrated into the steps of checkpoint-signal amplification is poorly understood. In a functional genomic screen targeting human kinases and phosphatases, we identified a microtubule affinity-regulating kinase kinase, TAO1 (also known as MARKK) as an important regulator of mitotic progression, required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 interacts with the checkpoint kinase BubR1 and promotes enrichment of the checkpoint protein Mad2 at sites of defective attachment, providing evidence for a regulatory step that precedes the proposed Mad2-Mad1 dependent checkpoint- signal amplification step(3). We propose that the dual functions of TAO1 in regulating microtubule dynamics and checkpoint signalling may help to coordinate the establishment and monitoring of correct congression of chromosomes, thereby protecting genomic stability in human cells.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Partners Ctr Genet & Genom, Dept Genet,Howard Hughes Med Inst, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Partners Healthcare System; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019	Lab, Nalepa/0000-0002-7560-1906; Harper, Jeffrey/0000-0002-6944-7236; Draviam, Viji/0000-0001-8295-3689; Sorger, Peter/0000-0002-3364-1838; Nalepa, Grzegorz/0000-0002-5779-9103	NCI NIH HHS [CA78048] Funding Source: Medline; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	31	79	83	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					556	U136		10.1038/ncb1569	http://dx.doi.org/10.1038/ncb1569			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417629				2022-12-25	WOS:000246181500014
J	Chuck, G; Cigan, AM; Saeteurn, K; Hake, S				Chuck, George; Cigan, A. Mark; Saeteurn, Koy; Hake, Sarah			The heterochronic maize mutant Corngrass1 results from overexpression of a tandem microRNA	NATURE GENETICS			English	Article							PHASE-CHANGE; GLOSSY15; MUTATIONS; SHOOT; MORPHOGENESIS; EXPRESSION; IDENTITY; PROTEIN; GENE	Retention of juvenile traits in the adult reproductive phase characterizes a process known as neoteny, and speculation exists over whether it has contributed to the evolution of new species. The dominant Corngrass1 (Cg1) mutant of maize is a neotenic mutation that results in phenotypes that may be present in the grass-like ancestors of maize. We cloned Cg1 and found that it encodes two tandem miR156 genes that are overexpressed in the meristem and lateral organs. Furthermore, a target of Cg1 is teosinte glume architecture1 (tga1) 1, a gene known to have had a role in the domestication of maize from teosinte. Cg1 mutant plants overexpressing miR156 have lower levels of mir172, a microRNA that targets genes controlling juvenile development(2). By altering the relative levels of both microRNAs, it is possible to either prolong or shorten juvenile development in maize, thus providing a mechanism for how species-level heterochronic changes can occur in nature.	Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Chuck, G (corresponding author), Plant Gene Express Ctr, 800 Buchanan St, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu						Allsopp A., 1965, DIFFERENTIATION DEV, P1236; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Cigan AM, 2001, SEX PLANT REPROD, V14, P135, DOI 10.1007/s004970100099; DOEBLEY J, 1991, GENETICS, V129, P285; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; GALINAT WC, 1954, AM J BOT, V41, P803, DOI 10.2307/2438545; GALINAT WC, 1954, AM NAT, V88, P101, DOI 10.1086/281815; Goldschmidt R.B., 1940, MAT BASIS EVOLUTION, P436; GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson DP, 1991, MOL PLANT PATHOL, P163; KELLOGG EA, 2000, P 2 INT C COMP BIOL, V2; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; POETHIG RS, 1988, GENETICS, V119, P959; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SINGLETON WR, 1951, AM NAT, V85, P81, DOI 10.1086/281656; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; TAKHTAJAN A, 1976, NEOTENY ORIGIN FLOW, P207; Unger E, 2002, TRANSGENIC RES, V11, P455, DOI 10.1023/A:1020350208095; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WHALEY W. GORDON, 1950, BULL TORREY BOT CLUB, V77, P274, DOI 10.2307/2481899	30	446	490	3	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					544	549		10.1038/ng2001	http://dx.doi.org/10.1038/ng2001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369828				2022-12-25	WOS:000245271200027
J	Gareus, R; Huth, M; Breiden, B; Nenci, A; Rosch, N; Haase, I; Bloch, W; Sandhoff, K; Pasparakis, M				Gareus, Ralph; Huth, Marion; Breiden, Bernadette; Nenci, Arianna; Rosch, Nora; Haase, Ingo; Bloch, Wilhelm; Sandhoff, Konrad; Pasparakis, Manolis			Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation	NATURE CELL BIOLOGY			English	Article							KAPPA-B KINASE; MICE LACKING; ALPHA; MORPHOGENESIS; EXPRESSION; MUTANT; MOUSE; LIMB; GENE; PROLIFERATION	The kinase IKK1 (also known as IKK alpha) was previously reported to regulate epidermal development and skeletal morphogenesis by acting in keratinocytes to induce their differentiation in an NF-kappa B independent manner(1-5). Here, we show that mice with epidermal keratinocyte-specific IKK1 ablation (hereafter referred to as IKK1(EKO)) develop a normally differentiated stratified epidermis, demonstrating that the function of IKK1 in inducing epidermal differentiation is not keratinocyte-autonomous. Despite normal epidermal stratification, the IKK1(EKO) mice display impaired epidermal-barrier function and increased transepidermal water loss, due to defects in stratum corneum lipid composition and in epidermal tight junctions. These defects are caused by the deregulation of retinoic acid target genes, encoding key lipid modifying enzymes and tight junction proteins, in the IKK1-deficient epidermis. Furthermore, we show that IKK1-deficient cells display impaired retinoic acid-induced gene transcription, and that IKK1 is recruited to the promoters of retinoic acid-regulated genes, suggesting that one mechanism by which IKK1 controls epidermal-barrier formation is by regulating the expression of retinoic acid receptor target genes in keratinocytes.	Univ Cologne, Inst Genet, Dept Mouse Genet & Inflammat, D-50674 Cologne, Germany; MBL Mouse Biol Unit, I-00016 Monterotondo, Italy; Univ Bonn, LIMES, Membrane Biol & Lipid Biochem Unit, CO Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; German Sport Univ Cologne, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany	University of Cologne; University of Bonn; University of Cologne; German Sport University Cologne	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Inflammat, Zulpicher Str 47, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109; Pasparakis, Manolis/0000-0002-9870-0966				Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Attar PS, 1997, MOL ENDOCRINOL, V11, P792, DOI 10.1210/me.11.6.792; Bouwstra J A, 1998, J Investig Dermatol Symp Proc, V3, P69; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Elias PM, 2001, J CELL BIOL, V153, P243, DOI 10.1083/jcb.153.2.243; Fisher C, 2000, TRENDS GENET, V16, P482, DOI 10.1016/S0168-9525(00)02121-1; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GIGUERE V, 1990, P NATL ACAD SCI USA, V87, P6233, DOI 10.1073/pnas.87.16.6233; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Hughes PJ, 2001, BIOCHEM J, V355, P361, DOI 10.1042/0264-6021:3550361; Humphries JD, 1998, BRIT J DERMATOL, V139, P577; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Reichelt J, 2004, EUR J CELL BIOL, V83, P747, DOI 10.1078/0171-9335-00429; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Weninger W, 1998, J INVEST DERMATOL, V111, P907, DOI 10.1046/j.1523-1747.1998.00393.x; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zettersten E, 1998, J INVEST DERMATOL, V111, P784, DOI 10.1046/j.1523-1747.1998.00386.x	35	69	71	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					461	U185		10.1038/ncb1560	http://dx.doi.org/10.1038/ncb1560			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351639				2022-12-25	WOS:000245359400018
J	Janowski, BA; Younger, ST; Hardy, DB; Ram, R; Huffman, KE; Corey, DR				Janowski, Bethany A.; Younger, Scott T.; Hardy, Daniel B.; Ram, Rosalyn; Huffman, Kenneth E.; Corey, David R.			Activating gene expression in mammalian cells with promoter-targeted duplex RNAs	NATURE CHEMICAL BIOLOGY			English	Article							PROGESTERONE-RECEPTOR GENE; BREAST-CANCER-CELLS; CHROMOSOMAL DNA; HISTONE CODE; TRANSCRIPTION; METHYLATION; PROTEIN; LINE; DESIGN; ACID	The ability to selectively activate or inhibit gene expression is fundamental to understanding complex cellular systems and developing therapeutics. Recent studies have demonstrated that duplex RNAs complementary to promoters within chromosomal DNA are potent gene silencing agents in mammalian cells. Here we report that chromosome-targeted RNAs also activate gene expression. We have identified multiple duplex RNAs complementary to the progesterone receptor ( PR) promoter that increase expression of PR protein and RNA after transfection into cultured T47D or MCF7 human breast cancer cells. Upregulation of PR protein reduced expression of the downstream gene encoding cyclooygenase 2 but did not change concentrations of estrogen receptor, which demonstrates that activating RNAs can predictably manipulate physiologically relevant cellular pathways. Activation decreased over time and was sequence specific. Chromatin immunoprecipitation assays indicated that activation is accompanied by reduced acetylation at histones H3K9 and H3K14 and by increased di- and trimethylation at histone H3K4. These data show that, like proteins, hormones and small molecules, small duplex RNAs interact at promoters and can activate or repress gene expression.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Janowski, BA (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	bethany.janowski@utsouthwestern.edu; david.corey@utsouthwestern.eud	Younger, Scott/M-3177-2019	Hardy, Daniel/0000-0001-5445-273X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073042] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073042] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER IE, 1989, MOL ENDOCRINOL, V3, P1377, DOI 10.1210/mend-3-9-1377; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Badia E, 2000, CANCER RES, V60, P4130; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Chau CM, 2004, J VIROL, V78, P12308, DOI 10.1128/JVI.78.22.12308-12319.2004; CHO HS, 1994, ENDOCRINOLOGY, V134, P658, DOI 10.1210/en.134.2.658; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Corey DR, 2005, TRENDS BIOCHEM SCI, V30, P655, DOI 10.1016/j.tibs.2005.09.007; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Eckstein F, 2005, TRENDS BIOCHEM SCI, V30, P445, DOI 10.1016/j.tibs.2005.06.008; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Huffman KE, 2005, BIOCHEMISTRY-US, V44, P2253, DOI 10.1021/bi047948g; HURD C, 1995, J BIOL CHEM, V270, P28507, DOI 10.1074/jbc.270.48.28507; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Janowski BA, 2006, NAT PROTOC, V1, P436, DOI 10.1038/nprot.2006.64; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kwonj Y, 2004, J AM CHEM SOC, V126, P15940, DOI 10.1021/ja0445140; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liu B, 2003, CHEM BIOL, V10, P909, DOI 10.1016/j.chembiol.2003.09.008; Majmudar CY, 2005, CURR OPIN CHEM BIOL, V9, P467, DOI 10.1016/j.cbpa.2005.08.012; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; MISRAHI M, 1993, BIOCHIM BIOPHYS ACTA, V1216, P289, DOI 10.1016/0167-4781(93)90156-8; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; READ LD, 1988, MOL ENDOCRINOL, V2, P263, DOI 10.1210/mend-2-3-263; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ruh MF, 1999, ENDOCRINE, V11, P157, DOI 10.1385/ENDO:11:2:157; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102	44	385	439	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2007	3	3					166	173		10.1038/nchembio860	http://dx.doi.org/10.1038/nchembio860			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	138BD	17259978				2022-12-25	WOS:000244336600013
J	Zhao, Y; Chow, TF; Puckrin, RS; Alfred, SE; Korir, AK; Larive, CK; Cutler, SR				Zhao, Yang; Chow, Tszfung F.; Puckrin, Rachel S.; Alfred, Simon E.; Korir, Albert K.; Larive, Cynthia K.; Cutler, Sean R.			Chemical genetic interrogation of natural variation uncovers a molecule that is glycoactivated	NATURE CHEMICAL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; GLYCOSYLTRANSFERASES; PHARMACOGENOMICS; METABOLISM; REVEALS; ACID	Natural variation in human drug metabolism and target genes can cause pharmacogenetic or interindividual variation in drugsensitivity(1,2). We reasoned that natural pharmacogenetic variation in model organisms could be systematically exploited to facilitate the characterization of new small molecules. To test this, we subjected multiple Arabidopsis thaliana accessions to chemical genetic screens and discovered 12 accession-selective hit molecules. As a model for understanding this variation, we characterized natural resistance to hypostatin, a new inhibitor of cell expansion. Map-based cloning identified HYR1, a UDP glycosyltransferase (UGT), as causative for hypostatin resistance. Multiple lines of evidence demonstrate that HYR1 glucosylates hypostatin in vivo to form a bioactive glucoside. Additionally, we delineated a HYR1 substrate motif and used it to identify another molecule modulated by glucosylation. Our results demonstrate that natural variation can be exploited to inform the biology of new small molecules, and that UGT sequence variation affects xenobiotic sensitivity across biological kingdoms.	Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of Toronto; University of California System; University of California Riverside; University of California System; University of California Riverside	Cutler, SR (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	sean.cutler@ucr.edu	Cutler, Sean R/D-6617-2011; Larive, Cynthia K/E-4640-2012	Larive, Cynthia/0000-0003-3458-0771				Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Bergelson J, 1998, GENETICS, V148, P1311; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Girke T, 2005, PLANT PHYSIOL, V138, P573, DOI 10.1104/pp.105.062687; Guillemette C, 2003, PHARMACOGENOMICS J, V3, P136, DOI 10.1038/sj.tpj.6500171; Ilic K, 2004, TRENDS GENET, V20, P280, DOI 10.1016/j.tig.2004.04.012; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; KROEMER HK, 1992, CLIN PHARMACOKINET, V23, P292, DOI 10.2165/00003088-199223040-00005; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; MULDER GJ, 1992, TRENDS PHARMACOL SCI, V13, P302, DOI 10.1016/0165-6147(92)90095-N; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; TEUTONICO RA, 1991, PLANT PHYSIOL, V97, P288, DOI 10.1104/pp.97.1.288; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157	27	84	92	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					716	721		10.1038/nchembio.2007.32	http://dx.doi.org/10.1038/nchembio.2007.32			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17891152				2022-12-25	WOS:000250311500013
J	Kozlov, SV; Bogenpohl, JW; Howell, MP; Wevrick, R; Panda, S; Hogenesch, JB; Muglia, LJ; Van Gelder, RN; Herzog, ED; Stewart, CL				Kozlov, Serguei V.; Bogenpohl, James W.; Howell, Maureen P.; Wevrick, Rachel; Panda, Satchin; Hogenesch, John B.; Muglia, Louis J.; Van Gelder, Russell N.; Herzog, Erik D.; Stewart, Colin L.			The imprinted gene Magel2 regulates normal circadian output	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; MOUSE; DISRUPTION; NECDIN; SNRPN; MICE; EXPRESSION; OBESITY; GROWTH; ROLES	Mammalian circadian rhythms of activity are generated within the suprachiasmatic nucleus ( SCN). Transcripts from the imprinted, paternally expressed Magel2 gene, which maps to the chromosomal region associated with Prader-Willi Syndrome (PWS), are highly enriched in the SCN. The Magel2 message is circadianly expressed and peaks during the subjective day. Mice deficient in Magel2 expression entrain to light cycles and express normal running-wheel rhythms, but with markedly reduced amplitude of activity and increased daytime activity. These changes are associated with reductions in food intake and male fertility. Orexin levels and orexin-positive neurons in the lateral hypothalamus are substantially reduced, suggesting that some of the consequences of Magel2 loss are mediated through changes in orexin signaling. The robust rhythmicity of Magel2 expression in the SCN and the altered behavioral rhythmicity of null mice reveal Magel2 to be a clock-controlled circadian output gene whose disruption results in some of the phenotypes characteristic of PWS.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Salk Inst Biol Studies, Regulat Biol Lab, La Jolla, CA 92037 USA; Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA; Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	Washington University (WUSTL); Washington University (WUSTL); University of Alberta; Salk Institute; Novartis; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, CL (corresponding author), Inst Med Biol, 03-03 Proteos,61 Biopolis Dr, Singapore 113867, Singapore.	stewartc@ncifcrf.gov	Panda, Satchidananda/J-6891-2012; Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Herzog, Erik/0000-0001-7209-5174; Wevrick, Rachel/0000-0002-3343-5794; Bogenpohl, James/0000-0001-7214-3404	NATIONAL CANCER INSTITUTE [Z01BC010349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NEI NIH HHS [EY14988] Funding Source: Medline; NIMH NIH HHS [MH63104] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Card JP, 2000, J BIOL RHYTHM, V15, P453, DOI 10.1177/074873000129001567; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Goldstone AP, 2006, PROG BRAIN RES, V153, P57, DOI 10.1016/S0079-6123(06)53033-1; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Pagliardini S, 2005, AM J PATHOL, V167, P175, DOI 10.1016/S0002-9440(10)62964-1; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PAXINOS G, 1990, TRENDS NEUROSCI, V13, P169, DOI 10.1016/0166-2236(90)90041-8; Ren J, 2003, J NEUROSCI, V23, P1569; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	29	134	141	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1266	1272		10.1038/ng2114	http://dx.doi.org/10.1038/ng2114			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17893678				2022-12-25	WOS:000249737400024
J	Pipper, J; Inoue, M; Ng, LFP; Neuzil, P; Zhang, Y; Novak, L				Pipper, Juergen; Inoue, Masafumi; Ng, Lisa F-P; Neuzil, Pavel; Zhang, Yi; Novak, Lukas			Catching bird flu in a droplet	NATURE MEDICINE			English	Article							INFLUENZA-A H5N1; AVIAN INFLUENZA; MICROFLUIDIC SYSTEMS; CHIP; LAB; VIRUS; ASIA; PCR	It is assumed that a timely mass administration of antiviral drugs, backed by quarantines and social distancing, could contain a nascent influenza epidemic at its source, provided that the first clusters of cases were localized within a short time. However, effective routine surveillance may be impossible in countries lacking basic public health resources. For a global containment strategy to be successful, low- cost, easy-to- use handheld units that permit decentralized testing would be vital. Here we present a microfluidic platform that can detect the highly pathogenic avian influenza virus H5N1 in a throat swab sample by using magnetic forces to manipulate a free droplet containing superparamagnetic particles. In a sequential process, the viral RNA is isolated, purified, preconcentrated by 50,000% and subjected to ultrafast real- time RT-PCR. Compared to commercially available tests, the bioassay is equally sensitive and is 440% faster and 2,000 - 5,000% cheaper.	Inst Bioengn & Nanotechnol, Singapore 138669, Singapore; Inst Mol & Cell Biol, Singapore 138673, Singapore; Genome Inst Singapore, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Pipper, J (corresponding author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,Nanos 04-01, Singapore 138669, Singapore.	j.pipper@ibn.a-star.edu.sg	Neuzil, Pavel/B-9981-2012; Neuzil, Pavel/ABC-5530-2020; Zhang, Yi/F-5817-2010; Novak, Lukas/A-7903-2008	Neuzil, Pavel/0000-0001-9040-281X; Zhang, Yi/0000-0002-1239-3441; Ng, Lisa/0000-0003-4071-5222				Abbott A, 2004, NATURE, V427, P472, DOI 10.1038/427472a; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Daw R, 2006, NATURE, V442, P367, DOI 10.1038/442367a; de Mello AJ, 2003, LAB CHIP, V3, p11N, DOI 10.1039/b301019h; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Enserink M, 2006, SCIENCE, V311, P314, DOI 10.1126/science.311.5759.314; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gascoyne PRC, 2004, LAB CHIP, V4, P299, DOI 10.1039/b404130e; Guttenberg Z, 2005, LAB CHIP, V5, P308, DOI 10.1039/b412712a; Ho D, 2005, NATURE, V435, P421, DOI 10.1038/435421a; Holmes EC, 2005, SCIENCE, V309, P989, DOI 10.1126/science.1117128; Lehmann U, 2006, ANGEW CHEM INT EDIT, V45, P3062, DOI 10.1002/anie.200503624; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Mukhopadhyay R, 2006, ANAL CHEM, V78, P1401, DOI 10.1021/ac069373u; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Normile D, 2006, SCIENCE, V311, P315, DOI 10.1126/science.311.5759.315; Novak L, 2007, LAB CHIP, V7, P27, DOI 10.1039/b611745g; Pamme N, 2006, LAB CHIP, V6, P24, DOI 10.1039/b513005k; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Srinivasan V, 2004, ANAL CHIM ACTA, V507, P145, DOI 10.1016/j.aca.2003.12.030; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; *WHO, 2007, WHO PAND INFL DRAFT; Wilschut J, 2006, INFLUENZA, P49; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	28	177	188	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2007	13	10					1259	1263		10.1038/nm1634	http://dx.doi.org/10.1038/nm1634			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17891145	Green Published, Bronze			2022-12-25	WOS:000249980200044
J	Gong, LW; de Toledo, GA; Lindau, M				Gong, Liang-Wei; Alvarez de Toledo, Guillermo; Lindau, Manfred			Exocytotic catecholamine release is not associated with cation flux through channels in the vesicle membrane but Na+ influx through the fusion pore	NATURE CELL BIOLOGY			English	Article							ADRENAL CHROMAFFIN CELLS; SYNAPTIC VESICLES; TRANSMITTER RELEASE; PATCH AMPEROMETRY; BIOGENIC-AMINES; ION-EXCHANGE; GRANULES; RECORDINGS; RESOLUTION; SECRETION	Release of charged neurotransmitter molecules through a narrow fusion pore requires charge compensation by other ions. It has been proposed that this may occur by ion flow from the cytosol through channels in the vesicle membrane, which would generate a net outward current. This hypothesis was tested in chromaffin cells using cell-attached patch amperometry that simultaneously measured catecholamine release from single vesicles and ionic current across the patch membrane. No detectable current was associated with catecholamine release indicating that < 2% of cations, if any, enter the vesicle through its membrane. Instead, we show that flux of catecholamines through the fusion pore, measured as an amperometric foot signal, decreases when the extracellular cation concentration is reduced. The results reveal that the rate of transmitter release through the fusion pore is coupled to net Na+ influx through the fusion pore, as predicted by electrodiffusion theory applied to fusion-pore permeation, and suggest a prefusion rather than postfusion role for vesicular cation channels.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14850 USA; Univ Seville, Fac Med, Dept Physiol & Biophys, E-41009 Seville, Spain	Cornell University; University of Sevilla	Lindau, M (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14850 USA.	ml95@cornell.edu	Lindau, Manfred/ABD-3449-2021; Alvarez de Toledo, Guillermo/I-2888-2015	Lindau, Manfred/0000-0002-5722-9557; Alvarez de Toledo, Guillermo/0000-0001-7193-2663	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038200] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038200-07, R01-NS38200, R01 NS038200] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ARISPE N, 1992, J MEMBRANE BIOL, V130, P191; BAUR JE, 1988, ANAL CHEM, V60, P1268, DOI 10.1021/ac00164a006; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Burgoyne RD, 1996, BIOCHEM SOC T, V24, P653, DOI 10.1042/bst0240653; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Dernick G, 2003, NAT CELL BIOL, V5, P358, DOI 10.1038/ncb956; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; GERHARDT G, 1982, ANAL CHEM, V54, P2618, DOI 10.1021/ac00251a054; Gong LW, 2003, J NEUROSCI, V23, P7917; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOLZ RW, 1986, ANNU REV PHYSIOL, V48, P175; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; Montell C, 2006, NEURON, V52, P395, DOI 10.1016/j.neuron.2006.10.012; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; POLLARD HB, 1979, J BIOL CHEM, V254, P1170; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Tabares L, 2003, BIOCHEM SOC T, V31, P837, DOI 10.1042/bst0310837; UVNAS B, 1989, NEWS PHYSIOL SCI, V4, P68; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; WOODBURY DJ, 1995, MOL MEMBR BIOL, V12, P165, DOI 10.3109/09687689509027504; YAKIR N, 1995, J PHYSIOL-LONDON, V485, P683, DOI 10.1113/jphysiol.1995.sp020762; Yin Y, 2002, J PHYSIOL-LONDON, V539, P409, DOI 10.1013/jphysiol.2001.012943; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	39	37	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					915	+		10.1038/ncb1617	http://dx.doi.org/10.1038/ncb1617			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643118	Green Published, Green Accepted			2022-12-25	WOS:000248486700013
J	Zanke, BW; Greenwood, CMT; Rangrej, J; Kustra, R; Tenesa, A; Farrington, SM; Prendergast, J; Olschwang, S; Chiang, T; Crowdy, E; Ferretti, V; Laflamme, P; Sundararajan, S; Roumy, S; Olivier, JF; Robidoux, F; Sladek, R; Montpetit, A; Campbell, P; Bezieau, S; O'Shea, AM; Zogopoulos, G; Cotterchio, M; Newcomb, P; McLaughlin, J; Younghusband, B; Green, R; Green, J; Porteous, MEM; Campbell, H; Blanche, H; Sahbatou, M; Tubacher, E; Bonaiti-Pellie, C; Buecher, B; Riboli, E; Kury, S; Chanock, SJ; Potter, J; Thomas, G; Gallinger, S; Hudson, TJ; Dunlop, MG				Zanke, Brent W.; Greenwood, Celia M. T.; Rangrej, Jagadish; Kustra, Rafal; Tenesa, Albert; Farrington, Susan M.; Prendergast, James; Olschwang, Sylviane; Chiang, Theodore; Crowdy, Edgar; Ferretti, Vincent; Laflamme, Philippe; Sundararajan, Saravanan; Roumy, Stephanie; Olivier, Jean-Francois; Robidoux, Frederick; Sladek, Robert; Montpetit, Alexandre; Campbell, Peter; Bezieau, Stephane; O'Shea, Anne Marie; Zogopoulos, George; Cotterchio, Michelle; Newcomb, Polly; McLaughlin, John; Younghusband, Ban; Green, Roger; Green, Jane; Porteous, Mary E. M.; Campbell, Harry; Blanche, Helene; Sahbatou, Mourad; Tubacher, Emmanuel; Bonaiti-Pellie, Catherine; Buecher, Bruno; Riboli, Elio; Kury, Sebastien; Chanock, Stephen J.; Potter, John; Thomas, Gilles; Gallinger, Steven; Hudson, Thomas J.; Dunlop, Malcolm G.			Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24	NATURE GENETICS			English	Article							PROSTATE-CANCER	Using a multistage genetic association approach comprising 7,480 affected individuals and 7,779 controls, we identified markers in chromosomal region 8q24 associated with colorectal cancer. In stage 1, we genotyped 99,632 SNPs in 1,257 affected individuals and 1,336 controls from Ontario. In stages 2-4, we performed serial replication studies using 4,024 affected individuals and 4,042 controls from Seattle, Newfoundland and Scotland. We identified one locus on chromosome 8q24 and another on 9p24 having combined odds ratios (OR) for stages 1-4 of 1.18 (trend; P = 1.41 x 10(-8)) and 1.14 (trend; P = 1.32 x 10(-5)), respectively. Additional analyses in 2,199 affected individuals and 2,401 controls from France and Europe supported the association at the 8q24 locus (OR = 1.16, trend; 95% confidence interval (c.i.): 1.07-1.26; P = 5.05 = 10-4). A summary across all seven studies at the 8q24 locus was highly significant (OR = 1.17, c.i.: 1.12-1.23; P = 3.16 x 10(-11)). This locus has also been implicated in prostate cancer(1-3).	Ontario Inst Canc Res, Toronto, ON M5G 2L7, Canada; Canc Care Ontario, Toronto, ON M5G 1L7, Canada; Univ Ottawa, Fac Med, Div Hematol, Ottawa, ON K1H 8L6, Canada; Hosp Sick Children, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5T 3M7, Canada; Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Human Genet Unit, UK Med Res Council, Edinburgh EH4 2XU, Midlothian, Scotland; Inst J Paoli I Calmettes, INSERM, U599, F-13009 Marseille, France; McGill Univ, Montreal, PQ H3G 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3G 1A4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON M5G 1X5, Canada; Ctr Hosp Univ Hotel Dieu, IMAD, F-44093 Nantes 01, France; Ctr Hosp Univ Hotel Dieu, EA3823, F-44093 Nantes 01, France; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; Univ Edinburgh, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Hop Paul Brousse, INSERM, U535, F-94800 Villejuif, France; Imperial Coll, Fac Med, London W2 1PG, England; NCI, Canc Res Ctr, NIH, DHHS, Gaithersburg, MD 20877 USA; NCI, Div Canc Genet & Epidemiol, NIH, DHHS, Gaithersburg, MD 20877 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Edinburgh; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Fred Hutchinson Cancer Center; Memorial University Newfoundland; University of Edinburgh; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hudson, TJ (corresponding author), Ontario Inst Canc Res, 101 Coll St, Toronto, ON M5G 2L7, Canada.	tom.hudson@oicr.on.ca	Campbell, Harry/E-2959-2010; Farrington, Susan M/Q-2710-2019; Gallinger, Steven/E-4575-2013; McLaughlin, John R/E-4577-2013; Bézieau, stéphane/G-5621-2015; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/C-7319-2013; KÜRY, Sébastien/G-5971-2015; Olschwang, Sylviane/G-2716-2013; Sladek, Robert/R-2391-2019	Campbell, Harry/0000-0002-6169-6262; Farrington, Susan M/0000-0001-5955-7389; Bézieau, stéphane/0000-0003-0095-1319; Dunlop, Malcolm G/0000-0002-3033-5851; KÜRY, Sébastien/0000-0001-5497-0465; Olschwang, Sylviane/0000-0001-7078-3029; Sladek, Robert/0000-0002-2730-1204; Riboli, Elio/0000-0001-6795-6080; Tenesa, Albert/0000-0003-4884-4475; Cotterchio, Michelle/0000-0003-2862-7895; Potter, John/0000-0001-5439-1500; Prendergast, James/0000-0001-8916-018X	NATIONAL CANCER INSTITUTE [U01CA074794, U01CA074783, K22CA095011, Z01SC010083] Funding Source: NIH RePORTER; Medical Research Council [MC_U127527198] Funding Source: Medline; NCI NIH HHS [U01 CA076783, U01 CA074783, RFA CA-95-011, U01 CA074794] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline; MRC [MC_U127527198] Funding Source: UKRI	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cotterchio M, 2000, Chronic Dis Can, V21, P81; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Greenwood CMT, 2007, GENET EPIDEMIOL, V31, P396, DOI 10.1002/gepi.20220; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	579	602	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					989	994		10.1038/ng2089	http://dx.doi.org/10.1038/ng2089			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618283				2022-12-25	WOS:000248446900016
J	Mitchell, P				Mitchell, Peter			GM giants pair up to do battle	NATURE BIOTECHNOLOGY			English	News Item								Monsanto is making a bid to dominate commercialized plant biotechnology's second decade. In March, it announced a 1.5 billion dollar collaboration deal with BASF, of Ludwigshafen, Germany. The arrangement promises to be the anchor for much of Monsanto's ongoing research and development, including the introduction of complex second generation traits to counter drought tolerance, an issue of global importance to agriculture.											0	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					695	696		10.1038/nbt0707-695	http://dx.doi.org/10.1038/nbt0707-695			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621277				2022-12-25	WOS:000247994000002
J	Nagaraj, S; Gupta, K; Pisarev, V; Kinarsky, L; Sherman, S; Kang, L; Herber, DL; Schneck, J; Gabrilovich, DI				Nagaraj, Srinivas; Gupta, Kapil; Pisarev, Vladimir; Kinarsky, Leo; Sherman, Simon; Kang, Loveleen; Herber, Donna L.; Schneck, Jonathan; Gabrilovich, Dmitry I.			Altered recognition of antigen is a mechanism of CD8(+) T cell tolerance in cancer	NATURE MEDICINE			English	Article							MYELOID SUPPRESSOR-CELLS; NITRIC-OXIDE; IN-VIVO; IMMUNE DYSFUNCTION; DENDRITIC CELLS; PEROXYNITRITE; ACTIVATION; INHIBITION; ANERGY; MICE	Antigen-specific CD8(+) T-cell tolerance, induced by myeloid-derived suppressor cells (MDSCs), is one of the main mechanisms of tumor escape. Using in vivo models, we show here that MDSCs directly disrupt the binding of specific peptide-major histocompatibility complex (pMHC) dimers to CD8-expressing T cells through nitration of tyrosines in a T-cell receptor (TCR)-CD8 complex. This process makes CD8-expressing T cells unable to bind pMHC and to respond to the specific peptide, although they retain their ability to respond to nonspecific stimulation. Nitration of TCR-CD8 is induced by MDSCs through hyperproduction of reactive oxygen species and peroxynitrite during direct cell-cell contact. Molecular modeling suggests specific sites of nitration that might affect the conformational flexibility of TCR-CD8 and its interaction with pMHC. These data identify a previously unknown mechanism of T-cell tolerance in cancer that is also pertinent to many pathological conditions associated with accumulation of MDSCs.	Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33647 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Univ Nebraska Med Ctr, Omaha, NE 68198 USA; Eppley Canc Ctr, Omaha, NE 68198 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Johns Hopkins University; University of Nebraska System; University of Nebraska Medical Center	Gabrilovich, DI (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, 12902 Magnolia Dr, Tampa, FL 33647 USA.	dmitry.gabrilovich@moffitt.org	Bharadwaj, Srinivas Nagaraj/I-4947-2012; Pisarev, Vladimir M./E-1373-2012; Gabrilovich, Dmitry/ABE-7122-2020	Pisarev, Vladimir M./0000-0002-5729-9846; 	NATIONAL CANCER INSTITUTE [R01CA084488] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA 84488, R01 CA084488, R01 CA084488-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Appleman LJ, 2001, J MOL MED, V78, P673, DOI 10.1007/s001090000180; Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; Balavoine GGA, 1999, NITRIC OXIDE-BIOL CH, V3, P40, DOI 10.1006/niox.1999.0206; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Cuenca A, 2003, CANCER RES, V63, P9007; De Santo C, 2005, P NATL ACAD SCI USA, V102, P4185, DOI 10.1073/pnas.0409783102; Drake DR, 2005, J IMMUNOL, V175, P1507, DOI 10.4049/jimmunol.175.3.1507; DUTZ JP, 1994, MOL IMMUNOL, V31, P967, DOI 10.1016/0161-5890(94)90091-4; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Haqqani AS, 2002, J BIOL CHEM, V277, P3614, DOI 10.1074/jbc.M105730200; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Kusmartsev S, 2003, J LEUKOCYTE BIOL, V74, P186, DOI 10.1189/jlb.0103010; Kusmartsev S, 2003, CANCER RES, V63, P4441; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mencacci A, 2002, J IMMUNOL, V169, P3180, DOI 10.4049/jimmunol.169.6.3180; Nikitina EY, 2002, GENE THER, V9, P345, DOI 10.1038/sj.gt.3301670; Pandit R, 2000, ANN OTO RHINOL LARYN, V109, P749, DOI 10.1177/000348940010900809; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Quinn MT, 2005, NEUTROPHILS: NEW OUTLOOK FOR OLD CELLS, 2ND EDITION, P35, DOI 10.1142/9781860946059_0002; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; Regoli F, 1999, TOXICOL APPL PHARM, V156, P96, DOI 10.1006/taap.1999.8637; Schmielau J, 2001, CANCER RES, V61, P4756; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; SQUADRITO GL, 1995, CHEM-BIOL INTERACT, V96, P203, DOI 10.1016/0009-2797(94)03591-U; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Udaka K, 1996, J IMMUNOL, V157, P670; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zingarelli B, 1998, INT J MOL MED, V1, P787	43	769	816	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					828	835		10.1038/nm1609	http://dx.doi.org/10.1038/nm1609			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17603493	Green Accepted			2022-12-25	WOS:000247902800029
J	Khidekel, N; Ficarro, SB; Clark, PM; Bryan, MC; Swaney, DL; Rexach, JE; Sun, YE; Coon, JJ; Peters, EC; Hsieh-Wilson, LC				Khidekel, Nelly; Ficarro, Scott B.; Clark, Peter M.; Bryan, Marian C.; Swaney, Danielle L.; Rexach, Jessica E.; Sun, Yi E.; Coon, Joshua J.; Peters, Eric C.; Hsieh-Wilson, Linda C.			Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics	NATURE CHEMICAL BIOLOGY			English	Article							ELECTRON-TRANSFER DISSOCIATION; N-ACETYLGLUCOSAMINE LEVELS; MUTATIONAL HOT-SPOT; MASS-SPECTROMETRY; MODIFIED PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; NUCLEOCYTOPLASMIC PROTEINS; MI-2/NURD COMPLEX; ION/ION REACTIONS; C-MYC	The addition of the monosaccharide beta-N-acetyl-D-glucosamine to proteins (O-GlcNAc glycosylation) is an intracellular, post-translational modification that shares features with phosphorylation. Understanding the cellular mechanisms and signaling pathways that regulate O-GlcNAc glycosylation has been challenging because of the difficulty of detecting and quantifying the modification. Here, we describe a new strategy for monitoring the dynamics of O-GlcNAc glycosylation using quantitative mass spectrometry-based proteomics. Our method, which we have termed quantitative isotopic and chemoenzymatic tagging (QUIC-Tag), combines selective, chemoenzymatic tagging of O-GlcNAc proteins with an efficient isotopic labeling strategy. Using the method, we detect changes in O-GlcNAc glycosylation on several proteins involved in the regulation of transcription and mRNA translocation. We also provide the first evidence that O-GlcNAc glycosylation is dynamically modulated by excitatory stimulation of the brain in vivo. Finally, we use electron-transfer dissociation mass spectrometry to identify exact sites of O-GlcNAc modification. Together, our studies suggest that O-GlcNAc glycosylation occurs reversibly in neurons and, akin to phosphorylation, may have important roles in mediating the communication between neurons.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Calif Los Angeles, David Geffen Sch Med, Mental Retardat Res Ctr, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hsieh-Wilson, LC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lhw@caltech.edu	Peters, Eric/W-2739-2019		NINDS NIH HHS [R01 NS045061] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045061] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Beckmann AM, 1997, J NEUROCHEM, V69, P2227; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Chalkley RJ, 2001, J AM SOC MASS SPECTR, V12, P1106, DOI 10.1016/S1044-0305(01)00295-1; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Coon JJ, 2004, INT J MASS SPECTROM, V236, P33, DOI 10.1016/j.ijms.2004.05.005; Datta R, 2003, BIOCHEMISTRY-US, V42, P5453, DOI 10.1021/bi020699g; Elvira G, 2006, J NEUROCHEM, V96, P105, DOI 10.1111/j.1471-4159.2005.03523.x; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gong ZH, 2006, MOL CELL BIOL, V26, P4519, DOI 10.1128/MCB.00409-06; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hogan JM, 2005, J PROTEOME RES, V4, P628, DOI 10.1021/pr049770q; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Iyer SPN, 2003, BIOCHEMISTRY-US, V42, P2493, DOI 10.1021/bi020685a; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Khidekel N, 2004, ORG BIOMOL CHEM, V2, P1, DOI 10.1039/b312466e; Kneass ZT, 2004, J BIOL CHEM, V279, P45759, DOI 10.1074/jbc.M407911200; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; LOVE DC, 2005, SCI STKE, pRE165; Ludemann N, 2005, J BIOL CHEM, V280, P31648, DOI 10.1074/jbc.M504395200; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; Marin P, 1997, J NEUROSCI, V17, P3445; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang RJ, 2001, ANAL CHEM, V73, P5142, DOI 10.1021/ac010583a	54	249	258	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2007	3	6					339	348		10.1038/nchembio881	http://dx.doi.org/10.1038/nchembio881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172PN	17496889				2022-12-25	WOS:000246816400013
J	Blair, JA; Rauh, D; Kung, C; Yun, CH; Fan, QW; Rode, H; Zhang, C; Eck, MJ; Weiss, WA; Shokat, KM				Blair, Jimmy A.; Rauh, Daniel; Kung, Charles; Yun, Cai-Hong; Fan, Qi-Wen; Rode, Haridas; Zhang, Chao; Eck, Michael J.; Weiss, William A.; Shokat, Kevan M.			Structure-guided development of affinity probes for tyrosine kinases using chemical genetics	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; IRREVERSIBLE INHIBITORS; ACQUIRED-RESISTANCE; EGF RECEPTOR; PROTEIN; MUTATION; COMPLEX; DOMAIN; CONFORMATION	As key components in nearly every signal transduction pathway, protein kinases are attractive targets for the regulation of cellular signaling by small-molecule inhibitors. We report the structure-guided development of 6-acrylamido-4-anilinoquinazoline irreversible kinase inhibitors that potently and selectively target rationally designed kinases bearing two selectivity elements that are not found together in any wild-type kinase: an electrophile-targeted cysteine residue and a glycine gatekeeper residue. Cocrystal structures of two irreversible quinazoline inhibitors bound to either epidermal growth factor receptor (EGFR) or engineered c-Src show covalent inhibitor binding to the targeted cysteine (Cys797 in EGFR and Cys345 in engineered c-Src). To accommodate the new covalent bond, the quinazoline core adopts positions that are different from those seen in kinase structures with reversible quinazoline inhibitors. Based on these structures, we developed a fluorescent 6-acrylamido-4-anilinoquinazoline affinity probe to report the fraction of kinase necessary for cellular signaling, and we used these reagents to quantitate the relationship between EGFR stimulation by EGF and its downstream outputs-Akt, Erk1 and Erk2.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society	Shokat, KM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	shokat@cmp.ucsf.edu	云, 彩红/E-1437-2018; Rauh, Daniel/G-1595-2013	Weiss, William/0000-0003-2230-9132; Blair, Jimmy/0000-0003-0303-5981; Rauh, Daniel/0000-0002-1970-7642	NCI NIH HHS [CA080942, CA116020] Funding Source: Medline; NCRR NIH HHS [RR015804, RR001614] Funding Source: Medline; NIAID NIH HHS [AI44009] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA116020, R01CA080942] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fan QW, 2003, CANCER RES, V63, P8930; Fan QW, 2002, CURR BIOL, V12, P1386, DOI 10.1016/S0960-9822(02)01070-9; Fry DW, 2003, EXP CELL RES, V284, P131, DOI 10.1016/S0014-4827(02)00095-2; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kung C, 2006, CHEM BIOL, V13, P399, DOI 10.1016/j.chembiol.2006.02.004; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Leftheris K, 2004, J MED CHEM, V47, P6283, DOI 10.1021/jm049521d; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pollack VA, 1999, J PHARMACOL EXP THER, V291, P739; Rasmussen SGF, 2001, J BIOL CHEM, V276, P4717, DOI 10.1074/jbc.M008067200; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Shewchuk L, 2000, J MED CHEM, V43, P133, DOI 10.1021/jm990401t; Shreder KR, 2004, ORG LETT, V6, P3715, DOI 10.1021/ol048656a; Singh J, 1997, J MED CHEM, V40, P1130, DOI 10.1021/jm960380s; Smaill JB, 2000, J MED CHEM, V43, P1380, DOI 10.1021/jm990482t; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tsou HR, 2001, J MED CHEM, V44, P2719, DOI 10.1021/jm0005555; Uchiyama S, 2001, BIOMED CHROMATOGR, V15, P295, DOI 10.1002/bmc.75.abs; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wakeling AE, 2002, CANCER RES, V62, P5749; Wissner A, 2000, J MED CHEM, V43, P3244, DOI 10.1021/jm000206a; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yee M, 2005, J BIOL CHEM, V280, P29053, DOI 10.1074/jbc.M504730200; Yuan HS, 2005, BIOCONJUGATE CHEM, V16, P669, DOI 10.1021/bc049714f; YUN CH, IN PRESS CANC CELL	50	180	199	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2007	3	4					229	238		10.1038/nchembio866	http://dx.doi.org/10.1038/nchembio866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148UW	17334377				2022-12-25	WOS:000245103000013
J	Wang, XB; Belguise, K; Kersual, N; Kirsch, KH; Mineva, ND; Galtier, F; Chalbos, D; Sonenshein, GE				Wang, Xiaobo; Belguise, Karine; Kersual, Nathalie; Kirsch, Kathrin H.; Mineva, Nora D.; Galtier, Florence; Chalbos, Dany; Sonenshein, Gail E.			Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; ACTIVATOR PROTEIN-1 ACTIVITY; PROSTATE-CANCER; MESENCHYMAL TRANSITION; ALPHA EXPRESSION; TRANSGENIC MICE; KINASE CK2; IN-VIVO; RECEPTOR	Aberrant constitutive expression of c-Rel, p65 and p50 NF-kappa B subunits has been reported in over 90% of breast cancers(1,2). Recently, we characterized a de novo RelB NF-kappa B subunit synthesis pathway, induced by the cytomegalovirus (CMV) IE1 protein, in which binding of p50-p65 NF-kappa B and c-Jun-Fra-2 AP-1 complexes to the RELB promoter work in synergy to potently activate transcription(3). Although RelB complexes were observed in mouse mammary tumours induced by either ectopic c-Rel expression(4) or carcinogen exposure(5), little is known about RelB in human breast disease. Here, we demonstrate constitutive de novo RelB synthesis is selectively active in invasive oestrogen receptor alpha (ER alpha)-negative breast cancer cells. ERa signalling reduced levels of functional NF-kappa B and Fra-2 AP-1 and inhibited de novo RelB synthesis, leading to an inverse correlation between RELB and ERa gene expression in human breast cancer tissues and cell lines. Induction of Bcl-2 by RelB promoted the more invasive phenotype of ER alpha-negative cancer cells. Thus, inhibition of de novo RelB synthesis represents a new mechanism whereby ERa controls epithelial to mesenchymal transition (EMT).	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Boston Univ, Sch Med, Lab Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Womens Hlth Interdisciplinary Res Ctr, Boston, MA 02118 USA; INSERM, U540, F-34090 Montpellier, France; Univ Montpellier 1, F-34000 Montpellier, France	Boston University; Boston University; Boston University; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Sonenshein, GE (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	gsonensh@bu.edu	Wang, Xiaobo/A-8604-2011	Kirsch, Kathrin/0000-0003-1532-1715; Wang, Xiaobo/0000-0002-3311-1378; Belguise, Karine/0000-0003-3426-8040	NCI NIH HHS [CA36355, R01 CA036355] Funding Source: Medline; NIEHS NIH HHS [P01 ES011624, ES11624] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; de Moissac D, 1998, J BIOL CHEM, V273, P23946, DOI 10.1074/jbc.273.37.23946; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HORWITZ KB, 1993, BREAST CANCER RES TR, V26, P119, DOI 10.1007/BF00689685; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hyder SM, 1997, CANCER RES, V57, P2547; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Oliveira Cleida A, 2003, Reprod Biol Endocrinol, V1, P75, DOI 10.1186/1477-7827-1-75; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06	35	177	183	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					470	U197		10.1038/ncb1559	http://dx.doi.org/10.1038/ncb1559			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369819	Green Accepted, Green Submitted			2022-12-25	WOS:000245359400019
J	Chen, TP; Hevi, S; Gay, F; Tsujimoto, N; He, T; Zhang, BL; Ueda, Y; Li, E				Chen, Taiping; Hevi, Sarah; Gay, Frederique; Tsujimoto, Naomi; He, Timothy; Zhang, Bailin; Ueda, Yoshihide; Li, En			Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; METHYLATION PATTERNS; MAMMALIAN-CELLS; CPG METHYLATION; DNA; P53; PHOSPHORYLATION; EXPRESSION; COOPERATE; DAMAGE	Studies have shown that DNA (cytosine-5-)-methyltransferase 1 (DNMT1) is the principal enzyme responsible for maintaining CpG methylation and is required for embryonic development and survival of somatic cells in mice(1-3). The role of DNMT1 in human cancer cells, however, remains highly controversial(4-7). Using homologous recombination, here we have generated a DNMT1 conditional allele in the human colorectal carcinoma cell line HCT116 in which several exons encoding the catalytic domain are flanked by loxP sites. Cre recombinase-mediated disruption of this allele results in hemimethylation of similar to 20% of CpG-CpG dyads in the genome, coupled with activation of the G2/M checkpoint, leading to arrest in the G2 phase of the cell cycle. Although cells gradually escape from this arrest, they show severe mitotic defects and undergo cell death either during mitosis or after arresting in a tetraploid G1 state. Our results thus show that DNMT1 is required for faithfully maintaining DNA methylation patterns in human cancer cells and is essential for their proliferation and survival.	Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA; Novartis Inst Biomed Res, Cent Technol, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Novartis; Novartis; Harvard University; Massachusetts General Hospital	Li, E (corresponding author), Novartis Inst Biomed Res, Epigenet Program, 250 Massachusette Ave, Cambridge, MA 02139 USA.	en.li@novartis.com	Ueda, Yoshihide/S-7620-2016	Ueda, Yoshihide/0000-0003-3196-3494				Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fenech M, 2002, DRUG DISCOV TODAY, V7, P1128, DOI 10.1016/S1359-6446(02)02502-3; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Ting AH, 2004, NAT GENET, V36, P582, DOI 10.1038/ng1365; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293	23	249	260	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					391	396		10.1038/ng1982	http://dx.doi.org/10.1038/ng1982			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322882				2022-12-25	WOS:000244480000023
J	Dellavalle, A; Sampaolesi, M; Tonlorenzi, R; Tagliafico, E; Sacchetti, B; Perani, L; Innocenzi, A; Galvez, BG; Messina, G; Morosetti, R; Li, S; Belicchi, M; Peretti, G; Chamberlain, JS; Wright, WE; Torrente, Y; Ferrari, S; Bianco, P; Cossu, G				Dellavalle, Arianna; Sampaolesi, Maurilio; Tonlorenzi, Rossana; Tagliafico, Enrico; Sacchetti, Benedetto; Perani, Laura; Innocenzi, Anna; Galvez, Beatriz G.; Messina, Graziella; Morosetti, Roberta; Li, Sheng; Belicchi, Marzia; Peretti, Giuseppe; Chamberlain, Jeffrey S.; Wright, Woodring E.; Torrente, Yvan; Ferrari, Stefano; Bianco, Paolo; Cossu, Giulio			Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; DYSTROPHIN EXPRESSION; PROGENITOR CELLS; BONE-MARROW; MULTIPOTENT; POPULATION; DELIVERY; REPAIR; MESOANGIOBLASTS; TRANSPLANTATION	Cells derived from blood vessels of human skeletal muscle can regenerate skeletal muscle, similarly to embryonic mesoangioblasts. However, adult cells do not express endothelial markers, but instead express markers of pericytes, such as NG2 proteoglycan and alkaline phosphatase ( ALP), and can be prospectively isolated from freshly dissociated ALP(+) cells. Unlike canonical myogenic precursors ( satellite cells), pericyte-derived cells express myogenic markers only in differentiated myotubes, which they form spontaneously with high efficiency. When transplanted into severe combined immune deficient-X-linked, mouse muscular dystrophy (scid-mdx) mice, pericyte-derived cells colonize host muscle and generate numerous fibres expressing human dystrophin. Similar cells isolated from Duchenne patients, and engineered to express human mini-dystrophin, also give rise to many dystrophin-positive fibres in vivo. These data show that myogenic precursors, distinct from satellite cells, are associated with microvascular walls in the human skeletal muscle, may represent a correlate of embryonic 'mesoangioblasts' present after birth and may be a promising candidate for future cell-therapy protocols in patients.	Ist Sci San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy; Univ Roma La Sapienza, Dept Cellular & Dev Biol, I-00161 Rome, Italy; Catholic Univ, Dept Neurol, I-00168 Rome, Italy; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Milan, Osped Maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Roma La Sapienza, Dept Expt Pathol, I-00161 Rome, Italy; Univ Milan, Dept Biol, I-20130 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; Universita di Modena e Reggio Emilia; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Washington; University of Washington Seattle; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome; University of Milan	Bianco, P (corresponding author), Ist Sci San Raffaele, Stem Cell Res Inst, 58 Via Olgettina, I-20132 Milan, Italy.	p.bianco@flashnet.it; cossu.giulio@hsr.it	MOROSETTI, ROBERTA/ABE-1045-2021; Tonlorenzi, Rossana/AAN-2241-2020; sacchetti, benedetto/A-3314-2009; Peretti, Giuseppe/K-6358-2016; Sampaolesi, Maurilio/H-6509-2013; Tagliafico, Enrico/C-9079-2009; Perani, Laura/AAN-2838-2020; Gálvez, Beatriz G./H-1644-2015; Messina, Graziella/A-1469-2014; TORRENTE, YVAN/A-2964-2015	MOROSETTI, ROBERTA/0000-0001-5017-4904; Peretti, Giuseppe/0000-0001-9341-7187; Sampaolesi, Maurilio/0000-0002-2422-3757; Tagliafico, Enrico/0000-0003-0981-2542; Perani, Laura/0000-0001-8616-3377; Gálvez, Beatriz G./0000-0002-8082-9323; Messina, Graziella/0000-0001-8189-0727; Tonlorenzi, Rossana/0000-0002-6060-8208; TORRENTE, YVAN/0000-0002-2705-3984; Chamberlain, Jeffrey/0000-0001-5299-0059	Telethon [GSP030543] Funding Source: Medline	Telethon(Fondazione Telethon)		Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li S, 2005, GENE THER, V12, P1099, DOI 10.1038/sj.gt.3302505; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; NEUMEYER AM, 1992, NEUROLOGY, V42, P2258, DOI 10.1212/WNL.42.12.2258; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; SAFADI A, 1991, J HISTOCHEM CYTOCHEM, V39, P199, DOI 10.1177/39.2.1987264; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794	38	733	763	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					255	U30		10.1038/ncb1542	http://dx.doi.org/10.1038/ncb1542			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293855				2022-12-25	WOS:000244558600010
J	Zhao, WN; Malinin, N; Yang, FC; Staknis, D; Gekakis, N; Maier, B; Reischl, S; Kramer, A; Weitz, CJ				Zhao, Wen-Ning; Malinin, Nikolay; Yang, Fu-Chia; Staknis, David; Gekakis, Nicholas; Maier, Bert; Reischl, Silke; Kramer, Achim; Weitz, Charles J.			CIPC is a mammalian circadian clock protein without invertebrate homologues	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; FEEDBACK LOOPS; NUCLEAR ENTRY; NEGATIVE LIMB; MOUSE; MPER1; TIME; TRANSCRIPTION; OSCILLATORS; MECHANISMS	At the core of the mammalian circadian clock is a feedback loop in which the heterodimeric transcription factor CLOCK-Brain, Muscle Arnt-like-1 (BMAL1) drives expression of its negative regulators, periods (PERs) and cryptochromes (CRYs). Here, we provide evidence that CLOCK-Interacting Protein, Circadian ( CIPC) is an additional negative-feedback regulator of the circadian clock. CIPC exhibits circadian regulation in multiple tissues, and it is a potent and specific inhibitor of CLOCK-BMAL1 activity that functions independently of CRYs. CIPC-CLOCK protein complexes are present in vivo, and depletion of endogenous CIPC shortens the circadian period length. CIPC is unrelated to known proteins and has no recognizable homologues outside vertebrates. Our results suggest that negative feedback in the mammalian circadian clock is divided into distinct pathways, and that the addition of new genes has contributed to the complexity of vertebrate clocks.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Charite Univ Med Berlin, Lab Chronobiol, Inst Med Immunol, D-10098 Berlin, Germany	Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Malinin, Nikolay/Z-5308-2019; Malinin, Nikolay/J-4271-2012; Maier, Bert/B-2501-2009	Malinin, Nikolay/0000-0002-2654-1783; Kramer, Achim/0000-0001-9671-6078	NIMH NIH HHS [R01-MH59943] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059943] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	38	58	64	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					268	U53		10.1038/ncb1539	http://dx.doi.org/10.1038/ncb1539			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310242				2022-12-25	WOS:000244558600011
J	Kadi, N; Oves-Costales, D; Barona-Gomez, F; Challis, GL				Kadi, Nadia; Oves-Costales, Daniel; Barona-Gomez, Francisco; Challis, Gregory L.			A new family of ATP-dependent oligomerization-macrocyclization biocatalysts	NATURE CHEMICAL BIOLOGY			English	Article							STOFFWECHSELPRODUKTE VON ACTINOMYCETEN; NONRIBOSOMAL PEPTIDE SYNTHETASES; THIOESTERASE DOMAIN; STRUCTURAL BASIS; SIDEROPHORE; BIOSYNTHESIS; CYCLIZATION; LIPOPEPTIDE; SUBSTRATE; MACROLACTONIZATION	Oligomerization and macrocyclization reactions are key steps in the biosynthesis of many bioactive natural products. Important macrocycles include the antibiotic daptomycin ( 1; ref. 1), the immunosuppressant FK- 506 ( 2; ref. 2), the anthelmintic avermectin B1a ( 3; ref. 3) and the insecticide spinosyn A ( 4; ref. 4); important oligomeric macrocycles include the siderophores enterobactin ( 5; ref. 5) and desferrioxamine E ( 6; ref. 6). Biosynthetic oligomerization and macrocyclization reactions typically involve covalently tethered intermediates and are catalyzed by thioesterase domains of polyketide synthase and nonribosomal peptide synthetase multienzymes(7). Here we report that the purified recombinant desferrioxamine siderophore synthetase DesD from Streptomyces coelicolor M145 catalyzes ATP- dependent trimerization- macrocyclization of a chemically synthesized 10- aminocarboxylic acid substrate via noncovalently bound intermediates. DesD is dissimilar to other known synthetase families but is similar to other enzymes known or proposed to be required for the biosynthesis of omega- aminocarboxylic acid - derived cyclodimeric siderophores(8,9). This suggests that DesD is the first biochemically characterized member of a new family of oligomerizing and macrocyclizing synthetases.	Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Ing Celular & Biocatal, Cuernavaca 62250, Morelos, Mexico; Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	Universidad Nacional Autonoma de Mexico; University of Warwick	Challis, GL (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Ing Celular & Biocatal, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	g.l.challis@warwick.ac.uk	Oves-Costales, Daniel/I-1543-2015	Oves-Costales, Daniel/0000-0001-9986-4623; Barona Gomez, Francisco/0000-0003-1492-9497; Challis, Gregory/0000-0001-5976-3545	Biotechnology and Biological Sciences Research Council [BBS/B/14450] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; ANDEREGG G, 1963, HELV CHIM ACTA, V46, P1409, DOI 10.1002/hlca.19630460436; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Barona-Gomez F, 2006, MICROBIOL-SGM, V152, P3355, DOI 10.1099/mic.0.29161-0; BERGERON RJ, 1992, J MED CHEM, V35, P4739, DOI 10.1021/jm00103a012; BICKEL H, 1960, HELV CHIM ACTA, V43, P2118, DOI 10.1002/hlca.19600430731; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; DEBONO M, 1988, J ANTIBIOT, V41, P1093, DOI 10.7164/antibiotics.41.1093; Giraldes JW, 2006, NAT CHEM BIOL, V2, P531, DOI 10.1038/nchembio822; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; HOSSAIN MB, 1983, ACTA CRYSTALLOGR B, V39, P258, DOI 10.1107/S0108768183002360; Hoyer KM, 2007, CHEM BIOL, V14, P13, DOI 10.1016/j.chembiol.2006.10.011; Kang HY, 1996, J BACTERIOL, V178, P4877, DOI 10.1128/jb.178.16.4877-4884.1996; KELLERSCHIERLEI.W, 1962, HELV CHIM ACTA, V45, P590, DOI 10.1002/hlca.19620450222; KIRST HA, 1991, TETRAHEDRON LETT, V32, P4839, DOI 10.1016/S0040-4039(00)93474-9; Ledyard KM, 1997, J BIOL INORG CHEM, V2, P93, DOI 10.1007/s007750050110; NISHIO T, 1988, J AM CHEM SOC, V110, P8733, DOI 10.1021/ja00234a045; PARKIN KL, 2003, ENZYME KINETICS MODE, P174; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; SPRINGER JP, 1981, J AM CHEM SOC, V103, P4221, DOI 10.1021/ja00404a041; TAKAHASHI A, 1987, J ANTIBIOT, V40, P1671, DOI 10.7164/antibiotics.40.1671; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177	30	91	92	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					652	656		10.1038/nchembio.2007.23	http://dx.doi.org/10.1038/nchembio.2007.23			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17704771				2022-12-25	WOS:000249642700014
J	Kertesz, M; Iovino, N; Unnerstall, U; Gaul, U; Segal, E				Kertesz, Michael; Iovino, Nicola; Unnerstall, Ulrich; Gaul, Ulrike; Segal, Eran			The role of site accessibility in microRNA target recognition	NATURE GENETICS			English	Article							ANIMAL MICRORNAS; RNA RECOGNITION; GENE-EXPRESSION; PREDICTION; CARDIOGENESIS; COMPLEX	MicroRNAs are key regulators of gene expression(1-4), but the precise mechanisms underlying their interaction with their mRNA targets are still poorly understood. Here, we systematically investigate the role of target-site accessibility, as determined by base-pairing interactions within the mRNA, in microRNA target recognition. We experimentally show that mutations diminishing target accessibility substantially reduce microRNA-mediated translational repression, with effects comparable to those of mutations that disrupt sequence complementarity. We devise a parameter-free model for microRNA-target interaction that computes the difference between the free energy gained from the formation of the microRNA-target duplex and the energetic cost of unpairing the target to make it accessible to the microRNA. This model explains the variability in our experiments, predicts validated targets more accurately than existing algorithms, and shows that genomes accommodate site accessibility by preferentially positioning targets in highly accessible regions. Our study thus demonstrates that target accessibility is a critical factor in microRNA function.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA	Weizmann Institute of Science; Rockefeller University	Gaul, U (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	gaul@mail.rockefeller.edu; eran@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164; Iovino, Nicola/0000-0002-3335-7618				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Wiese KC, 2006, BIOINFORMATICS, V22, P934, DOI 10.1093/bioinformatics/btl043; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	30	1797	1856	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1278	1284		10.1038/ng2135	http://dx.doi.org/10.1038/ng2135			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17893677				2022-12-25	WOS:000249737400026
J	Miyawaki, A; Karasawa, S				Miyawaki, Atsushi; Karasawa, Satoshi			Memorizing spatiotemporal patterns	NATURE CHEMICAL BIOLOGY			English	Editorial Material							GREEN-FLUORESCENT PROTEIN; CROSS-CORRELATION SPECTROSCOPY; TO-RED CONVERSION; LIVING CELLS; COMPLEMENTATION ANALYSIS; LIVE CELLS; VISUALIZATION; MULTICOLOR; VARIANT; CORAL	Live samples are intrinsically highly dynamic, yet techniques to monitor these complex environments usually reflect snapshots, thus making time-lapse imaging necessary to explore temporal progression of biological functions. Recent results indicate that exploiting some basic features of fluorescent protein maturation, such as green-to-red maturation of engineered proteins, should allow probing of temporally regulated information.	Brain Sci Inst, RIKEN, Lab Cell Funct & Dynam, Adv Technol Dev Grp, Wako, Saitama 351, Japan; Exploratory Res Adv Technol, Life Funct & Dynam Project, Wako, Saitama 351, Japan; Amalgaam Co Ltd, Itabashi Ku, Tokyo 173, Japan	RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, A (corresponding author), Brain Sci Inst, RIKEN, Lab Cell Funct & Dynam, Adv Technol Dev Grp, Wako, Saitama 351, Japan.	matsushi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235				Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bertera S, 2003, BIOTECHNIQUES, V35, P718, DOI 10.2144/03354st01; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Demidov VV, 2006, P NATL ACAD SCI USA, V103, P2052, DOI 10.1073/pnas.0511078103; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sprengel R, 2007, Handb Exp Pharmacol, P49; Stolpe T, 2005, PROTOPLASMA, V226, P137, DOI 10.1007/s00709-005-0122-6; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	41	9	9	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					598	601		10.1038/nchembio1007-598	http://dx.doi.org/10.1038/nchembio1007-598			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17876311				2022-12-25	WOS:000249642700003
J	Umetani, M; Domoto, H; Gormley, AK; Yuhanna, IS; Cummins, CL; Javitt, NB; Korach, KS; Shaul, PW; Mangelsdorf, DJ				Umetani, Michihisa; Domoto, Hideharu; Gormley, Andrew K.; Yuhanna, Ivan S.; Cummins, Carolyn L.; Javitt, Norman B.; Korach, Kenneth S.; Shaul, Philip W.; Mangelsdorf, David J.			27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen	NATURE MEDICINE			English	Article							CORONARY-HEART-DISEASE; NITRIC-OXIDE; OXIDATION-PRODUCTS; RECEPTOR-ALPHA; PLUS PROGESTIN; FATTY STREAKS; REENDOTHELIALIZATION; CHOLESTEROL; CONTROVERSIES; OXYSTEROLS	The cardioprotective effects of estrogen are mediated by receptors expressed in vascular cells. Here we show that 27- hydroxycholesterol ( 27HC), an abundant cholesterol metabolite that is elevated with hypercholesterolemia and found in atherosclerotic lesions, is a competitive antagonist of estrogen receptor action in the vasculature. 27HC inhibited both the transcription- mediated and the non- transcription- mediated estrogen- dependent production of nitric oxide by vascular cells, resulting in reduced estrogen- induced vasorelaxation of rat aorta. Furthermore, increasing 27HC levels in mice by diet- induced hypercholesterolemia, pharmacologic administration or genetic manipulation ( by knocking out the gene encoding the catabolic enzyme CYP7B1) decreased estrogen- dependent expression of vascular nitric oxide synthase and repressed carotid artery reendothelialization. As well as antiestrogenic effects, there were proestrogenic actions of 27HC that were cell- type specific, indicating that 27HC functions as an endogenous selective estrogen receptor modulator ( SERM). Taken together, these studies point to 27HC as a contributing factor in the loss of estrogen protection from vascular disease.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	Umetani, Michi/AAP-3964-2020	Umetani, Michi/0000-0001-8474-7088; Mangelsdorf, David/0000-0002-4355-0796; Cummins, Carolyn/0000-0001-7603-6577; Korach, Kenneth/0000-0002-7765-418X; Javitt, Norman B/0000-0001-9265-3508	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL87564] Funding Source: Medline; NIDDK NIH HHS [U19DK62434] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Brouchet L, 2001, CIRCULATION, V103, P423; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Clark James H, 2006, Nucl Recept Signal, V4, pe023; Clarkson TB, 2005, MATURITAS, V51, P64, DOI 10.1016/j.maturitas.2005.02.016; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Crisby M, 1997, BBA-LIPID LIPID MET, V1344, P278, DOI 10.1016/S0005-2760(96)00152-X; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; Hanke H, 1999, ATHEROSCLEROSIS, V147, P123, DOI 10.1016/S0021-9150(99)00182-3; Herrington DM, 2002, CIRCULATION, V105, P2962, DOI 10.1161/01.CIR.0000019406.74017.B2; Hodgin JB, 2002, ENDOCRINOLOGY, V143, P4495, DOI 10.1210/en.2002-220844; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Karas RH, 2004, CLIN OBSTET GYNECOL, V47, P489, DOI 10.1097/00003081-200406000-00024; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; Lund EG, 2003, METHOD ENZYMOL, V364, P24; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P2814, DOI 10.1073/pnas.0500198102; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; PARKER MG, 1993, ANN NY ACAD SCI, V684, P119, DOI 10.1111/j.1749-6632.1993.tb32276.x; RAVI J, 1994, AM J HYPERTENS, V7, P1065, DOI 10.1093/ajh/7.12.1065; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rosenfeld ME, 2002, ATHEROSCLEROSIS, V164, P251, DOI 10.1016/S0021-9150(02)00178-8; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Takahashi K, 2003, J ENDOCRINOL, V178, P319, DOI 10.1677/joe.0.1780319; Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; Yu LQ, 2004, J LIPID RES, V45, P889, DOI 10.1194/jlr.M300461-JLR200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	49	283	288	1	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1185	1192		10.1038/nm1641	http://dx.doi.org/10.1038/nm1641			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17873880				2022-12-25	WOS:000249980200034
J	van der Laan, M; Meinecke, M; Dudek, J; Hutu, DP; Lind, M; Perschil, I; Guiard, B; Wagner, R; Pfanner, N; Rehling, P				van der Laan, Martin; Meinecke, Michael; Dudek, Jan; Hutu, Dana P.; Lind, Maria; Perschil, Inge; Guiard, Bernard; Wagner, Richard; Pfanner, Nikolaus; Rehling, Peter			Motor-free mitochondrial presequence translocase drives membrane integration of preproteins	NATURE CELL BIOLOGY			English	Article							PROTEIN IMPORT CHANNEL; CONTACT SITES; INTERMEMBRANE SPACE; PRECURSOR PROTEINS; OUTER-MEMBRANE; TIM21; IDENTIFICATION; COMPLEX; ABSENCE; MATRIX	The mitochondrial inner membrane is the central energy-converting membrane of eukaryotic cells. the electrochemical proton gradient generated by the respiratory chain drives the ATP synthase. to maintain this proton-motive force, the inner membrane forms a tight barrier and strictly controls the translocation of ions(1). However, the major preprotein transport machinery of the inner membrane, termed the presequence translocase, translocates polypeptide chains into or across the membrane(2-9). Different views exist of the molecular mechanism of the translocase, in particular of the coupling with the import motor of the matrix(8,10,11). Wehave reconstituted preprotein transport into the mitochondrial inner membrane by incorporating the purified presequence translocase into cardiolipin-containing liposomes. We show that the motor-free form of the presequence translocase integrates preproteins into the membrane. the reconstituted presequence translocase responds to targeting peptides and mediates voltage-driven preprotein translocation, lateral release and insertion into the lipid phase. thus, the minimal system for preprotein integration into the mitochondrial inner membrane is the presequence translocase, a cardiolipin-rich membrane and a membrane potential.	Univ Freiburg, Inst Biochem & Molekularbiol, Zent Biochem & Mol Zellforschung, D-79104 Freiburg, Germany; Univ Osnabruck, D-49034 Osnabruck, Germany; Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; Uppsala Univ, Evolut Biol Ctr, Dept Comparat Physiol, S-75236 Uppsala, Sweden; CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University Osnabruck; University of Freiburg; Uppsala University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Molekularbiol, Zent Biochem & Mol Zellforschung, Hermann-Herder Str 7, D-79104 Freiburg, Germany.	wagner@uos.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; van der Laan, Martin/0000-0003-0789-9912				Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; PFANNER N, 1987, EUR J BIOCHEM, V169, P289, DOI 10.1111/j.1432-1033.1987.tb13610.x; Rapaport D, 2001, MOL BIOL CELL, V12, P1189, DOI 10.1091/mbc.12.5.1189; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; ZWIZINSKI C, 1983, J BIOL CHEM, V258, P3340	30	138	137	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1152	1159		10.1038/ncb1635	http://dx.doi.org/10.1038/ncb1635			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828250				2022-12-25	WOS:000249882300010
J	Wolfrum, C; Shi, S; Jayaprakash, KN; Jayaraman, M; Wang, G; Pandey, RK; Rajeev, KG; Nakayama, T; Charrise, K; Ndungo, EM; Zimmermann, T; Koteliansky, V; Manoharan, M; Stoffel, M				Wolfrum, Christian; Shi, Shuanping; Jayaprakash, K. Narayanarmair; Jayaraman, Muthusamy; Wang, Gang; Pandey, Rajendra K.; Rajeev, Kallanthottathil G.; Nakayama, Tomoko; Charrise, Klaus; Ndungo, Esther M.; Zimmermann, Tracy; Koteliansky, Victor; Manoharan, Muthiah; Stoffel, Markus			Mechanisms and optimization of in vivo delivery of lipophilic siRNAs	NATURE BIOTECHNOLOGY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; TRANSMEMBRANE PROTEIN SID-1; SMALL INTERFERING RNAS; SCAVENGER RECEPTOR; CLASS-B; SR-BI; GENE; CHOLESTEROL; METABOLISM; TRANSPORT	Cholesterol-conjugated siRNAs can silence gene expression in vivo. Here we synthesize a variety of lipophilic siRNAs and use them to elucidate the requirements for siRNA delivery in vivo. We show that conjugation to bile acids and long-chain fatty acids, in addition to cholesterol, mediates siRNA uptake into cells and gene silencing in vivo. Efficient and selective uptake of these siRNA conjugates depends on interactions with lipoprotein particles, lipoprotein receptors and transmembrane proteins. High-density lipoprotein (HDL) directs siRNA delivery into liver, gut, kidney and steroidogenic organs, whereas low-density lipoprotein (LDL) targets siRNA primarily to the liver. LDL-receptor expression is essential for siRNA delivery by LDL particles, and SR-BI receptor expression is required for uptake of HDL-bound siRNAs. Cellular uptake also requires the mammalian homolog of the Caenorhabditis elegans transmembrane protein Sid1. Our results demonstrate that conjugation to lipophilic molecules enables effective siRNA uptake through a common mechanism that can be exploited to optimize therapeutic siRNA delivery.	ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; ETH, Competence Ctr Syst Biol & Metab Dis, CH-8093 Zurich, Switzerland; Rockefeller Univ, New York, NY 10021 USA; Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Rockefeller University	Stoffel, M (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817; Wolfrum, Christian/0000-0002-3862-6805; Ndungo, Esther/0000-0002-9975-7032	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM073047-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409; BRECKENRIDGE WC, 1985, CAN J BIOCHEM CELL B, V63, P890, DOI 10.1139/o85-110; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; BROWN MS, 1985, ANN NY ACAD SCI, V454, P178, DOI 10.1111/j.1749-6632.1985.tb11856.x; BROWN MS, 1976, ANN NY ACAD SCI, V275, P244, DOI 10.1111/j.1749-6632.1976.tb43358.x; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Damha M J, 1993, Methods Mol Biol, V20, P81; DAUGAARD H, 1987, PFLUG ARCH EUR J PHY, V409, P220, DOI 10.1007/BF00584776; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; IYER RP, 1990, J AM CHEM SOC, V112, P1253, DOI 10.1021/ja00159a059; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li MJ, 2005, METH MOL B, V309, P261; MANOHARAN M, 2005, Patent No. 2005107325; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836	28	714	803	10	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1149	1157		10.1038/nbt1339	http://dx.doi.org/10.1038/nbt1339			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17873866				2022-12-25	WOS:000250226600026
J	Bantscheff, M; Eberhard, D; Abraham, Y; Bastuck, S; Boesche, M; Hobson, S; Mathieson, T; Perrin, J; Raida, M; Rau, C; Reader, V; Sweetman, G; Bauer, A; Bouwmeester, T; Hopf, C; Kruse, U; Neubauer, G; Ramsden, N; Rick, J; Kuster, B; Drewes, G				Bantscheff, Marcus; Eberhard, Dirk; Abraham, Yann; Bastuck, Sonja; Boesche, Markus; Hobson, Scott; Mathieson, Toby; Perrin, Jessica; Raida, Manfred; Rau, Christina; Reader, Valerie; Sweetman, Gavain; Bauer, Andreas; Bouwmeester, Tewis; Hopf, Carsten; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel; Rick, Jens; Kuster, Bernhard; Drewes, Gerard			Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors	NATURE BIOTECHNOLOGY			English	Article							BCR-ABL; AFFINITY-CHROMATOGRAPHY; IMATINIB MESYLATE; TYROSINE KINASE; PROTEIN-KINASES; DRUG; RESISTANT; DISCOVERY; TARGETS; BMS-354825	We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ). By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. By mapping drug-induced changes in the phosphorylation state of the captured proteome, we also analyze signaling pathways downstream of target kinases. Quantitative profiling of the drugs imatinib (Gleevec), dasatinib (Sprycel) and bosutinib in K562 cells confirms known targets including ABL and SRC family kinases and identifies the receptor tyrosine kinase DDR1 and the oxidoreductase NQO2 as novel targets of imatinib. The data suggest that our approach is a valuable tool for drug discovery.	Cellzome AG, D-69117 Heidelberg, Germany; Cellzome UK Ltd, Cambridge CB10 1XL, England	GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; Cellzome GmbH	Kuster, B (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bernhard.kuster@cellzome.com; gerard.drewes@cellzome.com	Bantscheff, Marcus/AAQ-2903-2021; Kuster, Bernhard/Q-6031-2016; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Kuster, Bernhard/0000-0002-9094-1677; Drewes, Gerard/0000-0003-0575-6766; Hopf, Carsten/0000-0003-0802-6451; Abraham, Yann/0000-0001-5600-5896; Mathieson, Toby/0000-0002-6153-3113				Avivi-Green C, 2006, AM J RESP CRIT CARE, V174, P420, DOI 10.1164/rccm.200603-333OC; Boschelli DH, 2004, J MED CHEM, V47, P1599, DOI 10.1021/jm0499458; Buchdunger E, 1996, CANCER RES, V56, P100; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; DREWES G, 2006, Patent No. 2006134056A1; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fabbro D, 2002, CURR OPIN DRUG DISC, V5, P701; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Golas JM, 2003, CANCER RES, V63, P375; Graves PR, 2002, MOL PHARMACOL, V62, P1364, DOI 10.1124/mol.62.6.1364; Hall SE, 2006, DRUG DISCOV TODAY, V11, P495, DOI 10.1016/j.drudis.2006.04.014; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Haystead TAJ, 2006, CURR TOP MED CHEM, V6, P1117; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Kneidinger M, 2006, BLOOD, V108, p398A; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Knox RJ, 2000, CANCER RES, V60, P4179; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; LOWE CR, 1973, BIOCHEM J, V133, P499, DOI 10.1042/bj1330499; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mol CD, 2004, CURR OPIN DRUG DISC, V7, P639; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rossler J, 2006, BIOCHEM BIOPH RES CO, V342, P1405, DOI 10.1016/j.bbrc.2006.02.059; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Shah NP, 2006, BLOOD, V108, P286, DOI 10.1182/blood-2005-10-3969; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; SZARDENINGS K, 2004, DRUG DISCOV TODAY TE, V3, P9; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vella F, 2005, BIOCHEM PHARMACOL, V71, P1, DOI 10.1016/j.bcp.2005.09.019; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wissing J, 2004, MOL CELL PROTEOMICS, V3, P1181, DOI 10.1074/mcp.M400124-MCP200; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005	50	819	872	2	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1035	1044		10.1038/nbt1328	http://dx.doi.org/10.1038/nbt1328			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17721511				2022-12-25	WOS:000249444200027
J	Norman, PJ; Abi-Rached, L; Gendzekhadze, K; Korbel, D; Gleimer, M; Rowley, D; Bruno, D; Carrington, CVF; Chandanayingyong, D; Chang, YH; Crespi, C; Saruhan-Direskeneli, G; Fraser, PA; Hameed, K; Kamkamidze, G; Koram, KA; Layrisse, Z; Matamoros, N; Mila, J; Park, MH; Pitchappan, RM; Ramdath, DD; Shiau, MY; Stephens, HAF; Struik, S; Verity, DH; Vaughan, RW; Tyan, D; Davis, RW; Riley, EM; Ronaghi, M; Parham, P				Norman, Paul J.; Abi-Rached, Laurent; Gendzekhadze, Ketevan; Korbel, Daniel; Gleimer, Michael; Rowley, Don; Bruno, Dan; Carrington, Christine V. F.; Chandanayingyong, Dasdayanee; Chang, Yih-Hsin; Crespi, Catalina; Saruhan-Direskeneli, Gueher; Fraser, Patricia A.; Hameed, Kamran; Kamkamidze, Giorgi; Koram, Kwadwo A.; Layrisse, Zulay; Matamoros, Nuria; Mila, Joan; Park, Myoung Hee; Pitchappan, Ramasamy M.; Ramdath, D. Dan; Shiau, Ming-Yuh; Stephens, Henry A. F.; Struik, Siske; Verity, David H.; Vaughan, Robert W.; Tyan, Dolly; Davis, Ronald W.; Riley, Eleanor M.; Ronaghi, Mostafa; Parham, Peter			Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans	NATURE GENETICS			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; CRYSTAL-STRUCTURE; HLA-B; CUTTING EDGE; GENES; KIR3DS1; HISTORY; COMPLEX; MODEL; POLYMORPHISMS	Interactions of killer cell immunoglobulin- like receptors ( KIRs) with major histocompatibility complex ( MHC) class I ligands diversify natural killer cell responses to infection. By analyzing sequence variation in diverse human populations, we show that the KIR3DL1/ S1 locus encodes two lineages of polymorphic inhibitory KIR3DL1 allotypes that recognize Bw4 epitopes of HLA- A and HLA- B and one lineage of conserved activating KIR3DS1 allotypes, also implicated in Bw4 recognition. Balancing selection has maintained these three lineages for over 3 million years. Variation was selected at D1 and D2 domain residues that contact HLA class I and at two sites on D0, the domain that enhances the binding of KIR3D to HLA class I. HLA- B variants that gained Bw4 through interallelic microconversion are also products of selection. A worldwide comparison uncovers unusual KIR3DL1/ S1 evolution in modern sub- Saharan Africans. Balancing selection is weak and confined to D0, KIR3DS1 is rare and KIR3DL1 allotypes with similar binding sites predominate. Natural killer cells express the dominant KIR3DL1 at a high frequency and with high surface density, providing strong responses to cells perturbed in Bw4 expression.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ W Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; Mahidol Univ, Fac Med, Dept Transfus Med, Bangkok 10700, Thailand; Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung 402, Taiwan; Hosp Univ Son Dureta, Serv Immunol, Palma de Mallorca 07014, Spain; Istanbul Univ, Dept Physiol, Fac Med, Istanbul, Turkey; CBR, Biomed Res Inst, Boston, MA 02115 USA; Aga Khan Univ Hosp, Dept Med, Karachi, Pakistan; REA Ctr, Dept Clin Immunol, GE-0160 Tbilisi, Georgia; Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; IVIC, Ctr Expt Med Miguel Layrisse, Caracas 21827, Venezuela; Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea; Madurai Kamaraj Univ, Sch Biol Sci, Ctr Adv Studies Funct Genom, Madurai 625021, Tamil Nadu, India; Hungkuang Univ, Inst Technol, Taichung 433, Taiwan; Royal Free & Unic Coll Med Sch, Ctr Nephrol & Anthony Nolan Trust, London NW3 2QG, England; Moorfields Eye Hosp, London EC1V 2PD, England; Guys & St Thomas Fdn Trust, Clin Transplantat Lab, London SE1 9RT, England; Kings Coll London, London SE1 9RT, England; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; University of London; London School of Hygiene & Tropical Medicine; Stanford University; University West Indies Mona Jamaica; University West Indies Saint Augustine; Mahidol University; Mahidol University; Chung Shan Medical University; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Istanbul University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Aga Khan University; University of Ghana; Venezuelan Institute Science Research; Seoul National University (SNU); Madurai Kamaraj University; Fooyin University; Hungkuang University; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; King's College London; Stanford University	Norman, PJ (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	paul.norman@stanford.edu; peropa@stanford.edu	Abi-Rached, Laurent/H-7236-2012; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; Crespí, Catalina/A-5543-2013; Park, Myoung Hee/J-5483-2012	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Crespí, Catalina/0000-0003-0781-9708; Korbel, Daniel/0000-0002-4682-9928; Carrington, Christine/0000-0001-6533-9302; Verity, David/0000-0001-6982-6896; Norman, Paul/0000-0001-8370-7703	NIAID NIH HHS [AI64520, AI24258, AI17892] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024258, R01AI017892, R55AI024258, P01AI064520, R37AI017892] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khakoo SI, 2002, J EXP MED, V196, P911, DOI 10.1084/jem.20020304; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Luque I, 1996, EUR J IMMUNOL, V26, P1974, DOI 10.1002/eji.1830260845; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Marsh SGE, 2003, IMMUNOGENETICS, V55, P220, DOI 10.1007/s00251-003-0571-z; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; TAJIMA F, 1989, GENETICS, V123, P585; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; WAN AM, 1986, J IMMUNOL, V137, P3671; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	49	182	186	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1092	1099		10.1038/ng2111	http://dx.doi.org/10.1038/ng2111			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694054				2022-12-25	WOS:000249122400018
J	St John, J; Lovell-Badge, R				St John, Justin; Lovell-Badge, Robin			Human-animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate	NATURE CELL BIOLOGY			English	Article							NUCLEAR TRANSFER; GENE-EXPRESSION; STEM-CELLS; DNA-REPLICATION; MOUSE; OOCYTES; MTDNA; FIBROBLASTS; TRANSPLANTATION; TRANSCRIPTION	Scientists are seeking permission to generate human embryonic stem cells to study disease by introducing human genetic material into an animal oocyte. this has raised ethical questions that centre on whether the entities being generated are actually human. the answer to these questions will determine how this area of research will be regulated and whether such work will be legal. the function of the extra-nuclear mitochondrial genome lies at the heart of these issues and forms the focus of this commentary.	Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; Univ Warwick, Warwick Med Sch, Reprod Genet Grp, Coventry CV2 2DX, W Midlands, England	MRC National Institute for Medical Research; University of Warwick	St John, J (corresponding author), Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, Ridgeway Mill Hill, London NW7 1AA, England.	j.c.st-john@warwick.ac.uk; rlovell@nimr.mrc.ac.uk	St. John, Justin C/A-2942-2010	St. John, Jus/0000-0002-3993-1449; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; Bowles EJ, 2007, GENETICS, V176, P1511, DOI 10.1534/genetics.106.070177; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Chang KH, 2003, FERTIL STERIL, V80, P1380, DOI 10.1016/j.fertnstert.2003.07.006; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; *DEP HLTH COMM, 2006, 698 DEP HLTH COMM; *EDIT, 2007, NATURE, V447, P353; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Holden C, 2005, SCIENCE, V310, P1402, DOI 10.1126/science.310.5753.1402; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; JOHN JC, 2004, REPRODUCTION, V127, P631; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; Moyes CD, 1998, J EXP BIOL, V201, P299; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pacheco-Trigon S, 2002, BIOL REPROD, V67, P1907, DOI 10.1095/biolreprod67.6.1907; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; SPOLSKY CM, 1972, FEBS LETT, V25, P319, DOI 10.1016/0014-5793(72)80514-3; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 2005, SCIENCE, V310, P1903; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang CX, 2003, MOL REPROD DEV, V65, P396, DOI 10.1002/mrd.10320	45	18	18	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					988	992		10.1038/ncb436	http://dx.doi.org/10.1038/ncb436			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762888				2022-12-25	WOS:000249256500002
J	Vogl, T; Tenbrock, K; Ludwig, S; Leukert, N; Ehrhardt, C; van Zoelen, MAD; Nacken, W; Foell, D; van der Poll, T; Sorg, C; Roth, J				Vogl, Thomas; Tenbrock, Klaus; Ludwig, Stephan; Leukert, Nadja; Ehrhardt, Christina; van Zoelen, Marieke A. D.; Nacken, Wolfgang; Foell, Dirk; van der Poll, Tom; Sorg, Clemens; Roth, Johannes			Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock	NATURE MEDICINE			English	Article							CALCIUM-BINDING PROTEINS; SEVERE SEPSIS; GENE-EXPRESSION; S100 PROTEINS; RECEPTOR; INNATE; MIGRATION; ALPHA; RESPONSIVENESS; PHAGOCYTES	To identify new components that regulate the inflammatory cascade during sepsis, we characterized the functions of myeloidrelated protein-8 (Mrp8, S100A8) and myeloid-related protein-14 (Mrp14, S100A9), two abundant cytoplasmic proteins of phagocytes. We now demonstrate that mice lacking Mrp8-Mrp14 complexes are protected from endotoxin-induced lethal shock and Escherichia coli-induced abdominal sepsis. Both proteins are released during activation of phagocytes, and Mrp8-Mrp14 complexes amplify the endotoxin-triggered inflammatory responses of phagocytes. Mrp8 is the active component that induces intracellular translocation of myeloid differentiation primary response protein 88 and activation of interleukin-1 receptor-associated kinase-1 and nuclear factor-kappa B, resulting in elevated expression of tumor necrosis factor-alpha (TNF-alpha). Using phagocytes expressing a nonfunctional Toll- like receptor 4 (TLR4), HEK293 cells transfected with TLR4, CD14 and MD2, and by surface plasmon resonance studies in vitro, we demonstrate that Mrp8 specifically interacts with the TLR4-MD2 complex, thus representing an endogenous ligand of TLR4. Therefore Mrp8-Mrp14 complexes are new inflammatory components that amplify phagocyte activation during sepsis upstream of TNF alpha-dependent effects.	Univ Munster, Inst Expt Dermatol, D-48129 Munster, Germany; Univ Munster, Interdisciplinary Ctr Clin Res, D-48129 Munster, Germany; Univ Munster, Dept Pediat, D-48129 Munster, Germany; Univ Munster, Inst Mol Virol, D-48129 Munster, Germany; Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands	University of Munster; University of Munster; University of Munster; University of Munster; University of Amsterdam; Academic Medical Center Amsterdam	Roth, J (corresponding author), Univ Munster, Inst Expt Dermatol, D-48129 Munster, Germany.	rothj@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052				Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Brandl K, 2005, J ENDOTOXIN RES, V11, P197, DOI 10.1179/096805105X58670; Clark MA, 1998, CRIT CARE MED, V26, P1650, DOI 10.1097/00003246-199810000-00016; Corr M, 2005, ARTHRITIS RHEUM, V52, P2233, DOI 10.1002/art.21214; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Fuellen G, 2003, TRENDS IMMUNOL, V24, P622, DOI 10.1016/j.it.2003.10.004; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Nacken W, 2000, EUR J BIOCHEM, V267, P560, DOI 10.1046/j.1432-1327.2000.01040.x; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Passey RJ, 1999, J IMMUNOL, V163, P2209; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; ROTH J, 1993, BLOOD, V82, P1875; Sampson B, 2002, LANCET, V360, P1742, DOI 10.1016/S0140-6736(02)11683-7; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tenbrock K, 2003, J IMMUNOL, V170, P2971, DOI 10.4049/jimmunol.170.6.2971; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051	46	971	1034	1	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1042	1049		10.1038/nm1638	http://dx.doi.org/10.1038/nm1638			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17767165				2022-12-25	WOS:000249353100031
J	Barnett, BP; Arepally, A; Karmarkar, PV; Qian, D; Gilson, WD; Walczak, P; Howland, V; Lawler, L; Lauzon, C; Stuber, M; Kraitchman, DL; Bulte, JWM				Barnett, Brad P.; Arepally, Aravind; Karmarkar, Parag V.; Qian, Di; Gilson, Wesley D.; Walczak, Piotr; Howland, Valerie; Lawler, Leo; Lauzon, Cal; Stuber, Matthias; Kraitchman, Dara L.; Bulte, Jeff W. M.			Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells	NATURE MEDICINE			English	Article							STEM-CELLS; PORCINE ISLETS; TRANSPLANTATION; NANOPARTICLES; INJECTION; REJECTION; TRACKING; ALGINATE; MODEL; MRI	In type I diabetes mellitus, islet transplantation provides a moment-to-moment fine regulation of insulin. Success rates vary widely, however, necessitating suitable methods to monitor islet delivery, engraftment and survival. Here magnetic resonance-trackable magnetocapsules have been used simultaneously to immunoprotect pancreatic beta-cells and to monitor, non-invasively in real-time, hepatic delivery and engraftment by magnetic resonance imaging (MRI). Magnetocapsules were detected as single capsules with an altered magnetic resonance appearance on capsule rupture. Magnetocapsules were functional in vivo because mouse beta-cells restored normal glycemia in streptozotocin-induced diabetic mice and human islets induced sustained C-peptide levels in swine. In this large-animal model, magnetocapsules could be precisely targeted for infusion by using magnetic resonance fluoroscopy, whereas MRI facilitated monitoring of liver engraftment over time. These findings are directly applicable to ongoing improvements in islet cell transplantation for human diabetes, particularly because our magnetocapsules comprise clinically applicable materials.	Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21212 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Arepally, A (corresponding author), Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St,Blalock 644, Baltimore, MD 21212 USA.	aarepal@jhmi.edu	Stuber, Matthias/B-2949-2010; Barnett, Brad/AAY-2578-2020; Walczak, Piotr/B-8707-2008; Barnett, Bradley/AAN-1628-2020; Bulte, Jeff W.M./A-3240-2008	Stuber, Matthias/0000-0001-9843-2028; Walczak, Piotr/0000-0002-3733-3322; Barnett, Bradley/0000-0002-8301-404X; Bulte, Jeff W.M./0000-0003-1202-1610	NIBIB NIH HHS [K08 EB004348, R01 EB007825] Funding Source: Medline; NINDS NIH HHS [R01 NS045062] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007825, K08EB004348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045062] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arepally A, 2006, RADIOLOGY, V238, P113, DOI 10.1148/radiol.2381041533; Ault A, 2003, LANCET, V361, P2054; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Cunningham CH, 2005, MAGNET RESON MED, V53, P999, DOI 10.1002/mrm.20477; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Hunkeler D, 2001, ANN NY ACAD SCI, V944, P456; Jacobson RM, 2005, VACCINE, V23, P2315, DOI 10.1016/j.vaccine.2005.01.025; Jirak D, 2004, MAGN RESON MED, V52, P1228, DOI 10.1002/mrm.20282; Karmarkar PV, 2004, MAGN RESON MED, V51, P1163, DOI 10.1002/mrm.20086; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Kriz J, 2005, TRANSPLANTATION, V80, P1596, DOI 10.1097/01.tp.0000183959.73681.b9; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Oca-Cossio J, 2004, BIOCHEM BIOPH RES CO, V319, P569, DOI 10.1016/j.bbrc.2004.04.195; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shen F, 2005, HUM GENE THER, V16, P971, DOI 10.1089/hum.2005.16.971; SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1; STUBER M, 2006, J CARDIOVASC MAGN R, V8, P13; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Toso C, 2005, CELL TRANSPLANT, V14, P159, DOI 10.3727/000000005783983223; Toso C, 2003, TRANSPLANT INT, V16, P405, DOI 10.1007/s00147-003-0555-9; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; White SA, 2000, CELL TRANSPLANT, V9, P19, DOI 10.1177/096368970000900103; ZHOU D, 1994, TRANSPLANT P, V26, P1091	30	183	186	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					986	991		10.1038/nm1581	http://dx.doi.org/10.1038/nm1581			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17660829				2022-12-25	WOS:000248674600031
J	Dierks, C; Grbic, J; Zirlik, K; Beigi, R; Englund, NP; Guo, GR; Veelken, H; Engelhardt, M; Mertelsmann, R; Kelleher, JF; Schultz, P; Warmuth, M				Dierks, Christine; Grbic, Jovana; Zirlik, Katja; Beigi, Ronak; Englund, Nathan P.; Guo, Gui-Rong; Veelken, Hendrik; Engelhardt, Monika; Mertelsmann, Roland; Kelleher, Joseph F.; Schultz, Peter; Warmuth, Markus			Essential role of stromally induced hedgehog signaling in B-cell malignancies	NATURE MEDICINE			English	Article							SONIC HEDGEHOG; C-MYC; ACTIVATION; GROWTH; MICE; PROLIFERATION; REQUIREMENT; EXPRESSION; DEFICIENT; MUTATIONS	Interaction of cancer cells with their microenvironment generated by stromal cells is essential for tumor cell survival and influences the localization of tumor growth. Here we demonstrate that hedgehog ligands secreted by bone-marrow, nodal and splenic stromal cells function as survival factors for malignant lymphoma and plasmacytoma cells derived from transgenic E mu-Myc mice or isolated from humans with these malignancies. Hedgehog pathway inhibition in lymphomas induced apoptosis through downregulation of Bc12, but was independent of p53 or Bmi1 expression. Blockage of hedgehog signaling in vivo inhibited expansion of mouse lymphoma cells in a syngeneic mouse model and reduced tumor mass in mice with fully developed disease. Our data indicate that stromally induced hedgehog signaling may provide an important survival signal for B- and plasma-cell malignancies in vitro and in vivo. Disruption of this interaction by hedgehog pathway inhibition could provide a new strategy in lymphoma and multiple myeloma therapy.	Novartis Res Fdn, Kinase Biol In Vivo Oncol, Dept Pharmacol, Genom Inst, San Diego, CA 92121 USA; Novartis Res Fdn, Dept Med Chem, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, San Diego, CA 92121 USA; Univ Freiburg, Dept Hematol Oncol, D-79111 Freiburg, Germany; Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Novartis; Novartis; Scripps Research Institute; University of Freiburg; Novartis	Dierks, C (corresponding author), Novartis Res Fdn, Kinase Biol In Vivo Oncol, Dept Pharmacol, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	chdierks@yahoo.de; mwarmuth@gnf.org	Dierks, Christine/L-4358-2013	Veelken, Hendrik/0000-0002-9108-3125				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; GeorgiiHemming P, 1996, BLOOD, V88, P2250, DOI 10.1182/blood.V88.6.2250.bloodjournal8862250; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kimlinger T, 2006, HAEMATOLOGICA, V91, P1033; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kobune M, 2004, BLOOD, V104, P1002, DOI 10.1182/blood-2003-09-3347; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Moller C, 2003, LEUKEMIA, V17, P203, DOI 10.1038/sj.leu.2402717; MULLER JR, 1995, CANCER RES, V55, P5012; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tassone P, 2005, CLIN CANCER RES, V11, P4251, DOI 10.1158/1078-0432.CCR-04-2611; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	46	266	287	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					944	951		10.1038/nm1614	http://dx.doi.org/10.1038/nm1614			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17632527				2022-12-25	WOS:000248674600025
J	Idzko, M; Hammad, H; van Nimwegen, M; Kool, M; Willart, MAM; Muskens, F; Hoogsteden, HC; Luttmann, W; Ferrari, D; Di Virgilio, F; Virchow, JC; Lambrecht, BN				Idzko, Marco; Hammad, Hamida; van Nimwegen, Menno; Kool, Mirjam; Willart, Monique A. M.; Muskens, Femke; Hoogsteden, Henk C.; Luttmann, Werner; Ferrari, Davide; Di Virgilio, Francesco; Virchow, J. Christian, Jr.; Lambrecht, Bart N.			Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells	NATURE MEDICINE			English	Article							NUCLEOTIDE RECEPTORS; PLATELET ACTIVATION; ADENINE-NUCLEOTIDES; ALLERGEN CHALLENGE; EPITHELIAL-CELLS; IMMUNE-RESPONSE; TH2 RESPONSES; LUNG; RELEASE; ADENOSINE	Extracellular ATP serves as a danger signal to alert the immune system of tissue damage by acting on P2X or P2Y receptors. Here we show that allergen challenge causes acute accumulation of ATP in the airways of asthmatic subjects and mice with experimentally induced asthma. All the cardinal features of asthma, including eosinophilic airway inflammation, Th2 cytokine production and bronchial hyper-reactivity, were abrogated when lung ATP levels were locally neutralized using apyrase or when mice were treated with broad-spectrum P2-receptor antagonists. In addition to these effects of ATP in established inflammation, Th2 sensitization to inhaled antigen was enhanced by endogenous or exogenous ATP. The adjuvant effects of ATP were due to the recruitment and activation of lung myeloid dendritic cells that induced Th2 responses in the mediastinal nodes. Together these data show that purinergic signaling has a key role in allergen-driven lung inflammation that is likely to be amenable to therapeutic intervention.	Univ Hosp Freiburg, Dept Pulm Med, D-79106 Freiburg, Germany; Erasmus Univ, Ctr Med, Dept Pulm Med, NL-3000 DR Rotterdam, Netherlands; Univ Hosp Rostock, Dept Pulm Med, D-18055 Rostock, Germany; Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, ICSI, I-44100 Ferrara, Italy	University of Freiburg; Erasmus University Rotterdam; University of Rostock; University of Ferrara; University of Ferrara	Idzko, M (corresponding author), Univ Hosp Freiburg, Dept Pulm Med, Killianstr 5, D-79106 Freiburg, Germany.	marco.idzko@uniklinik-freiburg.de; b.lambrecht@erasmusmc.nl	Ferrari, Davide/F-5644-2015; Lambrecht, Bart N/K-2484-2014; DI VIRGILIO, Francesco/O-4634-2019; Hammad, Hamida/J-9391-2015; Di Virgilio, Francesco/J-3754-2018	Ferrari, Davide/0000-0002-5727-9204; Lambrecht, Bart N/0000-0003-4376-6834; DI VIRGILIO, Francesco/0000-0003-3566-1362; Hammad, Hamida/0000-0003-3762-8603; Di Virgilio, Francesco/0000-0003-3566-1362				Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adriaensen D, 2004, CURR OPIN PHARMACOL, V4, P207, DOI 10.1016/j.coph.2004.01.010; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hollander GA, 1999, TRANSPL P, V31, p25S, DOI 10.1016/S0041-1345(98)02078-8; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kowal K, 2006, CLIN EXP ALLERGY, V36, P426, DOI 10.1111/j.1365-2222.2006.02446.x; la Sala A, 2002, BLOOD, V99, P1715, DOI 10.1182/blood.V99.5.1715; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Laubinger W, 2006, EUR J PHARMACOL, V543, P1, DOI 10.1016/j.ejphar.2006.06.029; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pelleg Amir, 2002, Am J Ther, V9, P454, DOI 10.1097/00045391-200209000-00014; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Pitchford SC, 2006, CLIN EXP ALLERGY, V36, P399, DOI 10.1111/j.1365-2222.2006.02462.x; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; van den Berge M, 2004, J ALLERGY CLIN IMMUN, V114, P737, DOI 10.1016/j.jaci.2004.05.071; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wilkin F, 2002, EUR J IMMUNOL, V32, P2409, DOI 10.1002/1521-4141(200209)32:9<2409::AID-IMMU2409>3.0.CO;2-H; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	49	465	487	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					913	919		10.1038/nm1617	http://dx.doi.org/10.1038/nm1617			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17632526				2022-12-25	WOS:000248674600021
J	Arts, HH; Doherty, D; van Beersum, SEC; Parisi, MA; Letteboer, SJF; Gorden, NT; Peters, TA; Marker, T; Voesenek, K; Kartono, A; Ozyurek, H; Farin, FM; Kroes, HY; Wolfrum, U; Brunner, HG; Cremers, FPM; Glass, IA; Knoers, NVAM; Roepman, R				Arts, Heleen H.; Doherty, Dan; van Beersum, Sylvia E. C.; Parisi, Melissa A.; Letteboer, Stef J. F.; Gorden, Nicholas T.; Peters, Theo A.; Maerker, Tina; Voesenek, Krysta; Kartono, Aileen; Ozyurek, Hamit; Farin, Federico M.; Kroes, Hester Y.; Wolfrum, Uwe; Brunner, Han G.; Cremers, Frans P. M.; Glass, Ian A.; Knoers, Nine V. A. M.; Roepman, Ronald			Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; PIGMENTOSA GTPASE REGULATOR; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; CHOROID-PLEXUS; SENIOR-LOKEN; CILIA; PHOTORECEPTORS; DELETION; CEP290	Protein- protein interaction analyses have uncovered a ciliary and basal body protein network that, when disrupted, can result in nephronophthisis ( NPHP), Leber congenital amaurosis, Senior- Loken syndrome ( SLSN) or Joubert syndrome ( JBTS)(1-6). However, details of the molecular mechanisms underlying these disorders remain poorly understood. RPGRIP1- like protein ( RPGRIP1L) is a homolog of RPGRIP1 ( RPGR-interacting protein 1), a ciliary protein defective in Leber congenital amaurosis(7,8). We show that RPGRIP1L interacts with nephrocystin- 4 and that mutations in the gene encoding nephrocystin- 4 ( NPHP4) that are known to cause SLSN disrupt this interaction. RPGRIP1L is ubiquitously expressed, and its protein product localizes to basal bodies. Therefore, we analyzed RPGRIP1L as a candidate gene for JBTS and identified loss- of- function mutations in three families with typical JBTS, including the characteristic mid- hindbrain malformation. This work identifies RPGRIP1L as a gene responsible for JBTS and establishes a central role for cilia and basal bodies in the pathophysiology of this disorder.	Radboud Univ Nijmegen, Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Univ Mainz, Inst Zool, D-55099 Mainz, Germany; Ondokuz Mayis Univ, Dept Pediat, TR-55139 Kurupelit, Turkey; Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Univ Utrecht, Med Ctr, Div Biomed Genet, NL-3508 AB Utrecht, Netherlands	Radboud University Nijmegen; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Johannes Gutenberg University of Mainz; Ondokuz Mayis University; University of Washington; University of Washington Seattle; Utrecht University	Roepman, R (corresponding author), Radboud Univ Nijmegen, Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	r.roepman@antrg.umcn.nl	Peters, T.A./L-4571-2015; Brunner, Han/C-9928-2013; Roepman, Ronald/B-1339-2014; van Beersum, Sylvia E.C./P-8653-2015; Cremers, Frans/A-5625-2014; arts, heleen/ACL-6040-2022; Letteboer, Stef JF/P-8272-2015	Peters, T.A./0000-0001-8443-5500; Roepman, Ronald/0000-0002-5178-8163; van Beersum, Sylvia E.C./0000-0002-4552-2908; Cremers, Frans/0000-0002-4954-5592; Arts, Heleen/0000-0002-9860-3744	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD046712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045832] Funding Source: NIH RePORTER; NCRR NIH HHS [K12-RR023265] Funding Source: Medline; NICHD NIH HHS [P30 HD02274, K24-HD46712] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NINDS NIH HHS [K23-NS45832] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DOOLIN PF, 1966, J CELL BIOL, V29, P333, DOI 10.1083/jcb.29.2.333; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Mogensen MM, 2000, J CELL SCI, V113, P3013; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Pellegrino JE, 1997, AM J MED GENET, V72, P59, DOI 10.1002/(SICI)1096-8628(19971003)72:1<59::AID-AJMG12>3.0.CO;2-T; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rattner A, 2004, J BIOL CHEM, V279, P42202, DOI 10.1074/jbc.M407928200; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Roepman R, 2000, METHOD ENZYMOL, V316, P688; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Satran D, 1999, AM J MED GENET, V86, P459; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107	30	242	250	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					882	888		10.1038/ng2069	http://dx.doi.org/10.1038/ng2069			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558407				2022-12-25	WOS:000247619800019
J	Chen, F; Dixon, RA				Chen, Fang; Dixon, Richard A.			Lignin modification improves fermentable sugar yields for biofuel production	NATURE BIOTECHNOLOGY			English	Article							DOWN-REGULATION; ALFALFA; FORAGE; ACID; SHIKIMATE; PLANTS; COA	Recalcitrance to saccharification is a major limitation for conversion of lignocellulosic biomass to ethanol. In stems of transgenic alfalfa lines independently downregulated in each of six lignin biosynthetic enzymes, recalcitrance to both acid pretreatment and enzymatic digestion is directly proportional to lignin content. Some transgenics yield nearly twice as much sugar from cell walls as wild-type plants. Lignin modification could bypass the need for acid pretreatment and thereby facilitate bioprocess consolidation.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Dixon, RA (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	fchen@noble.org; radixon@noble.org						Badger P. C., 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P17; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Davison BH, 2006, APPL BIOCHEM BIOTECH, V130, P427, DOI 10.1385/ABAB:130:1:427; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Guo DG, 2001, TRANSGENIC RES, V10, P457, DOI 10.1023/A:1012278106147; Hamelinck CN, 2005, BIOMASS BIOENERG, V28, P384, DOI 10.1016/j.biombioe.2004.09.002; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; O'Connell A, 2002, TRANSGENIC RES, V11, P495, DOI 10.1023/A:1020362705497; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003; Vogel KP, 2001, CRIT REV PLANT SCI, V20, P15, DOI 10.1016/S0735-2689(01)80011-3	14	964	1023	11	393	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					759	761		10.1038/nbt1316	http://dx.doi.org/10.1038/nbt1316			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17572667				2022-12-25	WOS:000247994000026
J	Darrah, PA; Patel, DT; De Luca, PM; Lindsay, RWB; Davey, DF; Flynn, BJ; Hoff, ST; Andersen, P; Reed, SG; Morris, SL; Roederer, M; Seder, RA				Darrah, Patricia A.; Patel, Dipti T.; De Luca, Paula M.; Lindsay, Ross W. B.; Davey, Dylan F.; Flynn, Barbara J.; Hoff, Soren T.; Andersen, Peter; Reed, Steven G.; Morris, Sheldon L.; Roederer, Mario; Seder, Robert A.			Multifunctional T(H)1 cells define a correlate of vaccine-mediated protection against Leishmania major	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; CD8(+) T-CELLS; INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; FLOW-CYTOMETRY; MEMORY CD4(+); NITRIC-OXIDE; IN-VIVO; INFECTION	CD4(+) T cells have a crucial role in mediating protection against a variety of pathogens through production of specific cytokines. However, substantial heterogeneity in CD4(+) T-cell cytokine responses has limited the ability to define an immune correlate of protection after vaccination. Here, using multiparameter flow cytometry to assess the immune responses after immunization, we show that the degree of protection against Leishmania major infection in mice is predicted by the frequency of CD4(+) T cells simultaneously producing interferon-gamma, interleukin-2 and tumor necrosis factor. Notably, multifunctional effector cells generated by all vaccines tested are unique in their capacity to produce high amounts of interferon-gamma. These data show that the quality of a CD4(+) T-cell cytokine response can be a crucial determinant in whether a vaccine is protective, and may provide a new and useful prospective immune correlate of protection for vaccines based on T-helper type 1 (T(H)1) cells.	NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; Infect Dis Res Inst, Seattle, WA 98104 USA; US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis & Cellular Immunol, Bethesda, MD 20892 USA; NIAID, Vaccine Res Ctr, ImmunoTechnol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Statens Serum Institut; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Seder, RA (corresponding author), NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	Roederer, Mario/G-1887-2011	Andersen, Peter/0000-0002-5869-2551	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005017, Z01AI005021, ZIAAI005021, Z01AI005016, ZIAAI005018, ZIAAI005017, ZIAAI005016, Z01AI005018] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Barouch DH, 2006, J PATHOL, V208, P283, DOI 10.1002/path.1874; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gicheru MM, 2001, INFECT IMMUN, V69, P245, DOI 10.1128/IAI.69.1.245-251.2001; Hayashi N, 2002, P NATL ACAD SCI USA, V99, P6187, DOI 10.1073/pnas.092129899; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jelley-Gibbs DM, 2005, J EXP MED, V201, P1101, DOI 10.1084/jem.20041852; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LIEW FY, 1990, J IMMUNOL, V145, P4306; Modabber F, 1995, ANN TROP MED PARASIT, V89, P83, DOI 10.1080/00034983.1995.11813017; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Oliveira MR, 2005, PARASITOLOGY, V131, P477, DOI 10.1017/S0031182005008073; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scott P, 2003, IMMUNOL RES, V27, P489, DOI 10.1385/IR:27:2-3:489; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; von Stebut E, 2002, J INVEST DERMATOL, V119, P621, DOI 10.1046/j.1523-1747.2002.01850.x; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	49	1058	1088	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					843	850		10.1038/nm1592	http://dx.doi.org/10.1038/nm1592			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17558415	Bronze			2022-12-25	WOS:000247902800031
J	Dickins, RA; McJunkin, K; Hernando, E; Premsrirut, PK; Krizhanovsky, V; Burgess, DJ; Kim, SY; Cordon-Cardo, C; Zender, L; Hannon, GJ; Lowe, SW				Dickins, Ross A.; McJunkin, Katherine; Hernando, Eva; Premsrirut, Prem K.; Krizhanovsky, Valery; Burgess, Darren J.; Kim, Sang Yong; Cordon-Cardo, Carlos; Zender, Lars; Hannon, Gregory J.; Lowe, Scott W.			Tissue-specific and reversible RNA interference in transgenic mice	NATURE GENETICS			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; IN-VIVO; P53 RESTORATION; MOUSE; PHENOTYPES; APOPTOSIS; MYC; LYMPHOMAGENESIS; TUMORIGENESIS	Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline ( tet)- responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference ( RNAi) in mice. Transgenic mice harboring a tet- responsive RNA polymerase II promoter driving a microRNA- based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue- specific 'tet- on' or 'tet- off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue- specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012; Krizhanovsky, Valery/D-1336-2010	Dickins, Ross A/0000-0003-4112-5304; Krizhanovsky, Valery/0000-0002-3977-5482; Kim, Sang Yong/0000-0001-7326-7505; McJunkin, Katherine/0000-0001-9730-442X; Burgess, Darren/0000-0002-8434-7540; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P01 CA013106, P30 CA008748, P01 CA087497] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA087497, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Ceccarelli AV, 2002, COMPARATIVE MED, V52, P171; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fritsch L, 2004, EMBO REP, V5, P178, DOI 10.1038/sj.embor.7400064; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HSU B, 1995, ONCOGENE, V11, P175; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	39	135	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					914	921		10.1038/ng2045	http://dx.doi.org/10.1038/ng2045			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572676	Green Accepted			2022-12-25	WOS:000247619800024
J	Fontana, L; Pelosi, E; Greco, P; Racanicchi, S; Testa, U; Liuzzi, F; Croce, CM; Brunetti, E; Grignani, F; Peschle, C				Fontana, Laura; Pelosi, Elvira; Greco, Paolo; Racanicchi, Serena; Testa, Ugo; Liuzzi, Francesca; Croce, Carlo M.; Brunetti, Ercole; Grignani, Francesco; Peschle, Cesare			MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation	NATURE CELL BIOLOGY			English	Article							COLONY-STIMULATING FACTOR; DIFFERENTIATION; GENE; ERYTHROPOIESIS; IDENTIFICATION; HEMATOPOIESIS; EXPRESSION; PROMOTES; LEUKEMIA; GROWTH	We investigated the role of microRNAs (miRNA) 17-5p, 20a and 106a in monocytic differentiation and maturation. In unilineage monocytic culture generated by haematopoietic progenitor cells these miRNAs are downregulated, whereas the transcription factor acute myeloid leukaemia-1 (AML1; also known as Runt-related transcription factor 1, Runx1) is upregulated at protein but not mRNA level. As miRNAs 17-5p, 20a and 106a bind the AML1 mRNA 3'UTR, their decline may unblock AML1 translation. Accordingly, transfection with miRNA 17-5p-20a-106a suppresses AML1 protein expression, leading to M- CSF receptor (M-CSFR) downregulation, enhanced blast proliferation and inhibition of monocytic differentiation and maturation. Treatment with anti-miRNA 17-5p, 20a and 106a causes opposite effects. Knockdown of AML1 or M-CSFR by short interfering RNA (siRNA) mimics the action of the miRNA 17-5p-20a-106a, confirming that these miRNAs target AML1, which promotes M-CSFR transcription. In addition, AML1 binds the miRNA 17-5p-92 and 106a-92 cluster promoters and transcriptionally inhibits the expression of miRNA 17-5p 20a -106a. These studies indicate that monocytopoiesis is controlled by a circuitry involving sequentially miRNA 17-5p-20a-106a, AML1 and M-CSFR, whereby miRNA 17-5p-20a-106a function as a master gene complex interlinked with AML1 in a mutual negative feedback loop.	Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; Univ Perugia, Dept Gen Pathol, I-06100 Perugia, Italy; Ohio State Univ, Columbus, OH 43210 USA; San Pietro FBF, Ctr Ric AFaR, I-00189 Rome, Italy	Istituto Superiore di Sanita (ISS); University of Perugia; University System of Ohio; Ohio State University	Fontana, L (corresponding author), Ist Super Sanita, Dept Haematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lfontana@iss.it; c.peschle@iss.it	Testa, Ugo/J-6472-2016; Young, Richard A/F-6495-2012; pelosi, elvira/J-7298-2016; Grignani, Francesco/AAC-2565-2022	Testa, Ugo/0000-0001-7900-8942; Young, Richard A/0000-0001-8855-8647; pelosi, elvira/0000-0002-3043-6249; 	NHLBI NIH HHS [1R01HL63168] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063168] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Frank R, 1995, ONCOGENE, V11, P2667; Gordon AT, 2000, GENE CHROMOSOME CANC, V28, P220, DOI 10.1002/(SICI)1098-2264(200006)28:2<220::AID-GCC11>3.3.CO;2-K; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuchenbauer F, 2005, CELL CYCLE, V4, P1716, DOI 10.4161/cc.4.12.2256; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rhoades KL, 2000, BLOOD, V96, P2108; Schmidt H, 2005, MODERN PATHOL, V18, P638, DOI 10.1038/modpathol.3800326; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; STANLEY ER, 1986, CIBA F SYMP, V118, P29, DOI 10.1002/9780470720998.ch3; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Testa U, 1996, BLOOD, V88, P3391, DOI 10.1182/blood.V88.9.3391.bloodjournal8893391; Uchida H, 1997, J IMMUNOL, V158, P2251; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Zeuner A, 2006, BLOOD, V107, P3495, DOI 10.1182/blood-2005-07-3037; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Ziegler B, 1998, Stem Cells, V16 Suppl 1, P51	50	363	401	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					775	U90		10.1038/ncb1613	http://dx.doi.org/10.1038/ncb1613			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17589498				2022-12-25	WOS:000247760700013
J	Iioka, H; Iemura, S; Natsume, T; Kinoshita, N				Iioka, Hidekazu; Iemura, Shun-ichiro; Natsume, Tohru; Kinoshita, Noriyuki			Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility	NATURE CELL BIOLOGY			English	Article							RING FINGER PROTEIN; CONVERGENT EXTENSION; GASTRULATION MOVEMENTS; ACTIN DYNAMICS; FOCAL ADHESION; PROTEASOME; POLARITY; XWNT11; TALIN; PKC	Gastrulation movements are critical for establishing the three germ layers and the architecture of vertebrate embryos. During Xenopus laevis gastrulation, mesodermal tissue migrates on the blastocoel roof and elongates along the antero-posterior axis(1),(2). During this process, cells in the dorsal mesoderm are polarized and intercalate with each other, which is defined as convergent extension and is known to be regulated by the non-canonical Wnt pathway(3-5). Here, we show that paxillin plays an essential role in this process. Paxillin is a focal-adhesion associated protein implicated in the regulation of actin cytoskeletal organization and cell motility(6),7, but its role in Xenopus embryogenesis has not yet been clarified. We demonstrate that the Wnt pathway controls the ubiquitination and stability of paxillin, and that this regulatory mechanism is essential for convergent extension movements. We identified a RING finger protein XRNF185, which physically binds to paxillin and the proteasome. XRNF185 destabilizes paxillin at focal adhesions and promotes mesodermal cell migration during convergent extension. We propose a mechanism to regulate gastrulation movements that involves paxillin ubiquitination and stability controlled by Wnt signalling.	Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan; Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; Biol Informat Res Ctr, Tokyo 1350064, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Advanced Industrial Science & Technology (AIST); Graduate University for Advanced Studies - Japan	Kinoshita, N (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan.	nkinoshi@nibb.ac.jp	Iioka, Hidekazu/AAB-1424-2021; Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Kinoshita, Noriyuki/0000-0002-1362-4045; Iioka, Hidekazu/0000-0002-2639-8315				Broday L, 2004, J CELL BIOL, V165, P857, DOI 10.1083/jcb.200401133; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Li M, 2004, DEV BIOL, V275, P202, DOI 10.1016/j.ydbio.2004.08.005; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Tada M, 2000, DEVELOPMENT, V127, P2227; TOKUMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P1106, DOI 10.1006/bbrc.1993.1531; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	32	47	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					813	U150		10.1038/ncb1607	http://dx.doi.org/10.1038/ncb1607			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558393				2022-12-25	WOS:000247760700017
J	Miller, JC; Holmes, MC; Wang, JB; Guschin, DY; Lee, YL; Rupniewski, I; Beausejour, CM; Waite, AJ; Wang, NS; Kim, KA; Gregory, PD; Pabo, CO; Rebar, EJ				Miller, Jeffrey C.; Holmes, Michael C.; Wang, Jianbin; Guschin, Dmitry Y.; Lee, Ya-Li; Rupniewski, Igor; Beausejour, Christian M.; Waite, Adam J.; Wang, Nathaniel S.; Kim, Kenneth A.; Gregory, Philip D.; Pabo, Carl O.; Rebar, Edward J.			An improved zinc-finger nuclease architecture for highly specific genome editing	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; DNA-RECOGNITION; IN-VIVO; RESTRICTION-ENDONUCLEASE; COMPUTATIONAL REDESIGN; TRANSCRIPTION FACTORS; HOMING ENDONUCLEASES; GENE-REGULATION	Genome editing driven by zinc-finger nucleases (ZFNs) yields high gene-modification efficiencies (> 10%) by introducing a recombinogenic double-strand break into the targeted gene. The cleavage event is induced using two custom-designed ZFNs that heterodimerize upon binding DNA to form a catalytically active nuclease complex. Using the current ZFN architecture, however, cleavage-competent homodimers may also form that can limit safety or efficacy via off- target cleavage. Here we develop an improved ZFN architecture that eliminates this problem. Using structure-based design, we engineer two variant ZFNs that efficiently cleave DNA only when paired as a heterodimer. These ZFNs modify a native endogenous locus as efficiently as the parental architecture, but with a > 40-fold reduction in homodimer function and much lower levels of genome- wide cleavage. This architecture provides a general means for improving the specificity of ZFNs as gene modification reagents.	Sangamo BioSci Inc, Pt Richmond Tech Ctr, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Rebar, EJ (corresponding author), Sangamo BioSci Inc, Pt Richmond Tech Ctr, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA.	erebar@sangamo.com	Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018; Wilson, Matthew H/K-3193-2013	Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; Gregory, Philip/0000-0001-9249-2468; Waite, Adam/0000-0002-3537-7313				Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Chames P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni175; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Guan X, 2002, P NATL ACAD SCI USA, V99, P13296, DOI 10.1073/pnas.192412899; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; KACZOROWSKI T, 1989, GENE, V80, P209, DOI 10.1016/0378-1119(89)90285-0; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Miller JC, 2001, J MOL BIOL, V313, P309, DOI 10.1006/jmbi.2001.4975; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Nohaile MJ, 2001, P NATL ACAD SCI USA, V98, P3109, DOI 10.1073/pnas.051624498; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Richardson C, 1999, METH MOL B, V113, P453; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Zhu ZP, 1997, PROTEIN SCI, V6, P781	57	752	966	7	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					778	785		10.1038/nbt1319	http://dx.doi.org/10.1038/nbt1319			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17603475				2022-12-25	WOS:000247994000029
J	Carrico, IS; Carlson, BL; Bertozzi, CR				Carrico, Isaac S.; Carlson, Brian L.; Bertozzi, Carolyn R.			Introducing genetically encoded aldehydes into proteins	NATURE CHEMICAL BIOLOGY			English	Article							MULTIPLE SULFATASE DEFICIENCY; CELL-SURFACE PROTEINS; FORMYLGLYCINE; GENE; MOLECULES; CYSTEINE	Methods for introducing bioorthogonal functionalities into proteins have become central to protein engineering efforts. Here we describe a method for the site-specific introduction of aldehyde groups into recombinant proteins using the 6-amino-acid consensus sequence recognized by the formylglycine-generating enzyme. This genetically encoded 'aldehyde tag' is no larger than a His(6) tag and can be exploited for numerous protein labeling applications.	Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, B84 Hildebrand Hall, Berkeley, CA 94720 USA.	crb@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059907] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59907] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Clarke KM, 2005, J AM CHEM SOC, V127, P11234, DOI 10.1021/ja052911k; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Yin J, 2004, J AM CHEM SOC, V126, P7754, DOI 10.1021/ja047749k	15	329	360	6	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2007	3	6					321	322		10.1038/nchembio878	http://dx.doi.org/10.1038/nchembio878			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172PN	17450134				2022-12-25	WOS:000246816400009
J	Buffin, E; Emre, D; Karess, RE				Buffin, Eulalie; Emre, Doruk; Karess, Roger E.			Flies without a spindle checkpoint	NATURE CELL BIOLOGY			English	Article							MITOTIC CHECKPOINT; CHROMOSOME MISSEGREGATION; ROUGH DEAL; CYCLIN-B; DROSOPHILA; MAD2; MITOSIS; CDC20; KINETOCHORE; REVEALS	Mad2 has a key role in the spindle- assembly checkpoint (SAC) - the mechanism delaying anaphase onset until all chromosomes correctly attach to the spindle. Here, we show that unlike every other reported case of SAC inactivation in metazoans, mad2-null Drosophila are viable and fertile, and their cells almost always divide correctly despite having no SAC and an accelerated 'clock', which is caused by premature degradation of cyclin B. Mitosis in Drosophila does not need the SAC because correct chromosome attachment is achieved very rapidly, before even the cell lacking Mad2 can initiate anaphase. Experimentally reducing spindle-assembly efficiency renders the cells Mad2-dependent. In fact, the robustness of the SAC may generally mask minor mitotic defects of mutations affecting spindle function. The reported lethality of other Drosophila SAC mutations may be explained by their multifunctionality, and thus the 'checkpoint' phenotypes previously ascribed to these mutations should be considered the consequence of eliminating both the checkpoint and a second mitotic function.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Karess, RE (corresponding author), CNRS, Ctr Genet Mol, Ave Terrasse, F-91198 Gif Sur Yvette, France.	karess@cgm.cnrs-gif.fr		Karess, Roger/0000-0002-7299-0600; Buffin, Eulalie/0000-0002-0471-7258				Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; KARESS RE, 1989, J CELL BIOL, V109, P2951, DOI 10.1083/jcb.109.6.2951; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Lopes CS, 2005, J CELL SCI, V118, P187, DOI 10.1242/jcs.01602; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Savoian MS, 2002, J CELL SCI, V115, P3061; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759	32	97	99	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					565	U150		10.1038/ncb1570	http://dx.doi.org/10.1038/ncb1570			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417628				2022-12-25	WOS:000246181500015
J	Care, A; Catalucci, D; Felicetti, F; Bonci, D; Addario, A; Gallo, P; Bang, ML; Segnalini, P; Gu, YS; Dalton, ND; Elia, L; Latronico, MVG; Hoydal, M; Autore, C; Russo, MA; Dorn, GW; Ellingsen, O; Ruiz-Lozano, P; Peterson, KL; Croce, CM; Peschle, C; Condorelli, G				Care, Alessandra; Catalucci, Daniele; Felicetti, Federica; Bonci, Desiree; Addario, Antonio; Gallo, Paolo; Bang, Marie-Louise; Segnalini, Patrizia; Gu, Yusu; Dalton, Nancy D.; Elia, Leonardo; Latronico, Michael V. G.; Hoydal, Morten; Autore, Camillo; Russo, Matteo A.; Dorn, Gerald W., II; Ellingsen, Oyvind; Ruiz-Lozano, Pilar; Peterson, Kirk L.; Croce, Carlo M.; Peschle, Cesare; Condorelli, Gianluigi			MicroRNA-133 controls cardiac hypertrophy	NATURE MEDICINE			English	Article							IN-VIVO; CELL-GROWTH; EXPRESSION; HEART	Growing evidence indicates that microRNAs (miRNAs or miRs) are involved in basic cell functions and oncogenesis. Here we report that miR-133 has a critical role in determining cardiomyocyte hypertrophy. We observed decreased expression of both miR-133 and miR-1, which belong to the same transcriptional unit, in mouse and human models of cardiac hypertrophy. In vitro overexpression of miR-133 or miR-1 inhibited cardiac hypertrophy. In contrast, suppression of miR-133 by 'decoy' sequences induced hypertrophy, which was more pronounced than that after stimulation with conventional inducers of hypertrophy. In vivo inhibition of miR-133 by a single infusion of an antagomir caused marked and sustained cardiac hypertrophy. We identified specific targets of miR-133: RhoA, a GDP-GTP exchange protein regulating cardiac hypertrophy; Cdc42, a signal transduction kinase implicated in hypertrophy; and Nelf-A/WHSC2, a nuclear factor involved in cardiogenesis. Our data show that miR-133, and possibly miR-1, are key regulators of cardiac hypertrophy, suggesting their therapeutic application in heart disease.	Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; IRCCS Multimedia, I-20099 Milan, Italy; San Raffaele Biomed Sci Pk, I-00128 Rome, Italy; Norwegian Univ Sci & Technol, N-7491 Trondheim, Norway; Univ Roma La Sapienza, Fac Med 2, I-00161 Rome, Italy; IRCCS, I-00163 Rome, Italy; Univ Cincinnati, Div Cardiol, Cincinnati, OH 45267 USA; Burnham Inst Med Res, La Jolla, CA 92037 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Istituto Superiore di Sanita (ISS); University of California System; University of California San Diego; IRCCS Multimedica; Norwegian University of Science & Technology (NTNU); Sapienza University Rome; University System of Ohio; University of Cincinnati; Sanford Burnham Prebys Medical Discovery Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Peschle, C (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	cesare.peschle@iss.it; gcondorelli@ucsd.edu	Addario, Antonio/AAC-4707-2022; Latronico, Michael/AAB-3691-2019; Catalucci, Daniele/B-6745-2015; Catalucci, Daniele/AAA-6056-2022; gu, yu/GSD-4507-2022; CARE', Alessandra/H-5090-2016; Elia, Leonardo/A-3749-2016; Young, Richard A/F-6495-2012; Bang, Marie-Louise/B-5683-2015; Felicetti, Federica/N-7077-2017; Høydal, Morten A/K-2806-2012; Russo, Matteo/AAD-7733-2021; Bonci, Desiree/K-6488-2016; Condorelli, Gianluigi/Q-6736-2017	Addario, Antonio/0000-0001-8527-8738; Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; CARE', Alessandra/0000-0003-4106-3342; Elia, Leonardo/0000-0001-5011-0206; Young, Richard A/0000-0001-8855-8647; Bang, Marie-Louise/0000-0001-8859-5034; Felicetti, Federica/0000-0003-4628-0696; Høydal, Morten A/0000-0003-1804-2578; Bonci, Desiree/0000-0002-2472-5140; autore, camillo/0000-0002-6542-7342; Latronico, Michele/0000-0003-4017-5764; Condorelli, Gianluigi/0000-0003-0481-6843	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063168, R01HL078797] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL078797-01A1, 1R01HL63168] Funding Source: Medline; PHS HHS [HLO65484] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ikeda Y, 2003, GENE THER, V10, P1161, DOI 10.1038/sj.gt.3301973; Iwatate M, 2003, GENE THER, V10, P1814, DOI 10.1038/sj.gt.3302077; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Nagai T, 2003, BIOCHEM BIOPH RES CO, V305, P806, DOI 10.1016/S0006-291X(03)00838-6; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	29	1418	1548	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					613	618		10.1038/nm1582	http://dx.doi.org/10.1038/nm1582			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17468766				2022-12-25	WOS:000246302800029
J	Dierick, HA; Greenspan, RJ				Dierick, Herman A.; Greenspan, Ralph J.			Serotonin and neuropeptide F have opposite modulatory effects on fly aggression	NATURE GENETICS			English	Article							TARGETED GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; BEHAVIOR; DOPAMINE; NEURONS; RECEPTOR; SYSTEMS; BRAIN	Both serotonin (5-HT) and neuropeptide Y have been shown to affect a variety of mammalian behaviors(1-3), including aggression(4,5). Here we show in Drosophila melanogaster that both 5-HT and neuropeptide F, the invertebrate homolog of neuropeptide Y, modulate aggression. We show that drug-induced increases of 5-HT in the fly brain increase aggression. Elevating 5-HT genetically in the serotonergic circuits recapitulates these pharmacological effects, whereas genetic silencing of these circuits makes the flies behaviorally unresponsive to the drug-induced increase of 5-HT but leaves them capable of aggression. Genetic silencing of the neuropeptide F (npf) circuit also increases fly aggression, demonstrating an opposite modulation to 5-HT. Moreover, this neuropeptide F effect seems to be independent of 5-HT. The implication of these two modulatory systems in fly and mouse aggression suggest a marked degree of conservation and a deep molecular root for this behavior.	Inst Neurosci, San Diego, CA 92121 USA		Dierick, HA (corresponding author), Inst Neurosci, 10640 John J Hopkins Dr, San Diego, CA 92121 USA.	dierick@nsi.edu						Baier A, 2002, J EXP BIOL, V205, P1233; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carvajal C., 2006, CNS & Neurological Disorders-Drug Targets, V5, P181, DOI 10.2174/187152706776359592; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Cransac H, 1996, J NEURAL TRANSM, V103, P391, DOI 10.1007/BF01276416; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Karl T, 2004, P NATL ACAD SCI USA, V101, P12742, DOI 10.1073/pnas.0404085101; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lindsey JW, 1998, J TOXICOL ENV HEAL A, V54, P421; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Popova NK, 2006, BIOESSAYS, V28, P495, DOI 10.1002/bies.20412; SLEMMON JR, 1982, J BIOL CHEM, V257, P3847; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	29	218	222	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					678	682		10.1038/ng2029	http://dx.doi.org/10.1038/ng2029			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17450142				2022-12-25	WOS:000245971300026
J	Grohmann, U; Volpi, C; Fallarino, F; Bozza, S; Bianchi, R; Vacca, C; Orabona, C; Belladonna, ML; Ayroldi, E; Nocentini, G; Boon, L; Bistoni, F; Fioretti, MC; Romani, L; Riccardi, C; Puccetti, P				Grohmann, Ursula; Volpi, Claudia; Fallarino, Francesca; Bozza, Silvia; Bianchi, Roberta; Vacca, Carmine; Orabona, Ciriana; Belladonna, Maria L.; Ayroldi, Emira; Nocentini, Giuseppe; Boon, Louis; Bistoni, Francesco; Fioretti, Maria C.; Romani, Luigina; Riccardi, Carlo; Puccetti, Paolo			Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy	NATURE MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; KAPPA-B ACTIVATION; REGULATORY T-CELLS; TRYPTOPHAN CATABOLISM; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNOSUPPRESSIVE PATHWAY; CUTTING EDGE; CO-STIMULATION; RECEPTOR; TOLERANCE	Glucocorticoid-induced tumor necrosis factor receptor (GITR) on T cells and its natural ligand, GITRL, on accessory cells contribute to the control of immune homeostasis. Here we show that reverse signaling through GITRL after engagement by soluble GITR initiates the immunoregulatory pathway of tryptophan catabolism in mouse plasmacytoid dendritic cells, by means of noncanonical NF-kappa B-dependent induction of indoleamine 2,3-dioxygenase (IDO). The synthetic glucocorticoid dexamethasone administered in vivo activated IDO through the symmetric induction of GITR in CD4+ T cells and GITRL in plasmacytoid dendritic cells. The drug exerted IDO-dependent protection in a model of allergic airway inflammation. Modulation of tryptophan catabolism via the GITR-GITRL coreceptor system might represent an effective therapeutic target in immune regulation. Induction of IDO could be an important mechanism underlying the anti-inflammatory action of corticosteroids.	Univ Perugia, Dept Expt Med & Biochem Sci, I-06126 Perugia, Italy; Univ Perugia, Dept Clin & Expt Med, I-06126 Perugia, Italy; Bioceros BV, NL-3584 CM Utrecht, Netherlands	University of Perugia; University of Perugia; Bioceros B.V.	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06126 Perugia, Italy.	plopcc@tin.it	Boon, Laurence/HCI-3629-2022; Riccardi, Carlo/N-4610-2014; Romani, Luigina/O-9987-2018; Vacca, Carmine/AAE-7046-2019; Grohmann, Ursula/T-6545-2019; Orabona, Ciriana/L-8725-2015; Fallarino, Francesca/O-3358-2013; Nocentini, Giuseppe/B-9412-2013; Nocentini, Giuseppe/GZB-0146-2022	Riccardi, Carlo/0000-0001-9257-3997; Vacca, Carmine/0000-0002-3799-8164; Orabona, Ciriana/0000-0003-3113-0572; Fallarino, Francesca/0000-0002-8501-2136; Nocentini, Giuseppe/0000-0002-5209-0488; Grohmann, Ursula/0000-0001-7952-1850; Belladonna, Maria Laura/0000-0001-6522-0870; Bianchi, Roberta/0000-0001-5914-4701; Puccetti, Paolo/0000-0001-6674-2128; Boon, Louis/0000-0002-0937-9171; VOLPI, CLAUDIA/0000-0002-3967-7954; Ayroldi, Emira/0000-0002-9073-7297; Romani, Luigina/0000-0002-1356-525X				Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, EUR J IMMUNOL, V36, P8, DOI 10.1002/eji.200535667; Fallarino F, 2005, INT IMMUNOL, V17, P1429, DOI 10.1093/intimm/dxh321; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/j.gastro.2003.08.031; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Judson M A, 2001, Expert Opin Pharmacother, V2, P1065, DOI 10.1517/14656566.2.7.1065; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Vacca C, 2005, MICROBES INFECT, V7, P1040, DOI 10.1016/j.micinf.2005.03.030; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200	50	264	281	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					579	586		10.1038/nm1563	http://dx.doi.org/10.1038/nm1563			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17417651				2022-12-25	WOS:000246302800025
J	Mazor, Y; Van Blarcom, T; Mabry, R; Iverson, BL; Georgiou, G				Mazor, Yariv; Van Blarcom, Thomas; Mabry, Robert; Iverson, Brent L.; Georgiou, George			Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-A; HUMAN-IGG; TECHNOLOGY; DISPLAY; AFFINITY; SURFACE	We describe facile isolation of full-length IgG antibodies from combinatorial libraries expressed in E. coli. Full-length heavy and light chains are secreted into the periplasm, where they assemble into aglycosylated IgGs that are captured by an Fc-binding protein that is tethered to the inner membrane. After permeabilizing the outer membrane, spheroplast clones expressing so-called E-clonal antibodies, which specifically recognize fluorescently labeled antigen, are selected using flow cytometry. Screening of a library constructed from an immunized animal yielded several antibodies with nanomolar affinities toward the protective antigen of Bacillus anthracis.	Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA; Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	gg@che.utexas.edu	Mazor, Yariv/C-6735-2008					Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen G, 1999, PROTEIN ENG, V12, P349, DOI 10.1093/protein/12.4.349; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; KOHLER G, 1975, NATURE, V256, P497; Li J, 2006, P NATL ACAD SCI USA, V103, P3557, DOI 10.1073/pnas.0511285103; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; TAO MH, 1989, J IMMUNOL, V143, P2595; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	15	141	183	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					563	565		10.1038/nbt1296	http://dx.doi.org/10.1038/nbt1296			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17435747				2022-12-25	WOS:000246369400023
J	Xanthou, G; Alissafi, T; Semitekolou, M; Simoes, DCM; Economidou, E; Gaga, M; Lambrecht, BN; Lloyd, CM; Panoutsakopoulou, V				Xanthou, Georgina; Alissafi, Themis; Semitekolou, Maria; Simoes, Davina C. M.; Economidou, Erasmia; Gaga, Mina; Lambrecht, Bart N.; Lloyd, Clare M.; Panoutsakopoulou, Vily			Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets	NATURE MEDICINE			English	Article							LYMPH-NODES; T-CELLS; BACTERIAL-INFECTION; GENETIC-RESISTANCE; EPITHELIAL-CELLS; IN-VIVO; ASTHMA; INFLAMMATION; CYTOKINE; ANTIGEN	Osteopontin (Opn) is important for T helper type 1 (T(H)1) immunity and autoimmunity. However, the role of this cytokine in T(H)2-mediated allergic disease as well as its effects on primary versus secondary antigenic encounters remain unclear. Here we demonstrate that OPN is expressed in the lungs of asthmatic individuals and that Opn-s, the secreted form of Opn, exerts opposing effects on mouse T(H)2 effector responses and subsequent allergic airway disease: pro-inflammatory at primary systemic sensitization, and anti-inflammatory during secondary pulmonary antigenic challenge. These effects of Opn-s are mainly mediated by the regulation of T(H)2-suppressing plasmacytoid dendritic cells (DCs) during primary sensitization and T(H)2-promoting conventional DCs during secondary antigenic challenge. Therapeutic administration of recombinant Opn during pulmonary secondary antigenic challenge decreased established T(H)2 responses and protected mice from allergic disease. These effects on T(H)2 allergic responses suggest that Opn-s is an important therapeutic target and provide new insight into its role in immunity.	Acad Athens, Fdn Biomed Res, Cellular Immunol Lab, Div Cell Biol,Ctr Basic Res, Athens 11527, Greece; Natl & Kapodistrian Univ Athens, Sch Med, M Simou & GP Livanos Labs, Dept Crit Care & Pulm Med, Athens 10675, Greece; Sotiria Athens Chest Hosp, Asthma Ctr, Athens 11527, Greece; Sotiria Athens Chest Hosp, Resp Med Dept 7, Athens 11527, Greece; Erasmus Univ, Med Ctr, Dept Pulm Med, NL-3015 GE Rotterdam, Netherlands; Univ London Imperial Coll Sci & Technol, Leukocyte Biol Sect, Natl Heart & Lung Inst, Fac Med, London SW7 2AZ, England	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Erasmus University Rotterdam; Erasmus MC; Imperial College London	Panoutsakopoulou, V (corresponding author), Acad Athens, Fdn Biomed Res, Cellular Immunol Lab, Div Cell Biol,Ctr Basic Res, 4 Soranou Efessiou St, Athens 11527, Greece.	vpan@bioacademy.gr	Lambrecht, Bart N/K-2484-2014; Xanthou, Georgina/AAH-8682-2019; Alissafi, Themis/HDM-5785-2022; Gaga, Mina/AAP-8348-2020	Lambrecht, Bart N/0000-0003-4376-6834; Alissafi, Themis/0000-0002-4002-6008; Simoes, Davina Camargo Madeira/0000-0002-7262-1784; Semitekolou, Maria/0000-0002-0318-6774; Lloyd, Clare/0000-0001-8977-6726; Gaga, Mina/0000-0002-9949-6012; Panoutsakopoulou, Vily/0000-0002-1569-1508	Wellcome Trust [057704, 087618] Funding Source: Medline; Medical Research Council [G0400503B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Begum MD, 2007, MICROBIOL IMMUNOL, V51, P135, DOI 10.1111/j.1348-0421.2007.tb03884.x; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Farkas L, 2004, J ALLERGY CLIN IMMUN, V114, P436, DOI 10.1016/j.jaci.2004.04.035; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Haeryfar SMM, 2005, TRENDS IMMUNOL, V26, P311, DOI 10.1016/j.it.2005.04.002; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hessel EM, 2005, J EXP MED, V202, P1563, DOI 10.1084/jem.20050631; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Liu AH, 2002, ALLERGY ASTHMA PROC, V23, P289; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Niino M, 2003, J NEUROIMMUNOL, V136, P125, DOI 10.1016/S0165-5728(03)00004-3; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wang J, 2005, J ALLERGY CLIN IMMUN, V115, P1318, DOI 10.1016/j.jaci.2005.02.021; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219; Xu GW, 2005, J CLIN INVEST, V115, P1060	50	148	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					570	578		10.1038/nm1580	http://dx.doi.org/10.1038/nm1580			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17435770	Green Accepted			2022-12-25	WOS:000246302800024
J	Kumari, S; Bugaut, A; Huppert, JL; Balasubramanian, S				Kumari, Sunita; Bugaut, Anthony; Huppert, Julian L.; Balasubramanian, Shankar			An RNA G-quadruplex in the 5 ' UTR of the NRAS proto-oncogene modulates translation	NATURE CHEMICAL BIOLOGY			English	Article							RAS; HAIRPIN; GENE	Guanine-rich nucleic acid sequences can adopt noncanonical four-stranded secondary structures called guanine (G)- quadruplexes(1). Bioinformatics analysis suggests that G-quadruplex motifs are prevalent in genomes(2), which raises the need to elucidate their function. There is now evidence for the existence of DNA G-quadruplexes at telomeres with associated biological function(3). A recent hypothesis supports the notion that gene promoter elements contain DNA G-quadruplex motifs that control gene expression at the transcriptional level(4). We discovered a highly conserved, thermodynamically stable RNA G-quadruplex in the 5' untranslated region (UTR) of the gene transcript of the human NRAS proto-oncogene. Using a cell-free translation system coupled to a reporter gene assay, we have demonstrated that this NRAS RNA G-quadruplex modulates translation. This is the first example of translational repression by an RNA G-quadruplex. Bioinformatics analysis has revealed 2,922 other 5' UTR RNA G-quadruplex elements in the human genome. We propose that RNA G-quadruplexes in the 5' UTR modulate gene expression at the translational level.	Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; Wellcome Trust Sanger Institute	Kumari, S (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk	Anthony, BUGAUT/AAF-8024-2021; Huppert, Julian/C-6664-2008; Balasubramanian, Shankar/C-1671-2009	Anthony, BUGAUT/0000-0001-5152-6262; Huppert, Julian/0000-0001-5207-4886; Balasubramanian, Shankar/0000-0002-0281-5815	Cancer Research UK [A4081] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; DILELLA AG, 1988, NUCLEIC ACIDS RES, V16, P4159, DOI 10.1093/nar/16.9.4159; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eskandarpour M, 2005, INT J CANCER, V115, P65, DOI 10.1002/ijc.20873; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; NEIDLE S, 2006, QUADRUPTEX NUCL ACID; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Searle MS, 2006, RSC BIOMOL SCI, P131; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2	19	547	559	6	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2007	3	4					218	221		10.1038/nchembio864	http://dx.doi.org/10.1038/nchembio864			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148UW	17322877	Green Accepted			2022-12-25	WOS:000245103000011
J	Qi, ML; Tagawa, K; Enokido, Y; Yoshimura, N; Wada, Y; Watase, K; Ishiura, S; Kanazawa, I; Botas, J; Saitoe, M; Wanker, EE; Okazawa, H				Qi, Mei-Ling; Tagawa, Kazuhiko; Enokido, Yasushi; Yoshimura, Natsue; Wada, Yo-ichi; Watase, Kei; Ishiura, Sho-ichi; Kanazawa, Ichiro; Botas, Juan; Saitoe, Minoru; Wanker, Erich E.; Okazawa, Hitoshi			Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases	NATURE CELL BIOLOGY			English	Article							HUNTINGTONS-DISEASE; TRANSCRIPTIONAL REPRESSION; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASE; NEURONAL DEATH; MOUSE MODEL; DNA-REPAIR; CELL-DEATH; IN-VITRO; DROSOPHILA	Nuclear dysfunction is a key feature of the pathology of polyglutamine (polyQ) diseases. It has been suggested that mutant polyQ proteins impair functions of nuclear factors by interacting with them directly in the nucleus. However, a systematic analysis of quantitative changes in soluble nuclear proteins in neurons expressing mutant polyQ proteins has not been performed. Here, we perform a proteome analysis of soluble nuclear proteins prepared from neurons expressing huntingtin (Htt) or ataxin-1 (AT1) protein, and show that mutant AT1 and Htt similarly reduce the concentration of soluble high mobility group B1/2 (HMGB1/2) proteins. Immunoprecipitation and pulldown assays indicate that HMGBs interact with mutant AT1 and Htt. Immunohistochemistry showed that these proteins were reduced in the nuclear region outside of inclusion bodies in affected neurons. Compensatory expression of HMGBs ameliorated polyQ-induced pathology in primary neurons and in Drosophila polyQ models. Furthermore, HMGBs repressed genotoxic stress signals induced by mutant Htt or transcriptional repression. Thus, HMGBs may be critical regulators of polyQ disease pathology and could be targets for therapy development.	Tokyo Med & Dent Univ, Dept Neuropathol, Inst Med Res, Tokyo 113, Japan; Tokyo Med & Dent Univ, Century COE Program Brain Integrat & Its Dysfinct, Tokyo 113, Japan; Univ Tokyo, Fac Culture & Sci, Tokyo 106, Japan; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Baylor College of Medicine; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Okazawa, H (corresponding author), Tokyo Med & Dent Univ, Dept Neuropathol, Inst Med Res, Tokyo 113, Japan.	okazawa-tky@umin.ac.jp	; Yoshimura, Natsue/E-7087-2014	Saitoe, Minoru/0000-0001-9731-4214; Yoshimura, Natsue/0000-0002-7495-9113; Enokido, Yasushi/0000-0003-3252-504X; Wanker, Erich/0000-0001-8072-1630				Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Hoshino M, 2004, BIOCHEM BIOPH RES CO, V313, P110, DOI 10.1016/j.bbrc.2003.11.086; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tagawa K, 2004, J NEUROCHEM, V89, P974, DOI 10.1111/j.1471-4159.2004.02372.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	84	90	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					402	414		10.1038/ncb1553	http://dx.doi.org/10.1038/ncb1553			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17384639				2022-12-25	WOS:000245359400011
J	Bowman, AB; Lam, YC; Jafar-Nejad, P; Chen, HK; Richman, R; Samaco, RC; Fryer, JD; Kahle, JJ; Orr, HT; Zoghbi, HY				Bowman, Aaron B.; Lam, Yung C.; Jafar-Nejad, Paymaan; Chen, Hung-Kai; Richman, Ronald; Samaco, Rodney C.; Fryer, John D.; Kahle, Juliette J.; Orr, Harry T.; Zoghbi, Huda Y.			Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes	NATURE GENETICS			English	Article							NEURODEGENERATION IN-VIVO; MUTANT HUNTINGTIN; MEDIATES NEURODEGENERATION; TRANSCRIPTIONAL REPRESSION; NEURONAL DYSFUNCTION; INCLUSION FORMATION; CELLULAR TOXICITY; AXH DOMAIN; DISEASE; PROTEIN	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by expansion of a glutamine tract in ataxin-1 (ATXN1). SCA1 pathogenesis studies support a model in which the expanded glutamine tract causes toxicity by modulating the normal activities of ATXN1. To explore native interactions that modify the toxicity of ATXN1, we generated a targeted duplication of the mouse ataxin-1-like (Atxn1I, also known as Boat) locus, a highly conserved paralog of SCA1, and tested the role of this protein in SCA1 pathology. Using a knock-in mouse model of SCA1 that recapitulates the selective neurodegeneration seen in affected individuals, we found that elevated Atxn1I levels suppress neuropathology by displacing mutant Atxn1 from its native complex with Capicua (CIC). Our results provide genetic evidence that the selective neuropathology of SCA1 arises from modulation of a core functional activity of ATXN1, and they underscore the importance of studying the paralogs of genes mutated in neurodegenerative diseases to gain insight into mechanisms of pathogenesis.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Dept Biochem, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine	Zoghbi, HY (corresponding author), Vanderbilt Univ, Vanderbilt Kennedy Ctr Res & Human Dev, Dept Neurol, Nashville, TN 37232 USA.	hzoghbi@bcm.tmc.edu		Chen, Hung-Kai/0000-0002-2169-4924; Bowman, Aaron/0000-0001-8728-3346; Samaco, Rodney/0000-0001-5636-5314; Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD024064] Funding Source: Medline; NINDS NIH HHS [NS45667, NS27699, NS22920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045667, R01NS027699, R37NS022920, R01NS022920] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	29	62	67	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					373	379		10.1038/ng1977	http://dx.doi.org/10.1038/ng1977			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322884				2022-12-25	WOS:000244480000020
J	Even-Ram, S; Doyle, AD; Conti, MA; Matsumoto, K; Adelstein, RS; Yamada, KM				Even-Ram, Sharona; Doyle, Andrew D.; Conti, Mary Anne; Matsumoto, Kazue; Adelstein, Robert S.; Yamada, Kenneth M.			Myosin IIA regulates cell motility and actomyosin microtubule crosstalk	NATURE CELL BIOLOGY			English	Article							MITOTIC KINESIN EG5; MIGRATING CELLS; INHIBITORS; DYNAMICS; ADHESION; RAC; CONTRACTILITY; TRANSLOCATION; ORGANIZATION; CYTOSKELETON	Non-muscle myosin II has diverse functions in cell contractility, cytokinesis and locomotion, but the specific contributions of its different isoforms have yet to be clarified. Here, we report that ablation of the myosin IIA isoform results in pronounced defects in cellular contractility, focal adhesions, actin stress fibre organization and tail retraction. Nevertheless, myosin IIA-deficient cells display substantially increased cell migration and exaggerated membrane ruffling, which was dependent on the small G-protein Rac1, its activator Tiam1 and the microtubule moter kinesin Eg5. Myosin IIA deficiency stabilized microtubules, shifting the balance between actomyosin and microtubules with increased microtubules in active membrane ruffles. When microtubule polymerization was suppressed, myosin IIB could partially compensate for the absence of the IIA isoform in cellular contractility, but not in cell migration. We conclude that myosin IIA negatively regulates cell migration and suggest that it maintains a balance between the actomyosin and microtubule systems by regulating microtubule dynamics.	NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yamada, KM (corresponding author), NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.	ky4w@nih.gov		Yamada, Kenneth/0000-0003-1512-6805; Even-Ram, Sharona/0000-0002-5540-3822; Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004218, ZIAHL004218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; CONLEY BJ, 2005, CURR PROTOCOLS CELL, V23, P22; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; GORDON SR, 1990, CELL MOTIL CYTOSKEL, V16, P47, DOI 10.1002/cm.970160107; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; HONER B, 1988, J CELL BIOL, V107, P2181, DOI 10.1083/jcb.107.6.2181; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kaverina I, 2002, J CELL SCI, V115, P2283; Koivisto L, 2004, EXP CELL RES, V293, P68, DOI 10.1016/j.yexcr.2003.09.026; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; Thompson RF, 2002, ANAT RECORD, V268, P276, DOI 10.1002/ar.10160; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; WATERMANSTORER CM, 1995, J CELL BIOL, V130, P1161, DOI 10.1083/jcb.130.5.1161; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; Yoon SY, 2005, CELL MOTIL CYTOSKEL, V60, P181, DOI 10.1002/cm.20057	37	380	388	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					299	U104		10.1038/ncb1540	http://dx.doi.org/10.1038/ncb1540			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310241				2022-12-25	WOS:000244558600014
J	Fu, GL; Condon, KC; Epton, MJ; Gong, P; Jin, L; Condon, GC; Morrison, NI; Dafa'alla, TH; Alphey, L				Fu, Guoliang; Condon, Kirsty C.; Epton, Matthew J.; Gong, Peng; Jin, Li; Condon, George C.; Morrison, Neil I.; Dafa'alla, Tarig H.; Alphey, Luke			Female-specific insect lethality engineered using alternative splicing	NATURE BIOTECHNOLOGY			English	Article							GENETIC SYSTEM; AUTOCIDAL CONTROL; TRANSFORMER GENE; IN-VIVO; FLY; ERADICATION; CONSERVATION; EXPRESSION; MANAGEMENT; DOMINANT	The Sterile Insect Technique is a species-specific and environmentally friendly method of pest control involving mass release of sterilized insects that reduce the wild population through infertile matings(1-5). Insects carrying a female-specific autocidal genetic system offer an attractive alternative to conventional sterilization methods(6,7) while also eliminating females from the release population(7-10). We exploited sex-specific alternative splicing in insects to engineer female-specific autocidal genetic systems in the Mediterranean fruit fly, Ceratitis capitata. These rely on the insertion of cassette exons from the C. capitata transformer gene into a heterologous tetracycline-repressible transactivator such that the transactivator transcript is disrupted in male splice variants but not in the female-specific one. As the key components of these systems function across a broad phylogenetic range, this strategy addresses the paucity of sex-specific expression systems (e. g., early-acting, female-specific promoters) in insects other than Drosophila melanogaster. The approach may have wide applicability for regulating gene expression in other organisms, particularly for combinatorial control with appropriate promoters.	Oxitec Ltd, Oxford OX14 4RX, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Alphey, L (corresponding author), Oxitec Ltd, 71 Milton Pk, Oxford OX14 4RX, England.	luke.alphey@zoo.ox.ac.uk		Alphey, Luke/0000-0002-2916-3802				Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chiu YL, 2006, BIOCHEM BIOPH RES CO, V341, P663, DOI 10.1016/j.bbrc.2005.12.218; Dyck V.A., 2006, STERILE INSECT TECHN; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697; Horn C, 2003, NAT BIOTECHNOL, V21, P64, DOI 10.1038/nbt769; KENGHONG T, 2000, AREA WIDE CONTROL FR; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x; Lyman RF, 1996, GENETICS, V143, P277; Marec F, 2005, J ECON ENTOMOL, V98, P248, DOI 10.1603/0022-0493-98.2.248; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Saccone G., 2000, P491; Saccone G, 2002, GENETICA, V116, P15, DOI 10.1023/A:1020903523907; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Tortiglione C, 1997, DEV GENES EVOL, V207, P264, DOI 10.1007/s004270050114; Wimmer EA, 2005, NAT BIOTECHNOL, V23, P432, DOI 10.1038/nbt0405-432	30	184	211	4	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					353	357		10.1038/nbt1283	http://dx.doi.org/10.1038/nbt1283			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17322873				2022-12-25	WOS:000244748300028
J	Harper, C				Harper, Claire			Tuberculosis, a neglected opportunity?	NATURE MEDICINE			English	Article									Wood Mackenzie, Edinburgh EH2 4NS, Midlothian, Scotland		Harper, C (corresponding author), Wood Mackenzie, Kintore House,74-77 Queen St, Edinburgh EH2 4NS, Midlothian, Scotland.	claire.harper@woodmac.com						*COLL CTR CHRON CO, 2006, TUB GUID; DIX K, 2007, INFECT CONTROL TODAY; Gurwitz JH, 2006, NEW ENGL J MED, V354, P1413, DOI 10.1056/NEJMe068051; Spigelman M, 2006, LANCET, V367, P945, DOI 10.1016/S0140-6736(06)68388-8; *WHO, 2006, WHO REP; *WHO, 2006, WHO FACTSH, V104; 2006, PROGR REPORT; 2001, EC TB DRUG DEV; 2006, NY TIMES        0914; 2006, TUBERCULOSIS DIS REP	10	23	24	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					309	312		10.1038/nm0307-309	http://dx.doi.org/10.1038/nm0307-309			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17342146				2022-12-25	WOS:000244715700043
J	Sherer, NM; Lehmann, MJ; Jimenez-Soto, LF; Horensavitz, C; Pypaert, M; Mothes, W				Sherer, Nathan M.; Lehmann, Maik J.; Jimenez-Soto, Luisa F.; Horensavitz, Christina; Pypaert, Marc; Mothes, Walther			Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission	NATURE CELL BIOLOGY			English	Article							ACTIN CYTOSKELETON; ENVELOPE PROTEIN; VIRUS; RECEPTOR; DROSOPHILA; SYNAPSE; ENTRY; LYMPHOCYTES; MACROPHAGES; HEMIFUSION	The spread of retroviruses between cells is estimated to be 2-3 orders of magnitude more efficient when cells can physically interact with each other(1,2). The underlying mechanism is largely unknown, but transfer is believed to occur through large-surface interfaces, called virological or infectious synapses(3-6). Here, we report the direct visualization of cell-to-cell transmission of retroviruses in living cells. Our results reveal a mechanism of virus transport from infected to non-infected cells, involving thin filopodial bridges. These filopodia originate from noninfected cells and interact, through their tips, with infected cells. A strong association of the viral envelope glycoprotein (Env) in an infected cell with the receptor molecules in a target cell generates a stable bridge. Viruses then move along the outer surface of the filopodial bridge toward the target cell. Our data suggest that retroviruses spread by exploiting an inherent ability of filopodia to transport ligands from cell to cell.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University	Mothes, W (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	walther.mothes@yale.edu		Jimenez Soto, Luisa Fernanda/0000-0001-8551-5019	NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065284] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098727-05, R01CA098727, R01 CA098727] Funding Source: Medline; NIAID NIH HHS [R21 AI065284] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Chen CP, 2004, J VIROL, V78, P882, DOI 10.1128/JVI.78.2.882-891.2004; Davey RA, 1999, J VIROL, V73, P3758, DOI 10.1128/JVI.73.5.3758-3763.1999; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KLEMENT V, 1969, P NATL ACAD SCI USA, V63, P753, DOI 10.1073/pnas.63.3.753; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zavorotinskaya T, 2004, J VIROL, V78, P473, DOI 10.1128/JVI.78.1.473-481.2004; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	26	333	342	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					310	U106		10.1038/ncb1544	http://dx.doi.org/10.1038/ncb1544			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293854	Green Accepted			2022-12-25	WOS:000244558600015
J	Yamanouchi, J; Rainbow, D; Serra, P; Howlett, S; Hunter, K; Garner, VES; Gonzalez-Munoz, A; Clark, J; Veijola, R; Cubbon, R; Chen, SL; Rosa, R; Cumiskey, AM; Serreze, DV; Gregory, S; Rogers, J; Lyons, PA; Healy, B; Smink, LJ; Todd, JA; Peterson, LB; Wicker, LS; Santamaria, P				Yamanouchi, Jun; Rainbow, Dan; Serra, Pau; Howlett, Sarah; Hunter, Kara; Garner, Valerie E. S.; Gonzalez-Munoz, Andrea; Clark, Jan; Veijola, Riitta; Cubbon, Rose; Chen, Show-Ling; Rosa, Raymond; Cumiskey, Anne Marie; Serreze, David V.; Gregory, Simon; Rogers, Jane; Lyons, Paul A.; Healy, Barry; Smink, Luc J.; Todd, John A.; Peterson, Laurence B.; Wicker, Linda S.; Santamaria, Pere			Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity	NATURE GENETICS			English	Article							NONOBESE DIABETIC MICE; ALPHA-CHAIN; NOD MICE; IL-2; REGION; LOCUS; ACTIVATION; EXPRESSION; DISEASE; COMPLEX	Autoimmune diseases are thought to result from imbalances in normal immune physiology and regulation. Here, we show that autoimmune disease susceptibility and resistance alleles on mouse chromosome 3 (Idd3) correlate with differential expression of the key immunoregulatory cytokine interleukin-2 (IL-2). In order to test directly that an approximately twofold reduction in IL-2 underpins the Idd3-linked destabilization of immune homeostasis, we show that engineered haplodeficiency of Il2 gene expression not only reduces T cell IL-2 production by twofold but also mimics the autoimmune dysregulatory effects of the naturally occurring susceptibility alleles of Il2. Reduced IL-2 production achieved by either genetic mechanism correlates with reduced function of CD4(+) CD25(+) regulatory T cells, which are critical for maintaining immune homeostasis.	Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Cambridge, Cambridge Inst Med Genet, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2XY, England; Merck Res Labs, Rahway, NJ 07065 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	University of Calgary; University of Calgary; University of Cambridge; Merck & Company; Jackson Laboratory; Wellcome Trust Sanger Institute	Wicker, LS (corresponding author), Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada.	linda.wicker@cimr.cam.ac.uk; psantama@ucalgary.ca	Santamaria, Pere/ABF-6823-2021; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Gregory, Simon/0000-0002-7805-1743	Wellcome Trust [061859] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Cervino ACL, 2006, MAMM GENOME, V17, P565, DOI 10.1007/s00335-005-0170-4; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; LORD CJ, 1995, MAMM GENOME, V6, P563, DOI 10.1007/BF00352359; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Teuscher C, 1996, J EXP MED, V183, P631, DOI 10.1084/jem.183.2.631; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang L, 2005, BIOCHEM BIOPH RES CO, V331, P589, DOI 10.1016/j.bbrc.2005.03.216; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	50	301	311	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					329	337		10.1038/ng1958	http://dx.doi.org/10.1038/ng1958			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277778	Green Accepted			2022-12-25	WOS:000244480000014
J	Galonic, DP; Barr, EW; Walsh, CT; Bollinger, JM; Krebs, C				Galonic, Danica P.; Barr, Eric W.; Walsh, Christopher T.; Bollinger, J. Martin, Jr.; Krebs, Carsten			Two interconverting Fe((IV)) intermediates in aliphatic chlorination by the halogenase CytC3	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-KETOGLUTARATE DIOXYGENASE; SPIN FE(IV) COMPLEX; OXYGEN ACTIVATION; CATALYTIC MECHANISM; ESCHERICHIA-COLI; IRON ENZYMES; ACTIVE-SITE; NONHEME; BIOSYNTHESIS; TAUD	Enzymatic incorporation of a halogen atom is a common feature in the biosyntheses of more than 4,500 natural products(1-5). Halogenation of unactivated carbon centers in the biosyntheses of several compounds of nonribosomal peptide origin is carried out by a class of mononuclear nonheme iron enzymes that require alpha-ketoglutarate ( alpha KG, 1), chloride and oxygen(6). To investigate the ability of these enzymes to functionalize unactivated methyl groups, we characterized the chlorination of the gamma-methyl substituent of L-2-aminobutyric acid ( L-Aba, 2) attached to the carrier protein CytC2 by iron halogenase ( CytC3) from soil Streptomyces sp. We identified an intermediate state comprising two high-spin Fe(IV) complexes in rapid equilibrium. At least one of the Fe( IV) complexes abstracts hydrogen from the substrate. The demonstration that chlorination proceeds through an Fe( IV) intermediate that cleaves a C-H bond reveals the mechanistic similarity of aliphatic halogenases to the iron- and alpha KG- dependent hydroxylases.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	christopher_walsh@hms.harvard.edu; jmb21@psu.edu; ckrebs@psu.edu	Bollinger, Joseph/C-1425-2016; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020011, R01GM069657, R01GM020011] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-69657, R01 GM069657, GM-49338, GM-20011] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gribble GW, 2004, J CHEM EDUC, V81, P1441, DOI 10.1021/ed081p1441; Gribble GW, 1998, ACCOUNTS CHEM RES, V31, P141, DOI 10.1021/ar9701777; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KOJIMA T, 1993, J AM CHEM SOC, V115, P11328, DOI 10.1021/ja00077a035; Krebs C, 2005, INORG CHEM, V44, P742, DOI 10.1021/ic048523l; Liu PH, 2004, J AM CHEM SOC, V126, P10306, DOI 10.1021/ja0475050; Neese F, 2006, J INORG BIOCHEM, V100, P716, DOI 10.1016/j.jinorgbio.2006.01.020; Pavel EG, 1998, J AM CHEM SOC, V120, P743, DOI 10.1021/ja972408a; Pestovsky O, 2005, ANGEW CHEM INT EDIT, V44, P6871, DOI 10.1002/anie.200502686; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Ryle MJ, 2003, BIOCHEMISTRY-US, V42, P1854, DOI 10.1021/bi026832m; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Ueki M, 2006, CHEM BIOL, V13, P1183, DOI 10.1016/j.chembiol.2006.09.012; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; van Pee KH, 2003, CHEMOSPHERE, V52, P299, DOI 10.1016/S0045-6535(03)00204-2	32	252	254	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2007	3	2					113	116		10.1038/nchembio856	http://dx.doi.org/10.1038/nchembio856			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	128UZ	17220900				2022-12-25	WOS:000243685800015
J	Gao, BB; Clermont, A; Rook, S; Fonda, SJ; Srinivasan, VJ; Wojtkowski, M; Fujimoto, JG; Avery, RL; Arrigg, PG; Bursell, SE; Aiello, LP; Feener, EP				Gao, Ben-Bo; Clermont, Allen; Rook, Susan; Fonda, Stephanie J.; Srinivasan, Vivek J.; Wojtkowski, Maciej; Fujimoto, James G.; Avery, Robert L.; Arrigg, Paul G.; Bursell, Sven-Erik; Aiello, Lloyd Paul; Feener, Edward P.			Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-RETINOPATHY; MACULAR EDEMA; PIGMENT EPITHELIUM; BLOOD-FLOW; BRADYKININ; CELLS; PROLYLCARBOXYPEPTIDASE; ACETAZOLAMIDE; PROGRESSION	Excessive retinal vascular permeability contributes to the pathogenesis of proliferative diabetic retinopathy and diabetic macular edema, leading causes of vision loss in working-age adults. Using mass spectroscopy-based proteomics, we detected 117 proteins in human vitreous and elevated levels of extracellular carbonic anhydrase-I (CA-I) in vitreous from individuals with diabetic retinopathy, suggesting that retinal hemorrhage and erythrocyte lysis contribute to the diabetic vitreous proteome. Intravitreous injection of CA-I in rats increased retinal vessel leakage and caused intraretinal edema. CA-I-induced alkalinization of vitreous increased kallikrein activity and its generation of factor XIIa, revealing a new pathway for contact system activation. CA-I-induced retinal edema was decreased by complement 1 inhibitor, neutralizing antibody to prekallikrein and bradykinin receptor antagonism. Subdural infusion of CA-I in rats induced cerebral vascular permeability, suggesting that extracellular CA-I could have broad relevance to neurovascular edema. Inhibition of extracellular CA-I and kallikrein-mediated innate inflammation could provide new therapeutic opportunities for the treatment of hemorrhage-induced retinal and cerebral edema.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA; Santa Barbara Cottage Hosp Eye Ctr, Santa Barbara, CA 93103 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Santa Barbara Cottage Hospital; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Feener, EP (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	edward.feener@joslin.harvard.edu	Wojtkowski, Maciej/D-6822-2014	Wojtkowski, Maciej/0000-0003-0599-0878	NATIONAL EYE INSTITUTE [R01EY014106, R01EY011289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK060165] Funding Source: NIH RePORTER; NEI NIH HHS [EY011289, EY014106] Funding Source: Medline; NIDDK NIH HHS [DK 36836, DK 60165] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; [Anonymous], 1991, Ophthalmology, V98, P786; Carugati A, 2001, MOL IMMUNOL, V38, P161, DOI 10.1016/S0161-5890(01)00040-2; Ferris FL, 1999, NEW ENGL J MED, V341, P667, DOI 10.1056/NEJM199908263410907; Giusti Cristiano, 2001, International Ophthalmology, V24, P79, DOI 10.1023/A:1016354517304; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Henricsson M, 1999, ACTA OPHTHALMOL SCAN, V77, P218, DOI 10.1034/j.1600-0420.1999.770221.x; Houle S, 2003, HYPERTENSION, V41, P611, DOI 10.1161/01.HYP.0000054971.03046.9B; Iwaki T, 2006, THROMB HAEMOSTASIS, V95, P1003, DOI 10.1160/TH06-03-0128; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Knudsen ST, 2002, DIABETES CARE, V25, P2328, DOI 10.2337/diacare.25.12.2328; KROGSAA B, 1981, ACTA OPHTHALMOL, V59, P689, DOI 10.1111/j.1755-3768.1981.tb08735.x; Lattanzio R, 2002, EUR J OPHTHALMOL, V12, P482, DOI 10.1177/112067210201200606; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; Nakanishi T, 2002, J CHROMATOGR B, V776, P89, DOI 10.1016/S1570-0232(02)00078-8; Ogata N, 2002, AM J OPHTHALMOL, V134, P348, DOI 10.1016/S0002-9394(02)01568-4; Ouchi M, 2005, EXP EYE RES, V81, P176, DOI 10.1016/j.exer.2005.01.020; PLEHWE WE, 1989, BRIT J OPHTHALMOL, V73, P255, DOI 10.1136/bjo.73.4.255; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; RASSAM SMB, 1993, EYE, V7, P697, DOI 10.1038/eye.1993.159; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shariat-Madar Z, 2004, BLOOD, V103, P4554, DOI 10.1182/blood-2003-07-2510; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Srinivas SP, 2002, INVEST OPHTH VIS SCI, V43, P3273; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stefansson E, 1999, INVEST OPHTH VIS SCI, V40, P2756; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; van Doorn MBA, 2005, J ALLERGY CLIN IMMUN, V116, P876, DOI 10.1016/j.jaci.2005.05.019; VELOSO D, 1987, BLOOD, V70, P1053; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; Weber A, 2004, J MED CHEM, V47, P550, DOI 10.1021/jm030912m; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; WOLFENSBERGER TJ, 1994, INVEST OPHTH VIS SCI, V35, P3401; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Yamane K, 2003, MOL CELL PROTEOMICS, V2, P1177, DOI 10.1074/mcp.M300038-MCP200; Yang ZL, 2005, HUM MOL GENET, V14, P255, DOI 10.1093/hmg/ddi023	47	227	261	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2007	13	2					181	188		10.1038/nm1534	http://dx.doi.org/10.1038/nm1534			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	133RW	17259996				2022-12-25	WOS:000244031700027
J	Xia, B; Dorsman, JC; Ameziane, N; de Vries, Y; Rooimans, MA; Sheng, Q; Pals, G; Errami, A; Gluckman, E; Llera, J; Wang, W; Livingston, DM; Joenje, H; de Winter, JP				Xia, Bing; Dorsman, Josephine C.; Ameziane, Najim; de Vries, Yne; Rooimans, Martin A.; Sheng, Qing; Pals, Gerard; Errami, Abdellatif; Gluckman, Eliane; Llera, Julian; Wang, Weidong; Livingston, David M.; Joenje, Hans; de Winter, Johan P.			Fanconi anemia is associated with a defect in the BRCA2 partner PALB2	NATURE GENETICS			English	Article								The Fanconi anemia and BRCA networks are considered interconnected, as BRCA2 gene defects have been discovered in individuals with Fanconi anemia subtype D1. Here we show that a defect in the BRCA2- interacting protein PALB2 is associated with Fanconi anemia in an individual with a new subtype. PALB2- deficient cells showed hypersensitivity to cross- linking agents and lacked chromatin- bound BRCA2; these defects were corrected upon ectopic expression of PALB2 or by spontaneous reversion.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MRC Holland BV, NL-1057 SN Amsterdam, Netherlands; Hop St Louis, Bone Marrow Transplant Unit, F-75475 Paris 10, France; Hosp Italiano Buenos Aires, Dept Pediat, Buenos Aires, DF, Argentina; NIA, Genet Lab, US Natl Inst Hlth, Baltimore, MD 21224 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Italiano de Buenos Aires; University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Van Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	David_Livingston@dfci.harvard.edu; j.dewinter@vumc.nl	Pals, Gerard/A-5198-2011; Wang, Weidong/AAV-2446-2021; eliane, Gluckman/AAA-5024-2021	Pals, Gerard/0000-0003-4091-7115; Wang, Weidong/0000-0002-0658-7928	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000688, ZIAAG000688] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bermejo JL, 2004, ANN ONCOL, V15, P1834, DOI [10.1093/annone/mdh474, 10.1093/annonc/mdh474]; Chang Mary Wu, 2003, Lymphat Res Biol, V1, P259; Friedenson Bernard, 2005, MedGenMed, V7, P60; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Mueller BU, 1999, SEMIN PERINATOL, V23, P332, DOI 10.1016/S0146-0005(99)80041-X; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	13	352	358	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					159	161		10.1038/ng1942	http://dx.doi.org/10.1038/ng1942			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200672				2022-12-25	WOS:000244063900011
J	Zhu, XJ; Wang, CZ; Dai, PG; Xie, Y; Song, NN; Liu, Y; Du, QS; Mei, L; Ding, YQ; Xiong, WC				Zhu, Xiao-Juan; Wang, Cheng-Zhong; Dai, Peng-Gao; Xie, Yi; Song, Ning-Ning; Liu, Yu; Du, Quan-Sheng; Mei, Lin; Ding, Yu-Qiang; Xiong, Wen-Cheng			Myosin X regulates netrin receptors and functions in axonal path-finding	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; PLECKSTRIN HOMOLOGY; NEURITE OUTGROWTH; DCC; PROTEIN; CELLS; MOTOR; SRC	Netrins regulate axon path-finding during development, but the underlying mechanisms are not well understood. Here, we provide evidence for the involvement of the unconventional myosin X (Myo X) in netrin-1 function. We find that Myo X interacts with the netrin receptor deleted in colorectal cancer (DCC) and neogenin, a DCC-related protein. Expression of Myo X redistributes DCC to the cell periphery or to the tips of neurites, whereas its silencing prevents DCC distribution in neurites. Moreover, expression of DCC, but not neogenin, stimulates Myo X-mediated formation and elongation of filopodia, suggesting that Myo X function may be differentially regulated by DCC and neogenin. The involvement of Myo X in netrin-1 function was further supported by the effects of inhibiting Myo X function in neurons. Cortical explants derived from mouse embryos expressing a motor-less Myo X exhibit reduced neurite outgrowth in response to netrin-1 and chick commissural neurons expressing the motor-less Myo X, or in which Myo X is silenced using microRNA (miRNA), show impaired axon projection in vivo. Taken together, these results identify a novel role for Myo X in regulating netrin-1 function.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Coll Georgia, Program Dev Neurobiol, IMMAG, Augusta, GA 30912 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham	Ding, YQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	dingyq@ion.ac.cn; wxiong@mcg.edu	Mei, Lin/G-8755-2012; Wang, Chengzhong/A-6039-2015	Ding, Yu-Qiang/0000-0003-1202-4635; Song, Ning-Ning/0000-0001-5206-1911; Du, Quansheng/0000-0003-4079-8662	NINDS NIH HHS [R01 NS060648] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richards LJ, 1997, J NEUROSCI, V17, P2445; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	32	110	123	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					184	U79		10.1038/ncb1535	http://dx.doi.org/10.1038/ncb1535			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237772				2022-12-25	WOS:000243903000011
J	De Coppi, P; Bartsch, G; Siddiqui, MM; Xu, T; Santos, CC; Perin, L; Mostoslavsky, G; Serre, AC; Snyder, EY; Yoo, JJ; Furth, ME; Soker, S; Atala, A				De Coppi, Paolo; Bartsch, Georg, Jr.; Siddiqui, M. Minhaj; Xu, Tao; Santos, Cesar C.; Perin, Laura; Mostoslavsky, Gustavo; Serre, Angeline C.; Snyder, Evan Y.; Yoo, James J.; Furth, Mark E.; Soker, Shay; Atala, Anthony			Isolation of amniotic stem cell lines with potential for therapy	NATURE BIOTECHNOLOGY			English	Article							TYROSINE KINASE RECEPTOR; HUMAN BLASTOCYSTS; PROGENITOR CELLS; MOUSE EMBRYOS; IN-VITRO; FLUID; CULTURE; DERIVATION; DIFFERENTIATION; EPITOPES	Stem cells capable of differentiating to multiple lineages may be valuable for therapy. We report the isolation of human and rodent amniotic fluid-derived stem (AFS) cells that express embryonic and adult stem cell markers. Undifferentiated AFS cells expand extensively without feeders, double in 36 h and are not tumorigenic. Lines maintained for over 250 population doublings retained long telomeres and a normal karyotype. AFS cells are broadly multipotent. Clonal human lines verified by retroviral marking were induced to differentiate into cell types representing each embryonic germ layer, including cells of adipogenic, osteogenic, myogenic, endothelial, neuronal and hepatic lineages. Examples of differentiated cells derived from human AFS cells and displaying specialized functions include neuronal lineage cells secreting the neurotransmitter L-glutamate or expressing G-protein-gated inwardly rectifying potassium channels, hepatic lineage cells producing urea, and osteogenic lineage cells forming tissue-engineered bone.	Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Wake Forest University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Atala, A (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Siddiqui, Mohummad/V-1196-2019; Yoo, James J./L-4850-2017	Atala, Anthony/0000-0001-8186-2160; De Coppi, Paolo/0000-0002-1659-0207; Mostoslavsky, Gustavo/0000-0002-0784-2169; Siddiqui, Mohummad/0000-0002-4484-6820	Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		Atala A, 2006, CURR OPIN PEDIATR, V18, P167, DOI 10.1097/01.mop.0000193294.94646.be; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; De Coppi P., 2001, AM AC PED NAT C SAN, P210; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FLEISCHMAN RA, 1993, TRENDS GENET, V9, P285, DOI 10.1016/0168-9525(93)90015-A; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Guo CS, 1997, DEV BIOL, V184, P61, DOI 10.1006/dbio.1997.8520; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hampson RE, 2003, J NEUROPHYSIOL, V90, P55, DOI 10.1152/jn.01161.2002; HIPP J, 2006, PRINCIPLES REGENERAT; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liao YJ, 1996, J NEUROSCI, V16, P7137; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; POLGAR K, 1989, AM J HUM GENET, V45, P786; PRIEST RE, 1978, LAB INVEST, V39, P106; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85; Rosenblatt J. David, 1995, In Vitro Cellular and Developmental Biology Animal, V31, P773, DOI 10.1007/BF02634119; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; SIDDIQUI MM, 2004, HDB STEM CELLS, V2, P175; SUZUKI K, 1995, BRAIN PATHOL, V5, P249, DOI 10.1111/j.1750-3639.1995.tb00601.x; Taylor RM, 1997, TRANSPL P, V29, P845, DOI 10.1016/S0041-1345(96)00163-7; Taylor RM, 2006, J NEUROCHEM, V97, P1585, DOI 10.1111/j.1471-4159.2006.03986.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	47	1338	1426	2	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2007	25	1					100	106		10.1038/nbt1274	http://dx.doi.org/10.1038/nbt1274			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	126CY	17206138				2022-12-25	WOS:000243491000035
J	Weedon, MN; Lettre, G; Freathy, RM; Lindgren, CM; Voight, BF; Perry, JRB; Elliott, KS; Hackett, R; Guiducci, C; Shields, B; Zeggini, E; Lango, H; Lyssenko, V; Timpson, NJ; Burtt, NP; Rayner, NW; Saxena, R; Ardlie, K; Tobias, JH; Ness, AR; Ring, SM; Palmer, CNA; Morris, AD; Peltonen, L; Salomaa, V; Smith, GD; Groop, LC; Hattersley, AT; McCarthy, MI; Hirschhorn, JN; Frayling, TM				Weedon, Michael N.; Lettre, Guillaume; Freathy, Rachel M.; Lindgren, Cecilia M.; Voight, Benjamin F.; Perry, John R. B.; Elliott, Katherine S.; Hackett, Rachel; Guiducci, Candace; Shields, Beverley; Zeggini, Eleftheria; Lango, Hana; Lyssenko, Valeriya; Timpson, Nicholas J.; Burtt, Noel P.; Rayner, Nigel W.; Saxena, Richa; Ardlie, Kristin; Tobias, Jonathan H.; Ness, Andrew R.; Ring, Susan M.; Palmer, Colin N. A.; Morris, Andrew D.; Peltonen, Leena; Salomaa, Veikko; Smith, George Davey; Groop, Leif C.; Hattersley, Andrew T.; McCarthy, Mark I.; Hirschhorn, Joel N.; Frayling, Timothy M.		Diabet Genetics Initiative; Wellcome Trust Case Control Con	A common variant of HMGA2 is associated with adult and childhood height in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY HEIGHT; C GENE; RISK; HERITABILITY; DISEASE; STRATIFICATION; SUSCEPTIBILITY; METHODOLOGY; PHENOTYPE	Human height is a classic, highly heritable quantitative trait. To begin to identify genetic variants influencing height, we examined genome-wide association data from 4,921 individuals. Common variants in the HMGA2 oncogene, exemplified by rs1042725, were associated with height (P= 4x10(-8)). HMGA2 is also a strong biological candidate for height, as rare, severe mutations in this gene alter body size in mice and humans, so we tested rs1042725 in additional samples. We confirmed the association in 19,064 adults from four further studies (P= 3x10(-11), overall P= 4x10(-16), including the genome-wide association data). We also observed the association in children (P=1x 10(-6), N= 6,827) and a tall/short case-control study (P= 4x10(-6), N=3,207). We estimate that rs1042725 explains similar to 0.3% of population variation in height (similar to 0.4 cm increased adult height per C allele). There are few examples of common genetic variants reproducibly associated with human quantitative traits; these results represent, to our knowledge, the first consistently replicated association with adult and childhood height.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Childrens Hosp, Div Genet & Endocrinol, Program Genom, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diab Endocrinol & Metab, Oxford OX3 7LJ, England; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diab & Endocrinol, S-20502 Malmo, Sweden; Univ Helsinki, Helsinki Univ Cent Hosp,Dep Med, Folkhalsan Genet Inst,Folkhalsan Res Ctr, Res Program Mol Med, Helsinki, Finland; Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS8 2PR, Avon, England; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Bristol, Clin Sci S Bristol, Bristol BS2 8AE, Avon, England; Univ Bristol, Bristol Dent Sch, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Dundee, Ninewells Hosp, Sch Med,Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp, Sch Med, Div Med & Therapeut,Diab Res Grp, Dundee DD1 9SY, Scotland; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Exeter; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Bristol; Harvard University; Massachusetts General Hospital; University of Bristol; University of Bristol; University of Bristol; University of Dundee; University of Dundee; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Harvard Medical School	Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Tobias, Jon/E-2832-2014; Attrill, Lauren/V-1688-2018; Allen, Hana Lango/G-9026-2012; Fox, Laura J/C-6249-2016; Ness, Andy R/M-7612-2013; Timpson, Nicholas John/O-7548-2015; Study, GoDARTS/K-9448-2016; Saxena, Richa/AAG-7279-2020; Berryman, Katie/J-4236-2014; Voight, Benjamin/F-1775-2011; Morris, Andrew D/C-2837-2009; Palmer, Colin NA/C-7053-2008; Davey Smith, George/A-7407-2013; McCarthy, Mark/M-3763-2015	Tobias, Jon/0000-0002-7475-3932; Allen, Hana Lango/0000-0002-7803-8688; Ness, Andy R/0000-0003-3548-9523; Timpson, Nicholas John/0000-0002-7141-9189; Palmer, Colin NA/0000-0002-6415-6560; Davey Smith, George/0000-0002-1407-8314; Frayling, Timothy/0000-0001-8362-2603; Voight, Benjamin/0000-0002-6205-9994; McCarthy, Mark/0000-0002-4393-0510; Saxena, Richa/0000-0003-2233-1065; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; Hattersley, Andrew/0000-0001-5620-473X; Freathy, Rachel/0000-0003-4152-2238; Weedon, Michael/0000-0002-6174-6135; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; MRC [G0500070, G0600705] Funding Source: UKRI; Medical Research Council [G9815508(74882), G0600705, G9815508, G0500070] Funding Source: Medline; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; Wellcome Trust [GR072960, 079557, 090532, 076113, 072960, 076467] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust)		Battista S, 1999, CANCER RES, V59, P4793; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Ruyter-Spira CP, 1998, J HERED, V89, P295, DOI 10.1093/jhered/89.4.295; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	30	321	341	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1245	1250		10.1038/ng2121	http://dx.doi.org/10.1038/ng2121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767157	Green Accepted			2022-12-25	WOS:000249737400020
J	Weber, MS; Prod'homme, T; Youssef, S; Dunn, SE; Rundle, CD; Lee, L; Patarroyo, JC; Stuve, O; Sobel, RA; Steinman, L; Zamvil, SS				Weber, Martin S.; Prod'homme, Thomas; Youssef, Sawsan; Dunn, Shannon E.; Rundle, Cynthia D.; Lee, Linda; Patarroyo, Juan C.; Stuve, Olaf; Sobel, Raymond A.; Steinman, Lawrence; Zamvil, Scott S.			Type II monocytes modulate T cell-mediated central nervous system autoimmune disease	NATURE MEDICINE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; REMITTING MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR FOXP3; GLATIRAMER ACETATE; COPOLYMER 1; DEVELOPMENTAL PATHWAYS; IL-10 PRODUCTION; DENDRITIC CELLS; IN-VIVO	Treatment with glatiramer acetate (GA, copolymer-1, Copaxone), a drug approved for multiple sclerosis ( MS), in a mouse model promoted development of anti-inflammatory type II monocytes, characterized by increased secretion of interleukin (IL)-10 and transforming growth factor (TGF)-beta, and decreased production of IL-12 and tumor necrosis factor (TNF). This anti-inflammatory cytokine shift was associated with reduced STAT-1 signaling. Type II monocytes directed differentiation of T(H)2 cells and CD4(+) CD25(+) FoxP3(+) regulatory T cells (T-reg) independent of antigen specificity. Type II monocyte-induced regulatory T cells specific for a foreign antigen ameliorated experimental autoimmune encephalomyelitis (EAE), indicating that neither GA specificity nor recognition of self-antigen was required for their therapeutic effect. Adoptive transfer of type II monocytes reversed EAE, suppressed T(H)17 cell development and promoted both T(H)2 differentiation and expansion of Treg cells in recipient mice. This demonstration of adoptive immunotherapy by type II monocytes identifies a central role for these cells in T cell immune modulation of autoimmunity.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA; Stanford Univ, Dept Neurol & Neurol Sci, Interdept Program Immunol, Stanford, CA 94305 USA; Vet Affairs N Texas Hlth Care Syst, Neurol Sect, Dallas, TX USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Stanford University	Zamvil, SS (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave,S-268, San Francisco, CA 94143 USA.	zamvil@ucsf.neuroimmunol.org	Weber, Martin/GPW-6095-2022	Sobel, Raymond/0000-0002-0477-9002; Steinman, Lawrence/0000-0002-2437-2250	NIAID NIH HHS [R01 AI059709] Funding Source: Medline; NINDS NIH HHS [R01 NS046721, NS06414] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046721] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 1998, J NEUROIMMUNOL, V91, P135, DOI 10.1016/S0165-5728(98)00166-0; Aharoni R, 1997, P NATL ACAD SCI USA, V94, P10821, DOI 10.1073/pnas.94.20.10821; Arnon R, 2004, P NATL ACAD SCI USA, V101, P14593, DOI 10.1073/pnas.0404887101; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen M, 2001, MULT SCLER, V7, P209, DOI 10.1191/135245801680209303; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Dhib-Jalbut S, 2002, NEUROLOGY, V58, pS3, DOI 10.1212/WNL.58.8_suppl_4.S3; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Farina C, 2005, LANCET NEUROL, V4, P567, DOI 10.1016/S1474-4422(05)70167-8; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; FRIDKISHARELI M, 1994, P NATL ACAD SCI USA, V91, P4872, DOI 10.1073/pnas.91.11.4872; Frisullo G, 2006, J NEUROSCI RES, V84, P1027, DOI 10.1002/jnr.20995; Gur C, 2006, CLIN IMMUNOL, V118, P307, DOI 10.1016/j.clim.2005.10.004; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jee Y, 2006, INT IMMUNOL, V18, P537, DOI 10.1093/intimm/dxh394; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; LISAK RP, 1983, J NEUROL SCI, V62, P281, DOI 10.1016/0022-510X(83)90205-8; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nestle FO, 2000, ONCOGENE, V19, P6673, DOI 10.1038/sj.onc.1204095; Neuhaus O, 2000, P NATL ACAD SCI USA, V97, P7452, DOI 10.1073/pnas.97.13.7452; Neuhaus O, 2001, NEUROLOGY, V56, P702, DOI 10.1212/WNL.56.6.702; Putheti P, 2003, J NEUROIMMUNOL, V144, P125, DOI 10.1016/j.jneuroim.2003.08.001; Ranger AM, 1996, INT IMMUNOL, V8, P1549, DOI 10.1093/intimm/8.10.1549; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Shimoda M, 2006, J IMMUNOL, V176, P6503, DOI 10.4049/jimmunol.176.11.6503; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Teitelbaum D, 1996, J NEUROIMMUNOL, V64, P209, DOI 10.1016/0165-5728(95)00180-8; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tran EH, 1998, J IMMUNOL, V161, P3767; VanDeusen JB, 2006, EUR J IMMUNOL, V36, P623, DOI 10.1002/eji.200535241; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Weber MS, 2004, BRAIN, V127, P1370, DOI 10.1093/brain/awh163; Wesemann DR, 2003, J IMMUNOL, V171, P5313, DOI 10.4049/jimmunol.171.10.5313; Zamora A, 2002, AUTOIMMUNITY, V35, P21, DOI 10.1080/08916930290005873; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zhang MF, 2000, J NEUROIMMUNOL, V103, P189, DOI 10.1016/S0165-5728(99)00239-8; Ziemssen T, 2002, BRAIN, V125, P2381, DOI 10.1093/brain/awf252	50	353	368	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2007	13	8					935	943		10.1038/nm1620	http://dx.doi.org/10.1038/nm1620			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17676050				2022-12-25	WOS:000248674600024
J	Behr, M; Wingen, C; Wolf, C; Schuh, R; Hoch, M				Behr, Matthias; Wingen, Christian; Wolf, Christian; Schuh, Reinhard; Hoch, Michael			Wurst is essential for airway clearance and respiratory-tube size control	NATURE CELL BIOLOGY			English	Article							GENETIC-CONTROL; J-DOMAIN; MECHANISMS; BIOSYNTHESIS; REQUIREMENT; ENDOCYTOSIS; AUXILIN; DYNAMIN; MATRIX; HSC70	The Drosophila melanogaster tracheal system and the mammalian lung are branching networks of tubular epithelia that convert during late embryogenesis from liquid- to air-filling(1-3). Little is known about how respiratory-tube size and physiology are coordinated. Here, we show that the Drosophila wurst gene encodes a unique J-domain transmembrane protein highly conserved in metazoa. In wurst mutants, respiratory-tube length is increased and lumen clearance is abolished, preventing gas filling of the airways. Wurst is essential for clathrin-mediated endocytosis(4), which is required for size determination and lumen clearance of the airways. wurst recruits heat shock cognate protein 70-4 and clathrin to the apical membrane of epithelial cells. The sequence conservation of the single Wurst orthologues in mice and humans offer new opportunities for genetic studies of clinically relevant lung syndromes caused by the failure of liquid clearance and respiratory-tube size control.	Univ Bonn, LIMES Inst, Lab Mol Dev Biol, Program Unit Dev & Genet, D-53115 Bonn, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Bonn; Max Planck Society	Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Lab Mol Dev Biol, Program Unit Dev & Genet, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257				Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Arias A.M., 1993, DEV DROSOPHILA, P609; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; OBrodovich HM, 1996, P ASSOC AM PHYSICIAN, V108, P345; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	29	48	49	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					847	U211		10.1038/ncb1611	http://dx.doi.org/10.1038/ncb1611			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558392	Green Published			2022-12-25	WOS:000247760700021
J	Kondo, T; Hashimoto, Y; Kato, K; Inagaki, S; Hayashi, S; Kageyama, Y				Kondo, Takefumi; Hashimoto, Yoshiko; Kato, Kagayaki; Inagaki, Sachi; Hayashi, Shigeo; Kageyama, Yuji			Small peptide regulators of actin-based cell morphogenesis encoded by a polycistronic mRNA	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER; DIFFERENTIATION; PROTEIN; IDENTIFICATION; ORGANIZATION; WINGLESS; DENTICLE; PATTERN; SYSTEM; GENOME	Transcriptome analyses in eukaryotes, including mice and humans, have identified polyA- containing transcripts that lack long open reading frames (ORFs; > 100 amino acids) 1,2. These transcripts are believed most likely to function as non-coding RNAs, but their translational capacities and biological activities have not been characterized in detail. Here, we report that polished rice (pri), which was previously identified as a gene for a non-coding RNA in Drosophila3,4, is in fact transcribed into a polycistronic mRNA that contains evolutionarily conserved short ORFs that encode 11 or 32 amino acid-long peptides. pri was expressed in all epithelial tissues during embryogenesis. The loss of pri function completely eliminated apical cuticular structures, including the epidermal denticles and tracheal taenidia, and also caused defective tracheal-tube expansion. We found that pri is essential for the formation of specific F-actin bundles that prefigures the formation of the denticles and taenidium. We provide evidences that pri acts non-cell autonomously and that four of the conserved pri ORFs are functionally redundant. These results demonstrate that pri has essential roles in epithelial morphogenesis by regulating F-actin organization.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Sci & Technol, Dept Life Sci, Kobe, Hyogo 657, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	RIKEN; Kobe University; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Kageyama, Y (corresponding author), Okazaki Inst Integrated Biosci, 5-1 Myoudaiji Higashiyama, Okazaki, Aichi 4448787, Japan.	kageyama@nibb.ac.jp	Hayashi, Shigeo/N-5128-2015; Hayashi, Shigeo/J-9628-2019; Inagaki, Sachi/P-8036-2019	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Inagaki, Sachi/0000-0002-2365-9938; Kondo, Takefumi/0000-0001-8127-1141; Kato, Kagayaki/0000-0003-4757-3773				BARTOSZEWSKI S, 1994, DROSOPHILA INFORMATI, V14; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Ohtake H, 2004, DNA RES, V11, P305, DOI 10.1093/dnares/11.4.305; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PATEL N, 1995, DROSOPHILA MELANOGAS, P445; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454	28	181	192	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					660	U87		10.1038/ncb1595	http://dx.doi.org/10.1038/ncb1595			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486114				2022-12-25	WOS:000246922700011
J	Bernhagen, J; Krohn, R; Lue, H; Gregory, JL; Zernecke, A; Koenen, RR; Dewor, M; Georgiev, I; Schober, A; Leng, L; Kooistra, T; Fingerle-Rowson, G; Ghezzi, P; Kleemann, R; McColl, SR; Bucala, R; Hickey, MJ; Weber, C				Bernhagen, Juergen; Krohn, Regina; Lue, Hongqi; Gregory, Julia L.; Zernecke, Alma; Koenen, Rory R.; Dewor, Manfred; Georgiev, Ivan; Schober, Andreas; Leng, Lin; Kooistra, Teake; Fingerle-Rowson, Guenter; Ghezzi, Pietro; Kleemann, Robert; McColl, Shaun R.; Bucala, Richard; Hickey, Michael J.; Weber, Christian			MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment	NATURE MEDICINE			English	Article							MIGRATION INHIBITORY FACTOR; DEFICIENT MICE; ATHEROSCLEROTIC PLAQUES; LESION PROGRESSION; MONOCYTE ARREST; CC CHEMOKINES; EXPRESSION; DISEASE; CYTOKINES; BINDING	The cytokine macrophage migration inhibitory factor (MIF) plays a critical role in inflammatory diseases and atherogenesis. We identify the chemokine receptors CXCR2 and CXCR4 as functional receptors for MIF. MIF triggered G(alpha i)- and integrin-dependent arrest and chemotaxis of monocytes and T cells, rapid integrin activation and calcium influx through CXCR2 or CXCR4. MIF competed with cognate ligands for CXCR4 and CXCR2 binding, and directly bound to CXCR2. CXCR2 and CD74 formed a receptor complex, and monocyte arrest elicited by MIF in inflamed or atherosclerotic arteries involved both CXCR2 and CD74. In vivo, Mif deficiency impaired monocyte adhesion to the arterial wall in atherosclerosis-prone mice, and MIF-induced leukocyte recruitment required II8rb (which encodes Cxcr2). Blockade of Mif but not of canonical ligands of Cxcr2 or Cxcr4 in mice with advanced atherosclerosis led to plaque regression and reduced monocyte and T-cell content in plaques. By activating both CXCR2 and CXCR4, MIF displays chemokine-like functions and acts as a major regulator of inflammatory cell recruitment and atherogenesis. Targeting MIF in individuals with manifest atherosclerosis can potentially be used to treat this condition.	Univ Aachen, Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Biochem Mol & Cell Biol,Inst Biochem, D-52074 Aachen, Germany; Univ Aachen, Rhein Westfal TH Aachen, Univ Hosp Aachen, Inst Mol Cardiovasc Res, D-52074 Aachen, Germany; Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3168, Australia; Univ Munich, Med Policlin, D-80336 Munich, Germany; Yale Univ, Sch Med, Anlyan Ctr, Dept Med Pathol Epidemiol & Publ Hlth, New Haven, CT 06520 USA; TNO Qual Life, Gaubius Lab Biosci, Dept Vasc & Metab Dis, NL-2301 CE Leiden, Netherlands; Univ Hosp Cologne, Med Clin 1, Dept Hematol & Oncol, D-50937 Cologne, Germany; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Leiden Univ, Dept Vasc Surg, NL-2333 CK Leiden, Netherlands; Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Monash University; University of Munich; Yale University; Netherlands Organization Applied Science Research; University of Cologne; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Leiden University; Leiden University - Excl LUMC; University of Adelaide	Bernhagen, J (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Biochem Mol & Cell Biol,Inst Biochem, D-52074 Aachen, Germany.	jbernhagen@ukaachen.de; cweber@ukaachen.de	Hickey, Michael J./A-5429-2012; Gregory, Julia L/K-8726-2012; Ghezzi, Pietro/A-4995-2010; Schober, Andreas/B-2866-2013; Gregory, Julia/AAW-6017-2020; Koenen, Rory/H-4172-2012; Weber, Christian/AAW-2153-2020	Hickey, Michael J./0000-0003-2354-357X; Schober, Andreas/0000-0001-7798-136X; Gregory, Julia/0000-0003-2408-677X; Koenen, Rory/0000-0002-9955-9730; Weber, Christian/0000-0003-4610-8714; Ghezzi, Pietro/0000-0003-0911-8358; Leng, Lin/0000-0002-0605-358X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43210] Funding Source: Medline; NIAMS NIH HHS [AR49610] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BenBaruch A, 1997, CYTOKINE, V9, P37, DOI 10.1006/cyto.1996.0133; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Degryse B, 2003, FEBS LETT, V553, P11, DOI 10.1016/S0014-5793(03)01027-5; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HAYASHI S, 1995, J IMMUNOL, V154, P814; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Kong YZ, 2005, ATHEROSCLEROSIS, V178, P207, DOI 10.1016/j.atherosclerosis.2004.08.030; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Murphy PM, 2000, PHARMACOL REV, V52, P145; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Schrans-Stassen BHGJ, 2005, ANTIOXID REDOX SIGN, V7, P1211, DOI 10.1089/ars.2005.7.1211; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; WEBER C, 1993, EUR J IMMUNOL, V23, P852, DOI 10.1002/eji.1830230413; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38	50	925	965	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2007	13	5					587	596		10.1038/nm1567	http://dx.doi.org/10.1038/nm1567			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17435771				2022-12-25	WOS:000246302800026
J	Martin, G; Elena, SF; Lenormand, T				Martin, Guillaume; Elena, Santiago F.; Lenormand, Thomas			Distributions of epistasis in microbes fit predictions from a fitness landscape model	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; ESCHERICHIA-COLI; RNA VIRUSES; EVOLUTION; RECOMBINATION; ADAPTATION; STRAINS	How do the fitness effects of several mutations combine? Despite its simplicity, this question is central to the understanding of multilocus evolution. Epistasis (the interaction between alleles at different loci), especially epistasis for fitness traits such as reproduction and survival, influences evolutionary predictions(1,2) "almost whenever multilocus genetics matters''(3). Yet very few models(4,5) have sought to predict epistasis, and none has been empirically tested. Here we show that the distribution of epistasis can be predicted from the distribution of single mutation effects, based on a simple fitness landscape model(6). We show that this prediction closely matches the empirical measures of epistasis that have been obtained for Escherichia coli(7) and the RNA virus vesicular stomatitis virus(8). Our results suggest that a simple fitness landscape model may be sufficient to quantitatively capture the complex nature of gene interactions. This model may offer a simple and widely applicable alternative to complex metabolic network models, in particular for making evolutionary predictions.	CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34293 Montpellier, France; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; UPV, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Martin, G (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, 1919 Route Mende, F-34293 Montpellier, France.	guillaume.martin@unil.ch	Elena, Santiago F./A-4191-2011; Martin, Guillaume/P-8964-2016; Lenormand, Thomas/A-5328-2012	Elena, Santiago F./0000-0001-8249-5593; Martin, Guillaume/0000-0002-5203-5091; Lenormand, Thomas/0000-0001-8930-5393				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; BURGER R, 2000, MATH THEORY SELECTIO, P158; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Fisher R.A., 1930, GENETICAL THEORY NAT; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; LANDE R, 1980, GENETICS, V94, P203; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Malmberg RL, 2005, GENET RES, V86, P89, DOI 10.1017/S0016672305007780; Martin G, 2006, EVOLUTION, V60, P2413, DOI 10.1554/06-162.1; Martin G, 2006, EVOLUTION, V60, P893; Mathai A., 1992, QUADRATIC FORMS RAND; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2001, EVOL DEV, V3, P121, DOI 10.1046/j.1525-142x.2001.003003121.x; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SZATHMARY E, 1993, GENETICS, V133, P127; Waxman D, 2005, AM NAT, V166, P447, DOI 10.1086/444404; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wloch DM, 2001, J EVOLUTION BIOL, V14, P310, DOI 10.1046/j.1420-9101.2001.00267.x	30	134	135	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					555	560		10.1038/ng1998	http://dx.doi.org/10.1038/ng1998			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369829	Green Published			2022-12-25	WOS:000245271200029
J	Cao, LQ; Shitara, H; Horii, T; Nagao, Y; Imai, H; Abe, K; Hara, T; Hayashi, JI; Yonekawa, H				Cao, Liqin; Shitara, Hiroshi; Horii, Takuro; Nagao, Yasumitsu; Imai, Hiroshi; Abe, Kuniya; Hara, Takahiko; Hayashi, Jun-Ichi; Yonekawa, Hiromichi			The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells	NATURE GENETICS			English	Article							PREIMPLANTATION DEVELOPMENT; RAPID SEGREGATION; HUMAN OOCYTES; DNA; EMBRYOGENESIS; ELIMINATION; OOGENESIS; EVOLUTION; MUTATION; DISEASE	Observations of rapid shifts in mitochondrial DNA (mtDNA) variants between generations prompted the creation of the bottleneck theory. A prevalent hypothesis is that a massive reduction in mtDNA content during early oogenesis leads to the bottleneck(1,2). To test this, we estimated the mtDNA copy number in single germline cells and in single somatic cells of early embryos in mice. Primordial germ cells (PGCs) show consistent, moderate mtDNA copy numbers across developmental stages, whereas primary oocytes demonstrate substantial mtDNA expansion during early oocyte maturation. Some somatic cells possess a very low mtDNA copy number. We also demonstrated that PGCs have more than 100 mitochondria per cell. We conclude that the mitochondrial bottleneck is not due to a drastic decline in mtDNA copy number in early oogenesis but rather to a small effective number of segregation units for mtDNA in mouse germ cells. These results provide new information for mtDNA segregation models and for understanding the recurrence risks for mtDNA diseases.	Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto 6068502, Japan; RIKEN, Tsukuba Inst, BRC, Technol & Dev Team Mammalian Cellular Disorders, Tsukuba, Ibaraki 3050074, Japan; Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Kyoto University; RIKEN; Tokyo Metropolitan Institute of Medical Science	Yonekawa, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan.	yonekawa@rinshoken.or.jp						ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; DHERDE K, 1995, REPROD NUTR DEV, V35, P305, DOI 10.1051/rnd:19950306; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; Meirelles FV, 1998, GENETICS, V148, P877; Nagy A., 2003, MANIPULATING MOUSE E; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NOGAWA T, 1988, J MORPHOL, V195, P225, DOI 10.1002/jmor.1051950208; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Shitara H, 2000, GENETICS, V156, P1277; Smith LC, 2005, REPROD FERT DEVELOP, V17, P15, DOI 10.1071/RD04084; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	30	233	243	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					386	390		10.1038/ng1970	http://dx.doi.org/10.1038/ng1970			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293866				2022-12-25	WOS:000244480000022
J	Esengil, H; Chang, V; Mich, JK; Chen, JK				Esengil, Hanife; Chang, Vicky; Mich, John K.; Chen, James K.			Small-molecule regulation of zebrafish gene expression	NATURE CHEMICAL BIOLOGY			English	Article							ECDYSONE RECEPTOR; INDUCIBLE EXPRESSION; TRANSGENE; PROMOTER; ANALOGS	The zebrafish has emerged as a versatile model organism for biomedical research, yet its potential has been limited by a lack of conditional reverse-genetic tools. Here we report a chemically inducible gene expression technology that has orthogonality to vertebrate signaling processes, high induction levels, and rapid kinetics. Coupled with tissue-specific promoters, this system provides multidimensional control of gene expression and will enable new models of human disorders and diseases.	Stanford Univ, Sch Med, Dept Chem & Syst Biol, Ctr Clin Sci Res, Stanford, CA 94305 USA	Stanford University	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Ctr Clin Sci Res, 269 Campus Dr,Room 3155, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	NIGMS NIH HHS [R01 GM072600] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam A, 2000, EXP CELL RES, V256, P282, DOI 10.1006/excr.2000.4805; de Graaf M, 1998, DEV GROWTH DIFFER, V40, P577; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Karzenowski D, 2005, BIOTECHNIQUES, V39, P191, DOI 10.2144/05392ST01; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Padidam M, 2003, TRANSGENIC RES, V12, P101, DOI 10.1023/A:1022113817892; Sawada Y, 2003, PEST MANAG SCI, V59, P25, DOI 10.1002/ps.604; Shimizu B, 1997, STEROIDS, V62, P638, DOI 10.1016/S0039-128X(97)00049-4; Xu YF, 1999, DNA CELL BIOL, V18, P85, DOI 10.1089/104454999315655; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0	11	54	54	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2007	3	3					154	155		10.1038/nchembio858	http://dx.doi.org/10.1038/nchembio858			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	138BD	17237798				2022-12-25	WOS:000244336600010
J	Wang, YM; Medvid, R; Melton, C; Jaenisch, R; Blelloch, R				Wang, Yangming; Medvid, Rostislav; Melton, Collin; Jaenisch, Rudolf; Blelloch, Robert			DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal	NATURE GENETICS			English	Article							NUCLEAR EXPORT; DICER; COMPLEX	The molecular controls that govern the differentiation of embryonic stem (ES) cells remain poorly understood. DGCR8 is an RNA-binding protein that assists the RNase III enzyme Drosha in the processing of microRNAs (miRNAs), a subclass of small RNAs. Here we study the role of miRNAs in ES cell differentiation by generating a Dgcr8 knockout model. Analysis of mouse knockout ES cells shows that DGCR8 is essential for biogenesis of miRNAs. On the induction of differentiation, DGCR8-deficient ES cells do not fully downregulate pluripotency markers and retain the ability to produce ES cell colonies; however, they do express some markers of differentiation. This phenotype differs from that reported for Dicer1 knockout cells, suggesting that Dicer has miRNA-independent roles in ES cell function. Our findings indicate that miRNAs function in the silencing of ES cell self-renewal that normally occurs with the induction of differentiation.	Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu	Wang, Yangming/J-8939-2015	Wang, Yangming/0000-0001-6974-6060	NINDS NIH HHS [K08 NS048118, K08 NS048118-01A1, K08 NS048118-02, K08 NS48118] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han J, 2001, DRUG DELIV, V8, P125; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Pelton TA, 2002, J CELL SCI, V115, P329; Rathjen J, 1999, J CELL SCI, V112, P601; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	28	750	806	1	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					380	385		10.1038/ng1969	http://dx.doi.org/10.1038/ng1969			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259983	Green Accepted			2022-12-25	WOS:000244480000021
J	Edwards, RJ; Moran, N; Devocelle, M; Kiernan, A; Meade, G; Signac, W; Foy, M; Park, SDE; Dunne, E; Kenny, D; Shields, DC				Edwards, Richard J.; Moran, Niamh; Devocelle, Marc; Kiernan, Aoife; Meade, Gerardene; Signac, William; Foy, Martina; Park, Stephen D. E.; Dunne, Eimear; Kenny, Dermot; Shields, Denis C.			Bioinformatic discovery of novel bioactive peptides	NATURE CHEMICAL BIOLOGY			English	Article							PLATELET ACTIVATION; CYTOPLASMIC TAIL; INTEGRIN ACTIVATION; ENDOTHELIAL-CELLS; DRUG TARGETS; PROTEIN; CD226; AGGREGATION; EXPRESSION; ADHESION	Short synthetic oligopeptides based on regions of human proteins that encompass functional motifs are versatile reagents for understanding protein signaling and interactions. They can either mimic or inhibit the parent protein's activity(1-4) and have been used in drug development(5). Peptide studies typically either derive peptides from a single identified protein or ( at the other extreme) screen random combinatorial peptides(4,6), often without knowledge of the signaling pathways targeted. Our objective was to determine whether rational bioinformatic design of oligopeptides specifically targeted to potentially signaling-rich juxtamembrane regions could identify modulators of human platelet function. High-throughput in vitro platelet function assays of palmitylated cell-permeable oligopeptides corresponding to these regions identified many agonists and antagonists of platelet function. Many bioactive peptides were from adhesion molecules, including a specific CD226-derived inhibitor of inside-out platelet signaling. Systematic screens of this nature are highly efficient tools for discovering short signaling motifs in molecular signaling pathways.	Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland; Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; Royal Coll Surgeons Ireland, Dept Pharmaceut & Med Chem, Ctr Synth & Chem Biol, Dublin 2, Ireland	Royal College of Surgeons - Ireland; University College Dublin; Royal College of Surgeons - Ireland; University College Dublin	Kenny, D (corresponding author), Royal Coll Surgeons Ireland, Dept Clin Pharmacol, 123 St Stephens Green, Dublin 2, Ireland.	dkenny@rcsi.ie; denis.shields@ucd.ie	Moran, Niamh/F-4188-2012; Dunne, Eimear/AGX-1949-2022; Edwards, Richard/C-8755-2011; Dunne, Eimear/C-6785-2012; Kenny, Dermot/C-3898-2012	Moran, Niamh/0000-0002-8614-3242; Dunne, Eimear/0000-0001-9862-1398; Edwards, Richard/0000-0002-3645-5539; Dunne, Eimear/0000-0001-9862-1398; Kenny, Dermot/0000-0001-5548-3263; Shields, Denis/0000-0003-4015-2474; Devocelle, Marc/0000-0001-7641-1306				Aylward K, 2006, J THROMB HAEMOST, V4, P1804, DOI 10.1111/j.1538-7836.2006.02041.x; Chen LH, 2003, LIFE SCI, V73, P2373, DOI 10.1016/S0024-3205(03)00606-4; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Edwards RJ, 2005, BIOINFORMATICS, V21, P4190, DOI 10.1093/bioinformatics/bti678; Godehardt AW, 2004, BIOCHEM J, V381, P877, DOI 10.1042/BJ20030919; Hillmann AG, 2006, J THROMB HAEMOST, V4, P349, DOI 10.1111/j.1538-7836.2006.01684.x; Kamb A, 2000, CURR OPIN MOL THER, V2, P662; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Martin K, 2003, J THROMB HAEMOST, V1, P2643, DOI 10.1046/j.1538-7836.2003.00478.x; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Moran N, 2006, ANAL BIOCHEM, V357, P77, DOI 10.1016/j.ab.2006.06.037; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; Searls DB, 2003, NAT REV DRUG DISCOV, V2, P613, DOI 10.1038/nrd1152; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Slupsky JR, 1997, BRIT J HAEMATOL, V96, P275, DOI 10.1046/j.1365-2141.1997.d01-2011.x; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Sun B, 2001, BIOTECHNIQUES, V31, P1174, DOI 10.2144/01315dd02; Sun Y, 1998, NEUROCOMPUTING, V19, P133, DOI 10.1016/S0925-2312(97)00092-1; Yamanouchi J, 2004, BIOCHEM J, V379, P317, DOI 10.1042/BJ20031753	28	74	78	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2007	3	2					108	112		10.1038/nchembio854	http://dx.doi.org/10.1038/nchembio854			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	128UZ	17220901				2022-12-25	WOS:000243685800014
J	Pel, HJ; de Winde, JH; Archer, DB; Dyer, PS; Hofmann, G; Schaap, PJ; Turner, G; de Vries, RP; Albang, R; Albermann, K; Andersen, MR; Bendtsen, JD; Benen, JAE; van den Berg, M; Breestraat, S; Caddick, MX; Contreras, R; Cornell, M; Coutinho, PM; Danchin, EGJ; Debets, AJM; Dekker, P; van Dijck, PWM; van Dijk, A; Dijkhuizen, L; Driessen, AJM; d'Enfert, C; Geysens, S; Goosen, C; Groot, GSP; de Groot, PWJ; Guillemette, T; Henrissat, B; Herweijer, M; van den Hombergh, JPTW; van den Hondel, CAMJJ; van der Heijden, RTJM; van der Kaaij, RM; Klis, FM; Kools, HJ; Kubicek, CP; van Kuyk, PA; Lauber, J; Lu, X; van der Maarel, MJEC; Meulenberg, R; Menke, H; Mortimer, MA; Nielsen, J; Oliver, SG; Olsthoorn, M; Pal, K; van Peij, NNME; Ram, AFJ; Rinas, U; Roubos, JA; Sagt, CMJ; Schmoll, M; Sun, JB; Ussery, D; Varga, J; Vervecken, W; de Vondervoort, PJJV; Wedler, H; Wosten, HAB; Zeng, AP; van Ooyen, AJJ; Visser, J; Stam, H				Pel, Herman J.; de Winde, Johannes H.; Archer, David B.; Dyer, Paul S.; Hofmann, Gerald; Schaap, Peter J.; Turner, Geoffrey; de Vries, Ronald P.; Albang, Richard; Albermann, Kaj; Andersen, Mikael R.; Bendtsen, Jannick D.; Benen, Jacques A. E.; van den Berg, Marco; Breestraat, Stefaan; Caddick, Mark X.; Contreras, Roland; Cornell, Michael; Coutinho, Pedro M.; Danchin, Etienne G. J.; Debets, Alfons J. M.; Dekker, Peter; van Dijck, Piet W. M.; van Dijk, Alard; Dijkhuizen, Lubbert; Driessen, Arnold J. M.; d'Enfert, Christophe; Geysens, Steven; Goosen, Coenie; Groot, Gert S. P.; de Groot, Piet W. J.; Guillemette, Thomas; Henrissat, Bernard; Herweijer, Marga; van den Hombergh, Johannes P. T. W.; van den Hondel, Cees A. M. J. J.; van der Heijden, Rene T. J. M.; van der Kaaij, Rachel M.; Klis, Frans M.; Kools, Harrie J.; Kubicek, Christian P.; van Kuyk, Patricia A.; Lauber, Juergen; Lu, Xin; van der Maarel, Marc J. E. C.; Meulenberg, Rogier; Menke, Hildegard; Mortimer, Martin A.; Nielsen, Jens; Oliver, Stephen G.; Olsthoorn, Maurien; Pal, Karoly; van Peij, Noel N. M. E.; Ram, Arthur F. J.; Rinas, Ursula; Roubos, Johannes A.; Sagt, Cees M. J.; Schmoll, Monika; Sun, Jibin; Ussery, David; Varga, Janos; Vervecken, Wouter; de Vondervoort, Peter J. J. van; Wedler, Holger; Wosten, Han A. B.; Zeng, An-Ping; van Ooyen, Albert J. J.; Visser, Jaap; Stam, Hein			Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; RECONSTRUCTION; METABOLISM; AUTOLYSIS; FUMIGATUS; NIDULANS; CLUSTER; STRESS	The filamentous fungus Aspergillus niger is widely exploited by the fermentation industry for the production of enzymes and organic acids, particularly citric acid. We sequenced the 33.9-megabase genome of A. niger CBS 513.88, the ancestor of currently used enzyme production strains. A high level of synteny was observed with other aspergilli sequenced. Strong function predictions were made for 6,506 of the 14,165 open reading frames identified. A detailed description of the components of the protein secretion pathway was made and striking differences in the hydrolytic enzyme spectra of aspergilli were observed. A reconstructed metabolic network comprising 1,069 unique reactions illustrates the versatile metabolism of A. niger. Noteworthy is the large number of major facilitator superfamily transporters and fungal zinc binuclear cluster transcription factors, and the presence of putative gene clusters for fumonisin and ochratoxin A synthesis.	DSM Food Specialities, NL-2600 MA Delft, Netherlands; Delft Univ Technol, Dept Biotechnol, Kluyver Ctr Gen Ind Fermentat, NL-2628 BC Delft, Netherlands; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; Tech Univ Denmark, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; Univ Wageningen & Res Ctr, Microbiol Lab, Sect Fungal Gen, NL-6703 HA Wageningen, Netherlands; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; Biomax Informat AG, D-82152 Martinsried, Germany; CLC Bio, DK-8000 Aarhus C, Denmark; DSM Anti Infect, NL-2600 KA Delft, Netherlands; Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Ghent VIB, Dept Mol Biomed Res, Unit Fundamental & Appl Mol Biol, B-9052 Ghent, Belgium; Univ Manchester, Fac Life Sci, Ctr Anal Biol Complex, Manchester M13 9PT, Lancs, England; Univ Aix Marseille 1, CNRS, UMR6098, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; Univ Aix Marseille 2, CNRS, UMR6098, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; Univ Wageningen & Res Ctr, Genet Lab, NL-6703 BD Wageningen, Netherlands; TNO, Ctr Carbohydrate Bioproc, NL-9750 AA Haren, Netherlands; Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol, Inst Mat Sci Ctr Plus, NL-9750 AA Haren, Netherlands; Inst Pasteur, INRA, USC 2019, Unite Postulante Biol & Pathogenicite Fong, F-75724 Paris 15, France; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1018 WV Amsterdam, Netherlands; Univ Angers, UMR 77, Microbiol Lab, F-49045 Angers, France; Leiden Univ, Inst Biol, NL-2333 AL Leiden, Netherlands; Radboud Univ Nijmegen, Med Ctr, CMBI, NL-6500 HB Nijmegen, Netherlands; Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1060 Vienna, Austria; Qiagen GmbH, Qiagen Gen Serv, D-40724 Hilden, Germany; Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; Univ Szeged, Fac Sci, Dept Microbiol, H-6701 Szeged, Hungary; Tech Univ Denmark, Bioctr, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; CBS Fungal Biodivers Ctr, NL-3584 CT Utrecht, Netherlands; Fungal Genet & Technol Consultancy, NL-6700 AJ Wageningen, Netherlands	DSM NV; Delft University of Technology; University of Nottingham; Technical University of Denmark; Wageningen University & Research; University of Sheffield; Utrecht University; Biomax Informatics; DSM NV; University of Liverpool; Flanders Institute for Biotechnology (VIB); Ghent University; University of Manchester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Wageningen University & Research; Netherlands Organization Applied Science Research; University of Groningen; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Amsterdam; Universite d'Angers; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; Technische Universitat Wien; QIAGEN GmbH; Helmholtz Association; Helmholtz-Center for Infection Research; Szeged University; Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Stam, H (corresponding author), DSM Food Specialities, POB 1, NL-2600 MA Delft, Netherlands.	hein.stam@dsm.com	Ussery, David/J-2026-2019; Pal, Karoly/AGG-7356-2022; Klis, Frans M/B-9085-2008; Henrissat, Bernard/J-2475-2012; de Winde, J.H./AAC-5520-2021; Coutinho, Pedro M/C-4473-2008; guillemette, thomas/H-2097-2011; Wösten, Han AB/K-2769-2016; Driessen, Arnold J.M./D-1876-2012; Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014; Schmoll, Monika/I-6541-2016; Andersen, Mikael Rørdam/P-6743-2019; Ram, Arthur FJ/S-4648-2017; De Groot, Piet/L-7737-2014; Andersen, Mikael R/F-9377-2013; Oliver, Stephen/AAQ-5992-2021; Danchin, Etienne G.J./A-6648-2008; Danchin, Etienne GJ/X-6969-2019; de Vries, Ronald P./F-8125-2011	Ussery, David/0000-0003-3632-5512; Pal, Karoly/0000-0002-8226-6560; Klis, Frans M/0000-0003-0079-9492; Henrissat, Bernard/0000-0002-3434-8588; de Winde, J.H./0000-0002-7999-9317; guillemette, thomas/0000-0002-5649-974X; Wösten, Han AB/0000-0002-0399-3648; Dijkhuizen, Lubbert/0000-0003-2312-7162; Schmoll, Monika/0000-0003-3918-0574; Andersen, Mikael Rørdam/0000-0003-4794-6808; Ram, Arthur FJ/0000-0002-2487-8016; De Groot, Piet/0000-0002-3112-6947; Andersen, Mikael R/0000-0003-4794-6808; Oliver, Stephen/0000-0003-3410-6439; Danchin, Etienne G.J./0000-0003-4146-5608; Danchin, Etienne GJ/0000-0003-4146-5608; de Vries, Ronald P./0000-0002-4363-1123; Schaap, Peter/0000-0002-4346-6084; Dyer, Paul/0000-0003-0237-026X; d'Enfert, Christophe/0000-0002-6235-3886; Dekker, Peter/0000-0002-8197-8822; Sun, Jibin/0000-0002-0208-504X; Driessen, Arnold J.M./0000-0001-9258-9104; Van den Hondel, Kees/0000-0003-4782-2725; Zeng, An-Ping/0000-0001-9768-7096; Rinas, Ursula/0000-0003-4940-5749	Biotechnology and Biological Sciences Research Council [CFB17724, CFB17726] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archer DB, 2006, MYCOTA, V13, P75; Askohn S, 2005, FEMS MICROBIOL LETT, V253, P281, DOI 10.1016/j.femsle.2005.09.047; Berka R M, 1992, Biotechnology, V23, P155; BERNARD M, 2001, MED MYCOL S9, V1; David H, 2003, EUR J BIOCHEM, V270, P4243, DOI 10.1046/j.1432-1033.2003.03798.x; De Vries R. P., 2002, P263; DEBETS F, 1993, CURR GENET, V23, P47, DOI 10.1007/BF00336749; Emri T, 2005, MYCOL RES, V109, P757, DOI 10.1017/S0953756205003023; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Moss MO, 1998, J APPL MICROBIOL, V84, p62S, DOI 10.1046/j.1365-2672.1998.0840s162S.x; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Callaghan J, 2003, MICROBIOL-SGM, V149, P3485, DOI 10.1099/mic.0.26619-0; Pandey A, 1999, CURR SCI INDIA, V77, P149; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pedersen H, 2000, MOL GEN GENET, V263, P281, DOI 10.1007/s004380051169; Poore RE, 1997, AM J PHYSIOL-CELL PH, V272, pC289, DOI 10.1152/ajpcell.1997.272.1.C289; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; RAJ HG, 1992, HDB APPL MYCOLOGY, V4, P881; Reiber K, 2005, FEMS MICROBIOL LETT, V248, P83, DOI 10.1016/j.femsle.2005.05.028; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruijter GJG, 2002, MYCOTA, V10, P213; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Samson R A, 1992, Biotechnology, V23, P355; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; VERDOES JC, 1994, MOL GEN GENET, V244, P75, DOI 10.1007/BF00280189; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625	50	864	1381	6	223	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					221	231		10.1038/nbt1282	http://dx.doi.org/10.1038/nbt1282			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17259976	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000244064000028
J	Benanti, JA; Cheung, SK; Brady, MC; Toczyski, DP				Benanti, Jennifer A.; Cheung, Stephanie K.; Brady, Mariska C.; Toczyski, David P.			A proteomic screen reveals sCFGrr1 targets that regulate the glycolytic-gluconeogenic switch	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASES; GLOBAL ANALYSIS; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAYS; KINASE-I; YEAST; PROTEIN; GLUCOSE; DEGRADATION	Entry into the cell cycle is regulated by nutrient availability such that cells do not divide when resources are limited. The Skp1-Cul1-F-box(SCF) ubiquitin ligase with the F-box protein Grr1 ( SCFGrr1) controls the proteolytic turnover of regulators of cell-cycle entry and a glucose sensor, suggesting that it links the cell cycle with nutrient availability. Here, we show that SCFGrr1 broadly regulates cellular metabolism. We have developed a proteomic screening method that uses high-throughput quantitative microscopy to comprehensively screen for ubiquitin-ligase substrates. Seven new metabolic targets of SCFGrr1 were identified, including two regulators of glycolysis-the transcription factor Tye7 and Pfk27. The latter produces the second messenger fructose-2,6- bisphosphate that activates glycolysis and inhibits gluconeogenesis. We show that SCFGrr1 targets Pfk27 and Tye7 in response to glucose removal. Moreover, Pfk27 is phosphorylated by the kinase Snf1, and unphosphorylatable Pfk27 is stable and inhibits growth in the absence of glucose. These results demonstrate a role for SCFGrr1 in regulating the glycolytic-gluconeogenic switch.	Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Toczyski, DP (corresponding author), Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys, 2340 Sutter St, San Francisco, CA 94115 USA.	toczyski@cc.ucsf.edu		Benanti, Jennifer/0000-0003-2484-5721				Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Eckert-Boulet N, 2005, CURR GENET, V47, P139, DOI 10.1007/s00294-004-0553-1; Espinoza FH, 1998, MOL CELL BIOL, V18, P6365, DOI 10.1128/MCB.18.11.6365; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goncalves PM, 1997, MOL MICROBIOL, V25, P483, DOI 10.1046/j.1365-2958.1997.4811847.x; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kishi T, 1998, J CELL SCI, V111, P3655; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; NISHI K, 1995, MOL CELL BIOL, V15, P2646; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purnapatre K, 2005, MOL CELL BIOL, V25, P440, DOI 10.1128/MCB.25.1.440-450.2005; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	27	71	71	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1184	1191		10.1038/ncb1639	http://dx.doi.org/10.1038/ncb1639			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828247				2022-12-25	WOS:000249882300014
J	Stroissnigg, H; Trancikova, A; Descovich, L; Fuhrmann, J; Kutschera, W; Kostan, J; Meixner, A; Nothias, F; Propst, F				Stroissnigg, Heike; Trancikova, Alzbeta; Descovich, Luise; Fuhrmann, Jakob; Kutschera, Waltraud; Kostan, Julius; Meixner, Arabella; Nothias, Fatiha; Propst, Friedrich			S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction	NATURE CELL BIOLOGY			English	Article							TRANSIENT RETINOTECTAL PROJECTION; GROWTH CONE COLLAPSE; LIGHT-CHAIN; NEURONAL MIGRATION; NERVOUS-SYSTEM; MOTOR PROTEINS; IN-VITRO; MAP1B; TRANSPORT; BINDING	Treatment of cultured vertebrate neurons with nitric oxide leads to growth-cone collapse, axon retraction and the reconfiguration of axonal microtubules. We show that the light chain of microtubule-associated protein ( MAP) 1B is a substrate for S-nitrosylation in vivo, in cultured cells and in vitro. S-nitrosylation occurs at Cys 2457 in the COOH terminus. Nitrosylation of MAP1B leads to enhanced interaction with microtubules and correlates with the inhibition of neuroblastoma cell differentiation. We further show, in dorsal root ganglion neurons, that MAP1B is necessary for neuronal nitric oxide synthase control of growth-cone size, growth-cone collapse and axon retraction. These results reveal an S-nitrosylation-dependent signal-transduction pathway that is involved in regulation of the axonal cytoskeleton and identify MAP1B as a major component of this pathway. We propose that MAP1B acts by inhibiting a microtubule- and dynein-based mechanism that normally prevents axon retraction.	Austrian Acad Sci, Inst Mol Biotechnol GmbH, A-1030 Vienna, Austria; Univ Vienna, Dept Mol & Cell Biol, A-1030 Vienna, Austria; Univ Paris 06, UMR7101 NSI, F-75005 Paris, France; CNRS, UMR7101, IFR83, F-75005 Paris, France	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Vienna; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Propst, F (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol GmbH, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	friedrich.propst@univie.ac.at	Trancikova, Alzbeta Kralova/X-7402-2018	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Kostan, Julius/0000-0002-8347-111X; Nothias-Chahir, Fatiha/0000-0002-2497-2096				Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Cramer KS, 1996, J NEUROSCI, V16, P7995; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ernst AF, 2000, J NEUROSCI, V20, P1458; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; FAWCETT JW, 1994, NEUROSCIENCE, V61, P789, DOI 10.1016/0306-4522(94)90402-2; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; He Y, 2002, J NEUROSCI, V22, P5982; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kaytor MD, 2001, CELL, V107, P555, DOI 10.1016/S0092-8674(01)00590-6; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Ma D, 1997, J NEUROSCI RES, V49, P319, DOI 10.1002/(SICI)1097-4547(19970801)49:3<319::AID-JNR7>3.0.CO;2-F; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mize RR, 1998, PROG BRAIN RES, V118, P133; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pigino G, 1997, J CELL SCI, V110, P257; Renteria RC, 1996, J NEUROBIOL, V29, P415; Sambrook J., 2002, MOL CLONING LAB MANU; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Soares S, 2002, EUR J NEUROSCI, V16, P593, DOI 10.1046/j.1460-9568.2002.02126.x; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885	49	60	62	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1035	U8		10.1038/ncb1625	http://dx.doi.org/10.1038/ncb1625			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704770				2022-12-25	WOS:000249256500011
J	Tomlinson, I; Webb, E; Carvajal-Carmona, L; Broderick, P; Kemp, Z; Spain, S; Penegar, S; Chandler, I; Gorman, M; Wood, W; Barclay, E; Lubbe, S; Martin, L; Sellick, G; Jaeger, E; Hubner, R; Wild, R; Rowan, A; Fielding, S; Howarth, K; Silver, A; Atkin, W; Muir, K; Logan, R; Kerr, D; Johnstone, E; Sieber, O; Gray, R; Thomas, H; Peto, J; Cazier, B; Houlston, R				Tomlinson, Ian; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Kemp, Zoe; Spain, Sarah; Penegar, Steven; Chandler, Ian; Gorman, Maggie; Wood, Wendy; Barclay, Ella; Lubbe, Steven; Martin, Lynn; Sellick, Gabrielle; Jaeger, Emma; Hubner, Richard; Wild, Ruth; Rowan, Andrew; Fielding, Sarah; Howarth, Kimberley; Silver, Andrew; Atkin, Wendy; Muir, Kenneth; Logan, Richard; Kerr, David; Johnstone, Elaine; Sieber, Oliver; Gray, Richard; Thomas, Huw; Peto, Julian; Cazier, Baptiste; Houlston, Richard		CORGI Consortium	A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21	NATURE GENETICS			English	Article							PROSTATE-CANCER; RISK; METAANALYSIS; TUMORS	Much of the variation in inherited risk of colorectal cancer (CRC) is probably due to combinations of common low risk variants. We conducted a genome- wide association study of 550,000 tag SNPs in 930 familial colorectal tumor cases and 960 controls. The most strongly associated SNP (P = 1.72 x 10(-7), allelic test) was rs6983267 at 8q24.21. To validate this finding, we genotyped rs6983267 in three additional CRC case-control series (4,361 affected individuals and 3,752 controls; 1,901 affected individuals and 1,079 controls; 1,072 affected individuals and 415 controls) and replicated the association, providing P = 1.27 x 10(-14) (allelic test) overall, with odds ratios (ORs) of 1.27 (95% confidence interval (c.i.): 1.16-1.39) and 1.47 (95% c.i.: 1.34-1.62) for heterozygotes and rare homozygotes, respectively. Analyses based on 1,477 individuals with colorectal adenoma and 2,136 controls suggest that susceptibility to CRC is mediated through development of adenomas (OR = 1.21, 95% c.i.: 1.10-1.34; P = 6.89 x 10(-5)). These data show that common, low-penetrance susceptibility alleles predispose to colorectal neoplasia.	Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London WC1E 7HU, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; St Marks Hosp, Canc Res UK, Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England; Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham NG7 2UH, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; Univ Oxford, Canc & Immunogenet Lab, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England; St Marks Hosp, Canc Res UK, Family Canc Clin, Harrow HA1 3UJ, Middx, England; Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Queen Mary University London; University of London; Institute of Cancer Research - UK; Cancer Research UK; Imperial College London; University of Nottingham; Radcliffe Infirmary; University of Oxford; University of Oxford; University of Birmingham; Cancer Research UK; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK	Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk	Cazier, Jean-Baptiste/GLR-2949-2022; Hubner, Richard/N-8051-2015; Sieber, Oliver/ABA-9211-2021; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Evans, D Gareth/AAB-4308-2022; Carvajal-Carmona, Luis G/B-3882-2010; Sieber, Oliver/M-9473-2015; Spain, Sarah/G-1968-2010	Cazier, Jean-Baptiste/0000-0001-7581-9051; Hubner, Richard/0000-0002-7081-8823; Sieber, Oliver/0000-0001-9480-0786; Lubbe, Steven/0000-0002-7103-6671; Cazier, Jean-Baptiste/0000-0001-7581-9051; Evans, D Gareth/0000-0002-8482-5784; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Sieber, Oliver/0000-0001-9480-0786; Atkin, Wendy/0000-0001-9073-9658; Penegar, Steven/0000-0002-3768-0236; Broderick, Peter/0000-0002-8348-5829; Gray, Richard/0000-0003-4440-574X; Houlston, Richard/0000-0002-5268-0242; Spain, Sarah/0000-0002-7591-8364; Webb, Emily/0000-0002-4019-7456	MRC [G9615910, G0301100] Funding Source: UKRI; Medical Research Council [G9615910, G0301100] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Boland CR, 1998, CANCER RES, V58, P5248; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LOGAN RFA, 2006, GUT, V55, pA90; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; PETITTI D, 1994, MEAT ANAL DECISION A; World Health Organization, 1977, INT CLASS DIS; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	16	661	719	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					984	988		10.1038/ng2085	http://dx.doi.org/10.1038/ng2085			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618284				2022-12-25	WOS:000248446900015
J	Mougous, JD; Gifford, CA; Ramsdell, TL; Mekalanos, JJ				Mougous, Joseph D.; Gifford, Casey A.; Ramsdell, Talia L.; Mekalanos, John J.			Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa	NATURE CELL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; FHA DOMAINS; ACUTE INFECTION; III SECRETION; VIRULENCE; KINASE; GENES; IDENTIFICATION; EXPRESSION; STRAIN	Secreted proteins are crucial to the arsenal of bacterial pathogens. Although optimal activity of these proteins is likely to require precise regulation of release, the signalling events that trigger secretion are poorly understood. Here, we identify a threonine phosphorylation event that post-translationally regulates the Hcp secretion island-I-encoded type VI secretion system of Pseudomonas aeruginosa (H-T6SS). We show that a serine-threonine kinase, PpkA, is required for assembly of the H-T6SS and for secretion of Hcp1. PpkA activity is antagonized by PppA, a Ser-Thr phosphatase. These proteins exhibit reciprocal effects on the H-T6SS by acting on an FHA domain-containing protein, termed Fha1. Colocalization experiments with the T6S AAA+ family protein, ClpV1, indicate that Fha1 is a core scaffolding protein of the H-T6SS. Mutations affecting this H- T6S regulatory pathway provide a molecular explanation for the variation in Hcp1 secretion among clinical P. aeruginosa isolates. This mechanism of triggering secretion may be general, as many T6SSs contain orthologues of these proteins. Post-translational regulation of protein secretion by Thr phosphorylation is unprecedented in bacteria, and is likely to reflect the requirement for T6S to respond rapidly and reversibly to its environment.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu		Gifford, Casey/0000-0002-7757-573X	NIAID NIH HHS [AI26289, R01 AI026289] Funding Source: Medline; NIGMS NIH HHS [U54 GM074942] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Yahr TL, 2006, NEW ENGL J MED, V355, P1171, DOI 10.1056/NEJMcibr063931; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009	31	221	235	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					797	U121		10.1038/ncb1605	http://dx.doi.org/10.1038/ncb1605			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558395				2022-12-25	WOS:000247760700015
J	Ohashi, K; Yokoyama, T; Yamato, M; Kuge, H; Kanehiro, H; Tsutsumi, M; Amanuma, T; Iwata, H; Yang, J; Okano, T; Nakajima, Y				Ohashi, Kazuo; Yokoyama, Takashi; Yamato, Masayuki; Kuge, Hiroyuki; Kanehiro, Hiromichi; Tsutsumi, Masahiro; Amanuma, Toshihiro; Iwata, Hiroo; Yang, Joseph; Okano, Teruo; Nakajima, Yoshiyuki			Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets	NATURE MEDICINE			English	Article							HEPATOCYTE TRANSPLANTATION; CELL SHEETS; MICE	Hepatic tissue engineering using primary hepatocytes has been considered a valuable new therapeutic modality for several classes of liver diseases. Recent progress in the development of clinically feasible liver tissue engineering approaches, however, has been hampered mainly by insufficient cell-to-cell contact of the engrafted hepatocytes. We developed a method to engineer a uniformly continuous sheet of hepatic tissue using isolated primary hepatocytes cultured on temperature-responsive surfaces. Sheets of hepatic tissue transplanted into the subcutaneous space resulted in efficient engraftment to the surrounding cells, with the formation of two-dimensional hepatic tissues that stably persisted for longer than 200 d. The engineered hepatic tissues also showed several characteristics of liver-specific functionality. Additionally, when the hepatic tissue sheets were layered in vivo, three-dimensional miniature liver systems having persistent survivability could be also engineered. This technology for liver tissue engineering is simple, minimally invasive and free of potentially immunogenic biodegradable scaffolds.	Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; Nihon Noyaku Co Ltd, Osaka 5860094, Japan; Saiseikai Chuwa Hosp, Dept Pathol, Nara 6330054, Japan; Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Nara Medical University; Tokyo Women's Medical University; Kyoto University	Ohashi, K (corresponding author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ohashi@abmes.twmu.ac.jp	Okano, Teruo/J-4028-2012					Bumgardner GL, 1998, TRANSPLANTATION, V65, P47, DOI 10.1097/00007890-199801150-00010; Dhawan A, 2004, TRANSPLANTATION, V78, P1812, DOI 10.1097/01.TP.0000146386.77076.47; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; Fox IJ, 2006, AM J TRANSPLANT, V6, P5, DOI 10.1111/j.1600-6143.2005.01188.x; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961; JOLLEY ME, 1981, CLIN CHEM, V27, P1190; Kuge H, 2006, CELL TRANSPLANT, V15, P1, DOI 10.3727/000000006783982214; Lee HM, 2003, TISSUE ENG, V9, P1227, DOI 10.1089/10763270360728134; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Muraca M, 2002, LANCET, V359, P317, DOI 10.1016/S0140-6736(02)07529-3; Nahmias Y, 2006, HEPATOLOGY, V43, P257, DOI 10.1002/hep.21016; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohashi K, 2005, CELL TRANSPLANT, V14, P621, DOI 10.3727/000000005783982620; Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484; Ohashi K, 2000, NAT MED, V6, P327; Ohashi K, 2002, TRANSPLANT P, V34, P1431, DOI 10.1016/S0041-1345(02)02916-0; Ohashi K, 2001, J MOL MED, V79, P617, DOI 10.1007/s001090100260; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Stephenne X, 2006, GASTROENTEROLOGY, V130, P1317, DOI 10.1053/j.gastro.2006.01.008; Strom S, 2003, GASTROENTEROLOGY, V124, P568, DOI 10.1053/gast.2003.50072; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Yokoyama T, 2006, AM J TRANSPLANT, V6, P50, DOI 10.1111/j.1600-6143.2005.01155.x	29	403	431	3	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					880	885		10.1038/nm1576	http://dx.doi.org/10.1038/nm1576			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17572687				2022-12-25	WOS:000247902800037
J	Stelter, P; Kunze, R; Flemming, D; Hopfner, D; Diepholz, M; Philippsen, P; Bottcher, B; Hurt, E				Stelter, Philipp; Kunze, Ruth; Flemming, Dirk; Hoepfner, Dominic; Diepholz, Meikel; Philippsen, Peter; Boettcher, Bettina; Hurt, Ed			Molecular basis for the functional interaction of dynein light chain with the nuclear-pore complex	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; NUCLEOPORIN COMPLEX; TERMINAL DOMAIN; PROTEIN IMPORT; TRANSPORT; YEAST; MECHANISM; NSP1P; RAT7P/NUP159P	Nucleocytoplasmic transport occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope(1). Here, we discovered an unexpected role for yeast dynein light chain (Dyn2) 2 in the NPC. Dyn2 is a previously undescribed nucleoporin that functions as molecular glue to dimerize and stabilize the Nup82-Nsp1-Nup159 complex, a module of the cytoplasmic pore filaments(3). Biochemical analyses showed that Dyn2 binds to a linear motif ( termed DIDNup159) inserted between the Phe-Gly repeat and coiled-coil domain of Nup159. Electron microscopy revealed that the reconstituted Dyn2 DIDNup159 complex forms a rigid rod-like structure, in which five Dyn2 homodimers align like 'pearls on a string' between two extented DIDNup159 strands. These findings imply that the rigid 20 nm long Dyn2-DIDNup159 filament projects the Nup159 Phe-Gly repeats from the Nup82 module. Thus, it is possible that dynein light chain plays a role in organizing natively unfolded Phe-Gly repeats within the NPC scaffold to facilitate nucleocytoplasmic transport.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; EMBL, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Basel; European Molecular Biology Laboratory (EMBL)	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Bottcher, Bettina/E-9397-2010; Flemming, Dirk/AAP-3274-2021; Ed Hurt, Dr./AAE-8874-2019	Bottcher, Bettina/0000-0002-7962-4849; Ed Hurt, Dr./0000-0002-4535-8255				BABLER J, 2001, MOL CELL, V8, P517; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Del Priore V, 1997, J CELL SCI, V110, P2987; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dick T, 1996, MOL GEN GENET, V251, P38; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig O, 1998, YEAST, V14, P1139; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032	40	75	77	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					788	U108		10.1038/ncb1604	http://dx.doi.org/10.1038/ncb1604			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17546040				2022-12-25	WOS:000247760700014
J	Segal, E; Sirlin, CB; Ooi, C; Adler, AS; Gollub, J; Chen, X; Chan, BK; Matcuk, GR; Barry, CT; Chang, HY; Kuo, MD				Segal, Eran; Sirlin, Claude B.; Ooi, Clara; Adler, Adam S.; Gollub, Jeremy; Chen, Xin; Chan, Bryan K.; Matcuk, George R.; Barry, Christopher T.; Chang, Howard Y.; Kuo, Michael D.			Decoding global gene expression programs in liver cancer by noninvasive imaging	NATURE BIOTECHNOLOGY			English	Article							SIGNATURE; MARKERS	Paralleling the diversity of genetic and protein activities, pathologic human tissues also exhibit diverse radiographic features. Here we show that dynamic imaging traits in noninvasive computed tomography (CT) systematically correlate with the global gene expression programs of primary human liver cancer. Combinations of twenty-eight imaging traits can reconstruct 78% of the global gene expression profiles, revealing cell proliferation, liver synthetic function, and patient prognosis. Thus, genomic activity of human liver cancers can be decoded by noninvasive imaging, thereby enabling noninvasive, serial and frequent molecular profiling for personalized medicine.	Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Univ Hong Kong, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; Program Epithelial Biol, Stanford, CA 94305 USA; Dept Biochem, Stanford, CA 94305 USA; Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Weizmann Institute of Science; University of Hong Kong; University of Southern California; University of California System; University of California San Francisco	Kuo, MD (corresponding author), Univ Calif San Diego, Dept Radiol, 200 W Arbor Dr, San Diego, CA 92103 USA.	howchang@stanford.edu; mkuo@ucsd.edu	Segal, Eran/AAF-4855-2019; Matcuk, George R./H-3350-2019; Sirlin, Claude/AAU-1376-2020	Matcuk, George R./0000-0002-2858-0794; Sirlin, Claude/0000-0002-6639-9072; Segal, Eran/0000-0002-6859-1164; Adler, Adam/0000-0001-9301-0037				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Eisenberg R.L, 1991, RADIOLOGY ILLUSTRATE; Giannelli G, 2002, INT J CANCER, V97, P425, DOI 10.1002/ijc.1635; Kerr DJ, 2004, NAT CLIN PRACT ONCOL, V1, P39, DOI 10.1038/ncponc0026; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Nino-Murcia M, 2000, RADIOLOGY, V215, P746, DOI 10.1148/radiology.215.3.r00jn03746; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Poon RT, 2004, CLIN CANCER RES, V10, P4150, DOI 10.1158/1078-0432.CCR-03-0435; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Qin LX, 2002, WORLD J GASTROENTERO, V8, P385, DOI 10.3748/wjg.v8.i3.385; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Thomas MB, 2005, J CLIN ONCOL, V23, P8093, DOI 10.1200/JCO.2004.00.1537; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802	21	397	435	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					675	680		10.1038/nbt1306	http://dx.doi.org/10.1038/nbt1306			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17515910				2022-12-25	WOS:000247077500025
J	Wang, XC; Wang, J; Gengyo-Ando, K; Gu, LC; Sun, CL; Yang, CL; Shi, Y; Kobayashi, T; Shi, YG; Mitani, SH; Xie, XS; Xue, D				Wang, Xiaochen; Wang, Jin; Gengyo-Ando, Keiko; Gu, Lichuan; Sun, Chun-Ling; Yang, Chonglin; Shi, Yong; Kobayashi, Tetsuo; Shi, Yigong; Mitani, Shohei; Xie, Xiao-Song; Xue, Ding			C-elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1	NATURE CELL BIOLOGY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CORPSE ENGULFMENT; MEMBRANE PHOSPHOLIPIDS; TRANSBILAYER MOVEMENT; DEATH; PROTEIN; DNA; RECEPTOR; RECOGNITION; LYMPHOCYTES	Externalization of phosphatidylserine, which is normally restricted to the inner leaflet of plasma membrane, is a hallmark of mammalian apoptosis1-4. It is not known what activates and mediates the phosphatidylserine externalization process in apoptotic cells. Here, we report the development of an annexin V-based phosphatidylserine labelling method and show that a majority of apoptotic germ cells in Caenorhabditis elegans have surface-exposed phosphatidylserine, indicating that phosphatidylserine externalization is a conserved apoptotic event in worms. Importantly, inactivation of the gene encoding either the C. elegans apoptosis- inducing factor (AIF) homologue (WAH-1) 5, a mitochondrial apoptogenic factor, or the C. elegans phospholipid scramblase 1 (SCRM-1), a plasma membrane protein, reduces phosphatidylserine exposure on the surface of apoptotic germ cells and compromises cell-corpse engulfment. WAH-1 associates with SCRM-1 and activates its phospholipid scrambling activity in vitro. Thus WAH-1, after its release from mitochondria during apoptosis, promotes plasma membrane phosphatidylserine externalization through its downstream effector, SCRM-1.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Texas, Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan; JST, CREST, Tokyo 1628666, Japan; Princeton Univ, Dept Mol biol, Princeton, NJ 08544 USA	University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Princeton University	Xue, D (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	ding.xue@colorado.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Gengyo-Ando, Keiko/B-2753-2012	XUE, DING/0000-0002-8429-8136; Shi, Yigong/0000-0003-2030-168X				Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BRENNER S, 1974, GENETICS, V77, P71; ELLIS RE, 1991, GENETICS, V129, P79; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, CELL DEATH DIFFER, V8, P582, DOI 10.1038/sj.cdd.4400856; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; MARTIN SJ, 1995, ABL J EXP MED, V182, P1545; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Riddle DL, 1997, C ELEGANS; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Vahsen N, 2006, ONCOGENE, V25, P1763, DOI 10.1038/sj.onc.1209206; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; WOODLE MC, 1989, METHOD ENZYMOL, V171, P193; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Zhou QS, 1998, BIOCHEMISTRY-US, V37, P2356, DOI 10.1021/bi972625o; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	92	112	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					541	U111		10.1038/ncb1574	http://dx.doi.org/10.1038/ncb1574			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17401362				2022-12-25	WOS:000246181500012
J	Amit, I; Citri, A; Shay, T; Lu, YL; Katz, M; Zhang, F; Tarcic, G; Siwak, D; Lahad, J; Jacob-Hirsch, J; Amariglio, N; Vaisman, N; Segal, E; Rechavi, G; Alon, U; Mills, GB; Domany, E; Yarden, Y				Amit, Ido; Citri, Ami; Shay, Tal; Lu, Yiling; Katz, Menachem; Zhang, Fan; Tarcic, Gabi; Siwak, Doris; Lahad, John; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Vaisman, Nora; Segal, Eran; Rechavi, Gideon; Alon, Uri; Mills, Gordon B.; Domany, Eytan; Yarden, Yosef			A module of negative feedback regulators defines growth factor signaling	NATURE GENETICS			English	Article							KRUPPEL-LIKE FACTOR-2; NF-KAPPA-B; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNAS; C-FOS; SPECIFICITY; ACTIVATION; PROTEINS; CANCER	Signaling pathways invoke interplays between forward signaling and feedback to drive robust cellular response. In this study, we address the dynamics of growth factor signaling through profiling of protein phosphorylation and gene expression, demonstrating the presence of a kinetically defined cluster of delayed early genes that function to attenuate the early events of growth factor signaling. Using epidermal growth factor receptor signaling as the major model system and concentrating on regulation of transcription and mRNA stability, we demonstrate that a number of genes within the delayed early gene cluster function as feedback regulators of immediate early genes. Consistent with their role in negative regulation of cell signaling, genes within this cluster are downregulated in diverse tumor types, in correlation with clinical outcome. More generally, our study proposes a mechanistic description of the cellular response to growth factors by defining architectural motifs that underlie the function of signaling networks.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Baylor Coll Med, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Pediat Hematooncol & Funct Genom, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Sigma Aldrich Israel Ltd, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Merck KGaA; MilliporeSigma; Weizmann Institute of Science; Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Shay, Tal/J-4028-2016; Segal, Eran/AAF-4855-2019; Citri, Ami/R-8973-2019; YARDEN, YOSEF/K-1467-2012; DOMANY, EYTAN/K-1560-2012	Shay, Tal/0000-0003-0755-1350; Citri, Ami/0000-0002-9914-0278; Segal, Eran/0000-0002-6859-1164	NCI NIH HHS [CA099031, CA102537, CA72981, CA64602, CA65930] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072981, R01CA102537, P01CA064602, R37CA072981, P01CA065930, P01CA099031, R56CA102537] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alon U., 2006, INTRO SYSTEMS BIOL D; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Qu ZC, 1998, J CELL BIOL, V142, P1075, DOI 10.1083/jcb.142.4.1075; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; WISDOM R, 1993, MOL CELL BIOL, V13, P2635, DOI 10.1128/MCB.13.5.2635; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	50	359	368	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					503	512		10.1038/ng1987	http://dx.doi.org/10.1038/ng1987			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322878				2022-12-25	WOS:000245271200020
J	Scheper, GC; van der Klok, T; van Andel, RJ; van Berkel, CGM; Sissler, M; Smet, J; Muravina, TI; Serkov, SV; Uziel, G; Bugiani, M; Schiffmann, R; Krageloh-Mann, I; Smeitink, JAM; Florentz, C; Van Coster, R; Pronk, JC; van der Knaap, MS				Scheper, Gert C.; van der Klok, Thom; van Andel, Rob J.; van Berkel, Carola G. M.; Sissler, Marie; Smet, Joel; Muravina, Tatjana I.; Serkov, Sergey V.; Uziel, Graziella; Bugiani, Marianna; Schiffmann, Raphael; Kraegeloh-Mann, Ingeborg; Smeitink, Jan A. M.; Florentz, Catherine; Van Coster, Rudy; Pronk, Jan C.; van der Knaap, Marjo S.			Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	NATURE GENETICS			English	Article							VANISHING WHITE-MATTER; DISEASE; FIBROBLASTS; TRANSLATION; MUTATIONS; DEFECTS; GENE	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) has recently been defined based on a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy(1). LBSL is an autosomal recessive disease, most often manifesting in early childhood. Affected individuals develop slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. We performed linkage mapping with microsatellite markers in LBSL families and found a candidate region on chromosome 1, which we narrowed by means of shared haplotypes. Sequencing of genes in this candidate region uncovered mutations in DARS2, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals from all 30 families. Enzyme activities of mutant proteins were decreased. We were surprised to find that activities of mitochondrial complexes from fibroblasts and lymphoblasts derived from affected individuals were normal, as determined by different assays.	Vrije Univ Amsterdam, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; Univ Strasbourg 1, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Univ Hosp, Dept Pediat, Div Neurol & Metab, B-9000 Ghent, Belgium; Ist Nazl Neurol, Child Neurol Dept, I-20133 Milan, Italy; Russian Acad Med Sci, Burdenko Neurosurg Inst, Dept Neuroimaging, Moscow, Russia; NINDS, Dev & Metab Neurol BRanch, NIH, Bethesda, MD 20892 USA; Univ Tubingen, Childrens Hosp, Dept Pediat Neurol, D-72076 Tubingen, Germany; Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University; Ghent University Hospital; Burnazyan Federal Medical Biophysical Center; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Scheper, GC (corresponding author), Vrije Univ Amsterdam, Dept Pediat & Child Neurol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	gc.scheper@vumc.nl	Smeitink, Jan A.M./D-6064-2011; Scheper, Gert C/D-7001-2014; Smeitink, Jan/C-1351-2013; Smet, Joel/B-7428-2013	SISSLER, Marie/0000-0001-8594-5238; Smet, Joel/0000-0002-9551-6282	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Forshew T, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023663; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973; Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854; Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; SMET J, 2005, CELL BIOL LAB HDB, P259; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50	30	334	354	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					534	539		10.1038/ng2013	http://dx.doi.org/10.1038/ng2013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17384640				2022-12-25	WOS:000245271200025
J	Voets, T; Owsianik, G; Janssens, A; Talavera, K; Nilius, B				Voets, Thomas; Owsianik, Grzegorz; Janssens, Annelies; Talavera, Karel; Nilius, Bernd			TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli	NATURE CHEMICAL BIOLOGY			English	Article							COLD RECEPTOR; GATING CHARGE; MICE LACKING; CHANNELS; ACTIVATION; SHAKER; TEMPERATURE; HEAT; K+; SENSITIVITY	TRPM8, a member of the transient receptor potential (TRP) channel superfamily, is expressed in thermosensitive neurons, in which it functions as a cold and menthol sensor. TRPM8 and most other temperature-sensitive TRP channels (thermoTRPs) are voltage gated; temperature and ligands regulate channel opening by shifting the voltage dependence of activation. The mechanisms and structures underlying gating of thermoTRPs are currently poorly understood. Here we show that charge-neutralizing mutations in transmembrane segment 4 (S4) and the S4-S5 linker of human TRPM8 reduce the channel's gating charge, which indicates that this region is part of the voltage sensor. Mutagenesis-induced changes in voltage sensitivity translated into altered thermal sensitivity, thereby establishing the strict coupling between voltage and temperature sensing. Specific mutations in this region also affected menthol affinity, which indicates a direct interaction between menthol and the TRPM8 voltage sensor. Based on these findings, we present a Monod-Wyman-Changeux-type model explaining the combined effects of voltage, temperature and menthol on TRPM8 gating.	Katholieke Univ Leuven, Lab Ion Channel Res, Div Physiol, Dept Mol Cell Biol, B-3000 Louvain, Belgium	KU Leuven	Voets, T (corresponding author), Katholieke Univ Leuven, Lab Ion Channel Res, Div Physiol, Dept Mol Cell Biol, Campus Gasthuisberg O&N1,Herestr 49 Bus 802, B-3000 Louvain, Belgium.	thomas.voets@med.kuleuven.be	Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012; Talavera, Karel/K-7990-2014	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Talavera, Karel/0000-0002-3124-138X; Janssens, Annelies/0000-0002-6735-8248				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; CORREA AM, 1992, BIOPHYS J, V61, P1332, DOI 10.1016/S0006-3495(92)81941-0; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; ROTHBERG BS, 2004, SCI STKE, pPE16; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wright CE, 1998, BRIT J PHARMACOL, V123, P481, DOI 10.1038/sj.bjp.0701642; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	49	210	216	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2007	3	3					174	182		10.1038/nchembio862	http://dx.doi.org/10.1038/nchembio862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	138BD	17293875	Green Accepted			2022-12-25	WOS:000244336600014
J	Ingale, S; AWolfert, M; Gaekwad, J; Buskas, T; Boons, GJ				Ingale, Sampat; AWolfert, Margreet; Gaekwad, Jidnyasa; Buskas, Therese; Boons, Geert-Jan			Robust immune responses elicited by a fully synthetic three-component vaccine	NATURE CHEMICAL BIOLOGY			English	Article							CARBOHYDRATE-BASED VACCINES; TOLL-LIKE RECEPTOR-2; ANTIBODY-RESPONSES; DENDRITIC CELLS; PROSTATE-CANCER; TN; GLYCOPEPTIDE; ANTIGEN; EPITOPE; MUC1	The overexpression of saccharides such as Globo- H, Lewis(Y) and Tn antigen is a common feature of oncogenic transformed cells. Endeavors to exploit this aberrant glycosylation for cancer vaccine development have been complicated by difficulties in eliciting high titers of IgG antibodies against classical conjugates of tumor- associated carbohydrates to carrier proteins. We have designed, chemically synthesized and immunologically evaluated a number of fully synthetic vaccine candidates to establish strategies to overcome the poor immunogenicity of tumor- associated carbohydrates and glycopeptides. We have found that a three- component vaccine composed of a TLR2 agonist, a promiscuous peptide T- helper epitope and a tumor- associated glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor- associated carbohydrate. The superior properties of the vaccine candidate are attributed to the local production of cytokines, upregulation of costimulatory proteins, enhanced uptake by macrophages and dendritic cells and avoidance of epitope suppression.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Wolfert, Margreet A/J-1726-2016; Boons, Geert-Jan P H/J-3211-2016	Wolfert, Margreet A/0000-0003-4864-0026; Boons, Geert-Jan P H/0000-0003-3111-5954	NCI NIH HHS [R01 CA88986, R01 CA088986, R01 CA088986-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM061761] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander J, 2000, J IMMUNOL, V164, P1625, DOI 10.4049/jimmunol.164.3.1625; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Buskas T, 2005, ANGEW CHEM INT EDIT, V44, P5985, DOI 10.1002/anie.200501818; Buskas T, 2004, CHEM-EUR J, V10, P3517, DOI 10.1002/chem.200400074; Cato D, 2005, J CARBOHYD CHEM, V24, P503, DOI 10.1081/CAR-200067091; Dabbagh K, 2003, CURR OPIN INFECT DIS, V16, P199, DOI 10.1097/00001432-200306000-00003; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Dziadek S, 2005, ANGEW CHEM INT EDIT, V44, P7624, DOI 10.1002/anie.200501593; Ingale S, 2006, ORG LETT, V8, P5785, DOI 10.1021/ol062423x; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jiang ZH, 2003, CURR MED CHEM, V10, P1423, DOI 10.2174/0929867033457340; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Krikorian D, 2005, BIOCONJUGATE CHEM, V16, P812, DOI 10.1021/bc049703m; Kudryashov V, 2001, P NATL ACAD SCI USA, V98, P3264, DOI 10.1073/pnas.051623598; Kuduk SD, 1998, J AM CHEM SOC, V120, P12474, DOI 10.1021/ja9825128; LECLERC C, 1991, J VIROL, V65, P711, DOI 10.1128/JVI.65.2.711-718.1991; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lo-Man R, 2001, J IMMUNOL, V166, P2849, DOI 10.4049/jimmunol.166.4.2849; METZGER JW, 1991, INT J PEPT PROT RES, V38, P545; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; Ni JH, 2006, BIOCONJUGATE CHEM, V17, P493, DOI 10.1021/bc0502816; Ouerfelli O, 2005, EXPERT REV VACCINES, V4, P677, DOI 10.1586/14760584.4.5.677; Pan YB, 2005, J MED CHEM, V48, P875, DOI 10.1021/jm0494422; Reichel F, 1997, CHEM COMMUN, P2087, DOI 10.1039/a704127f; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Slovin SF, 2003, J CLIN ONCOL, V21, P4292, DOI 10.1200/JCO.2003.04.112; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144	30	261	287	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					663	667		10.1038/nchembio.2007.25	http://dx.doi.org/10.1038/nchembio.2007.25			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17767155	Green Accepted, Bronze			2022-12-25	WOS:000249642700016
J	Keinan, A; Mullikin, JC; Patterson, N; Reich, D				Keinan, Alon; Mullikin, James C.; Patterson, Nick; Reich, David			Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans	NATURE GENETICS			English	Article							HUMAN GENOME; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; SEQUENCE; POLYMORPHISMS; SELECTION; PATTERNS; ISRAEL	Large data sets on human genetic variation have been collected recently, but their usefulness for learning about history and natural selection has been limited by biases in the ways polymorphisms were chosen. We report large subsets of SNPs from the International HapMap Project(1,2) that allow us to overcome these biases and to provide accurate measurement of a quantity of crucial importance for understanding genetic variation: the allele frequency spectrum. Our analysis shows that East Asian and northern European ancestors shared the same population bottleneck expanding out of Africa but that both also experienced more recent genetic drift, which was greater in East Asians.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; NIH, Natl Human Genome Res Inst, Genome Technol Branch, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Keinan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	akeinan@genetics.med.harvard.edu		Keinan, Alon/0000-0002-9760-1122	Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [U01 HG004168] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004168, Z01HG200330] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lahiri S. N., 2003, RESAMPLING METHODS D, P115; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pluzhnikov A, 2002, GENETICS, V161, P1209; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	29	209	210	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1251	1255		10.1038/ng2116	http://dx.doi.org/10.1038/ng2116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828266	Green Accepted			2022-12-25	WOS:000249737400021
J	Tang, XL; Jang, SW; Wang, XR; Liu, ZX; Bahr, SM; Sun, SY; Brat, D; Gutmann, DH; Ye, KQ				Tang, Xiaoling; Jang, Sung-Wuk; Wang, Xuerong; Liu, Zhixue; Bahr, Scott M.; Sun, Shi-Yong; Brat, Daniel; Gutmann, David H.; Ye, Keqiang			Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation	NATURE CELL BIOLOGY			English	Article							GENE-PRODUCT; BINDING; PROTEIN; GROWTH; INHIBITION; SPECTRIN; REVEALS; RICTOR; ASSOCIATION; INTERACTS	The neurofibromatosis-2 (NF2) tumour-suppressor gene encodes an intracellular membrane-associated protein, called merlin, whose growth-suppressive function is dependent on its ability to form interactions through its intramolecular amino-terminal domain ( NTD) and carboxy-terminal domain (CTD)(1-3). Merlin phosphorylation plays a critical part in dictating merlin NTD/ CTD interactions as well as in controlling binding to its effector proteins4-7. Merlin is partially regulated by phosphorylation of Ser 518, such that hyperphosphorylated merlin is inactive and fails to form productive intramolecular and intermolecular interactions(8,9).Here, we show that the protein kinase Akt directly binds to and phosphorylates merlin on residues Thr 230 and Ser 315, which abolishes merlin NTD/ CTD interactions and binding to merlin's effector protein PIKE-L and other binding partners. Furthermore, Akt-mediated phosphorylation leads to merlin degradation by ubiquitination. These studies demonstrate that Akt-mediated merlin phosphorylation regulates the function of merlin in the absence of an inactivating mutation.	Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Emory University; Emory University; Washington University (WUSTL)	Ye, KQ (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu		Gutmann, David/0000-0002-3127-5045	NATIONAL CANCER INSTITUTE [R01CA117872] Funding Source: NIH RePORTER; NCI NIH HHS [R01 (CA117872)] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; ALFTHAN K, 2004, J BIOL CHEM; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen YW, 2001, J MOL NEUROSCI, V17, P59, DOI 10.1385/JMN:17:1:59; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Gautreau A, 2002, J BIOL CHEM, V277, P31279, DOI 10.1074/jbc.C200125200; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gutmann DH, 1999, J NEUROSCI RES, V58, P706, DOI 10.1002/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.3.CO;2-Q; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kakhniashvili DG, 2001, BIOCHEMISTRY-US, V40, P11630, DOI 10.1021/bi010176t; Kim H, 2004, J BIOL CHEM, V279, P7812, DOI 10.1074/jbc.M305526200; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lee JY, 2006, ONCOGENE, V25, P1143, DOI 10.1038/sj.onc.1209150; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Neill GW, 2001, BIOCHEM J, V358, P727, DOI 10.1042/0264-6021:3580727; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	28	62	65	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1199	1207		10.1038/ncb1641	http://dx.doi.org/10.1038/ncb1641			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891137				2022-12-25	WOS:000249882300016
J	Waltz, E				Waltz, Emily			Industry waits for fallout from Cabilly	NATURE BIOTECHNOLOGY			English	News Item								Monoclonal antibody companies are eyeing their license agreements with Genentech after the US Patent and Trademark Office in February rejected a widely licensed patent, called Cabilly II, held by the San Francisco, California-based biotech. Genentech's appeal of the decision could drag on for up to a decade and many experts say the patent is likely to be invalidated in the end. The momentum against Cabilly II is encouraging licensees and potential licensees to consider ways to avoid royalty payments while the patent is in question. Cabilly is one of the most ubiquitous patents in biotech. Nearly any company wishing to use host cell culture to make therapeutic recombinant antibodies has to obtain rights to the patent. There are 21 monoclonal antibody drugs on the market and nearly 40 in either phase 2 or 3 trials, many involving the Cabilly technology.											0	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					699	700		10.1038/nbt0707-699	http://dx.doi.org/10.1038/nbt0707-699			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621279				2022-12-25	WOS:000247994000004
J	Zheng, L; Dai, HF; Zhou, M; Li, M; Singh, P; Qiu, JZ; Tsark, W; Huang, Q; Kernstine, K; Zhang, XM; Lin, DX; Shen, BH				Zheng, Li; Dai, Huifang; Zhou, Mian; Li, Mei; Singh, Purnima; Qiu, Junzhuan; Tsark, Walter; Huang, Qin; Kernstine, Kemp; Zhang, Xuemei; Lin, Dongxin; Shen, Binghui			Fen1 mutations result in autoimmunity, chronic inflammation and cancers	NATURE MEDICINE			English	Article							NF-KAPPA-B; APOPTOTIC DNA-DEGRADATION; FLAP ENDONUCLEASE-1; LUNG-CANCER; SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; EXCISION-REPAIR; NZB/W MICE; CELLS; ACTIVATION	Functional deficiency of the FEN1 gene has been suggested to cause genomic instability and cancer predisposition. We have identified a group of FEN1 mutations in human cancer specimens. Most of these mutations abrogated two of three nuclease activities of flap endonuclease 1 ( FEN1). To demonstrate the etiological significance of these somatic mutations, we inbred a mouse line harboring the E160D mutation representing mutations identified in human cancers. Selective elimination of nuclease activities led to frequent spontaneous mutations and accumulation of incompletely digested DNA fragments in apoptotic cells. The mutant mice were predisposed to autoimmunity, chronic inflammation and cancers. The mutator phenotype results in the initiation of cancer, whereas chronic inflammation promotes the cancer progression. The current work exemplifies the approach of studying the mechanisms of individual polymorphisms and somatic mutations in cancer development, and may serve as a reference in developing new therapeutic regimens through the suppression of inflammatory responses.	City Hope Natl Med Ctr, Dept Radiat Biol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Div Biol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Div Pathol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Div Surg, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; Chinese Acad Med Sci, Inst Canc, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China	City of Hope; City of Hope; City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Chinese Academy of Medical Sciences - Peking Union Medical College	Shen, BH (corresponding author), City Hope Natl Med Ctr, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	bshen@coh.org	zhang, xuemei/F-3818-2010	Shen, Binghui/0000-0002-4408-407X; Singh, Purnima/0000-0002-4968-7398	NATIONAL CANCER INSTITUTE [R01CA073764] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA073764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fournie GJ, 1996, CLIN EXP IMMUNOL, V104, P236, DOI 10.1046/j.1365-2249.1996.26736.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henneke G, 2003, TRENDS BIOCHEM SCI, V28, P384, DOI 10.1016/S0968-0004(03)00138-5; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; LAMBERT PH, 1968, J EXP MED, V127, P507, DOI 10.1084/jem.127.3.507; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee SO, 2005, PROSTATE, V64, P160, DOI 10.1002/pros.20218; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Lutz HU, 2006, MOL IMMUNOL, V43, P2, DOI 10.1016/j.molimm.2005.06.020; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Moller B, 1996, J INFECT DIS, V174, P557, DOI 10.1093/infdis/174.3.557; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Romanelli RG, 2006, AM J PHYSIOL-GASTR L, V290, pG120, DOI 10.1152/ajpgi.00350.2004; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Zeng DF, 2003, J CLIN INVEST, V112, P1211, DOI 10.1172/JCI200317165; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	49	174	188	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2007	13	7					812	819		10.1038/nm1599	http://dx.doi.org/10.1038/nm1599			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17589521				2022-12-25	WOS:000247902800027
J	Berkovich, E; Monnat, RJ; Kastan, MB				Berkovich, Elijahu; Monnat, Raymond J., Jr.; Kastan, Michael B.			Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; S-PHASE; DAMAGE; ACTIVATION; AUTOPHOSPHORYLATION; IDENTIFICATION; ENDONUCLEASE; RECRUITMENT; CHECKPOINT	We developed a novel system to create DNA double-strand breaks (DSBs) at defined endogenous sites in the human genome, and used this system to detect protein recruitment and loss at and around these breaks by chromatin immunoprecipitation (ChIP). The detection of human ATM protein at site-specific DSBs required functional NBS1 protein, ATM kinase activity and ATM autophosphorylation on Ser 1981. DSB formation led to the localized disruption of nucleosomes, a process that depended on both functional NBS1 and ATM. These two proteins were also required for efficient recruitment of the repair cofactor XRCC4 to DSBs, and for efficient DSB repair. These results demonstrate the functional importance of ATM kinase activity and phosphorylation in the response to DSBs, and support a model in which ordered chromatin structure changes that occur after DNA breakage depend on functional NBS1 and ATM, and facilitate DNA DSB repair.	St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kastan, MB (corresponding author), St Jude Childrens Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org			NATIONAL CANCER INSTITUTE [R01CA071387, R01CA048022, P30CA021765, R29CA048022] Funding Source: NIH RePORTER; NCI NIH HHS [CA71387, CA21765, CA48022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; Berkovich E, 2003, CELL CYCLE, V2, P127, DOI 10.4161/cc.2.2.293; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Monnat RJ, 1999, BIOCHEM BIOPH RES CO, V255, P88, DOI 10.1006/bbrc.1999.0152; MUSCARELLA DE, 1990, MOL CELL BIOL, V10, P3386, DOI 10.1128/MCB.10.7.3386; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200	27	364	370	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					683	U137		10.1038/ncb1599	http://dx.doi.org/10.1038/ncb1599			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486112				2022-12-25	WOS:000246922700014
J	Dueber, JE; Mirsky, EA; Lim, WA				Dueber, John E.; Mirsky, Ethan A.; Lim, Wendell A.			Engineering synthetic signaling proteins with ultrasensitive input/output control	NATURE BIOTECHNOLOGY			English	Article							CELL; NETWORKS; PATHWAYS; COMPLEX; SWITCH	Many signaling proteins are built from simple, modular components, yet display highly complex signal-processing behavior. Here we explore how modular domains can be used to build an ultrasensitive switch-a nonlinear input/output function that is central to many complex biological behaviors. By systematically altering the number and affinity of modular autoinhibitory interactions, we show that we can predictably convert a simple linear signaling protein into an ultrasensitive switch.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, UC Berkeley, Nanomed Dev Ctr, San Francisco, CA 94158 USA; NSF Synth Biol Engn Res Ctr, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco; National Science Foundation (NSF)	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu						Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PERUTZ MF, 1978, SCI AM, V239, P92, DOI 10.1038/scientificamerican1278-92; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; YEH BJ, IN PRESS NATURE	12	102	117	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					660	662		10.1038/nbt1308	http://dx.doi.org/10.1038/nbt1308			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17515908				2022-12-25	WOS:000247077500022
J	Ohsawa, I; Ishikawa, M; Takahashi, K; Watanabe, M; Nishimaki, K; Yamagata, K; Katsura, K; Katayama, Y; Asoh, S; Ohta, S				Ohsawa, Ikuroh; Ishikawa, Masahiro; Takahashi, Kumiko; Watanabe, Megumi; Nishimaki, Kiyomi; Yamagata, Kumi; Katsura, Ken-ichiro; Katayama, Yasuo; Asoh, Sadamitsu; Ohta, Shigeo			Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals	NATURE MEDICINE			English	Article							TRANSIENT FOCAL ISCHEMIA; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; CELL-DEATH; MITOCHONDRIA; BRAIN; DEFICIENCY; CALCIUM; DISEASE; INJURY	Acute oxidative stress induced by ischemia-reperfusion or inflammation causes serious damage to tissues, and persistent oxidative stress is accepted as one of the causes of many common diseases including cancer. We show here that hydrogen (H-2) has potential as an antioxidant in preventive and therapeutic applications. We induced acute oxidative stress in cultured cells by three independent methods. H-2 selectively reduced the hydroxyl radical, the most cytotoxic of reactive oxygen species (ROS), and effectively protected cells; however, H-2 did not react with other ROS, which possess physiological roles. We used an acute rat model in which oxidative stress damage was induced in the brain by focal ischemia and reperfusion. The inhalation of H-2 gas markedly suppressed brain injury by buffering the effects of oxidative stress. Thus H-2 can be used as an effective antioxidant therapy; owing to its ability to rapidly diffuse across membranes, it can reach and react with cytotoxic ROS and thus protect against oxidative damage.	Inst Dev & Aging Sci, Dept Biochem & Cell Biol, Grad Sch Med, Nippon Med Sch,Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan; Nippon Med Sch, Dept Internal Med, Bunkyo Ku, Tokyo 1138602, Japan	Nippon Medical School; Nippon Medical School	Ohta, S (corresponding author), Inst Dev & Aging Sci, Dept Biochem & Cell Biol, Grad Sch Med, Nippon Med Sch,Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	ohta@nms.ac.jp						Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; FALICK AM, 1965, J CHEM PHYS, V42, P1837, DOI 10.1063/1.1696199; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; Fontanari P, 2000, EUR J APPL PHYSIOL, V81, P325, DOI 10.1007/s004210050050; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; James AM, 2005, MECH AGEING DEV, V126, P982, DOI 10.1016/j.mad.2005.03.026; Kamiya H, 2004, BIOL PHARM BULL, V27, P475, DOI 10.1248/bpb.27.475; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1007/BF03206567; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Murad F, 2004, BIOSCIENCE REP, V24, P452, DOI 10.1007/s10540-005-2741-8; Murakami K, 1998, J NEUROSCI, V18, P205; Nito C, 2004, BRAIN RES, V1008, P179, DOI 10.1016/j.brainres.2004.02.031; Ohsawa I, 2003, J NEUROCHEM, V84, P1110, DOI 10.1046/j.1471-4159.2003.01619.x; Ohta S, 2003, CURR MED CHEM, V10, P2485, DOI 10.2174/0929867033456440; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Takada J, 2003, EXP GERONTOL, V38, P423, DOI 10.1016/S0531-5565(02)00241-3; Tomizawa S, 2005, NEUROSCI RES, V53, P304, DOI 10.1016/j.neures.2005.08.002; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06	31	1454	1728	38	468	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					688	694		10.1038/nm1577	http://dx.doi.org/10.1038/nm1577			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17486089				2022-12-25	WOS:000247084300031
J	Baines, CP; Kaiser, RA; Sheiko, T; Craigen, WJ; Molkentin, JD				Baines, Christopher P.; Kaiser, Robert A.; Sheiko, Tatiana; Craigen, William J.; Molkentin, Jeffery D.			Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death	NATURE CELL BIOLOGY			English	Article							PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; CYCLOPHILIN-D; CYTOCHROME-C; VDAC CHANNELS; BCL-2 FAMILY; BAX; RESPIRATION; APOPTOSIS; RELEASE	Mitochondria are critically involved in necrotic cell death induced by Ca2+ overload, hypoxia and oxidative damage. The mitochondrial permeability transition (MPT) pore-a protein complex that spans both the outer and inner mitochondrial membranes - is considered the mediator of this event and has been hypothesized to minimally consist of the voltage-dependent anion channel (Vdac) in the outer membrane, the adenine-nucleotide translocase (Ant) in the inner membrane and cyclophilin-D in the matrix(1-3). Here, we report the effects of deletion of the three mammalian Vdac genes on mitochondrial-dependent cell death. Mitochondria from Vdac1-, Vdac3-, and Vdac1-Vdac3-null mice exhibited a Ca2+- and oxidative stress- induced MPT that was indistinguishable from wild- type mitochondria. Similarly, Ca2+- and oxidative- stress- induced MPT and cell death was unaltered, or even exacerbated, in fibroblasts lacking Vdac1, Vdac2, Vdac3, Vdac1-Vdac3 and Vdac1-Vdac2-Vdac3. Wildtype and Vdac-deficient mitochondria and cells also exhibited equivalent cytochrome c release, caspase cleavage and cell death in response to the pro- death Bcl-2 family members Bax and Bid. These results indicate that Vdacs are dispensable for both MPT and Bcl-2 family member-driven cell death.	Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; Baines, Christopher/0000-0002-4473-3869	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779, R01HL062927, P50HL077101, R01HL060562, R01HL081104] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL060562, R01 HL081104, R01 HL081104-04, P01 HL069779-06A10003, R01 HL062927-10A1, R01 HL060562-11, R01 HL062927, P50 HL077101, P01 HL069779, P50 HL077101-050004] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Kagawa S, 2000, GENE THER, V7, P75, DOI 10.1038/sj.gt.3301048; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Polcic P, 2003, BIOCHEM J, V374, P393, DOI 10.1042/BJ20030690; Priault M, 1999, EUR J BIOCHEM, V260, P684, DOI 10.1046/j.1432-1327.1999.00198.x; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	33	734	760	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					550	U122		10.1038/ncb1575	http://dx.doi.org/10.1038/ncb1575			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417626	Green Accepted			2022-12-25	WOS:000246181500013
J	Barberi, T; Bradbury, M; Dincer, Z; Panagiotakos, G; Socci, ND; Studer, L				Barberi, Tiziano; Bradbury, Michelle; Dincer, Zehra; Panagiotakos, Georgia; Socci, Nicholas D.; Studer, Lorenz			Derivation of engraftable skeletal myoblasts from human embryonic stem cells	NATURE MEDICINE			English	Article							DEFINITIVE ENDODERM; PARAXIAL MESODERM; MUSCLE-CELLS; DIFFERENTIATION; GENERATION; ANTIGEN; LINE	Human embryonic stem cells (hESCs) are a promising source for cell therapy in degenerative diseases. A key step in establishing the medical potential of hESCs is the development of techniques for the conversion of hESCs into tissue-restricted precursors suitable for transplantation. We recently described the derivation of multipotent mesenchymal precursors from hESCs. Nevertheless, our previous study was limited by the requirement for mouse feeders and the lack of in vivo data. Here we report a stroma-free induction system for deriving mesenchymal precursors. Selective culture conditions and fluorescence-activated cell sorting (FACS)-mediated purification yielded multipotent mesenchymal precursors and skeletal myoblasts. Skeletal muscle cells undergo in vitro maturation resulting in myotube formation and spontaneous twitching. We found that hESC-derived skeletal myoblasts were viable after transplantation into the tibialis anterior muscle of SCID/Beige mice, as assessed by bioluminescence imaging. Lack of teratoma formation and evidence of long-term myoblast engraftment suggests considerable potential for future therapeutic applications.	Sloan Kettering Inst, Dept Radiol, New York, NY 10021 USA; Sloan Kettering Inst, Computat Biol Ctr, New York, NY 10021 USA; Sloan Kettering Inst, Dev Biol Program, Div Neurosurg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Barberi, T (corresponding author), Beckman Res Inst City Hope, Div Neurosci, Duarte, CA 91010 USA.	tbarberi@coh.org; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021; Dincer, Zehra/U-6023-2019	Studer, Lorenz/0000-0003-0741-7987; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480				Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; De Angelis MGC, 2003, EXP CELL RES, V290, P207, DOI 10.1016/S0014-4827(03)00314-8; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Guettier-Sigrist S, 2000, EXP CELL RES, V259, P204, DOI 10.1006/excr.2000.4968; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lanctot C, 1997, DEVELOPMENT, V124, P2807; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Saito D, 2006, DEV BIOL, V292, P79, DOI 10.1016/j.ydbio.2006.01.002; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; WALSH FS, 1981, NATURE, V289, P60, DOI 10.1038/289060a0; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	25	236	256	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					642	648		10.1038/nm1533	http://dx.doi.org/10.1038/nm1533			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17417652				2022-12-25	WOS:000246302800034
J	Sarkisian, CJ; Keister, BA; Stairs, DB; Boxer, RB; Moody, SE; Chodosh, LA				Sarkisian, Christopher J.; Keister, Blaine A.; Stairs, Douglas B.; Boxer, Robert B.; Moody, Susan E.; Chodosh, Lewis A.			Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE ARREST; K-RAS ONCOGENE; CONDITIONAL EXPRESSION; PREMATURE SENESCENCE; TUMOR INITIATION; PROLIFERATION; ACTIVATION; GLAND; MICE; P53	Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline- inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation - similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 - stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation - similar to those found in tumours bearing endogenous Kras2 mutations - induce cellular senescence that is Ink4a-Arf-dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53-Ink4a-Arf-dependent senescence checkpoints.	Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Chodosh, LA (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.	chodosh@mail.med.upenn.edu			NATIONAL CANCER INSTITUTE [U01CA105490, R01CA093719, R01CA098371] Funding Source: NIH RePORTER; NCI NIH HHS [CA98371, CA93719, CA92910, CA105490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Algarra Ignacio, 1998, Invasion and Metastasis, V18, P261, DOI 10.1159/000024519; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; Fujita M, 1996, J BIOL CHEM, V271, P4349; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; IMAGAWA W, 1994, PHYSL REPRODUCTION; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; NARARITA M, 2003, CELL, V113, P703; Okamura M, 2006, TOXICOLOGY, V217, P129, DOI 10.1016/j.tox.2005.09.021; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sarkisian CJ, 2001, J BIOL CHEM, V276, P37640, DOI 10.1074/jbc.M106281200; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stairs DB, 2005, TRANSGENIC RES, V14, P919, DOI 10.1007/s11248-005-1806-6; Stoeber K, 2001, J CELL SCI, V114, P2027; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wolf JS, 2001, CLIN CANCER RES, V7, P1812	51	332	344	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					493	U25		10.1038/ncb1567	http://dx.doi.org/10.1038/ncb1567			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450133				2022-12-25	WOS:000246181500007
J	Vermulst, M; Bielas, JH; Kujoth, GC; Ladiges, WC; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Bielas, Jason H.; Kujoth, Gregory C.; Ladiges, Warren C.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			Mitochondrial point mutations do not limit the natural lifespan of mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; DNA MUTATIONS; OXIDATIVE DAMAGE; DELETIONS; REPAIR; POLYMERASE; DISEASE; AGE	Whether mitochondrial mutations cause mammalian aging, or are merely correlated with it, is an area of intense debate(1). Here, we use a new, highly sensitive assay(2) to redefine the relationship between mitochondrial mutations and age. We measured the in vivo rate of change of the mitochondrial genome at a single-base pair level in mice, and we demonstrate that the mutation frequency in mouse mitochondria is more than ten times lower than previously reported. Although we observed an 11-fold increase in mitochondrial point mutations with age, we report that a mitochondrial mutator mouse(3) was able to sustain a 500-fold higher mutation burden than normal mice, without any obvious features of rapidly accelerated aging. Thus, our results strongly indicate that mitochondrial mutations do not limit the lifespan of wild-type mice.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu		Kujoth, Gregory/0000-0002-6636-2800	NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG001751, AG021905] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P01AG001751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Copeland William C, 2002, Methods Mol Biol, V197, pv; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333	28	288	298	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					540	543		10.1038/ng1988	http://dx.doi.org/10.1038/ng1988			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334366				2022-12-25	WOS:000245271200026
J	Lawrence, S				Lawrence, Stacy			Agbiotech booms in emerging nations	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					271	271		10.1038/nbt0307-271	http://dx.doi.org/10.1038/nbt0307-271			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17344870				2022-12-25	WOS:000244748300008
J	Mikule, K; Delaval, B; Kaldis, P; Jurcyzk, A; Hergert, P; Doxsey, S				Mikule, Keith; Delaval, Benedicte; Kaldis, Philipp; Jurcyzk, Agata; Hergert, Polla; Doxsey, Stephen			Loss of centrosome integrity induces p38-p53-p21dependent G1-S arrest	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; CENTRIOLE DUPLICATION; C-ELEGANS; S-PHASE; MICROTUBULE NUCLEATION; CANCER PROGRESSION; TUMOR SUPPRESSION; MAMMALIAN-CELLS; DNA-DAMAGE; PROTEIN	Centrosomes organize the microtubule cytoskeleton for both interphase and mitotic functions. They are implicated in cell-cycle progression but the mechanism is unknown. Here, we show that depletion of 14 out of 15 centrosome proteins arrests human diploid cells in G1 with reduced Cdk2-cyclin A activity and that expression of a centrosome-disrupting dominant-negative construct gives similar results. Cell-cycle arrest is always accompanied by defects in centrosome structure and function (for example, duplication and primary cilia assembly). The arrest occurs from within G1, excluding contributions from mitosis and cytokinesis. The arrest requires p38, p53 and p21, and is preceded by p38-dependent activation and centrosomal recruitment of p53. p53-deficient cells fail to arrest, leading to centrosome and spindle dysfunction and aneuploidy. We propose that loss of centrosome integrity activates a checkpoint that inhibits G1-S progression. This model satisfies the definition of a checkpoint in having three elements: a perturbation that is sensed, a transducer (p53) and a receiver (p21).	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; NCI, Frederick, MD 21702 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doxsey, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Stephen.Doxsey@umassmed.edu	Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM51994] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051994, R56GM051994] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balczon R, 2002, CELL MOTIL CYTOSKEL, V52, P183, DOI 10.1002/cm.10043; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GERDES J, 1984, J IMMUNOL, V133, P1710; Gillingham AK, 2000, EMBO REP, V1, P524; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HARPER JW, 1993, CELL, V75, P805; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Jouvenet N, 2005, J GEN VIROL, V86, P589, DOI 10.1099/vir.0.80623-0; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; LACEYKR, 1999, P NATL ACAD SCI USA, V96, P2817; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; TUFFANELLI DL, 1983, ARCH DERMATOL, V119, P560, DOI 10.1001/archderm.119.7.560; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	49	233	238	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					160	U49		10.1038/ncb1529	http://dx.doi.org/10.1038/ncb1529			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17330329				2022-12-25	WOS:000243903000008
J	Yu, HYE; Bement, WM				Yu, Hoi-Ying E.; Bement, William M.			Control of local actin assembly by membrane fusion-dependent compartment mixing	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CORTICAL GRANULE EXOCYTOSIS; XENOPUS EGGS; N-WASP; PHOSPHOLIPASE-D; PHORBOL ESTER; DIACYLGLYCEROL; ACTIVATION; BINDING; CALCIUM	Local actin assembly is associated with sites of exocytosis in processes ranging from phagocytosis to compensatory endocytosis. Here, we examine whether the trigger for actin-coat assembly around exocytosing Xenopus egg cortical granules is 'compartment mixing' - the union of the contents of the plasma membrane with that of the secretory granule membrane. Consistent with this model, compartment mixing occurs on cortical granule - plasma membrane fusion and is required for actin assembly. Compartment mixing triggers actin assembly, at least in part, through diacylglycerol (DAG), which incorporates into the cortical granule membranes from the plasma membrane after cortical granule - plasma membrane fusion. DAG, in turn, directs long-term recruitment of protein kinase C beta (PKC beta) to exocytosing cortical granules, where it is required for activation of Cdc42 localized on the cortical granules. The results demonstrate that mixing of two membrane compartments can direct local actin assembly and indicate that this process is harnessed during Xenopus egg cortical granule exocytosis to drive compensatory endocytosis.	Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, HYE (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	heyu@uwalumni.com	Bement, William/AAA-5444-2021		NIGMS NIH HHS [R01 GM052932, R01 GM052932-09, GM52932] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052932] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abousalham A, 1997, J BIOL CHEM, V272, P1069, DOI 10.1074/jbc.272.2.1069; Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; Becker KA, 1999, J CELL SCI, V112, P97; BEMENT WM, 1989, J CELL BIOL, V108, P885, DOI 10.1083/jcb.108.3.885; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chen K H, 1988, Second Messengers Phosphoproteins, V12, P251; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; GRANDIN N, 1991, DEVELOPMENT, V112, P461; Gundersen CB, 2002, J CELL SCI, V115, P1313; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Larabell CA, 2004, DIFFERENTIATION, V72, P41, DOI 10.1111/j.1432-0436.2004.07201005.x; Li WQ, 1996, ONCOGENE, V13, P731; LIAO L, 1994, CELL GROWTH DIFFER, V5, P1185; May RC, 2001, J CELL SCI, V114, P1061; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; OHNO S, 1990, J BIOL CHEM, V265, P6296; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Stith BJ, 1997, MOL BIOL CELL, V8, P755, DOI 10.1091/mbc.8.4.755; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	36	56	56	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					149	U31		10.1038/ncb1527	http://dx.doi.org/10.1038/ncb1527			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237773	Green Accepted			2022-12-25	WOS:000243903000007
J	Plun-Favreau, H; Klupsch, K; Moisoi, N; Gandhi, S; Kjaer, S; Frith, D; Harvey, K; Deas, E; Harvey, RJ; McDonald, N; Wood, NW; Martins, LM; Downward, J				Plun-Favreau, Helene; Klupsch, Kristina; Moisoi, Nicoleta; Gandhi, Sonia; Kjaer, Svend; Frith, David; Harvey, Kirsten; Deas, Emma; Harvey, Robert J.; McDonald, Neil; Wood, Nicholas W.; Martins, L. Miguel; Downward, Julian			The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1	NATURE CELL BIOLOGY			English	Article							EARLY-ONSET PARKINSONISM; SERINE-PROTEASE; CELL-DEATH; RECESSIVE PARKINSONISM; STRESS-RESPONSE; PDZ DOMAIN; MUTATIONS; OMI/HTRA2; APOPTOSIS; INHIBITOR	In mice, targeted deletion of the serine protease HtrA2 ( also known as Omi) causes mitochondrial dysfunction leading to a neurodegenerative disorder with parkinsonian features. In humans, point mutations in HtrA2 are a susceptibility factor for Parkinson's disease ( PARK13 locus). Mutations in PINK1, a putative mitochondrial protein kinase, are associated with the PARK6 autosomal recessive locus for susceptibility to early-onset Parkinson's disease. Here we determine that HtrA2 interacts with PINK1 and that both are components of the same stress-sensing pathway. HtrA2 is phosphorylated on activation of the p38 pathway, occurring in a PINK1-dependent manner at a residue adjacent to a position found mutated in patients with Parkinson's disease. HtrA2 phosphorylation is decreased in brains of patients with Parkinson's disease carrying mutations in PINK1. We suggest that PINK1-dependent phosphorylation of HtrA2 might modulate its proteolytic activity, thereby contributing to an increased resistance of cells to mitochondrial stress.	MRC Toxicol Unit, Cell Death Regulat Lab, Leicester LE1 9HN, Leics, England; Canc Res UK London Res Inst, Prot Anal Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Struct Biol Lab, London WC2A 3PX, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of Leicester; Cancer Research UK; Cancer Research UK; Cancer Research UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London School of Pharmacy	Martins, LM (corresponding author), MRC Toxicol Unit, Cell Death Regulat Lab, Lancaster Rd, Leicester LE1 9HN, Leics, England.	lmm24@leicester.ac.uk; julian.downward@cancer.org.uk	Plun-Favreau, Helene/Q-4111-2016; Martins, Miguel/AAH-3971-2019; Downward, Julian/A-3251-2012; Deas, Emma/A-6755-2010; Harvey, Robert/D-3994-2016; Wood, Nicholas W/C-2505-2009; PLUN-FAVREAU, Helene/C-8513-2009	Plun-Favreau, Helene/0000-0002-1401-9656; Martins, Miguel/0000-0002-3019-4809; Harvey, Robert/0000-0001-5956-6664; Wood, Nicholas W/0000-0002-9500-3348; Downward, Julian/0000-0002-2331-4729; Moisoi, Nicoleta/0000-0002-0400-9227; Kjaer, Susanne/0000-0002-8347-1398	MRC [G0400000, G0700183, MC_U132674518] Funding Source: UKRI; Medical Research Council [G0700183, G0400000, MC_U132674518] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; GAMER AP, 2002, ONCOGENE, V21, P8089; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/14728222.7.2.187; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Li Y, 2005, NEUROLOGY, V64, P1955, DOI 10.1212/01.WNL.0000164009.36740.4E; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rohe CF, 2004, ANN NEUROL, V56, P427, DOI 10.1002/ana.20247; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vyas S, 2004, J BIOL CHEM, V279, P30983, DOI 10.1074/jbc.M400692200; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	42	364	372	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1243	U63		10.1038/ncb1644	http://dx.doi.org/10.1038/ncb1644			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17906618				2022-12-25	WOS:000250659600010
J	Reddy, ST; van der Vlies, AJ; Simeoni, E; Angeli, V; Randolph, GJ; O'Neill, CP; Lee, LK; Swartz, MA; Hubbell, JA				Reddy, Sai T.; van der Vlies, Andre J.; Simeoni, Eleonora; Angeli, Veronique; Randolph, Gwendalyn J.; O'Neill, Conlin P.; Lee, Leslie K.; Swartz, Melody A.; Hubbell, Jeffrey A.			Exploiting lymphatic transport and complement activation in nanoparticle vaccines	NATURE BIOTECHNOLOGY			English	Article							TARGETING DENDRITIC CELLS; IN-VIVO; COMPONENT C3; IMMUNITY; INNATE; SYSTEM; MICROPARTICLES; INFLAMMATION; RESPONSES; SURFACES	Antigen targeting(1-5) and adjuvancy schemes(6,7) that respectively facilitate delivery of antigen to dendritic cells and elicit their activation have been explored in vaccine development. Here we investigate whether nanoparticles can be used as a vaccine platform by targeting lymph noderesiding dendritic cells via interstitial flow and activating these cells by in situ complement activation. After intradermal injection, interstitial flow transported ultra-small nanoparticles (25 nm) highly efficiently into lymphatic capillaries and their draining lymph nodes, targeting half of the lymph noderesiding dendritic cells, whereas 100-nm nanoparticles were only 10% as efficient. The surface chemistry of these nanoparticles activated the complement cascade, generating a danger signal in situ and potently activating dendritic cells. Using nanoparticles conjugated to the model antigen ovalbumin, we demonstrate generation of humoral and cellular immunity in mice in a size- and complement-dependent manner.	Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Icahn School of Medicine at Mount Sinai; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Reddy, ST (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Swartz, Melody/B-7633-2009; Swartz, Melody A./F-9563-2011; Hubbell, Jeffrey A/A-9266-2008; van der vlies, andre/A-8956-2010; Reddy, Sai/B-4190-2012	Hubbell, Jeffrey A/0000-0003-0276-5456; Reddy, Sai/0000-0002-9177-0857				Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Gadjeva M, 1998, J IMMUNOL, V161, P985; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102; Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1073/pnas.0403549101; Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020; Nishioka Y, 2001, ADV DRUG DELIVER REV, V47, P55, DOI 10.1016/S0169-409X(00)00121-6; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Pack DW, 2004, NAT MATER, V3, P133, DOI 10.1038/nmat1084; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; Rehor A, 2005, LANGMUIR, V21, P411, DOI 10.1021/la0478043; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513	30	921	991	5	326	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1159	1164		10.1038/nbt1332	http://dx.doi.org/10.1038/nbt1332			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17873867	Green Published, Green Submitted			2022-12-25	WOS:000250226600027
J	Yildirim, MA; Goh, KI; Cusick, ME; Barabasi, AL; Vidal, M				Yildirim, Muhammed A.; Goh, Kwang-Il; Cusick, Michael E.; Barabasi, Albert-Laszlo; Vidal, Marc			Drug-target network	NATURE BIOTECHNOLOGY			English	Article							HUMAN-DISEASE; DISCOVERY; EVOLUTION; RESOURCE; GENOME; GENES; BIOLOGY	The global set of relationships between protein targets of all drugs and all disease-gene products in the human protein-protein interaction or 'interactome' network remains uncharacterized. We built a bipartite graph composed of US Food and Drug Administration-approved drugs and proteins linked by drug-target binary associations. The resulting network connects most drugs into a highly interlinked giant component, with strong local clustering of drugs of similar types according to Anatomical Therapeutic Chemical classification. Topological analyses of this network quantitatively showed an overabundance of 'follow-on' drugs, that is, drugs that target already targeted proteins. By including drugs currently under investigation, we identified a trend toward more functionally diverse targets improving polypharmacology. To analyze the relationships between drug targets and disease-gene products, we measured the shortest distance between both sets of proteins in current models of the human interactome network. Significant differences in distance were found between etiological and palliative drugs. A recent trend toward more rational drug design was observed.	Harvard Univ, Sch Med, CCSB, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Korea Univ, Dept Phys, Seoul 136713, South Korea; Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Dept Comp Sci & Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; University of Notre Dame; University of Notre Dame; Korea University; Northeastern University; Northeastern University; Northeastern University	Barabasi, AL (corresponding author), Harvard Univ, Sch Med, CCSB, 44 Binney St, Boston, MA 02115 USA.	alb@nd.edu; marc_vidal@dfci.harvard.edu	Yildirim, Muhammed/J-3695-2014; Barabasi, Albert-Laszlo/S-6474-2017; Longo, Kenneth A/A-5631-2010	Yildirim, Muhammed/0000-0003-2826-1766; Barabasi, Albert/0000-0002-4028-3522	NATIONAL CANCER INSTITUTE [U56CA113004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chanda SK, 2003, DRUG DISCOV TODAY, V8, P168, DOI 10.1016/S1359-6446(02)02595-3; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Drews J, 2003, DRUG DISCOV TODAY, V8, P411, DOI 10.1016/S1359-6446(03)02690-4; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Gershell LJ, 2003, NAT REV DRUG DISCOV, V2, P321, DOI 10.1038/nrd1064; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lindpaintner Klaus, 2002, Nat Rev Drug Discov, V1, P463, DOI 10.1038/nrd823; Mencher S.K., 2005, BMC CLIN PHARM, V5, P3, DOI DOI 10.1186/1472-6904-5-3; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Rodriguez-Caso C, 2005, FEBS J, V272, P6423, DOI 10.1111/j.1742-4658.2005.05041.x; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Searls DB, 2003, NAT REV DRUG DISCOV, V2, P613, DOI 10.1038/nrd1152; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	37	1257	1319	5	211	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1119	1126		10.1038/nbt1338	http://dx.doi.org/10.1038/nbt1338			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17921997				2022-12-25	WOS:000250226600022
J	Derynck, R; Akhurst, RJ				Derynck, Rik; Akhurst, Rosemary J.			Differentiation plasticity regulated by TGF-beta family proteins in development and disease	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN; EPITHELIAL-MESENCHYMAL TRANSFORMATION; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INTERSTITIAL FLUID PRESSURE; CARDIAC-VALVE FORMATION; HUMAN BREAST-CANCER; GROWTH-FACTOR-BETA; STEM-CELLS; PULMONARY-FIBROSIS; CALVARIAL DEFECTS	During development, stem and progenitor cells gradually commit to differentiation pathways. Cell fate decisions are regulated by differentiation factors, which activate transcription programmes that specify lineage and differentiation status. Among these factors, the transforming growth factor (TGF)-beta family is important in both lineage selection and progression of differentiation of most, if not all, cell and tissue types. There is now increasing evidence that TGF-beta family proteins have the ability to redirect the differentiation of cells that either have fully differentiated or have engaged in differentiation along a particular lineage, and can thereby elicit 'transdifferentiation'. This capacity for cellular plasticity is critical for normal embryonic development, but when recapitulated in the adult it can give rise to, or contribute to, a variety of diseases. This is illustrated by the ability of TGF-beta family members to redirect epithelial cells into mesenchymal differentiation and to cause switching of mesenchymal cells from one lineage to another. Hence, various pathologies in adults may be considered diseases of abnormal development and differentiation.	Univ Calif San Francisco, Program Cell & Dev Biol, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Program Cell & Dev Biol, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu; rakhurst@cc.ucsf.edu		AKHURST, ROSEMARY/0000-0002-4474-9668				Aker FV, 2004, ENDOCR J, V51, P457, DOI 10.1507/endocrj.51.457; AKHURST RJ, 2007, TGF BETA FAMILY; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Carnac G, 2006, MINI-REV MED CHEM, V6, P765, DOI 10.2174/138955706777698642; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Dandachi N, 2001, J PATHOL, V193, P181, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V; DERYNCK R, 2006, SMAD SIGNAL TRANSDUC, P93; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hjelmeland AB, 2005, MOL CELL BIOL, V25, P9460, DOI 10.1128/MCB.25.21.9460-9468.2005; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kane CL, 2004, SEMIN CUTAN MED SURG, V23, P54, DOI 10.1016/S1085-5629(03)00088-9; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398	52	284	306	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1000	1004		10.1038/ncb434	http://dx.doi.org/10.1038/ncb434			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762890				2022-12-25	WOS:000249256500004
J	Rolls, A; Shechter, R; London, A; Ziv, Y; Ronen, A; Levy, R; Schwartz, M				Rolls, Asya; Shechter, Ravid; London, Anat; Ziv, Yaniv; Ronen, Ayal; Levy, Rinat; Schwartz, Michal			Toll-like receptors modulate adult hippocampal neurogenesis	NATURE CELL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; INNATE IMMUNITY; DENTATE GYRUS; CELLS; ACTIVATION; INFLAMMATION; RECOGNITION; EXPRESSION; RESPONSES	Neurogenesis-the formation of new neurons in the adult brain - is considered to be one of the mechanisms by which the brain maintains its lifelong plasticity in response to extrinsic and intrinsic changes(1). The mechanisms underlying the regulation of neurogenesis are largely unknown. Here, we show that Toll-like receptors (TLRs), a family of highly conserved pattern-recognizing receptors involved in neural system development in Drosophila(2) and innate immune activity in mammals(3,4), regulate adult hippocampal neurogenesis. We show that TLR2 and TLR4 are found on adult neural stem/progenitor cells (NPCs) and have distinct and opposing functions in NPC proliferation and differentiation both in vitro and in vivo. TLR2 deficiency in mice impaired hippocampal neurogenesis, whereas the absence of TLR4 resulted in enhanced proliferation and neuronal differentiation. In vitro studies further indicated that TLR2 and TLR4 directly modulated self-renewal and the cell-fate decision of NPCs. The activation of TLRs on the NPCs was mediated via MyD88 and induced PKC alpha/beta-dependent activation of the NF-kappa B signalling pathway. Thus, our study identified TLRs as players in adult neurogenesis and emphasizes their specified and diverse role in cell renewal.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	michal.schwartz@weizmann.ac.il	Shechter, Ravid/GYA-5446-2022	Shechter, Ravid/0000-0002-5956-413X; Rolls, Asya/0000-0001-5862-4287				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Reome JB, 2000, J IMMUNOL, V165, P4226, DOI 10.4049/jimmunol.165.8.4226; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Spitzer JH, 2002, EUR J IMMUNOL, V32, P1182, DOI 10.1002/1521-4141(200204)32:4<1182::AID-IMMU1182>3.0.CO;2-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	32	438	459	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1081	U61		10.1038/ncb1629	http://dx.doi.org/10.1038/ncb1629			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704767				2022-12-25	WOS:000249256500016
J	Franck, AD; Powers, AF; Gestaut, DR; Gonen, T; Davis, TN; Asbury, CL				Franck, Andrew D.; Powers, Andrew F.; Gestaut, Daniel R.; Gonen, Tamir; Davis, Trisha N.; Asbury, Charles L.			Tension applied through the Dam1 complex promotes microtubule elongation providing a direct mechanism for length control in mitosis	NATURE CELL BIOLOGY			English	Article							KINETOCHORE MOTILITY; DYNAMIC INSTABILITY; RING COMPLEX; FORCE; CHROMOSOME; SPINDLE; CENTROMERE; MOVEMENTS; METAPHASE; YEAST	In dividing cells, kinetochores couple chromosomes to the tips of growing and shortening microtubule fibres(1,2) and tension at the kinetochore-microtubule interface promotes fibre elongation(3-6). Tension-dependent microtubule fibre elongation is thought to be essential for coordinating chromosome alignment and separation(1,3,7-10), but the mechanism underlying this effect is unknown. Using optical tweezers, we applied tension to a model of the kinetochore-microtubule interface composed of the yeast Dam1 complex(11-13) bound to individual dynamic microtubule tips(14). Higher tension decreased the likelihood that growing tips would begin to shorten, slowed shortening, and increased the likelihood that shortening tips would resume growth. These effects are similar to the effects of tension on kinetochore-attached microtubule fibres in many cell types, suggesting that we have reconstituted a direct mechanism for microtubule-length control in mitosis.	Univ Washington, Dept Physiol, Seattle, WA 98195 USA; Univ Washington, Dept Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Asbury, CL (corresponding author), Univ Washington, Dept Physiol, Seattle, WA 98195 USA.	casbury@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, T32GM007270] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079373, T32 GM07270, R01 GM079373-01, T32 GM007270, R01 GM079373-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Inoue S, 1975, Soc Gen Physiol Ser, V30, P3; Janson ME, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.248101; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Skibbens RV, 1997, EXP CELL RES, V235, P314, DOI 10.1006/excr.1997.3691; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Waters JC, 1996, J CELL SCI, V109, P2823; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	34	119	123	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					832	U171		10.1038/ncb1609	http://dx.doi.org/10.1038/ncb1609			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17572669	Green Accepted			2022-12-25	WOS:000247760700019
J	Dina, C; Meyre, D; Gallina, S; Durand, E; Korner, A; Jacobson, P; Carlsson, LMS; Kiess, W; Vatin, V; Lecoeur, C; Delplanque, J; Vaillant, E; Pattou, F; Ruiz, J; Weill, J; Levy-Marchal, C; Horber, F; Potoczna, N; Hercberg, S; Le Stunff, C; Bougneres, P; Kovacs, P; Marre, M; Balkau, B; Cauchi, S; Chevre, JC; Froguel, P				Dina, Christian; Meyre, David; Gallina, Sophie; Durand, Emmanuelle; Koerner, Antje; Jacobson, Peter; Carlsson, Lena M. S.; Kiess, Wieland; Vatin, Vincent; Lecoeur, Cecile; Delplanque, Jerome; Vaillant, Emmanuel; Pattou, Francois; Ruiz, Juan; Weill, Jacques; Levy-Marchal, Claire; Horber, Fritz; Potoczna, Natascha; Hercberg, Serge; Le Stunff, Catherine; Bougneres, Pierre; Kovacs, Peter; Marre, Michel; Balkau, Beverley; Cauchi, Stephane; Chevre, Jean-Claude; Froguel, Philippe			Variation in FTO contributes to childhood obesity and severe adult obesity	NATURE GENETICS			English	Article							INSULIN-RESISTANCE; MOUSE	We identified a set of SNPs in the first intron of the FTO (fat mass and obesity associated) gene on chromosome 16q12.2 that is consistently strongly associated with early-onset and severe obesity in both adults and children of European ancestry with an experiment-wise P value of 1.67 x 10(-26) in 2,900 affected individuals and 5,100 controls. The at- risk haplotype yields a proportion of attributable risk of 22% for common obesity. We conclude that FTO contributes to human obesity and hence may be a target for subsequent functional analyses.	Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; Univ Leipzig, Univ Hosp Children & Adolescents, D-7010 Leipzig, Germany; Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, S-40020 Gothenburg, Sweden; Univ Lille 2, INSERM, U859, F-59045 Lille, France; CHU Vaudois, Lausanne, Switzerland; Jeanne Flandre Hosp, Paediat Endocrine Unit, Lille, France; Hop Robert Debre, INSERM, U690, F-75019 Paris, France; Klin Lindberg, Winterthur, Switzerland; INRA, U1125, Bobigny, France; INSERM, U557, Bobigny, France; CNAM, EA3200, Paris, France; Univ Paris 13, Paris, France; CRNH, Paris, France; Univ Paris 05, St Vincent Paul Hosp, Dept Pediat Endocrinol, F-75005 Paris, France; Univ Paris 05, St Vincent Paul Hosp, INSERM U561, F-75005 Paris, France; Univ Leipzig, Dept Internal Med 2, D-7010 Leipzig, Germany; Univ Leipzig, Interdisciplinary Ctr Clin Res, D-7010 Leipzig, Germany; Hop Bichat Claude Bernard, AP HP, Dept Diabetol, F-75877 Paris 18, France; INSERM, U780, IFR69, Villejuif, France; Univ Paris Sud, Villejuif, France; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London SW7 2AY, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Leipzig University; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leipzig University; Leipzig University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Dina, C (corresponding author), Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France.	dina@good.ibl.fr	Serge, Hercberg/F-3038-2017; Dina, Christian R/D-3535-2015; Carlsson, Lena/F-7570-2018; Meyre, David/D-7315-2011; HERCBERG, Serge/B-4429-2008; Körner, Antje/B-3988-2015; Pattou, Francois/O-6151-2017; LE STUNFF, CATHERINE/Y-3270-2018; Chèvre, Jean-Claude/C-3943-2015; FROGUEL, Philippe/O-6799-2017; horber, Fritz/AAL-5419-2020	Serge, Hercberg/0000-0002-3168-1350; Dina, Christian R/0000-0002-7722-7348; Carlsson, Lena/0000-0003-4145-6242; Meyre, David/0000-0003-4850-7444; HERCBERG, Serge/0000-0002-3168-1350; Körner, Antje/0000-0001-6001-0356; Pattou, Francois/0000-0001-8388-3766; LE STUNFF, CATHERINE/0000-0001-8419-0451; Chèvre, Jean-Claude/0000-0002-5329-5231; FROGUEL, Philippe/0000-0003-2972-0784; Marre, Michel/0000-0002-3071-1837; Kovacs, Peter/0000-0002-0290-5423; Jacobson, Peter/0000-0002-1769-1827; Gallina, Sophie/0000-0002-6194-3649	MRC [G0000477, G0600331] Funding Source: UKRI; Medical Research Council [G0000477, G0600331] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Jacobson P, 2007, AM J EPIDEMIOL, V165, P101, DOI 10.1093/aje/kwj342; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; KORNER A, 2007, J CLIN ENDOCRINOL ME; Le Fur S, 2002, DIABETES, V51, pS304, DOI 10.2337/diabetes.51.2007.S304; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Stratakis CA, 2000, J CLIN ENDOCR METAB, V85, P3396, DOI 10.1210/jc.85.9.3396; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vu-Hong TA, 2006, J CLIN ENDOCR METAB, V91, P2437, DOI 10.1210/jc.2005-2245	12	1350	1418	1	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					724	726		10.1038/ng2048	http://dx.doi.org/10.1038/ng2048			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496892				2022-12-25	WOS:000246859100014
J	Ventura, JJ; Tenbaum, S; Perdiguero, E; Huth, M; Guerra, C; Barbacid, M; Pasparakis, M; Nebreda, AR				Ventura, Juan Jose; Tenbaum, Stephan; Perdiguero, Eusebio; Huth, Marion; Guerra, Carmen; Barbacid, Mariano; Pasparakis, Manolis; Nebreda, Angel R.			p38 alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; K-RAS ONCOGENE; GENE-EXPRESSION; C/EBP-ALPHA; TUMOR-SUPPRESSOR; CYCLIN D1; CANCER; MICE; GROWTH; PHOSPHORYLATION	Stem cell function is central for the maintenance of normal tissue homeostasis. Here we show that deletion of p38 alpha mitogenactivated protein ( MAP) kinase in adult mice results in increased proliferation and defective differentiation of lung stem and progenitor cells both in vivo and in vitro. We found that p38a positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation. In addition, p38a controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor. As a consequence, the inactivation of p38a leads to an immature and hyperproliferative lung epithelium that is highly sensitized to K-RasG12V-induced tumorigenesis. Our results indicate that by coordinating proliferation and differentiation signals in lung stem and progenitor cells, p38a has a key role in the regulation of lung cell renewal and tumorigenesis.	CNIO, Spanish Natl Canc Ctr, E-28029 Madrid, Spain; European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); European Molecular Biology Laboratory (EMBL); University of Cologne	Nebreda, AR (corresponding author), CNIO, Spanish Natl Canc Ctr, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	jjventura@cnio.es; anebreda@cnio.es	Perdiguero, Eusebio/F-3178-2013; Ventura, Juan-Jose/J-7913-2016; Guerra, Carmen/K-5852-2014; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Nebreda, Angel Rodriguez/R-9594-2019	Perdiguero, Eusebio/0000-0003-3529-8989; Ventura, Juan-Jose/0000-0002-9252-843X; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Guerra, Carmen/0000-0002-3891-046X	Medical Research Council [G0800346] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Ambrosino C, 2006, BIOCHEM J, V396, P163, DOI 10.1042/BJ20051502; Bardeesy N, 2005, MOL CELL BIOL, V25, P4176, DOI 10.1128/MCB.25.10.4176-4188.2005; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen JP, 1999, FEBS LETT, V457, P162, DOI 10.1016/S0014-5793(99)01031-5; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Craxton A, 1998, J IMMUNOL, V161, P3225; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Deng JB, 2006, BIOCHEM BIOPH RES CO, V339, P923, DOI 10.1016/j.bbrc.2005.10.217; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lawson GW, 2002, AM J PATHOL, V160, P315, DOI 10.1016/S0002-9440(10)64375-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Mialon A, 2005, MOL CELL BIOL, V25, P5040, DOI 10.1128/MCB.25.12.5040-5051.2005; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pirrotta V, 2006, CURR OPIN GENET DEV, V16, P443, DOI 10.1016/j.gde.2006.08.014; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sugahara K, 2001, CELL TISSUE RES, V306, P57, DOI 10.1007/s004410100420; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	45	239	246	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					750	758		10.1038/ng2037	http://dx.doi.org/10.1038/ng2037			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468755				2022-12-25	WOS:000246859100019
J	Chang, MCY; Eachus, RA; Trieu, W; Ro, DK; Keasling, JD				Chang, Michelle C. Y.; Eachus, Rachel A.; Trieu, William; Ro, Dae-Kyun; Keasling, Jay D.			Engineering Escherichia coli for production of functionalized terpenoids using plant P450s	NATURE CHEMICAL BIOLOGY			English	Article							INDOLE ALKALOID BIOSYNTHESIS; CANDIDA-TROPICALIS; ARTEMISINIC ACID; MINT MENTHA; EXPRESSION; CYTOCHROME-P450; ENZYME; IDENTIFICATION; CONVERSION; SYNTHASE	Terpenoids are a highly diverse class of natural products that have historically provided a rich source for discovery of pharmacologically active small molecules(1), such as paclitaxel ( Taxol) and artemisinin. Unfortunately, these secondary metabolites are typically produced in low abundance in their host organism, and their isolation consequently suffers from low yields and high consumption of natural resources. Furthermore, chemical synthesis of terpenoids can also be difficult to scale for industrial production. For these reasons, an attractive alternative strategy is to engineer metabolic pathways for production of pharmaceuticals or their precursors in a microbial host such as Escherichia coli. A key step is developing methods to carry out cytochrome P450 ( P450)based oxidation chemistry in vivo. Toward this goal, we have assembled two heterologous pathways for the biosynthesis of plant- derived terpenoid natural products, and we present the first examples of in vivo production of functionalized terpenoids in E. coli at high titer using native plant P450s.	Univ Calif Berkeley, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Dept Bioengn, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Keasling, JD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Ro, Dae-Kyun/G-9289-2012	Keasling, Jay D/0000-0003-4170-6088; Ro, Dae-Kyun/0000-0003-1288-5347				BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bertea CM, 2001, ARCH BIOCHEM BIOPHYS, V390, P279, DOI 10.1006/abbi.2001.2378; Carter OA, 2003, PHYTOCHEMISTRY, V64, P425, DOI 10.1016/S0031-9422(03)00204-8; Chau M, 2004, CHEM BIOL, V11, P663, DOI 10.1016/j.chembiol.2004.02.025; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; CONOLLY JD, 1991, DICT TORPONOIDS; Craft DL, 2003, APPL ENVIRON MICROB, V69, P5983, DOI 10.1128/AEM.69.10.5983-5991.2003; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P189; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Haudenschild C, 2000, ARCH BIOCHEM BIOPHYS, V379, P127, DOI 10.1006/abbi.2000.1864; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Leonard E, 2006, METAB ENG, V8, P172, DOI 10.1016/j.ymben.2005.11.001; Luo SN, 2004, AIP CONF PROC, V706, P95; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Naur P, 2003, ARCH BIOCHEM BIOPHYS, V409, P235, DOI 10.1016/S0003-9861(02)00567-2; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; ROTH RJ, 1989, J NAT PROD, V52, P1183, DOI 10.1021/np50065a050; SCHAFMEISTER CE, 1993, SCIENCE, V262, P734, DOI 10.1126/science.8235592; Schoch GA, 2003, PLANT PHYSIOL, V133, P1198, DOI 10.1104/pp.103.020305; Schroder G, 1999, FEBS LETT, V458, P97, DOI 10.1016/S0014-5793(99)01138-2; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; SUEYOSHI T, 1995, ARCH BIOCHEM BIOPHYS, V322, P265, DOI 10.1006/abbi.1995.1461; SUTTER TR, 1990, J BIOL CHEM, V265, P16428; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; Wuts P G, 1998, Curr Opin Drug Discov Devel, V1, P329	29	265	300	7	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2007	3	5					274	277		10.1038/nchembio875	http://dx.doi.org/10.1038/nchembio875			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159FP	17438551				2022-12-25	WOS:000245851100011
J	Chen, T; Muratore, TL; Schaner-Tooley, CE; Shabanowitz, J; Hunt, DF; Macara, IG				Chen, Ting; Muratore, Tara L.; Schaner-Tooley, Christine E.; Shabanowitz, Jeffrey; Hunt, Donald F.; Macara, Ian G.			N-terminal alpha-methylation of RCC1 is necessary for stable chromatin association and normal mitosis	NATURE CELL BIOLOGY			English	Article							NUCLEAR IMPORT; CHROMOSOME CONDENSATION; SEQUENCE-ANALYSIS; PROTEIN; EXCHANGE; PHOSPHORYLATION; PEPTIDE; H2A; RAN	Regulator of chromatin condensation 1 (RCC1) is the only known guanine nucleotide-exchange factor for the Ran GTPase and has pivotal roles in nucleo-cytoplasmic transport, mitosis, and nuclear-envelope assembly(1). RCC1 associates dynamically with chromatin through binding to histones H2A and/ or H2B in a Ran-regulated manner(2,3). Here, we report that, unexpectedly, the amino-terminal serine or proline residue of RCC1 is uniquely methylated on its alpha-amino group. Methylation requires removal of the initiating methionine, and the presence of proline and lysine at positions 3 and 4, respectively. Methylation-defective mutants of RCC1 bind less effectively than wild-type protein to chromatin during mitosis, which causes spindle-pole defects. We propose a bimodal attachment mechanism for RCC1 in which the tail promotes stable RCC1 association with chromatin through DNA binding in an alpha-N-methylation-dependent manner. These data provide the first known function for N-terminal protein methylation.	Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Chem, Charlottetown, PE 22904, Canada; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Macara, IG (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA.	igm9c@virginia.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368	NCI NIH HHS [CA040042, P01 CA040042] Funding Source: Medline; NIGMS NIH HHS [R01 GM070902, R01 GM050526, GM070902, GM37537, R01 GM037537] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902, R01GM037537, R01GM050526] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAI R, 1986, MOL CELL BIOL, V6, P2027, DOI 10.1128/MCB.6.6.2027; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Sluder G, 1997, J CELL SCI, V110, P421; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099	23	104	108	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					596	U203		10.1038/ncb1572	http://dx.doi.org/10.1038/ncb1572			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435751	Green Accepted			2022-12-25	WOS:000246181500019
J	Carter, S; Bischof, O; Dejean, A; Vousden, KH				Carter, Stephanie; Bischof, Oliver; Dejean, Anne; Vousden, Karen H.			C-terminal modifications regulate MDM2 dissociation and nuclear export of p53	NATURE CELL BIOLOGY			English	Article							RING-FINGER DOMAIN; SUMO-1 MODIFICATION; WILD-TYPE; IN-VIVO; UBIQUITIN; PROTEIN; PHOSPHORYLATION; LOCALIZATION; BINDING; SIGNAL	p53 functions to prevent malignant progression, in part by inhibiting proliferation or inducing the death of potential tumour cells(1). One of the most important regulators of p53 is MDM2, a RING domain E3 ligase that ubiquitinates p53, leading to both proteasomal degradation and relocation of p53 from the nucleus to the cytoplasm(1). Previous studies have suggested that although polyubiquitination is required for degradation, monoubiquitination of p53 is sufficient for nuclear export(2). Using a p53-ubiquitin fusion protein we show that ubiquitination contributes to two steps before export: exposure of a carboxy-terminal nuclear export sequence (NES), and dissociation of MDM2. Monoubiquitination can directly promote further modifications of p53 with ubiquitin-like proteins and MDM2 promotes the interaction of the SUMO E3 ligase PIASy with p53, enhancing both sumoylation and nuclear export. Our results suggest that modifications such as sumoylation can regulate the strength of the p53-MDM2 interaction and participate in driving the export of p53.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Inst Pasteur, INSERM, U579, F-75724 Paris 15, France	Beatson Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Dejean, Anne/L-5145-2018; Bischof, Oliver/K-1548-2019					Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lee JC, 2005, APOPTOSIS, V10, P1483, DOI 10.1007/s10495-005-1833-z; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; MARSTON NJ, 1995, ONCOGENE, V10, P1709; MARSTON NJ, 1994, ONCOGENE, V9, P2707; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; ZERRAHN J, 1992, ONCOGENE, V7, P1371; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	35	184	191	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					428	U111		10.1038/ncb1562	http://dx.doi.org/10.1038/ncb1562			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369817				2022-12-25	WOS:000245359400014
J	Drepper, T; Eggert, T; Circolone, F; Heck, A; Krauss, U; Guterl, JK; Wendorff, M; Losi, A; Gartner, W; Jaeger, KE				Drepper, Thomas; Eggert, Thorsten; Circolone, Franco; Heck, Achim; Krauss, Ulrich; Guterl, Jan-Karl; Wendorff, Marion; Losi, Aba; Gaertner, Wolfgang; Jaeger, Karl-Erich			Reporter proteins for in vivo fluorescence without oxygen	NATURE BIOTECHNOLOGY			English	Article								Fluorescent reporter proteins such as green fluorescent protein are valuable noninvasive molecular tools for in vivo real- time imaging of living specimens. However, their use is generally restricted to aerobic systems, as the formation of their chromophores strictly requires oxygen. Starting with blue- light photoreceptors from Bacillus subtilis and Pseudomonas putida that contain light- oxygen- voltage - sensing domains, we engineered flavin mononucleotide - based fluorescent proteins that can be used as fluorescent reporters in both aerobic and anaerobic biological systems.	Univ Dusseldorf, Res Ctr Julich, Inst Mol Enzyme Technol, D-52426 Julich, Germany; EVOcatal GmbH, D-40225 Dusseldorf, Germany; Univ Parma, Dept Phys, I-43100 Parma, Italy; Max Planck Inst Bioinorgan Chem, D-45470 Mulheim, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Parma; Max Planck Society	Drepper, T (corresponding author), Univ Dusseldorf, Res Ctr Julich, Inst Mol Enzyme Technol, Stetternicher Forst, D-52426 Julich, Germany.	t.drepper@fz-juelich.de; karl-erich.jaeger@fz-juelich.de	Losi, Aba/M-8709-2015; drepper, thomas/ABB-4717-2020; jaeger, karl/ABB-1955-2020; Krauss, Ulrich/F-6334-2010; Drepper, Thomas/ABA-8291-2020	Losi, Aba/0000-0003-0497-2723; drepper, thomas/0000-0002-0096-8084; Drepper, Thomas/0000-0002-0096-8084; Gartner, Wolfgang/0000-0002-6898-7011; Krauss, Ulrich/0000-0003-2219-7388; Heck, Achim/0000-0002-4975-9961				Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Buttani V, 2007, PHOTOCH PHOTOBIO SCI, V6, P41, DOI 10.1039/b610375h; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Drepper Thomas, 2006, Biotechnology Journal, V1, P777, DOI 10.1002/biot.200600059; Karatani H, 2004, PHOTOCHEM PHOTOBIOL, V79, P120, DOI 10.1111/j.1751-1097.2004.tb09866.x; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; March JC, 2003, APPL MICROBIOL BIOT, V62, P303, DOI 10.1007/s00253-003-1339-y; Masepohl B, 2004, GENETICS AND REGULATION OF NITROGEN FIXATION IN FREE-LIVING BACTERIA, P141; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Patterson G, 2001, J CELL SCI, V114, P837; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Zhang C, 2005, FEMS MICROBIOL LETT, V249, P211, DOI 10.1016/j.femsle.2005.05.051	18	280	289	5	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					443	445		10.1038/nbt1293	http://dx.doi.org/10.1038/nbt1293			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17351616				2022-12-25	WOS:000245651800025
J	Stevanin, G; Santorelli, FM; Azzedine, H; Coutinho, P; Chomilier, J; Denora, PS; Martin, E; Ouvrard-Hernandez, AM; Tessa, A; Bouslam, N; Lossos, A; Charles, P; Loureiro, JL; Elleuch, N; Confavreux, C; Cruz, VT; Ruberg, M; Leguern, E; Grid, D; Tazir, M; Fontaine, B; Filla, A; Bertini, E; Durr, A; Brice, A				Stevanin, Giovanni; Santorelli, Filippo M.; Azzedine, Hamid; Coutinho, Paula; Chomilier, Jacques; Denora, Paola S.; Martin, Elodie; Ouvrard-Hernandez, Anne-Marie; Tessa, Alessandra; Bouslam, Naima; Lossos, Alexander; Charles, Perrine; Loureiro, Jose L.; Elleuch, Nizar; Confavreux, Christian; Cruz, Vitor T.; Ruberg, Merle; Leguern, Eric; Grid, Djamel; Tazir, Meriem; Fontaine, Bertrand; Filla, Alessandro; Bertini, Enrico; Durr, Alexandra; Brice, Alexis			Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum	NATURE GENETICS			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; GENETIC-HETEROGENEITY; MENTAL IMPAIRMENT; LOCUS; PROTEINS; LINKAGE	Autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) is a common and clinically distinct form of familial spastic paraplegia that is linked to the SPG11 locus on chromosome 15 in most affected families. We analyzed 12 ARHSP-TCC families, refined the SPG11 candidate interval and identified ten mutations in a previously unidentified gene expressed ubiquitously in the nervous system but most prominently in the cerebellum, cerebral cortex, hippocampus and pineal gland. The mutations were either nonsense or insertions and deletions leading to a frameshift, suggesting a loss-of-function mechanism. The identification of the function of the gene will provide insight into the mechanisms leading to the degeneration of the corticospinal tract and other brain structures in this frequent form of ARHSP.	Hop La Pitie Salpetriere, INSERM, UMR679, Fed Inst Neurosci Res, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, UMR679, Paris, France; Hop La Pitie Salpetriere, APHP, Dept Cytogenet & Genet, Paris, France; Bambino Gesu Pediat Hosp, IRCCS, Mol Med Unit, Rome, Italy; Univ Porto, UnIGENe, P-4100 Oporto, Portugal; Hosp S Sebastiao, Dept Neurol, Santa Maria Feira, Portugal; Univ Paris 06, Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France; Univ Paris 07, Inst Mineral & Phys Milieux Condenses, F-75221 Paris 05, France; CHU Grenoble, Dept Neurol, F-38043 Grenoble, France; Hebrew Univ Jerusalem, Hadassah Med Ctr, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91905 Jerusalem, Israel; Hop Neurol & Neurochirurg P Wertheimer, Lyon, France; Genethon, Evry, France; Mustapha Hosp, Dept Neurol, Algiers, Algeria; Grp Hosp Pitie Salpetriere, INSERM, U546, F-75634 Paris, France; Hop La Pitie Salpetriere, APHP, Federat Neurol, Paris, France; Univ Paris 06, Pitie Salpetriere Med Sch, F-75252 Paris 05, France; Univ Naples Federico II, Dept Neurol Sci, Naples, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Bambino Gesu; Universidade do Porto; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Hebrew University of Jerusalem; Hadassah University Medical Center; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Naples Federico II	Stevanin, G (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR679, Fed Inst Neurosci Res, Paris, France.	stevanin@ccr.jussieu.fr	Brice, Alexis/A-2170-2009; Loureiro, José Leal/K-6379-2013; Santorelli, Filippo M/ABE-5124-2020; Tessa, Alessandra/K-2325-2016; Stevanin, Giovanni/E-5038-2016; Cruz, Vítor Tedim/AAM-3014-2020; Bertini, Enrico/ABG-1278-2020; Tessa, Alessandra/AAA-4442-2021; Coutinho, Paula/K-6053-2013; MARTIN, Elodie/ABF-3563-2020; Bertini, Enrico/A-2284-2014; brice, alexis/AAE-8275-2019	Loureiro, José Leal/0000-0002-6195-5412; Santorelli, Filippo M/0000-0002-1359-9062; Tessa, Alessandra/0000-0002-1445-6434; Stevanin, Giovanni/0000-0001-9368-8657; Cruz, Vítor Tedim/0000-0002-5333-4771; Tessa, Alessandra/0000-0002-1445-6434; MARTIN, Elodie/0000-0002-4494-9168; Bertini, Enrico/0000-0001-9276-4590; brice, alexis/0000-0002-0941-3990; Coutinho, Paula/0000-0002-3461-230X; CHOMILIER, Jacques/0000-0002-4250-0762	Telethon [GGP06188] Funding Source: Medline	Telethon(Fondazione Telethon)		Al-Yahyaee S, 2006, NEUROLOGY, V66, P1230, DOI 10.1212/01.wnl.0000208501.52849.dd; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Casali C, 2004, NEUROLOGY, V62, P262, DOI 10.1212/WNL.62.2.262; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARDING AE, 1983, LANCET, V1, P1151; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Hughes CA, 2001, NEUROLOGY, V56, P1230, DOI 10.1212/WNL.56.9.1230; Kikuno R, 2002, NUCLEIC ACIDS RES, V30, P166, DOI 10.1093/nar/30.1.166; Lossos A, 2006, ARCH NEUROL-CHICAGO, V63, P756, DOI 10.1001/archneur.63.5.756; MARTINEZ MF, 1999, NEUROLOGY, V53, P50; Moutsimilli L, 2005, NEUROPHARMACOLOGY, V49, P890, DOI 10.1016/j.neuropharm.2005.06.017; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; NAGANATHAN PB, 1995, PACKAGING TECHNOLOGY, V8, P85, DOI DOI 10.1002/PTS.2770080204; NAKAMURA A, 1995, J NEUROL SCI, V131, P35, DOI 10.1016/0022-510X(95)00028-Z; Olmez A, 2006, NEUROPEDIATRICS, V37, P59, DOI 10.1055/s-2006-923982; Orlacchio A, 2005, MOVEMENT DISORD, V20, P1055, DOI 10.1002/mds.20494; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Shibasaki Y, 2000, ANN NEUROL, V48, P108, DOI 10.1002/1531-8249(200007)48:1<108::AID-ANA17>3.3.CO;2-1; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Stevanin G, 2006, NEUROGENETICS, V7, P149, DOI 10.1007/s10048-006-0044-2; Winner B, 2004, ARCH NEUROL-CHICAGO, V61, P117, DOI 10.1001/archneur.61.1.117; WOODCOCK S, 1992, PROTEIN ENG, V5, P629, DOI 10.1093/protein/5.7.629	24	234	251	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					366	372		10.1038/ng1980	http://dx.doi.org/10.1038/ng1980			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322883				2022-12-25	WOS:000244480000019
J	Trivedi, CM; Luo, Y; Yin, Z; Zhang, MZ; Zhu, WT; Wang, T; Floss, T; Goettlicher, M; Noppinger, PR; Wurst, W; Ferrari, VA; Abrams, CS; Gruber, PJ; Epstein, JA				Trivedi, Chinmay M.; Luo, Yang; Yin, Zhan; Zhang, Maozhen; Zhu, Wenting; Wang, Tao; Floss, Thomas; Goettlicher, Martin; Noppinger, Patricia Ruiz; Wurst, Wolfgang; Ferrari, Victor A.; Abrams, Charles S.; Gruber, Peter J.; Epstein, Jonathan A.			Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE INHIBITORS; GLYCOGEN-SYNTHASE KINASE-3-BETA; HEART-FAILURE; CLASS-I; GENE; EXPRESSION; AKT; ACETYLATION; HOP; IDENTIFICATION	In the adult heart, a variety of stresses induce re-expression of a fetal gene program in association with myocyte hypertrophy and heart failure. Here we show that histone deacetylase-2 (Hdac2) regulates expression of many fetal cardiac isoforms. Hdac2 deficiency or chemical histone deacetylase ( HDAC) inhibition prevented the re-expression of fetal genes and attenuated cardiac hypertrophy in hearts exposed to hypertrophic stimuli. Resistance to hypertrophy was associated with increased expression of the gene encoding inositol polyphosphate-5-phosphatase f (Inpp5f) resulting in constitutive activation of glycogen synthase kinase 3b (Gsk3b) via inactivation of thymoma viral proto-oncogene (Akt) and 3-phosphoinositide- dependent protein kinase-1 (Pdk1). In contrast, Hdac2 transgenic mice had augmented hypertrophy associated with inactivated Gsk3b. Chemical inhibition of activated Gsk3b allowed Hdac2-deficient adults to become sensitive to hypertrophic stimulation. These results suggest that Hdac2 is an important molecular target of HDAC inhibitors in the heart and that Hdac2 and Gsk3b are components of a regulatory pathway providing an attractive therapeutic target for the treatment of cardiac hypertrophy and heart failure.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; Tech Univ Munich, D-85764 Neuherberg, Germany; GSF Natl Res Ctr Environm & Hlth, Dept Toxicol, D-85764 Neuherberg, Germany; Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-10115 Berlin, Germany; Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Epstein, JA (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1156 Basic Res Bldg 2,421 Curie Blvd, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu	Zhu, Wenting/A-2718-2012; Göttlicher, Martin/M-7342-2014; Zhu, Wendy/G-3079-2010; Noppinger, Patricia Ruiz/AAH-1753-2019	Göttlicher, Martin/0000-0003-0619-2181; Noppinger, Patricia Ruiz/0000-0001-5617-8965; Wurst, Wolfgang/0000-0003-4422-7410; Epstein, Jonathan/0000-0001-8637-4465; Ferrari, Victor/0000-0001-8696-3243; Trivedi, Chinmay/0000-0002-3544-0474	NHLBI NIH HHS [R01 HL071546] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Baldinu P, 2004, HUM MUTAT, V23, P318, DOI 10.1002/humu.20015; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kook H, 2003, TRENDS CARDIOVAS MED, V13, P261, DOI 10.1016/S1050-1738(03)00107-5; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Minagawa T, 2001, J BIOL CHEM, V276, P22011, DOI 10.1074/jbc.M101579200; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Peiffer-Schneider S, 1998, GENOMICS, V52, P9, DOI 10.1006/geno.1998.5399; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhou R, 2003, MAGN RESON MED, V49, P760, DOI 10.1002/mrm.10423	41	359	378	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2007	13	3					324	331		10.1038/nm1552	http://dx.doi.org/10.1038/nm1552			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17322895				2022-12-25	WOS:000244715700045
J	Luo, L; Parrish, CA; Nevins, N; McNulty, DE; Chaudhari, AM; Carson, JD; Sudakin, V; Shaw, AN; Lehr, R; Zhao, H; Sweitzer, S; Lad, L; Wood, KW; Sakowicz, R; Annan, RS; Huang, PS; Jackson, JR; Dhanak, D; Copeland, RA; Auger, KR				Luo, Lusong; Parrish, Cynthia A.; Nevins, Neysa; McNulty, Dean E.; Chaudhari, Amita M.; Carson, Jeffery D.; Sudakin, Valery; Shaw, Antony N.; Lehr, Ruth; Zhao, Huizhen; Sweitzer, Sharon; Lad, Latesh; Wood, Kenneth W.; Sakowicz, Roman; Annan, Roland S.; Huang, Pearl S.; Jackson, Jeffrey R.; Dhanak, Dashyant; Copeland, Robert A.; Auger, Kurt R.			ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; SPINDLE PROTEIN KSP; TRITYL-L-CYSTEINE; MOTOR PROTEIN; EG5; MONASTROL; RESISTANCE; POTENT; MICROTUBULES; DISCOVERY	The mitotic kinesin KSP (kinesin spindle protein, or Eg5) has an essential role in centrosome separation and formation of the bipolar mitotic spindle(1,2). Its exclusive involvement in the mitotic spindle of proliferating cells presents an opportunity for developing new anticancer agents with reduced side effects relative to antimitotics that target tubulin(3-5). Ispinesib (1) is an allosteric small-molecule KSP inhibitor in phase 2 clinical trials. Mutations that attenuate ispinesib binding to KSP have been identified, which highlights the need for inhibitors that target different binding sites. We describe a new class of selective KSP inhibitors that are active against ispinesib-resistant forms of KSP. These ATP-competitive KSP inhibitors do not bind in the nucleotide binding pocket. Cumulative data from generation of resistant cells, site-directed mutagenesis and photo-affinity labeling suggest that they compete with ATP binding via a novel allosteric mechanism.	Dept Enzymol & Mechanist Pharmacol, Oncol CEDD, Collegeville, PA 19426 USA; Dept Med Chem, Oncol CEDD, Collegeville, PA 19426 USA; Dept Computat Analyt & Struct Sci, Mol Discovery Res, Collegeville, PA 19426 USA; Dept Biol, Oncol CEDD, Collegeville, PA 19426 USA; GlaxSmithKline, Biol Reagents & Assay Dev, Mol Discovery Res, Collegeville, PA 19426 USA; Cytokinet Inc, San Francisco, CA 94080 USA		Parrish, CA (corresponding author), Merck & Co Inc, Oncol Franchise, 770 Sumneytown Pike, West Point, PA 19486 USA.	cynthia.a.parrish@gsk.com; lusong.luo@gsk.com		Nevins, Neysa/0000-0003-2378-7283				Bacheler LT, 1999, DRUG RESIST UPDATE, V2, P56, DOI 10.1054/drup.1998.0064; Basavapathruni A, 2004, J BIOL CHEM, V279, P6221, DOI 10.1074/jbc.C300523200; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; Brier S, 2004, BIOCHEMISTRY-US, V43, P13072, DOI 10.1021/bi049264e; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Copeland RA, 2005, ANAL BIOCHEM, V337, P351, DOI 10.1016/j.ab.2004.10.010; Cox CD, 2006, BIOORG MED CHEM LETT, V16, P3175, DOI 10.1016/j.bmcl.2006.03.040; Cox CD, 2005, BIOORG MED CHEM LETT, V15, P2041, DOI 10.1016/j.bmcl.2005.02.055; Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; JACKSON JR, 2005, P AACR NCI EORTC MOL; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kull FJ, 2004, TRENDS BIOCHEM SCI, V29, P103, DOI 10.1016/j.tibs.2004.01.001; Luo LS, 2004, BIOCHEMISTRY-US, V43, P15258, DOI 10.1021/bi048282t; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mellinghoff IK, 2002, PHARMACOGENOMICS, V3, P603, DOI 10.1517/14622416.3.5.603; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Parrish CA, 2007, J MED CHEM, V50, P4939, DOI 10.1021/jm070435y; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhu QY, 1996, AIDS RES HUM RETROV, V12, P507, DOI 10.1089/aid.1996.12.507	27	90	91	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					722	726		10.1038/nchembio.2007.34	http://dx.doi.org/10.1038/nchembio.2007.34			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17922005				2022-12-25	WOS:000250311500014
J	Cheng, Q; Xiang, L; Izumikawa, M; Meluzzi, D; Moore, BS				Cheng, Qian; Xiang, Longkuan; Izumikawa, Miho; Meluzzi, Dario; Moore, Bradley S.			Enzymatic total synthesis of enterocin polyketides	NATURE CHEMICAL BIOLOGY			English	Article							BIOSYNTHESIS; SYNTHASE; ATTACHMENT; ENZYMES	Polyketides are clinically important natural products that often require elaborate organic syntheses owing to their complex chemical structures. Here we report the multienzyme total synthesis of the Streptomyces maritimus enterocin and wailupemycin bacteriostatic agents in a single reaction vessel from simple benzoate and malonate substrates. To our knowledge, our results represent the first in vitro assembly of a complete type II polyketide synthase enzymatic pathway to natural products.	Univ Arizona, Scripps Inst Oceanog, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Arizona; University of Arizona; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Arizona, Scripps Inst Oceanog, 1703 E Mabel St, Tucson, AZ 85721 USA.	bsmoore@ucsd.edu		Moore, Bradley/0000-0002-4652-1253	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047818, R56AI047818] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47818] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Caro AA, 2005, BIOCHEM PHARMACOL, V69, P1081, DOI 10.1016/j.bcp.2005.01.007; Florova G, 2002, BIOCHEMISTRY-US, V41, P10462, DOI 10.1021/bi0258804; Hertweck C, 2004, CHEM BIOL, V11, P461, DOI 10.1016/j.chembiol.2004.03.018; IAUMIKAWA M, 2006, J AM CHEM SOC, V128, P1428; Kalaitzis JA, 2003, J AM CHEM SOC, V125, P9290, DOI 10.1021/ja035973o; Lee HY, 2000, EUR J BIOCHEM, V267, P7224, DOI 10.1046/j.1432-1327.2000.01834.x; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; Piel J, 2000, CHEM BIOL, V7, P943, DOI 10.1016/S1074-5521(00)00044-2; Pohl NL, 2001, J AM CHEM SOC, V123, P5822, DOI 10.1021/ja0028368; Roessner CA, 1996, CHEM BIOL, V3, P325, DOI 10.1016/S1074-5521(96)90114-3; Xiang L, 2004, P NATL ACAD SCI USA, V101, P15609, DOI 10.1073/pnas.0405508101; YU TW, 1995, MICROBIOL-UK, V141, P2779, DOI 10.1099/13500872-141-11-2779	13	100	109	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					557	558		10.1038/nchembio.2007.22	http://dx.doi.org/10.1038/nchembio.2007.22			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17704772				2022-12-25	WOS:000248968000012
J	Green, JBA; Davidson, LA				Green, Jeremy B. A.; Davidson, Lance A.			Convergent extension and the hexahedral cell	NATURE CELL BIOLOGY			English	Article							GASTRULATION MOVEMENTS; XENOPUS-LAEVIS; VERTEBRATE GASTRULATION; ZEBRAFISH GASTRULATION; CARTILAGE DEVELOPMENT; EXTRACELLULAR-MATRIX; SELF-ORGANIZATION; PLANAR POLARITY; MESODERM; FIBRONECTIN	During development, embryonic cells sculpt three-dimensional tissues. Although cell polarity is commonly analysed along one, and sometimes two, dimensions, this perspective illustrates how higher-order cell polarity regulates convergent extension-the coordinated cell rearrangement that produces solid tissue elongation.	Kings Coll Med, Dept Craniofac Dev, London SE1 9RT, England; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA	University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Green, JBA (corresponding author), Kings Coll Med, Dept Craniofac Dev, London SE1 9RT, England.	jeremy.green@kcl.ac.uk	Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620	Medical Research Council [G0601131] Funding Source: Medline; NICHD NIH HHS [R01 HD044750, R01 HD044750-03, HD044750] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Axelrod JD, 2001, GENE DEV, V15, P1182; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Chung HA, 2005, DEV BIOL, V282, P95, DOI 10.1016/j.ydbio.2005.02.030; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dabdoub A, 2005, J NEUROBIOL, V64, P446, DOI 10.1002/neu.20171; Davidson LA, 2004, DEV DYNAM, V231, P888, DOI 10.1002/dvdy.20217; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; ELSDALE T, 1972, NATURE, V236, P152, DOI 10.1038/236152a0; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Green JBA, 2004, DEV DYNAM, V231, P576, DOI 10.1002/dvdy.20163; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hannus M, 2002, DEVELOPMENT, V129, P3493; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 2003, GASTRULATION CELLS E, P171; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; SHIH J, 1992, DEVELOPMENT, V116, P915; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Stern C.D., 2004, GASTRULATION CELLS E; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; SYMES K, 1987, DEVELOPMENT, V101, P339; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Trinkaus J. P., 1984, CELLS ORGANS FORCES; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	56	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1010	1015		10.1038/ncb438	http://dx.doi.org/10.1038/ncb438			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762892				2022-12-25	WOS:000249256500006
J	Serrels, B; Serrels, A; Brunton, VG; Holt, M; McLean, GW; Gray, CH; Jones, GE; Frame, MC				Serrels, Bryan; Serrels, Alan; Brunton, Valerie G.; Holt, Mark; McLean, Gordon W.; Gray, Christopher H.; Jones, Gareth E.; Frame, Margaret C.			Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex	NATURE CELL BIOLOGY			English	Article							N-WASP; DOMAIN; VINCULIN; FAK; LOCALIZATION; PROTEINS; SRC	Networks of actin filaments, controlled by the Arp2/3 complex, drive membrane protrusion during cell migration. How integrins signal to the Arp2/3 complex is not well understood. Here, we show that focal adhesion kinase (FAK) and the Arp2/ 3 complex associate and colocalize at transient structures formed early after adhesion. Nascent lamellipodia, which originate at these structures, do not form in FAK-deficient cells, or in cells in which FAK mutants cannot be autophosphorylated after integrin engagement. The FERM domain of FAK binds directly to Arp3 and can enhance Arp2/3-dependent actin polymerization. Critically, Arp2/ 3 is not bound when FAK is phosphorylated on Tyr 397. Interfering peptides and FERM-domain point mutants show that FAK binding to Arp2/ 3 controls protrusive lamellipodia formation and cell spreading. This establishes a new function for the FAK FERM domain in forming a phosphorylation-regulated complex with Arp2/ 3, linking integrin signalling directly with the actin polymerization machinery.	Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh	Frame, MC (corresponding author), Univ Edinburgh, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.	m.frame@beatson.gla.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048; Holt, Mark/0000-0001-7775-8539; Frame, Margaret/0000-0001-5882-1942	Medical Research Council [G0100152] Funding Source: Medline; MRC [G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Butler B, 2006, CURR BIOL, V16, P242, DOI 10.1016/j.cub.2005.12.033; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; ILLC D, 1995, NATURE, V377, P539; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xu WM, 1998, DEVELOPMENT, V125, P327; Yarrow JC, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-5	28	200	203	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1046	U15		10.1038/ncb1626	http://dx.doi.org/10.1038/ncb1626			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721515				2022-12-25	WOS:000249256500012
J	Blodgett, JAV; Thomas, PM; Li, GY; Velasquez, JE; van der Donk, WA; Kelleher, NL; Metcalf, WW				Blodgett, Joshua A. V.; Thomas, Paul M.; Li, Gongyong; Velasquez, Juan E.; van der Donk, Wilfred A.; Kelleher, Neil L.; Metcalf, William W.			Unusual transformations in the biosynthesis of the antibiotic phosphinothricin tripeptide	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-VIRIDOCHROMOGENES TU494; BIALAPHOS-PRODUCING ORGANISM; GENE-CLUSTER; PHOSPHONOPYRUVATE DECARBOXYLASE; 2-HYDROXYETHYLPHOSPHONIC ACID; HYGROSCOPICUS SF-1293; BLOCKED MUTANTS; EXPRESSION; FOSFOMYCIN; MECHANISM	Phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus ATCC 21705 (ref. 1) and Streptomyces viridochromogenes DSM 40736 (ref. 2). PTT has attracted widespread interest because of its commercial applications and unique phosphinic acid functional group. Despite intensive study since its discovery in 1972 (see ref. 3 for a comprehensive review), a number of steps early in the PTT biosynthetic pathway remain uncharacterized. Here we report a series of interdisciplinary experiments involving the construction of defined S. viridochromogenes mutants, chemical characterization of accumulated intermediates, and in vitro assay of selected enzymes to examine these critical steps in PTT biosynthesis. Our results indicate that early PTT biosynthesis involves a series of catalytic steps that to our knowledge has not been described so far, including a highly unusual reaction for carbon bond cleavage. In sum, we define a pathway for early PTT biosynthesis that is more complex than previously appreciated.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), Univ Illinois, Dept Microbiol, B103 CLSL,601 S Goodwin, Urbana, IL 61801 USA.	metcalf@uiuc.edu	Blodgett, Joshua/G-9355-2011; van der Donk, Wilfred/K-2961-2015; Thomas, Paul/C-2777-2008; Thomas, Paul M/A-6233-2011; Blodgett, Joshua/AAW-8242-2020	Blodgett, Joshua/0000-0002-7080-5870; van der Donk, Wilfred/0000-0002-5467-7071; Thomas, Paul M/0000-0003-2887-4765; Blodgett, Joshua/0000-0002-7080-5870	NIGMS NIH HHS [P01 GM077596-01A1, GM59334, 5T32 GM070421, GM067725, R01 GM059334-09, R01 GM059334, R01 GM067725, P01 GM077596, T32 GM070421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059334, R01GM067725, T32GM070421, P01GM077596] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELL LM, 1991, BIOCHEMISTRY-US, V30, P6135, DOI 10.1021/bi00239a008; ALIJAH R, 1991, APPL MICROBIOL BIOT, V34, P749; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; BAILEY RR, 1990, CHEMOTHERAPY, V36, P27, DOI 10.1159/000238812; BAYER E, 1972, HELV CHIM ACTA, V55, P224, DOI 10.1002/hlca.19720550126; Ben Potters M, 2003, J BACTERIOL, V185, P2112, DOI 10.1128/JB.185.7.2112-2121.2003; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; HARA O, 1991, J GEN MICROBIOL, V137, P351, DOI 10.1099/00221287-137-2-351; HIDAKA T, 1990, AGR BIOL CHEM TOKYO, V54, P2121, DOI 10.1080/00021369.1990.10870254; HIDAKA T, 1992, J ANTIBIOT, V45, P1977, DOI 10.7164/antibiotics.45.1977; HIRSCH CF, 1976, J BACTERIOL, V126, P24, DOI 10.1128/JB.126.1.24-30.1976; IMAI S, 1984, J ANTIBIOT, V37, P1505, DOI 10.7164/antibiotics.37.1505; IMAI S, 1985, AGR BIOL CHEM TOKYO, V49, P873, DOI 10.1080/00021369.1985.10866818; Keiser T, 2000, PRACTICAL STREPTOMYC; LEE SH, 1995, GENE, V153, P143, DOI 10.1016/0378-1119(94)00832-D; Martinez A, 2004, APPL ENVIRON MICROB, V70, P2452, DOI 10.1128/AEM.70.4.2452-2463.2004; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Nakashita H, 2000, BBA-GENE STRUCT EXPR, V1490, P159, DOI 10.1016/S0167-4781(99)00249-3; Schwartz D, 1998, FEMS MICROBIOL LETT, V163, P149, DOI 10.1016/S0378-1097(98)00165-7; Schwartz D, 2004, APPL ENVIRON MICROB, V70, P7093, DOI 10.1128/AEM.70.12.7093-7102.2004; SETO H, 1982, J ANTIBIOT, V35, P1719, DOI 10.7164/antibiotics.35.1719; SETO H, 1983, BIOCHEM BIOPH RES CO, V111, P1008, DOI 10.1016/0006-291X(83)91400-6; SETO H, 1991, J ANTIBIOT, V44, P1286, DOI 10.7164/antibiotics.44.1286; Taylor PP, 1998, TRENDS BIOTECHNOL, V16, P412, DOI 10.1016/S0167-7799(98)01240-2; Thompson C J, 1995, Biotechnology, V28, P197; VASAVADA KV, 1984, J INORG BIOCHEM, V21, P323, DOI 10.1016/0162-0134(84)85054-0; Vidal G, 2000, NMR BIOMED, V13, P289, DOI 10.1002/1099-1492(200008)13:5<289::AID-NBM647>3.3.CO;2-7; Wanner B.L., 1994, METH MOL G, V3, P291; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007	30	89	98	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2007	3	8					480	485		10.1038/nchembio.2007.9	http://dx.doi.org/10.1038/nchembio.2007.9			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	193VB	17632514	Green Accepted			2022-12-25	WOS:000248302200014
J	Mills, AE; Tereskerz, PM				Mills, Ann E.; Tereskerz, Patti M.			Changing patent strategies: what will they mean for the industry?	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Virginia, Sch Med, Ctr Biomed Eth, Program Eth & Policy Hlth Care, Charlottesville, VA 22908 USA	University of Virginia	Mills, AE (corresponding author), Univ Virginia, Sch Med, Ctr Biomed Eth, Program Eth & Policy Hlth Care, POB 800758, Charlottesville, VA 22908 USA.	amh2r@virginia.edu						Aggarwal S, 2006, NAT BIOTECHNOL, V24, P643, DOI 10.1038/nbt0606-643; Allison JR, 2004, GEORGETOWN LAW J, V92, P435; [Anonymous], 2001, FED REG, V66; BESSEN J, 2005, M LEWIS CLARK L REV, V9; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Lanjouw JO, 2001, RAND J ECON, V32, P129, DOI 10.2307/2696401; Lawrence S, 2004, NAT BIOTECHNOL, V22, P930, DOI 10.1038/nbt0804-930; PARCHOMOVSKY G, 2005, U PA L REV, V154; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31	10	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					867	868		10.1038/nbt0807-867	http://dx.doi.org/10.1038/nbt0807-867			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17687359				2022-12-25	WOS:000248725800018
J	Wang, FD; Paradkar, PN; Custodio, AO; Ward, DM; Fleming, MD; Campagna, D; Roberts, KA; Boyartchuk, V; Dietrich, WF; Kaplan, J; Andrews, NC				Wang, Fudi; Paradkar, Prasad N.; Custodio, Angel O.; Ward, Diane Mcvey; Fleming, Mark D.; Campagna, Dean; Roberts, Kristina A.; Boyartchuk, Victor; Dietrich, William F.; Kaplan, Jerry; Andrews, Nancy C.			Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASE; HEREDITARY HEMOCHROMATOSIS; SACCHAROMYCES-CEREVISIAE; HOMEOSTASIS; HEPCIDIN; FERROPORTIN; MUTATIONS; MOUSE; HFE; IDENTIFICATION	We undertook a quantitative trait locus (QTL) analysis in mice to identify modifier genes that might influence the severity of human iron disorders. We identified a strong QTL on mouse chromosome 9 that differentially affected macrophage iron burden in C57BL/10J and SWR/J mice. A C57BL/10J missense allele of an evolutionarily conserved gene, Mon1a, cosegregated with the QTL in congenic mouse lines. We present evidence that Mon1a is involved in trafficking of ferroportin, the major mammalian iron exporter, to the surface of iron- recycling macrophages. Differences in amounts of surface ferroportin correlate with differences in cellular iron content. Mon1a is also important for trafficking of cell- surface and secreted molecules unrelated to iron metabolism, suggesting that it has a fundamental role in the mammalian secretory apparatus.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; Novartis Inst Biomed Res, Models Dis Ctr, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Novartis	Andrews, NC (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	nandrews@enders.tch.harvard.edu	Paradkar, Prasad/ABA-5851-2020; Wang, Fudi/L-7888-2018	Paradkar, Prasad/0000-0002-6553-2214; Wang, Fudi/0000-0001-8730-0003; Andrews, Nancy/0000-0003-0243-4462; Custodio, Angel Omar/0000-0003-0916-2826; Fleming, Mark/0000-0003-0948-4024	NIDDK NIH HHS [R01 DK066373, R01 DK066373-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066373] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beutler E, 2002, CLIN CHEM, V48, P2232; Biasiotto G, 2004, BLOOD CELL MOL DIS, V33, P338, DOI 10.1016/j.bcmd.2004.08.002; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Clothier B, 2000, BIOCHEM PHARMACOL, V59, P115, DOI 10.1016/S0006-2952(99)00306-8; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Grant GR, 2006, HEPATOLOGY, V44, P174, DOI 10.1002/hep.21233; Gu SY, 2005, MOL BIOL REP, V32, P247, DOI 10.1007/s11033-005-3005-1; Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lee P, 2002, BLOOD CELL MOL DIS, V29, P471, DOI 10.1006/bcmd.2002.0586; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P783, DOI 10.1006/bcmd.2001.0445; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Meiling-Wesse K, 2002, FEBS LETT, V530, P174, DOI 10.1016/S0014-5793(02)03456-7; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Muraoka RS, 1999, J CLIN INVEST, V103, P1277, DOI 10.1172/JCI6091; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	26	54	58	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1025	1032		10.1038/ng2059	http://dx.doi.org/10.1038/ng2059			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632513				2022-12-25	WOS:000248446900022
J	Yamasaki, K; Di Nardo, A; Bardan, A; Murakami, M; Ohtake, T; Coda, A; Dorschner, RA; Bonnart, C; Descargues, P; Hovnanian, A; Morhenn, VB; Gallo, RL				Yamasaki, Kenshi; Di Nardo, Anna; Bardan, Antonella; Murakami, Masamoto; Ohtake, Takaaki; Coda, Alvin; Dorschner, Robert A.; Bonnart, Chrystelle; Descargues, Pascal; Hovnanian, Alain; Morhenn, Vera B.; Gallo, Richard L.			Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea	NATURE MEDICINE			English	Article							ANTIMICROBIAL PEPTIDE; STRATUM-CORNEUM; DEFENSE; LL-37; IDENTIFICATION; EXPRESSION; DERMATITIS; WOUNDS; GENE; MICE	Acne rosacea is an inflammatory skin disease that affects 3% of the US population over 30 years of age and is characterized by erythema, papulopustules and telangiectasia(1-3). The etiology of this disorder is unknown, although symptoms are exacerbated by factors that trigger innate immune responses, such as the release of cathelicidin antimicrobial peptides(4). Here we show that individuals with rosacea express abnormally high levels of cathelicidin in their facial skin and that the proteolytically processed forms of cathelicidin peptides found in rosacea are different from those present in normal individuals. These cathelicidin peptides are a result of a post-translational processing abnormality associated with an increase in stratum corneum tryptic enzyme ( SCTE) in the epidermis. In mice, injection of the cathelicidin peptides found in rosacea, addition of SCTE, and increasing protease activity by targeted deletion of the serine protease inhibitor gene Spink5 each increases inflammation in mouse skin. The role of cathelicidin in enabling SCTE-mediated inflammation is verified in mice with a targeted deletion of Camp, the gene encoding cathelicidin. These findings confirm the role of cathelicidin in skin inflammatory responses and suggest an explanation for the pathogenesis of rosacea by demonstrating that an exacerbated innate immune response can reproduce elements of this disease.	Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; VA San Diego Hlth Care Syst, San Diego, CA 92161 USA; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; Asahikawa Med Coll, Dept Med, Asahikawa, Hokkaido 0788510, Japan; INSERM, U563, F-31000 Toulouse, France; Univ Toulouse 3, F-31000 Toulouse, France; CHU Toulouse, Dept Genet, F-31000 Toulouse, France	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Asahikawa Medical College; Asahikawa Medical College; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rgallo@ucsd.edu	BONNART, Chrystelle/A-1309-2011; di nardo, anna/AAI-1629-2020; Gallo, Richard L/A-8931-2009; Yamasaki, Kenshi/C-8905-2018; Hovnanian, Alain/I-4711-2017	di nardo, anna/0000-0002-5575-9968; Gallo, Richard L/0000-0002-1401-7861; Yamasaki, Kenshi/0000-0002-5495-4956; Hovnanian, Alain/0000-0003-3412-7512; Coda, Alvin/0000-0002-8509-8590	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045676] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI052453] Funding Source: Medline; NIAMS NIH HHS [R01-AR45676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Acharya MR, 2004, DRUG RESIST UPDATE, V7, P195, DOI 10.1016/j.drup.2004.04.002; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; BRINNEL H, 1989, ARCH DERMATOL RES, V281, P66, DOI 10.1007/BF00424276; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Crawford GH, 2004, J AM ACAD DERMATOL, V51, P327, DOI 10.1016/j.jaad.2004.03.030; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; KELLY AP, 1996, PINCIPLES PRACTICE D; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; STRAUS J, 1991, DERMATOLOGY, P337; van Dijk A, 2005, VET IMMUNOL IMMUNOP, V106, P321, DOI 10.1016/j.vetimm.2005.03.003; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	30	526	579	5	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					975	980		10.1038/nm1616	http://dx.doi.org/10.1038/nm1616			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17676051				2022-12-25	WOS:000248674600029
J	Goga, A; Yang, D; Tward, AD; Morgan, DO; Bishop, JM				Goga, Andrei; Yang, Dun; Tward, Aaron D.; Morgan, David O.; Bishop, J. Michael			Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC	NATURE MEDICINE			English	Article							CELL-CYCLE PROGRESSION; C-MYC; MITOCHONDRIAL APOPTOSIS; CYTOCHROME-C; N-MYC; SURVIVIN; PATHWAY; CANCER; MUTANT; CHECKPOINT	Tumor cells have a dysregulated cell cycle that may render their proliferation especially sensitive to the inhibition of cyclin-dependent kinases (CDKs), important regulators of cell cycle progression. We examined the effects of CDK1 inhibition in the context of different oncogenic signals. Cells transformed with MYC, but not cells transformed by a panel of other activated oncogenes, rapidly underwent apoptosis when treated with small-molecule CDK1 inhibitors. The inhibitor of apoptosis protein BIRC5 (survivin), a known CDK1 target, is required for the survival of cells over-expressing MYC. Inhibition of CDK1 rapidly downregulates survivin expression and induces MYC-dependent apoptosis. CDK1 inhibitor treatment of MYC-dependent mouse lymphoma and hepatoblastoma tumors decreased tumor growth and prolonged their survival. As there are no effective small-molecule inhibitors that selectively target the MYC pathway, we propose that CDK1 inhibition might therefore be useful in the treatment of human malignancies that overexpress MYC.	Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Goga, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	andrei.goga@ucsf.edu		Morgan, David/0000-0001-8753-4416	NCI NIH HHS [K08 CA104032] Funding Source: Medline; NIGMS NIH HHS [R01 GM069901, R01 GM69901] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA104032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi S, 2001, MOL CELL BIOL, V21, P4929, DOI 10.1128/MCB.21.15.4929-4937.2001; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AFAR DEH, 1994, SCIENCE, V264, P424, DOI 10.1126/science.8153630; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; DAVENPORT EA, 1988, ANTICANCER RES, V8, P959; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hirose Y, 2001, CANCER RES, V61, P5843; HOLLIS GF, 1988, MOL CELL BIOL, V8, P124, DOI 10.1128/MCB.8.1.124; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Klefstrom J, 2002, J BIOL CHEM, V277, P43224, DOI 10.1074/jbc.M206967200; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; MINEO C, 1986, EXP CELL RES, V167, P53, DOI 10.1016/0014-4827(86)90203-X; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nesbit CE, 1998, CELL GROWTH DIFFER, V9, P731; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Schuldiner O, 2001, ONCOGENE, V20, P4984, DOI 10.1038/sj.onc.1204459; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shan B, 1996, CELL GROWTH DIFFER, V7, P689; SoferLevi Y, 1996, ONCOGENE, V13, P2431; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; VANROY FM, 1986, CANCER RES, V46, P4787; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	42	245	250	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2007	13	7					820	827		10.1038/nm1606	http://dx.doi.org/10.1038/nm1606			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17589519				2022-12-25	WOS:000247902800028
J	Ju, ZY; Jiang, H; Jaworski, M; Rathinam, C; Gompf, A; Klein, C; Trumpp, A; Rudolph, KL				Ju, Zhenyu; Jiang, Hong; Jaworski, Maike; Rathinam, Chozhavendan; Gompf, Anne; Klein, Christoph; Trumpp, Andreas; Rudolph, K. Lenhard			Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment	NATURE MEDICINE			English	Article							BONE-MARROW; LIFE-SPAN; B-CELL; MICE; PROGENITOR; CANCER; LONGEVITY	Cell-intrinsic checkpoints limit the proliferative capacity of primary cells in response to telomere dysfunction. It is not known, however, whether telomere dysfunction contributes to cell-extrinsic alterations that impair stem cell function and organ homeostasis. Here we show that telomere dysfunction provokes defects of the hematopoietic environment that impair B lymphopoiesis but increase myeloid proliferation in aging telomerase knockout (Terc(-/-)) mice. Moreover, the dysfunctional environment limited the engraftment of transplanted wild-type hematopoietic stem cells (HSCs). Dysfunction of the hematopoietic environment was age dependent and correlated with progressive telomere shortening in bone marrow stromal cells. Telomere dysfunction impaired mesenchymal progenitor cell function, reduced the capacity of bone marrow stromal cells to maintain functional HSCs, and increased the expression of various cytokines, including granulocyte colony-stimulating factor (G-CSF), in the plasma of aging mice. Administration of G-CSF to wild-type mice mimicked some of the defects seen in aging Terc(-/)-mice, including impairment of B lymphopoiesis and HSC engraftment. Conversely, inhibition of G-CSF improved HSC engraftment in aged Terc(-/)-mice. Taken together, these results show that telomere dysfunction induces alterations of the environment that can have implications for organismal aging and cell transplantation therapies.	Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; Ecole Polytech Fed Lausanne, Genet & Stem Cell Lab, Swiss Inst Expt Canc Res, ISREC,Sch Life Sci, CH-1015 Lausanne, Switzerland; Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany	Hannover Medical School; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Hannover Medical School	Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	rudolph.lenhard@MH-Hannover.de	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Rudolph, Karl Lenhard/0000-0002-4839-2862				Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Caruso C, 2004, ANN NY ACAD SCI, V1028, P1, DOI 10.1196/annals.1322.001; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Davis T, 2006, REJUV RES, V9, P402, DOI 10.1089/rej.2006.9.402; Djojosubroto MW, 2003, MOL CELLS, V15, P164; DRIZE N, 1993, EXP HEMATOL, V21, P1289; Hardy Richard R, 2004, Methods Mol Biol, V271, P1; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; HORNSBY PJ, 2003, METH MOL B, V240, P147; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; Min HY, 2005, IMMUNOL REV, V205, P7, DOI 10.1111/j.0105-2896.2005.00263.x; NEBEN S, 1993, BLOOD, V81, P1960; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Saba H I, 2001, Cancer Control, V8, P79; Shay JW, 2000, NAT BIOTECHNOL, V18, P22, DOI 10.1038/71872; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; ZATZ MM, 1985, GERONTOLOGY, V31, P263, DOI 10.1159/000212709	30	207	220	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					742	747		10.1038/nm1578	http://dx.doi.org/10.1038/nm1578			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17486088				2022-12-25	WOS:000247084300039
J	Sarkar, S; Perlstein, EO; Imarisio, S; Pineau, S; Cordenier, A; Maglathlin, RL; Webster, JA; Lewis, TA; O'Kane, CJ; Schreiber, SL; Rubinsztein, DC				Sarkar, Sovan; Perlstein, Ethan O.; Imarisio, Sara; Pineau, Sandra; Cordenier, Axelle; Maglathlin, Rebecca L.; Webster, John A.; Lewis, Timothy A.; O'Kane, Cahir J.; Schreiber, Stuart L.; Rubinsztein, David C.			Small molecules enhance autophagy and reduce toxicity in Huntington's disease models	NATURE CHEMICAL BIOLOGY			English	Article							AGGREGATE-PRONE PROTEINS; ALPHA-SYNUCLEIN; CELLS; POLYGLUTAMINE; DEGRADATION; INHIBITION; DROSOPHILA; EXPANSIONS; PROTEASOME; PATHWAY	The target of rapamycin proteins regulate various cellular processes including autophagy, which may play a protective role in certain neurodegenerative and infectious diseases. Here we show that a primary small-molecule screen in yeast yields novel small-molecule modulators of mammalian autophagy. We first identified new small-molecule enhancers (SMER) and inhibitors (SMIR) of the cytostatic effects of rapamycin in Saccharomyces cerevisiae. Three SMERs induced autophagy independently of rapamycin in mammalian cells, enhancing the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein, which are associated with Huntington's disease and familial Parkinson's disease, respectively. These SMERs, which seem to act either independently or downstream of the target of rapamycin, attenuated mutant huntingtin-fragment toxicity in Huntington's disease cell and Drosophila melanogaster models, which suggests therapeutic potential. We also screened structural analogs of these SMERs and identified additional candidate drugs that enhanced autophagy substrate clearance. Thus, we have demonstrated proof of principle for a new approach for discovery of small-molecule modulators of mammalian autophagy.	Broad Inst Harvard & MIT, Howard Hughes Med Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Med Genet, Addenbrookes Hosp, Inst Med Res, Cambridge CB2 2XY, England; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University	Schreiber, SL (corresponding author), Broad Inst Harvard & MIT, Howard Hughes Med Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA.	stuart_schreiber@harvard.edu; dcr1000@cam.ac.uk	O'Kane, Cahir/Q-6681-2019; Rubinsztein, David C/C-3472-2011; Sarkar, Sovan/F-8486-2017; O'Kane, Cahir J/C-4413-2011	O'Kane, Cahir/0000-0002-3488-2078; Sarkar, Sovan/0000-0002-9456-4362; Lewis, Timothy/0000-0001-9748-9575; Perlstein, Ethan/0000-0002-4734-4391	Medical Research Council [G0600194(77639), G0600194] Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline; Wellcome Trust [064354] Funding Source: Medline; MRC [G0600194] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Franceschini N., 1972, INFORMATION PROCESSI, P75; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	29	477	498	2	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2007	3	6					331	338		10.1038/nchembio883	http://dx.doi.org/10.1038/nchembio883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172PN	17486044	Green Accepted			2022-12-25	WOS:000246816400012
J	Berdeaux, R; Goebel, N; Banaszynski, L; Takemori, H; Wandless, T; Shelton, GD; Montminy, M				Berdeaux, Rebecca; Goebel, Naomi; Banaszynski, Laura; Takemori, Hiroshi; Wandless, Thomas; Shelton, G. Diane; Montminy, Marc			SIK1 is a class IIHDAC kinase that promotes survival of skeletal myocytes	NATURE MEDICINE			English	Article							ELEMENT-BINDING PROTEIN; CREB COACTIVATOR TORC2; TRANSCRIPTION FACTOR; MICE LACKING; NUCLEAR EXPORT; MUSCLE; GENE; PHOSPHORYLATION; CAMP; ACTIVATION	During physical exercise, increases in motor neuron activity stimulate the expression of muscle-specific genes through the myocyte enhancer factor 2 (MEF2) family of transcription factors. Elevations in intracellular calcium increase MEF2 activity via the phosphorylation-dependent inactivation of class II histone deacetylases (HDACs). In studies to determine the role of the cAMP responsive element binding protein (CREB) in skeletal muscle, we found that mice expressing a dominant-negative CREB transgene (M-ACREB mice) exhibited a dystrophic phenotype along with reduced MEF2 activity. Class II HDAC phosphorylation was decreased in M-ACREB myofibers due to a reduction in amounts of Snf1lk (encoding salt inducible kinase, SIK1), a CREB target gene that functions as a class II HDAC kinase. Inhibiting class II HDAC activity either by viral expression of Snf1lk or by the administration of a small molecule antagonist improved the dystrophic phenotype in M-ACREB mice, pointing to an important role for the SIK1-HDAC pathway in regulating muscle function.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Stanford Univ, Stanford, CA 94305 USA; Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Salk Institute; Stanford University; National Institute of Health Sciences - Japan; University of California System; University of California San Diego	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Banaszynski, Laura/B-9612-2009	Berdeaux, Rebecca/0000-0002-9929-1711	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070502] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK070502, F32 DK070502-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dubowitz V, 1985, MUSCLE BIOPSY PRACTI, P19; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LI H, 1993, NUCLEIC ACIDS RES, V21, P335, DOI 10.1093/nar/21.2.335; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mikkelsen UR, 2006, AM J PHYSIOL-REG I, V290, pR265, DOI 10.1152/ajpregu.00392.2005; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Talanian JL, 2006, AM J PHYSIOL-REG I, V291, pR1094, DOI 10.1152/ajpregu.00130.2006; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	41	210	224	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					597	603		10.1038/nm1573	http://dx.doi.org/10.1038/nm1573			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17468767				2022-12-25	WOS:000246302800027
J	Lee, SH; Goswami, S; Grudo, A; Song, LZ; Bandi, V; Goodnight-White, S; Green, L; Hacken-Bitar, J; Huh, J; Bakaeen, F; Coxson, HO; Cogswell, S; Storness-Bliss, C; Corry, DB; Kheradmand, F				Lee, Seung-Hyo; Goswami, Sangeeta; Grudo, Ariel; Song, Li-zhen; Bandi, Venkata; Goodnight-White, Sheila; Green, Linda; Hacken-Bitar, Joan; Huh, Joseph; Bakaeen, Faisal; Coxson, Harvey O.; Cogswell, Sebastian; Storness-Bliss, Claudine; Corry, David B.; Kheradmand, Farrah			Antielastin autoimmunity in tobacco smoking-induced emphysema	NATURE MEDICINE			English	Article							DISEASE; ELASTIN; AIRWAYS; HEALTH	Chronic obstructive pulmonary disease and emphysema are common destructive inflammatory diseases that are leading causes of death worldwide. Here we show that emphysema is an autoimmune disease characterized by the presence of antielastin antibody and T-helper type 1 (T(H)1) responses, which correlate with emphysema severity. These findings link emphysema to adaptive immunity against a specific lung antigen and suggest the potential for autoimmune pathology of other elastin-rich tissues such as the arteries and skin of smokers.	Baylor Coll Med, Dept Med, Sect Pulm & Crit Care, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Dept Pathol, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Dept Radiol, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; Vancouver Gen Hosp, Dept Radiol, Vancouver, BC V6Z 1Y6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of British Columbia	Kheradmand, F (corresponding author), Baylor Coll Med, Dept Med, Sect Pulm & Crit Care, Houston, TX 77030 USA.	dcorry@bcm.tmc.edu; farrahk@bcm.tmc.edu	Coxson, Harvey O/A-9861-2017; Lee, Seung-Hyo/B-9922-2015; Lee, Seung Hyo/C-1689-2011	Coxson, Harvey O/0000-0001-5750-9711; Lee, Seung-Hyo/0000-0003-0010-4072; Goswami, Sangeeta/0000-0001-9201-4503				Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Cosio MG, 1999, AM J RESP CRIT CARE, V160, pS21, DOI 10.1164/ajrccm.160.supplement_1.7; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DeMeo DL, 2004, AM J RESP CRIT CARE, V170, P1294, DOI 10.1164/rccm.200404-524OC; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Pepine CJ, 2006, J AM COLL CARDIOL, V47, P547, DOI 10.1016/j.jacc.2005.09.031; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356	15	391	435	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					567	569		10.1038/nm1583	http://dx.doi.org/10.1038/nm1583			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17450149				2022-12-25	WOS:000246302800023
J	Sakuma, R; Noser, JA; Ohmine, S; Ikeda, Y				Sakuma, Ryuta; Noser, Josh A.; Ohmine, Seiga; Ikeda, Yasuhiro			Rhesus monkey TRIM5 alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS MOLECULAR CLONE; RETROVIRUS RESTRICTION; CELL TROPISM; OLD-WORLD; GENE; PROTEIN; REPLICATION; GENERATION; MUTANT	Mammalian cells have developed diverse strategies to restrict retroviral infection(1-5). Retroviruses have therefore evolved to counteract such restriction factors, in order to colonize their hosts(4,6). Tripartite motif-containing 5 isoform-alpha (TRIM5 alpha) protein from rhesus monkey (TRIM5 alpha rh) restricts human immunodeficiency virus type 1 (HIV-1) infection at a postentry, preintegration stage in the viral life cycle, by recognizing the incoming capsid and promoting its premature disassembly(7,8). TRIM5 alpha comprises an RBCC (RING, B-box 2 and coiled-coil motifs) domain and a B30.2(SPRY) domain. Sequences in the B30.2( SPRY) domain dictate the potency and specificity of the restriction(8-11). As TRIM5 alpha rh targets incoming mature HIV-1 capsid, but not precursor Gag(12), it was assumed that TRIM5 alpha rh did not affect HIV-1 production. Here we provide evidence that TRIM5 alpha rh, but not its human ortholog (TRIM5 alpha hu), blocks HIV-1 production through rapid degradation of HIV-1 Gag polyproteins. The specificity for this restriction is determined by sequences in the RBCC domain. Our observations suggest that TRIM5 alpha rh interacts with HIV-1 Gag during or before Gag assembly through a mechanism distinct from the well-characterized postentry restriction. This finding demonstrates a cellular factor blocking HIV-1 production by actively degrading a viral protein. Further understanding of this previously unknown restriction mechanism may reveal new targets for future anti-HIV-1 therapy.	Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Ikeda, Y (corresponding author), Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu	Liu, FL/D-1795-2009					ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; Ikeda Y, 2003, NAT BIOTECHNOL, V21, P569, DOI 10.1038/nbt815; Kamada K, 2006, P NATL ACAD SCI USA, V103, P16959, DOI 10.1073/pnas.0608289103; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; LUCIW PA, 1992, AIDS RES HUM RETROV, V8, P395, DOI 10.1089/aid.1992.8.395; Morner A, 1999, J VIROL, V73, P2343; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TAKEUCHI Y, 1991, J VIROL, V65, P1710, DOI 10.1128/JVI.65.4.1710-1718.1991; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	30	86	95	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2007	13	5					631	635		10.1038/nm1562	http://dx.doi.org/10.1038/nm1562			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17435772				2022-12-25	WOS:000246302800032
J	Collis, SJ; Barber, LJ; Clark, AJ; Martin, JS; Ward, JD; Boulton, SJ				Collis, Spencer J.; Barber, Louise J.; Clark, Allison J.; Martin, Julie S.; Ward, Jordan D.; Boulton, Simon J.			HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE-RESPONSE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPLICATION STRESS; STRAND BREAKS; CAENORHABDITIS-ELEGANS; TUMOR SUPPRESSION; GENOME INTEGRITY; GENOTOXIC STRESS; CLOCK GENES	Here, we show that the human homologue of the Caenorhabditis elegans biological clock protein CLK-2 (HCLK2) associates with the S-phase checkpoint components ATR, ATRIP, claspin and Chk1. Consistent with a critical role in the S-phase checkpoint, HCLK2-depleted cells accumulate spontaneous DNA damage in S-phase, exhibit radio-resistant DNA synthesis, are impaired for damage-induced monoubiquitination of FANCD2 and fail to recruit FANCD2 and Rad51 (critical components of the Fanconi anaemia and homologous recombination pathways, respectively) to sites of replication stress. Although Thr 68 phosphorylation of the checkpoint effector kinase Chk2 remains intact in the absence of HCLK2, claspin phosphorylation and degradation of the checkpoint phosphatase Cdc25A are compromised following replication stress as a result of accelerated Chk1 degradation. ATR phosphorylation is known to both activate Chk1 and target it for proteolytic degradation, and depleting ATR or mutation of Chk1 at Ser 345 restored Chk1 protein levels in HCLK2-depleted cells. We conclude that HCLK2 promotes activation of the S-phase checkpoint and downstream repair responses by preventing unscheduled Chk1 degradation by the proteasome.	London Res Inst, DNA Damage Res Lab, Potters Bar EN6 3LD, Herts, England		Boulton, SJ (corresponding author), London Res Inst, DNA Damage Res Lab, Potters Bar EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Ward, Jordan/H-3444-2019; Barber, Louise J./L-8579-2019	Ward, Jordan/0000-0001-9870-8936; Barber, Louise J./0000-0001-9265-3516; Collis, Spencer/0000-0002-7874-1891	Breast Cancer Now [2003:569] Funding Source: Medline	Breast Cancer Now		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Jaspers Nicolaas G J, 2006, Methods Mol Biol, V314, P51; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; WANG X, 2007, MOL CELL BIOL; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	103	103	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					391	U62		10.1038/ncb1555	http://dx.doi.org/10.1038/ncb1555			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17384638	Green Published			2022-12-25	WOS:000245359400010
J	Jancic, C; Savina, A; Wasmeier, C; Tolmachova, T; El-Benna, J; Dang, PMC; Pascolo, S; Gougerot-Pocidalo, MA; Raposo, G; Seabra, MC; Amigorena, S				Jancic, Carolina; Savina, Ariel; Wasmeier, Christina; Tolmachova, Tanya; El-Benna, Jamel; Dang, Pham My-Chan; Pascolo, Steve; Gougerot-Pocidalo, Maire-Anne; Raposo, Graca; Seabra, Miguel C.; Amigorena, Sebastian			Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes	NATURE CELL BIOLOGY			English	Article							CROSS-PRESENTATION; ANTIGEN; COMPARTMENT; MELANOSOMES; LYSOSOMES; EFFECTOR; IMMUNITY; BURST	To prevent excessive degradation of internalized antigens, which could destroy the peptides recognized by T lymphocytes, dendritic cells have developed several strategies that limit proteolytic activity in phagosomes. The recruitment of the NADPH oxidase NOX2 prevents acidification of phagosomes, limiting antigen degradation. Here, we show that dendritic cells derived from Rab27a-deficient ashen mice show increased phagosome acidification and antigen degradation, causing a defect in antigen cross-presentation. Enhanced acidification results from a delay in the recruitment to phagosomes of a subset of lysosome-related organelles containing the membrane subunits of NOX2. The Rab27a-dependent recruitment of these "inhibitory lysosome-related organelles" to phagosomes continuously limits acidification and degradation of ingested particles in dendritic cells, thus promoting antigen cross-presentation.	INSERM, U653, Inst Curie, Paris 05, France; Univ London Imperial Coll Sci Technol & Med, NHLI, London SW7 2AZ, England; Univ Paris 07, INSERM, U773, CRB3,UMRS 773, F-75018 Paris, France; Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany; CNRS, Inst Curie, UMR144, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Amigorena, S (corresponding author), INSERM, U653, Inst Curie, 26 Rue Ulm, Paris 05, France.	sebastian.amigorena@curie.fr	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019	Seabra, Miguel C/0000-0002-6404-4892; Amigorena, Sebastian/0000-0001-8583-8416; Tolmachova, Tanya/0000-0002-8841-0797; Raposo, graca/0000-0001-9590-1298	MRC [G9805886] Funding Source: UKRI; Medical Research Council [G9805886] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; CALAFAT J, 1993, BLOOD, V81, P3122; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; RAPOSO G, 1997, HDB EXP IMMUNOL, V208, P1; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	27	178	181	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					367	U29		10.1038/ncb1552	http://dx.doi.org/10.1038/ncb1552			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351642				2022-12-25	WOS:000245359400008
J	Brunham, LR; Kruit, JK; Pape, TD; Timmins, JM; Reuwer, AQ; Vasanji, Z; Marsh, BJ; Rodrigues, B; Johnson, JD; Parks, JS; Verchere, CB; Hayden, MR				Brunham, Liam R.; Kruit, Janine K.; Pape, Terry D.; Timmins, Jenelle M.; Reuwer, Anne Q.; Vasanji, Zainisha; Marsh, Brad J.; Rodrigues, Brian; Johnson, James D.; Parks, John S.; Verchere, C. Bruce; Hayden, Michael R.			beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment	NATURE MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; LIPID-ACCUMULATION; HDL CHOLESTEROL; FATTY-ACIDS; EXOCYTOSIS; APOPTOSIS; PATHWAY; BINDING; MICE	Type 2 diabetes is characterized by both peripheral insulin resistance and reduced insulin secretion by beta-cells. The reasons for beta-cell dysfunction in this disease are incompletely understood but may include the accumulation of toxic lipids within this cell type. We examined the role of Abca1, a cellular cholesterol transporter, in cholesterol homeostasis and insulin secretion in beta-cells. Mice with specific inactivation of Abca1 in beta-cells had markedly impaired glucose tolerance and defective insulin secretion but normal insulin sensitivity. Islets isolated from these mice showed altered cholesterol homeostasis and impaired insulin secretion in vitro. We found that rosiglitazone, an activator of the peroxisome proliferator-activated receptor-gamma, which upregulates Abca1 in beta-cells, requires beta-cell Abca1 for its beneficial effects on glucose tolerance. These experiments establish a new role for Abca1 in beta-cell cholesterol homeostasis and insulin secretion, and suggest that cholesterol accumulation may contribute to beta-cell dysfunction in type 2 diabetes.	Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Wake Forest Univ, Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z4, Canada	Child & Family Research Institute; University of British Columbia; Wake Forest University; Child & Family Research Institute; University of British Columbia; University of Queensland; University of British Columbia	Verchere, CB (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	verchere@interchange.ubc.ca; mrh@cmmt.ubc.ca	Marsh, Brad/A-4981-2008; Hayden, Michael R/D-8581-2011; Kruit, Janine/AGI-8582-2022	Hayden, Michael R/0000-0001-5159-1419; Kruit, Janine/0000-0002-5414-0485; Rodrigues, Brian/0000-0002-0129-4261; Johnson, James/0000-0002-7523-9433; Maijer-Reuwer, Anne/0000-0003-3016-5749	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 49373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Cavaghan MK, 1997, J CLIN INVEST, V100, P530, DOI 10.1172/JCI119562; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Cnop M, 2000, AM J PATHOL, V156, P237, DOI 10.1016/S0002-9440(10)64724-4; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Daimon M, 2005, BIOCHEM BIOPH RES CO, V329, P205, DOI 10.1016/j.bbrc.2005.01.119; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grupping AY, 1997, ENDOCRINOLOGY, V138, P4064, DOI 10.1210/en.138.10.4064; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Oram JF, 2001, J LIPID RES, V42, P1173; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Ruan XZ, 2003, J AM SOC NEPHROL, V14, P593, DOI 10.1097/01.ASN.0000050414.52908.DA; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	39	317	326	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2007	13	3					340	347		10.1038/nm1546	http://dx.doi.org/10.1038/nm1546			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17322896				2022-12-25	WOS:000244715700047
J	Linares, LK; Kiernan, R; Triboulet, R; Chable-Bessia, C; Latreille, D; Cuvier, O; Lacroix, M; Le Cam, L; Coux, O; Benkirane, M				Linares, Laetitia K.; Kiernan, Rosemary; Triboulet, Robinson; Chable-Bessia, Christine; Latreille, Daniel; Cuvier, Olivier; Lacroix, Matthieu; Le Cam, Laurent; Coux, Olivier; Benkirane, Monsef			Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; P53 ACTIVATION; MDM2; DEGRADATION; ACETYLATION; LIGASE; DOMAINS; SYSTEM; CELLS; P300	The p300-CBP-associated factor ( PCAF) is a histone acetyltransferase ( HAT) involved in the reversible acetylation of various transcriptional regulators(1), including the tumour suppressor p53. It is implicated in many cellular processes, such as transcription, differentiation, proliferation and apoptosis. We observed that knockdown of PCAF expression in HeLa or U2OS cell lines induces stabilization of the oncoprotein Hdm2, a RING finger E3 ligase primarily known for its role in controlling p53 stability(2,3). To investigate the molecular basis of this effect, we examined whether PCAF is involved in Hdm2 ubiquitination. Here, we show that PCAF, in addition to its acetyltransferase activity, possesses an intrinsic ubiquitination activity that is critical for controlling Hdm2 expression levels, and thus p53 functions. Our data highlight a regulatory crosstalk between PCAF and Hdm2 activities, which is likely to have a central role in the subtle control of p53 activity after DNA damage.	UNII, Ctr Rech Biochim Macromol, CNRS, UMR5237, Montpellier, France; CNRS, UPR1142, Mol Virol Lab, Inst Genet Humaine, Montpellier, France; CNRS, UPR1142, Lab Dynam Genome & Dev, Inst Genet Humaine, Montpellier, France; UNII, Inst Genet Mol Montpellier, CNRS, UMR5535, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Coux, O (corresponding author), UNII, Ctr Rech Biochim Macromol, CNRS, UMR5237, Montpellier, France.	olivier.coux@crbm.cnrs.fr; monsef.benkirane@igh.cnrs.fr	Linares, Laetitia LKL/F-9901-2018; Kiernan, Rosemary/GXV-8695-2022; Coux, Olivier/P-6847-2019; Coux, Olivier/B-3406-2010; Cuvier, Olivier/ADO-0657-2022; CUVIER, Olivier/AAC-4693-2019; Le Cam, Laurent/O-1408-2016; Lacroix, Matthieu/O-1928-2018	Linares, Laetitia LKL/0000-0003-1661-2119; Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849; CUVIER, Olivier/0000-0003-0644-2734; Lacroix, Matthieu/0000-0002-1268-9058; Kiernan, Rosemary/0000-0001-6645-0686; LE CAM, Laurent/0000-0003-0325-878X				Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bres V, 2002, EMBO J, V21, P6811, DOI 10.1093/emboj/cdf669; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Robinson PA, 2004, J CELL SCI, V117, P5191, DOI 10.1242/jcs.01539; SCHILTZ RL, 2000, BIOCHIM BIOPHYS ACTA, V1470, P37; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun Xiu Zhu, 2003, Methods Mol Biol, V234, P17; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103	31	137	146	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					331	U153		10.1038/ncb1545	http://dx.doi.org/10.1038/ncb1545			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293853				2022-12-25	WOS:000244558600018
J	Liang, Y; Jansen, M; Aronow, B; Geiger, H; Van Zant, G				Liang, Ying; Jansen, Michael; Aronow, Bruce; Geiger, Hartmut; Van Zant, Gary			The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice	NATURE GENETICS			English	Article							MAMMALIAN CARBOXYPEPTIDASE INHIBITOR; TAZAROTENE-INDUCED GENE-1; RETINOID RESPONSE GENE; IN-VIVO; REGIONAL SPECIFICATION; PROGENITOR CELLS; LIFE-SPAN; EXPRESSION; TIG1; FREQUENCY	We mapped quantitative trait loci that accounted for the variation in hematopoietic stem cell ( HSC) numbers between young adult C57BL/6 ( B6) and DBA/ 2 ( D2) mice. In reciprocal chromosome 3 congenic mice, introgressed D2 alleles increased HSC numbers owing to enhanced proliferation and self-renewal and reduced apoptosis, whereas B6 alleles had the opposite effects. Using oligonucleotide arrays, real-time PCR and protein blots, we identified latexin ( Lxn), a gene whose differential transcription and expression was associated with the allelic differences. Expression was inversely correlated with the number of HSCs; therefore, ectopic expression of Lxn using a retroviral vector decreased stem cell population size. We identified clusters of SNPs upstream of the Lxn transcriptional start site, at least two of which are associated with potential binding sites for transcription factors regulating stem cells. Thus, promoter polymorphisms between the B6 and D2 alleles may affect Lxn gene expression and consequently influence the population size of hematopoietic stem cells.	Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Expt Hematol, Cincinnati, OH 45229 USA	University of Kentucky; University of Kentucky; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Van Zant, G (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA.	gvzant1@uky.edu	Aronow, Bruce J/F-8438-2012		NIA NIH HHS [AG024950, AG022859, AG020917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024950, R01AG022859, R01AG020917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; ARIMATSU Y, 1994, J NEUROSCI, V14, P2020; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; ARIMATSU Y, 1994, NEUROSCI RES, V20, P131, DOI 10.1016/0168-0102(94)90030-2; BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; CALLAHAN G, 1999, FASEB J, pF637; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Henckaerts E, 2002, BLOOD, V99, P3947, DOI 10.1182/blood.V99.11.3947; Jin MH, 1997, GENOMICS, V39, P419, DOI 10.1006/geno.1996.4469; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Liang Y, 2003, CURR OPIN HEMATOL, V10, P195, DOI 10.1097/00062752-200305000-00001; Liu Q, 2000, MOL BIOL REP, V27, P241, DOI 10.1023/A:1010971219806; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; VANDERSLUIJS JP, 1990, EXP HEMATOL, V18, P893; VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	42	77	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					178	188		10.1038/ng1938	http://dx.doi.org/10.1038/ng1938			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220891				2022-12-25	WOS:000244063900015
J	Passador-Gurgel, G; Hsieh, WP; Hunt, P; Deighton, N; Gibson, G				Passador-Gurgel, Gisele; Hsieh, Wen-Ping; Hunt, Priscilla; Deighton, Nigel; Gibson, Greg			Quantitative trait transcripts for nicotine resistance in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; EXPRESSION DATA; EGFR; GLUTAMATE; CAFFEINE; LINDANE; PATHWAY; MODELS; NUMBER; GABA	Although most genetic association studies are performed with the intention of detecting nucleotide polymorphisms that are correlated with a complex trait, transcript abundance should also be expected to associate with diseases or phenotypes. We performed a scan for such quantitative trait transcripts in adult female heads of the fruit fly ( Drosophila melanogaster) that might explain variation for nicotine resistance. The strongest association was seen for abundance of ornithine aminotransferase transcripts, implicating detoxification and neurotransmitter biosynthesis as mediators of the quantitative response to the drug. Subsequently, genetic analysis and metabolite profiling confirmed a complex role for ornithine and GABA levels in modification of survival time upon chronic nicotine exposure. Differences between populations from North Carolina and California suggest that the resistance mechanism may be an evolved response to environmental exposure.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Natl Tsing Hua Univ, Dept Stat, Hsinchu 30013, Taiwan; N Carolina State Univ, Metabolom & Proteom Lab, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; National Tsing Hua University; University of North Carolina; North Carolina State University	Gibson, G (corresponding author), N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA.	ggibson@ncsu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01-GM45344] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beleboni RO, 2004, CELL MOL NEUROBIOL, V24, P707, DOI 10.1007/s10571-004-6913-z; Carrillo R, 2002, GENET RES, V80, P205, DOI 10.1017/S0016672302005888; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; COHEN C, 1991, PHARMACOL BIOCHEM BE, V40, P121, DOI 10.1016/0091-3057(91)90331-U; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Palsson A, 2004, GENETICS, V167, P1199, DOI 10.1534/genetics.104.026252; Palsson A, 2004, GENETICS, V167, P1187, DOI 10.1534/genetics.103.021766; Parmar D, 2003, FOOD CHEM TOXICOL, V41, P1077, DOI 10.1016/S0278-6915(03)00045-0; Seiler Nikolaus, 2000, Current Drug Targets, V1, P119, DOI 10.2174/1389450003349254; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Vale C, 1998, J NEUROSCI RES, V52, P276, DOI 10.1002/(SICI)1097-4547(19980501)52:3<276::AID-JNR4>3.0.CO;2-A; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang HP, 2003, MOL BIOL EVOL, V20, P800, DOI 10.1093/molbev/msg087; YONEDA Y, 1982, J NEUROCHEM, V38, P1686, DOI 10.1111/j.1471-4159.1982.tb06650.x	27	59	60	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					264	268		10.1038/ng1944	http://dx.doi.org/10.1038/ng1944			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237783				2022-12-25	WOS:000244063900027
J	Lacefield, S; Murray, AW				Lacefield, Soni; Murray, Andrew W.			The spindle checkpoint rescues the meiotic segregation of chromosomes whose crossovers are far from the centromere	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MEIOSIS-I; YEAST; RECOMBINATION; NONDISJUNCTION; PROGRESSION; DIVERSITY; SPO11P; MAD2	Improper meiotic chromosome segregation causes conditions such as Down's syndrome(1). Recombination promotes proper chromosome segregation in meiosis I; chromosomes without crossovers near the centromere are more likely to segregate to the same spindle pole (nondisjoin). Here we have used budding yeast to determine whether the spindle checkpoint promotes segregation of such chromosomes. In checkpoint-defective mad2 Delta cells, properly segregating chromosomes have more crossovers near the centromere than their wild-type counterparts, and an artificial tether that holds chromosomes together suppresses nondisjunction as long as the tether is near the centromere. The tether partially rescues the segregation of chromosomes that lack crossovers.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Lacefield, S (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divinity Ave, Cambridge, MA 02138 USA.	soni@mcb.harvard.edu	Grafström, Roland C/N-7217-2016		NIGMS NIH HHS [R37 GM043987, GM 055840] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043987] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Boumil RM, 2003, MOL GENET GENOMICS, V268, P750, DOI 10.1007/s00438-002-0796-9; Cha RS, 2000, GENE DEV, V14, P493; CHEN J, 1994, BIOCHEMISTRY-US, V33, P8728, DOI 10.1021/bi00195a014; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Gilliland WD, 2005, CURR BIOL, V15, P672; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; KABACK DB, 1989, P NATL ACAD SCI USA, V86, P3694, DOI 10.1073/pnas.86.10.3694; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; MORTIMER RK, 1989, YEAST, V5, P321, DOI 10.1002/yea.320050503; NICKLAS RB, 1967, CHROMOSOMA, V21, P17, DOI 10.1007/BF00330545; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Winzeler EA, 2003, GENETICS, V163, P79	30	43	43	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1273	1277		10.1038/ng2120	http://dx.doi.org/10.1038/ng2120			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828265				2022-12-25	WOS:000249737400025
J	Kuepfer, L; Peter, M; Sauer, U; Stelling, J				Kuepfer, Lars; Peter, Matthias; Sauer, Uwe; Stelling, Joerg			Ensemble modeling for analysis of cell signaling dynamics	NATURE BIOTECHNOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; TOR PROTEINS; SACCHAROMYCES-CEREVISIAE; NETWORKS; GROWTH; TAP42; ASSOCIATION; NITROGEN; YEAST; SIT4	Systems biology iteratively combines experimentation with mathematical modeling. However, limited mechanistic knowledge, conflicting hypotheses and scarce experimental data severely hamper the development of predictive mechanistic models in many areas of biology. Even under such high uncertainty, we show here that ensemble modeling, when combined with targeted experimental analysis, can unravel key operating principles in complex cellular pathways. For proof of concept, we develop a library of mechanistically alternative dynamic models for the highly conserved target-of-rapamycin ( TOR) pathway of Saccharomyces cerevisiae. In contrast to the prevailing view of a de novo assembly of type 2A phosphatases (PP2As), our integrated computational and experimental analysis proposes a specificity factor, based on Tap42p-Tip41p, for PP2As as the key signaling mechanism that is quantitatively consistent with all available experimental data. Beyond revising our picture of TOR signaling, we expect ensemble modeling to help elucidate other insufficiently characterized cellular circuits.	ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; ETH, Inst Mol Syst Biol, CH-8092 Zurich, Switzerland; ETH, Inst Biochem, CH-8092 Zurich, Switzerland; ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8092 Zurich, Switzerland; Bayer Technol Serv, D-51368 Leverkusen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Bayer AG	Stelling, J (corresponding author), ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland.	joerg.stelling@inf.ethz.ch	Sauer, Uwe/Y-3556-2019; Kuepfer, Lars/A-5762-2012; Stelling, Joerg/F-7499-2010; Kuepfer, Lars/F-5795-2012; Kuepfer, Lars/AAD-5884-2022	Stelling, Joerg/0000-0002-1145-891X; Kuepfer, Lars/0000-0002-8741-7786; Peter, Matthias/0000-0002-2160-6824				Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; CHWEFEL HP, 1995, EVOLUTION OPTIMUM SE; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Harlow E., 1988, ANTIBODIES LAB MANUA; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubner IA, 2005, P NATL ACAD SCI USA, V102, P18914, DOI 10.1073/pnas.0502181102; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; LI H, 2006, NATURE; Ljung L., 1999, SYSTEM IDENTIFICATIO; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Turkheimer FE, 2003, J CEREBR BLOOD F MET, V23, P490, DOI 10.1097/01.WCB.0000050065.57184.BB; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wahl SA, 2006, IEE P SYST BIOL, V153, P275, DOI 10.1049/ip-syb:20050089; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x	38	140	141	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1001	1006		10.1038/nbt1330	http://dx.doi.org/10.1038/nbt1330			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17846631				2022-12-25	WOS:000249444200023
J	Magalhaes, JV; Liu, J; Guimaraes, CT; Lana, UGP; Alves, VMC; Wang, YH; Schaffert, RE; Hoekenga, OA; Pineros, MA; Shaff, JE; Klein, PE; Carneiro, NP; Coelho, CM; Trick, HN; Kochian, LV				Magalhaes, Jurandir V.; Liu, Jiping; Guimaraes, Claudia T.; Lana, Ubiraci G. P.; Alves, Vera M. C.; Wang, Yi-Hong; Schaffert, Robert E.; Hoekenga, Owen A.; Pineros, Miguel A.; Shaff, Jon E.; Klein, Patricia E.; Carneiro, Newton P.; Coelho, Cintia M.; Trick, Harold N.; Kochian, Leon V.			A gene in the multidrug and toxic compound extrusion (MATE) family confers aluminum tolerance in sorghum	NATURE GENETICS			English	Article							EFFLUX; TRANSPORTER; CITRATE; MEMBER; PLANTS; ROOTS	Crop yields are significantly reduced by aluminum toxicity on highly acidic soils, which comprise up to 50% of the world's arable land(1-3). Candidate aluminum tolerance proteins include organic acid efflux transporters, with the organic acids forming non- toxic complexes with rhizosphere aluminum(1,4). In this study, we used positional cloning to identify the gene encoding a member of the multidrug and toxic compound extrusion ( MATE) family, an aluminum- activated citrate transporter, as responsible for the major sorghum ( Sorghum bicolor) aluminum tolerance locus, Alt(SB)(5). Polymorphisms in regulatory regions of AltSB are likely to contribute to large allelic effects, acting to increase AltSB expression in the root apex of tolerant genotypes. Furthermore, aluminum- inducible AltSB expression is associated with induction of aluminum tolerance via enhanced root citrate exudation. These findings will allow us to identify superior AltSB haplotypes that can be incorporated via molecular breeding and biotechnology into acid soil breeding programs, thus helping to increase crop yields in developing countries where acidic soils predominate.	Embrapa Maize & Sorghum, BR-35701970 Sete Lagoas, MG, Brazil; Cornell Univ, US Plant Soil & Nutr Lab, USDA ARS, Ithaca, NY 14853 USA; Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Kansas State University	Magalhaes, JV (corresponding author), Embrapa Maize & Sorghum, Rod Mg 424,Km 65, BR-35701970 Sete Lagoas, MG, Brazil.	jurandir@cnpms.embrapa.br; Leon.Kochian@ars.usda.gov	Magalhaes, Jurandir/AAH-4349-2020; Coelho, Cíntia M/M-9939-2017; Kochian, Leon/ABH-6148-2020	Magalhaes, Jurandir/0000-0002-6673-6497; Coelho, Cíntia M/0000-0002-8564-3587; Kochian, Leon/0000-0003-3416-089X; Hoekenga, Owen/0000-0003-4427-2000; LIU, JIPING/0000-0002-7558-0025; Pineros, Miguel/0000-0002-7166-1848; Trick, Harold/0000-0001-5255-5575				Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; MAGALHAES JV, 2003, THESIS CORNELL U; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nguyen VT, 2001, THEOR APPL GENET, V102, P1002, DOI 10.1007/s001220000472; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Raman H, 2005, GENOME, V48, P781, DOI 10.1139/g05-054; RYAN PR, 1993, J EXP BOT, V44, P437, DOI 10.1093/jxb/44.2.437; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Uhde-Stone C, 2005, PLANT J, V44, P840, DOI 10.1111/j.1365-313X.2005.02573.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; WOOD S, 2000, PILOT ANAL GLOB ECOS; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528	29	516	564	11	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1156	1161		10.1038/ng2074	http://dx.doi.org/10.1038/ng2074			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17721535				2022-12-25	WOS:000249122400028
J	Hsieh, PCH; Segers, VFM; Davis, ME; MacGillivray, C; Gannon, J; Molkentin, JD; Robbins, J; Lee, RT				Hsieh, Patrick C. H.; Segers, Vincent F. M.; Davis, Michael E.; MacGillivray, Catherine; Gannon, Joseph; Molkentin, Jeffery D.; Robbins, Jeffrey; Lee, Richard T.			Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury	NATURE MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-MUSCLE; BONE-MARROW; REGENERATION; MULTIPOTENT; PROTEIN	An emerging concept is that the mammalian myocardium has the potential to regenerate, but that regeneration might be too inefficient to repair the extensive myocardial injury that is typical of human disease(1-8). However, the degree to which stem cells or precursor cells contribute to the renewal of adult mammalian cardiomyocytes remains controversial. Here we report evidence that stem cells or precursor cells contribute to the replacement of adult mammalian cardiomyocytes after injury but do not contribute significantly to cardiomyocyte renewal during normal aging. We generated double-transgenic mice to track the fate of adult cardiomyocytes in a 'pulsechase' fashion: after a 4-OH-tamoxifen pulse, green fluorescent protein (GFP) expression was induced only in cardiomyocytes, with 82.7% of cardiomyocytes expressing GFP. During normal aging up to one year, the percentage of GFP(+) cardiomyocytes remained unchanged, indicating that stem or precursor cells did not refresh uninjured cardiomyocytes at a significant rate during this period of time. By contrast, after myocardial infarction or pressure overload, the percentage of GFP(+) cardiomyocytes decreased from 82.8% in heart tissue from sham-treated mice to 67.5% in areas bordering a myocardial infarction, 76.6% in areas away from a myocardial infarction, and 75.7% in hearts subjected to pressure overload, indicating that stem cells or precursor cells had refreshed the cardiomyocytes.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Cambridge, MA 02139 USA; Univ Cincinnati, Cincinnati Childrens Hosp, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Harvard University; Brigham & Women's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lee, RT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Cambridge, MA 02139 USA.	rlee@partners.org	Segers, Vincent F/J-1191-2019; Hsieh, Patrick Ching-Ho/H-5108-2015	Segers, Vincent F/0000-0001-7796-2222; Hsieh, Patrick C.H./0000-0002-8910-3596; Lee, Richard/0000-0003-4687-1381; Molkentin, Jeffery/0000-0002-3558-6529	NHLBI NIH HHS [F32 HL073574, F32 HL073574-03, R01 HL081404, R01HL081404] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL073574, R01HL081404] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oh H, 2004, ANN NY ACAD SCI, V1015, P182, DOI 10.1196/annals.1302.015; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326	15	563	585	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2007	13	8					970	974		10.1038/nm1618	http://dx.doi.org/10.1038/nm1618			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17660827	Green Accepted			2022-12-25	WOS:000248674600028
J	Katz, M; Amit, I; Citri, A; Shay, T; Carvalho, S; Lavi, S; Milanezi, F; Lyass, L; Amariglio, N; Jacob-Hirsch, J; Ben-Chetrit, N; Tarcic, G; Lindzen, M; Avraham, R; Liao, YC; Trusk, P; Lyass, A; Rechavi, G; Spector, NL; Lo, SH; Schmitt, F; Bacus, SS; Yarden, Y				Katz, Menachem; Amit, Ido; Citri, Ami; Shay, Tal; Carvalho, Silvia; Lavi, Sara; Milanezi, Fernanda; Lyass, Ljuba; Amariglio, Ninette; Jacob-Hirsch, Jasmine; Ben-Chetrit, Nir; Tarcic, Gabi; Lindzen, Moshit; Avraham, Roi; Liao, Yi-Chun; Trusk, Patricia; Lyass, Asya; Rechavi, Gideon; Spector, Neil L.; Lo, Su Hao; Schmitt, Fernando; Bacus, Sarah S.; Yarden, Yosef			A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA EXPRESSION; TUMOR PROGRESSION; GROWTH; TENSIN; CYTOSKELETON; PROTEIN; CTEN; ACTIVATION; INHIBITOR; DIVERSITY	Cell migration driven by the epidermal growth factor receptor ( EGFR) propels morphogenesis(1) and involves reorganization of the actin cytoskeleton(2). Although de novo transcription precedes migration(3,4), transcript identity remains largely unknown. Through their actin-binding domains, tensins link the cytoskeleton to integrin-based adhesion sites(5). Here we report that EGF downregulates tensin-3 expression, and concomitantly upregulates cten, a tensin family member that lacks the actin-binding domain(6). Knockdown of cten or tensin-3, respectively, impairs or enhances mammary cell migration. Furthermore, cten displaces tensin-3 from the cytoplasmic tail of integrin beta(1), thereby instigating actin fibre disassembly. In invasive breast cancer, cten expression correlates not only with high EGFR and HER2, but also with metastasis to lymph nodes. Moreover, treatment of inflammatory breast cancer patients with an EGFR/HER2 dual-specificity kinase inhibitor significantly downregulated cten expression. In conclusion, a transcriptional tensin-3-cten switch may contribute to the metastasis of mammary cancer.	Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; Targeted Mol Diagnost, Westmont, IL 60559 USA; Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Pediat Hemato Oncol & Funct Genom, IL-69978 Tel Aviv, Israel; Univ Calif Davis, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA; Boston Univ, Boston, MA 02215 USA; Univ GlaxosmithKline, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA; Boston Univ, Boston, MA 02215 USA; GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Univ Porto, Med Fac, P-4200465 Oporto, Portugal	Weizmann Institute of Science; Weizmann Institute of Science; Universidade do Porto; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Davis; Boston University; GlaxoSmithKline; Boston University; GlaxoSmithKline; Universidade do Porto	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012; Liao, Yi-Chun/H-2383-2014; Citri, Ami/R-8973-2019; Schmitt, Fernando/A-5270-2008; Hsiao, Wei-Hung/B-9931-2013; Shay, Tal/J-4028-2016	Citri, Ami/0000-0002-9914-0278; Schmitt, Fernando/0000-0002-3711-8681; Shay, Tal/0000-0003-0755-1350; Avraham, Roi/0000-0002-9098-3885; Schmitt, Fernando/0000-0003-1006-6946; Liao, Yi-Chun/0000-0002-0399-0201; Lo, Su Hao/0000-0002-2675-9387	NCI NIH HHS [CA72981, CA102537] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA102537, R01CA072981, R37CA072981, R01CA102537] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; ALLRED DC, 1992, J CLIN ONCOL, V10, P599, DOI 10.1200/JCO.1992.10.4.599; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Cui YM, 2004, MOL CANCER RES, V2, P225; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GORDON SR, 1990, CELL MOTIL CYTOSKEL, V16, P47, DOI 10.1002/cm.970160107; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kook S, 2003, BIOCHEM BIOPH RES CO, V303, P37, DOI 10.1016/S0006-291X(03)00280-8; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Manos EJ, 2001, ONCOGENE, V20, P2781, DOI 10.1038/sj.onc.1204379; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodrigue CM, 2005, ONCOGENE, V24, P3274, DOI 10.1038/sj.onc.1208485; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Wu Mei, 2005, Breast Dis, V22, P25; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	30	143	149	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					961	U124		10.1038/ncb1622	http://dx.doi.org/10.1038/ncb1622			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643115				2022-12-25	WOS:000248486700018
J	Kouznetsova, A; Lister, L; Nordenskjold, M; Herbert, M; Hoog, C				Kouznetsova, Anna; Lister, Lisa; Nordenskjold, Magnus; Herbert, Mary; Hoog, Christer			Bi-orientation of achiasmatic chromosomes in meiosis I oocytes contributes to aneuploidy in mice	NATURE GENETICS			English	Article							SPINDLE-CHECKPOINT; NONDISJUNCTION; ASSOCIATION; MECHANISM; TENSION; MAD2	The spindle assembly checkpoint guards against chromosomal missegregation but does not induce arrest in oocytes that contain a few achiasmatic chromosomes ( univalents). We followed the fate of univalents in oocytes during the first meiotic division, and although these preserved a meiotic kinetochore structure, they were also bi-oriented in a mitotic manner. The hybrid chromosomal configuration attained by univalents allows them to evade the spindle assembly checkpoint and contribute to aneuploidy in oocytes.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Univ Newcastle, Int Ctr Life, N E England Stem Cell Inst, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Solna, Sweden; Karolinska Univ Hosp, Ctr Mol Med, S-17176 Solna, Sweden	Karolinska Institutet; Newcastle University - UK; Newcastle University - UK; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hoog, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	christer.hoog@ki.se	Kouznetsova, Anna/AAF-2312-2019	Kouznetsova, Anna/0000-0001-9059-4567; Herbert, Mary/0000-0002-8488-2770; Nordenskjold, Magnus/0000-0002-4974-425X				Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Kallio M, 2000, DEV BIOL, V225, P112, DOI 10.1006/dbio.2000.9818; Kuliev A, 2004, HUM REPROD UPDATE, V10, P401, DOI 10.1093/humupd/dmh036; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	15	90	95	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					966	968		10.1038/ng2065	http://dx.doi.org/10.1038/ng2065			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618286				2022-12-25	WOS:000248446900012
J	Pandit, B; Sarkozy, A; Pennacchio, LA; Carta, C; Oishi, K; Martinelli, S; Pogna, EA; Schackwitz, W; Ustaszewska, A; Landstrom, A; Bos, JM; Ommen, SR; Esposito, G; Lepri, F; Faul, C; Mundel, P; Siguero, JPL; Tenconi, R; Selicorni, A; Rossi, C; Mazzanti, L; Torrente, I; Marino, B; Digilio, MC; Zampino, G; Ackerman, MJ; Dallapiccola, B; Tartaglia, M; Gelb, BD				Pandit, Bhaswati; Sarkozy, Anna; Pennacchio, Len A.; Carta, Claudio; Oishi, Kimihiko; Martinelli, Simone; Pogna, Edgar A.; Schackwitz, Wendy; Ustaszewska, Anna; Landstrom, Andrew; Bos, J. Martijn; Ommen, Steve R.; Esposito, Giorgia; Lepri, Francesca; Faul, Christian; Mundel, Peter; Siguero, Juan P. Lopez; Tenconi, Romano; Selicorni, Angelo; Rossi, Cesare; Mazzanti, Laura; Torrente, Isabella; Marino, Bruno; Digilio, Maria C.; Zampino, Giuseppe; Ackerman, Michael J.; Dallapiccola, Bruno; Tartaglia, Marco; Gelb, Bruce D.			Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy	NATURE GENETICS			English	Article							CARDIAC-HYPERTROPHY; PHENOTYPE CORRELATION; GERMLINE MUTATIONS; SIGNALING PATHWAY; COSTELLO-SYNDROME; PTPN11 MUTATIONS; TRANSGENIC MICE; HUMAN CANCER; C-RAF; B-RAF	Noonan and LEOPARD syndromes are developmental disorders with overlapping features, including cardiac abnormalities, short stature and facial dysmorphia. Increased RAS signaling owing to PTPN11, SOS1 and KRAS mutations causes similar to 60% of Noonan syndrome cases(1-6), and PTPN11 mutations cause 90% of LEOPARD syndrome cases7. Here, we report that 18 of 231 individuals with Noonan syndrome without known mutations (corresponding to 3% of all affected individuals) and two of six individuals with LEOPARD syndrome without PTPN11 mutations have missense mutations in RAF1, which encodes a serine- threonine kinase that activates MEK1 and MEK2. Most mutations altered a motif flanking Ser259, a residue critical for autoinhibition of RAF1 through 14-3-3 binding. Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general. Ectopically expressed RAF1 mutants from the two HCM hotspots had increased kinase activity and enhanced ERK activation, whereas non-HCM-associated mutants were kinase impaired. Our findings further implicate increased RAS signaling in pathological cardiomyocyte hypertrophy.	CUNY Mt Sinai Sch Med, Dept Pediat, Ctr Mol Cardiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; CSS Mendel Inst, I-00198 Rome, Italy; CSS, Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo, Italy; Univ Roma La Sapienza, Dept Expt Med, I-00198 Rome, Italy; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Hosp Materno Infantil, Malaga 29011, Spain; Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; Univ Milan, Pediat Clin, I-20122 Milan, Italy; Univ Bologna, Policlin S Orsola Malpighi, Dipartimento Pediat, I-40138 Bologna, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dipartimento Pediat, I-00161 Rome, Italy; Osped Bambino Gesu, I-00165 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Istituto Superiore di Sanita (ISS); Mayo Clinic; Mayo Clinic; Mayo Clinic; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Padua; University of Milan; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Tartaglia, M (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, Ctr Mol Cardiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	mtartaglia@iss.it; bruce.gelb@mssm.edu	Rossi, Cesare/AAC-2083-2022; Schackwitz, Wendy/GXH-9536-2022; Martinelli, Simone/J-9432-2018; Zampino, Giuseppe/AAC-2152-2019; Lepri, Francesca Romana/AAA-6115-2020; Digilio, Maria Cristina/AAI-2434-2019; Carta, Claudio/A-7305-2013; Tartaglia, Marco/K-2955-2018; Landstrom, Andrew/A-9221-2017; Faul, Christian/D-1549-2011; Dallapiccola, Bruno/K-8692-2016	Rossi, Cesare/0000-0003-1826-615X; Martinelli, Simone/0000-0002-5843-419X; Carta, Claudio/0000-0003-3545-198X; Tartaglia, Marco/0000-0001-7736-9672; Landstrom, Andrew/0000-0002-1878-9631; Lepri, Francesca Romana/0000-0001-5331-0473; Pennacchio, Len/0000-0002-8748-3732; Schackwitz, Wendy/0000-0002-3013-9180; Dallapiccola, Bruno/0000-0002-5031-1013; mazzanti, laura/0000-0002-7670-6494; Oishi, Kimihiko/0000-0001-9446-8912	NHLBI NIH HHS [HL066681, HL074728, HL71207] Funding Source: Medline; NICHD NIH HHS [HD042569, HD01294] Funding Source: Medline; NIDDK NIH HHS [DK57683] Funding Source: Medline; NIGMS NIH HHS [T32 GM072474] Funding Source: Medline; Telethon [GGP07115, GGP04172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042569] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, R01HL071207, U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gripp KW, 2006, AM J MED GENET A, V140A, P1, DOI 10.1002/ajmg.a.31047; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Merks JHM, 2005, AM J MED GENET A, V134A, P132, DOI 10.1002/ajmg.a.30603; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NILHORI T, 2006, NAT GENET, V38, P294; Patel R, 2001, CIRCULATION, V104, P317, DOI 10.1161/hc2801.094031; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sarkozy A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013466; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Ucar C, 2006, J PEDIAT HEMATOL ONC, V28, P123; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	30	481	503	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1007	1012		10.1038/ng2073	http://dx.doi.org/10.1038/ng2073			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603483				2022-12-25	WOS:000248446900019
J	Rodina, A; Vilenchik, M; Moulick, K; Aguirre, J; Kim, JN; Chiang, A; Litz, J; Clement, CC; Kang, YL; She, YH; Wu, N; Felts, S; Wipf, P; Massague, J; Jiang, XJ; Brodsky, JL; Krystal, GW; Chiosis, G				Rodina, Anna; Vilenchik, Maria; Moulick, Kamalika; Aguirre, Julia; Kim, Joungnam; Chiang, Anne; Litz, Julie; Clement, Cristina C.; Kang, Yanlong; She, Yuhong; Wu, Nian; Felts, Sara; Wipf, Peter; Massague, Joan; Jiang, Xuejun; Brodsky, Jeffrey L.; Krystal, Geoffrey W.; Chiosis, Gabriela			Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK-PROTEIN; SMALL-MOLECULE MODULATORS; NEGATIVE REGULATION; HSP70; GELDANAMYCIN; CHEMOTHERAPY; RESISTANCE; HEAT-SHOCK-PROTEIN-90; SENSITIVITY; SURVIVAL	The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.	Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23249 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Virginia Commonwealth University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	chiosisg@mskcc.org	Moulick, Kamalika/E-1723-2018; kang, yanlong/F-8172-2012; Clement, Cristina/ABG-4525-2021; Wipf, Peter/AAG-1771-2021	Moulick, Kamalika/0000-0002-6131-1270; Clement, Cristina/0000-0003-1464-407X; Wipf, Peter/0000-0001-7693-5863; Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [R01CA113890, U01CA091178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA091178, R01 CA113890] Funding Source: Medline; NIGMS NIH HHS [P50-GM067082] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534; Ciombor Kristen Keon, 2006, Curr Treat Options Oncol, V7, P59, DOI 10.1007/s11864-006-0032-7; Cysyk RL, 2006, CHEM RES TOXICOL, V19, P376, DOI 10.1021/tx050237e; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Ferguson HA, 2003, J BIOL CHEM, V278, P45793, DOI 10.1074/jbc.M307979200; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Hostein I, 2001, CANCER RES, V61, P4003; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joseph B, 1999, BIOCHEM BIOPH RES CO, V262, P381, DOI 10.1006/bbrc.1999.1191; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Koishi M, 2001, CLIN CANCER RES, V7, P215; Krystal GW, 2002, MOL CANCER THER, V1, P913; Llauger L, 2005, J MED CHEM, V48, P2892, DOI 10.1021/jm049012b; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Moulick K, 2006, BIOORG MED CHEM LETT, V16, P4515, DOI 10.1016/j.bmcl.2006.06.025; Neckers L, 2006, HANDB EXP PHARM, V172, P259; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Onganer PU, 2005, BRIT J CANCER, V93, P1197, DOI 10.1038/sj.bjc.6602857; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sandler AB, 2003, SEMIN ONCOL, V30, P9, DOI 10.1053/sonc.2003.50012; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Tian ZQ, 2004, BIOORGAN MED CHEM, V12, P5317, DOI 10.1016/j.bmc.2004.07.053; Tsurutani J, 2005, CANCER RES, V65, P8423, DOI 10.1158/0008-5472.CAN-05-0058; Viktorsson K, 2005, ADV CANCER RES, V94, P143, DOI 10.1016/S0065-230X(05)94004-9; Vilenchik M, 2004, CHEM BIOL, V11, P787, DOI 10.1016/j.chembiol.2004.04.008; Warshamana-Greene GS, 2005, CLIN CANCER RES, V11, P1563, DOI 10.1158/1078-0432.CCR-04-1544; WEI YQ, 1994, CANCER RES, V54, P4952; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200	46	137	145	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2007	3	8					498	507		10.1038/nchembio.2007.10	http://dx.doi.org/10.1038/nchembio.2007.10			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	193VB	17603540				2022-12-25	WOS:000248302200017
J	Mora-Bermudez, F; Gerlich, D; Ellenberg, J				Mora-Bermudez, Felipe; Gerlich, Daniel; Ellenberg, Jan			Maximal chromosome compaction occurs by axial shortening in anaphase and depends on Aurora kinase	NATURE CELL BIOLOGY			English	Article							MITOTIC CHROMOSOME; IN-VIVO; TIME-LAPSE; CHROMATID SEGREGATION; CONDENSIN-I; HUMAN-CELLS; DYNAMICS; MITOSIS; ORGANIZATION; ARCHITECTURE	Eukaryotic cells must first compact their chromosomes before faithfully segregating them during cell division. Failure to do so can lead to segregation defects with pathological consequences, such as aneuploidy and cancer(1,2). Duplicated interphase chromosomes are, therefore, reorganized into tight rods before being separated and directed to the newly forming daughter cells(3). This vital reorganization of chromatin remains poorly understood. To address the dynamics of mitotic condensation of single chromosomes in intact cells, we developed quantitative assays based on confocal time-lapse microscopy of live mammalian cells stably expressing fluorescently tagged core histones. Surprisingly, maximal compaction was not reached in metaphase, but in late anaphase, after sister chromatid segregation. We show that anaphase compaction proceeds by a mechanism of axial shortening of the chromatid arms from telomere to centromere. Chromatid axial shortening was not affected in condensin-depleted cells, but depended instead on dynamic microtubules and Aurora kinase. Acute perturbation of this compaction resulted in failure to rescue segregation defects and in multilobed daughter nuclei, suggesting functions in chromosome segregation and nuclear architecture.	European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Gerlich, Daniel Wolfram W/A-6991-2016; Ellenberg, Jan/I-4688-2014	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Ellenberg, Jan/0000-0001-5909-701X				Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Cimini D, 2002, J CELL SCI, V115, P507; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Gerlich D, 2003, NAT CELL BIOL, pS14, DOI 10.1038/ncb1033; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HIRAOKA Y, 1989, NATURE, V342, P293, DOI 10.1038/342293a0; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Manders EMM, 2003, CHROMOSOME RES, V11, P537, DOI 10.1023/A:1024995215340; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; SWEDLOW JR, 1993, CELL, V73, P97, DOI 10.1016/0092-8674(93)90163-K; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	39	127	128	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					822	U170		10.1038/ncb1606	http://dx.doi.org/10.1038/ncb1606			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558394				2022-12-25	WOS:000247760700018
J	Alexander, JJ; Umino, Y; Everhart, D; Chang, B; Min, SH; Li, QH; Timmers, AM; Hawes, NL; Pang, JJ; Barlow, RB; Hauswirth, WW				Alexander, John J.; Umino, Yumiko; Everhart, Drew; Chang, Bo; Min, Seok H.; Li, Qiuhong; Timmers, Adrian M.; Hawes, Norman L.; Pang, Ji-jing; Barlow, Robert B.; Hauswirth, William W.			Restoration of cone vision in a mouse model of achromatopsia	NATURE MEDICINE			English	Article							LOCUS-CONTROL REGION; MOLECULAR-GENETICS; PIGMENT GENES; HUMAN RED; MUTATIONS; EXPRESSION; CNGB3; GNAT2	Loss of cone function in the central retina is a pivotal event in the development of severe vision impairment for many prevalent blinding diseases. Complete achromatopsia is a genetic defect resulting in cone vision loss in 1 in 30,000 individuals. Using adeno-associated virus (AAV) gene therapy, we show that it is possible to target cones and rescue both the cone-mediated electroretinogram response and visual acuity in the Gnat2(cpfl3) mouse model of achromatopsia.	Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; SUNY Upstate Med Univ, Ctr Vis Res, Dept Ophthalmol, Syracuse, NY 13210 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Jackson Laboratory; State University System of Florida; University of Florida	Hauswirth, WW (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	hauswrth@eye.ufl.edu	Alexander, John/GVS-7271-2022	Chang, Bo/0000-0001-8259-7290	NEI NIH HHS [P30 EY021721, EY007132, R56 EY000667, EY008571, EY007758, EY00667, T32 EY007132, P30 EY008571, F32 EY017246, EY011123, R01 EY000667, R01 EY011123, R01 EY007758, EY017246] Funding Source: Medline; NINDS NIH HHS [P01 NS036302, NS36302] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY008571, R56EY000667, R01EY007758, R01EY011123, R01EY000667, T32EY007132, P30EY021721, F32EY017246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS036302] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Deeb SS, 2004, VISUAL NEUROSCI, V21, P191, DOI 10.1017/S0952523804213244; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Johnson S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011437; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P1036; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Zhu XM, 2002, MOL VIS, V8, P462	13	172	191	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					685	687		10.1038/nm1596	http://dx.doi.org/10.1038/nm1596			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17515894	Green Accepted			2022-12-25	WOS:000247084300030
J	Ziouzenkova, O; Orasanu, G; Sharlach, M; Akiyama, TE; Berger, JP; Viereck, J; Hamilton, JA; Tang, GW; Dolnikowski, GG; Vogel, S; Duester, G; Plutzky, J				Ziouzenkova, Ouliana; Orasanu, Gabriela; Sharlach, Molly; Akiyama, Taro E.; Berger, Joel P.; Viereck, Jason; Hamilton, James A.; Tang, Guangwen; Dolnikowski, Gregory G.; Vogel, Silke; Duester, Gregg; Plutzky, Jorge			Retinaldehyde represses adipogenesis and diet-induced obesity	NATURE MEDICINE			English	Article							RETINOL-BINDING-PROTEIN; INSULIN-RESISTANCE; BETA-CAROTENE; VITAMIN-A; ACID; ADIPONECTIN; INHIBITION; FAT; RETINOL-BINDING-PROTEIN-4; DIFFERENTIATION	The metabolism of vitamin A and the diverse effects of its metabolites are tightly controlled by distinct retinoid-generating enzymes, retinoid-binding proteins and retinoid-activated nuclear receptors. Retinoic acid regulates differentiation and metabolism by activating the retinoic acid receptor and retinoid X receptor (RXR), indirectly influencing RXR heterodimeric partners. Retinoic acid is formed solely from retinaldehyde (Rald), which in turn is derived from vitamin A. Rald currently has no defined biologic role outside the eye. Here we show that Rald is present in rodent fat, binds retinol-binding proteins (CRBP1, RBP4), inhibits adipogenesis and suppresses peroxisome proliferator-activated receptor-c and RXR responses. In vivo, mice lacking the Rald-catabolizing enzyme retinaldehyde dehydrogenase 1 (Raldh1) resisted diet-induced obesity and insulin resistance and showed increased energy dissipation. In ob/ob mice, administrating Rald or a Raldh inhibitor reduced fat and increased insulin sensitivity. These results identify Rald as a distinct transcriptional regulator of the metabolic responses to a high-fat diet.	Harvard Univ, Sch Med, Div Cardiovasc, Brigham & Womens Hosp, Boston, MA 02115 USA; Merck Res Labs, Rahway, NJ 07065 USA; Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10032 USA; Burnham Inst, OncoDev Biol Program, La Jolla, CA 92037 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Merck & Company; Boston University; Tufts University; United States Department of Agriculture (USDA); Columbia University; Sanford Burnham Prebys Medical Discovery Institute	Plutzky, J (corresponding author), Harvard Univ, Sch Med, Div Cardiovasc, Brigham & Womens Hosp, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Dolnikowski, Gregory G/C-4354-2008; Ziouzenkova, Ouliana/B-3690-2012; Plutzky, Jorge/V-3410-2019; Eckhardt, Erik/G-1567-2010; Ziouzenkova, Ouliana/AAM-1971-2020	Dolnikowski, Gregory G/0000-0001-5886-2656; Ziouzenkova, Ouliana/0000-0003-2449-2591; Hamilton, James/0000-0002-4747-7071; Duester, Gregg/0000-0003-4335-3650	NEI NIH HHS [R01 EY013969-05A2, R01 EY013969] Funding Source: Medline; NHLBI NIH HHS [P01 HL48743, R01 HL071745, P01 HL048743] Funding Source: Medline; NICHD NIH HHS [K12 HD051959-01, K12 HD051959] Funding Source: Medline; NIDDK NIH HHS [5P30DK046200, P30 DK046200] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051959] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071745, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; Cavasotto CN, 2004, J MED CHEM, V47, P4360, DOI 10.1021/jm030651g; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Fliers E, 2003, J NEUROENDOCRINOL, V15, P1005, DOI 10.1046/j.1365-2826.2003.01096.x; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hallsten K, 2002, DIABETES, V51, P3479, DOI 10.2337/diabetes.51.12.3479; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kikonyogo A, 1999, EUR J BIOCHEM, V262, P704, DOI 10.1046/j.1432-1327.1999.00415.x; Koch SSC, 1999, J MED CHEM, V42, P742, DOI 10.1021/jm980621r; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; LAKSHMAN MR, 1989, P NATL ACAD SCI USA, V86, P9124, DOI 10.1073/pnas.86.23.9124; Lee S, 2006, DIABETES CARE, V29, P51, DOI 10.2337/diacare.29.1.51; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Paydas S, 2003, LEUKEMIA LYMPHOMA, V44, P547, DOI 10.1080/1042819021000055101; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Redlich CA, 1999, ATHEROSCLEROSIS, V143, P427, DOI 10.1016/S0021-9150(98)00303-7; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; Ress NB, 2003, TOXICOL SCI, V71, P198, DOI 10.1093/toxsci/71.2.198; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	43	300	312	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					695	702		10.1038/nm1587	http://dx.doi.org/10.1038/nm1587			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17529981	Green Accepted			2022-12-25	WOS:000247084300032
J	Brunner, E; Ahrens, CH; Mohanty, S; Baetschmann, H; Loevenich, S; Potthast, F; Deutsch, EW; Panse, C; de Lichtenberg, U; Rinner, O; Lee, H; Pedrioli, PGA; Malmstrom, J; Koehler, K; Schrimpf, S; Krijgsveld, J; Kregenow, F; Heck, AJR; Hafen, E; Schlapbach, R; Aebersold, R				Brunner, Erich; Ahrens, Christian H.; Mohanty, Sonali; Baetschmann, Hansruedi; Loevenich, Sandra; Potthast, Frank; Deutsch, Eric W.; Panse, Christian; de Lichtenberg, Ulrik; Rinner, Oliver; Lee, Hookeun; Pedrioli, Patrick G. A.; Malmstrom, Johan; Koehler, Katja; Schrimpf, Sabine; Krijgsveld, Jeroen; Kregenow, Floyd; Heck, Albert J. R.; Hafen, Ernst; Schlapbach, Ralph; Aebersold, Ruedi			A high-quality catalog of the Drosophila melanogaster proteome	NATURE BIOTECHNOLOGY			English	Article							MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; IDENTIFICATION; GENOME; MODEL; CHROMATOGRAPHY; PREDICTION; PEPTIDES; SYSTEM; YEAST	Understanding how proteins and their complex interaction networks convert the genomic information into a dynamic living organism is a fundamental challenge in biological sciences. As an important step towards understanding the systems biology of a complex eukaryote, we cataloged 63% of the predicted Drosophila melanogaster proteome by detecting 9,124 proteins from 498,000 redundant and 72,281 distinct peptide identifications. This unprecedented high proteome coverage for a complex eukaryote was achieved by combining sample diversity, multidimensional biochemical fractionation and analysis-driven experimentation feedback loops, whereby data collection is guided by statistical analysis of prior data. We show that high-quality proteomics data provide crucial information to amend genome annotation and to confirm many predicted gene models. We also present experimentally identified proteotypic peptides matching similar to 50% of D. melanogaster gene models. This library of proteotypic peptides should enable fast, targeted and quantitative proteomic studies to elucidate the systems biology of this model organism.	ETH Honggerberg, Inst Mol Syst Biol, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; Univ Zurich, Ctr Model Organism Proteomes, CH-8057 Zurich, Switzerland; ETH, Funct Genom Ctr, CH-8057 Zurich, Switzerland; Inst Syst Biol, Seattle, WA 98103 USA; Tech Univ Denmark, Ctr Biol Sequence Anal, Biocentrum, DK-2800 Lyngby, Denmark; Leo Pharmaceut Prod, DK-2750 Ballerup, Denmark; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Utrecht, Dept Biomol Mass Spectrometry, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; Univ Utrecht, Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); Technical University of Denmark; University of Zurich; Utrecht University; Utrecht University; University of Zurich	Brunner, E (corresponding author), ETH Honggerberg, Inst Mol Syst Biol, Swiss Fed Inst Technol, Wolfgang Pauli Str 16,HPT, CH-8093 Zurich, Switzerland.	erich.brunner@molbio.uzh.ch; christian.ahrens@fgcz.ethz.ch; aebersold@imsb.biol.ethz.ch	Deutsch, Eric/AAF-5912-2020; Malmström, Johan A/B-7660-2009; Ahrens, Christian H./F-4656-2011; Krijgsveld, Jeroen/F-5974-2011; Schlapbach, Ralph/R-8234-2016; de Lichtenberg, Ulrik/AAY-7279-2020; Heck, Albert/D-7098-2011	Malmström, Johan A/0000-0002-2889-7169; Ahrens, Christian H./0000-0002-8148-7257; Heck, Albert/0000-0002-2405-4404; Lee, Hookeun/0000-0002-0696-8421; Schlapbach, Ralph/0000-0002-7488-4262; Deutsch, Eric/0000-0001-8732-0928; Krijgsveld, Jeroen/0000-0001-7549-9326; de Lichtenberg, Ulrik/0000-0002-0985-9343	DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28179] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Corthals GL, 2005, METHOD ENZYMOL, V405, P66, DOI 10.1016/S0076-6879(05)05004-4; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Desiere F, 2005, GENOME BIOL, V6; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gopal S, 2001, NAT GENET, V27, P337, DOI 10.1038/85922; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Pennisi E, 2004, SCIENCE, V306, P632, DOI 10.1126/science.306.5696.632; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang H, 2005, MOL CELL PROTEOMICS, V4, P144, DOI 10.1074/mcp.M400090-MCP200	26	221	226	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					576	583		10.1038/nbt1300	http://dx.doi.org/10.1038/nbt1300			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17450130	Green Published			2022-12-25	WOS:000246369400026
J	Regad, T; Roth, M; Bredenkamp, N; Illing, N; Papalopulu, N				Regad, Tarik; Roth, Martin; Bredenkamp, Nicholas; Illing, Nicola; Papalopulu, Nancy			The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF	NATURE CELL BIOLOGY			English	Article							HELIX TRANSCRIPTION FACTOR; CASEIN KINASE-I; CORTICAL NEUROGENESIS; CELL-PROLIFERATION; CEREBRAL-CORTEX; PROTEIN; XENOPUS; DIFFERENTIATION; REPRESSION; SMAD	FoxG1 is an evolutionarily conserved, winged-helix transcriptional repressor that maintains progenitor cells in the vertebrate forebrain. How the activity of FoxG1 is regulated is not known. Here, we report that in the developing Xenopus and mouse forebrain, FoxG1 is nuclear in progenitor cells but cytoplasmic in differentiating cells. The subcellular localisation of FoxG1 is regulated at the post-translational level by casein kinase I (CKI) and fibroblast growth factor (FGF) signalling. CKI phosphorylation of Ser 19 of FoxG1 promotes nuclear import, whereas FGF-induced phosphorylation of Thr 226 promotes nuclear export. Interestingly, FGF-induced phosphorylation of FoxG1 is mediated Akt kinase (also known as protein B kinase, PKB) kinase, rather than the MAPK pathway. Phosphorylation of endogenous FoxG1 is blocked by CKI and Akt inhibitors. In the mouse olfactory placode cell line OP27, and in cortical progenitors, increased FGF signalling causes FoxG1 to exit the nucleus and promotes neuronal differentiation, whereas FGF and Akt inhibitors block this effect. Thus, CKI and FGF signalling converge on an antagonistic regulation of FoxG1, which in turn controls neurogenesis in the forebrain.	Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; Canc Res UK Gurdon Inst, Wellcome Trust, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	University of Cape Town; Cancer Research UK; Wellcome Trust Sanger Institute; University of Cambridge	Papalopulu, N (corresponding author), MRC Toxicol Unit, Leicester LE1 9HN, Leics, England.	nancy.papalopulu@manchester.ac.uk	Regad, Tarik/A-6095-2012	Regad, Tarik/0000-0003-4028-6368; Papalopulu, Nancy/0000-0001-6992-6870	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Chen JA, 2005, MECH DEVELOP, V122, P307, DOI 10.1016/j.mod.2004.11.008; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Kaestner KH, 2000, GENE DEV, V14, P142; Li J, 1997, P NATL ACAD SCI USA, V94, P10885, DOI 10.1073/pnas.94.20.10885; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Raballo R, 2000, J NEUROSCI, V20, P5012; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rodriguez C, 2001, J BIOL CHEM, V276, P30224, DOI 10.1074/jbc.M102759200; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Vaccarino FM, 2001, NEUROPSYCHOPHARMACOL, V25, P805, DOI 10.1016/S0893-133X(01)00349-9; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Zhang C, 2004, DEV BIOL, V273, P23, DOI 10.1016/j.ydbio.2004.05.019; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	35	70	74	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					531	U87		10.1038/ncb1573	http://dx.doi.org/10.1038/ncb1573			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435750				2022-12-25	WOS:000246181500011
J	Scott, MG; Dullaghan, E; Mookherjee, N; Glavas, N; Waldbrook, M; Thompson, A; Wang, AK; Lee, K; Doria, S; Hamill, P; Yu, JJ; Li, YX; Donini, O; Guarna, MM; Finlay, BB; North, JR; Hancock, REW				Scott, Monisha G.; Dullaghan, Edie; Mookherjee, Neeloffer; Glavas, Natalie; Waldbrook, Matthew; Thompson, Annick; Wang, Aikun; Lee, Ken; Doria, Silvana; Hamill, Pam; Yu, Jie Jessie; Li, Yuexin; Donini, Oreola; Guarna, M. Marta; Finlay, B. Brett; North, John R.; Hancock, Robert E. W.			An anti-infective peptide that selectively modulates the innate immune response	NATURE BIOTECHNOLOGY			English	Article							TOLL-LIKE RECEPTORS; C/EBP-EPSILON; CELLS; LL-37; INFECTION; RELEASE; SERUM; EXPRESSION; PATHWAYS; CYTOKINE	We show that an innate defense - regulator peptide ( IDR-1) was protective in mouse models of infection with important Gram- positive and Gram- negative pathogens, including methicillin- resistant Staphylococcus aureus, vancomycin- resistant Enterococcus and Salmonella enterica serovar Typhimurium. When given from 48 h before to 6 h after infection, the peptide was effective by both local and systemic administration. Because protection by IDR-1 was prevented by in vivo depletion of monocytes and macrophages, but not neutrophils or B- and T- lymphocytes, we conclude that monocytes and macrophages are key effector cells. IDR-1 was not directly antimicrobial: gene and protein expression analysis in human and mouse monocytes and macrophages indicated that IDR- 1, acting through mitogen- activated protein kinase and other signaling pathways, enhanced the levels of monocyte chemokines while reducing pro- inflammatory cytokine responses. To our knowledge, an innate defense regulator that counters infection by selective modulation of innate immunity without obvious toxicities has not been reported previously.	Inimex Pharmaceut Inc, Vancouver, BC V6S 2L2, Canada; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Hancock, REW (corresponding author), Inimex Pharmaceut Inc, 3650 Wesbrook Mall, Vancouver, BC V6S 2L2, Canada.		Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Mookherjee, Neeloffer/0000-0002-9350-4157; Guarna, Maria Marta/0000-0002-4638-9475				Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Fessele S, 2001, FASEB J, V15, P577; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Gehlhar K, 2005, INT ARCH ALLERGY IMM, V136, P311, DOI 10.1159/000083976; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Hokamp K, 2004, NUCLEIC ACIDS RES, V32, pW457, DOI 10.1093/nar/gkh446; Kubota T, 2000, BLOOD, V96, P3953, DOI 10.1182/blood.V96.12.3953.h8003953_3953_3957; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Marcinkowska E, 2006, EXP CELL RES, V312, P2054, DOI 10.1016/j.yexcr.2006.03.003; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Niyonsaba F, 2001, EUR J IMMUNOL, V31, P1066, DOI 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#; *NRC, 2005, TREAT INF DIS MICR W; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRINS JM, 1995, INFECT IMMUN, V63, P2236, DOI 10.1128/IAI.63.6.2236-2242.1995; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Theuretzbacher U, 2006, CURR OPIN INVEST DR, V7, P158; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Tsuji M, 2003, ANTIMICROB AGENTS CH, V47, P2507, DOI 10.1128/AAC.47.8.2507-2512.2003; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	29	305	317	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					465	472		10.1038/nbt1288	http://dx.doi.org/10.1038/nbt1288			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17384586				2022-12-25	WOS:000245651800028
J	Zhang, Q; Bengtsson, M; Partridge, C; Salehi, A; Braun, M; Cox, R; Eliasson, L; Johnson, PRV; Renstrom, E; Schneider, T; Berggren, PO; Gopel, S; Ashcroft, FM; Rorsman, P				Zhang, Quan; Bengtsson, Martin; Partridge, Chris; Salehi, Albert; Braun, Matthias; Cox, Roger; Eliasson, Lena; Johnson, Paul R. V.; Renstrom, Erik; Schneider, Toni; Berggren, Per-Olof; Gopel, Sven; Ashcroft, Frances M.; Rorsman, Patrik			R-type Ca2+-channel-evoked CICR regulates glucose-induced somatostatin secretion	NATURE CELL BIOLOGY			English	Article							PANCREATIC BETA-CELLS; PERFUSED RAT PANCREAS; DELTA-CELLS; INSULIN-SECRETION; RYANODINE RECEPTOR; INTACT ISLETS; ALPHA-CELLS; CAPACITANCE MEASUREMENTS; GLUCAGON-SECRETION; CALCIUM-RELEASE	Pancreatic islets have a central role in blood glucose homeostasis. In addition to insulin-producing beta-cells and glucagon-secreting alpha-cells, the islets contain somatostatin-releasing delta-cells(1). Somatostatin is a powerful inhibitor of insulin and glucagon secretion(2). It is normally secreted in response to glucose(3) and there is evidence suggesting its release becomes perturbed in diabetes(4). Little is known about the control of somatostatin release. Closure of ATP-regulated K+-channels (K-ATP-channels)(5) and a depolarization-evoked increase in cytoplasmic free Ca2+ concentration ([Ca2+](i))(6-8) have been proposed to be essential. Here, we report that somatostatin release evoked by high glucose (>= 10 mM) is unaffected by the K-ATP-channel activator diazoxide and proceeds normally in K-ATP-channel-deficient islets. Glucose-induced somatostatin secretion is instead primarily dependent on Ca2+-induced Ca2+-release (CICR). This constitutes a novel mechanism for K-ATP-channel-independent metabolic control of pancreatic hormone secretion.	Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Lund Univ, Clin Res Ctr, Dept Clin Sci, SE-20502 Malmo, Sweden; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; John Radcliffe Hosp, Suffield Dept Surg, Oxford OX3 9DU, England; Univ Cologne, Insneurophysiol, D-50931 Cologne, Germany; Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; AstraZeneca R&D, SE-43183 Molndal, Sweden; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford; Lund University; MRC Harwell; University of Oxford; University of Cologne; Karolinska Institutet; AstraZeneca; University of Oxford	Rorsman, P (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	patrik.rorsman@drl.ox.ac.uk	Tuluc, Petronel/C-2527-2011; Rorsman, Patrik/A-4331-2016; Zhang, Quan/AAZ-1154-2021; Salehi, Albert/F-7768-2018; Eliasson, Lena/E-9294-2012	Rorsman, Patrik/0000-0001-7578-0767; Salehi, Albert/0000-0001-6120-3539; Eliasson, Lena/0000-0002-6467-5029; Zhang, Quan/0000-0002-3626-4855; Cox, Roger/0000-0001-7170-5014; Berggren, Per-Olof/0000-0001-8991-413X	MRC [MC_U142684172, MC_U142661184, MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684175, MC_U142661184] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ABDELHALIM SM, 1993, ACTA PHYSIOL SCAND, V148, P219, DOI 10.1111/j.1748-1716.1993.tb09551.x; BISHOP AE, 1997, TXB DIABETES, V1, P6; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; EFENDIC S, 1979, P NATL ACAD SCI USA, V76, P5901, DOI 10.1073/pnas.76.11.5901; EFENDIC S, 1982, DIABETOLOGIA, V22, P475, DOI 10.1007/BF00282593; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kanno T, 2004, METHODS, V33, P302, DOI 10.1016/j.ymeth.2004.01.003; LEITER EH, 1979, DIABETOLOGIA, V17, P297, DOI 10.1007/BF01235886; Lollike K, 1999, J IMMUNOL METHODS, V232, P111, DOI 10.1016/S0022-1759(99)00169-6; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; SCHUIT FC, 1989, DIABETOLOGIA, V32, P207, DOI 10.1007/BF00265096; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; SQUIRES PE, 1994, PFLUG ARCH EUR J PHY, V428, P275, DOI 10.1007/BF00724507; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038	30	81	83	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					453	U171		10.1038/ncb1563	http://dx.doi.org/10.1038/ncb1563			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369816				2022-12-25	WOS:000245359400017
J	Berner, V; Liu, H; Zhou, Q; Alderson, KL; Sun, K; Weiss, JM; Back, TC; Longo, DL; Blazar, BR; Wiltrout, RH; Welniak, LA; Redelman, D; Murphy, WJ				Berner, Vanessa; Liu, Haiyan; Zhou, Qing; Alderson, Kory L.; Sun, Kai; Weiss, Jonathan M.; Back, Timothy C.; Longo, Dan L.; Blazar, Bruce R.; Wiltrout, Robert H.; Welniak, Lisbeth A.; Redelman, Doug; Murphy, William J.			IFN-gamma mediates CD4(+) T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy	NATURE MEDICINE			English	Article							HOMEOSTATIC PROLIFERATION; CD8-T-CELL MEMORY; INTERFERON-GAMMA; CD4-T-CELL HELP; ACUTE INFECTION; LYMPHOCYTES; EXPRESSION; GENERATION; DEATH; MICE	Protective cell-mediated immune responses in cancer are critically dependent on T-helper type 1 (T(H)1) cytokines such as interferon-gamma (IFN-gamma). We have previously shown that the combination of CD40 stimulation and interleukin- 2 (IL-2) leads to synergistic antitumor responses in several models of advanced metastatic disease. We now report that after this treatment and other immunotherapy regimens, the CD4(+)T- cell population, in contrast to CD8(+)T cells, did not significantly increase but rather exhibited a substantial level of apoptosis that was dependent on IFN-gamma. Mice immunized with tumor cells and treated with an immunotherapy regimen that was initially protective were later unable to mount effective memory responses compared with immunized mice not receiving immunotherapy. Immunotherapy given to tumor-bearing Ifngr(-/-) mice resulted in restoration of secondary responses. Thus, although immunotherapeutic regimens inducing strong IFN-gamma responses can lead to successful early antitumor efficacy, they may also impair the development of durable antitumor responses.	Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA; Univ Nevada, Dept Physiol & Cell Biol, Reno, NV 89557 USA; Natl Canc Inst, Ctr Canc Res, Expt Immunol Lab, Frederick, MD 21702 USA; NIA, Baltimore, MD 21224 USA; Univ Minnesota, Div Bone Marrow Transplantat, Ctr Canc, Minneapolis, MN 55455 USA; Univ Minnesota, Div Bone Marrow Transplantat, Dept Pediat, Minneapolis, MN 55455 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Murphy, WJ (corresponding author), Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA.	wmurphy@medicine.nevada.edu	Liu, Haiyan/ABD-8689-2021; Longo, Dan L./F-6022-2011	Liu, Haiyan/0000-0002-4652-469X; 	NCI NIH HHS [R01 CA095572, N01-CO-12400, R01 CA72669, R01 CA095572-04A1, R01 CA95572] Funding Source: Medline; NCRR NIH HHS [P20 RR16464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095572, Z01BC009262, R01CA072669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abdalla AO, 2003, SCAND J IMMUNOL, V58, P601, DOI 10.1111/j.1365-3083.2003.01348.x; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Elsasser-Beile U, 2000, BRIT J CANCER, V83, P637, DOI 10.1054/bjoc.2000.1275; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Honeychurch J, 2003, BLOOD, V102, P1449, DOI 10.1182/blood-2002-12-3717; Hunter KW, 2004, IMMUNOL LETT, V93, P71, DOI 10.1016/j.imlet.2004.02.006; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murphy WJ, 2003, J IMMUNOL, V170, P2727, DOI 10.4049/jimmunol.170.5.2727; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sobek V, 2002, EUR J IMMUNOL, V32, P2490, DOI 10.1002/1521-4141(200209)32:9<2490::AID-IMMU2490>3.0.CO;2-G; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Switaj T, 2004, CLIN CANCER RES, V10, P4165, DOI 10.1158/1078-0432.CCR-04-0022; Wigginton JM, 2001, J CLIN INVEST, V108, P51; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; ZHOU Q, IN PRESS J IMMUNOL	25	128	131	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					354	360		10.1038/nm1554	http://dx.doi.org/10.1038/nm1554			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17334371				2022-12-25	WOS:000244715700049
J	Lymperopoulos, A; Rengo, G; Funakoshi, H; Eckhart, AD; Koch, WJ				Lymperopoulos, Anastasios; Rengo, Giuseppe; Funakoshi, Hajime; Eckhart, Andrea D.; Koch, Walter J.			Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure	NATURE MEDICINE			English	Article							PLASMA NOREPINEPHRINE; CARDIAC-FUNCTION; RECEPTOR KINASE; IN-VIVO; ALPHA(2)-ADRENOCEPTOR SUBTYPES; CATECHOLAMINE RELEASE; MYOCARDIAL-INFARCTION; CHROMAFFIN CELLS; NERVOUS-SYSTEM; BETA-ARRESTINS	Cardiac overstimulation by the sympathetic nervous system (SNS) is a salient characteristic of heart failure, reflected by elevated circulating levels of catecholamines. The success of beta-adrenergic receptor (bAR) antagonists in heart failure argues for SNS hyperactivity being pathogenic; however, sympatholytic agents targeting alpha(2)AR-mediated catecholamine inhibition have been unsuccessful. By investigating adrenal adrenergic receptor signaling in heart failure models, we found molecular mechanisms to explain the failure of sympatholytic agents and discovered a new strategy to lower SNS activity. During heart failure, there is substantial alpha(2)AR dysregulation in the adrenal gland, triggered by increased expression and activity of G protein-coupled receptor kinase 2 (GRK2). Adrenal gland-specific GRK2 inhibition reversed a2AR dysregulation in heart failure, resulting in lowered plasma catecholamine levels, improved cardiac bAR signaling and function, and increased sympatholytic efficacy of a a2AR agonist. This is the first demonstration, to our knowledge, of a molecular mechanism for SNS hyperactivity in heart failure, and our study identifies adrenal GRK2 activity as a new sympatholytic target.	Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, George Zallie & Family Lab Cardiovasc Gene Therap, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Eugene Feiner Lab Vasc Biol & Trombosis, Dept Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Koch, WJ (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA.	walter.koch@jefferson.edu	Lymperopoulos, Tasos/AAA-4366-2020; Rengo, Giuseppe/AAA-2870-2021; Rengo, Giuseppe/K-4963-2016	Rengo, Giuseppe/0000-0002-9701-0437; Rengo, Giuseppe/0000-0002-9701-0437; Lymperopoulos, Anastasios/0000-0001-9817-6319	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061690, P01HL075443, R01HL056205] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL075443, R01 HL56205, R01 HL61690] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal A, 2001, J AM COLL CARDIOL, V37, P1246, DOI 10.1016/S0735-1097(01)01121-4; Brede M, 2003, MOL ENDOCRINOL, V17, P1640, DOI 10.1210/me.2003-0035; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; BYLUND DB, 1994, PHARMACOL REV, V46, P121; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Floras JS, 2002, CIRCULATION, V105, P1753, DOI 10.1161/01.CIR.0000013788.71817.16; Guyenet PG, 1997, AM J PHYSIOL-REG I, V273, pR1580, DOI 10.1152/ajpregu.1997.273.5.R1580; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hoffman B.B., 2001, GOODMAN GILMANS PHAR, P115; Iaccarino G, 2005, EUR HEART J, V26, P1752, DOI 10.1093/eurheartj/ehi429; Iaccarino G, 1999, HYPERTENSION, V33, P396, DOI 10.1161/01.HYP.33.1.396; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; JewellMotz EA, 1996, J BIOL CHEM, V271, P18082, DOI 10.1074/jbc.271.30.18082; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KUROSE H, 1994, J BIOL CHEM, V269, P10093; Lang CC, 1997, HYPERTENSION, V30, P392, DOI 10.1161/01.HYP.30.3.392; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Neumeister A, 2005, PHARMACOGENET GENOM, V15, P143, DOI 10.1097/01213011-200503000-00002; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Rich MW, 1997, J AM GERIATR SOC, V45, P968, DOI 10.1111/j.1532-5415.1997.tb02968.x; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Swedberg K, 2002, CIRCULATION, V105, P1797, DOI 10.1161/01.CIR.0000014212.04920.62; Swedberg K, 2000, J AM COLL CARDIOL, V35, P398, DOI 10.1016/S0735-1097(99)00565-3; Uhlen S, 1998, EUR J PHARMACOL, V343, P93, DOI 10.1016/S0014-2999(97)01521-5; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; WILSON SP, 1983, J NEUROSCI, V3, P1971; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI, P665; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	40	185	191	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					315	323		10.1038/nm1553	http://dx.doi.org/10.1038/nm1553			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17322894				2022-12-25	WOS:000244715700044
J	Santos, SDM; Verveer, PJ; Bastiaens, PIH				Santos, Silvia D. M.; Verveer, Peter J.; Bastiaens, Philippe I. H.			Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate	NATURE CELL BIOLOGY			English	Article							SIGNAL-REGULATED KINASE; ACTIVATION; PHOSPHORYLATION; PROTEIN; RAF-1; IDENTIFICATION; DYNAMICS; CASCADE; SPECIFICITY; TRANSIENT	The mitogen-activated protein kinase ( MAPK) network is a conserved signalling module that regulates cell fate by transducing a myriad of growth-factor signals(1). The ability of this network to coordinate and process a variety of inputs from different growth-factor receptors into specific biological responses is, however, still not understood. We investigated how the MAPK network brings about signal specificity in PC-12 cells, a model for neuronal differentiation(2). Reverse engineering by modular-response analysis(3) uncovered topological differences in the MAPK core network dependent on whether cells were activated with epidermal or neuronal growth factor (EGF or NGF). On EGF stimulation, the network exhibited negative feedback only, whereas a positive feedback was apparent on NGF stimulation. The latter allows for bi-stable Erk activation dynamics, which were indeed observed. By rewiring these regulatory feedbacks, we were able to reverse the specific cell responses to EGF and NGF. These results show that growth factor context determines the topology of the MAPK signalling network and that the resulting dynamics govern cell fate.	European Mol Biol Lab, D-69117 Heidelberg, Germany; MPI Mol Physiol, Dept Syst Biol, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de						ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Andrec M, 2005, J THEOR BIOL, V232, P427, DOI 10.1016/j.jtbi.2004.08.022; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; BUDAY L, 1995, ONCOGENE, V11, P1327; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Ferrell JE, 1999, BIOESSAYS, V21, P866, DOI 10.1002/(SICI)1521-1878(199910)21:10<866::AID-BIES9>3.0.CO;2-1; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	24	483	489	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					324	U139		10.1038/ncb1543	http://dx.doi.org/10.1038/ncb1543			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310240				2022-12-25	WOS:000244558600017
J	Yang, ZM; Chang, YJ; Yu, IC; Yeh, SY; Wu, CC; Miyamoto, H; Merry, DE; Sobue, G; Chen, LM; Chang, SS; Chang, CS				Yang, Zhiming; Chang, Yu-Jia; Yu, I-Chen; Yeh, Shuyuan; Wu, Cheng-Chia; Miyamoto, Hiroshi; Merry, Diane E.; Sobue, Gen; Chen, Lu-Min; Chang, Shu-Shi; Chang, Chawnshang			ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor	NATURE MEDICINE			English	Article							TRANSGENIC MOUSE MODEL; MOTOR-NEURON DEGENERATION; PROSTATE-CANCER; NUCLEAR INCLUSIONS; HSP90 INHIBITOR; LATE-ONSET; POLYGLUTAMINE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; CELLS; MICE	Motor neuron degeneration resulting from the aggregation of the androgen receptor with an expanded polyglutamine tract (AR-polyQ) has been linked to the development of spinal and bulbar muscular atrophy (SBMA or Kennedy disease). Here we report that adding 5-hydroxy-1,7-bis(3,4-dimethoxyphenyl)-1,4,6-heptatrien-3-one (ASC-J9) disrupts the interaction between AR and its coregulators, and also increases cell survival by decreasing AR-polyQ nuclear aggregation and increasing AR-polyQ degradation in cultured cells. Intraperitoneal injection of ASC-J9 into AR-polyQ transgenic SBMA mice markedly improved disease symptoms, as seen by a reduction in muscular atrophy. Notably, unlike previous approaches in which surgical or chemical castration was used to reduce SBMA symptoms, ASC-J9 treatment ameliorated SBMA symptoms by decreasing AR-97Q aggregation and increasing VEGF164 expression with little change of serum testosterone. Moreover, mice treated with ASC-J9 retained normal sexual function and fertility. Collectively, our results point to a better therapeutic and preventative approach to treating SBMA, by disrupting the interaction between AR and AR coregulators.	Univ Rochester, Dept Pathol, George Whipple Lab Canc Res, Med Ctr, Rochester, NY 14642 USA; Univ Rochester, Dept Urol, George Whipple Lab Canc Res, Med Ctr, Rochester, NY 14642 USA; Univ Rochester, Dept Radiat Oncol, George Whipple Lab Canc Res, Med Ctr, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA; Zhejiang Univ, Hangzhou 310009, Peoples R China; 2nd Hosp, Hangzhou 310009, Peoples R China; Taipei Med Univ & Hosp, Taipei 110, Taiwan; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Nagoya Univ, Nagoya, Aichi 4668550, Japan; China Med Univ & Hosp, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Zhejiang University; Taipei Medical University; Taipei Medical University Hospital; Jefferson University; Nagoya University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Dept Pathol, George Whipple Lab Canc Res, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	chang@URMC.rochester.edu	Yang, Zhiming/C-3812-2012	Miyamoto, Hiroshi/0000-0001-7610-7769; Wu, Cheng-Chia/0000-0002-5908-0143; Yu, I-Chen/0000-0001-5270-9888; Chang, Yu-Jia/0000-0003-3978-3244; Chang, Chawnshang/0000-0001-8510-3516	NIDDK NIH HHS [DK067686] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067686] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Beauchemin AMJ, 2001, BRAIN RES BULL, V56, P285, DOI 10.1016/S0361-9230(01)00583-4; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hostein I, 2001, CANCER RES, V61, P4003; Katsuno M, 2004, NEURON, V41, P677, DOI 10.1016/S0896-6273(04)00110-2; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kennedy WR, 1998, NEUROLOGY, V50, P583, DOI 10.1212/WNL.50.3.583; LA SA, 1991, NATURE, V352, P77; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Mandrusiak LM, 2003, HUM MOL GENET, V12, P1497, DOI 10.1093/hmg/ddg161; McCampbell A, 2001, NAT MED, V7, P528, DOI 10.1038/87842; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Ohtsu H, 2002, J MED CHEM, V45, P5037, DOI 10.1021/jm020200g; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; RINGEL SP, 1978, MUSCLE NERVE, V1, P297, DOI 10.1002/mus.880010406; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Solit DB, 2002, CLIN CANCER RES, V8, P986; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Terao S, 1996, ACTA NEUROPATHOL, V92, P109, DOI 10.1007/s004010050497; Thin TH, 2002, J BIOL CHEM, V277, P36499, DOI 10.1074/jbc.M202824200; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	37	129	142	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					348	353		10.1038/nm1547	http://dx.doi.org/10.1038/nm1547			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17334372				2022-12-25	WOS:000244715700048
J	van der Heijden, GW; Derijck, AAHA; Posfai, E; Giele, M; Pelczar, P; Ramos, L; Wansink, DG; van der Vlag, J; Peters, AHFM; de Boer, P				van der Heijden, Godfried W.; Derijck, Alwin A. H. A.; Posfai, Eszter; Giele, Maud; Pelczar, Pawel; Ramos, Liliana; Wansink, Derick G.; van der Vlag, Johan; Peters, Antoine H. F. M.; de Boer, Peter			Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation	NATURE GENETICS			English	Article							HISTONE MODIFICATIONS; SYNAPTONEMAL COMPLEX; RNA-SYNTHESIS; XY BODY; MOUSE; CHROMATIN; MICE; SPERMATOCYTES; MEIOSIS; SPERMATOGENESIS	In mammalian males, the first meiotic prophase is characterized by formation of a separate chromatin domain called the sex body(1). In this domain, the X and Y chromosomes are partially synapsed and transcriptionally silenced, a process termed meiotic sex-chromosome inactivation ( MSCI)(2,3). Likewise, unsynapsed autosomal chromatin present during pachytene is also silenced ( meiotic silencing of unsynapsed chromatin, MSUC)(2,4,5). Although it is known that MSCI and MSUC are both dependent on histone H2A.X phosphorylation mediated by the kinase ATR, and cause repressive H3 Lys9 dimethylation(4), the mechanisms underlying silencing are largely unidentified. Here, we demonstrate an extensive replacement of nucleosomes within unsynapsed chromatin, depending on and initiated shortly after induction of MSCI and MSUC. Nucleosomal eviction results in the exclusive incorporation of the H3.3 variant, which to date has primarily been associated with transcriptional activity. Nucleosomal exchange causes loss and subsequent selective reacquisition of specific histone modifications. This process therefore provides a means for epigenetic reprogramming of sex chromatin presumably required for gene silencing in the male mammalian germ line.	Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nephrol Res Lab,Div Nephrol, Nijmegen, Netherlands; Univ Zurich, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland	Radboud University Nijmegen; Friedrich Miescher Institute for Biomedical Research; Radboud University Nijmegen; Radboud University Nijmegen; University of Zurich	van der Heijden, GW (corresponding author), Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Van der Vlag, Johan/E-4636-2010; Wansink, Derick G./F-3404-2010; van der Heijden, Godfried/ABC-5623-2021; Ramos, L./L-4590-2015; Peters, Antoine/ABA-6283-2020	Van der Vlag, Johan/0000-0001-7843-5918; van der Heijden, Godfried/0000-0001-5894-7027; Posfai, Eszter/0000-0002-4871-6652; Peters, Antoine/0000-0002-0311-1887				Ashley T, 2004, CHROMOSOMA, V113, P126, DOI 10.1007/s00412-004-0293-5; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baart EB, 2000, CHROMOSOMA, V109, P139, DOI 10.1007/s004120050422; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DEBOER P, 1986, CHROMOSOMA, V93, P326, DOI 10.1007/BF00327591; DIETRICH AJJ, 1983, GENETICA, V61, P119, DOI 10.1007/BF00123222; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kramers K, 1996, J AUTOIMMUN, V9, P723, DOI 10.1006/jaut.1996.0094; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MOENS PB, 1995, CHROMOSOMA, V104, P169, DOI 10.1007/BF00352181; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; SPEED RM, 1986, CHROMOSOMA, V93, P267, DOI 10.1007/BF00292748; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TURNER JM, 2003, DEV CELL, V10, P521; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009	30	175	177	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					251	258		10.1038/ng1949	http://dx.doi.org/10.1038/ng1949			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237782				2022-12-25	WOS:000244063900025
J	Karlsson, EK; Baranowska, I; Wade, CM; Salmon Hillbertz, NHC; Zody, MC; Anderson, N; Biagi, TM; Patterson, N; Pielberg, GR; Kulbokas, EJ; Comstock, KE; Keller, ET; Mesirov, JP; von Euler, H; Kampe, O; Hedhammar, A; Lander, ES; Andersson, R; Andersson, L; Lindblad-Toh, K				Karlsson, Elinor K.; Baranowska, Izabella; Wade, Claire M.; Salmon Hillbertz, Nicolette H. C.; Zody, Michael C.; Anderson, Nathan; Biagi, Tara M.; Patterson, Nick; Pielberg, Gerli Rosengren; Kulbokas, Edward J., III; Comstock, Kenine E.; Keller, Evan T.; Mesirov, Jill P.; von Euler, Henrik; Kampe, Olle; Hedhammar, Ake; Lander, Eric S.; Andersson, Ran; Andersson, Leif; Lindblad-Toh, Kerstin			Efficient mapping of mendelian traits in dogs through genome-wide association	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GENE; WAARDENBURG-SYNDROME; DOMESTIC DOG; MITF; DIFFERENTIATION; PIGMENTATION; INHERITANCE; NEURULATION; MELANOCYTES; REGULATOR	With several hundred genetic diseases and an advantageous genome structure, dogs are ideal for mapping genes that cause disease. Here we report the development of a genotyping array with similar to 27,000 SNPs and show that genome-wide association mapping of mendelian traits in dog breeds can be achieved with only similar to 20 dogs. Specifically, we map two traits with mendelian inheritance: the major white spotting ( S) locus and the hair ridge in Rhodesian ridgebacks. For both traits, we map the loci to discrete regions of <1 Mb. Fine-mapping of the S locus in two breeds refines the localization to a region of similar to 100 kb contained within the pigmentation-related gene MITF. Complete sequencing of the white and solid haplotypes identifies candidate regulatory mutations in the melanocyte-specific promoter of MITF. Our results show that genome-wide association mapping within dog breeds, followed by fine-mapping across multiple breeds, will be highly efficient and generally applicable to trait mapping, providing insights into canine and human health.	MIT, Broad Inst Harvard, Cambridge, MA 02142 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, SE-75124 Uppsala, Sweden; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Uppsala Univ, Dept Med Biochem, SE-75124 Uppsala, Sweden; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden; Uppsala Univ, Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts General Hospital; Uppsala University; University of Michigan System; University of Michigan; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Karlsson, EK (corresponding author), MIT, Broad Inst Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	elinor@broad.mit.edu; leif.andersson@imbim.uu.se; kersli@broad.mit.edu	Keller, Evan T/M-1446-2016; Fiumefreddo, Andrea/T-2977-2019; Ronnberg, HENRIK Paul Olof/AAP-9678-2021; Andersson, Goran/AAK-6564-2020; Mesirov, Jill/AGF-7626-2022	Keller, Evan T/0000-0002-7592-7535; Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Andersson, Goran/0000-0001-5131-3144; Kampe, Olle/0000-0001-6091-9914; Wade, Claire/0000-0003-3413-4771; Karlsson, Elinor/0000-0002-4343-3776; Hedhammar, Ake/0000-0001-7048-3851				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; BURNS M, 1966, GENETICWS DOG BASIS; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Dourmishev AL, 1999, INT J DERMATOL, V38, P656, DOI 10.1046/j.1365-4362.1999.00750.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hart D. L., 2007, PRINCIPLES POPULATIO; Hillbertz NHCS, 2006, J SMALL ANIM PRACT, V47, P184, DOI 10.1111/j.1748-5827.2006.00016.x; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Jacquemin P, 2001, BIOCHEM BIOPH RES CO, V285, P1200, DOI 10.1006/bbrc.2001.5294; Jordan SF, 2000, MECH DEVELOP, V92, P135, DOI 10.1016/S0925-4773(99)00332-9; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Little C., 1957, INHERITANCE COAT COL; METALLINOS D, 2000, GENOME BIOL, V1; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TIETZ W, 1963, AM J HUM GENET, V15, P259; Udono T, 2000, BBA-GENE STRUCT EXPR, V1491, P205, DOI 10.1016/S0167-4781(00)00051-8; van Hagen MAE, 2004, J HERED, V95, P526, DOI 10.1093/jhered/esh083; Wade CM, 2006, COLD SPRING HARB MON, V44, P179; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yoshida H, 1996, DEVELOPMENT, V122, P1207	36	409	422	1	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1321	1328		10.1038/ng.2007.10	http://dx.doi.org/10.1038/ng.2007.10			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906626				2022-12-25	WOS:000250575900016
J	Wu, CB; Ying, H; Grinnell, C; Bryant, S; Miller, R; Clabbers, A; Bose, S; McCarthy, D; Zhu, RR; Santora, L; Davis-Taber, R; Kunes, Y; Fung, E; Schwartz, A; Sakorafas, P; Gu, JJ; Tarcsa, E; Murtaza, A; Ghayur, T				Wu, Chengbin; Ying, Hua; Grinnell, Christine; Bryant, Shaughn; Miller, Renee; Clabbers, Anca; Bose, Sahana; McCarthy, Donna; Zhu, Rong-Rong; Santora, Ling; Davis-Taber, Rachel; Kunes, Yune; Fung, Emma; Schwartz, Annette; Sakorafas, Paul; Gu, Jijie; Tarcsa, Edit; Murtaza, Anwar; Ghayur, Tariq			Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin	NATURE BIOTECHNOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; BISPECIFIC ANTIBODIES; CANCER-THERAPY; T-CELLS; MICE; PROTEIN; INTERLEUKIN-12; COMBINATION; CYTOKINES; ACTIVATOR	For complex diseases in which multiple mediators contribute to overall disease pathogenesis by distinct or redundant mechanisms, simultaneous blockade of multiple targets may yield better therapeutic efficacy than inhibition of a single target. However, developing two separate monoclonal antibodies for clinical use as combination therapy is impractical, owing to regulatory hurdles and cost. Multi-specific, antibody-based molecules have been investigated; however, their therapeutic use has been hampered by poor pharmacokinetics, stability and manufacturing feasibility. Here, we describe a generally applicable model of a dual-specific, tetravalent immunoglobulin G (IgG)-like molecule-termed dual-variable-domain immunoglobulin (DVD-Ig)-that can be engineered from any two monoclonal antibodies while preserving activities of the parental antibodies. This molecule can be efficiently produced from mammalian cells and exhibits good physicochemical and pharmacokinetic properties. Preclinical studies of a DVD-Ig protein in an animal disease model demonstrate its potential for therapeutic application in human diseases.	Abbott Res Ctr, Dept Biolog, Worcester, MA 01605 USA; Abbott Res Ctr, Discovery Ssafety Metab & Pharmacokinet, Worcester, MA 01605 USA; Abbott Res Ctr, Dept Pharmacol, Worcester, MA 01605 USA; Abbott Res Ctr, Dept Proc Sci, Worcester, MA 01605 USA		Wu, CB (corresponding author), Abbott Res Ctr, Dept Biolog, 100 Res Dr, Worcester, MA 01605 USA.	chengbin.wu@abbott.com		WU, CHENGBIN/0000-0001-6160-5327; Bryant, Shaughn/0000-0001-9006-9922				Abbott GmbH and Co KG, 2005, [No title captured], Patent No. [US6914128B1, 6914128]; Arend WP, 2001, J CLIN INVEST, V107, P1081, DOI 10.1172/JCI12952; Arndt Michaela, 2003, Methods Mol Biol, V207, P305; BONARDI MA, 1993, CANCER RES, V53, P3015; CHEONG HS, 1990, BIOCHEM BIOPH RES CO, V173, P795; CLARK EA, 1985, P NATL ACAD SCI USA, V82, P1766, DOI 10.1073/pnas.82.6.1766; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DINARELLO CA, 2000, CURRENT PROTOCOLS IM; GHAYUR T, 2005, Patent No. 37971; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; JOOSTEN LAB, 1994, CLIN EXP IMMUNOL, V97, P204; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KAUFMAN RJ, 1985, MOL CELL BIOL, V5, P1750, DOI 10.1128/MCB.5.7.1750; Khaw BA, 2005, ASSAY DRUG DEV TECHN, V3, P319, DOI 10.1089/adt.2005.3.319; Konishi K, 1997, J IMMUNOL METHODS, V209, P187, DOI 10.1016/S0022-1759(97)00164-6; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; LACY S, 2007, Patent No. 25584; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lattenmayer C, 2007, BIOTECHNOL BIOENG, V96, P1118, DOI 10.1002/bit.21183; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Madrenas J, 2004, J IMMUNOL, V172, P5948, DOI 10.4049/jimmunol.172.10.5948; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Marvin JS, 2006, CURR OPIN DRUG DISC, V9, P184; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Neumann D, 2006, INT IMMUNOL, V18, P1779, DOI 10.1093/intimm/dxl112; Peipp M, 2002, BIOCHEM SOC T, V30, P507, DOI 10.1042/bst0300507; Sandin S, 2004, STRUCTURE, V12, P409, DOI 10.1016/j.str.2004.02.011; Shen JQ, 2007, J IMMUNOL METHODS, V318, P65, DOI 10.1016/j.jim.2006.09.020; Strauss SJ, 2006, J CLIN ONCOL, V24, P3880, DOI 10.1200/JCO.2006.05.6291; TARYLEHMANN M, 1995, IMMUNOL TODAY, V16, P529, DOI 10.1016/0167-5699(95)80046-8; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; Vasu C, 2003, INT IMMUNOL, V15, P641, DOI 10.1093/intimm/dxg061; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yu JJ, 2003, J IMMUNOL, V171, P6112, DOI 10.4049/jimmunol.171.11.6112	40	257	528	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1290	1297		10.1038/nbt1345	http://dx.doi.org/10.1038/nbt1345			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17934452				2022-12-25	WOS:000251086500030
J	Williams, GJ; Zhang, C; Thorson, JS				Williams, Gavin J.; Zhang, Changsheng; Thorson, Jon S.			Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE-SPECIFICITY; MACROLIDE GLYCOSYLTRANSFERASES; BIOSYNTHETIC-PATHWAY; CRYSTAL-STRUCTURE; GLYCORANDOMIZATION; REVERSIBILITY; INHIBITION; NOVOBIOCIN; REVEALS	Natural products, many of which are decorated with essential sugar residues, continue to serve as a key platform for drug development(1). Adding or changing sugars attached to such natural products can improve the parent compound's pharmacological properties, specificity at multiple levels(2), and/ or even the molecular mechanism of action(3). Though some natural-product glycosyltransferases ( GTs) are sufficiently promiscuous for use in altering these glycosylation patterns, the stringent specificity of others remains a limiting factor in natural-product diversification and highlights a need for general GT engineering and evolution platforms. Herein we report the use of a simple high-throughput screen based on a fluorescent surrogate acceptor substrate to expand the promiscuity of a natural-product GT via directed evolution. Cumulatively, this study presents variant GTs for the glycorandomization of a range of therapeutically important acceptors, including aminocoumarins, flavonoids and macrolides, and a potential template for engineering other natural-product GTs.	Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem,Natl Cooperat Drug Discovery, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Thorson, JS (corresponding author), Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem,Natl Cooperat Drug Discovery, 777 Highland Ave, Madison, WI 53705 USA.	jsthorson@pharmacy.wisc.edu	Williams, Gavin/AAG-3977-2019; Williams, Gavin/AGR-6936-2022; Zhang, Changsheng/B-5965-2012; Thorson, Jon S/L-3696-2013	Williams, Gavin/0000-0003-2172-9063; Williams, Gavin/0000-0003-2172-9063; Zhang, Changsheng/0000-0003-2349-3138; Thorson, Jon S/0000-0002-7148-0721	NCI NIH HHS [U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed A, 2006, J AM CHEM SOC, V128, P14224, DOI 10.1021/ja064686s; Albermann C, 2003, ORG LETT, V5, P933, DOI 10.1021/ol0341086; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Bonay P, 1996, J BIOL CHEM, V271, P3719; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Carr R, 2003, ANGEW CHEM INT EDIT, V42, P4807, DOI 10.1002/anie.200352100; Collier AC, 2000, DRUG METAB DISPOS, V28, P1184; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; Fylaktakidou KC, 2004, CURR PHARM DESIGN, V10, P3813, DOI 10.2174/1381612043382710; Griffith BR, 2005, CURR OPIN BIOTECH, V16, P622, DOI 10.1016/j.copbio.2005.10.002; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hoffmeister D, 2002, CHEM BIOL, V9, P287, DOI 10.1016/S1074-5521(02)00114-X; Hoffmeister D, 2001, CHEM BIOL, V8, P557, DOI 10.1016/S1074-5521(01)00039-4; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; HUI JP, 2007, E COLI HOST CHEM BIO, V8, P1180; Katz L, 2005, CHEM REV, V105, P499, DOI 10.1021/cr030107f; Lacy A, 2004, CURR PHARM DESIGN, V10, P3797, DOI 10.2174/1381612043382693; Mayer C, 2001, CHEM BIOL, V8, P437, DOI 10.1016/S1074-5521(01)00022-9; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Oberthur M, 2005, J AM CHEM SOC, V127, P10747, DOI 10.1021/ja052945s; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Quiros LM, 1998, MOL MICROBIOL, V28, P1177, DOI 10.1046/j.1365-2958.1998.00880.x; THORSON JS, 2002, CARBOHYDRATE BASED D, P685; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Williams CA, 2004, NAT PROD REP, V21, P539, DOI 10.1039/b311404j; Yang M, 2005, J AM CHEM SOC, V127, P9336, DOI 10.1021/ja051482n; Yuan HQ, 2004, CURR ORG SYNTH, V1, P1, DOI 10.2174/1570179043485411; Zhang CS, 2006, J AM CHEM SOC, V128, P16420, DOI 10.1021/ja065950k; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028; ZHANG ZR, 1990, J PHARMACEUT BIOMED, V8, P385, DOI 10.1016/0731-7085(90)80054-S	32	204	213	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					657	662		10.1038/nchembio.2007.28	http://dx.doi.org/10.1038/nchembio.2007.28			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17828251				2022-12-25	WOS:000249642700015
J	Koyama-Nasu, R; David, G; Tanese, N				Koyama-Nasu, Ryo; David, Gregory; Tanese, Naoko			The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN UV RESPONSE; DNA METHYLTRANSFERASE; CPG ISLANDS; GENE; ACTIVATION; DOMAIN; INDUCTION; ONCOGENE; GROWTH	c-Jun is a component of the heterodimeric transcription factor AP-1 that is rapidly activated in response to ultraviolet light (UV)(1). In unstressed cells, c-Jun activity is negatively regulated by transcriptional repressor complexes. Here we show that the F-box protein Fbl10/JHDM1B interacts with c-Jun and represses c-Jun-mediated transcription. Chromatin-immunoprecipitation assays demonstrate that Fbl10 is present at the c-jun promoter, and that c-Jun is required for the recruitment of Fbl10. Fbl10 binds to the unmethylated CpG sequences in the c-jun promoter through the CxxC zinc finger and tethers transcriptional repressor complexes. Suppression of Fbl10 expression by RNA interference (RNAi) induces transcription of c-jun and other c-Jun-target genes, and causes an aberrant cell-cycle progression and increased UV-induced cell death. Furthermore, Fbl10 protein and messenger RNA are downregulated in response to UV in an inverse correlation with c-Jun. Taken together, our results demonstrate that Fbl10 is a key regulator of c-Jun function.	NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; NYU Canc Inst, Dept Microbiol, New York, NY 10016 USA; NYU Canc Inst, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Koyama-Nasu, R (corresponding author), NYU Canc Inst, Dept Pathol, New York, NY 10016 USA.	ryo.nasu@med.nyu.edu		, gregory/0000-0002-3371-4558; Tanese, Naoko/0000-0002-1946-3211				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCH TM, 1989, MOL CELL BIOL, V9, P1327, DOI 10.1128/MCB.9.3.1327; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VANDAM H, 1990, MOL CELL BIOL, V10, P5857, DOI 10.1128/MCB.10.11.5857; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	30	49	49	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1074	U49		10.1038/ncb1628	http://dx.doi.org/10.1038/ncb1628			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704768				2022-12-25	WOS:000249256500015
J	Li, YG; Drummond, DA; Sawayama, AM; Snow, CD; Bloom, JD; Arnold, FH				Li, Yougen; Drummond, D. Allan; Sawayama, Andrew M.; Snow, Christopher D.; Bloom, Jesse D.; Arnold, Frances H.			A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments	NATURE BIOTECHNOLOGY			English	Article							ENZYMES; ASTEMIZOLE; VERAPAMIL; PROTEINS	Thermostable enzymes combine catalytic specificity with the toughness required to withstand industrial reaction conditions(1,2). Stabilized enzymes also provide robust starting points for evolutionary improvement of other protein properties(3). We recently created a library(4) of at least 2,300 new active chimeras of the biotechnologically important(5-9) cytochrome P450 enzymes. Here we show that a chimera's thermostability can be predicted from the additive contributions of its sequence fragments. Based on these predictions, we constructed a family of 44 novel thermostable P450s with half-lives of inactivation at 57 degrees C up to 108 times that of the most stable parent. Although they differ by as many as 99 amino acids from any known P450, the stable sequences are catalytically active. Among the novel functions they exhibit is the ability to produce drug metabolites. This chimeric P450 family provides a unique ensemble for biotechnological applications and for studying sequence-stability-function relationships.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Program Computat & Neural Syst, Pasadena, CA 91125 USA; Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	California Institute of Technology; California Institute of Technology; Harvard University	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 210-40, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu	Snow, Christopher/L-5624-2013; Bloom, Jesse D/C-6837-2013; Bloom, Jesse D/K-3695-2019; Drummond, D. Allan/A-1250-2015	Snow, Christopher/0000-0002-7690-3519; Bloom, Jesse D/0000-0003-1267-3408; Drummond, D. Allan/0000-0001-7018-7059; Arnold, Frances H./0000-0002-4027-364X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068664] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 068664-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERNETHY DR, 1993, J PHARMACOL EXP THER, V266, P904; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Busse D, 1995, N-S ARCH PHARMACOL, V353, P116; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Fox R, 2003, PROTEIN ENG, V16, P589, DOI 10.1093/protein/gzg077; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; HEYKANTS J, 1986, DRUG DEVELOP RES, V8, P71, DOI 10.1002/ddr.430080109; Johannes TW, 2005, APPL ENVIRON MICROB, V71, P5728, DOI 10.1128/AEM.71.10.5728-5734.2005; Landwehr M, 2007, CHEM BIOL, V14, P269, DOI 10.1016/j.chembiol.2007.01.009; Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; MEULDERMANS W, 1986, DRUG DEVELOP RES, V8, P37, DOI 10.1002/ddr.430080106; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Otey CR, 2006, PLOS BIOL, V4, P789, DOI 10.1371/journal.pbio.0040112; Otey CR, 2006, BIOTECHNOL BIOENG, V93, P494, DOI 10.1002/bit.20744; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; van Vugt-Lussenburg BMA, 2006, BIOCHEM BIOPH RES CO, V346, P810, DOI 10.1016/j.bbrc.2006.05.179; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Zeikus JG, 1998, EXTREMOPHILES, V2, P179, DOI 10.1007/s007920050058	22	108	116	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1051	1056		10.1038/nbt1333	http://dx.doi.org/10.1038/nbt1333			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17721510				2022-12-25	WOS:000249444200029
J	Li, YX; Migueles, SA; Welcher, B; Svehla, K; Phogat, A; Louder, MK; Wu, XL; Shaw, GM; Connors, M; Wyatt, RT; Mascola, JR				Li, Yuxing; Migueles, Stephen A.; Welcher, Brent; Svehla, Krisha; Phogat, Adhuna; Louder, Mark K.; Wu, Xueling; Shaw, George M.; Connors, Mark; Wyatt, Richard T.; Mascola, John R.			Broad HIV-1 neutralization mediated by CD4-binding site antibodies	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEINS; GP120; SERA	We have identified several patient sera showing potent and broad HIV-1 neutralization. Using antibody adsorption and elution from selected gp120 variants, the neutralizing specificities of the two most broadly reactive sera were mapped to the primary receptor CD4-binding region of HIV-1 gp120. Novel antibodies to the CD4-binding site are elicited in some HIV-1-infected individuals, and new approaches to present this conserved region of gp120 to the immune system may result in improved vaccine immunogens.	Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Dept Med & Microbiol, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham	Wyatt, RT (corresponding author), Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD 20892 USA.	richardwyatt@nih.gov	Mascola, John/AAI-7193-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000855, Z01AI005089, U19AI067854, Z01AI005091, Z01AI005095] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [U19 AI067854-03, U19 AI067854] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Stamatos NM, 1998, J VIROL, V72, P9656, DOI 10.1128/JVI.72.12.9656-9667.1998; STEIMER KS, 1991, SCIENCE, V254, P105, DOI 10.1126/science.1718036; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	15	335	359	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1032	1034		10.1038/nm1624	http://dx.doi.org/10.1038/nm1624			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17721546	Green Accepted			2022-12-25	WOS:000249353100029
J	Manolio, TA; Rodriguez, LL; Brooks, L; Abecasis, G; Ballinger, D; Daly, M; Donnelly, P; Faraone, SV; Frazer, K; Gabriel, S; Gejman, P; Guttmacher, A; Harris, EL; Insel, T; Kelsoe, JR; Lander, E; McCowin, N; Mailman, MD; Nabel, E; Ostell, J; Pugh, E; Sherry, S; Sullivan, PF; Thompson, JF; Warram, J; Study, G; Wholley, D; Milos, PM; Collins, FS				Manolio, Teri A.; Rodriguez, Laura Lyman; Brooks, Lisa; Abecasis, Goncalo; Ballinger, Dennis; Daly, Mark; Donnelly, Peter; Faraone, Stephen V.; Frazer, Kelly; Gabriel, Stacey; Gejman, Pablo; Guttmacher, Alan; Harris, Emily L.; Insel, Thomas; Kelsoe, John R.; Lander, Eric; McCowin, Norma; Mailman, Matthew D.; Nabel, Elizabeth; Ostell, James; Pugh, Elizabeth; Sherry, Stephen; Sullivan, Patrick F.; Thompson, John F.; Warram, James; Study, GoKinD; Wholley, David; Milos, Patrice M.; Collins, Francis S.		Gain Collaborative Res Grp; Collaborative Assoc Study; Int Multi-Center ADHD Genetics; Mol Genetics Schizophrenia Collab; Bipolar Genome Study; Major Depression Stage 1 Genomewid	New models of collaboration in genome-wide association studies: the Genetic Association Information Network	NATURE GENETICS			English	Editorial Material							BREAST-CANCER; SUSCEPTIBILITY; LOCI; VARIANTS; MULTIPLE; LINKAGE; SAMPLE; RISK	The Genetic Association Information Network ( GAIN) is a public- private partnership established to investigate the genetic basis of common diseases through a series of collaborative genome-wide association studies. GAIN has used new approaches for project selection, data deposition and distribution, collaborative analysis, publication and protection from premature intellectual property claims. These demonstrate a new commitment to shared scientific knowledge that should facilitate rapid advances in understanding the genetics of complex diseases.	US NIH, NHGRI, Bethesda, MD 20892 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Perlegen Sci, Mountain View, CA 94043 USA; Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; Univ Oxford, Oxford OX1 3TG, England; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Evanston NW Healthcare, Evanston, IL 60201 USA; Northwestern Univ, Evanston, IL 60201 USA; NIMH, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Vet Admin San Diego Healthcare Syst, La Jolla, CA 92093 USA; Fdn NIH, Bethesda, MD 20892 USA; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; Natl Lib Med, NIH, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Pfizer Inc, Pharmacogenom Pfizer Global Res & Dev, Groton, CT 06340 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Helicos BioSci Corp, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Scripps Research Institute; NorthShore University Health System; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Harvard University; Joslin Diabetes Center, Inc.	Manolio, TA (corresponding author), US NIH, NHGRI, 31 Ctr Dr, Bethesda, MD 20892 USA.	manolio@nih.gov; manolio@nih.gov	Daly, Mark J/B-2453-2017; Faraone, Stephen V/O-7239-2018; Abecasis, Goncalo R/B-7840-2010; Peng, Bo/A-6920-2009; Faraone, Stephen/AAE-7334-2019	Daly, Mark J/0000-0002-0949-8752; Faraone, Stephen V/0000-0002-9217-3982; Peng, Bo/0000-0001-8225-2284; Faraone, Stephen/0000-0002-9217-3982; Thompson, John/0000-0001-8568-3311; Frazer, Kelly/0000-0002-6060-8902; Sherry, Stephen/0000-0002-7982-076X; Donnelly, Peter/0000-0001-9495-3408; Abecasis, Goncalo/0000-0003-1509-1825	NCRR NIH HHS [U54RR020278-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200334, Z01HG200334] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; *DEP HLTH HUM SERV, 2000, FED REGISTER, V67, P53270; *DEP HLTH HUM SERV, 2005, FED REGISTER, V70, P36325; *DEP HLTH HUM SERV, 2000, FED REGISTER, V65, P82818; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHLESSELMAN JJ, CASE CONTROL STUDIES; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	25	229	234	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1045	1051		10.1038/ng2127	http://dx.doi.org/10.1038/ng2127			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17728769				2022-12-25	WOS:000249122400003
J	Zhang, Y; Liu, JS				Zhang, Yu; Liu, Jun S.			Bayesian inference of epistatic interactions in case-control studies	NATURE GENETICS			English	Article							ASSOCIATION; STRATEGIES	Epistatic interactions among multiple genetic variants in the human genome may be important in determining individual susceptibility to common diseases. Although some existing computational methods for identifying genetic interactions have been effective for small- scale studies, we here propose a method, denoted ' bayesian epistasis association mapping' ( BEAM), for genome- wide case- control studies. BEAM treats the disease- associated markers and their interactions via a bayesian partitioning model and computes, via Markov chain Monte Carlo, the posterior probability that each marker set is associated with the disease. Testing this on an age- related macular degeneration genome- wide association data set, we demonstrate that the method is significantly more powerful than existing approaches and that genome- wide case- control epistasis mapping with many thousands of markers is both computationally and statistically feasible.	Harvard Univ, Dept Stat, Sci Ctr 715, Cambridge, MA 02138 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA	Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Sci Ctr 715, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG002518-06] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LIU JS, 2001, MONTE CARLO STRATEGI; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Zee R. Y. L., 2002, Pharmacogenomics Journal, V2, P197, DOI 10.1038/sj.tpj.6500101; Zheng T, 2006, HUM HERED, V62, P196, DOI 10.1159/000096995; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	19	352	369	1	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1167	1173		10.1038/ng2110	http://dx.doi.org/10.1038/ng2110			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17721534				2022-12-25	WOS:000249122400030
J	Douglas, J; Cilliers, D; Coleman, K; Tatton-Brown, K; Barker, K; Bernhard, B; Burn, J; Huson, S; Josifova, D; Lacombe, D; Malik, M; Mansour, S; Reid, E; Cormier-Daire, V; Cole, T; Rahman, N				Douglas, Jenny; Cilliers, Deirdre; Coleman, Kim; Tatton-Brown, Katrina; Barker, Karen; Bernhard, Brigitte; Burn, John; Huson, Susan; Josifova, Dragana; Lacombe, Didier; Malik, Mohsin; Mansour, Sahar; Reid, Evan; Cormier-Daire, Valerie; Cole, Trevor; Rahman, Nazneen			Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth	NATURE GENETICS			English	Article							INDIVIDUALS; DELETIONS	17q11 microdeletions that encompass NF1 cause 5%-10% of cases of neurofibromatosis type 1, and individuals with microdeletions are typically taller than individuals with intragenic NF1 mutations, suggesting that deletion of a neighboring gene might promote human growth. We identified mutations in RNF135, which is within the NF1 microdeletion region, in six families characterized by overgrowth, learning disability, dysmorphic features and variable additional features. These data identify RNF135 as causative of a new overgrowth syndrome and demonstrate that RNF135 haploinsufficiency contributes to the phenotype of NF1 microdeletion cases.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; St George Hosp, Sch Med, SW Thames Reg Genet Serv, London SW17 0RE, England; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Hop Pellegrin Enfants, Dept Med Genet, EA2406, Bordeaux, France; Queen Elizabeth Queen Mothers Hosp, Margate CT9 4AN, England; Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; Hop Necker Enfants Malad, Dept Med Genet, F-75015 Paris, France; Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England	University of London; Institute of Cancer Research - UK; St Georges University London; Newcastle University - UK; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Milani, Donatella/AAC-8430-2019; Reid, Evan/F-3250-2010; Rahman, Nazneen/B-8890-2012; cormier-daire, valerie/H-6520-2017; Rahman, Nazneen/D-2802-2013; Grasso, Marina/AAC-8722-2019	Milani, Donatella/0000-0002-3087-8514; Reid, Evan/0000-0003-1623-7304; Reardon, Willie/0000-0001-7329-9179; cormier-daire, valerie/0000-0002-2839-9856; Rahman, Nazneen/0000-0003-4376-0440; Lynch, Sally Ann/0000-0003-3540-1333; Grasso, Marina/0000-0001-5682-1789; FitzPatrick, David R./0000-0003-4861-969X; Burn, John/0000-0002-9823-2322; Lacombe, Didier/0000-0002-8956-2207; Silengo, Margherita/0000-0002-6255-1532	Medical Research Council [G0400188] Funding Source: Medline; MRC [G0400188] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Devriendt Koen, 2004, Human Genomics, V1, P126; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Spiegel M, 2005, EUR J HUM GENET, V13, P883, DOI 10.1038/sj.ejhg.5201419; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; van Asperen CJ, 1998, J MED GENET, V35, P323, DOI 10.1136/jmg.35.4.323; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Weksberg R., 2002, OVERGROWTH SYNDROMES	15	61	69	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					963	965		10.1038/ng2083	http://dx.doi.org/10.1038/ng2083			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632510				2022-12-25	WOS:000248446900011
J	Kantarci, S; Al-Gazali, L; Hill, RS; Donnai, D; Black, GCM; Bieth, E; Chassaing, N; Lacombe, D; Devriendt, K; Teebi, A; Loscertales, M; Robson, C; Liu, TM; MacLaughlin, DT; Noonan, KM; Russell, MK; AWalsh, C; Donahoe, PK; Pober, BR				Kantarci, Sibel; Al-Gazali, Lihadh; Hill, R. Sean; Donnai, Dian; Black, Graeme C. M.; Bieth, Eric; Chassaing, Nicolas; Lacombe, Didier; Devriendt, Koen; Teebi, Ahmad; Loscertales, Maria; Robson, Caroline; Liu, Tianming; MacLaughlin, David T.; Noonan, Kristin M.; Russell, Meaghan K.; AWalsh, Christopher; Donahoe, Patricia K.; Pober, Barbara R.			Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes	NATURE GENETICS			English	Article							DIAPHRAGMATIC-HERNIA; SONIC HEDGEHOG; ANIMAL-MODEL; DEAFNESS; MICE; HYPERTELORISM; PROTEINURIA; HYPOPLASIA; RETINOL; MYOPIA	Donnai-Barrow syndrome is associated with agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay. By studying multiplex families, we mapped this disorder to chromosome 2q23.3-31.1 and identified LRP2 mutations in six families with Donnai-Barrow syndrome and one family with facio-oculo-acoustico-renal syndrome. LRP2 encodes megalin, a multiligand uptake receptor that regulates levels of diverse circulating compounds. This work implicates a pathway with potential pharmacological therapeutic targets.	Massachusetts Gen Hosp, Pediat Surg Res Lab, Boston, MA 02114 USA; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Univ Manchester, St Marys Hosp, Unit Med Genet, Manchester M13 0JH, Lancs, England; Hop Purpan, F-31059 Toulouse 9, France; CHU Pellegrin, Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Gen Med Serv, Bordeaux, France; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Weill Cornell Med Coll, Dept Pediat, Doha, Qatar; Weill Cornell Med Coll, Dept Med Genet, Doha, Qatar; Hamad Med City, Doha, Qatar; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Brigham & Womens Hosp, Harvard Ctr Neurodegenerat & Repair, Ctr Bioinformat, Boston, MA 02115 USA; MassGen Hosp Children, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; United Arab Emirates University; Harvard University; Beth Israel Deaconess Medical Center; University of Manchester; CHU de Toulouse; CHU Bordeaux; CHU Bordeaux; Universite Catholique Louvain; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Pober, BR (corresponding author), Massachusetts Gen Hosp, Pediat Surg Res Lab, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	bpober@partners.org	Congregado, Miguel/B-9062-2009; Liu, Tianming/AAA-4602-2022; Liu, Tianming/A-2512-2008; wei, wei/HHR-8613-2022; Black, Graeme/K-7374-2015	Congregado, Miguel/0000-0002-2404-0176; Lacombe, Didier/0000-0002-8956-2207; Robson, Caroline/0000-0001-5592-249X; Black, Graeme/0000-0001-8727-6592	NICHD NIH HHS [R01 HD055150, R01 HD055150-02, R01 HD55150-01] Funding Source: Medline; NINDS NIH HHS [R37 NS35129, R37 NS035129] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035129] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chassaing N, 2003, AM J MED GENET A, V121A, P258, DOI 10.1002/ajmg.a.20266; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Devriendt K, 1998, J MED GENET, V35, P70, DOI 10.1136/jmg.35.1.70; DONNAI D, 1993, AM J MED GENET, V47, P679, DOI 10.1002/ajmg.1320470518; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; HOLMES LB, 1972, J PEDIATR-US, V81, P552, DOI 10.1016/S0022-3476(72)80189-6; KLUTH D, 1990, J PEDIATR SURG, V25, P850, DOI 10.1016/0022-3468(90)90190-K; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Raila J, 2005, J NUTR, V135, P2512, DOI 10.1093/jn/135.11.2512; Unger S, 2003, AM J PATHOL, V162, P547, DOI 10.1016/S0002-9440(10)63848-5; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460	15	223	229	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					957	959		10.1038/ng2063	http://dx.doi.org/10.1038/ng2063			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632512	Green Accepted			2022-12-25	WOS:000248446900009
J	Zhang, ZJ; Chen, G; Zhou, W; Song, AH; Xu, T; Luo, QM; Wang, W; Gu, XS; Duan, SM				Zhang, Zhijun; Chen, Gang; Zhou, Wei; Song, Aihong; Xu, Tao; Luo, Qingming; Wang, Wei; Gu, Xiao-song; Duan, Shumin			Regulated ATP release from astrocytes through lysosome exocytosis	NATURE CELL BIOLOGY			English	Article							KISS-AND-RUN; HIPPOCAMPAL SYNAPSES; MULTIDRUG-RESISTANCE; SECRETORY LYSOSOMES; CALCIUM WAVES; CELLS; VESICLES; RECEPTORS; RELEVANCE; PROTEINS	Release of ATP from astrocytes is required for Ca2+ wave propagation among astrocytes(1-3) and for feedback modulation of synaptic functions(2,4,5). However, the mechanism of ATP release and the source of ATP in astrocytes are still not known. Here we show that incubation of astrocytes with FM dyes leads to selective labelling of lysosomes. Time-lapse confocal imaging of FM dye-labelled fluorescent puncta, together with extracellular quenching and total-internal-reflection fluorescence microscopy (TIRFM), demonstrated directly that extracellular ATP or glutamate induced partial exocytosis of lysosomes, whereas an ischaemic insult with potassium cyanide induced both partial and full exocytosis of these organelles. We found that lysosomes contain abundant ATP, which could be released in a stimulus-dependent manner. Selective lysis of lysosomes abolished both ATP release and Ca2+ wave propagation among astrocytes, implicating physiological and pathological functions of regulated lysosome exocytosis in these cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Nantong Univ, Jiangsu Key Lab Neuroregenerat, Jiangsu 226001, Peoples R China; Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; Chinese Acad Sci, Wuhan Biophys, Britton Chance Ctr Biomed Photon, Beijing 100101, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Neurol, Wuhan 430030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nantong University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Huazhong University of Science & Technology	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn		Chen, Gang/0000-0003-3669-5687; Luo, Qingming/0000-0002-6725-9311				ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; Ballerini P, 2002, NEUROREPORT, V13, P1789, DOI 10.1097/00001756-200210070-00019; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brake AJ, 1996, ANNU REV CELL DEV BI, V12, P519, DOI 10.1146/annurev.cellbio.12.1.519; Cabrita MA, 1999, CANCER RES, V59, P4890; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HARIKUMAR P, 1983, J BIOL CHEM, V258, P403; Hassinger TD, 1996, P NATL ACAD SCI USA, V93, P13268, DOI 10.1073/pnas.93.23.13268; Hayashi Takeshi, 2006, Current Alzheimer Research, V3, P351, DOI 10.2174/156720506778249498; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rizzoli SO, 2003, J NEUROCYTOL, V32, P539, DOI 10.1023/B:NEUR.0000020609.19873.e8; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Sperlagh B, 1996, SEMIN NEUROSCI, V8, P175, DOI 10.1006/smns.1996.0023; VAN LF, 1980, CELL, V20, P37; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	38	388	401	4	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					945	U115		10.1038/ncb1620	http://dx.doi.org/10.1038/ncb1620			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618272				2022-12-25	WOS:000248486700016
J	Zippo, A; De Robertis, A; Serafini, R; Oliviero, S				Zippo, Alessio; De Robertis, Alessandra; Serafini, Riccardo; Oliviero, Salvatore			PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation	NATURE CELL BIOLOGY			English	Article							E-MU-MYC; C-MYC; TRANSGENIC MICE; RIBOSOMAL DNA; GENE; BINDING; TARGET; GROWTH; LYMPHOMAGENESIS; IDENTIFICATION	The serine/threonine kinase human Pim1 ( hereafter PIM1) cooperates with human c-Myc ( hereafter MYC) in cell cycle progression and tumorigenesis. However, the nature of this cooperation is still unknown. Here we show that, after stimulation with growth factor, PIM1 forms a complex with the dimer of MYC with MAX ( Myc-associated factor X) via the MYC BoxII (MBII) domain. MYC recruits PIM1 to the E boxes of the MYC-target genes FOSL1 (FRA-1) and ID2, and PIM1 phosphorylates serine 10 of histone H3 (H3S10) on the nucleosome at the MYC-binding sites, contributing to their transcriptional activation. MYC and PIM1 colocalize at sites of active transcription, and expression profile analysis revealed that PIM1 contributes to the regulation of 20% of the MYC-regulated genes. Moreover, PIM1-dependent H3S10 phosphorylation contributes to MYC transforming capacity. These results establish a new function for PIM1 as a MYC cofactor that phosphorylates the chromatin at MYC-target loci and suggest that nucleosome phosphorylation, at E boxes, contributes to MYC-dependent transcriptional activation and cellular transformation.	Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.	oliviero@unisi.it	oliviero, salvatore/R-6657-2019	oliviero, salvatore/0000-0002-3405-765X; zippo, Alessio/0000-0002-3686-6151				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cirillo LA, 2004, METHOD ENZYMOL, V375, P131; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; CUYPERS HT, 1984, CELL, V37, P141; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang Z, 2001, J Vet Sci, V2, P167; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang SS, 1999, J CELL SCI, V112, P2693; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827	50	209	224	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					932	U106		10.1038/ncb1618	http://dx.doi.org/10.1038/ncb1618			47	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643117	Green Submitted			2022-12-25	WOS:000248486700015
J	Adewumi, O; Aflatoonian, B; Ahrlund-Richter, L; Amit, M; Andrews, PW; Beighton, G; Bello, PA; Benvenisty, N; Berry, LS; Bevan, S; Blum, B; Brooking, J; Chen, KG; Choo, ABH; Churchill, GA; Corbel, M; Damjanov, I; Draper, JS; Dvorak, P; Emanuelsson, K; Fleck, RA; Ford, A; Gertow, K; Gertsenstein, M; Gokhale, PJ; Hamilton, RS; Hampl, A; Healy, LE; Hovatta, O; Hyllner, J; Imreh, MP; Itskovitz-Eldor, J; Jackson, J; Johnson, JL; Jones, M; Kee, K; King, BL; Knowles, BB; Lako, M; Lebrin, F; Mallon, BS; Manning, D; Mayshar, Y; Mckay, RDG; Michalska, AE; Mikkola, M; Mileikovsky, M; Minger, SL; Moore, HD; Mummery, CL; Nagy, A; Nakatsuji, N; O'Brien, CM; Oh, SKW; Olsson, C; Otonkoski, T; Park, KY; Passier, R; Patel, H; Patel, M; Pedersen, R; Pera, MF; Piekarczyk, MS; Pera, RAR; Reubinoff, BE; Robins, AJ; Rossant, J; Rugg-Gunn, P; Schulz, TC; Semb, H; Sherrer, ES; Siemen, H; Stacey, GN; Stojkovic, M; Suemori, H; Szatkiewicz, J; Turetsky, T; Tuuri, T; van den Brink, S; Vintersten, K; Vuoristo, S; Ward, D; Weaver, TA; Young, LA; Zhang, WD				Adewumi, Oluseun; Aflatoonian, Behrouz; Ahrlund-Richter, Lars; Amit, Michal; Andrews, Peter W.; Beighton, Gemma; Bello, Paul A.; Benvenisty, Nissim; Berry, Lorraine S.; Bevan, Simon; Blum, Barak; Brooking, Justin; Chen, Kevin G.; Choo, Andre B. H.; Churchill, Gary A.; Corbel, Marie; Damjanov, Ivan; Draper, Jon S.; Dvorak, Petr; Emanuelsson, Katarina; Fleck, Roland A.; Ford, Angela; Gertow, Karin; Gertsenstein, Marina; Gokhale, Paul J.; Hamilton, Rebecca S.; Hampl, Ales; Healy, Lyn E.; Hovatta, Outi; Hyllner, Johan; Imreh, Marta P.; Itskovitz-Eldor, Joseph; Jackson, Jamie; Johnson, Jacqueline L.; Jones, Mark; Kee, Kehkooi; King, Benjamin L.; Knowles, Barbara B.; Lako, Majlinda; Lebrin, Franck; Mallon, Barbara S.; Manning, Daisy; Mayshar, Yoav; Mckay, Ronald D. G.; Michalska, Anna E.; Mikkola, Milla; Mileikovsky, Masha; Minger, Stephen L.; Moore, Harry D.; Mummery, Christine L.; Nagy, Andras; Nakatsuji, Norio; O'Brien, Carmel M.; Oh, Steve K. W.; Olsson, Cia; Otonkoski, Timo; Park, Kye-Yoon; Passier, Robert; Patel, Hema; Patel, Minal; Pedersen, Roger; Pera, Martin F.; Piekarczyk, Marian S.; Pera, Renee A. Reijo; Reubinoff, Benjamin E.; Robins, Allan J.; Rossant, Janet; Rugg-Gunn, Peter; Schulz, Thomas C.; Semb, Henrik; Sherrer, Eric S.; Siemen, Henrike; Stacey, Glyn N.; Stojkovic, Miodrag; Suemori, Hirofumi; Szatkiewicz, Jin; Turetsky, Tikva; Tuuri, Timo; van den Brink, Steineke; Vintersten, Kristina; Vuoristo, Sanna; Ward, Dorien; Weaver, Thomas A.; Young, Lesley A.; Zhang, Weidong		Int Stem Cell Initiative	Characterization of human embryonic stem cell lines by the International Stem Cell Initiative	NATURE BIOTECHNOLOGY			English	Article							X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; SURFACE-ANTIGENS; CARCINOMA-CELLS; GLOBO-SERIES; ES CELLS; DIFFERENTIATION; MOUSE; PLURIPOTENCY	The International Stem Cell Initiative characterized 59 human embryonic stem cell lines from 17 laboratories worldwide. Despite diverse genotypes and different techniques used for derivation and maintenance, all lines exhibited similar expression patterns for several markers of human embryonic stem cells. They expressed the glycolipid antigens SSEA3 and SSEA4, the keratan sulfate antigens TRA-1-60, TRA-1-81, GCTM2 and GCT343, and the protein antigens CD9, Thy1 (also known as CD90), tissue- nonspecific alkaline phosphatase and class 1 HLA, as well as the strongly developmentally regulated genes NANOG, POU5F1 (formerly known as OCT4), TDGF1, DNMT3B, GABRB3 and GDF3. Nevertheless, the lines were not identical: differences in expression of several lineage markers were evident, and several imprinted genes showed generally similar allele-specific expression patterns, but some gene-dependent variation was observed. Also, some female lines expressed readily detectable levels of XIST whereas others did not. No significant contamination of the lines with mycoplasma, bacteria or cytopathic viruses was detected.	Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; Natl Inst Biol Stand & Controls, UK Stem Cell Bank, Div Cell Biol & Imaging, S Mimms EN6 3QG, Herts, England; Univ Sheffield, Ctr Stem Cell Biol, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Karolinska Inst, Dept Lab Med, Unit Mol Embryol, S-14157 Huddinge, Sweden; Technion Israel Inst Technol, Rambam Med Ctr, IL-31096 Haifa, Israel; St James Univ Hosp, Canc Res UK Genotyping Facil, Leeds LS9 3LP, W Yorkshire, England; Geneservice Ltd, Cambridge CB3 0FE, England; Monash Univ, Stem Cell Sci Ltd, Clayton, Vic 3800, Australia; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; Thermo Fisher Sci, Matrix Technol, Handforth SK9 3LP, England; NIH, NIH Stem Cell Unit, Bethesda, MD 20892 USA; Bioproc Technol Inst, Singapore 138668, Singapore; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2XY, England; Univ Kansas, Sch Med, Dept Pathol, Kansas City, KS 66160 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; Acad Sci Czech Republ, Inst Expt Med, Dept Mol Embryol, Brno, Czech Republic; Cellartis AB, S-41346 Gothenburg, Sweden; Monash Univ, MISCL, Clayton, Vic 3800, Australia; Karolinska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet Gynecol, S-14186 Huddinge, Sweden; Karolinska Inst, Dept Lab Med, Clin Res Ctr, S-14157 Huddinge, Sweden; Uppsala Univ, Dept Genet & Dev, SE-7523236 Uppsala, Sweden; Stanford Univ, Ctr Human Embryon Stem Cell Res & Educ, Inst Stem Cell Biol & Regenerat Med, Dept Obstet & Gynecol, Palo Alto, CA 94304 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Inst Mol Biophys, Bar Harbor, ME 04609 USA; Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Paris 06, INSERM, UR 525, Paris, France; WiCell Res Inst, Madison, WI 53707 USA; WiCell Res Inst, St Louis, MO 63131 USA; Monash Univ, Monash Inst Med Res, Lab Embryon Stem Cell Biol, Clayton, Vic 3800, Australia; Australian Stem Cell Ctr, Clayton, Vic 3800, Australia; Univ Helsinki, Biomedicum Stem Cell Ctr, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan; UCL, Univ Coll London, Regenerat Med Bioproc Unit, Adv Ctr Biochem Engn,Dept Biochem Engn, London WC1E 7JE, England; Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3800, Australia; Univ So Calif, Keck Sch Med, Ctr Stem Cell & Regenerat Med, CO Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; Hadassah Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; Hadassah Univ, Med Ctr, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Novocell, Athens, GA 30606 USA; Hosp Sick Children, Dev Biol Program, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Dev Biol Program, Toronto, ON M5G 1X8, Canada; Lund Univ, Stem Cell Ctr, SE-22184 Lund, Sweden; Ctr Invest Principe Felipe, Valencia, Spain	University of Sheffield; National Institute for Biological Standards & Control; University of Sheffield; Karolinska Institutet; Rambam Health Care Campus; Technion Israel Institute of Technology; Saint James's University Hospital; Monash University; Hebrew University of Jerusalem; Thermo Fisher Scientific; National Institutes of Health (NIH) - USA; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Jackson Laboratory; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Kansas; University of Kansas Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Masaryk University Brno; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Takara Bio Inc.; Cellartis; Monash University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Stanford University; Jackson Laboratory; Newcastle University - UK; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; WiCell Research Institute; WiCell Research Institute; Monash University; University of Helsinki; University of London; King's College London; Kyoto University; University of London; University College London; Monash University; University of Southern California; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Lund University; Prince Felipe Research Center	Andrews, PW (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	p.w.andrews@sheffield.ac.uk	Aflatoonian, Behrouz/AAZ-4648-2021; Nagy, Andras/G-6465-2013; Ahrlund-Richter, Lars/C-6226-2012; PERA, MARTIN/A-9812-2012; Dvorak, Petr/N-8936-2016; Dvorak, Petr/G-2509-2013; O'Brien, Carmel M/I-5664-2017; Hampl, Ales/N-1632-2016; King, Benjamin/AAI-1492-2019; Fleck, Roland/AAL-1292-2020; Chen, Kevin/GYU-8963-2022; Chen, Kevin G/D-6769-2011; Otonkoski, Timo/F-1189-2011; Lako, Majlinda/B-6297-2013; Churchill, Gary/AAY-7496-2020	Aflatoonian, Behrouz/0000-0002-7250-9813; Nagy, Andras/0000-0003-4311-0413; PERA, MARTIN/0000-0001-6239-0428; Dvorak, Petr/0000-0002-3229-140X; Dvorak, Petr/0000-0002-3229-140X; O'Brien, Carmel M/0000-0001-6189-1343; Hampl, Ales/0000-0002-8963-9235; Fleck, Roland/0000-0003-1542-6218; Chen, Kevin G/0000-0003-2983-6330; Churchill, Gary/0000-0001-9190-9284; King, Benjamin/0000-0001-6463-1336; Choo, Andre/0000-0001-9648-0755; Semb, Henrik/0000-0002-6747-787X; Blum, Barak/0000-0002-5308-4194; Mayshar, Yoav/0000-0002-5553-2472; Gokhale, Paul/0000-0001-7225-4403; Stojkovic, Miodrag/0000-0001-7526-6573; Knowles, Barbara B./0000-0002-2597-5619; Reubinoff, Benjamin/0000-0003-0353-1299; Mummery, Christine/0000-0002-4549-6535; lako, majlinda/0000-0003-1327-8573; lebrin, franck/0000-0002-1650-6757; Andrews, Peter/0000-0001-7215-4410; Rugg-Gunn, Peter/0000-0002-9601-5949; Healy, Lyn/0000-0002-7044-8789; KEE, KEHKOOI/0000-0001-6926-7203	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017498, R24RR018405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002981] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E012841/1, BBS/B/14779] Funding Source: Medline; Intramural NIH HHS [Z99 NS999999] Funding Source: Medline; Medical Research Council [MC_QA137916, G0801059, G0300283, G0600275, G0300273, G0301182, G0300723] Funding Source: Medline; NCRR NIH HHS [R24RR017498-04, R24RR021314-04, R24RR018405] Funding Source: Medline; Medical Research Council [MC_qA137914, G0300723B, MC_qA137863, MC_qA137916] Funding Source: researchfish; BBSRC [BB/E012841/1] Funding Source: UKRI; MRC [MC_qA137916, G0300723, G0300273, G0301182, G0300283, G0600275, MC_qA137914] Funding Source: UKRI	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 2005, NAT BIOTECHNOL, V23, P795, DOI 10.1038/nbt0705-798; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, HYBRIDOMA, V3, P33, DOI 10.1089/hyb.1984.3.33; ANDREWS PW, 1987, CANCER RES, V47, P740; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; ANDREWS PW, 1987, TERATOCARCINOMAS EMB, P207; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Baldassarre G, 1996, INT J CANCER, V66, P538, DOI 10.1002/(SICI)1097-0215(19960516)66:4<538::AID-IJC19>3.0.CO;2-3; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brimble SN, 2007, STEM CELLS, V25, P54, DOI 10.1634/stemcells.2006-0232; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Civin CI, 2006, STEM CELLS, V24, P800, DOI 10.1634/stemcells.2006-0084; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; Dao D, 1998, HUM MOL GENET, V7, P597, DOI 10.1093/hmg/7.4.597; Dean W, 1998, DEVELOPMENT, V125, P2273; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; MARTIN GR, 1978, NATURE, V271, P329, DOI 10.1038/271329a0; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Mitalipov SM, 2006, REPROD FERT DEVELOP, V18, P817, DOI 10.1071/RD06112; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MONK M, 1987, DEVELOPMENT, V99, P371; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Pera MF, 2000, J CELL SCI, V113, P5; PERA MF, 1988, DIFFERENTIATION, V39, P139, DOI 10.1111/j.1432-0436.1988.tb00089.x; PERA MF, 1990, CANCER SURV, V9, P243; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; TIPPETT P, 1986, VOX SANG, V51, P53, DOI 10.1111/j.1423-0410.1986.tb00209.x; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wadman M, 2006, NATURE, V442, P335, DOI 10.1038/442335a; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; WILLIAMS BP, 1988, IMMUNOGENETICS, V27, P322, DOI 10.1007/BF00395127; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862	75	794	839	4	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					803	816		10.1038/nbt1318	http://dx.doi.org/10.1038/nbt1318			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17572666				2022-12-25	WOS:000247994000032
J	Tour, O; Adams, SR; Kerr, RA; Meijer, RM; Sejnowski, TJ; Tsien, RW; Tsien, RY				Tour, Oded; Adams, Stephen R.; Kerr, Rex A.; Meijer, Rene M.; Sejnowski, Terrence J.; Tsien, Richard W.; Tsien, Roger Y.			Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator	NATURE CHEMICAL BIOLOGY			English	Article							TRANSMITTER RELEASE; ENDOPLASMIC-RETICULUM; RECOMBINANT AEQUORIN; CHANNEL CONDUCTANCE; FLUORESCENT PROTEIN; CA2+ CONCENTRATION; ION CONCENTRATION; PLASMA-MEMBRANE; TIME-COURSE; CELLS	Intracellular Ca2+ regulates numerous proteins and cellular functions and can vary substantially over submicron and submillisecond scales, so precisely localized fast detection is desirable. We have created a similar to 1-kDa biarsenical Ca2+ indicator, called Calcium Green FlAsH (CaGF, 1), to probe [Ca2+] surrounding genetically targeted proteins. CaGF attached to a tetracysteine motif becomes ten-fold more fluorescent upon binding Ca2+, with a K-d of similar to 100 mu M, < 1-ms kinetics and good Mg2+ rejection. In HeLa cells expressing tetracysteine-tagged connexin 43, CaGF labels gap junctions and reports Ca2+ waves after injury. Total internal reflection microscopy of tetracysteine-tagged, CaGF-labeled alpha(1C) L-type calcium channels shows fast-rising depolarization-evoked Ca2+ transients, whose lateral nonuniformity suggests that the probability of channel opening varies greatly over micron dimensions. With moderate Ca2+ buffering, these transients decay surprisingly slowly, probably because most of the CaGF signal comes from closed channels feeling Ca2+ from a tiny minority of clustered open channels. With high Ca2+ buffering, CaGF signals decay as rapidly as the calcium currents, as expected for submicron Ca2+ domains immediately surrounding active channels. Thus CaGF can report highly localized, rapid [Ca2+] dynamics.	Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, San Diego, CA 92093 USA; Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Stanford Univ, Sch Med, Dept Mol & Celllar Physiol, Stanford, CA 94305 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Stanford University; University of California System; University of California San Diego	Tsien, RY (corresponding author), HHMI Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	rtsien@ucsd.edu	Sejnowski, Terrence/AAV-5558-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068630, P20GM072033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, P01NS044306, R37NS027177] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM068630, P20 GM072033, R01 GM068630, GM72033] Funding Source: Medline; NINDS NIH HHS [NS0044306, R01 NS027177, NS27177, P01 NS044306, R37 NS027177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Aharon S, 1996, B MATH BIOL, V58, P1075; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guia A, 2001, BIOPHYS J, V80, P2742, DOI 10.1016/S0006-3495(01)76242-X; KUHN MA, 1993, ACS SYM SER, V538, P147; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; LEVY LA, 1988, BIOCHEMISTRY-US, V27, P4041, DOI 10.1021/bi00411a021; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Luo DL, 2005, EUR J PHARMACOL, V509, P109, DOI 10.1016/j.ejphar.2004.12.038; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Naraghi M, 1997, J NEUROSCI, V17, P6961; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; RAMPE D, 1991, J PHARMACOL EXP THER, V259, P982; Regini JW, 2001, INT J BIOL MACROMOL, V28, P245, DOI 10.1016/S0141-8130(01)00120-9; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; Shuai JW, 2005, CELL CALCIUM, V37, P283, DOI 10.1016/j.ceca.2004.10.008; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; SUGIMORI M, 1994, BIOL BULL-US, V187, P300, DOI 10.2307/1542286; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zou H, 1999, J GEN PHYSIOL, V114, P575, DOI 10.1085/jgp.114.4.575	45	142	146	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					423	431		10.1038/nchembio.2007.4	http://dx.doi.org/10.1038/nchembio.2007.4			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17572670	Green Accepted			2022-12-25	WOS:000247462800018
J	Vikhanskaya, F; Toh, WH; Dulloo, I; Wu, Q; Boominathan, L; Ng, HH; Vousden, KH; Sabapathy, K				Vikhanskaya, Faina; Toh, Wen Hong; Dulloo, Iqbal; Wu, Qiang; Boominathan, Lakshmanane; Ng, Huck Hui; Vousden, Karen H.; Sabapathy, Kanaga			p73 supports cellular growth through c-Jun-dependent AP-1 transactivation	NATURE CELL BIOLOGY			English	Article							PHOSPHORYLATION; ABL; CYCLIN-D1; TARGET; CANCER	The cause or consequence of overexpression of p73 (refs 1, 2), the structural and functional homologue of the tumour-suppressor gene product p53 (refs 3, 4), in human cancers is poorly understood. Here, we report a role for p73 in supporting cellular growth through the upregulation of AP-1 transcriptional activity. p73 suppresses growth when overexpressed alone, but synergises with the proto-oncogene c-Jun to promote cellular survival. Conversely, silencing of p73 expression compromises cellular proliferation. Molecular analysis revealed that expression of the AP-1 target-gene product cyclinD1 (ref. 5) is reduced concomitant with p73, but not p53, silencing. Moreover, cyclinD1 was induced by p73 expression in a c-Jun-dependent manner, and was required for p73-mediated cell survival. Furthermore, c-Jun-dependent AP-1 transcriptional activity was augmented by p73 and, consistently, induction of endogenous AP-1 target genes was compromised in the absence of p73. Chromatin immunoprecipitation and electrophoretic mobility shift analysis indicated that p73 enhanced the binding of phosphorylated c-Jun and Fra1, another AP-1 family member, to AP-1 consensus DNA sequences, by regulating c-Jun phosphorylation and Fra-1 expression. Collectively, our data demonstrates a novel and unexpected role of p73 in augmenting AP-1 transcriptional activity through which it supports cellular growth.	Natl Canc Ctr, Lab Mol Carcinogenesis, Singapore, Singapore; Genome Inst Singapore, Biopolis, Singapore 138672, Singapore; Natl Univ Singapore, Dept Physiol, Singapore 119260, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore	National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Beatson Institute; National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Lab Mol Carcinogenesis, 11 Hosp Dr, Singapore, Singapore.	cmrksb@nccs.com.sg	Lakshamanane, Boominathan/AAW-5331-2020; Ng, Huck Hui/A-1135-2009	Wu, Qiang/0000-0003-2049-1639; NG, HUCK HUI/0000-0001-6352-8417; Dulloo, Iqbal/0000-0001-6899-8338				Agami R, 1999, NATURE, V399, P809; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; EL DW, 1993, CELL, V75, P817; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fulco M, 2003, J BIOL CHEM, V278, P49196, DOI 10.1074/jbc.M304921200; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HARVEY M, 1993, ONCOGENE, V8, P2457; HERBER B, 1994, ONCOGENE, V9, P1295; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika AI, 1999, CANCER RES, V59, P3257; Zhu JH, 1998, CANCER RES, V58, P5061	30	49	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					698	U162		10.1038/ncb1598	http://dx.doi.org/10.1038/ncb1598			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17496887				2022-12-25	WOS:000246922700016
J	Song, XJ; Huang, W; Shi, M; Zhu, MZ; Lin, HX				Song, Xian-Jun; Huang, Wei; Shi, Min; Zhu, Mei-Zhen; Lin, Hong-Xuan			A QTL for rice grain width and weight encodes a previously unknown RING-type E3 ubiquitin ligase	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; ADVANCED BACKCROSS POPULATION; ORYZA-SATIVA; NEGATIVE REGULATOR; PHOTOPERIOD SENSITIVITY; CANCER SUSCEPTIBILITY; MORPHOLOGICAL TRAITS; YIELD COMPONENTS; SEED SIZE; GENE	Grain weight is one of the most important components of grain yield and is controlled by quantitative trait loci (QTLs) derived from natural variations in crops. However, the molecular roles of QTLs in the regulation of grain weight have not been fully elucidated. Here, we report the cloning and characterization of GW2, a new QTL that controls rice grain width and weight. Our data show that GW2 encodes a previously unknown RING-type protein with E3 ubiquitin ligase activity, which is known to function in the degradation by the ubiquitin-proteasome pathway. Loss of GW2 function increased cell numbers, resulting in a larger ( wider) spikelet hull, and it accelerated the grain milk filling rate, resulting in enhanced grain width, weight and yield. Our results suggest that GW2 negatively regulates cell division by targeting its substrate(s) to proteasomes for regulated proteolysis. The functional characterization of GW2 provides insight into the mechanism of seed development and is a potential tool for improving grain yield in crops.	Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X				Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; CHOJECKI AJS, 1986, ANN BOT-LONDON, V58, P809, DOI 10.1093/oxfordjournals.aob.a087263; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; EVANS LT, 1972, RICE BREEDING; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang N, 1997, MOL BREEDING, V3, P105, DOI 10.1023/A:1009683603862; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; LANDER ES, 1989, GENETICS, V121, P185; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Lin HongXuan, 1995, Scientia Agricultura Sinica, V28, P1; Lin HX, 1996, THEOR APPL GENET, V92, P920, DOI 10.1007/BF00224031; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; REDDY VM, 1983, MAYDICA, V28, P339; Redona ED, 1998, THEOR APPL GENET, V96, P957, DOI 10.1007/s001220050826; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xu JianLong, 2002, Chinese Journal of Rice Science, V16, P6; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoon DB, 2006, THEOR APPL GENET, V112, P1052, DOI 10.1007/s00122-006-0207-4; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	49	1029	1352	32	414	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					623	630		10.1038/ng2014	http://dx.doi.org/10.1038/ng2014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417637				2022-12-25	WOS:000245971300017
J	Menne, TF; Goyenechea, B; Sanchez-Puig, N; Wong, CC; Tonkin, LM; Ancliff, PJ; Brost, RL; Costanzo, M; Boone, C; Warren, AJ				Menne, Tobias F.; Goyenechea, Beatriz; Sanchez-Puig, Nuria; Wong, Chi C.; Tonkin, Louise M.; Ancliff, Philip J.; Brost, Renee L.; Costanzo, Michael; Boone, Charles; Warren, Alan J.			The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast	NATURE GENETICS			English	Article							LINKED DYSKERATOSIS-CONGENITA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; DELETION MUTANTS; BLACKFAN ANEMIA; ORDERED ARRAYS; 60S SUBUNIT; GENE; RNA; MUTATIONS	The autosomal recessive disorder Shwachman-Diamond syndrome, characterized by bone marrow failure and leukemia predisposition, is caused by deficiency of the highly conserved Shwachman-Bodian-Diamond syndrome (SBDS) protein. Here, we identify the function of the yeast SBDS ortholog Sdo1, showing that it is critical for the release and recycling of the nucleolar shuttling factor Tif6 from pre-60S ribosomes, a key step in 60S maturation and translational activation of ribosomes. Using genome-wide synthetic genetic array mapping, we identified multiple TIF6 gain-of-function alleles that suppressed the pre-60S nuclear export defects and cytoplasmic mislocalization of Tif6 observed in sdo1D cells. Sdo1 appears to function within a pathway containing elongation factor-like 1, and together they control translational activation of ribosomes. Thus, our data link defective late 60S ribosomal subunit maturation to an inherited bone marrow failure syndrome associated with leukemia predisposition.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Univ Cambridge, Dept Hematol, Cambridge CB2 2XY, England; Great Ormond St Hosp Sick Children, Camelia Botnar Labs, London WC1N 3JH, England; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet & Microbiol, Toronto, ON M5S 3E1, Canada	MRC Laboratory Molecular Biology; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Toronto; University of Toronto	Warren, AJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ajw@mrc-lmb.cam.ac.uk		Sanchez Puig, Nuria/0000-0002-8945-7001	Medical Research Council [MC_U105161083, G84/6468] Funding Source: Medline; MRC [MC_U105161083, G84/6468] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; BOOCOCK GR, 2006, GENOMICS; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Dick FA, 1997, J BIOL CHEM, V272, P13372, DOI 10.1074/jbc.272.20.13372; Donadieu J, 2005, BONE MARROW TRANSPL, V36, P787, DOI 10.1038/sj.bmt.1705141; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Graindorge JS, 2005, J MOL BIOL, V352, P355, DOI 10.1016/j.jmb.2005.07.037; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Hall GW, 2006, ARCH DIS CHILD, V91, P521, DOI 10.1136/adc.2003.046151; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Jorgensen P, 2002, GENETICS, V162, P1091; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Savchenko A, 2005, J BIOL CHEM, V280, P19213, DOI 10.1074/jbc.M414421200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06	50	233	239	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					486	495		10.1038/ng1994	http://dx.doi.org/10.1038/ng1994			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353896				2022-12-25	WOS:000245271200018
J	Nishie, W; Sawamura, D; Goto, M; Ito, K; Shibaki, A; McMillan, JR; Sakai, K; Nakamura, H; Olasz, E; Yancey, KB; Akiyama, M; Shimizu, H				Nishie, Wataru; Sawamura, Daisuke; Goto, Maki; Ito, Kei; Shibaki, Akihiko; McMillan, James R.; Sakai, Kaori; Nakamura, Hideki; Olasz, Edit; Yancey, Kim B.; Akiyama, Masashi; Shimizu, Hiroshi			Humanization of autoantigen	NATURE MEDICINE			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; PEMPHIGOID ANTIGEN BPAG2; AUTOIMMUNE-DISEASES; PASSIVE TRANSFER; ANIMAL-MODELS; AUTOANTIBODIES; COL17A1; BP180; MICE; ANTIBODIES	Transmissibility of characteristic lesions to experimental animals may help us understand the pathomechanism of human autoimmune disease. Here we show that human autoimmune disease can be reproduced using genetically engineered model mice. Bullous pemphigoid ( BP) is the most common serious autoimmune blistering skin disease, with a considerable body of indirect evidence indicating that the underlying autoantigen is collagen XVII (COL17). Passive transfer of human BP autoantibodies into mice does not induce skin lesions, probably because of differences between humans and mice in the amino acid sequence of the COL17 pathogenic epitope. We injected human BP autoantibody into Col17-knockout mice rescued by the human ortholog. This resulted in BP-like skin lesions and a human disease phenotype. Humanization of autoantigens is a new approach to the study of human autoimmune diseases.	Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA	Hokkaido University; Medical College of Wisconsin	Shimizu, H (corresponding author), Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.	shimizu@med.hokudai.ac.jp	Akiyama, Masashi/I-1122-2012; Shimizu, Hiroshi/A-5193-2012; Nishie, Wataru/A-5236-2012; McMillan, James R/C-6657-2009		NIAMS NIH HHS [R01 AR048982] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048982] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; ANHALT GJ, 1981, J CLIN INVEST, V68, P1097, DOI 10.1172/JCI110333; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Gatalica B, 1997, AM J HUM GENET, V60, P352; Gregersen JW, 2004, TISSUE ANTIGENS, V63, P383, DOI 10.1111/j.0001-2815.2004.00243.x; ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Laczko I, 2000, J PEPT SCI, V6, P378, DOI 10.1002/1099-1387(200008)6:8<378::AID-PSC265>3.0.CO;2-Q; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; Shimizu H, 1998, J INVEST DERMATOL, V111, P887, DOI 10.1046/j.1523-1747.1998.00363.x; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Wen L, 2000, J EXP MED, V191, P97, DOI 10.1084/jem.191.1.97; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; Zillikens D, 2001, J PATHOL, V193, P117	17	223	231	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					378	383		10.1038/nm1496	http://dx.doi.org/10.1038/nm1496			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17322897				2022-12-25	WOS:000244715700053
J	He, XC; Yin, T; Grindley, JC; Tian, Q; Sato, T; Tao, WA; Dirisina, R; Porter-Westpfahl, KS; Hembree, M; Johnson, T; Wiedemann, LM; Barrett, TA; Hood, L; Wu, H; Li, LH				He, Xi C.; Yin, Tong; Grindley, Justin C.; Tian, Qiang; Sato, Toshiro; Tao, W. Andy; Dirisina, Raminarao; Porter-Westpfahl, Kimberly S.; Hembree, Mark; Johnson, Teri; Wiedemann, Leanne M.; Barrett, Terrence A.; Hood, Leroy; Wu, Hong; Li, Linheng			PTEN-deficient intestinal stem cells initiate intestinal polyposis	NATURE GENETICS			English	Article							BETA-CATENIN; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; CRYPT FISSION; SELF-RENEWAL; PROTEIN-KINASE; CANCER CELLS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION	Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells ( ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog ( PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear- localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN- deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta- catenin.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Inst Syst Biol, Seattle, WA 98103 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med Microbiol & Immunol, Chicago, IL 60611 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Stowers Institute for Medical Research; Institute for Systems Biology (ISB); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Sato, Toshiro/J-3522-2014; Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020; Wiedemann, Leanne/E-3316-2010	Sato, Toshiro/0000-0001-8353-8137; Tao, Weiguo/0000-0002-5535-5517; Wiedemann, Leanne/0000-0002-0964-4676; Li, Linheng/0000-0001-9963-430X; Barrett, Terrence/0000-0001-6428-3271	NIAID NIH HHS [R01 AI061701, R01 AI061701-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK070001] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070001] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Megy S, 2005, PEPTIDES, V26, P227, DOI 10.1016/j.peptides.2004.09.021; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Preston SL, 2003, CANCER RES, V63, P3819; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wasan HS, 1998, J PATHOL, V185, P246; Wirtzfeld DA, 2001, ANN SURG ONCOL, V8, P319, DOI 10.1245/aso.2001.8.4.319; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	50	340	357	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					189	198		10.1038/ng1928	http://dx.doi.org/10.1038/ng1928			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237784	Green Accepted			2022-12-25	WOS:000244063900016
J	Gerdes, JM; Liu, Y; Zaghloul, NA; Leitch, CC; Lawson, SS; Kato, M; Beachy, PA; Beales, PL; Demartino, GN; Fisher, S; Badano, JL; Katsanis, N				Gerdes, Jantje M.; Liu, Yangfan; Zaghloul, Norann A.; Leitch, Carmen C.; Lawson, Shaneka S.; Kato, Masaki; Beachy, Philip A.; Beales, Philip L.; Demartino, George N.; Fisher, Shannon; Badano, Jose L.; Katsanis, Nicholas			Disruption of the basal body comprises proteasomal function and perturbs intracellular Wnt response	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE DEFECTS; BETA-CATENIN; LOOP-TAIL; TRANSCRIPTION FACTORS; CONVERGENT EXTENSION; SIGNALING PATHWAYS; MOUSE	Primary cilia and basal bodies are evolutionarily conserved organelles that mediate communication between the intracellular and extracellular environments. Here we show that bbs1, bbs4 and mkks ( also known as bbs6), which encode basal body proteins, are required for convergence and extension in zebrafish and interact with wnt11 and wnt5b. Suppression of bbs1, bbs4 and mkks transcripts results in stabilization of beta-catenin with concomitant upregulation of T-cell factor ( TCF)-dependent transcription in both zebrafish embryos and mammalian ciliated cells, a defect phenocopied by the silencing of the axonemal kinesin subunit KIF3A but not by chemical disruption of the cytoplasmic microtubule network. These observations are attributable partly to defective degradation by the proteasome; suppression of BBS4 leads to perturbed proteasomal targeting and concomitant accumulation of cytoplasmic beta-catenin. Cumulatively, our data indicate that the basal body is an important regulator of Wnt signal interpretation through selective proteolysis and suggest that defects in this system may contribute to phenotypes pathognomonic of human ciliopathies.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Texas, Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Inst Pasteur, Montevideo, Uruguay; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; University of London; University College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Masaki, Kato/AAW-2603-2020; Beales, Philip L/C-7367-2009; Fisher, Shannon/K-7351-2012; Gerdes, Jantje Mareike/M-9868-2014; lawson, shaneka/AAV-1569-2021	Gerdes, Jantje Mareike/0000-0001-6885-5441; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; ITOH K, 2005, J BIOL, V4, P1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wigley WC, 1999, J CELL BIOL, V145, P481; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	50	309	318	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1350	1360		10.1038/ng.2007.12	http://dx.doi.org/10.1038/ng.2007.12			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906624				2022-12-25	WOS:000250575900019
J	Zhang, Q; Wang, HY; Liu, XB; Wasik, MA				Zhang, Qian; Wang, Hong Y.; Liu, Xiaobin; Wasik, Mariusz A.			STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression	NATURE MEDICINE			English	Article							MALIGNANT T-LYMPHOCYTES; NON-HODGKINS-LYMPHOMA; HUMAN BREAST-CANCER; SIGNAL TRANSDUCER; CELL LYMPHOMA; NPM-ALK; TRANSCRIPTION FACTORS; ACTIVATION; GENE; PROLIFERATION	Although STAT5A and STAT5B have some nonredundant functional properties, their distinct contributions to carcinogenesis are not clearly defined. Here we report that STAT5A expression is selectively inhibited by DNA methylation of the STAT5A gene promoter region in cells expressing the oncogenic tyrosine kinase NPM1-ALK ( also known as NPM-ALK). The DNA methylation is induced by NPM1-ALK itself via STAT3, and is associated with binding to the promoter of the gene encoding MeCP2 capping protein and with lack of binding of the STAT5A gene transcription activator SP1. Reversal of methylation by the DNA methyltransferase inhibitor 5'-aza-2'-deoxycytidine restores SP1 binding and STAT5A gene expression. Notably, the induced or exogenously expressed STAT5A protein binds to the enhancer and intron 14 of the NPM1-ALK gene and triggers selective suppression of NPM1-ALK expression. These results show that NPM1-ALK induces epigenetic silencing of STAT5A gene and that STAT5A protein can act as a key tumor suppressor by reciprocally inhibiting expression of NPM1-ALK.	Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Zhang, Q (corresponding author), Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	qian2@mail.med.upenn.edu			NCI NIH HHS [R01-CA89194, R01-CA96856] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089194, R01CA096856] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambrosio R, 2002, GENE, V285, P311, DOI 10.1016/S0378-1119(02)00421-3; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bondarenko VA, 2003, BIOCHEM CELL BIOL, V81, P241, DOI 10.1139/o03-051; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Crispi S, 2004, FEBS LETT, V562, P27, DOI 10.1016/S0014-5793(04)00166-8; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Davey HW, 1999, J BIOL CHEM, V274, P35331, DOI 10.1074/jbc.274.50.35331; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fujioka H, 2002, CHEM IMMUNOL, V80, P1; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Hehlmann R, 2005, ANN HEMATOL, V84, P487, DOI 10.1007/s00277-005-1039-z; Hendry L, 2004, EUR J BIOCHEM, V271, P4613, DOI 10.1111/j.1432-1033.2004.04424.x; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Nieborowska-Skorska M, 2001, CANCER RES, V61, P6517; SHIOTA M, 1994, ONCOGENE, V9, P1567; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Wasik Mariusz A, 2002, Am J Clin Pathol, V118 Suppl, pS81; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; XU X, 1995, J CLIN INVEST, V96, P1548, DOI 10.1172/JCI118193; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377	44	98	100	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2007	13	11					1341	1348		10.1038/nm1659	http://dx.doi.org/10.1038/nm1659			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17922009				2022-12-25	WOS:000250736900027
J	Anderson, DJ; Hetzer, MW				Anderson, Daniel J.; Hetzer, Martin W.			Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; MEMBRANE PROTEIN; GTP HYDROLYSIS; IN-VITRO; ORGANIZATION; DYNAMICS; MITOSIS; MICROTUBULES; NUCLEOPORINS; FUSION	The formation of the nuclear envelope ( NE) around chromatin is a major membrane-remodelling event that occurs during cell division of metazoa. It is unclear whether the nuclear membrane reforms by the fusion of NE fragments or if it reemerges from an intact tubular network of the endoplasmic reticulum ( ER). Here, we show that NE formation and expansion requires a tubular ER network and occurs efficiently in the presence of the membrane fusion inhibitor GTP gamma S. Chromatin recruitment of membranes, which is initiated by tubule-end binding, followed by the formation, expansion and sealing of flat membrane sheets, is mediated by DNA-binding proteins residing in the ER. Thus, chromatin plays an active role in reshaping of the ER during NE formation.	Salk Inst Biol Studies, Mol Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Anderson, Daniel/0000-0002-3249-2439	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073994, GM0739994-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOMAN AL, 1992, J CELL BIOL, V116, P281, DOI 10.1083/jcb.116.2.281; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; Cotter L, 2007, J MOL BIOL, V369, P683, DOI 10.1016/j.jmb.2007.03.051; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4; LOHKA MJ, 1983, EXP CELL RES, V148, P481, DOI 10.1016/0014-4827(83)90169-6; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PORTER KR, 1960, J BIOPHYS BIOCHEM CY, V7, P167, DOI 10.1083/jcb.7.1.167; Powell KS, 2000, TRAFFIC, V1, P689, DOI 10.1034/j.1600-0854.2000.010901.x; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	29	149	152	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1160	1166		10.1038/ncb1636	http://dx.doi.org/10.1038/ncb1636			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828249				2022-12-25	WOS:000249882300011
J	Lippow, SM; Wittrup, KD; Tidor, B				Lippow, Shaun M.; Wittrup, K. Dane; Tidor, Bruce			Computational design of antibody-affinity improvement beyond in vivo maturation	NATURE BIOTECHNOLOGY			English	Article							HYDRATION FREE-ENERGY; DE-NOVO DESIGN; BINDING AFFINITY; RATIONAL DESIGN; PROTEIN DESIGN; SPECIFICITY; SEQUENCES; SELECTION; VARIANTS; ANTIGEN	Antibodies are used extensively in diagnostics and as therapeutic agents. Achieving high-affinity binding is important for expanding detection limits, extending dissociation half-times, decreasing drug dosages and increasing drug efficacy. However, antibody-affinity maturation in vivo often fails to produce antibody drugs of the targeted potency(1), making further affinity maturation in vitro by directed evolution or computational design necessary. Here we present an iterative computational design procedure that focuses on electrostatic binding contributions and single mutants. By combining multiple designed mutations, a tenfold affinity improvement to 52 pM was engineered into the anti-epidermal growth factor receptor drug cetuximab (Erbitux), and a 140-fold improvement in affinity to 30 pM was obtained for the anti-lysozyme model antibody D44.1. The generality of the methods was further demonstrated through identification of known affinity-enhancing mutations the therapeutic antibody bevacizumab (Avastin) and the anti-fluorescein antibody 4-4-20. These results demonstrate computational capabilities for enhancing and accelerating the development of protein reagents and therapeutics.	MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tidor, B (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wittrup@mit.edu; tidor@mit.edu		/0000-0002-3320-3969	NCI NIH HHS [CA96504, R01 CA096504-07, R01 CA096504] Funding Source: Medline; NIGMS NIH HHS [R01 GM065418-04, R01 GM065418, GM65418, R56 GM065418] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065418, R01GM065418] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Dixon RW, 2002, J ORG CHEM, V67, P1827, DOI 10.1021/jo991846s; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Gallicchio E, 2004, J COMPUT CHEM, V25, P479, DOI 10.1002/jcc.10400; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Joughin BA, 2005, PROTEIN SCI, V14, P1363, DOI 10.1110/ps.041283105; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lassila JK, 2005, PROTEIN ENG DES SEL, V18, P161, DOI 10.1093/protein/gzi015; Levy RM, 2003, J AM CHEM SOC, V125, P9523, DOI 10.1021/ja029833a; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Midelfort KS, 2006, PROTEIN SCI, V15, P324, DOI 10.1110/ps.051842406; Presta LG, 1997, CANCER RES, V57, P4593; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Sato J D, 1983, Mol Biol Med, V1, P511; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Sood VD, 2006, J MOL BIOL, V357, P917, DOI 10.1016/j.jmb.2006.01.045; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103	30	245	285	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1171	1176		10.1038/nbt1336	http://dx.doi.org/10.1038/nbt1336			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17891135	Green Accepted			2022-12-25	WOS:000250226600029
J	Balibar, CJ; Howard-, AR; Walsh, CT				Balibar, Carl J.; Howard-Jones, Annaleise R.; Walsh, Christopher T.			Terrequinone A biosynthesis through L-tryptophan oxidation, dimerization and bisprenylation	NATURE CHEMICAL BIOLOGY			English	Article							LECHEVALIERIA-AEROCOLONIGENES ATCC-39243; NONRIBOSOMAL PEPTIDE BIOSYNTHESIS; SPONGE SPONGOSORITES SP; ASPERGILLUS-FUMIGATUS; CHROMOPYRROLIC ACID; GENE-CLUSTER; ANTITUMOR-ACTIVITY; NATURAL-PRODUCTS; MARINE SPONGE; REBECCAMYCIN	The antitumor fungal metabolite terrequinone A, identified in extracts of Aspergillus sp., is biosynthesized by the five-gene cluster tdiA- tdiE. In this work, we have overproduced all five proteins (TdiA-TdiE) in the bacterial host Escherichia coli, fully reconstituting the biosynthesis of terrequinone A. This pathway involves aminotransferase activity, head-to-tail dimerization and bisprenylation of the scaffold to yield the benzoquinone natural product. We have established that TdiD is a pyridoxal-5'-phosphate-dependent L-tryptophan aminotransferase that generates indolepyruvate for an unusual nonoxidative coupling by the tridomain nonribosomal peptide synthetase TdiA. TdiC, an NADH-dependent quinone reductase, generates the nucleophilic hydroquinone for two distinct rounds of prenylation by the single prenyltransferase TdiB. TdiE is required to shunt the benzoquinone away from an off-pathway monoprenylated species by an as yet unknown mechanism. Overall, we have biochemically characterized the complete biosynthetic pathway to terrequinone A, highlighting the nonoxidative dimerization pathway and the unique asymmetric prenylation involved in its maturation.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02116 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02116 USA.	christopher_walsh@hms.harvard.edu			NIGMS NIH HHS [GM 20011] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020011, R01GM020011] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI K, 1981, CHEM PHARM BULL, V29, P961; Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Bao BQ, 2007, J NAT PROD, V70, P2, DOI 10.1021/np060206z; BELSHAW E, 1999, EMBO J, V284, P486; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; BOUHIRED S, 2007, FUNGAL GENET BIOL; BREWER D, 1968, CAN J MICROBIOL, V14, P861, DOI 10.1139/m68-145; DEGUZMAN FS, 1994, J NAT PROD, V57, P634, DOI 10.1021/np50107a011; DOLENCE JM, 1999, COMPREHENSIVE NATURA, P18473; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Endo T, 2007, J NAT PROD, V70, P423, DOI 10.1021/np060420n; GEBLER JC, 1992, ARCH BIOCHEM BIOPHYS, V296, P308, DOI 10.1016/0003-9861(92)90577-J; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; He J, 2004, J NAT PROD, V67, P1985, DOI 10.1021/np040139d; Hibino S, 2002, NAT PROD REP, V19, P148, DOI 10.1039/b007740m; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; JERRAM WA, 1975, CAN J CHEM, V53, P727, DOI 10.1139/v75-102; Kaji A, 1997, ANTICANCER RES, V17, P3675; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; LEE SL, 1976, ARCH BIOCHEM BIOPHYS, V177, P84, DOI 10.1016/0003-9861(76)90418-5; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; MEILER D, 1971, CAN J MICROBIOL, V17, P83, DOI 10.1139/m71-014; Mocek U, 1996, J ANTIBIOT, V49, P854, DOI 10.7164/antibiotics.49.854; Nishizawa T, 2006, J AM CHEM SOC, V128, P724, DOI 10.1021/ja056749x; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; Oh KB, 2005, BIOORG MED CHEM LETT, V15, P4927, DOI 10.1016/j.bmcl.2005.08.021; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2006, NAT PROD REP, V23, P1007, DOI 10.1039/b601930g; SHIMIZU S, 1982, GANN, V73, P642; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Williams RM, 2000, TOP CURR CHEM, V209, P97; YAMAMOTO Y, 1976, GANN, V67, P623	45	115	126	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					584	592		10.1038/nchembio.2007.20	http://dx.doi.org/10.1038/nchembio.2007.20			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17704773				2022-12-25	WOS:000248968000017
J	Wagner, KW; Punnoose, EA; Januario, T; Lawrence, DA; Pitti, RM; Lancaster, K; Lee, D; von Goetz, M; Yee, SF; Totpal, K; Huw, L; Katta, V; Cavet, G; Hymowitz, SG; Amler, L; Ashkenazi, A				Wagner, Klaus W.; Punnoose, Elizabeth A.; Januario, Thomas; Lawrence, David A.; Pitti, Robert M.; Lancaster, Kate; Lee, Dori; von Goetz, Melissa; Yee, Sharon Fong; Totpal, Klara; Huw, Ling; Katta, Viswanatham; Cavet, Guy; Hymowitz, Sarah G.; Amler, Lukas; Ashkenazi, Avi			Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL	NATURE MEDICINE			English	Article							SIALYL-LEWIS-X; CANCER-CELLS; MUCIN-TYPE; GLYCAN BIOSYNTHESIS; INDUCED APOPTOSIS; TARGETING DEATH; ASSOCIATION; RESISTANCE; CASPASE-8; COMPLEX	dApo2L/TRAIL stimulates cancer cell death through the proapoptotic receptors DR4 and DR5, but the determinants of tumor susceptibility to this ligand are not fully defined. mRNA expression of the peptidyl O-glycosyltransferase GALNT14 correlated with Apo2L/ TRAIL sensitivity in pancreatic carcinoma, non-small-cell lung carcinoma and melanoma cell lines, and up to 30% of samples from various human malignancies showed GALNT14 overexpression. RNA interference of GALNT14 reduced cellular Apo2L/ TRAIL sensitivity, whereas overexpression increased responsiveness. Biochemical analysis of DR5 identified several ectodomain O-(N-acetyl galactosamine-galactose-sialic acid) structures. Sequence comparison predicted conserved extracellular DR4 and DR5 O- glycosylation sites; progressive mutation of the DR5 sites attenuated apoptotic signaling. O- glycosylation promoted ligand-stimulated clustering of DR4 and DR5, which mediated recruitment and activation of the apoptosis-initiating protease caspase-8. These results uncover a new link between death-receptor O- glycosylation and apoptotic signaling, providing potential predictive biomarkers for Apo2L/TRAIL-based cancer therapy.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Diagnost, San Francisco, CA 94080 USA; Genentech Inc, Dept Analyt Dev, San Francisco, CA 94080 USA; Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Delannoy P, 1996, GLYCOCONJUGATE J, V13, P717, DOI 10.1007/BF00702335; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Foster MM, 2003, CANCER RES, V63, P2775; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; TAKADA A, 1993, CANCER RES, V53, P354; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wang H, 2003, BIOCHEM BIOPH RES CO, V300, P738, DOI 10.1016/S0006-291X(02)02908-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	37	454	474	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1070	1077		10.1038/nm1627	http://dx.doi.org/10.1038/nm1627			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17767167				2022-12-25	WOS:000249353100034
J	Bachmaier, K; Toya, S; Gao, XP; Triantafillou, T; Garrean, S; Park, GY; Frey, RS; Vogel, S; Minshall, R; Christman, JW; Tiruppathi, C; Malik, AB				Bachmaier, Kurt; Toya, Sophie; Gao, Xiaopei; Triantafillou, Thomas; Garrean, Sean; Park, Gye Young; Frey, Randall S.; Vogel, Stephen; Minshall, Richard; Christman, John W.; Tiruppathi, Chinnaswamy; Malik, Asrar B.			E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury	NATURE MEDICINE			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; C-CBL; RECEPTOR; MICE; EXPRESSION; ACTIVATION; PROTEIN; SEPSIS; ALPHA	The E3 ubiquitin ligase Cblb has a crucial role in the prevention of chronic inflammation and autoimmunity. Here we show that Cblb also has an unexpected function in acute lung inflammation. Cblb attenuates the sequestration of inflammatory cells in the lungs after administration of lipopolysaccharide (LPS). In a model of polymicrobial sepsis in which acute lung inflammation depends on the LPS receptor (Toll-like receptor 4, TLR-4), the loss of Cblb expression accentuates acute lung inflammation and reduces survival. Loss of Cblb significantly increases sepsis-induced release of inflammatory cytokines and chemokines. Cblb controls the association between TLR4 and the intracellular adaptor MyD88. Expression of wild-type Cblb, but not expression of a Cblb mutant that lacks E3 ubiquitin ligase function, prevents the activity of a reporter gene for the transcription factor nuclear factor-kappa B (NF-kappa B) in monocytes that have been challenged with LPS. The downregulation of TLR4 expression on the cell surface of neutrophils is impaired in the absence of Cblb. Our data reveal that Cblb regulates the TLR4-mediated acute inflammatory response that is induced by sepsis.	Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; Univ Illinois, Dept Med, Coll Med, Chicago, IL 60612 USA; Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bachmaier, K (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, E403,Med Sci Bldg,MC 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	kbachmai@uic.edu	Bachmaier, Kurt/B-6331-2014; Bachmaier, Kurt/AHC-5491-2022	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128	NHLBI NIH HHS [T32 HL 07829, P01 HL77806, P01 HL60678] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, T32HL007829, P01HL060678] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Ankermann T, 2005, CRIT CARE MED, V33, P1384, DOI 10.1097/01.CCM.0000166371.18066.5E; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beutler B, 2001, CRIT CARE MED, V29, pS2, DOI 10.1097/00003246-200107001-00002; Blackwell TS, 2000, AM J RESP CRIT CARE, V162, P1095, DOI 10.1164/ajrccm.162.3.9906129; Bosco MC, 2000, J IMMUNOL, V164, P3283, DOI 10.4049/jimmunol.164.6.3283; Brueckmann M, 2004, INFLAMM RES, V53, P528, DOI 10.1007/s00011-004-1291-z; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hickey MJ, 2002, FASEB J, V16, P1141, DOI 10.1096/fj.01-0764fje; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KEANE MM, 1995, ONCOGENE, V10, P2367; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levy H, 2005, CRIT CARE, V9, pR502, DOI 10.1186/cc3778; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Matsuda N, 2005, MOL PHARMACOL, V67, P1018, DOI 10.1124/mol.104.005926; Melkonyan H, 1996, NUCLEIC ACIDS RES, V24, P4356, DOI 10.1093/nar/24.21.4356; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Neumann B, 1996, J IMMUNOL, V156, P1587; Richards GA, 2005, CLIN MICROBIOL INFEC, V11, P18, DOI 10.1111/j.1469-0691.2005.01266.x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SHANLEY TP, 1995, J IMMUNOL, V154, P4793; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407	50	66	69	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					920	926		10.1038/nm1607	http://dx.doi.org/10.1038/nm1607			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17618294				2022-12-25	WOS:000248674600022
J	Rhee, J; Buchan, T; Zukerberg, L; Lilien, J; Balsamo, J				Rhee, Jinseol; Buchan, Tim; Zukerberg, Lawrence; Lilien, Jack; Balsamo, Janne			Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription	NATURE CELL BIOLOGY			English	Article							TYROSINE-KINASE; AXON GUIDANCE; C-ABL; ASSOCIATION; PHOSPHORYLATION; PROTEINS; GROWTH; CDK5; RECOGNITION; INHIBITION	Binding of the secreted axon guidance cue Slit to its Robo receptor results in inactivation of the neural, calcium-dependent cell cell adhesion molecule N-cadherin, providing a rapid epigenetic mechanism for integrating guidance and adhesion information. This requires the formation of a multimolecular complex containing Robo, Abl tyrosine kinase and N-cadherin. Here we show that on binding of Slit to Robo, the adaptor protein Cables is recruited to Robo-associated Abl and forms a multimeric complex by binding directly to N-cadherin-associated beta-catenin. Complex formation results in Abl-mediated phosphorylation of beta-catenin on tyrosine 489, leading to a decrease in its affinity for N-cadherin, loss of N-cadherin function, and targeting of phospho-Y489-beta-catenin to the nucleus. Nuclear beta-catenin combines with the transcription factor Tcf/Lef and activates transcription. Thus, Slit-induced formation of the Robo-N-cadherin complex results in a rapid loss of cadherin-mediated adhesion and has more lasting effects on gene transcription.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	University of Iowa; Harvard University; Massachusetts General Hospital	Lilien, J (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.	jack-lilien@uiowa.edu			NEI NIH HHS [EY13363] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013363] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; BALSAMO J, 1995, J CELL BIOL, V129, P1391, DOI 10.1083/jcb.129.5.1391; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Gao CY, 2004, J CELL SCI, V117, P4089, DOI 10.1242/jcs.01271; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hoffmans R, 2007, MECH DEVELOP, V124, P59, DOI 10.1016/j.mod.2006.09.006; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jin Z, 2003, DEVELOPMENT, V130, P1037, DOI 10.1242/dev.00326; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Monga SPS, 2002, CANCER RES, V62, P2064; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wu JJ, 2002, COMB CHEM HIGH T SCR, V5, P83, DOI 10.2174/1386207023330516; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	40	123	128	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					883	U30		10.1038/ncb1614	http://dx.doi.org/10.1038/ncb1614			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618275				2022-12-25	WOS:000248486700010
J	Torres-Rosell, J; Sunjevaric, I; De Piccoli, G; Sacher, M; Eckert-Boulet, N; Reid, R; Jentsch, S; Rothstein, R; Aragon, L; Lisby, M				Torres-Rosell, Jordi; Sunjevaric, Ivana; De Piccoli, Giacomo; Sacher, Meik; Eckert-Boulet, Nadine; Reid, Robert; Jentsch, Stefan; Rothstein, Rodney; Aragon, Luis; Lisby, Michael			The Smc5-Smc6 complex and SUMO modification of Rad52 regulates recombinational repair at the ribosomal gene locus	NATURE CELL BIOLOGY			English	Article							STRAND-BREAK REPAIR; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; PROTEIN; HELICASE; REPLICATION; CHECKPOINT; REPEATS; RNA	Homologous recombination (HR) is crucial for maintaining genome integrity by repairing DNA double-strand breaks (DSBs) and rescuing collapsed replication forks. In contrast, uncontrolled HR can lead to chromosome translocations, loss of heterozygosity, and deletion of repetitive sequences. Controlled HR is particularly important for the preservation of repetitive sequences of the ribosomal gene ( rDNA) cluster. Here we show that recombinational repair of a DSB in rDNA in Saccharomyces cerevisiae involves the transient relocalization of the lesion to associate with the recombination machinery at an extranucleolar site. The nucleolar exclusion of Rad52 recombination foci entails Mre11 and Smc5-Smc6 complexes and depends on Rad52 SUMO ( small ubiquitin-related modifier) modification. Remarkably, mutations that abrogate these activities result in the formation of Rad52 foci within the nucleolus and cause rDNA hyperrecombination and the excision of extrachromosomal rDNA circles. Our study also suggests a key role of sumoylation for nucleolar dynamics, perhaps in the compartmentalization of nuclear activities.	Imperial Coll London, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England; Columbia Univ, Ctr Med, Dept Genet & Dev, New York, NY 10032 USA; Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Imperial College London; Columbia University; Max Planck Society	Lisby, M (corresponding author), Imperial Coll London, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	mlisby@my.molbio.ku.dk	Lisby, Michael/K-9814-2014; Torres-Rosell, Jordi/A-4213-2010; Reid, Robert/AAR-1560-2020	Lisby, Michael/0000-0002-4830-5247; Torres-Rosell, Jordi/0000-0003-1308-6926; Reid, Robert/0000-0002-7424-3537; Rothstein, Rodney/0000-0002-4107-9654	Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [GM67055, GM50237] Funding Source: Medline; MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM067055, R01GM050237] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aragon L, 2005, P NATL ACAD SCI USA, V102, P4661, DOI 10.1073/pnas.0501342102; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; Moore CW, 2000, GENETICS, V154, P1085; Park PU, 1999, MOL CELL BIOL, V19, P3848; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; THOMAS BJ, 1989, GENETICS, V123, P725; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	284	288	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					923	U72		10.1038/ncb1619	http://dx.doi.org/10.1038/ncb1619			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643116				2022-12-25	WOS:000248486700014
J	Zeisberg, EM; Tarnavski, O; Zeisberg, M; Dorfman, AL; McMullen, JR; Gustafsson, E; Chandraker, A; Yuan, XL; Pu, WT; Roberts, AB; Neilson, EG; Sayegh, MH; Izumo, S; Kalluri, R				Zeisberg, Elisabeth M.; Tarnavski, Oleg; Zeisberg, Michael; Dorfman, Adam L.; McMullen, Julie R.; Gustafsson, Erika; Chandraker, Anil; Yuan, Xueli; Pu, William T.; Roberts, Anita B.; Neilson, Eric G.; Sayegh, Mohamed H.; Izumo, Seigo; Kalluri, Raghu			Endothelial-to-mesenchymal transition contributes to cardiac fibrosis	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; NITRIC-OXIDE SYNTHESIS; LONG-TERM BLOCKADE; DIASTOLIC DYSFUNCTION; TGF-BETA; CELL-TRANSFORMATION; EMBRYONIC HEART; GENE-EXPRESSION; CRE RECOMBINASE; TRANSGENIC MICE	Cardiac fibrosis, associated with a decreased extent of microvasculature and with disruption of normal myocardial structures, results from excessive deposition of extracellular matrix, which is mediated by the recruitment of fibroblasts. The source of these fibroblasts is unclear and specific anti-fibrotic therapies are not currently available. Here we show that cardiac fibrosis is associated with the emergence of fibroblasts originating from endothelial cells, suggesting an endothelial-mesenchymal transition (EndMT) similar to events that occur during formation of the atrioventricular cushion in the embryonic heart. Transforming growth factor-beta 1 (TGF-beta 1) induced endothelial cells to undergo EndMT, whereas bone morphogenic protein 7 (BMP-7) preserved the endothelial phenotype. The systemic administration of recombinant human BMP-7 (rhBMP-7) significantly inhibited EndMT and the progression of cardiac fibrosis in mouse models of pressure overload and chronic allograft rejection. Our findings show that EndMT contributes to the progression of cardiac fibrosis and that rhBMP-7 can be used to inhibit EndMT and to intervene in the progression of chronic heart disease associated with fibrosis.	Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Cardiol, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; Lund Univ, Dept Expt Pathol, S-22185 Lund, Sweden; Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02215 USA; Childrens Hosp, Boston, MA 02215 USA; NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37215 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Novartis; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Lund University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Harvard University; Harvard Medical School; Harvard University	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Pu, William/AAJ-8301-2020; Zeisberg, Elisabeth/ABG-4970-2021; Chandraker, Anil/L-3908-2019; Kalluri, Raghu/E-2677-2015	Pu, William/0000-0002-4551-8079; Kalluri, Raghu/0000-0002-2190-547X; Sayegh, Mohamed/0000-0002-2847-588X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK074558, R01DK062987, R01DK061688, R01DK046282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER; NHLBI NIH HHS [5 F32 HL082436-01] Funding Source: Medline; NIAAA NIH HHS [AA13913] Funding Source: Medline; NIDDK NIH HHS [DK62987, DK61688, DK55001, 5K08DK074558-01, DK-46282] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Gustafsson E, 2001, J CELL SCI, V114, P671; Hocht-Zeisberg E, 2004, EUR HEART J, V25, P749, DOI 10.1016/j.ehj.2004.01.017; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; KORHONEN J, 1994, ONCOGENE, V9, P395; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lang HN, 2001, DEV BIOL, V234, P120, DOI 10.1006/dbio.2001.0248; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LEFER AM, 1992, J MOL CELL CARDIOL, V24, P585, DOI 10.1016/0022-2828(92)91043-5; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lips DJ, 2004, BASIC RES CARDIOL, V99, P351, DOI 10.1007/s00395-004-0476-5; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAESHIMA Y, 2001, J BIOL CHEM, V7, P7; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Maresh JG, 2004, ARTERIOSCL THROM VAS, V24, P1836, DOI 10.1161/01.ATV.0000143097.90868.c8; Maric C, 1997, ANAT EMBRYOL, V195, P503, DOI 10.1007/s004290050070; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Nicoletti A, 1999, CARDIOVASC RES, V41, P532, DOI 10.1016/S0008-6363(98)00305-8; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramsdell AF, 1998, ACTA ANAT, V162, P1; Razeghi P, 2007, CARDIOVASC RES, V74, P133, DOI 10.1016/j.cardiores.2006.12.021; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Takemoto M, 1997, HYPERTENSION, V30, P1621, DOI 10.1161/01.HYP.30.6.1621; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tokumasa A, 2004, BIOCHEM BIOPH RES CO, V317, P377, DOI 10.1016/j.bbrc.2004.03.047; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; Weber KT, 1997, CIRCULATION, V96, P2488; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	50	1547	1636	6	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2007	13	8					952	961		10.1038/nm1613	http://dx.doi.org/10.1038/nm1613			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17660828				2022-12-25	WOS:000248674600026
J	Delous, M; Baala, L; Salomon, R; Laclef, C; Vierkotten, J; Tory, K; Golzio, C; Lacoste, T; Besse, L; Ozilou, C; Moutkine, I; Hellman, NE; Anselme, I; Silbermann, F; Vesque, C; Gerhardt, C; Rattenberry, E; Wolf, MTF; Gubler, MC; Martinovic, J; Encha-Razavi, F; Boddaert, N; Gonzales, M; Macher, MA; Nivet, H; Champion, G; Bertheleme, JP; Niaudet, P; McDonald, F; Hildebrandt, F; Johnson, CA; Vekemans, M; Antignac, C; Ruther, U; Schneider-Maunoury, S; Attie-Bitach, T; Saunier, S				Delous, Marion; Baala, Lekbir; Salomon, Remi; Laclef, Christine; Vierkotten, Jeanette; Tory, Kalman; Golzio, Christelle; Lacoste, Tiphanie; Besse, Laurianne; Ozilou, Catherine; Moutkine, Imane; Hellman, Nathan E.; Anselme, Isabelle; Silbermann, Flora; Vesque, Christine; Gerhardt, Christoph; Rattenberry, Eleanor; Wolf, Matthias T. F.; Gubler, Marie Claire; Martinovic, Jelena; Encha-Razavi, Ferechte; Boddaert, Nathalie; Gonzales, Marie; Macher, Marie Alice; Nivet, Hubert; Champion, Gerard; Bertheleme, Jean Pierre; Niaudet, Patrick; McDonald, Fiona; Hildebrandt, Friedhelm; Johnson, Colin A.; Vekemans, Michel; Antignac, Corinne; Ruether, Ulrich; Schneider-Maunoury, Sylvie; Attie-Bitach, Tania; Saunier, Sophie			The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; MUTANT FUSED-TOES; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; MUTATIONS; MOUSE; NPHP1; NEPHROCYSTIN-4; ENCODES; CILIUM	Cerebello- oculo- renal syndrome ( CORS), also called Joubert syndrome type B, and Meckel ( MKS) syndrome belong to the group of developmental autosomal recessive disorders that are associated with primary cilium dysfunction. Using SNP mapping, we identified missense and truncating mutations in RPGRIP1L ( KIAA1005) in both CORS and MKS, and we show that inactivation of the mouse ortholog Rpgrip1l ( Ftm) recapitulates the cerebral, renal and hepatic defects of CORS and MKS. In addition, we show that RPGRIP1L colocalizes at the basal body and centrosomes with the protein products of both NPHP6 and NPHP4, known genes associated with MKS, CORS and nephronophthisis ( a related renal disorder and ciliopathy). In addition, the RPGRIP1L missense mutations found in CORS individuals diminishes the interaction between RPGRIP1L and nephrocystin- 4. Our findings show that mutations in RPGRIP1L can cause the multiorgan phenotypic abnormalities found in CORS or MKS, which therefore represent a continuum of the same underlying disorder.	INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France; Univ Paris 05, F-75006 Paris, France; Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, F-75015 Paris, France; CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Univ Dusseldorf, Inst Entwicklungs & Mol Biol Tiere, EMT, D-40225 Dusseldorf, Germany; Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; Womens Hosp Med Ctr, W Midlands Reg Genet, Birmingham B15 2TG, W Midlands, England; Univ Michigan, Dept Pediat & Human Genet, Ann Arbor, MI 48109 USA; Hop Necker Enfants Malad, F-75015 Paris, France; Hop Trousseau, Dept Foetopathol, F-75012 Paris, France; Hop Robert Debre, APHP, Dept Pediat, F-75019 Paris, France; CHU Bretonneau, Dept Nephrol & Clin Immunol, F-37000 Tours, France; CHU Angers, Dept Pediat Nephrol, F-49100 Angers, France; Ctr Perharidy, F-29680 Roscoff, France; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Saint James's University Hospital; University of Leeds	Saunier, S (corresponding author), INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France.	saunier@necker.fr	ANTIGNAC, Corinne/H-8945-2017; Vesque, Christine/L-9839-2017; Gerhardt, Christoph/AAO-4596-2020; ATTIE-BITACH, Tania/K-1453-2017; Delous, Marion/H-3850-2017; Schneider-Maunoury, Sylvie/K-6795-2017; boddaert, nathalie/GWV-2865-2022; Saunier, Sophie/G-6044-2015; Delous, Marion/Q-1835-2019; Vesque, Christine/Q-8461-2019	ANTIGNAC, Corinne/0000-0002-9934-4940; Gerhardt, Christoph/0000-0002-6340-549X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Delous, Marion/0000-0003-2666-4457; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Saunier, Sophie/0000-0002-1069-0047; Delous, Marion/0000-0003-2666-4457; boddaert, nathalie/0000-0003-0991-7774; Gubler, Marie-Claire/0000-0002-3526-5661; Vesque, Christine/0000-0001-7983-4953; Golzio, Christelle/0000-0002-4420-3921; legendre, flora/0000-0002-4149-1913	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK068306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; BAALA L, IN PRESS AM J HUM GE; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Espinosa-Parrilla Y, 2002, MECH DEVELOP, V114, P187, DOI 10.1016/S0925-4773(02)00062-X; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith A., 1996, Managing Information, V3, P38; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355	30	351	356	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					875	881		10.1038/ng2039	http://dx.doi.org/10.1038/ng2039			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558409				2022-12-25	WOS:000247619800018
J	Ja, WW; West, AP; Delker, SL; Bjorkman, PJ; Benzer, S; Roberts, RW				Ja, William W.; West, Anthony P., Jr.; Delker, Silvia L.; Bjorkman, Pamela J.; Benzer, Seymour; Roberts, Richard W.			Extension of Drosophila melanogaster life span with a GPCR peptide inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; MESSENGER-RNA DISPLAY; IN-VITRO SELECTION; CRYSTAL-STRUCTURE; LIGAND DISCOVERY; METHUSELAH; LONGEVITY; MUTANT; DOMAIN	G protein-coupled receptors (GPCRs) mediate signaling from extracellular ligands to intracellular signal transduction proteins(1). Methuselah (Mth) is a class B (secretin-like) GPCR, a family typified by their large, ligand-binding, N-terminal extracellular domains(2). Downregulation of mth increases the life span of Drosophila melanogaster(3); inhibitors of Mth signaling should therefore enhance longevity. We used mRNA display selection(4,5) to identify high-affinity (K-d = 15 to 30 nM) peptide ligands that bind to the N-terminal ectodomain of Mth. The selected peptides are potent antagonists of Mth signaling, and structural studies suggest that they perturb the interface between the Mth ecto- and transmembrane domains. Flies constitutively expressing a Mth antagonist peptide have a robust life span extension, which suggests that the peptides inhibit Mth signaling in vivo. Our work thus provides new life span-extending ligands for a metazoan and a general approach for the design of modulators of this important class of GPCRs.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92617 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem Engn, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol, Los Angeles, CA 90089 USA	University of California System; University of California Irvine; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Southern California; University of Southern California; University of Southern California	Roberts, RW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92617 USA.	richard.roberts@usc.edu	Gimenez, Luis E Diaz/D-9291-2011	Ja, William/0000-0002-4003-7356	NIA NIH HHS [R01 AG016630, R01 AG016630-08] Funding Source: Medline; NIGMS NIH HHS [R01 GM060416-05, R01 GM060416, R01 GM60416] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baldal EA, 2006, EXP GERONTOL, V41, P1126, DOI 10.1016/j.exger.2006.08.014; Bieri C, 1999, NAT BIOTECHNOL, V17, P1105, DOI 10.1038/15090; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Harmar AJ, 2001, GENOME BIOL, V2; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Ja WW, 2006, ACS CHEM BIOL, V1, P570, DOI 10.1021/cb600345k; Ja WW, 2005, PROTEIN ENG DES SEL, V18, P309, DOI 10.1093/protein/gzi038; Ja WW, 2005, TRENDS BIOCHEM SCI, V30, P318, DOI 10.1016/j.tibs.2005.04.001; Ja WW, 2004, BIOCHEMISTRY-US, V43, P9265, DOI 10.1021/bi0498398; Kurz M, 2000, Nucleic Acids Res, V28, pE83, DOI 10.1093/nar/28.18.e83; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Milligan G, 2002, BIOCHEM SOC T, V30, P789, DOI 10.1042/bst0300789; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Szekeres PG, 2002, RECEPTOR CHANNEL, V8, P297, DOI 10.1080/10606820214642; Takahashi TT, 2003, TRENDS BIOCHEM SCI, V28, P159, DOI 10.1016/S0968-0004(03)00036-7; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8	30	48	52	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					415	419		10.1038/nchembio.2007.2	http://dx.doi.org/10.1038/nchembio.2007.2			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17546039	Green Accepted			2022-12-25	WOS:000247462800016
J	Jimenez-Baranda, S; Gomez-Mouton, C; Rojas, A; Martinez-Prats, L; Mira, E; Lacalle, RA; Valencia, A; Dimitrov, DS; Viola, A; Delgado, R; Martinez, C; Manes, S				Jimenez-Baranda, Sonia; Gomez-Mouton, Concepcion; Rojas, Ana; Martinez-Prats, Lorena; Mira, Emilia; Lacalle, Rosa Ana; Valencia, Alfonso; Dimitrov, Dimiter S.; Viola, Antonella; Delgado, Rafael; Martinez, Carlos; Manes, Santos			Filamin-A regulates actin-dependent clustering of HIV receptors	NATURE CELL BIOLOGY			English	Article							CHEMOKINE RECEPTORS; LIPID RAFTS; VIRUS ENTRY; HOST-CELLS; CD4; INFECTION; TYPE-1; CHOLESTEROL; BINDING; ROCK	Human immunodeficiency virus ( HIV)-1 infection requires envelope ( Env) glycoprotein gp120-induced clustering of CD4 and coreceptors (CCR5 or CXCR4) on the cell surface; this enables Env gp41 activation and formation of a complex that mediates fusion between Env-containing and target-cell membranes(1). Kinetic studies show that viral receptors are actively transported to the Env-receptor interface in a process that depends on plasma membrane composition and the actin cytoskeleton(2-7). The mechanisms by which HIV-1 induces F-actin rearrangement in the target cell remain largely unknown. Here, we show that CD4 and the coreceptors interact with the actin-binding protein filamin-A, whose binding to HIV-1 receptors regulates their clustering on the cell surface. We found that gp120 binding to cell receptors induces transient cofilin-phosphorylation inactivation through a RhoA-ROCK-dependent mechanism. Blockade of filamin-A interaction with CD4 and/or coreceptors inhibits gp120-induced RhoA activation and cofilin inactivation. Our results thus identify filamin-A as an adaptor protein that links HIV-1 receptors to the actin cytoskeleton remodelling machinery, which may facilitate virus infection.	CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Bioinformat Unit, E-28049 Madrid, Spain; Hosp 12 Octubre, Microbiol Serv, E-28041 Madrid, Spain; NCI, CCR Nanobiol Program, NIH, Ft Detrick, MD 21702 USA; Univ Padua, Venetian Inst Mol Med, I-35100 Padua, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitario 12 de Octubre; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua; Veneto Institute Molecular Medicine	Manes, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,Campus Cantoblanco, E-28049 Madrid, Spain.	smanes@cnb.uam.es	Manes, Santos/E-4725-2011; Rojas, Ana M/C-3022-2008; Rojas, Ana M/D-5777-2011; Valencia, Alfonso/I-3127-2015; IBIS, BIOINFORMATICA/O-1882-2015; Agatea, Lisa/L-8267-2016; DELGADO, RAFAEL/A-2938-2012; Delgado, Rafael/C-4910-2016; Rojas, Ana M./I-2882-2019; MIRA, EMILIA/K-2456-2014; Viola, Antonella/A-4321-2015	Rojas, Ana M/0000-0003-0750-9099; Valencia, Alfonso/0000-0002-8937-6789; Delgado, Rafael/0000-0002-6912-4736; Rojas, Ana M./0000-0003-0750-9099; MIRA, EMILIA/0000-0002-4226-1829; Lacalle, Rosa Ana/0000-0003-0082-167X; Viola, Antonella/0000-0002-0125-9271; Manes, Santos/0000-0001-8023-957X; GOMEZ-MOUTON, CONCEPCION/0000-0002-1595-6027	NATIONAL CANCER INSTITUTE [ZIABC010701, Z01BC010701] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; del Real G, 2002, J EXP MED, V196, P293, DOI 10.1084/jem.20020308; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055	32	142	144	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					838	+		10.1038/ncb1610	http://dx.doi.org/10.1038/ncb1610			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17572668				2022-12-25	WOS:000247760700020
J	Popov, N; Wanzel, M; Madiredjo, M; Zhang, D; Beijersbergen, R; Bernards, R; Moll, R; Elledge, SJ; Eilers, M				Popov, Nikita; Wanzel, Michael; Madiredjo, Mandy; Zhang, Dong; Beijersbergen, Roderick; Bernards, Rene; Moll, Roland; Elledge, Stephen J.; Eilers, Martin			The ubiquitin-specific protease USP28 is required for MYC stability	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; C-MYC; DEUBIQUITINATING ENZYME; RNA INTERFERENCE; BINDING DOMAIN; S-PHASE; DEGRADATION; CANCER; PHOSPHORYLATION; PATHWAY	The MYC proto-oncogene encodes a transcription factor that has been implicated in the genesis of many human tumours. Here, we used a bar-code short hairpin RNA (shRNA) screen to identify multiple genes that are required for MYC function. One of these genes encodes USP28, an ubiquitin-specific protease. USP28 is required for MYC stability in human tumour cells. USP28 binds to MYC through an interaction with FBW7 alpha, an F-box protein that is part of an SCF-type ubiquitin ligase. Therefore, it stabilizes MYC in the nucleus, but not in the nucleolus, where MYC is degraded by FBW gamma.. High expression levels of USP28 are found in colon and breast carcinomas, and stabilization of MYC by USP28 is essential for tumour-cell proliferation.	Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Ctr Genet & Genom, Dept Genet, Boston, MA 02115 USA; Univ Marburg, Dept Pathol, D-35033 Marburg, Germany	Netherlands Cancer Institute; Harvard University; Harvard Medical School; Philipps University Marburg	Eilers, M (corresponding author), Inst Mol Biol & Tumor Res, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	eilers@imt.uni-marburg.de		Bernards, Rene/0000-0001-8677-3423; Zhang, Dong/0000-0002-4515-2070; Beijersbergen, Roderick/0000-0003-0116-4130; Eilers, Martin/0000-0002-0376-6533				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leung-Toung R, 2006, CURR MED CHEM, V13, P547, DOI 10.2174/092986706776055733; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	49	313	335	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					765	U71		10.1038/ncb1601	http://dx.doi.org/10.1038/ncb1601			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558397				2022-12-25	WOS:000247760700012
J	Wu, S; Ying, G; Wu, Q; Capecchi, MR				Wu, Sen; Ying, Guoxin; Wu, Qiang; Capecchi, Mario R.			Toward simpler and faster genome-wide mutagenesis in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GAMMA-PROTOCADHERINS; CHROMOSOME REARRANGEMENTS; DROSOPHILA-MELANOGASTER; DEVELOPMENTAL GENES; SPINAL-CORD; MOUSE; PIGGYBAC; TRANSPOSON; DISRUPTION	Here we describe a practical Cre- loxP and piggyBac transposon - based mutagenesis strategy to systematically mutate coding sequences and/ or the vast noncoding regions of the mouse genome for large- scale functional genomic analysis. To illustrate this approach, we first created loxP- containing loss-of-function alleles in the protocadherin alpha, beta and gamma gene clusters ( Pcdha, Pcdhb and Pcdhg). Using these alleles, we show that, under proper guidance, Cre- loxP site- specific recombination can mediate efficient trans- allelic recombination in vivo, facilitating the generation of large germline deletions and duplications including deletions of Pcdha, and Pcdha to Pcdhb, simply by breeding ( that is, at frequencies of 5.5% - 21.6%). The same breeding method can also generate designed germline translocations between nonhomologous chromosomes at unexpected frequencies of greater than 1%. By incorporating a piggyBac transposon to insert and to distribute loxP sites randomly throughout the mouse genome, we present a simple but comprehensive method for generating genome-wide deletions and duplications, in addition to insertional loss-of-function and conditional rescue alleles, again simply by breeding.	Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Wilson, Matthew H/K-3193-2013; Wu, Qiang/A-6751-2009	Wu, Qiang/0000-0003-3841-3591				Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; DRACOPOLI NC, 2006, CURRENT PROTOCOL HUM; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Genoud N, 2004, P NATL ACAD SCI USA, V101, P4198, DOI 10.1073/pnas.0400131101; Golic KG, 1996, GENETICS, V144, P1693; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Jung JY, 2003, AM J PHYSIOL-RENAL, V285, pF1210, DOI 10.1152/ajprenal.00111.2003; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Phillips GR, 2003, J NEUROSCI, V23, P5096; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	47	112	125	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					922	930		10.1038/ng2060	http://dx.doi.org/10.1038/ng2060			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572674				2022-12-25	WOS:000247619800025
J	Hernando, E; Charytonowicz, E; Dudas, ME; Menendez, S; Matushansky, I; Mills, J; Socci, ND; Behrendt, N; Ma, L; Maki, RG; Pandolfi, PP; Cordon-Cardo, C				Hernando, Eva; Charytonowicz, Elizabeth; Dudas, Maria E.; Menendez, Silvia; Matushansky, Igor; Mills, Joslyn; Socci, Nicholas D.; Behrendt, Nille; Ma, Li; Maki, Robert G.; Pandolfi, Pier Paolo; Cordon-Cardo, Carlos			The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE; TUBEROUS SCLEROSIS; SYNOVIAL SARCOMA; CANCER; GENE; MICE; TSC2; PHOSPHORYLATION; TUMORIGENESIS; DEFICIENT	We analyzed the PI3K-AKT signaling cascade in a cohort of sarcomas and found a marked induction of insulin receptor substrate-2 (IRS2) and phosphorylated AKT and a concomitant upregulation of downstream effectors in most leiomyosarcomas. To determine the role of aberrant PI3K-AKT signaling in leiomyosarcoma pathogenesis, we genetically inactivated Pten in the smooth muscle cell lineage by cross-breeding Pten(loxP/loxP) mice with Tagln-cre mice. Mice carrying homozygous deletion of Pten alleles developed widespread smooth muscle cell hyperplasia and abdominal leiomyosarcomas, with a very rapid onset and elevated incidence (similar to 80%) compared to other animal models. Constitutive mTOR activation was restricted to the leiomyosarcomas, revealing the requirement for additional molecular events besides Pten loss. The rapamycin derivative everolimus substantially decelerated tumor growth on Tagln-cre/ Pten(loxP/loxP) mice and prolonged their lifespan. Our data show a new and critical role for the AKT-mTOR pathway in smooth muscle transformation and leiomyosarcoma genesis, and support treatment of selected sarcomas by the targeting of this pathway with new compounds or combinations of these with conventional chemotherapy agents.	Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), NYU, Sch Med, Dept Pathol, Expt Pathol Program, New York, NY 10016 USA.	p-pandolfi@ski.mskcc.org; cc2791@columbia.edu	Maki, Robert G/J-9145-2019; Maki, Robert G./AAI-2793-2020; Ma, Li/GQR-1313-2022	Maki, Robert G/0000-0002-9853-2528; Ma, Li/0000-0001-9965-989X; Hernando, Eva/0000-0003-1023-0312	NATIONAL CANCER INSTITUTE [P01CA047179] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA47179] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Hornick Jason L, 2003, Ann Diagn Pathol, V7, P60, DOI 10.1053/adpa.2003.50010; Hu J, 2005, CANCER GENET CYTOGEN, V161, P20, DOI 10.1016/j.cancergencyto.2005.01.011; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Politi K, 2004, AM J PATHOL, V164, P325, DOI 10.1016/S0002-9440(10)63122-7; Radany EH, 1997, P NATL ACAD SCI USA, V94, P8664, DOI 10.1073/pnas.94.16.8664; Rieske P, 1999, J EXP CLIN CANC RES, V18, P403; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tos APD, 1996, AM J PATHOL, V148, P1037; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xie YT, 1999, CANCER RES, V59, P3588; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	29	212	223	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					748	753		10.1038/nm1560	http://dx.doi.org/10.1038/nm1560			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17496901				2022-12-25	WOS:000247084300040
J	Gudmundsson, J; Sulem, P; Manolescu, A; Amundadottir, LT; Gudbjartsson, D; Helgason, A; Rafnar, T; Bergthorsson, JT; Agnarsson, BA; Baker, A; Sigurdsson, A; Benediktsdottir, KR; Jakobsdottir, M; Xu, JF; Blondal, T; Kostic, J; Sun, JL; Ghosh, S; Stacey, SN; Mouy, M; Saemundsdottir, J; Backman, VM; Kristjansson, K; Tres, A; Partin, AW; Albers-Akkers, MT; Marcos, JGI; Walsh, PC; Swinkels, DW; Navarrete, S; Isaacs, SD; Aben, KK; Graif, T; Cashy, J; Ruiz-Echarri, M; Wiley, KE; Suarez, BK; Witjes, JA; Frigge, M; Ober, C; Jonsson, E; Einarsson, GV; Mayordomo, JI; Kiemeney, LA; Isaacs, WB; Catalona, WJ; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Manolescu, Andrei; Amundadottir, Laufey T.; Gudbjartsson, Daniel; Helgason, Agnar; Rafnar, Thorunn; Bergthorsson, Jon T.; Agnarsson, Bjarni A.; Baker, Adam; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Jakobsdottir, Margret; Xu, Jianfeng; Blondal, Thorarinn; Kostic, Jelena; Sun, Jielin; Ghosh, Shyamali; Stacey, Simon N.; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M.; Kristjansson, Kristleifur; Tres, Alejandro; Partin, Alan W.; Albers-Akkers, Marjo T.; Marcos, Javier Godino-Ivan; Walsh, Patrick C.; Swinkels, Dorine W.; Navarrete, Sebastian; Isaacs, Sarah D.; Aben, Katja K.; Graif, Theresa; Cashy, John; Ruiz-Echarri, Manuel; Wiley, Kathleen E.; Suarez, Brian K.; Witjes, J. Alfred; Frigge, Mike; Ober, Carole; Jonsson, Eirikur; Einarsson, Gudmundur V.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Isaacs, William B.; Catalona, William J.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24	NATURE GENETICS			English	Article							CERVICAL-CARCINOMA; CONFERS RISK; METAANALYSIS; INTEGRATION; DISEASES; LOCUS	Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions(1), with African American men having among the highest worldwide incidence and mortality rates(2). Here we report a second genetic variant in the 8q24 region that, in conjunction with another variant we recently discovered(3), accounts for about 11% - 13% of prostate cancer cases in individuals of European descent and 31% of cases in African Americans. We made the current discovery through a genome-wide association scan of 1,453 affected Icelandic individuals and 3,064 controls using the Illumina HumanHap 300 BeadChip followed by four replication studies. A key step in the discovery was the construction of a 14-SNP haplotype that efficiently tags a relatively uncommon (2% - 4%) susceptibility variant in individuals of European descent that happens to be very common (similar to 42%) in African Americans. The newly identified variant shows a stronger association with affected individuals who have an earlier age at diagnosis.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21209 USA; Thrombosis Serv, NL-6503 GM Nijmegen, Netherlands; Inst Hlth Sci, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands; Univ Hosp, Div Radiat Oncol, Zaragoza, Spain; Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Landspital Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Wake Forest University; Lozano Blesa University Clinical Hospital; University of Zaragoza; Johns Hopkins University; Johns Hopkins Medicine; Radboud University Nijmegen; Miguel Servet University Hospital; Radboud University Nijmegen; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Radboud University Nijmegen; University of Chicago; Landspitali National University Hospital; Radboud University Nijmegen	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Backman, Vadim/B-6689-2009; Swinkels, Dorine W./H-8098-2014; Mayordomo, Jose/K-3453-2013; Amundadottir, Laufey T/L-7656-2016; Aben, Katja KH/G-9686-2016; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Witjes, Fred/N-9665-2013; Manolescu, Andrei/G-4565-2014; Kiemeney, Lambertus A./D-3357-2009	Swinkels, Dorine W./0000-0002-1040-9446; Amundadottir, Laufey T/0000-0003-1859-8971; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudbjartsson, Daniel/0000-0002-5222-9857; Ober, Carole/0000-0003-4626-9809; Bergthorsson, Jon Thor/0000-0002-0560-2639; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767				Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Ferber MJ, 2004, CANCER GENET CYTOGEN, V154, P1, DOI 10.1016/j.cancergencyto.2004.01.028; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; REES LAG, 2006, SEER CANC STAT REV 1; Taylor ML, 2005, FAM MED, V37, P506; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	22	674	712	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					631	637		10.1038/ng1999	http://dx.doi.org/10.1038/ng1999			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401366				2022-12-25	WOS:000245971300018
J	Wang, ZZ; Au, P; Chen, T; Shao, Y; Daheron, LM; Bai, H; Arzigian, M; Fukumura, D; Jain, RK; Scadden, DT				Wang, Zack Z.; Au, Patrick; Chen, Tong; Shao, Ying; Daheron, Laurence M.; Bai, Hao; Arzigian, Melanie; Fukumura, Dai; Jain, Rakesh K.; Scadden, David T.			Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo	NATURE BIOTECHNOLOGY			English	Article							CD34(+) CELLS; DIFFERENTIATION; ANGIOGENESIS	We describe the differentiation of human embryonic stem (hES) cells into endothelial cells using a scalable two-dimensional method that avoids an embryoid-body intermediate. After transplantation into severe combined immunodeficient (SCID) mice, the differentiated cells contributed to arborized blood vessels that integrated into the host circulatory system and served as blood conduits for 150 d.	Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Fudan Univ, Shanghai Huashan Hosp, Dept Hematol, Shanghai 200040, Peoples R China; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Maine Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Fudan University; Harvard University	Wang, ZZ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA.	wangz@mmc.org; jain@steele.mgh.harvard.edu; scadden.david@mgh.harvard.edu	Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548	NCI NIH HHS [R01CA115767, R01CA96915, P01 CA080124, P01CA80124] Funding Source: Medline; NCRR NIH HHS [P20RR018789] Funding Source: Medline; NIDDK NIH HHS [K01DK064696] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096915, R01CA115767, P01CA080124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064696] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BARKER JE, 1968, DEV BIOL, V18, P14, DOI 10.1016/0012-1606(68)90020-1; BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Gehling UM, 2000, BLOOD, V95, P3106; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI24015; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649	13	233	262	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					317	318		10.1038/nbt1287	http://dx.doi.org/10.1038/nbt1287			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17322871				2022-12-25	WOS:000244748300023
J	Hillbertz, NHCS; Isaksson, M; Karlsson, EK; Hellmen, E; Pielberg, GR; Savolainen, P; Wade, CM; Von Euler, H; Gustafson, U; Hedhammar, K; Nilsson, M; Lindblad-Toh, K; Andersson, L; Andersson, G				Hillbertz, Nicolette H. C. Salmon; Isaksson, Magnus; Karlsson, Elinor K.; Hellmen, Eva; Pielberg, Gerli Rosengren; Savolainen, Peter; Wade, Claire M.; Von Euler, Henrik; Gustafson, Ulla; Hedhammar, Ake; Nilsson, Mats; Lindblad-Toh, Kerstin; Andersson, Leif; Andersson, Goran			Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs	NATURE GENETICS			English	Article							EXPRESSION; GENE	The dorsal hair ridge in Rhodesian and Thai Ridgeback dogs is caused by a dominant mutation that also predisposes to the congenital developmental disorder dermoid sinus. Here we show that the causative mutation is a 133-kb duplication involving three fibroblast growth factor (FGF) genes. FGFs play a crucial role in development, suggesting that the ridge and dermoid sinus are caused by dysregulation of one or more of the three FGF genes during development.	Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Broad Inst Harvard, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; SLU, Dept Physiol Anat & Biochem, SE-75007 Uppsala, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; SLU, Dept Clin Sci, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Boston University; Swedish University of Agricultural Sciences; Uppsala University; Royal Institute of Technology; Harvard University; Massachusetts General Hospital; Swedish University of Agricultural Sciences	Andersson, L (corresponding author), Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, Box 597, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se; goran.andersson@hgen.slu.se	Ronnberg, HENRIK Paul Olof/AAP-9678-2021; Andersson, Goran/AAK-6564-2020; Fiumefreddo, Andrea/T-2977-2019	Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Andersson, Goran/0000-0001-5131-3144; Karlsson, Elinor/0000-0002-4343-3776; Wade, Claire/0000-0003-3413-4771; Hedhammar, Ake/0000-0001-7048-3851				Ackerman LL, 2003, PEDIATRICS, V112, P641, DOI 10.1542/peds.112.3.641; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; ELTON S, 2001, NEUROSURG FOCUS, V10, P1; HALL S, 2003, DOGS AFRICA, P123; Hillbertz NHCS, 2006, J SMALL ANIM PRACT, V47, P184, DOI 10.1111/j.1748-5827.2006.00016.x; Hillbertz NHCS, 2005, J SMALL ANIM PRACT, V46, P71, DOI 10.1111/j.1748-5827.2005.tb00295.x; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; ISAKSSONM, 2007, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKM651; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Ornitz DM, 2001, GENOME BIOL, V2; Padmanabhan Rengasamy, 2006, Congenital Anomalies, V46, P55, DOI 10.1111/j.1741-4520.2006.00104.x; Powles N, 2004, DEV DYNAM, V230, P44, DOI 10.1002/dvdy.20028; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005	15	154	158	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1318	1320		10.1038/ng.2007.4	http://dx.doi.org/10.1038/ng.2007.4			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906623				2022-12-25	WOS:000250575900015
J	Apetoh, L; Ghiringhelli, F; Tesniere, A; Obeid, M; Ortiz, C; Criollo, A; Mignot, G; Maiuri, MC; Ullrich, E; Saulnier, P; Yang, H; Amigorena, S; Ryffel, B; Barrat, FJ; Saftig, P; Levi, F; Lidereau, R; Nogues, C; Mira, JP; Chompret, A; Joulin, V; Clavel-Chapelon, F; Bourhis, J; Andre, F; Delaloge, S; Tursz, T; Kroemer, G; Zitvogel, L				Apetoh, Lionel; Ghiringhelli, Francois; Tesniere, Antoine; Obeid, Michel; Ortiz, Carla; Criollo, Alfredo; Mignot, Gregoire; Maiuri, M. Chiara; Ullrich, Evelyn; Saulnier, Patrick; Yang, Huan; Amigorena, Sebastian; Ryffel, Bernard; Barrat, Franck J.; Saftig, Paul; Levi, Francis; Lidereau, Rosette; Nogues, Catherine; Mira, Jean-Paul; Chompret, Agnes; Joulin, Virginie; Clavel-Chapelon, Francoise; Bourhis, Jean; Andre, Fabrice; Delaloge, Suzette; Tursz, Thomas; Kroemer, Guido; Zitvogel, Laurence			Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy	NATURE MEDICINE			English	Article							DENDRITIC CELLS; APOPTOTIC CELLS; ANTIGEN PRESENTATION; INNATE IMMUNITY; NECROTIC CELLS; PROTEIN HMGB1; T-CELLS; TOLL-LIKE-RECEPTOR-4; DEATH; IMMUNOGENICITY	Conventional cancer treatments rely on radiotherapy and chemotherapy. Such treatments supposedly mediate their effects via the direct elimination of tumor cells. Here we show that the success of some protocols for anticancer therapy depends on innate and adaptive antitumor immune responses. We describe in both mice and humans a previously unrecognized pathway for the activation of tumor antigen-specific T-cell immunity that involves secretion of the high-mobility-group box 1 (HMGB1) alarmin protein by dying tumor cells and the action of HMGB1 on Toll-like receptor 4 (TLR4) expressed by dendritic cells (DCs). During chemotherapy or radiotherapy, DCs require signaling through TLR4 and its adaptor MyD88 for efficient processing and cross-presentation of antigen from dying tumor cells. Patients with breast cancer who carry a TLR4 loss-of-function allele relapse more quickly after radiotherapy and chemotherapy than those carrying the normal TLR4 allele. These results delineate a clinically relevant immunoadjuvant pathway triggered by tumor cell death.	Inst Gustave Roussy, F-94805 Villejuif, France; Univ Paris Sud, Le Kremlin Bicetre, France; Inst Natl Sante & Rech Med, Immunol & Immunotherapie Tumeurs U805, F-94805 Villejuif, France; IGR, Ctr Invest Biotherapies CBT507, F-94805 Villejuif, France; Inst Natl Sante & Rech Med, U848 Apoptosis Canc & Immun, F-94805 Villejuif, France; Univ Naples Federico 2, Fac Sci Biotecnol, Dipartimento Farmacol Sperimentale, I-80135 Naples, Italy; IGR, Lab Rech Tranlationnelle, F-94805 Villejuif, France; Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; Inst Curie, Inst Nat Sante & Rech Med U653, F-75248 Paris 05, France; Ctr Natl Rech Sci IEM2815, F-45071 Orleans, France; Dynavax Technol Corp, Berkeley, CA 94710 USA; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; Hop Paul Brousse, Inst Natl Sante & Rech Med U776 Biol Rhythms & Ca, F-94807 Villejuif, France; Ctr Rene Huguenin, FNCLCC, Inst Natl Sante & Rech med U735, F-92210 St Cloud, France; Univ Paris 05, Fac Med Rene Descartes, Dept Biol Cellulaire,Inst Natl Sante & Rech Med, Inst Cochin,CNRS,UMR 8104,U567, F-75014 Paris, France; IGR, Dept Med, F-94805 Villejuif, France; IGR, Dept Radiotherapy, F-94805 Villejuif, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Naples Federico II; UNICANCER; Gustave Roussy; Northwell Health; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Kiel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Zitvogel, L (corresponding author), Inst Gustave Roussy, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@igr.fr; zitvogel@igr.fr	Apetoh, Lionel/AIC-2384-2022; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Apetoh, Lionel/G-3310-2014; Mignot, Grégoire/R-4976-2017; ANDRE, Fabrice/AAL-2683-2020; Saftig, Paul/A-7966-2010; Clavel-Chapelon, Francoise/G-6733-2014; OBEID, Michel/HCI-9145-2022	Apetoh, Lionel/0000-0002-2774-438X; KROEMER, Guido/0000-0002-9334-4405; Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; ANDRE, Fabrice/0000-0001-5795-8357; ghiringhelli, francois/0000-0002-5465-8305; ZITVOGEL, laurence/0000-0003-1596-0998; Ullrich, Evelyn/0000-0001-8530-1192; JOULIN, Virginie/0000-0003-1091-7819; Bourhis, Jean/0000-0001-5162-1171; Amigorena, Sebastian/0000-0001-8583-8416; Criollo, Alfredo/0000-0002-2737-7751				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; GORLA R, 1994, AIDS RES HUM RETROV, V10, P1097, DOI 10.1089/aid.1994.10.1097; Granda TG, 2002, BRIT J CANCER, V86, P999, DOI 10.1038/sj.bjc.6600168; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Ronchetti A, 1999, J LEUKOCYTE BIOL, V66, P247, DOI 10.1002/jlb.66.2.247; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shi Y, 2002, EUR J IMMUNOL, V32, P155, DOI 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO;2-P; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; van der Graaf C, 2005, CYTOKINE, V30, P264, DOI 10.1016/j.cyto.2005.02.001; van Rijn BB, 2004, J IMMUNOL METHODS, V289, P81, DOI 10.1016/j.jim.2004.03.013; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015	48	2186	2269	14	295	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1050	1059		10.1038/nm1622	http://dx.doi.org/10.1038/nm1622			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17704786				2022-12-25	WOS:000249353100032
J	Nicot, AS; Toussaint, A; Tosch, V; Kretz, C; Wallgren-Pettersson, C; Iwarsson, E; Kingston, H; Garnier, JM; Biancalana, V; Oldfors, A; Mandel, JL; Laporte, J				Nicot, Anne-Sophie; Toussaint, Anne; Tosch, Valerie; Kretz, Christine; Wallgren-Pettersson, Carina; Iwarsson, Erik; Kingston, Helen; Garnier, Jean-Marie; Biancalana, Valerie; Oldfors, Anders; Mandel, Jean-Louis; Laporte, Jocelyn			Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR BIN1; MEMBRANE CURVATURE; SKELETAL-MUSCLE; SH3 DOMAIN; BAR; PHOSPHOINOSITIDES; MYOTUBULARINS; PHOSPHATASE; ENDOCYTOSIS; DOMINANT	Centronuclear myopathies are characterized by muscle weakness and abnormal centralization of nuclei in muscle fibers not secondary to regeneration. The severe neonatal X- linked form ( myotubular myopathy) is due to mutations in the phosphoinositide phosphatase myotubularin ( MTM1)(1), whereas mutations in dynamin 2 ( DNM2) have been found in some autosomal dominant cases(2). By direct sequencing of functional candidate genes, we identified homozygous mutations in amphiphysin 2 ( BIN1) in three families with autosomal recessive inheritance. Two missense mutations affecting the BAR ( Bin1/ amphiphysin/ RVS167) domain disrupt its membrane tubulation properties in transfected cells, and a partial truncation of the C- terminal SH3 domain abrogates the interaction with DNM2 and its recruitment to the membrane tubules. Our results suggest that mutations in BIN1 cause centronuclear myopathy by interfering with remodeling of T tubules and/ or endocytic membranes, and that the functional interaction between BIN1 and DNM2 is necessary for normal muscle function and positioning of nuclei.	IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg 1, F-67000 Strasbourg, France; Coll France, Chaire Genet Humaine, F-67400 Illkirch Graffenstaden, France; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Folkhalsan Inst Genet, Biomed, FIN-00014 Helsinki, Finland; Karolinska Univ Hosp, Dept Mol Med & Surg, Clin Genet Unit, S-17176 Stockholm, Sweden; Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Cent Manchester & Manchester Childrens Univ Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Strasbourg 1, Fac Med, CHRU, Lab Diagnost Genet, F-67085 Strasbourg, France; Univ Strasbourg 1, Med Genet Lab, EA3949, F-67085 Strasbourg, France; Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; University of Manchester; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Sahlgrenska University Hospital	Laporte, J (corresponding author), IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France.	mtm@igbmc.u-strasbg.fr	Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; Nicot, Anne-Sophie/GSE-6467-2022; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/J-7008-2012; Iwarsson, Erik/J-4677-2019; Mandel, Jean Louis/Q-2668-2016	Iwarsson, Erik/0000-0002-3827-0263; Mandel, Jean Louis/0000-0002-0535-6589; Oldfors, Anders/0000-0002-5758-7397				Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Engel A., 2004, MYOLOGY BASIC CLIN; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; KORSHUNOV A, 2006, ACTA NEUROPATHOL BER; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; MANDEL JL, 2002, STRUCTURAL MOL BASIS, P124; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; WALLGRENPETTERSSON C, 1995, J MED GENET, V32, P673, DOI 10.1136/jmg.32.9.673; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	29	258	268	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1134	1139		10.1038/ng2086	http://dx.doi.org/10.1038/ng2086			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676042				2022-12-25	WOS:000249122400024
J	Song, L; Kalyanaraman, C; Fedorov, AA; Fedorov, EV; Glasner, ME; Brown, S; Imker, HJ; Babbitt, PC; Almo, SC; Jacobson, MP; Gerlt, JA				Song, Ling; Kalyanaraman, Chakrapani; Fedorov, Alexander A.; Fedorov, Elena V.; Glasner, Margaret E.; Brown, Shoshana; Imker, Heidi J.; Babbitt, Patricia C.; Almo, Steven C.; Jacobson, Matthew P.; Gerlt, John A.			Prediction and assignment of function for a divergent N-succinyl amino acid racemase	NATURE CHEMICAL BIOLOGY			English	Article							D/L-GLU EPIMERASES; ENOLASE SUPERFAMILY; O-SUCCINYLBENZOATE; ENZYMATIC-ACTIVITIES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STRUCTURAL GENOMICS; EVOLUTION; SYNTHASE; AMYCOLATOPSIS	The protein databases contain many proteins with unknown function. A computational approach for predicting ligand specificity that requires only the sequence of the unknown protein would be valuable for directing experiment-based assignment of function. We focused on a family of unknown proteins in the mechanistically diverse enolase superfamily and used two approaches to assign function: (i) enzymatic assays using libraries of potential substrates, and (ii) in silico docking of the same libraries using a homology model based on the most similar (35% sequence identity) characterized protein. The results matched closely; an experimentally determined structure confirmed the predicted structure of the substrate-liganded complex. We assigned the N-succinyl arginine/lysine racemase function to the family, correcting the annotation (L-Ala-D/L-Glu epimerase) based on the function of the most similar characterized homolog. These studies establish that ligand docking to a homology model can facilitate functional assignment of unknown proteins by restricting the identities of the possible substrates that must be experimentally tested.	Univ Illinois, Dept Chem & Biochem, Urbana, IL 61801 USA; Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jacobson, MP (corresponding author), Univ Illinois, Dept Chem & Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	matt.jacobson@ucsf.edu	Jacobson, Matthew/Y-5161-2018; Imker, Heidi/F-5641-2012	Jacobson, Matthew/0000-0001-6262-655X; Imker, Heidi/0000-0003-4748-7453; Glasner, Margaret/0000-0003-1818-1965	NIGMS NIH HHS [1 P01 GM-71790] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071790] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams Michael, 2004, Journal of Structural and Functional Genomics, V5, P1, DOI 10.1023/B:JSFG.0000029244.65028.71; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Friedberg I, 2006, PROTEIN SCI, V15, P1527, DOI 10.1110/ps.062158406; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Gulick AM, 2001, BIOCHEMISTRY-US, V40, P15716, DOI 10.1021/bi011641p; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Klenchin VA, 2004, BIOCHEMISTRY-US, V43, P10370, DOI 10.1021/bi049197o; Lattman E, 2004, PROTEINS, V54, P611, DOI 10.1002/prot.20000; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Norvell JC, 2000, NAT STRUCT BIOL, V7, P931, DOI 10.1038/80694; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer DRJ, 1999, BIOCHEMISTRY-US, V38, P4252, DOI 10.1021/bi990140p; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ringia EAT, 2004, BIOCHEMISTRY-US, V43, P224, DOI 10.1021/bi035815+; Sakai A, 2006, BIOCHEMISTRY-US, V45, P4455, DOI 10.1021/bi060230b; Schmidt DMZ, 2001, BIOCHEMISTRY-US, V40, P15707, DOI 10.1021/bi011640x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Thoden JB, 2004, BIOCHEMISTRY-US, V43, P5716, DOI 10.1021/bi0497897; Thompson TB, 2000, BIOCHEMISTRY-US, V39, P10662, DOI 10.1021/bi000855o; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063	28	76	83	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2007	3	8					486	491		10.1038/nchembio.2007.11	http://dx.doi.org/10.1038/nchembio.2007.11			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	193VB	17603539				2022-12-25	WOS:000248302200015
J	Yang, M; Zhang, Y; Pan, J; Sun, J; Liu, J; Libby, P; Sukhova, GK; Doria, A; Katunuma, N; Peroni, OD; Guerre-Millo, M; Kahn, BB; Clement, K; Shi, GP				Yang, Min; Zhang, Yaou; Pan, Jiehong; Sun, Jiusong; Liu, Jian; Libby, Peter; Sukhova, Galina K.; Doria, Alessandro; Katunuma, Nobuhiko; Peroni, Odile D.; Guerre-Millo, Michele; Kahn, Barbara B.; Clement, Karine; Shi, Guo-Ping			Cathepsin L activity controls adipogenesis and glucose tolerance	NATURE CELL BIOLOGY			English	Article							ADIPOCYTE DIFFERENTIATION; INSULIN-RECEPTORS; GENE-EXPRESSION; VASCULAR CELLS; MUSCLE-CELLS; MICE; RESISTANCE; DEGRADATION; INHIBITION; PROTEASES	Cysteine proteases play an important part in human pathobiology(1). This report shows the participation of cathepsin L (CatL) in adipogenesis and glucose intolerance. In vitro studies demonstrate the role of CatL in the degradation of the matrix protein fibronectin, insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R), essential molecules for adipogenesis and glucose metabolism(2-5). CatL inhibition leads to the reduction of human and murine pre-adipocyte adipogenesis or lipid accumulation, protection of fibronectin from degradation, accumulation of IR and IGF-1R beta-subunits, and an increase in glucose uptake. CatL-deficient mice are lean and have reduced levels of serum glucose and insulin but increased levels of muscle IR beta-subunits, fibronectin and glucose transporter (Glut)-4, although food/water intake and energy expenditure of these mice are no less than their wildtype littermates. Importantly, the pharmacological inhibition of CatL also demonstrates reduced body weight gain and serum insulin levels, and increased glucose tolerance, probably due to increased levels of muscle IR beta-subunits, fibronectin and Glut-4 in both diet-induced obese mice and ob/ob mice. Increased levels of CatL in obese and diabetic patients suggest that this protease is a novel target for these metabolic disorders.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Med Sch, Boston, MA 02115 USA; Nanfang Hosp, Dept Rheumatol, Guangzhou 510515, Peoples R China; Nanfang Med Univ, Guangzhou 510515, Peoples R China; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; INSERM, U872, F-75006 Paris, France; Univ Paris 06, Ctr Rech Cordeliers, UMRS 872, F-75006 Paris, France; Univ Paris 05, UMRS 872, F-75006 Paris, France; Hop La Pitie Salpetriere, AP HP, Nutr Dept, F-75013 Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Southern Medical University - China; Southern Medical University - China; University of California System; University of California San Francisco; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Tokushima Bunri University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Shi, GP (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu	Guerre-Millo, Michele/G-7253-2017; Libby, Peter/AAY-6404-2021; Clément, karine/R-1120-2017; Doria, Alessandro/H-9157-2018; BRUNET, ERIKA/H-9297-2017	Libby, Peter/0000-0002-1502-502X; Doria, Alessandro/0000-0002-3830-4304; BRUNET, ERIKA/0000-0002-1726-4673; Zhang, Yaou/0000-0002-2501-8093	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL060942] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60942, HL073168] Funding Source: Medline; NIDDK NIH HHS [R01 DK043051] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; CHANG PY, 1995, J BIOL CHEM, V270, P12593, DOI 10.1074/jbc.270.21.12593; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Gagnon AM, 1998, J CELL PHYSIOL, V175, P370, DOI 10.1002/(SICI)1097-4652(199806)175:3<370::AID-JCP15>3.0.CO;2-9; Grabowska UB, 2005, CURR OPIN DRUG DISC, V8, P619; Huang XD, 2003, DIABETES, V52, P2411, DOI 10.2337/diabetes.52.9.2411; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; KNUTSON VP, 1995, J BIOL CHEM, V270, P24972, DOI 10.1074/jbc.270.42.24972; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MARSHALL S, 1981, J BIOL CHEM, V256, P1464; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Roberts R, 2005, DRUG NEWS PERSPECT, V18, P605, DOI 10.1358/dnp.2005.18.10.949485; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Shi GP, 2006, STROKE, V37, P537, DOI 10.1161/01.STR.0000198816.62266.e9; SHI GP, 1992, J BIOL CHEM, V267, P7258; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yajima Y, 2006, ENDOCRINOLOGY, V147, P4811, DOI 10.1210/en.2005-1647	29	97	104	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					970	U130		10.1038/ncb1623	http://dx.doi.org/10.1038/ncb1623			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643114	Green Accepted			2022-12-25	WOS:000248486700019
J	Dunoyer, P; Himber, C; Ruiz-Ferrer, V; Alioua, A; Voinnet, O				Dunoyer, Patrice; Himber, Christophe; Ruiz-Ferrer, Virginia; Alioua, Abdelmalek; Voinnet, Olivier			Intra- and intercellular RNA interference in Arabidopsis thaliana requires components of the microRNA and heterochromatic silencing pathways	NATURE GENETICS			English	Article							DICER-LIKE PROTEINS; TRANS-ACTING SIRNAS; DOUBLE-STRANDED-RNA; DNA METHYLATION; BIOGENESIS; ACCUMULATION; IV; DICER-LIKE-4; SUPPRESSION; ARGONAUTE1	In RNA interference ( RNAi), double- stranded RNA ( dsRNA) is processed into short interfering RNA ( siRNA) to mediate sequence-specific gene knockdown. The genetics of plant RNAi is not understood, nor are the bases for its spreading between cells. Here, we unravel the requirements for biogenesis and action of siRNAs directing RNAi in Arabidopsis thaliana and show how alternative routes redundantly mediate this process under extreme dsRNA dosages. We found that SMD1 and SMD2, required for intercellular but not intracellular RNAi, are allelic to RDR2 and NRPD1a, respectively, previously implicated in siRNA- directed heterochromatin formation through the action of DCL3 and AGO4. However, neither DCL3 nor AGO4 is required for non - cell autonomous RNAi, uncovering a new pathway for RNAi spreading or detection in recipient cells. Finally, we show that the genetics of RNAi is distinct from that of antiviral silencing and propose that this experimental silencing pathway has a direct endogenous plant counterpart.	CNRS, Inst Biol Mol Plantes, UPR2357, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, UPR2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544; Ruiz-Ferrer, Virginia/0000-0002-7840-297X				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bechtold N, 1998, METH MOL B, V82, P259; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	50	165	175	5	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					848	856		10.1038/ng2081	http://dx.doi.org/10.1038/ng2081			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558406				2022-12-25	WOS:000247619800014
J	Novak, B; Tyson, JJ; Gyorffy, B; Csikasz-Nagy, A				Novak, Bela; Tyson, John J.; Gyorffy, Bela; Csikasz-Nagy, Attila			Irreversible cell-cycle transitions are due to systems-level feedback	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; FISSION YEAST; S-PHASE; PROTEOLYSIS; MITOSIS; MODEL; DEGRADATION; HYSTERESIS; OSCILLATOR; ACTIVATION	The irreversibility of cell-cycle transitions is commonly thought to derive from the irreversible degradation of certain regulatory proteins. We argue that irreversible transitions in the cell cycle ( or in any other molecular control system) cannot be attributed to a single molecule or reaction, but that they derive from feedback signals in reaction networks. This systems-level view of irreversibility is supported by many experimental observations.	Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; Hungarian Acad Sci, Mol Network Dynam Res Grp, H-1521 Budapest, Hungary; Budapest Univ Technol & Econ, H-1521 Budapest, Hungary; Univ Trent, Microsoft Res, Ctr Computat & Syst Biol, I-38100 Povo, Trento, Italy	University of Oxford; Virginia Polytechnic Institute & State University; Hungarian Academy of Sciences; Budapest University of Technology & Economics; University of Trento	Novak, B (corresponding author), Univ Oxford, Oxford Ctr Integrat Syst Biol, S Parks Rd, Oxford OX1 3QU, England.	bela.novak@bioch.ox.ac.uk	Csikasz-Nagy, Attila/A-3487-2009; Tyson, John J/A-2942-2014; Novak, Bela/D-5365-2009	Csikasz-Nagy, Attila/0000-0002-2919-5601; Tyson, John J/0000-0001-7560-6013; Novak, Bela/0000-0002-6961-1366				AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lodish H., 2004, MOL CELL BIOL; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Novak B, 1998, PHILOS T ROY SOC B, V353, P2063, DOI 10.1098/rstb.1998.0352; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sveiczer A, 1999, J CELL SCI, V112, P1085; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	31	141	142	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					724	728		10.1038/ncb0707-724	http://dx.doi.org/10.1038/ncb0707-724			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17603504				2022-12-25	WOS:000247760700003
J	Buonpane, RA; Churchill, HRO; Moza, B; Sundberg, EJ; Peterson, ML; Schlievert, PM; Kranz, DM				Buonpane, Rebecca A.; Churchill, Hywyn R. O.; Moza, Beenu; Sundberg, Eric J.; Peterson, Marnie L.; Schlievert, Patrick M.; Kranz, David M.			Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists	NATURE MEDICINE			English	Article							TOXIC-SHOCK-SYNDROME; T-CELL-ACTIVATION; ANTIBODY FRAGMENTS; PYROGENIC EXOTOXIN; SUPERANTIGENS; LIBRARIES; INVOLVEMENT; ENDOTOXIN; DISPLAY	Exotoxins of Staphylococcus aureus belong to a family of bacterial proteins that act as superantigens by activating a large subset of the T-cell population, causing massive release of inflammatory cytokines. This cascade can ultimately result in toxic shock syndrome and death. Therapeutics targeting the early stage of the pathogenic process, when the superantigen binds to its receptor, could limit the severity of disease. We engineered picomolar binding affinity agents to neutralize the potent toxin staphylococcal enterotoxin B (SEB). A single immunoglobulin-like domain of the T-cell receptor (variable region, Vb) was subjected to multiple rounds of directed evolution using yeast display. Soluble forms of the engineered Vb proteins produced in Escherichia coli were effective inhibitors of SEB-mediated T-cell activation and completely neutralized the lethal activity of SEB in animal models. These Vb proteins represent an easily produced potential treatment for diseases mediated by bacterial superantigens.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Boston Biomed Res Inst, Watertown, MA 02472 USA; Univ Minnesota, Sch Med, Dept Expt & Clin Pharmacol, Coll Pharm, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA	University of Illinois System; University of Illinois Urbana-Champaign; Boston Biomedical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@uiuc.edu	Jalali, Beenu Moza/H-7224-2017	Jalali, Beenu Moza/0000-0003-0954-3485; Buonpane, Rebecca/0000-0002-8158-8074; Sundberg, Eric/0000-0003-0478-3033; Schlievert, Patrick/0000-0001-8314-9369	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER; NIAID NIH HHS [AI064611] Funding Source: Medline; NIGMS NIH HHS [T32 GM 07283] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews MM, 2001, CLIN INFECT DIS, V32, P1470, DOI 10.1086/320170; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; CRASS BA, 1986, J CLIN MICROBIOL, V23, P1138, DOI 10.1128/JCM.23.6.1138-1139.1986; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; HOO WS, 1993, J IMMUNOL, V150, P4331; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Horn DL, 2000, CLIN INFECT DIS, V31, P851, DOI 10.1086/318127; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kieke MC, 2001, J MOL BIOL, V307, P1305, DOI 10.1006/jmbi.2001.4560; LEE VTP, 1992, J INFECT DIS, V166, P911, DOI 10.1093/infdis/166.4.911; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; PARSONNET J, 1987, INFECT IMMUN, V55, P1070, DOI 10.1128/IAI.55.5.1070-1076.1987; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roggiani M, 1997, INFECT IMMUN, V65, P2868, DOI 10.1128/IAI.65.7.2868-2875.1997; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; STONE RL, 1987, J INFECT DIS, V155, P682, DOI 10.1093/infdis/155.4.682; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	26	68	74	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2007	13	6					725	729		10.1038/nm1584	http://dx.doi.org/10.1038/nm1584			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17515896				2022-12-25	WOS:000247084300036
J	Dengjel, J; Akimov, V; Olsen, JV; Bunkenborg, J; Mann, M; Blagoev, B; Andersen, JS				Dengjel, Joern; Akimov, Vyacheslav; Olsen, Jesper V.; Bunkenborg, Jakob; Mann, Matthias; Blagoev, Blagoy; Andersen, Jens S.			Quantitative proteomic assessment of very early cellular signaling events	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHORYLATION; MECHANISM; NETWORKS; DYNAMICS; TYROSINE	Technical limitations have prevented proteomic analyses of events occurring less than 30 s after signal initiation. We developed an automated, continuous quench-flow system allowing quantitative proteomic assessment of very early cellular signaling events (qPACE) with a time resolution of 1 s. Using this technique, we determined that autophosphorylation of the epidermal growth factor receptor occurs within 1 s after ligand stimulation and is followed rapidly by phosphorylation of the downstream signaling intermediates Src homologous and collagen-like protein and phospholipase C gamma 1.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Andersen, JS (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark.	jens.andersen@bmb.sdu.dk	Olsen, Jesper/C-4738-2008; Olsen, Jesper/ABH-4638-2020; Mann, Matthias/A-3454-2013; Dengjel, Joern/AAI-3682-2020; Andersen, Jens S/L-2100-2015	Olsen, Jesper/0000-0002-4747-4938; Mann, Matthias/0000-0003-1292-4799; Andersen, Jens S/0000-0002-6091-140X; Bunkenborg, Jakob/0000-0002-2908-9323; Dengjel, Joern/0000-0002-9453-4614; Blagoev, Blagoy/0000-0002-3596-0066				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Moehren G, 2002, BIOCHEMISTRY-US, V41, P306, DOI 10.1021/bi011506c; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567	16	93	98	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					566	568		10.1038/nbt1301	http://dx.doi.org/10.1038/nbt1301			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17450129				2022-12-25	WOS:000246369400024
J	Manak, R; Wen, H; Van, T; Andrejka, L; Lipsick, JS				Manak, Robert; Wen, Hong; Van, Tran; Andrejka, Laura; Lipsick, Joseph S.			Loss of Drosophila Myb interrupts the progression of chromosome condensation	NATURE CELL BIOLOGY			English	Article							HISTONE H3; B-MYB; GENOMIC INSTABILITY; HETEROCHROMATIN; MITOSIS; CELLS; PHOSPHORYLATION; EXPRESSION; COMPLEX; MELANOGASTER	Completion of chromosome condensation is required before segregation during the mitotic cell cycle to ensure the transmission of genetic material with high fidelity in a timely fashion. In many eukaryotes this condensation is regulated by phosphorylation of histone H3 on Ser 10 (H3S10). This phosphorylation normally begins in the late-replicating pericentric heterochromatin and then spreads to the earlier replicating euchromatin. Here, we show that these phases of condensation are genetically separable in that the absence of Drosophila Myb causes cells to arrest with H3S10 phosphorylation of heterochromatin but not euchromatin. In addition, we used mosaic analysis to demonstrate that although the Myb protein can be removed in a single cell cycle, the failure of chromosome condensation occurs only after many cell divisions in the absence of Myb protein. The Myb protein is normally located in euchromatic but not heterochromatic regions of the nucleus, suggesting that Myb may be essential for a modification of euchromatin that is required for the efficient spread of chromosome condensation.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Lipsick, JS (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	lipsick@stanford.edu		Wen, Hong/0000-0001-8739-4572; Manak, John/0000-0002-6562-7694	NATIONAL CANCER INSTITUTE [R01CA090307] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA90307] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Ahlbory DR, 2005, ONCOGENE, V24, P7127, DOI 10.1038/sj.onc.1208869; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fung SM, 2002, DEVELOPMENT, V129, P347; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GATTI M, 1983, SCIENCE, V221, P83, DOI 10.1126/science.6407113; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Katzen AL, 1998, GENE DEV, V12, P831, DOI 10.1101/gad.12.6.831; Katzen AL, 1996, P NATL ACAD SCI USA, V93, P13955, DOI 10.1073/pnas.93.24.13955; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Lipsick JS, 2004, GENE DEV, V18, P2837, DOI 10.1101/gad.1274804; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Okada M, 2002, EMBO J, V21, P675, DOI 10.1093/emboj/21.4.675; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; Stowers RS, 1999, GENETICS, V152, P1631; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277	34	30	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					581	U177		10.1038/ncb1580	http://dx.doi.org/10.1038/ncb1580			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450131				2022-12-25	WOS:000246181500017
J	McCusker, D; Denison, C; Anderson, S; Egelhofer, TA; Yates, JR; Gygi, SP; Kellogg, DR				McCusker, Derek; Denison, Carilee; Anderson, Scott; Egelhofer, Thea A.; Yates, John R., III; Gygi, Steven P.; Kellogg, Douglas R.			Cdk1 coordinates cell-surface growth with the cell cycle	NATURE CELL BIOLOGY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; EXCHANGE FACTOR CDC24; RHO-TYPE GTPASES; POLARIZED GROWTH; BUDDING YEAST; GENETIC CONTROL; DIVISION CYCLE; BUD EMERGENCE; G1 CYCLINS; PHOSPHORYLATION	The mechanisms that control cell growth during the cell cycle are poorly understood. In budding yeast, cyclin dependent kinase 1 (Cdk1) triggers polarization of the actin cytoskeleton and bud emergence in late G1 through activation of the Cdc42 GTPase. However, Cdk1 is not thought to be required for subsequent growth of the bud. Here, we show that Cdk1 has an unexpected role in controlling bud growth after bud emergence. Moreover, we show that G1 cyclin-Cdk1 complexes specifically phosphorylate multiple proteins associated with Cdc24, the guanine nucleotide-exchange factor (GEF) that activates the Cdc42 GTPase. A mutant form of a Cdc24- associated protein that fails to undergo Cdk1-dependent phosphorylation causes defects in bud growth. These results provide a direct link between Cdk1 activity and the control of polarized cell growth.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Cell Biol, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; Scripps Research Institute	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	kellogg@biology.ucsc.edu		McCusker, Derek/0000-0003-1455-1711	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; CROSS FR, 1990, MOL CELL BIOL, V10, P6482, DOI 10.1128/MCB.10.12.6482; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; GYGI MP, 2004, PROTEINS PROTEOMICS; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; KELLOGG DR, 1992, MOL BIOL CELL, V3, P1, DOI 10.1091/mbc.3.1.1; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; SLOAT BF, 1978, SCIENCE, V200, P1171, DOI 10.1126/science.349694; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	50	108	111	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					506	U45		10.1038/ncb1568	http://dx.doi.org/10.1038/ncb1568			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417630				2022-12-25	WOS:000246181500008
J	Bergman, K; Graff, GD				Bergman, Karl; Graff, Gregory D.			The global stem cell patent landscape: implications for efficient technology transfer and commercial development	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY	Characteristics of the complex and growing stem cell patent landscape indicate strategies by which public sector research institutions could improve the efficiency of intellectual property agreements and technology transfers in stem cells.	Chalmers Univ Technol, Goteborg Int Biosci Business Sch, S-41296 Gothenburg, Sweden; Univ Calif Davis, Davis, CA 95616 USA; Chalmers Univ Technol, Ctr Intellectual Property Studies, S-41296 Gothenburg, Sweden; Univ Gothenburg, Gothenburg, Sweden	Chalmers University of Technology; University of California System; University of California Davis; Chalmers University of Technology; University of Gothenburg	Bergman, K (corresponding author), Chalmers Univ Technol, Goteborg Int Biosci Business Sch, S-41296 Gothenburg, Sweden.	mail@karlbergman.se; gdgraff@ucdavis.edu		Graff, Gregory/0000-0002-9140-0901				Atkinson RC, 2003, SCIENCE, V301, P174, DOI 10.1126/science.1085553; BERGMAN K, IN PRESS COLLABORATI; Brower V, 1999, NAT BIOTECHNOL, V17, P139, DOI 10.1038/6140; Clark J., 2000, PATENT POOLS SOLUTIO; EBERSOLE TJ, 2005, STEM CELLS PATENT PO; Eisenberg R S, 2004, HDB STEM CELLS; Filip S, 2004, J CELL MOL MED, V8, P572, DOI 10.1111/j.1582-4934.2004.tb00483.x; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798; Graff G, 2001, NAT BIOTECHNOL, V19, P1179, DOI 10.1038/nbt1201-1179; Graff GD, 2003, NAT BIOTECHNOL, V21, P989, DOI 10.1038/nbt0903-989; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jaffe A.B., 2004, INNOVATION ITS DISCO; Loring JF, 2006, SCIENCE, V311, P1716, DOI 10.1126/science.1120953; Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996; OCONNOR SM, 2005, NEW ENG L REV, V39, P665; Rabin S, 2005, NAT BIOTECHNOL, V23, P817, DOI 10.1038/nbt0705-817; RAI AK, 2003, LAW CONTEMP PROBL, V289, P289; RAI AK, 2004, INT PUBLIC GOODS TRA; Rao M, 2005, J ALZHEIMERS DIS, V8, P75; ROHRBAUGH ML, 2006, REGENERATIVE MED 200; SCHEINFELD RC, 2001, NY LAW J        0927; Shapiro C., 2000, INNOVATION POLICY EC, P119; Taymor KS, 2006, NAT BIOTECHNOL, V24, P411, DOI 10.1038/nbt0406-411; THOMSON JA, 1998, Patent No. 5843780; Wadman M, 2005, NATURE, V435, P272, DOI 10.1038/435272a; Wisconsin Alumni Research Foundation, 2001, [No title captured], Patent No. [US6200806, 6200806]	27	63	66	4	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					419	424		10.1038/nbt0407-419	http://dx.doi.org/10.1038/nbt0407-419			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17420745				2022-12-25	WOS:000245651800018
J	El Khoury, J; Toft, M; Hickman, SE; Means, TK; Terada, K; Geula, C; Luster, AD				El Khoury, Joseph; Toft, Michelle; Hickman, Suzanne E.; Means, Terry K.; Terada, Kinya; Geula, Changiz; Luster, Andrew D.			Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease	NATURE MEDICINE			English	Article							AMYLOID-BETA-PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; TRANSGENIC MICE; MOUSE MODEL; REACTIVE MICROGLIA; SCAVENGER RECEPTOR; APOLIPOPROTEIN-E; PLAQUE-FORMATION; GAMMA-SECRETASE	Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (A beta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Ab earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased A beta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Ab clearance.	Ctr Immunol & Inflammat Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Charlestown, MA 02129 USA; Okayama Univ, Sch Med, Dept Neurol Surg, Okayama 7008558, Japan; Beth Israel Deaconess Med Ctr, Lab Neurodegenerat & Aging Res, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Okayama University; Harvard University; Beth Israel Deaconess Medical Center	El Khoury, J (corresponding author), Ctr Immunol & Inflammat Dis, Div Rheumatol Allergy & Immunol, 149 13th St, Charlestown, MA 02129 USA.	jelkhoury@partners.org; luster.andrew@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912				Babcock AA, 2003, J NEUROSCI, V23, P7922; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bennett JL, 2003, J NEUROVIROL, V9, P623, DOI 10.1080/714044484; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Boddeke EWGM, 1999, J NEUROIMMUNOL, V98, P176, DOI 10.1016/S0165-5728(99)00096-X; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; El Khoury J, 1998, NEUROBIOL AGING, V19, pS81, DOI 10.1016/S0197-4580(98)00036-0; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; ElKhoury J, 1996, NATURE, V382, P716; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Frautschy SA, 1998, AM J PATHOL, V152, P307; Fryer JD, 2003, J NEUROSCI, V23, P7889; Ghiso J, 2001, J ALZHEIMERS DIS, V3, P65, DOI 10.3233/JAD-2001-3110; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang DR, 2005, FASEB J, V19, P761, DOI 10.1096/fj.04-3104com; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kuo YM, 2000, MOL MED, V6, P430, DOI 10.1007/BF03401785; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Meda L, 1996, J IMMUNOL, V157, P1213; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Smits HA, 2002, J NEUROIMMUNOL, V127, P160, DOI 10.1016/S0165-5728(02)00112-1; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weldon DT, 1998, J NEUROSCI, V18, P2161; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	50	675	697	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2007	13	4					432	438		10.1038/nm1555	http://dx.doi.org/10.1038/nm1555			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	154YG	17351623				2022-12-25	WOS:000245543900031
J	Hampe, J; Franke, A; Rosenstiel, P; Till, A; Teuber, M; Huse, K; Albrecht, M; Mayr, G; De La Vega, FM; Briggs, J; Gunther, S; Prescott, NJ; Onnie, CM; Hasler, R; Sipos, B; Folsch, UR; Lengauer, T; Platzer, M; Mathew, CG; Krawczak, M; Schreiber, S				Hampe, Jochen; Franke, Andre; Rosenstiel, Philip; Till, Andreas; Teuber, Markus; Huse, Klaus; Albrecht, Mario; Mayr, Gabriele; De La Vega, Francisco M.; Briggs, Jason; Guenther, Simone; Prescott, Natalie J.; Onnie, Clive M.; Haesler, Robert; Sipos, Bence; Foelsch, Ulrich R.; Lengauer, Thomas; Platzer, Matthias; Mathew, Christopher G.; Krawczak, Michael; Schreiber, Stefan			A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; GENETIC-VARIATION; NOD2; POLYMORPHISM; MUTATION; VISUALIZATION; POPULATIONS; APG16L; SYSTEM	We performed a genome-wide association study of 19,779 nonsynonymous SNPs in 735 individuals with Crohn disease and 368 controls. A total of 7,159 of these SNPs were informative. We followed up on all 72 SNPs with P <= 0.01 with an allele- based disease association test in 380 independent Crohn disease trios, 498 Crohn disease singleton cases and 1,032 controls. Disease association of rs2241880 in the autophagy- related 16- like 1 gene ( ATG16L1) was replicated in these samples ( P 4.0 X 10(-8)) and confirmed in a UK case-control sample ( P =0.0004). By haplotype and regression analysis, we found that marker rs2241880, a coding SNP ( T300A), carries virtually all the disease risk exerted by the ATG16L1 locus. The ATG16L1 gene encodes a protein in the autophagosome pathway that processes intracellular bacteria. We found a statistically significant interaction with respect to Crohn disease risk between rs2241880 and the established CARD15 susceptibility variants ( P =0.039). Together with the lack of association between rs2241880 and ulcerative colitis ( P > 0.4), these data suggest that the underlying biological process may be specific to Crohn disease.	Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Fritz Lipmann Inst EV, Genome Anal Grp, Leibniz Inst Age Res, D-07745 Jena, Germany; Max Planck Inst Informat, D-66123 Saarbrucken, Germany; Appl Biosyst Inc, Foster City, CA 94404 USA; Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; Univ Kiel, Dept Pathol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Univ Kiel, Inst Med Informat & Stat, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Kiel; Schleswig Holstein University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society; Thermo Fisher Scientific; Applied Biosystems; University of London; King's College London; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society	Hampe, J (corresponding author), Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany.	jhampe@1med.uni-kiel.de; s.schreiber@mucosa.de	Albrecht, Mario/B-6694-2008; Prescott, Natalie J/F-6490-2011; Hampe, Jochen/A-2555-2010; Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Till, Andreas/E-9661-2013; Häsler, Robert/A-4908-2009; Krawczak, Michael/A-8964-2010; Till, Andreas/AAO-6375-2021; Mathew, Christopher G/G-3434-2015	Albrecht, Mario/0000-0002-3103-9624; Prescott, Natalie J/0000-0002-5901-7371; Hampe, Jochen/0000-0002-2421-6127; Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Till, Andreas/0000-0002-0139-9143; Häsler, Robert/0000-0003-4174-8229; Krawczak, Michael/0000-0003-2603-1502; Mathew, Christopher G/0000-0003-4178-1838; Huse, Klaus/0000-0003-3854-1884	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brant SR, 2003, AM J HUM GENET, V73, P1282, DOI 10.1086/379927; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; DUBRIDGE F, 2003, GENET EPIDEMIOL, V25, P115; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2006, HUM MUTAT, V27, P583, DOI 10.1002/humu.20306; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Shaw SH, 2003, HUM GENET, V113, P514, DOI 10.1007/s00439-003-1020-7; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Zheng HR, 2004, DNA SEQUENCE, V15, P303, DOI 10.1080/10425170400004104	30	1432	1484	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					207	211		10.1038/ng1954	http://dx.doi.org/10.1038/ng1954			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200669				2022-12-25	WOS:000244063900018
J	Macheboeuf, P; Fischer, DS; Brown, T; Zervosen, A; Luxen, A; Joris, B; Dessen, A; Schofield, CJ				Macheboeuf, Pauline; Fischer, Delphine S.; Brown, Tom, Jr.; Zervosen, Astrid; Luxen, Andre; Joris, Bernard; Dessen, Andrea; Schofield, Christopher J.			Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins	NATURE CHEMICAL BIOLOGY			English	Article							BETA-LACTAMASES; BIOLOGICAL-ACTIVITIES; CLAVULANIC ACID; INACTIVATION; RESISTANCE; PEPTIDASE	beta-lactam antibiotics, including penicillins and cephalosporins, inhibit penicillin-binding proteins (PBPs), which are essential for bacterial cell wall biogenesis. Pathogenic bacteria have evolved efficient antibiotic resistance mechanisms that, in Gram-positive bacteria, include mutations to PBPs that enable them to avoid beta-lactam inhibition(1). Lactivicin (LTV; 1) contains separate cycloserine and c-lactone rings and is the only known natural PBP inhibitor that does not contain a beta-lactam(2-4). Here we show that LTV and a more potent analog, phenoxyacetyl-LTV (PLTV; 2), are active against clinically isolated, penicillin-resistant Streptococcus pneumoniae strains. Crystallographic analyses of S. pneumoniae PBP1b reveal that LTV and PLTV inhibition involves opening of both monocyclic cycloserine and gamma-lactone rings. In PBP1b complexes, the ring-derived atoms from LTV and PLTV show a notable structural convergence with those derived from a complexed cephalosporin (cefotaxime; 3). The structures imply that derivatives of LTV will be useful in the search for new antibiotics with activity against beta-lactam-resistant bacteria.	Univ Grenoble 1, Ctr Natl Rech Sci, Inst Biol Struct Jean Pierre Ebel Commissariat En, F-38027 Grenoble, France; Univ Oxford, Chem Res Lab, Oxford OXI 3TA, England; Univ Liege, Ctr Rech Cyclotron, B-4000 Liege, Belgium; Univ Liege, Inst Chim, B-4000 Liege, Belgium	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Oxford; University of Liege; University of Liege	Schofield, CJ (corresponding author), Univ Grenoble 1, Ctr Natl Rech Sci, Inst Biol Struct Jean Pierre Ebel Commissariat En, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	christopher.schofield@chem.ox.ac.uk	Brown, Tom/A-6655-2010; luxen, andre/C-2116-2009	Dessen, Andrea/0000-0001-6487-4020; Schofield, Christopher/0000-0002-0290-6565; Macheboeuf, Pauline/0000-0003-4523-9923; Brown, Tom/0000-0002-8607-1226				ADAM M, 1990, BIOCHEM J, V270, P525, DOI 10.1042/bj2700525; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Brown RPA, 1996, BIOCHEMISTRY-US, V35, P12421, DOI 10.1021/bi961044g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; DEMEESTER F, 1987, BIOCHEM PHARMACOL, V36, P2393, DOI 10.1016/0006-2952(87)90609-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHUYSEN JM, 1986, BIOCHEM J, V235, P159, DOI 10.1042/bj2350159; Hakenbeck R, 1999, MICROB DRUG RESIST, V5, P91, DOI 10.1089/mdr.1999.5.91; HARADA S, 1986, TETRAHEDRON LETT, V27, P6229, DOI 10.1016/S0040-4039(00)85439-8; HARADA S, 1988, TETRAHEDRON, V44, P6589, DOI 10.1016/S0040-4020(01)90098-5; Imming P, 2000, J MED CHEM, V43, P4328, DOI 10.1021/jm000921k; IMTIAZ U, 1993, J AM CHEM SOC, V115, P4435, DOI 10.1021/ja00064a003; Inui T, 1999, ANTIMICROB AGENTS CH, V43, P2534, DOI 10.1128/AAC.43.10.2534; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LAKAYE B, 1994, BIOCHEM J, V300, P141, DOI 10.1042/bj3000141; Llinas A, 2005, BIOCHEMISTRY-US, V44, P7738, DOI 10.1021/bi050110o; Macheboeuf P, 2005, P NATL ACAD SCI USA, V102, P577, DOI 10.1073/pnas.0407186102; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; NATSUGARI H, 1989, Patent No. 4851422; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NOZAKI Y, 1987, NATURE, V325, P179, DOI 10.1038/325179a0; NOZAKI Y, 1989, J ANTIBIOT, V42, P84, DOI 10.7164/antibiotics.42.84; Page M.I., 1992, CHEM LACTAMS; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Wilmouth RC, 1999, BIOCHEMISTRY-US, V38, P7989, DOI 10.1021/bi990098y	28	53	56	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					565	569		10.1038/nchembio.2007.21	http://dx.doi.org/10.1038/nchembio.2007.21			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17676039				2022-12-25	WOS:000248968000014
J	Rohatgi, R; Scott, MP				Rohatgi, Rajat; Scott, Matthew P.			Patching the gaps in Hedgehog signalling	NATURE CELL BIOLOGY			English	Article							STEROL-SENSING DOMAIN; REPRESSOR FUNCTIONS; HUMAN HOMOLOG; LOCALIZATION; MUTATIONS; DROSOPHILA; TRANSPORT; PATHWAY; BINDING; SMO	The Hedgehog (Hh) pathway plays central roles in animal development and stem-cell function. Defects in Hh signalling lead to birth defects and cancer in humans. The first and often genetically damaged step in this pathway is the interaction between two membrane proteins-Patched (Ptc), encoded by a tumour suppressor gene, and Smoothened (Smo), encoded by a protooncogene. Recent work linking Hh signalling to sterol metabolites and protein-trafficking events at the primary cilium promises to shed light on the biochemical basis of how Patched inhibits Smoothened, and to provide new avenues for cancer treatment.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, W W252,318 Campus Dr, Stanford, CA 94305 USA.	mscott@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kuwabara PE, 2000, GENE DEV, V14, P1933; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ruiz-Gomez A, 2007, BBA-BIOMEMBRANES, V1768, P901, DOI 10.1016/j.bbamem.2006.09.020; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	51	152	161	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1005	1009		10.1038/ncb435	http://dx.doi.org/10.1038/ncb435			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762891				2022-12-25	WOS:000249256500005
J	Batada, NN; Hurst, LD				Batada, Nizar N.; Hurst, Laurence D.			Evolution of chromosome organization driven by selection for reduced gene expression noise	NATURE GENETICS			English	Article							GENOME-WIDE; YEAST; ORDER; HAPLOINSUFFICIENCY; IDENTIFICATION; ARCHITECTURE; LEVEL	The distribution of genes on eukaryotic chromosomes is nonrandom, but the reasons behind this are not well understood. The commonly observed clustering of essential genes is a case in point. Here we model and test a new hypothesis. Essential proteins are unusual in that random fluctuations in abundance (noise) can be highly deleterious. We hypothesize that persistently open chromatin domains are sinks for essential genes, as they enable reduced noise by avoidance of transcriptional bursting associated with chromatin remodeling. Simulation of the model captures clustering and correctly predicts that (i) essential gene clusters are associated with low nucleosome occupancy (ii) noise- sensitive nonessential genes cluster with essential genes (iii) nonessential genes of similar knockout fitness are physically linked (iv) genes in domains rich in essential genes have low noise (v) essential genes are rare subtelomerically and (vi) essential gene clusters are preferentially conserved. We conclude that different noise characteristics of different genomic domains favors nonrandom gene positioning. This has implications for gene therapy and understanding transgenic phenotypes.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Batada, NN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	nizar.batada@gmail.com; l.d.hurst@bath.ac.uk	Batada, Nizar/D-5605-2009; Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Batada, Nizar/0000-0002-8007-1487	MRC [G0300415] Funding Source: UKRI; Medical Research Council [G0300415] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; BATADA NN, IN PRESS TRENDS GENE; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hentges KE, 2007, PLOS GENET, V3, P661, DOI 10.1371/journal.pgen.0030072; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; NEI M, 1967, GENETICS, V57, P625; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5	25	145	146	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					945	949		10.1038/ng2071	http://dx.doi.org/10.1038/ng2071			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17660811				2022-12-25	WOS:000248446900006
J	Kirsch, DG; Dinulescu, DM; Miller, JB; Grimm, J; Santiago, PM; Young, NP; Nielsen, GP; Quade, BJ; Chaber, CJ; Schultz, CP; Takeuchi, O; Bronson, RT; Crowley, D; Korsmeyer, SJ; Yoon, SS; Hornicek, FJ; Weissleder, R; Jacks, T				Kirsch, David G.; Dinulescu, Daniela M.; Miller, John B.; Grimm, Jan; Santiago, Philip M.; Young, Nathan P.; Nielsen, G. Petur; Quade, Bradley J.; Chaber, Christopher J.; Schultz, Christian P.; Takeuchi, Osamu; Bronson, Roderick T.; Crowley, Denise; Korsmeyer, Stanley J.; Yoon, Sam S.; Hornicek, Francis J.; Weissleder, Ralph; Jacks, Tyler			A spatially and temporally restricted mouse model of soft tissue sarcoma	NATURE MEDICINE			English	Article							K-RAS; TUMOR SUPPRESSION; P53; APOPTOSIS; GENE; TUMORIGENESIS; DEFICIENCY; EXPRESSION; MUTATIONS; ABSENCE	Soft tissue sarcomas are mesenchymal tumors that are fatal in approximately one-third of patients. To explore mechanisms of sarcoma pathogenesis, we have generated a mouse model of soft tissue sarcoma. Intramuscular delivery of an adenovirus expressing Cre recombinase in mice with conditional mutations in Kras and Trp53 was sufficient to initiate high-grade sarcomas with myofibroblastic differentiation. Like human sarcomas, these tumors show a predilection for lung rather than lymph node metastasis. Using this model, we showed that a prototype handheld imaging device can identify residual tumor during intraoperative molecular imaging. Deletion of the Ink4a-Arf locus (Cdkn2a), but not Bak1 and Bax, could substitute for mutation of Trp53 in this model. Deletion of Bak1 and Bax, however, was able to substitute for mutation of Trp53 in the development of sinonasal adenocarcinoma. Therefore, the intrinsic pathway of apoptosis seems sufficient to mediate p53 tumor suppression in an epithelial cancer, but not in this model of soft tissue sarcoma.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Siemens Med Solut Inc, Charlestown, MA 02129 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Tufts Univ, Sch Med & Vet Med, North Grafton, MA 01536 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Siemens AG; Harvard University; Dana-Farber Cancer Institute; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Miller, John J/GZG-5663-2022; Takeuchi, Osamu/AAG-9359-2019; Grimm, Jan/B-1937-2008	Takeuchi, Osamu/0000-0002-1260-6232; /0000-0003-0828-4143	NATIONAL CANCER INSTITUTE [R24CA092782, U54CA119349, P30CA014051, P50CA086355, K08CA114176] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA119349, K08 CA 114176, P30-CA14051, P50 CA86355, R24 CA92782] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borden EC, 2003, CLIN CANCER RES, V9, P1941; CHIEN YH, 1979, J VIROL, V31, P752, DOI 10.1128/JVI.31.3.752-760.1979; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Garcia JM, 2000, BRIT J CANCER, V82, P1183; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hill MA, 1997, CANCER EPIDEM BIOMAR, V6, P1095; Hong HHL, 2000, TOXICOL PATHOL, V28, P529, DOI 10.1177/019262330002800404; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Marino S, 2000, GENE DEV, V14, P994; Matushansky I, 2005, HEMATOL ONCOL CLIN N, V19, P427, DOI 10.1016/j.hoc.2005.03.006; Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Sakamoto A, 2001, HUM PATHOL, V32, P1225, DOI 10.1053/hupa.2001.28953; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weihrauch M, 2002, ENVIRON MOL MUTAGEN, V40, P36, DOI 10.1002/em.10084; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; White LM, 2005, INT J RADIAT ONCOL, V61, P1439, DOI 10.1016/j.ijrobp.2004.08.036; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	30	218	222	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					992	997		10.1038/nm1602	http://dx.doi.org/10.1038/nm1602			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17676052				2022-12-25	WOS:000248674600032
J	Meisner, NC; Hintersteiner, M; Mueller, K; Bauer, R; Seifert, JM; Naegeli, HU; Ottl, J; Oberer, L; Guenat, C; Moss, S; Harrer, N; Woisetschlaeger, M; Buehler, C; Uhl, V; Auer, M				Meisner, Nicole-Claudia; Hintersteiner, Martin; Mueller, Kurt; Bauer, Roman; Seifert, Jan-Marcus; Naegeli, Hans-Ulrich; Ottl, Johannes; Oberer, Lukas; Guenat, Christian; Moss, Serge; Harrer, Nathalie; Woisetschlaeger, Maximilian; Buehler, Christof; Uhl, Volker; Auer, Manfred			Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA STABILITY; ENCEPHALOMYELITIS SENSORY NEURONOPATHY; INCREASED CYCLOOXYGENASE-2 EXPRESSION; INTENSITY DISTRIBUTION ANALYSIS; BINDING PROTEIN HUR; LIGHT-CHAIN KINASE; OVARIAN-CARCINOMA; CYCLIN-A; TUMOR; CELL	Careful regulation of mRNA half-lives is a fundamental mechanism allowing cells to quickly respond to changing environmental conditions. The mRNA-binding Hu proteins are important for stabilization of short-lived mRNAs. Here we describe the identification and mechanistic characterization of the first low-molecular-weight inhibitors for Hu protein R (HuR) from microbial broths (Actinomyces sp.): dehydromutactin (1), MS-444 (2) and okicenone (3). These compounds interfere with HuR RNA binding, HuR trafficking, cytokine expression and T-cell activation. A mathematical and experimental analysis of the compounds' mode of action suggests that HuR homodimerizes before RNA binding and that the compounds interfere with the formation of HuR dimers. Our results demonstrate the chemical drugability of HuR; to our knowledge HuR is the first example of a drugable protein within the Hu family. MS-444, dehydromutactin and okicenone may become valuable tools for studying HuR function. An assessment of HuR inhibition as a central node in malignant processes might open up new conceptual routes toward combatting cancer.	Novartis Inst Biomed Res, Discovery Technol, A-1235 Vienna, Austria; Novartis Inst Biomed Res, Discovery Technol, CH-4056 Basel, Switzerland; Novartis Inst Biomed Res, Autoimmun Transplantat, A-1235 Vienna, Austria	Novartis; Novartis; Novartis	Meisner, NC (corresponding author), Novartis Inst Biomed Res, Discovery Technol, Brunnerstr 59, A-1235 Vienna, Austria.	nicole-claudia.meisner@novartis.com; manfred.auer@novartis.com	Meisner-Kober, Nicole/AFL-9351-2022; Meisner-Kober, Nicole/AAH-1412-2022; Meisner-Kober, Nicole/N-2285-2014	Meisner-Kober, Nicole/0000-0002-8566-0483; Auer, Manfred/0000-0001-8920-3522; Meisner-Kober, Nicole/0000-0003-0912-5902				Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Carlsson A, 2000, ARCH VIROL, V145, P491, DOI 10.1007/s007050050041; DALMAU J, 1991, NEUROLOGY, V41, P1757, DOI 10.1212/WNL.41.11.1757; DALMAU J, 1992, AM J PATHOL, V141, P881; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; DESILANES LI, 2005, RNA BIOL, V2, pE11; Erkinheimo TL, 2005, GYNECOL ONCOL, V99, P14, DOI 10.1016/j.ygyno.2005.04.047; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Giannini G, 2003, FITOTERAPIA, V74, P323, DOI 10.1016/S0367-326X(03)00059-5; Goldberg-Cohen I, 2002, J BIOL CHEM, V277, P13635, DOI 10.1074/jbc.M108703200; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Kasashima K, 2002, NUCLEIC ACIDS RES, V30, P4519, DOI 10.1093/nar/gkf567; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kask P, 2000, BIOPHYS J, V78, P1703, DOI 10.1016/S0006-3495(00)76722-1; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; LIU J, 1995, NEUROLOGY, V45, P544, DOI 10.1212/WNL.45.3.544; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MCDANIEL R, 1994, P NATL ACAD SCI USA, V91, P11542, DOI 10.1073/pnas.91.24.11542; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Mrena J, 2006, INT J CANCER, V119, P1897, DOI 10.1002/ijc.21944; NAKANISHI S, 1995, J ANTIBIOT, V48, P948, DOI 10.7164/antibiotics.48.948; Sheflin LG, 2004, BIOCHEM BIOPH RES CO, V322, P644, DOI 10.1016/j.bbrc.2004.07.173; SNIDER BB, 1993, J ORG CHEM, V58, P3185, DOI 10.1021/jo00063a049; Tatsuta K, 1997, J ANTIBIOT, V50, P289, DOI 10.7164/antibiotics.50.289; TATSUTA K, 1997, Patent No. 9832750; TORIGOE K, 1994, Patent No. 06256338; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Voltz R, 2002, LANCET NEUROL, V1, P294, DOI 10.1016/S1474-4422(02)00135-7; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; WILKINSO.PC, 1965, BRAIN, V88, P529, DOI 10.1093/brain/88.3.529; YANO H, 1993, Patent No. 9405283; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	138	140	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2007	3	8					508	515		10.1038/nchembio.2007.14	http://dx.doi.org/10.1038/nchembio.2007.14			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	193VB	17632515				2022-12-25	WOS:000248302200018
J	Walker, MJ; Hollands, A; Sanderson-Smith, ML; Cole, JN; Kirk, JK; Henningham, A; McArthur, JD; Dinkla, K; Aziz, RK; Kansal, RG; Simpson, AJ; Buchanan, JT; Chhatwal, GS; Kotb, M; Nizet, V				Walker, Mark J.; Hollands, Andrew; Sanderson-Smith, Martina L.; Cole, Jason N.; Kirk, Joshua K.; Henningham, Anna; McArthur, Jason D.; Dinkla, Katrin; Aziz, Ramy K.; Kansal, Rita G.; Simpson, Amelia J.; Buchanan, John T.; Chhatwal, Gursharan S.; Kotb, Malak; Nizet, Victor			DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection	NATURE MEDICINE			English	Article							CYSTEINE PROTEASE; BINDING; PATHOGENESIS; PLASMINOGEN; EXPRESSION; PHAGOCYTOSIS; EMERGENCE; SURFACE; CLONE; SPEB	Most invasive bacterial infections are caused by species that more commonly colonize the human host with minimal symptoms. Although phenotypic or genetic correlates underlying a bacterium's shift to enhanced virulence have been studied, the in vivo selection pressures governing such shifts are poorly understood. The globally disseminated M1T1 clone of group A Streptococcus (GAS) is linked with the rare but life-threatening syndromes of necrotizing fasciitis and toxic shock syndrome(1). Mutations in the GAS control of virulence regulatory sensor kinase (covRS) operon are associated with severe invasive disease, abolishing expression of a broad-spectrum cysteine protease (SpeB) 2,3 and allowing the recruitment and activation of host plasminogen on the bacterial surface(4). Here we describe how bacteriophage-encoded GAS DNase (Sda1), which facilitates the pathogen's escape from neutrophil extracellular traps(5,6),serves as a selective force for covRS mutation. The results provide a paradigm whereby natural selection exerted by the innate immune system generates hypervirulent bacterial variants with increased risk of systemic dissemination.	Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis & Vaccine Dev, D-38124 Braunschweig, Germany; Cairo Univ, Dept Microbiol & Immunol, Cairo, Egypt; Vet Affairs Med Ctr, Memphis, TN 38163 USA; MidS Ctr Biodef & Secur, Memphis, TN 38163 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Wollongong; Helmholtz Association; Helmholtz-Center for Infection Research; Egyptian Knowledge Bank (EKB); Cairo University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	mwalker@uow.edu.au	Sanderson-Smith, Martina L/H-9614-2013; Walker, Mark J./F-6940-2011; Nizet, Victor/AAF-3190-2019; Henningham, Anna/C-7355-2017; Simpson, Amelia/HGB-1823-2022; Sanderson-Smith, Martina/O-9387-2019; Aziz, Ramy/B-2918-2009	Sanderson-Smith, Martina L/0000-0002-6366-4993; Henningham, Anna/0000-0002-0554-6593; Aziz, Ramy/0000-0002-4448-7100; Nizet, Victor/0000-0003-3847-0422; Walker, Mark/0000-0001-7423-2769	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI048176] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006	26	304	307	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					981	985		10.1038/nm1612	http://dx.doi.org/10.1038/nm1612			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17632528	Green Submitted, Bronze			2022-12-25	WOS:000248674600030
J	Ori, N; Cohen, AR; Etzioni, A; Brand, A; Yanai, O; Shleizer, S; Menda, N; Amsellem, Z; Efroni, I; Pekker, I; Alvarez, JP; Blum, E; Zamir, D; Eshed, Y				Ori, Naomi; Cohen, Aya Refael; Etzioni, Adi; Brand, Arnon; Yanai, Osnat; Shleizer, Sharona; Menda, Naama; Amsellem, Ziva; Efroni, Idan; Pekker, Irena; Alvarez, John Paul; Blum, Eyal; Zamir, Dani; Eshed, Yuval			Regulation of LANCEOLATE by miR319 is required for compound-leaf development in tomato	NATURE GENETICS			English	Article							MICRORNAS; GROWTH; MUTANT; LOCUS; GENE; MORPHOGENESIS; SHAPE; FORM	Plant leaves show pronounced plasticity of size and form. In the classical, partially dominant mutation Lanceolate ( La) 1, the large compound leaves of tomato (Solanum lycopersicum) are converted into small simple ones. We show that LA encodes a transcription factor from the TCP family(2,3) containing an miR319-binding site(4). Five independent La isolates are gain-offunction alleles that result from point mutations within the miR319-binding site and confer partial resistance of the La transcripts to microRNA (miRNA)-directed inhibition. The reduced sensitivity to miRNA regulation leads to elevated LA expression in very young La leaf primordia and to precocious differentiation of leaf margins. In contrast, downregulation of several LA-like genes using ectopic expression of miR319 resulted in larger leaflets and continuous growth of leaf margins. Our results imply that regulation of LA by miR319 defines a flexible window of morphogenetic competence along the developing leaf margin that is required for leaf elaboration.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Fac Agr, Otto Warburg Minerva Ctr Agr Biotechnol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science	Ori, N (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	ori@agri.huji.ac.il; yuval.eshed@weizmann.ac.il	Menda, Naama/G-2915-2012	Eshed, Yuval/0000-0001-8290-0018; Efroni, Idan/0000-0002-0219-8685				Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOYNTON JE, 1965, TOMATO GENET COOP RE, V15, P24; CARUSO JL, 1968, AM J BOT, V55, P1169, DOI 10.2307/2440737; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; DENGLER NG, 1984, BOT GAZ, V145, P66, DOI 10.1086/337428; Dengler NG, 2001, INT J PLANT SCI, V162, P459, DOI 10.1086/320145; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Holtan HEE, 2003, GENETICS, V165, P1541; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; LIFSCHYTZ E, 1969, GENETICS, V62, P353; MATHAN DS, 1960, SCIENCE, V131, P36, DOI 10.1126/science.131.3392.36; MATHAN DS, 1962, AM J BOT, V49, P504, DOI 10.2307/2439421; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stadler LJ, 1930, J HERED, V21, P3, DOI 10.1093/oxfordjournals.jhered.a103249; STETTLER RF, 1964, AM J BOT, V51, P253, DOI 10.2307/2440294; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x	30	354	396	7	120	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					787	791		10.1038/ng2036	http://dx.doi.org/10.1038/ng2036			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486095				2022-12-25	WOS:000246859100024
J	Lahortiga, I; De Keersmaecker, K; Van Vlierberghe, P; Graux, C; Cauwelier, B; Lambert, F; Mentens, N; Beverloo, HB; Pieters, R; Speleman, F; Odero, MD; Bauters, M; Froyen, G; Marynen, P; Vandenberghe, P; Wlodarska, I; Meijerink, JPP; Cools, J				Lahortiga, Idoya; De Keersmaecker, Kim; Van Vlierberghe, Pieter; Graux, Carlos; Cauwelier, Barbara; Lambert, Frederic; Mentens, Nicole; Beverloo, H. Berna; Pieters, Rob; Speleman, Frank; Odero, Maria D.; Bauters, Marijke; Froyen, Guy; Marynen, Peter; Vandenberghe, Peter; Wlodarska, Iwona; Meijerink, Jules P. P.; Cools, Jan			Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							C-MYB; CANCER	We identified a duplication of the MYB oncogene in 8.4% of individuals with T cell acute lymphoblastic leukemia (T-ALL) and in five T-ALL cell lines. The duplication is associated with a threefold increase in MYB expression, and knockdown of MYB expression initiates T cell differentiation. Our results identify duplication of MYB as an oncogenic event and suggest that MYB could be a therapeutic target in human T-ALL.	VIV, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, Human Genome Lab, Louvain, Belgium; Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain; Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; Catholic Univ Louvain, Clin Univ, Dept Hematol, Yvoir, Belgium; Ghent Univ Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Univ Liege, Dept Human Genet, Ctr Biomed Integrated Genoproteom, Liege, Belgium; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	KU Leuven; University of Navarra; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universite Catholique Louvain; Ghent University; Ghent University Hospital; University of Liege; Erasmus University Rotterdam; Erasmus MC	Cools, J (corresponding author), VIV, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium.	jan.cools@med.kuleuven.be	Van Vlierberghe, Pieter/G-8894-2013; Meijerink, Jules P/D-4393-2017; speleman, frank/AAR-5184-2020; De Keersmaecker, Kim/W-9702-2018; Odero/ABG-9860-2020	Van Vlierberghe, Pieter/0000-0001-9063-7205; Meijerink, Jules P/0000-0002-6860-798X; speleman, frank/0000-0002-6628-8559; De Keersmaecker, Kim/0000-0002-7420-9531; Odero/0000-0002-8858-2054; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935				Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	14	197	201	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					593	595		10.1038/ng2025	http://dx.doi.org/10.1038/ng2025			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435759				2022-12-25	WOS:000245971300013
J	Kitamura, T; Kometani, K; Hashida, H; Matsunaga, A; Miyoshi, H; Hosogi, H; Aoki, M; Oshima, M; Hattori, M; Takabayashi, A; Minato, N; Taketo, MM				Kitamura, Takanori; Kometani, Kohei; Hashida, Hiroki; Matsunaga, Akihiro; Miyoshi, Hiroyuki; Hosogi, Hisahiro; Aoki, Masahiro; Oshima, Masanobu; Hattori, Masakazu; Takabayashi, Arimichi; Minato, Nagahiro; Taketo, Makoto M.			SMAD4-deficient intestinal tumors recruit CCR1(+) myeloid cells that promote invasion	NATURE GENETICS			English	Article							TGF-BETA; BONE-MARROW; COLORECTAL-CANCER; CC-CHEMOKINE; MICROSATELLITE INSTABILITY; STROMAL FIBROBLASTS; MAMMARY-TUMORS; CD34(+) CELLS; COLON-CANCER; RECEPTOR	Inactivation of TGF-beta family signaling is implicated in colorectal tumor progression. Using cis-Apc(+/Delta 716) Smad4(+/-) mutant mice (referred to as cis-Apc/Smad4), a model of invasive colorectal cancer in which TGF-b family signaling is blocked, we show here that a new type of immature myeloid cell (iMC) is recruited from the bone marrow to the tumor invasion front. These CD34(+) iMCs express the matrix metalloproteinases MMP9 and MMP2 and the CC-chemokine receptor 1 (CCR1) and migrate toward the CCR1 ligand CCL9. In adenocarcinomas, expression of CCL9 is increased in the tumor epithelium. By deleting Ccr1 in the background of the cis-Apc/Smad4 mutant, we further show that lack of CCR1 prevents accumulation of CD34(+) iMCs at the invasion front and suppresses tumor invasion. These results indicate that loss of transforming growth factor-beta family signaling in tumor epithelium causes accumulation of iMCs that promote tumor invasion.	Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan; Kitano Hosp, Dept Gastroenterol Surg & Oncol, Osaka 5308480, Japan	Kyoto University; Kyoto University; Kitano Hospital	Taketo, MM (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan.	taketo@mfour.med.kyoto-u.ac.jp	Matsunaga, Akihiro/AAU-3255-2021; Aoki, Masahiro/A-5149-2016; Oshima, Masanobu/F-9958-2014; Hosogi, Hisahiro/AAK-2585-2020	Aoki, Masahiro/0000-0003-4316-9490; Oshima, Masanobu/0000-0002-3304-0004; Kitamura, Takanori/0000-0003-2032-3918; Miyoshi, Hiroyuki/0000-0001-7400-0714; Hashida, Hiroki/0000-0001-8044-9366; Kometani, Kohei/0000-0003-4281-4371				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BRUBAKER PL, 1987, ENDOCRINOLOGY, V120, P1976, DOI 10.1210/endo-120-5-1976; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Collins HM, 2001, BRIT J CANCER, V84, P1664, DOI 10.1054/bjoc.2001.1831; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Garmy-Susini B, 2005, BRIT J CANCER, V93, P855, DOI 10.1038/sj.bjc.6602808; Grady WM, 1998, CANCER RES, V58, P3101; Greaves DR, 2000, MICROBES INFECT, V2, P331, DOI 10.1016/S1286-4579(00)00293-8; Han IS, 2003, MOL CELLS, V15, P176; Ishiguro K, 2006, GUT, V55, P695, DOI 10.1136/gut.2005.079459; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krause DS, 1996, BLOOD, V87, P1; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Markowitz S, 2000, BBA-REV CANCER, V1470, pM13, DOI 10.1016/S0304-419X(99)00031-1; Matsuo SE, 2006, J ENDOCRINOL, V190, P141, DOI 10.1677/joe.1.06713; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mori Y, 2001, CANCER RES, V61, P6046; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; PARSONS R, 1995, CANCER RES, V55, P5548; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Robinson SC, 2003, CANCER RES, V63, P8360; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Scotton C, 2001, BRIT J CANCER, V85, P891, DOI 10.1054/bjoc.2001.2020; Seno H, 2002, CANCER RES, V62, P506; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yang MH, 2005, CYTOKINE, V31, P94, DOI 10.1016/j.cyto.2005.04.001; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	50	210	217	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					467	475		10.1038/ng1997	http://dx.doi.org/10.1038/ng1997			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369830				2022-12-25	WOS:000245271200016
J	Jeffries, TW; Grigoriev, IV; Grimwood, J; Laplaza, JM; Aerts, A; Salamov, A; Schmutz, J; Lindquist, E; Dehal, P; Shapiro, H; Jin, YS; Passoth, V; Richardson, PM				Jeffries, Thomas W.; Grigoriev, Igor V.; Grimwood, Jane; Laplaza, Jose M.; Aerts, Andrea; Salamov, Asaf; Schmutz, Jeremy; Lindquist, Erika; Dehal, Paramvir; Shapiro, Harris; Jin, Yong-Su; Passoth, Volkmar; Richardson, Paul M.			Genome sequence of the lignocellulose-bioconverting and xylose-fermenting yeast Pichia stipitis	NATURE BIOTECHNOLOGY			English	Article							RESPIRATORY YEAST; CANDIDA-SHEHATAE; GENES; ETHANOL; EVOLUTION; LOCI	Xylose is a major constituent of plant lignocellulose, and its fermentation is important for the bioconversion of plant biomass to fuels and chemicals. Pichia stipitis is a well-studied, native xylose-fermenting yeast. The mechanism and regulation of xylose metabolism in P. stipitis have been characterized and genes from P. stipitis have been used to engineer xylose metabolism in Saccharomyces cerevisiae. We have sequenced and assembled the complete genome of P. stipitis. The sequence data have revealed unusual aspects of genome organization, numerous genes for bioconversion, a preliminary insight into regulation of central metabolic pathways and several examples of colocalized genes with related functions. The genome sequence provides insight into how P. stipitis regulates its redox balance while very efficiently fermenting xylose under microaerobic conditions.	US Forest Serv, Forest Prod Lab, USDA, Madison, WI 53705 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Stanford Univ, Human Genome Ctr, JGI Stanford, Palo Alto, CA 94304 USA; Cargill, BioTechnol Dev Ctr, Minneapolis, MN 55440 USA; Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon, South Korea; Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden	United States Department of Agriculture (USDA); United States Forest Service; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Stanford University; Cargill; Sungkyunkwan University (SKKU); Swedish University of Agricultural Sciences	Jeffries, TW (corresponding author), US Forest Serv, Forest Prod Lab, USDA, 1 Gifford Pinchot Dr, Madison, WI 53705 USA.	twjeffri@wisc.edu; ivgrigoriev@lbl.gov	Jeffries, Thomas W/I-8576-2012; Passoth, Volkmar/AFP-0775-2022; Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013; Jin, Yong-Su/L-4530-2013; Jeffries, Thomas/AAH-7675-2021	Jeffries, Thomas W/0000-0001-7408-4065; Passoth, Volkmar/0000-0002-2059-9044; Schmutz, Jeremy/0000-0001-8062-9172; Jin, Yong-Su/0000-0002-4464-9536; Grigoriev, Igor/0000-0002-3136-8903				Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartlett O, 2006, BIOCHEM SOC SYMP, V73, P67, DOI 10.1042/bss0730067; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Burke D., 2000, METHODS YEAST GENETI; CHOW THC, 1989, MOL GEN GENET, V217, P60, DOI 10.1007/BF00330943; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Dehal PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-201; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; DUPREEZ JC, 1989, APPL MICROBIOL BIOT, V30, P53, DOI 10.1007/BF00255996; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Grotkjaer T, 2005, METAB ENG, V7, P437, DOI 10.1016/j.ymben.2005.07.003; Hahn-Hagerdal B, 2004, APPL BIOCHEM BIOTECH, V113, P1207; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jin YS, 2004, APPL ENVIRON MICROB, V70, P6816, DOI 10.1128/AEM.70.11.6816-6825.2004; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaiser C., 1994, METHODS YEAST GENETI; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Klinner U, 2005, APPL MICROBIOL BIOT, V67, P247, DOI 10.1007/s00253-004-1746-8; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; KURTZMAN CP, 1990, ANTON LEEUW INT J G, V57, P215, DOI 10.1007/BF00400153; Laplaza JM, 2006, ENZYME MICROB TECH, V38, P741, DOI 10.1016/j.enzmictec.2005.07.024; LEANDRO MJ, 2006, BIOCH J; LEE H, 1986, APPL ENVIRON MICROB, V52, P320, DOI 10.1128/AEM.52.2.320-324.1986; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Melake T, 1996, CURR MICROBIOL, V33, P237, DOI 10.1007/s002849900106; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nardi JB, 2006, ARTHROPOD STRUCT DEV, V35, P57, DOI 10.1016/j.asd.2005.06.003; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; Nigam JN, 2001, J BIOTECHNOL, V87, P17, DOI 10.1016/S0168-1656(00)00385-0; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; PAREKH SR, 1988, APPL BIOCHEM BIOTECH, V18, P325, DOI 10.1007/BF02930836; Passoth V, 2003, YEAST, V20, P39, DOI 10.1002/yea.933; PASSOTH V, 1992, CURR GENET, V22, P429, DOI 10.1007/BF00352445; Saha BC, 1998, APPL BIOCHEM BIOTECH, V70-2, P115, DOI 10.1007/BF02920129; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; SMITH TF, 1981, J THEOR BIOL, V91, P379, DOI 10.1016/0022-5193(81)90239-3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; TAGONSKI Z, 1992, ZENTRALBL MIKROBIOL, V147, P244; van Dijken J P, 1986, Yeast, V2, P123, DOI 10.1002/yea.320020208; Vidgren V, 2005, APPL ENVIRON MICROB, V71, P7846, DOI 10.1128/AEM.71.12.7846-7857.2005; Weierstall T, 1999, MOL MICROBIOL, V31, P871, DOI 10.1046/j.1365-2958.1999.01224.x; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhan S, 2006, PLANT J, V45, P347, DOI 10.1111/j.1365-313X.2005.02619.x	50	350	648	6	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					319	326		10.1038/nbt1290	http://dx.doi.org/10.1038/nbt1290			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17334359	Green Submitted, hybrid			2022-12-25	WOS:000244748300024
J	Goring, HHH; Curran, JE; Johnson, MP; Dyer, TD; Charlesworth, J; Cole, SA; Jowett, JBM; Abraham, LJ; Rainwater, DL; Comuzzie, AG; Mahaney, MC; Almasy, L; MacCluer, JW; Kissebah, AH; Collier, GR; Moses, EK; Blangero, J				Goering, Harald H. H.; Curran, Joanne E.; Johnson, Matthew P.; Dyer, Thomas D.; Charlesworth, Jac; Cole, Shelley A.; Jowett, Jeremy B. M.; Abraham, Lawrence J.; Rainwater, David L.; Comuzzie, Anthony G.; Mahaney, Michael C.; Almasy, Laura; MacCluer, Jean W.; Kissebah, Ahmed H.; Collier, Gregory R.; Moses, Eric K.; Blangero, John			Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes	NATURE GENETICS			English	Article							HUMAN GENE-EXPRESSION; LINKAGE ANALYSIS; HUMAN GENOME; YEAST; IDENTIFICATION; ASSOCIATION; SEGREGATION; POPULATIONS; NUCLEOTIDE; PHENOTYPES	Quantitative differences in gene expression are thought to contribute to phenotypic differences between individuals. We generated genome-wide transcriptional profiles of lymphocyte samples from 1,240 participants in the San Antonio Family Heart Study. The expression levels of 85% of the 19,648 detected autosomal transcripts were significantly heritable. Linkage analysis uncovered > 1,000 cis-regulated transcripts at a false discovery rate of 5% and showed that the expression quantitative trait loci with the most significant linkage evidence are often located at the structural locus of a given transcript. To highlight the usefulness of this much- enlarged map of cis-regulated transcripts for the discovery of genes that influence complex traits in humans, as an example we selected high-density lipoprotein cholesterol concentration as a phenotype of clinical importance, and identified the cis-regulated vanin 1 (VNN1) gene as harboring sequence variants that influence high-density lipoprotein cholesterol concentrations.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Int Diab Inst, Caulfield, Vic 3162, Australia; ChemGenex Pharmaceut, Geelong, Vic 3216, Australia; Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; Med Coll Wisconsin, TOPS Ctr Obes & Metab Res, Milwaukee, WI 53226 USA; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic 3216, Australia	Texas Biomedical Research Institute; University of Western Australia; Medical College of Wisconsin; Deakin University	Goring, HHH (corresponding author), SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA.	hgoring@sfbrgenetics.org	Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019; Jowett, Jeremy/A-3809-2009; Charlesworth, Jac/J-7661-2014; Moses, Eric/A-3101-2010	Charlesworth, Jac/0000-0001-6201-3518; Moses, Eric/0000-0001-7781-4465; Curran, Joanne/0000-0002-6898-155X	NCRR NIH HHS [RR013556] Funding Source: Medline; NHLBI NIH HHS [HL045222] Funding Source: Medline; NIMH NIH HHS [MH059490] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kent JW, 2007, GENET EPIDEMIOL, V31, P173, DOI 10.1002/gepi.20200; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Perez-Enciso M, 2004, GENETICS, V166, P547, DOI 10.1534/genetics.166.1.547; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yamazaki K, 2002, BIOCHEM BIOPH RES CO, V290, P1114, DOI 10.1006/bbrc.2001.6319; Young Christine E, 2004, Cardiol Rev, V12, P107, DOI 10.1097/01.crd.0000097140.29929.8a; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	50	387	404	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1208	1216		10.1038/ng2119	http://dx.doi.org/10.1038/ng2119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873875				2022-12-25	WOS:000249737400016
J	Mailman, MD; Feolo, M; Jin, Y; Kimura, M; Tryka, K; Bagoutdinov, R; Hao, L; Kiang, A; Paschall, J; Phan, L; Popova, N; Pretel, S; Ziyabari, L; Lee, M; Shao, Y; Wang, ZY; Sirotkin, K; Ward, M; Kholodov, M; Zbicz, K; Beck, J; Kimelman, M; Shevelev, S; Preuss, D; Yaschenko, E; Graeff, A; Ostell, J; Sherry, ST				Mailman, Matthew D.; Feolo, Michael; Jin, Yumi; Kimura, Masato; Tryka, Kimberly; Bagoutdinov, Rinat; Hao, Luning; Kiang, Anne; Paschall, Justin; Phan, Lon; Popova, Natalia; Pretel, Stephanie; Ziyabari, Lora; Lee, Moira; Shao, Yu; Wang, Zhen Y.; Sirotkin, Karl; Ward, Minghong; Kholodov, Michael; Zbicz, Kerry; Beck, Jeffrey; Kimelman, Michael; Shevelev, Sergey; Preuss, Don; Yaschenko, Eugene; Graeff, Alan; Ostell, James; Sherry, Stephen T.			The NCBI dbGaP database of genotypes and phenotypes	NATURE GENETICS			English	Editorial Material							GENOMIC CONTROL; ASSOCIATION	The National Center for Biotechnology Information has created the dbGaP public repository for individual-level phenotype, exposure, genotype and sequence data and the associations between them. dbGaP assigns stable, unique identifiers to studies and subsets of information from those studies, including documents, individual phenotypic variables, tables of trait data, sets of genotype data, computed phenotype-genotype associations, and groups of study subjects who have given similar consents for use of their data.	Natl Ctr Biotechnol Informat, NIH, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Sherry, ST (corresponding author), Natl Ctr Biotechnol Informat, NIH, Natl Lib Med, Bethesda, MD 20892 USA.	sherry@ncbi.nlm.nih.gov		Sherry, Stephen/0000-0002-7982-076X; Beck, Jeffrey/0000-0002-1798-9797; Tryka, Kimberly/0000-0002-5399-4235	NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BRAY T, 2006, EXTENSIBEL MARKUP LA; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; HAROLD ER, 2001, XML BIBLE; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127	6	746	758	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1181	1186		10.1038/ng1007-1181	http://dx.doi.org/10.1038/ng1007-1181			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17898773	Green Submitted, Green Accepted			2022-12-25	WOS:000249737400003
J	Palomero, T; Sulis, ML; Cortina, M; Real, PJ; Barnes, K; Ciofani, M; Caparros, E; Buteau, J; Brown, K; Perkins, SL; Bhagat, G; Agarwal, AM; Basso, G; Castillo, M; Nagase, S; Cordon-Cardo, C; Parsons, R; Zuniga-Pflucker, JC; Dominguez, M; Ferrando, AA				Palomero, Teresa; Sulis, Maria Luisa; Cortina, Maria; Real, Pedro J.; Barnes, Kelly; Ciofani, Maria; Caparros, Esther; Buteau, Jean; Brown, Kristy; Perkins, Sherrie L.; Bhagat, Govind; Agarwal, Archana M.; Basso, Giuseppe; Castillo, Mireia; Nagase, Satoru; Cordon-Cardo, Carlos; Parsons, Ramon; Zuniga-Pflucker, Juan Carlos; Dominguez, Maria; Ferrando, Adolfo A.			Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; C-MYC; EPIGENETIC SILENCERS; DROSOPHILA EYE; BREAST-CANCER; PRE-TCR; EXPRESSION	Gain-of-function mutations in NOTCH1 are common in T- cell lymphoblastic leukemias and lymphomas ( T- ALL), making this receptor a promising target for drugs such as gamma-secretase inhibitors, which block a proteolytic cleavage required for NOTCH1 activation. However, the enthusiasm for these therapies has been tempered by tumor resistance and the paucity of information on the oncogenic programs regulated by oncogenic NOTCH1. Here we show that NOTCH1 regulates the expression of PTEN ( encoding phosphatase and tensin homolog) and the activity of the phosphoinositol- 3 kinase ( PI3K)-AKT signaling pathway in normal and leukemic T cells. Notch signaling and the PI3K-AKT pathway synergize in vivo in a Drosophila melanogaster model of Notch- induced tumorigenesis, and mutational loss of PTEN is associated with human T- ALL resistance to pharmacological inhibition of NOTCH1. Overall, these findings identify transcriptional control of PTEN and regulation of the PI3K-AKT pathway as key elements of the leukemogenic program activated by NOTCH1 and provide the basis for the design of new therapeutic strategies for T- ALL.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Endocrinol, New York, NY 10032 USA; Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Padua, Dept Pediat, Hematooncol Lab, I-35128 Padua, Italy; Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808574, Japan; Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; Inst Neurociencias Alicante, Alicante 03550, Spain	Columbia University; Columbia University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Columbia University; Columbia University; Utah System of Higher Education; University of Utah; University of Padua; Tohoku University; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Dominguez, M (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	m.dominguez@umh.es; af2196@columbia.edu	Zuniga-Pflucker, Juan C/H-1295-2012; Castillo-Martin, Mireia/H-6152-2013; Real, Pedro J./ABH-3493-2021; Caparrós, Esther/AHD-3233-2022; Dominguez, Maria/G-2171-2014; Real, Pedro J./K-2994-2014; Bhagat, Govind/AAE-9493-2021; Ferrando, Adolfo A/Q-7026-2016	Caparrós, Esther/0000-0002-9681-0408; Dominguez, Maria/0000-0002-3329-7862; Real, Pedro J./0000-0001-7968-5353; Bhagat, Govind/0000-0001-6250-048X; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Ciofani, Maria/0000-0001-6472-5260; Nagase, Satoru/0000-0001-5212-1128; BASSO, GIUSEPPE/0000-0002-2634-9302; Parsons, Ramon/0000-0002-6656-3514; Cortina, Maria/0000-0001-7684-3424	NCI NIH HHS [R01 CA082783, R01 CA082783-06, R01 CA082783-07, R01 CA120196-02, CA120196, R01 CA082783-08, R01 CA120196] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082783, R01CA120196] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; DE SB, 1999, NATURE, V398, P518; deGraffenried LA, 2004, ANN ONCOL, V15, P1510, DOI 10.1093/annonc/mdh388; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 2006, CANCER RES, V66, P8931, DOI 10.1158/0008-5472.CAN-06-1858; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Pahlman S, 2004, SEMIN CANCER BIOL, V14, P365, DOI 10.1016/j.semcancer.2004.04.016; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; She QB, 2003, CLIN CANCER RES, V9, P4340; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Swainson L, 2005, P NATL ACAD SCI USA, V102, P12867, DOI 10.1073/pnas.0503603102; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	49	678	726	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1203	1210		10.1038/nm1636	http://dx.doi.org/10.1038/nm1636			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17873882	Green Accepted			2022-12-25	WOS:000249980200036
J	Haygood, R; Fedrigo, O; Hanson, B; Yokoyama, KD; Awray, G				Haygood, Ralph; Fedrigo, Olivier; Hanson, Brian; Yokoyama, Ken-Daigoro; Awray, Gregory			Promoter regions of many neural- and nutrition-related genes have experienced positive selection during human evolution	NATURE GENETICS			English	Article							HUMAN GENOME; NATURAL-SELECTION; CHIMPANZEE GENOME; SEQUENCES; INSIGHTS; LINEAGE; MOUSE	Surveys of protein- coding sequences for evidence of positive selection in humans or chimpanzees have flagged only a few genes known to function in neural or nutritional processes(1-5), despite pronounced differences between humans and chimpanzees in behavior, cognition and diet(6-8). It may be that most such differences are due to changes in gene regulation rather than protein structure(9). Here, we present the first survey of promoter ( 5'- flanking) regions, which are rich in cis-regulatory sequences, for evidence of positive selection in humans. Our results indicate that positive selection has targeted the regulation of many genes known to be involved in neural development and function, both in the brain and elsewhere in the nervous system, and in nutrition, particularly in glucose metabolism.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Haygood, R (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	rhaygood@duke.edu						Arcadi AC, 2005, CURR BIOL, V15, pR884, DOI 10.1016/j.cub.2005.10.020; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Johnson-Frey SH, 2003, NEURON, V39, P201, DOI 10.1016/S0896-6273(03)00424-0; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Loftus SK, 2005, PLOS GENET, V1, P369, DOI 10.1371/journal.pgen.0010038; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Ungar P.S, 2007, EVOLUTION HUMAN DIET; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	30	211	216	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1140	1144		10.1038/ng2104	http://dx.doi.org/10.1038/ng2104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694055				2022-12-25	WOS:000249122400025
J	Kaida, D; Motoyoshi, H; Tashiro, E; Nojima, T; Hagiwara, M; Ishigami, K; Watanabe, H; Kitahara, T; Yoshida, T; Nakajima, H; Tani, T; Horinouchi, S; Yoshida, M				Kaida, Daisuke; Motoyoshi, Hajime; Tashiro, Etsu; Nojima, Takayuki; Hagiwara, Masatoshi; Ishigami, Ken; Watanabe, Hidenori; Kitahara, Takeshi; Yoshida, Tatsuhiko; Nakajima, Hidenori; Tani, Tokio; Horinouchi, Sueharu; Yoshida, Minoru			Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA	NATURE CHEMICAL BIOLOGY			English	Article							ANTITUMOR SUBSTANCES; PROTEIN COMPLEX; LEPTOMYCIN-B; FR901464; YEAST; MACHINERY; INTRON; U2; RIBONUCLEOPROTEINS; PHOSPHORYLATION	The removal of intervening sequences from transcripts is catalyzed by the spliceosome, a multicomponent complex that assembles on the newly synthesized pre-mRNA. Pre-mRNA translation in the cytoplasm leads to the generation of aberrant proteins that are potentially harmful. Therefore, tight control to prevent undesired pre-mRNA export from the nucleus and its subsequent translation is an essential requirement for reliable gene expression. Here, we show that the natural product FR901464 (1) and its methylated derivative, spliceostatin A (2), inhibit in vitro splicing and promote pre-mRNA accumulation by binding to SF3b, a subcomplex of the U2 small nuclear ribonucleoprotein in the spliceosome. Importantly, treatment of cells with these compounds resulted in leakage of pre-mRNA to the cytoplasm, where it was translated. Knockdown of SF3b by small interfering RNA induced phenotypes similar to those seen with spliceostatin A treatment. Thus, the inhibition of pre-mRNA splicing during early steps involving SF3b allows unspliced mRNA leakage and translation.	RIKEN, Chem Genet LAb, Wako, Saitama 3510198, Japan; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Tokyo Med & Dent Univ, Dept Funct Genom, Med Res Ctr, Tokyo 1138510, Japan; Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; Astellas Pharma Inc, Fermentat Res Labs, Drug Discovery Res, Tsukuba, Ibaraki 3002698, Japan; Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan; Japan Sci & Technol Corp, CREST Res Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo; Astellas Pharmaceuticals; Kumamoto University; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), RIKEN, Chem Genet LAb, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshidam@riken.jp	Yoshida, Minoru/C-8049-2014; Ishigami, Ken/V-8090-2019	Yoshida, Minoru/0000-0002-4376-5674; Kaida, Daisuke/0000-0003-4014-5231; Nojima, Takayuki/0000-0003-1236-4162; Ishigami, Ken/0000-0002-6917-1532; Tashiro, Etsu/0000-0003-4533-623X				Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; Das BK, 1999, MOL CELL BIOL, V19, P6796; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; HARPER JW, 1993, CELL, V75, P805; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; MAQUAT LE, 1995, RNA, V1, P453; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Motoyoshi H, 2004, BIOSCI BIOTECH BIOCH, V68, P2178, DOI 10.1271/bbb.68.2178; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Thompson CF, 2001, J AM CHEM SOC, V123, P9974, DOI 10.1021/ja016615t; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; WATAKABE A, 1989, NUCLEIC ACIDS RES, V17, P8159, DOI 10.1093/nar/17.20.8159; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	47	461	480	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					576	583		10.1038/nchembio.2007.18	http://dx.doi.org/10.1038/nchembio.2007.18			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17643111				2022-12-25	WOS:000248968000016
J	Rosenthal, N; Brown, S				Rosenthal, Nadia; Brown, Steve			The mouse ascending: perspectives for human-disease models	NATURE CELL BIOLOGY			English	Article							OTITIS-MEDIA; GENE; MUTAGENESIS; RESOURCE	The laboratory mouse is widely considered the model organism of choice for studying the diseases of humans, with whom they share 99% of their genes. A distinguished history of mouse genetic experimentation has been further advanced by the development of powerful new tools to manipulate the mouse genome. The recent launch of several international initiatives to analyse the function of all mouse genes through mutagenesis, molecular analysis and phenotyping underscores the utility of the mouse for translating the information stored in the human genome into increasingly accurate models of human disease.	Mouse Biol Unit, I-00016 Rome, Italy; MRC, Mammalian Genet Unit, Didcot OX11 ORD, Oxon, England		Rosenthal, N (corresponding author), Mouse Biol Unit, EMBL Monterotondo Outstn,Via Ramarina, I-00016 Rome, Italy.	rsn@embl-monterotondo.it	Rose, Rebecca J/B-7812-2011; Rosenthal, Nadia/O-7009-2015	Rosenthal, Nadia/0000-0002-7599-7365	Medical Research Council [MC_U142684172, MC_U142684175, MC_UP_1502/1] Funding Source: Medline; MRC [MC_UP_1502/1, MC_U142684172, MC_U142684175] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown SDM, 2006, PLOS GENET, V2, P1131, DOI 10.1371/journal.pgen.0020118; CARDINANOS J, 2007, NUCLEIC ACIDS RES, V35, pE87; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; *COMPL TRAIT CONS, 2004, NATURE, V26, P1133; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; Davisson M, 2006, MAMM GENOME, V17, P363, DOI 10.1007/s00335-006-0001-2; Deidda G, 2003, NAT BIOTECHNOL, V21, P1499, DOI 10.1038/nbt908; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Eisen EJ, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P1, DOI 10.1142/9781860947162; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Oliver PL, 2007, MAMM GENOME, V18, P412, DOI 10.1007/s00335-007-9014-8; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Paigen K, 2003, GENETICS, V163, P1; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Rubio-Aliaga I, 2007, GENETICS, V175, P1451, DOI 10.1534/genetics.106.067298; Segade F, 2006, ARCH OTOLARYNGOL, V132, P729, DOI 10.1001/archotol.132.7.729; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060	33	256	269	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					993	999		10.1038/ncb437	http://dx.doi.org/10.1038/ncb437			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762889				2022-12-25	WOS:000249256500003
J	Sagare, A; Deane, R; Bell, RD; Johnson, B; Hamm, K; Pendu, R; Marky, A; Lenting, PJ; Wu, ZH; Zarcone, T; Goate, A; Mayo, K; Perlmutter, D; Coma, M; Zhong, ZH; Zlokovic, BV				Sagare, Abhay; Deane, Rashid; Bell, Robert D.; Johnson, Bradley; Hamm, Katie; Pendu, Ronan; Marky, Andrew; Lenting, Peter J.; Wu, Zhenhua; Zarcone, Troy; Goate, Alison; Mayo, Kevin; Perlmutter, David; Coma, Mireia; Zhong, Zhihui; Zlokovic, Berislav V.			Clearance of amyloid-beta by circulating lipoprotein receptors	NATURE MEDICINE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PROTEIN LRP; PEPTIDE; TRANSPORT; PLAQUES; COMPLEX; PLASMA	Low-density lipoprotein receptor-related protein-1 (LRP) on brain capillaries clears amyloid beta-peptide (Ab) from brain. Here, we show that soluble circulating LRP (sLRP) provides key endogenous peripheral 'sink' activity for Ab in humans. Recombinant LRP cluster IV (LRP-IV) bound Ab in plasma in mice and Alzheimer's disease-affected humans with compromised sLRP-mediated Ab binding, and reduced Ab-related pathology and dysfunction in a mouse model of Alzheimer disease, suggesting that LRP-IV can effectively replace native sLRP and clear Ab.	Univ Rochester, Sch Med, Dept Neurosurg, Frank P Smith Lab Neurosci & Neurosurg Res, Rochester, NY 14642 USA; Univ Med Ctr Utrecht, Dept Hematol, Lab Thrombosis & Haemostasis, NL-3584 CX Utrecht, Netherlands; Univ Rochester, Sch Med, Dept Environm Med, Neurobehav Facil Lab, Rochester, NY USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	University of Rochester; Utrecht University; Utrecht University Medical Center; University of Rochester; Washington University (WUSTL)	Zlokovic, BV (corresponding author), Univ Rochester, Sch Med, Dept Neurosurg, Frank P Smith Lab Neurosci & Neurosurg Res, Rochester, NY 14642 USA.	Berislav_Zlokovic@urmc.rochester.edu	Sagare, Abhay/Y-3273-2019; Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Sagare, Abhay/0000-0002-8178-3785; Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Goate, Alison/0000-0002-0576-2472	NIA NIH HHS [R37 AG023084, P50 AG005681, P50 AG05681, R37 AG023084-02] Funding Source: Medline; NINDS NIH HHS [R37 NS034467, R37 NS34467, R01 NS034467, R01 NS034467-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, P50AG005681] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Tamaki C, 2006, PHARM RES-DORDR, V23, P1407, DOI 10.1007/s11095-006-0208-7; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; Zerbinatti CV, 2005, REV NEUROSCIENCE, V16, P123	15	333	344	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1029	1031		10.1038/nm1635	http://dx.doi.org/10.1038/nm1635			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17694066	Green Accepted			2022-12-25	WOS:000249353100028
J	Salman, H; Libchaber, A				Salman, Hanna; Libchaber, Albert			A concentration-dependent switch in the bacterial response to temperature	NATURE CELL BIOLOGY			English	Article							ESCHERICHIA-COLI; CHEMOTAXIS; THERMORESPONSE	We observed that bacteria grown below a critical concentration, in batch-mode cultures, swim towards warm regions when subjected to a temperature gradient. above that concentration, they swim towards colder regions. our findings indicate that the secreted intercellular signal, glycine, mediates this switch through methylation of Tsr receptors. at high bacterial concentration, the switch is reinforced by an inversion of the Tar/Tsr expression ratio.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA	Rockefeller University	Salman, H (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA.	salmanh@rockefeller.edu	Buma, P./H-8019-2014; Buma, Pieter/C-9828-2013; Schreurs, B.W./L-4639-2015	Salman, Hanna/0000-0002-5847-524X				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Berg H. C. E., 2003, COLI MOTION; Braun D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.188103; Imae Y., 1985, SENSING RESPONSE MIC, P73; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; MAEDA K, 1979, P NATL ACAD SCI USA, V76, P91, DOI 10.1073/pnas.76.1.91; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MIZUNO T, 1984, J BACTERIOL, V159, P360, DOI 10.1128/JB.159.1.360-367.1984; Nishiyama S, 1999, MOL MICROBIOL, V32, P357, DOI 10.1046/j.1365-2958.1999.01355.x; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Salman H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118101; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; STEWART RC, 1987, CHEM REV, V87, P997, DOI 10.1021/cr00081a007; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0	17	63	63	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1098	U78		10.1038/ncb1632	http://dx.doi.org/10.1038/ncb1632			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17694049				2022-12-25	WOS:000249256500018
J	Single, RM; Martin, MP; Gao, XJ; Meyer, DG; Yeager, M; Kidd, JR; Kidd, KK; Carrington, M				Single, Richard M.; Martin, Maureen P.; Gao, Xiaojiang; Meyer, Diogo; Yeager, Meredith; Kidd, Judith R.; Kidd, Kenneth K.; Carrington, Mary			Global diversity and evidence for coevolution of KIR and HLA	NATURE GENETICS			English	Article							NATURAL-SELECTION; SIGNATURES; MOLECULES; EVOLUTION; HISTORY; GENES	The killer immunoglobulin- like receptor ( KIR) gene cluster shows extensive genetic diversity, as do the HLA class I loci, which encode ligands for KIR molecules. We genotyped 1,642 individuals from 30 geographically distinct populations to examine population- level evidence for coevolution of these two functionally related but unlinked gene clusters. We observed strong negative correlations between the presence of activating KIR genes and their corresponding HLA ligand groups across populations, especially KIR3DS1 and its putative HLA- B Bw4-80I ligands ( r=- 0.66, P 0.038). In contrast, we observed weak positive relationships between the various inhibitory KIR genes and their ligands. We observed a negative correlation between distance from East Africa and frequency of activating KIR genes and their corresponding ligands, suggesting a balance between selection on HLA and KIR loci. Most KIR- HLA genetic association studies indicate a primary influence of activating KIR- HLA genotypes in disease risk(1,2); concomitantly, activating receptor- ligand pairs in this study show the strongest signature of coevolution of these two complex genetic systems as compared with inhibitory receptor- ligand pairs.	NCI, SAIC Frederick, Lab Genom Divers, Ft Detrick, MD 21702 USA; Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; Univ Sao Paulo, Dept Genet & Biol Evolut, BR-05608900 Sao Paulo, SP, Brazil; NCI, SAIC Frederick Inc, Adv Technol Program, Core Genotyping Facil, Ft Detrick, MD 21702 USA; NCI, US Natl Inst Hlth, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Vermont; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University	Carrington, M (corresponding author), NCI, SAIC Frederick, Lab Genom Divers, Ft Detrick, MD 21702 USA.	carringt@ncifcrf.gov	Meyer, Diogo/A-1868-2008; Yeager, Meredith/AAA-5322-2020		NATIONAL CANCER INSTITUTE [Z01BC010792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIGMS NIH HHS [GM35326] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrim ZI, 2005, PHLEBOLOGY, V20, P196, DOI 10.1258/026835505774964919; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Cramer H., 1946, MATH METHODS STAT; Fisher R., 1970, STAT METHODS RES WOR; Gumperz JE, 1997, J IMMUNOL, V158, P5237; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; Lancaster Alex, 2003, Pac Symp Biocomput, P514; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; MARTIN MP, IN PRESS METHODS MOL; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Salamon H, 1999, GENETICS, V152, P393; SINGLE RM, 2007, IMMUNOBIOLOGY HUMAN; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409	30	173	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1114	1119		10.1038/ng2077	http://dx.doi.org/10.1038/ng2077			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694058				2022-12-25	WOS:000249122400021
J	Zou, CB; Ma, JH; Wang, X; Guo, L; Zhu, ZQ; Stoops, J; Eaker, AE; Johnson, CJ; Strom, S; Michalopoulos, GK; DeFrances, MC; Zarnegar, R				Zou, Chunbin; Ma, Jihong; Wang, Xue; Guo, Lida; Zhu, Zhenqi; Stoops, John; Eaker, Amanda E.; Johnson, Carla J.; Strom, Stephen; Michalopoulos, George K.; DeFrances, Marie C.; Zarnegar, Reza			Lack of Fas antagonism by Met in human fatty liver disease	NATURE MEDICINE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; HEPATOCYTE APOPTOSIS; RECEPTOR; MICE; INJURY; REGENERATION; MECHANISM; THERAPY; GROWTH	Hepatocytes in fatty livers are hypersensitive to apoptosis and undergo escalated apoptotic activity via death receptor-mediated pathways, particularly that of Fas-FasL, causing hepatic injury that can eventually proceed to cirrhosis and end-stage liver disease. Here we report that the hepatocyte growth factor receptor, Met, plays an important part in preventing Fas-mediated apoptosis of hepatocytes by sequestering Fas. We also show that Fas antagonism by Met is abrogated in human fatty liver disease (FLD). Through structure-function studies, we found that a YLGA amino-acid motif located near the extracellular N terminus of the Met alpha-subunit is necessary and sufficient to specifically bind the extracellular portion of Fas and to act as a potent FasL antagonist and inhibitor of Fas trimerization. Using mouse models of FLD, we show that synthetic YLGA peptide tempers hepatocyte apoptosis and liver damage and therefore has therapeutic potential.	Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarnegar, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S411A Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	rezazar@pitt.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726; Strom, Stephen/0000-0002-2889-3387	NCI NIH HHS [R01CA095782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Connolly K, 2001, J PHARMACOL EXP THER, V298, P25; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein A, 2004, AM J GASTROENTEROL, V99, P1718, DOI 10.1111/j.1572-0241.2004.40573.x; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Guicciardi ME, 2004, NAT MED, V10, P587, DOI 10.1038/nm0604-587; Hasegawa A, 2004, P NATL ACAD SCI USA, V101, P6599, DOI 10.1073/pnas.0401597101; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; LEON LDA, 1985, J HISTOCHEM CYTOCHEM, V33, P737; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MEAGAN J, 2004, HEPATOLOGY, V39, P1230; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moriya K, 2001, BIOCHEM BIOPH RES CO, V281, P1207, DOI 10.1006/bbrc.2001.4523; Nakamoto Y, 2002, J EXP MED, V196, P1105, DOI 10.1084/jem.20020633; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Starling GC, 1997, J EXP MED, V185, P1487, DOI 10.1084/jem.185.8.1487; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Yin XM, 2003, CURR MOL MED, V3, P491, DOI 10.2174/1566524033479555; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100	35	66	71	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1078	1085		10.1038/nm1625	http://dx.doi.org/10.1038/nm1625			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17704785				2022-12-25	WOS:000249353100035
J	Marcotte, EM				Marcotte, Edward M.			How do shotgun proteomics algorithms identify proteins?	NATURE BIOTECHNOLOGY			English	Editorial Material							MASS-SPECTROMETRY; IDENTIFICATION; PEPTIDES; DATABASE; SEARCH; MODEL		Univ Texas, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway,MBB 3-210, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu		Marcotte, Edward/0000-0001-8808-180X				Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fischer B, 2005, ANAL CHEM, V77, P7265, DOI 10.1021/ac0508853; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gooley A.A., 1997, PROTEOME RES NEW FRO, P65, DOI [10.1007/978-3-662-03493-4_4, DOI 10.1007/978-3-662-03493-4_4]; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Wysocki VH, 2005, METHODS, V35, P211, DOI 10.1016/j.ymeth.2004.08.013	12	63	70	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					755	757		10.1038/nbt0707-755	http://dx.doi.org/10.1038/nbt0707-755			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621303				2022-12-25	WOS:000247994000025
J	Strobel, SA; Strobel, GA				Strobel, Scott A.; Strobel, Gary A.			Plant endophytes as a platform for discovery-based undergraduate science education	NATURE CHEMICAL BIOLOGY			English	Editorial Material								Project ownership is an essential but sometimes overlooked ingredient for a successful undergraduate research experience. We have embarked on an experiment in undergraduate education that targets isolation of microbes from rainforest plants and characterization of natural products as objectives for discovery-based undergraduate research.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Montana State Univ, Dept Plant Sci, Bozeman, MT 59717 USA	Yale University; Montana State University System; Montana State University Bozeman	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	strobel@mail.csb.yale.edu						Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Ash C, 2001, SCIENCE, V294, P2298, DOI 10.1126/science.1068061; BROWNE L, 2004, YEMENI J SCI, V6, P47; Castillo U, 2005, SCANNING, V27, P305, DOI 10.1002/sca.4950270606; Castillo UF, 2007, MICROB ECOL, V53, P12, DOI 10.1007/s00248-006-9129-6; Daisy B, 2002, MYCOTAXON, V84, P39; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Honigsbaum Mark, 2001, FEVER TRAIL; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; POPIK P, 1995, PHARMACOL REV, V47, P235; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o	20	21	23	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					356	359		10.1038/nchembio0707-356	http://dx.doi.org/10.1038/nchembio0707-356			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17576416				2022-12-25	WOS:000247462800004
J	van Heel, DA; Franke, L; Hunt, KA; Gwilliam, R; Zhernakova, A; Inouye, M; Wapenaar, MC; Barnardo, MCNM; Bethel, G; Holmes, GKT; Feighery, C; Jewell, D; Kelleher, D; Kumar, P; Travis, S; Walters, JRF; Sanders, DS; Howdle, P; Swift, J; Playford, RJ; McLaren, WM; Mearin, ML; Mulder, CJ; McManus, R; McGinnis, R; Cardon, LR; Deloukas, P; Wijmenga, C				van Heel, David A.; Franke, Lude; Hunt, Karen A.; Gwilliam, Rhian; Zhernakova, Alexandra; Inouye, Mike; Wapenaar, Martin C.; Barnardo, Martin C. N. M.; Bethel, Graeme; Holmes, Geoffrey K. T.; Feighery, Con; Jewell, Derek; Kelleher, Dermot; Kumar, Parveen; Travis, Simon; Walters, Julian R. F.; Sanders, David S.; Howdle, Peter; Swift, Jill; Playford, Raymond J.; McLaren, William M.; Mearin, M. Luisa; Mulder, Chris J.; McManus, Ross; McGinnis, Ralph; Cardon, Lon R.; Deloukas, Panos; Wijmenga, Cisca			A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21	NATURE GENETICS			English	Article							INTERLEUKIN-2 GENE	We tested 310,605 SNPs for association in 778 individuals with celiac disease and 1,422 controls. Outside the HLA region, the most significant finding ( rs13119723; P = 2.0 x 10(-7)) was in the KIAA1109- TENR- IL2- IL21 linkage disequilibrium block. We independently confirmed association in two further collections ( strongest association at rs6822844, 24 kb 5' of IL21; meta-analysis P = 1.3 x 10(- 14), odds ratio 0.63), suggesting that genetic variation in this region predisposes to celiac disease.	Queen Mary Univ London, Inst Cell & Mol Sci, Ctr Gastroenterol, London E1 2AT, England; Univ Utrecht, Med Ctr, Ctr Biomed Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Groningen, Med Ctr, Dept Genet, NL-9700 RB Groningen, Netherlands; Churchill Hosp, Oxford Transplant Ctr, Oxford OX3 7LJ, England; Derbyshire Royal Infirm, Dept Gastroenterol, Derby DE1 2QY, England; Univ Dublin Trinity Coll, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Mol Med, Dept Immunol, Dublin 2, Ireland; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Gastroenterol Unit, Oxford OX3 7BN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Gastroenterol Sect, London W12 0HS, England; Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Liver Unit, Sheffield S10 2JF, S Yorkshire, England; St James Univ Hosp, Dept Gastroenterol, Leeds LS9 7TF, W Yorkshire, England; Llandough Hosp, Dept Gastroenterol, Penarth CF64 2XX, S Glam, Wales; Leiden Univ, Med Ctr, Dept Paediat Gastroenterol, NL-2300 RC Leiden, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Pediat Gastroenterol, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands	University of London; Queen Mary University London; Utrecht University; Wellcome Trust Sanger Institute; University of Groningen; University of Oxford; Trinity College Dublin; Trinity College Dublin; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Imperial College London; University of Sheffield; University of Sheffield; Saint James's University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Heel, DA (corresponding author), Queen Mary Univ London, Inst Cell & Mol Sci, Ctr Gastroenterol, London E1 2AT, England.	d.vanheel@qmul.ac.uk	Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016; Zhernakova, Alexandra/ABA-9372-2020; McManus, Ross/AAE-9236-2020; Walters, Julian/D-5189-2009; Deloukas, Panos/B-2922-2013; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; Walters, Julian/0000-0001-9720-5835; Deloukas, Panos/0000-0001-9251-070X; Playford, Raymond/0000-0003-1235-8504; Zhernakova, Alexandra/0000-0002-4574-0841; McGinnis, Ralph/0000-0003-4540-9857; McManus, Ross/0000-0002-0529-9617; Travis, Simon/0000-0002-2690-4361; van Heel, David/0000-0002-0637-2265; McLaren, William/0000-0001-6218-1116; Inouye, Michael/0000-0001-9413-6520	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02, GR068094MA, 068094] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123; Hunt KA, 2005, EUR J HUM GENET, V13, P440, DOI 10.1038/sj.ejhg.5201357; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	12	496	509	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					827	829		10.1038/ng2058	http://dx.doi.org/10.1038/ng2058			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558408	Green Accepted, Green Submitted			2022-12-25	WOS:000247619800009
J	[Anonymous]				[Anonymous]			Recent patent applications in gene expression	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					742	742		10.1038/nbt0707-742	http://dx.doi.org/10.1038/nbt0707-742			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621296	Bronze			2022-12-25	WOS:000247994000019
J	Kai, M; Furuya, K; Paderi, F; Carr, AM; Wang, TSF				Kai, Mihoko; Furuya, Kanji; Paderi, Francesca; Carr, Antony M.; Wang, Teresa S. F.			Rad3-dependent phosphorylation of the checkpoint clamp regulates repair-pathway choice	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE CONTROL; BOX DNA HELICASE; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SRS2 HELICASE; HOMOLOGOUS RECOMBINATION; CANCER; INVOLVEMENT; CEREVISIAE; DAMAGE	When replication forks collapse, Rad3 phosphorylates the checkpoint-clamp protein Rad9 in a manner that depends on Thr 225, a residue within the PCNA-like domain. The physiological function of Thr 225-dependent Rad9 phosphorylation, however, remains elusive. Here, we show that Thr 225-dependent Rad9 phosphorylation by Rad3 regulates DNA repair pathways. A rad9T225C mutant induces a translesion synthesis (TLS)-dependent high spontaneous mutation rate and a hyper-recombination phenotype. Consistent with this, Rad9 coprecipitates with the post-replication repair protein Mms2. This interaction is dependent on Rad9 Thr 225 and is enhanced by DNA damage. Genetic analyses indicate that Thr 225-dependent Rad9 phosphorylation prevents inappropriate Rhp51-dependent recombination, potentially by redirecting the repair through a Pli1-mediated sumoylation pathway into the error-free branch of the Rhp6 repair pathway. Our findings reveal a new mechanism by which phosphorylation of Rad9 at Thr 225 regulates the choice of repair pathways for maintaining genomic integrity during the cell cycle.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Stanford University; University of Sussex	Wang, TSF (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	tswang@stanford.edu	paderi, francesca/K-1798-2014	Carr, Antony Michael/0000-0002-2028-2389	NATIONAL CANCER INSTITUTE [R01CA054415] Funding Source: NIH RePORTER; MRC [G0001129] Funding Source: UKRI; Medical Research Council [G0001129] Funding Source: Medline; NCI NIH HHS [CA54415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kai M, 2001, MOL CELL BIOL, V21, P3289, DOI 10.1128/MCB.21.10.3289-3301.2001; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liberles DA, 2001, GENOME BIOL, V2; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maftahi M, 2002, NUCLEIC ACIDS RES, V30, P4781, DOI 10.1093/nar/gkf581; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang SW, 2001, NUCLEIC ACIDS RES, V29, P2963, DOI 10.1093/nar/29.14.2963	25	28	29	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					691	U148		10.1038/ncb1600	http://dx.doi.org/10.1038/ncb1600			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515930				2022-12-25	WOS:000246922700015
J	Theodorou, V; Kimm, MA; Boer, M; Wessels, L; Theelen, W; Jonkers, J; Hilkens, J				Theodorou, Vassiliki; Kimm, Melanie A.; Boer, Mandy; Wessels, Lodewyk; Theelen, Wendy; Jonkers, Jos; Hilkens, John			MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer	NATURE GENETICS			English	Article							TUMOR VIRUS; HUMAN BREAST; TUMORIGENESIS; ACTIVATION; EXPRESSION; MICE; PROTOONCOGENES; CARCINOGENESIS; ONCOGENE; KINASE	We performed a high-throughput retroviral insertional mutagenesis screen in mouse mammary tumor virus (MMTV)-induced mammary tumors and identified 33 common insertion sites, of which 17 genes were previously not known to be associated with mammary cancer and 13 had not previously been linked to cancer in general. Although members of the Wnt and fibroblast growth factors ( Fgf) families were frequently tagged, our exhaustive screening for MMTV insertion sites uncovered a new repertoire of candidate breast cancer oncogenes. We validated one of these genes, Rspo3, as an oncogene by overexpression in a p53-deficient mammary epithelial cell line. The human orthologs of the candidate oncogenes were frequently deregulated in human breast cancers and associated with several tumor parameters. Computational analysis of all MMTV-tagged genes uncovered specific gene families not previously associated with cancer and showed a significant overrepresentation of protein domains and signaling pathways mainly associated with development and growth factor signaling. Comparison of all tagged genes in MMTV and Moloney murine leukemia virus - induced malignancies showed that both viruses target mostly different genes that act predominantly in distinct pathways.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Hilkens, J (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.hilkens@nki.nl	Jonkers, Jos/AAG-3246-2019; Theodorou, Vasiliki/GON-4996-2022; Theodorou, Vasiliki/H-1576-2016	Jonkers, Jos/0000-0002-9264-9792; Theodorou, Vasiliki/0000-0003-1614-700X; Hilkens, John/0000-0002-0932-7793				Adams NC, 2002, DEVELOPMENT, V129, P965; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Chen JZ, 2002, MOL BIOL REP, V29, P287, DOI 10.1023/A:1020479301379; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Erny KM, 1996, ONCOGENE, V13, P2015; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; HYNES NE, 1980, COLD SPRING HARB SYM, V44, P1161, DOI 10.1101/SQB.1980.044.01.125; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; LAMMIE GA, 1992, ONCOGENE, V7, P2381; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lowther W, 2005, J VIROL, V79, P10093, DOI 10.1128/JVI.79.15.10093-10096.2005; MERLO GR, 1993, ANN NY ACAD SCI, V698, P108, DOI 10.1111/j.1749-6632.1993.tb17195.x; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Payton M, 2002, ONCOGENE, V21, P8529, DOI 10.1038/sj.onc.1206035; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; PETERS G, 1986, NATURE, V320, P628, DOI 10.1038/320628a0; Prasad V, 2005, CANCER RES, V65, P8655, DOI 10.1158/0008-5472.CAN-05-0026; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Sheskin D.J., 1997, HDB PARAMETRIC NONPA; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takeuchi JK, 2003, DEVELOPMENT, V130, P2729, DOI 10.1242/dev.00474; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; VANDERVALK MA, 1981, MAMMARY TUMORS MOUSE, P45; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	49	153	164	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					759	769		10.1038/ng2034	http://dx.doi.org/10.1038/ng2034			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468756				2022-12-25	WOS:000246859100020
J	Haiman, CA; Patterson, N; Freedman, ML; Myers, SR; Pike, MC; Waliszewska, A; Neubauer, J; Tandon, A; Schirmer, C; McDonald, GJ; Greenway, SC; Stram, DO; Le Marchand, L; Kolonel, LN; Frasco, M; Wong, D; Pooler, LC; Ardlie, K; Oakley-Girvan, I; Whittemore, AS; Cooney, KA; John, EM; Ingles, SA; Altshuler, D; Henderson, BE; Reich, D				Haiman, Christopher A.; Patterson, Nick; Freedman, Matthew L.; Myers, Simon R.; Pike, Malcolm C.; Waliszewska, Alicja; Neubauer, Julie; Tandon, Arti; Schirmer, Christine; McDonald, Gavin J.; Greenway, Steven C.; Stram, Daniel O.; Le Marchand, Loic; Kolonel, Laurence N.; Frasco, Melissa; Wong, David; Pooler, Loreall C.; Ardlie, Kristin; Oakley-Girvan, Ingrid; Whittemore, Alice S.; Cooney, Kathleen A.; John, Esther M.; Ingles, Sue A.; Altshuler, David; Henderson, Brian E.; Reich, David			Multiple regions within 8q24 independently affect risk for prostate cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; AFRICAN-AMERICAN MEN; VITAMIN-D-RECEPTOR; POLYMORPHISMS; LOCUS	After the recent discovery that common genetic variation in 8q24 influences inherited risk of prostate cancer, we genotyped 2,973 SNPs in up to 7,518 men with and without prostate cancer from five populations. We identified seven risk variants, five of them previously undescribed, spanning 430 kb and each independently predicting risk for prostate cancer (P = 7.9 x 10(-19) for the strongest association, and P < 1.5 x 10(-4) for five of the variants, after controlling for each of the others). The variants define common genotypes that span a more than fivefold range of susceptibility to cancer in some populations. None of the prostate cancer risk variants aligns to a known gene or alters the coding sequence of an encoded protein.	Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA; Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; Genom Collaborat, Cambridge, MA 02139 USA; No Calif Canc Ctr, Fremont, CA 94538 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Reich, D (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	reich@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019; Myers, Simon R/A-6792-2015; Altshuler, David M/A-4476-2009	Myers, Simon R/0000-0002-2585-9626; Altshuler, David M/0000-0002-7250-4107; Frasco, Melissa/0000-0002-3437-1518; Cooney, Kathleen/0000-0003-3831-6943	NCI NIH HHS [R01 CA063464-09S1, CA54281, CA79596, CA84979, R01 CA084979, CA63464, R01 CA063464, CA67044, R01 CA054281, U01 CA063464, R01 CA079596, R01 CA067044, R37 CA054281, P50 CA069568, CA69568, U01 CA067044] Funding Source: Medline; NHGRI NIH HHS [HG02758, K01 HG002758] Funding Source: Medline; NICHD NIH HHS [HD00850, K12 HD000850] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA063464, R37CA054281, R01CA054281, R01CA067044, P50CA069568, R01CA084979, R01CA079596, U01CA067044, R01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG002758] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Cooney KA, 2001, UROLOGY, V57, P91, DOI 10.1016/S0090-4295(00)00873-6; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Oakley-Girvan I, 2004, CANCER EPIDEM BIOMAR, V13, P1325; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; VISAKORPI T, 1995, CANCER RES, V55, P342	17	515	550	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					638	644		10.1038/ng2015	http://dx.doi.org/10.1038/ng2015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401364	Green Accepted			2022-12-25	WOS:000245971300019
J	Hyafil, F; Cornily, JC; Feig, JE; Gordon, R; Vucic, E; Amirbekian, V; Fisher, EA; Fuster, V; Feldman, LJ; Fayad, ZA				Hyafil, Fabien; Cornily, Jean-Christophe; Feig, Jonathan E.; Gordon, Ronald; Vucic, Esad; Amirbekian, Vardan; Fisher, Edward A.; Fuster, Valentin; Feldman, Laurent J.; Fayad, Zahi A.			Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography	NATURE MEDICINE			English	Article							ULTRASMALL SUPERPARAMAGNETIC PARTICLES; CORONARY ATHEROSCLEROTIC PLAQUE; INTRAVASCULAR ULTRASOUND; IRON-OXIDE; HIGH-RISK; VULNERABLE PLAQUE; PART I; CT; INFLAMMATION; ACCURACY	Sudden fibrous cap disruption of 'high-risk' atherosclerotic plaques can trigger the formation of an occlusive thrombus in coronary arteries, causing acute coronary syndromes. High-risk atherosclerotic plaques are characterized by their specific cellular and biological content (in particular, a high density of macrophages), rather than by their impact on the vessel lumen. Early identification of high-risk plaques may be useful for preventing ischemic events. One major hurdle in detecting high-risk atherosclerotic plaques in coronary arteries is the lack of an imaging modality that allows for the identification of atherosclerotic plaque composition with high spatial and temporal resolutions. Here we show that macrophages in atherosclerotic plaques of rabbits can be detected with a clinical X-ray computed tomography (CT) scanner after the intravenous injection of a contrast agent formed of iodinated nanoparticles dispersed with surfactant. This contrast agent may become an important adjunct to the clinical evaluation of coronary arteries with CT.	Mt Sinai Sch Med, Sinai Translat & Mol Imaging Inst, New York, NY 10029 USA; Mt Sinai Sch Med, Imaging Sci Labs, New York, NY 10029 USA; INSERM U698, F-75018 Paris, France; Hop Bichat, Dept Cardiol, APHP, F-75018 Paris, France; NYU, Sch Med, Dept Med, Marc & Ruti Bell Vasc Biol Program, New York, NY 10016 USA; Mt Sinai Hosp, Dept Pathol, New York, NY 10029 USA; Mt Sinai Hosp, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; Mt Sinai Hosp, Marie Josee & Henry R Kravis Cardiovasc Hlth Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fayad, ZA (corresponding author), Mt Sinai Sch Med, Sinai Translat & Mol Imaging Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.	zahi.fayad@mssm.edu	Fayad, Zahi/Z-3272-2019; Fuster, Valentin/H-4319-2015; Fisher, Edward/ABE-7469-2020	Fayad, Zahi/0000-0002-3439-7347; Fuster, Valentin/0000-0002-9043-9986; Fisher, Edward/0000-0001-9802-143X; Hyafil, Fabien/0000-0002-9600-0376	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078667] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL78667] Funding Source: Medline; PHITPO CDC HHS [R01 HK71021] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHITPO CDC HHS		Achenbach S, 2004, CIRCULATION, V109, P14, DOI 10.1161/01.CIR.0000111517.69230.0F; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Boll DT, 2006, J COMPUT ASSIST TOMO, V30, P804, DOI 10.1097/01.rct.0000228162.70849.26; Dunphy MPS, 2005, J NUCL MED, V46, P1278; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Fu YJ, 2006, BIOCONJUGATE CHEM, V17, P1043, DOI 10.1021/bc060019c; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Gupta R, 2006, EUR RADIOL, V16, P1191, DOI 10.1007/s00330-006-0156-y; Helft G, 2002, CIRCULATION, V105, P993, DOI 10.1161/hc0802.104325; Hoffmann U, 2004, CIRCULATION, V110, P2638, DOI 10.1161/01.CIR.0000145614.07427.9F; Hyafil F, 2006, ARTERIOSCL THROM VAS, V26, P176, DOI 10.1161/01.ATV.0000194098.82677.57; Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC; Krause W, 1999, ADV DRUG DELIVER REV, V37, P159, DOI 10.1016/S0169-409X(98)00105-7; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; McIntire GL, 2000, INVEST RADIOL, V35, P91, DOI 10.1097/00004424-200002000-00001; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Pohle K, 2007, ATHEROSCLEROSIS, V190, P174, DOI 10.1016/j.atherosclerosis.2006.01.013; Rabin O, 2006, NAT MATER, V5, P118, DOI 10.1038/nmat1571; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Ruehm SG, 2001, CIRCULATION, V103, P415; Schroeder S, 2001, CLIN RADIOL, V56, P466, DOI 10.1053/crad.2001.0687; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Trivedi RA, 2004, STROKE, V35, P1631, DOI 10.1161/01.STR.0000131268.50418.b7; Viles-Gonzalez JF, 2004, CIRCULATION, V110, P1467, DOI 10.1161/01.CIR.0000141732.28175.2A; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wisner E R, 1994, Acad Radiol, V1, P377; Zhang Zhuangyu, 2006, BMC Nucl Med, V6, P3, DOI 10.1186/1471-2385-6-3; Zheng JZ, 2006, INVEST RADIOL, V41, P339, DOI 10.1097/01.rli.0000186568.50265.64	35	342	359	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2007	13	5					636	641		10.1038/nm1571	http://dx.doi.org/10.1038/nm1571			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17417649				2022-12-25	WOS:000246302800033
J	Perlstein, EO; Ruderfer, DM; Roberts, DC; Schreiber, SL; Kruglyak, L				Perlstein, Ethan O.; Ruderfer, Douglas M.; Roberts, David C.; Schreiber, Stuart L.; Kruglyak, Leonid			Genetic basis of individual differences in the response to small-molecule drugs in yeast	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; SACCHAROMYCES-CEREVISIAE; CELL-LINES; PHOSPHATE TRANSPORTER; CANCER; POLYMORPHISMS; CYTOTOXICITY; EXPRESSION; RESISTANCE; DISCOVERY	Individual response to small-molecule drugs is variable; a drug that provides a cure for some may confer no therapeutic benefit or trigger an adverse reaction in others. To begin to understand such differences systematically, we treated 104 genotyped segregants from a cross between two yeast strains with a collection of 100 diverse small molecules. We used linkage analysis to identify 124 distinct linkages between genetic markers and response to 83 compounds. The linked markers clustered at eight genomic locations, or quantitative-trait locus 'hotspots', that contain one or more polymorphisms that affect response to multiple small molecules. We also experimentally verified that a deficiency in leucine biosynthesis caused by a deletion of LEU2 underlies sensitivity to niguldipine, which is structurally related to therapeutic calcium channel blockers, and that a natural coding-region polymorphism in the inorganic phosphate transporter PHO84 underlies sensitivity to two polychlorinated phenols that uncouple oxidative phosphorylation. Our results provide a step toward a systematic understanding of small-molecule drug action in genetically distinct individuals.	Harvard Univ, Broad Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87544 USA; Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87544 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Princeton University; Princeton University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University	Schreiber, SL (corresponding author), Harvard Univ, Broad Inst, Howard Hughes Med Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	stuart_schreiber@harvard.edu; leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Perlstein, Ethan/0000-0002-4734-4391	NIGMS NIH HHS [P50GM071508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENARI G, 2006, IN PRESS PLOS GENET; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; FOGEL S, 1988, J BASIC MICROB, V28, P147, DOI 10.1002/jobm.3620280302; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Hohmann S, 2005, CURR OPIN BIOTECH, V16, P356, DOI 10.1016/j.copbio.2005.04.006; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Le Morvan V, 2006, PHARMACOGENOMICS, V7, P843, DOI 10.2217/14622416.7.6.843; MARO B, 1982, EMBO J, V1, P1347, DOI 10.1002/j.1460-2075.1982.tb01321.x; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Moisan F, 2006, BRIT J CANCER, V95, P906, DOI 10.1038/sj.bjc.6603361; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Outeiro Tiago Fleming, 2006, Biotechnology Journal, V1, P258, DOI 10.1002/biot.200500043; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SOMERVILLE L, 1986, XENOBIOTICA, V16, P1017, DOI 10.3109/00498258609038980; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stoehlmacher J, 2004, BRIT J CANCER, V91, P344, DOI 10.1038/sj.bjc.6601975; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Tenreiro S, 2002, BIOCHEM BIOPH RES CO, V292, P741, DOI 10.1006/bbrc.2002.6703; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Urban TJ, 2006, GENOME RES, V16, P223, DOI 10.1101/gr.4356206; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; WEINBACH EUGENE C., 1957, PROC NATL ACAD SCI, V43, P393, DOI 10.1073/pnas.43.5.393; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yarosh DB, 2005, BIOMARKERS, V10, P188, DOI 10.1080/13547500500138732; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhou XF, 2005, DRUG METAB DISPOS, V33, P1220, DOI 10.1124/dmd.104.003558	45	88	93	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					496	502		10.1038/ng1991	http://dx.doi.org/10.1038/ng1991			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334364				2022-12-25	WOS:000245271200019
J	Flynt, AS; Li, N; Thatcher, EJ; Solnica-Krezel, L; Patton, JG				Flynt, Alex S.; Li, Nan; Thatcher, Elizabeth J.; Solnica-Krezel, Lilianna; Patton, James G.			Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate	NATURE GENETICS			English	Article							FLOOR PLATE; EXPRESSION; EMBRYO; GENE; SPECIFICATION; MORPHOGENESIS; INDUCTION; MICRORNAS	Numerous microRNAs ( miRNAs) have been discovered in the genomes of higher eukaryotes, and functional studies indicate that they are important during development. However, little is known concerning the function of individual miRNAs. We approached this problem in zebrafish by combining identification of miRNA expression, functional analyses and experimental validation of potential targets. We show that miR-214 is expressed during early segmentation stages in somites and that varying its expression alters the expression of genes regulated by Hedgehog signaling. Inhibition of miR-214 results in a reduction or loss of slow-muscle cell types. We show that su(fu) mRNA, encoding a negative regulator of Hedgehog signaling, is targeted by miR-214. Through regulation of su( fu), miR-214 enables precise specification of muscle cell types by sharpening cellular responses to Hedgehog.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.g.patton@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075790, T32GM008554] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007502] Funding Source: Medline; NIGMS NIH HHS [R01 GM075790-01, GM 075790, T32 GM008554, R01 GM075790, T32 GM 008554, R01 GM075790-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schaffer M, 2005, MECH DEVELOP, V122, P43, DOI 10.1016/j.mod.2004.09.002; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	22	252	285	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					259	263		10.1038/ng1953	http://dx.doi.org/10.1038/ng1953			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220889	Green Accepted			2022-12-25	WOS:000244063900026
J	Widschwendter, M; Fiegl, H; Egle, D; Mueller-Holzner, E; Spizzo, G; Marth, C; Weisenberger, DJ; Campan, M; Young, J; Jacobs, I; Laird, PW				Widschwendter, Martin; Fiegl, Heidi; Egle, Daniel; Mueller-Holzner, Elisabeth; Spizzo, Gilbert; Marth, Christian; Weisenberger, Daniel J.; Campan, Mihaela; Young, Joanne; Jacobs, Ian; Laird, Peter W.			Epigenetic stem cell signature in cancer	NATURE GENETICS			English	Article							PROMOTER METHYLATION; POLYCOMB; GENOME; HYPERMETHYLATION; BIOLOGY; ORIGIN	Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have cancer- specific promoter DNA hypermethylation than non-targets, supporting a stem cell origin of cancer in which reversible gene repression is replaced by permanent silencing, locking the cell into a perpetual state of self-renewal and thereby predisposing to subsequent malignant transformation.	Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biol Mol, Los Angeles, CA USA; UCL, Inst Womens Hlth, Dept Gynecol Oncol, London WC1E 6DH, England; Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria; Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia	University of Southern California; University of Southern California; University of Southern California; University of London; University College London; Medical University of Innsbruck; Medical University of Innsbruck; QIMR Berghofer Medical Research Institute	Laird, PW (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA.	M.Widschwendter@ucl.ac.uk; plaird@usc.edu	Young, Joanne P/H-7774-2014; Young, Joanne P/B-9981-2011; Spizzo, Gilbert/Q-6707-2016; Weisenberger, Daniel/AAA-8314-2020; Laird, Peter W/G-8683-2012; Fiegl, Heidi/K-4445-2017	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Jacobs, Ian/0000-0002-5005-2672; Young, Joanne/0000-0002-1514-1522; Widschwendter, Martin/0000-0002-7778-8380; Fiegl, Heidi/0000-0002-1236-6806; Spizzo, Gilbert/0000-0003-4121-0146	NATIONAL CANCER INSTITUTE [R01CA075090, R01CA001815, R01CA096958] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096958, R01 CA001815, R01 CA075090] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Eads CA, 2000, CANCER RES, V60, P5021; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; HOUGHTON J, 2006, SEMIN CANCER BIOL, DOI DOI 10.1016/J.SEMICANCER.2006.04.003; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2006, NATURE, V442, P754, DOI 10.1038/442754a; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	15	808	846	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					157	158		10.1038/ng1941	http://dx.doi.org/10.1038/ng1941			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200673				2022-12-25	WOS:000244063900010
J	Steinman, RM				Steinman, Ralph M.			Dendritic cells: versatile controllers of the immune system	NATURE MEDICINE			English	Editorial Material							REGULATORY T-CELLS; PERIPHERAL LYMPHOID ORGANS; EPIDERMAL LANGERHANS CELLS; MIXED LEUKOCYTE REACTION; MACROPHAGES IN-VITRO; ANTIGEN PRESENTATION; ACCESSORY CELLS; LYMPHOCYTIC CHORIOMENINGITIS; HORSERADISH-PEROXIDASE; ANTIBODY-RESPONSES		Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Steinman, RM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	steinma@rockefeller.edu	Steinman, Ralph/F-7729-2012					Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; COHN ZA, 1983, HARVEY LECT, V77, P63; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; DOHERTY PC, 1975, J EXP MED, V141, P502, DOI 10.1084/jem.141.2.502; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; INABA K, 1985, SCIENCE, V229, P475, DOI 10.1126/science.3160115; INABA K, 1983, P NATL ACAD SCI-BIOL, V80, P6041, DOI 10.1073/pnas.80.19.6041; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; MOSIER DE, 1967, SCIENCE, V158, P1573, DOI 10.1126/science.158.3808.1573; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; PALADE GE, 1975, LES PRIX NOBEL 1974, P36; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; Steinman RM, 2004, CLIN INVEST MED, V27, P231; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; STEINMAN RM, 1972, J CELL BIOL, V55, P616, DOI 10.1083/jcb.55.3.616; STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186; STEINMAN RM, IN PRESS EUR J IMMUN; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; UNANUE ER, 1970, J EXP MED, V131, P711, DOI 10.1084/jem.131.4.711; VANVOORHIS WC, 1983, J EXP MED, V158, P174, DOI 10.1084/jem.158.1.174; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	73	233	239	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1155	1159		10.1038/nm1643	http://dx.doi.org/10.1038/nm1643			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17917664				2022-12-25	WOS:000249980200028
J	Micu, I; Ridsdale, A; Zhang, LQ; Woulfe, J; McClintock, J; Brantner, CA; Andrews, SB; Stys, PK				Micu, Ileana; Ridsdale, Andrew; Zhang, Lingqing; Woulfe, John; McClintock, Jeff; Brantner, Christine A.; Andrews, S. Brian; Stys, Peter K.			Real-time measurement of free Ca2+ changes in CNS myelin by two-photon microscopy	NATURE MEDICINE			English	Article							CORD WHITE-MATTER; SHEATH THICKNESS; ION CHANNELS; OPTIC-NERVE; CALCIUM; MECHANISMS; ACTIVATION; RECEPTORS; GLYCINE; CELLS	Here we describe a technique for measuring changes in Ca2+ in the cytosolic domain of mature compact myelin of live axons in the central nervous system (CNS). We label the myelin sheath of optic nerve and dorsal column axons by using the Ca2+ indicator X-rhod-1 coupled with DiOC(6)(3) to produce bright myelin counterstaining, thereby providing unambiguous identification of the myelin sheath for analysis of two-photon excited fluorescence. We present evidence for localization of the Ca2+ reporter to the cytosolic domain of myelin, obtained by using fluorescence lifetime, spectral measurements and Mn2+ quenching. Chemical ischemia increased myelinic X-rhod-1 fluorescence (similar to 50% after 30 min) in a manner dependent on extracellular Ca2+. Inhibiting Na+-dependent glutamate transporters (with TBOA) or glycine transporters (with sarcosine and ALX-1393) reduced the ischemia-induced increase in Ca2+. We show that myelinic N-methyl-D-aspartate (NMDA) receptors are activated by the two conventional coagonists glutamate and glycine, which are released by specific transporters under conditions of cellular Na+ loading and depolarization in injured white matter. This new technique facilitates detailed studies of living myelin, a vital component of the mammalian CNS.	Univ Ottawa, Div Neurosci, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Ctr Canc Therapeut, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Stys, PK (corresponding author), Univ Ottawa, Div Neurosci, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada.	pstys@ucalgary.ca	Micu, Ileana/M-9468-2016	Micu, Ileana/0000-0001-7112-0075; Brantner, Christine/0000-0001-8172-901X	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002610, Z01NS002610] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER SPH, 2006, BRIT J PHARMACOL, V147, pS148; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CHERKSEY B, 1994, NEUROCHEM RES, V19, P1101, DOI 10.1007/BF00968722; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dingledine R, 1999, PHARMACOL REV, V51, P7; ELLISMAN M H, 1979, Scanning Electron Microscopy, P793; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; LEVRAM V, 1995, J NEUROSCI, V15, P2628; Li S, 1999, J Neurosci, V19, pRC16; MARTENSON RE, 1992, MYELIN BIOL CHEM; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; MINTA A, 1989, J BIOL CHEM, V264, P8171; MRSULJA BJ, 1985, BRAIN RES, V343, P154, DOI 10.1016/0006-8993(85)91170-9; Ness JK, 2005, GLIA, V50, P321, DOI 10.1002/glia.20206; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; RANVIER L, 1878, LECONS HIST SYTEME N; Ren Y, 2000, J NEUROSCI METH, V102, P165, DOI 10.1016/S0165-0270(00)00304-6; ROPTE S, 1990, J NEUROCYTOL, V19, P242, DOI 10.1007/BF01217302; SCHLAEPFER WW, 1977, NATURE, V265, P734, DOI 10.1038/265734a0; SIMPSON PB, 1995, EUR J NEUROSCI, V7, P831, DOI 10.1111/j.1460-9568.1995.tb01070.x; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Taylor CM, 2004, P NATL ACAD SCI USA, V101, P4643, DOI 10.1073/pnas.0400922101; Verbny Y, 2002, J NEUROPHYSIOL, V88, P802, DOI 10.1152/jn.2002.88.2.802; VIRCHOW RLK, 1854, ALLGEMEINE STORUNGEN	30	56	57	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2007	13	7					874	879		10.1038/nm1568	http://dx.doi.org/10.1038/nm1568			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17603496				2022-12-25	WOS:000247902800036
J	Sheridan, C				Sheridan, Cormac			Production technologies change flu vaccine landscape	NATURE BIOTECHNOLOGY			English	News Item								The imminent approval in the European Union of the first seasonal influenza vaccine based on mammalian cell culture marks the beginning of a technology shift in the industry. However, transitioning away from the 50-year-old, egg based manufacturing process is likely to be gradual rather than abrupt. The traditional vaccine franchises continue to expand, to the point that a significant oversupply in the USA during the 2007-2008 influenza season is a strong possibility. The viruses have to be adapted to grow in eggs, which can both delay delivery of finished vaccine and, if there is a significant mismatch between the adapted and circulating flu strains, impair the efficacy of the final product. The threat of an influenza pandemic has further sharpened awareness of the need to move beyond dependence on the old system, as the avian influenza strains that are considered likely to give rise to a human pandemic strain are toxic to the eggs used for cultivating epidemic strains.											0	2	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					701	701		10.1038/nbt0707-701	http://dx.doi.org/10.1038/nbt0707-701			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621280				2022-12-25	WOS:000247994000005
J	Bishop, BL; Duncan, MJ; Song, J; Li, GJ; Zaas, D; Abraham, SN				Bishop, Brian L.; Duncan, Mathew J.; Song, Jeongmin; Li, Guojie; Zaas, David; Abraham, Soman N.			Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells	NATURE MEDICINE			English	Article							UNIQUE DITERPENE ACTIVATOR; BACTERIAL INVASION; FORSKOLIN; INDUCTION; MEMBRANES; GROWTH	The superficial bladder epithelium is a powerful barrier to urine and also serves as a regulator of bladder volume, which is achieved by apical exocytosis of specialized fusiform vesicles during distension of the bladder. We report that type 1 fimbriated uropathogenic Escherichia coli (UPEC) circumvents the bladder barrier by harboring in these Rab27b/ CD63-positive and cAMP-regulatable fusiform vesicles within bladder epithelial cells (BECs). Incorporation of UPEC into BEC fusiform compartments enabled bacteria to escape elimination during voiding and to re-emerge in the urine as the bladder distended. Notably, treatment of UPEC-infected mice with a drug that increases intracellular cAMP and induces exocytosis of fusiform vesicles reduced the number of intracellular E. coli.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Bishop, BL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	blb7@duke.edu; soman.abraham@duke.edu		Song, Jeongmin/0000-0002-6777-3505	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI056101, R01AI035678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050814] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI-35678, R21 AI056101] Funding Source: Medline; NIDDK NIH HHS [R37DK50814] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM SN, 1985, INFECT IMMUN, V48, P625, DOI 10.1128/IAI.48.3.625-628.1985; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; ANDERSON JD, 1979, J CLIN MICROBIOL, V10, P766, DOI 10.1128/JCM.10.6.766-771.1979; Andrews Norma W., 1993, Biological Research, V26, P65; Apodaca G, 2001, Urology, V57, P103, DOI 10.1016/S0090-4295(01)01026-3; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Carbone M, 2002, ANN NY ACAD SCI, V963, P332; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Drewes SE, 2003, PHYTOCHEMISTRY, V62, P1019, DOI 10.1016/S0031-9422(02)00621-0; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MEYER BH, 1987, S AFR MED J, V71, P570; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; ORNDORFF PE, 1984, J BACTERIOL, V159, P736, DOI 10.1128/JB.159.2.736-744.1984; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Styczynski J, 2006, BRIT J HAEMATOL, V133, P397, DOI 10.1111/j.1365-2141.2006.06032.x; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Uehling DT, 1999, WORLD J UROL, V17, P351, DOI 10.1007/s003450050160; VERGARA J, 1974, J CELL BIOL, V61, P83, DOI 10.1083/jcb.61.1.83; Wajima Z, 2002, CRIT CARE MED, V30, P820, DOI 10.1097/00003246-200204000-00017; Wang E, 2003, METHODS, V30, P207, DOI 10.1016/S1046-2023(03)00027-6	32	149	157	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					625	630		10.1038/nm1572	http://dx.doi.org/10.1038/nm1572			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17417648				2022-12-25	WOS:000246302800031
J	Dong, YM; VandenBeldt, KJ; Meng, X; Khodjakov, A; McEwen, BF				Dong, Yimin; VandenBeldt, Kristin J.; Meng, Xing; Khodjakov, Alexey; McEwen, Bruce F.			The outer plate in vertebrate kinetochores is a flexible network with multiple microtubule interactions	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST; COMPLEX; ATTACHMENT; SPINDLE; CELLS; ARCHITECTURE; DYNAMICS; ORIENTATION; CENTROMERES; TOMOGRAPHY	Intricate interactions between kinetochores and microtubules are essential for the proper distribution of chromosomes during mitosis. A crucial long-standing question is how vertebrate kinetochores generate chromosome motion while maintaining attachments to the dynamic plus ends of the multiple kinetochore MTs (kMTs) in a kinetochore fibre. Here, we demonstrate that individual kMTs in PtK1 cells are attached to the kinetochore outer plate by several fibres that either embed the microtubule plus- end tips in a radial mesh, or extend out from the outer plate to bind microtubule walls. The extended fibres also interact with the walls of nearby microtubules that are not part of the kinetochore fibre. These structural data, in combination with other recent reports, support a network model of kMT attachment wherein the fibrous network in the unbound outer plate, including the Hec1-Ndc80 complex, dissociates and rearranges to form kMT attachments.	SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	McEwen, BF (corresponding author), SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA.	bruce.mcewen@wadsworth.org			NCRR NIH HHS [P41 RR01219, P41 RR001219] Funding Source: Medline; NIGMS NIH HHS [R01 GM059363, GM59363, R01 GM06627, R01 GM066270-05A1, R01 GM059363-09, R01 GM066270] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363, R01GM066270] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; McEwen BF, 2002, J STRUCT BIOL, V138, P47, DOI 10.1016/S1047-8477(02)00020-5; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	32	101	104	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					516	U56		10.1038/ncb1576	http://dx.doi.org/10.1038/ncb1576			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435749	Green Accepted			2022-12-25	WOS:000246181500009
J	Kebeish, R; Niessen, M; Thiruveedhi, K; Bari, R; Hirsch, HJ; Rosenkranz, R; Stabler, N; Schonfeld, B; Kreuzaler, F; Peterhansel, C				Kebeish, Rashad; Niessen, Markus; Thiruveedhi, Krishnaveni; Bari, Rafijul; Hirsch, Heinz-Josef; Rosenkranz, Ruben; Staebler, Norma; Schoenfeld, Barbara; Kreuzaler, Fritz; Peterhaensel, Christoph			Chloroplastic photorespiratory bypass increases photosynthesis and biomass production in Arabidopsis thaliana	NATURE BIOTECHNOLOGY			English	Article							C-4 PHOTOSYNTHESIS; LEAF PHOTOSYNTHESIS; CO2 CONCENTRATIONS; ESCHERICHIA-COLI; PLANT; GLYOXYLATE; GLYCOLATE; OVEREXPRESSION; METABOLISM; RESPIRATION	We introduced the Escherichia coli glycolate catabolic pathway into Arabidopsis thaliana chloroplasts to reduce the loss of fixed carbon and nitrogen that occurs in C-3 plants when phosphoglycolate, an inevitable by-product of photosynthesis, is recycled by photorespiration. Using step-wise nuclear transformation with five chloroplast-targeted bacterial genes encoding glycolate dehydrogenase, glyoxylate carboligase and tartronic semialdehyde reductase, we generated plants in which chloroplastic glycolate is converted directly to glycerate. This reduces, but does not eliminate, flux of photorespiratory metabolites through peroxisomes and mitochondria. Transgenic plants grew faster, produced more shoot and root biomass, and contained more soluble sugars, reflecting reduced photorespiration and enhanced photosynthesis that correlated with an increased chloroplastic CO2 concentration in the vicinity of ribulose-1,5-bisphosphate carboxylase/oxygenase. These effects are evident after overexpression of the three subunits of glycolate dehydrogenase, but enhanced by introducing the complete bacterial glycolate catabolic pathway. Diverting chloroplastic glycolate from photorespiration may improve the productivity of crops with C-3 photosynthesis.	Rhein Westfal TH Aachen, Inst Biol 1, D-52056 Aachen, Germany	RWTH Aachen University	Peterhansel, C (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Worringer Weg 1, D-52056 Aachen, Germany.	cp@bio1.rwth-aachen.de		Kebeish, Rashad/0000-0002-4781-1914				Arp WJ, 1998, PLANT CELL ENVIRON, V21, P1, DOI 10.1046/j.1365-3040.1998.00257.x; Atkin OK, 1998, AUST J PLANT PHYSIOL, V25, P437, DOI 10.1071/PP97159; CAMPBELL WJ, 1990, PHOTOSYNTH RES, V23, P257, DOI 10.1007/BF00034856; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; GIVAN CV, 1992, PLANT PHYSIOL, V100, P552, DOI 10.1104/pp.100.2.552; GOTTO AM, 1961, BIOCHEM J, V81, P273, DOI 10.1042/bj0810273; Goyal A, 1996, P NATL ACAD SCI USA, V93, P3319, DOI 10.1073/pnas.93.8.3319; GOYAL A, 1988, PLANT PHYSIOL, V88, P543, DOI 10.1104/pp.88.3.543; Gutheil WG, 1998, ANAL BIOCHEM, V259, P62, DOI 10.1006/abio.1998.2642; Hausler RE, 1999, J EXP BOT, V50, P1231, DOI 10.1093/jexbot/50.336.1231; Hausler RE, 2002, J EXP BOT, V53, P591, DOI 10.1093/jexbot/53.369.591; Herman PL, 2002, PLANT SCI, V163, P1137, DOI 10.1016/S0168-9452(02)00326-6; Igamberdiev AU, 2002, PHYTOCHEMISTRY, V60, P651, DOI 10.1016/S0031-9422(02)00179-6; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; KISAKI T, 1969, PLANT PHYSIOL, V44, P242, DOI 10.1104/pp.44.2.242; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Kruger EL, 2006, FUNCT PLANT BIOL, V33, P421, DOI 10.1071/FP05310; KU SB, 1977, PLANT PHYSIOL, V59, P986, DOI 10.1104/pp.59.5.986; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; Lechtenberg B, 2003, PLANT J, V34, P507, DOI 10.1046/j.1365-313X.2003.01746.x; LEEGOOD RC, 1995, J EXP BOT, V46, P1397, DOI 10.1093/jxb/46.special_issue.1397; Leegood RC, 2002, J EXP BOT, V53, P581, DOI 10.1093/jexbot/53.369.581; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; LORD JM, 1972, BIOCHIM BIOPHYS ACTA, V267, P227, DOI 10.1016/0005-2728(72)90111-9; Mann CC, 1999, SCIENCE, V283, P314, DOI 10.1126/science.283.5400.314; MEDRANO H, 1995, J EXP BOT, V46, P1389, DOI 10.1093/jxb/46.special_issue.1389; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; Novitskaya L, 2002, PLANT CELL ENVIRON, V25, P821, DOI 10.1046/j.1365-3040.2002.00866.x; OLIVER DJ, 1981, PLANT PHYSIOL, V68, P1031, DOI 10.1104/pp.68.5.1031; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pellicer MT, 1996, J BACTERIOL, V178, P2051, DOI 10.1128/jb.178.7.2051-2059.1996; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; Somerville C.R., 1984, OXFORD SURVEYS PLANT, V1, P103; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; STITT M, 1989, METHOD ENZYMOL, V174, P518; TOLBERT NE, 1970, J BIOL CHEM, V245, P5129; Tolbert NE, 1997, ANNU REV PLANT PHYS, V48, P1, DOI 10.1146/annurev.arplant.48.1.1; von Caemmerer S, 2003, PLANT CELL ENVIRON, V26, P1191, DOI 10.1046/j.0016-8025.2003.01061.x; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; ZELITCH I, 1972, ARCH BIOCHEM BIOPHYS, V150, P698, DOI 10.1016/0003-9861(72)90088-4; Zhu XG, 2004, PLANT CELL ENVIRON, V27, P155, DOI 10.1046/j.1365-3040.2004.01142.x	49	353	388	7	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					593	599		10.1038/nbt1299	http://dx.doi.org/10.1038/nbt1299			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17435746				2022-12-25	WOS:000246369400028
J	Miller, EW; Tulyanthan, O; Isacoff, EY; Chang, CJ				Miller, Evan W.; Tulyanthan, Orapim; Isacoff, Ehud Y.; Chang, Christopher J.			Molecular imaging of hydrogen peroxide produced for cell signaling	NATURE CHEMICAL BIOLOGY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; FLUORESCENT-PROBES; H2O2; INACTIVATION; GENERATION; OXIDATION; OXIDASE	Hydrogen peroxide ( H2O2) is emerging as a newly recognized messenger in cellular signal transduction(1,2). However, a substantial challenge in elucidating its diverse roles in complex biological environments is the lack of methods for probing this reactive oxygen metabolite in living systems with molecular specificity. Here we report the synthesis and application of Peroxy Green 1 ( PG1) and Peroxy Crimson 1 ( PC1), two new fluorescent probes that show high selectivity for H2O2 and are capable of visualizing endogenous H2O2 produced in living cells by growth factor stimulation, including the first direct imaging of peroxide produced for brain cell signaling. The combined features of reactive oxygen species selectivity, sensitivity to signaling levels of H2O2, and live- cell compatibility presage many new opportunities for PG1, PC1 and related synthetic reagents for exploring the physiological roles of H2O2 in living systems with molecular imaging.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, 532A Latimer Hall, Berkeley, CA 94720 USA.	chrischang@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM079465] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 79465, T32 GM066698] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; FIRKEL T, 2003, CURR OPIN CELL BIOL, V15, P247; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; KIMURA T, 1995, ENDOCRINOLOGY, V136, P116, DOI 10.1210/en.136.1.116; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Soh N, 2006, ANAL BIOANAL CHEM, V386, P532, DOI 10.1007/s00216-006-0366-9; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	29	362	369	1	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2007	3	5					263	267		10.1038/nchembio871	http://dx.doi.org/10.1038/nchembio871			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159FP	17401379				2022-12-25	WOS:000245851100009
J	Bettendorff, L; Wirtzfeld, B; Makarchikov, AF; Mazzucchelli, G; Frederich, M; Gigliobianco, T; Gangolf, M; De Pauw, E; Angenot, L; Wins, P				Bettendorff, Lucien; Wirtzfeld, Barbara; Makarchikov, Alexander F.; Mazzucchelli, Gabriel; Frederich, Michel; Gigliobianco, Tiziana; Gangolf, Marjorie; De Pauw, Edwin; Angenot, Luc; Wins, Pierre			Discovery of a natural thiamine adenine nucleotide	NATURE CHEMICAL BIOLOGY			English	Article							TRIPHOSPHATE	Several important cofactors are adenine nucleotides with a vitamin as the catalytic moiety. Here, we report the discovery of the first adenine nucleotide containing vitamin B1: adenosine thiamine triphosphate (AThTP, 1), or thiaminylated ATP. We discovered AThTP in Escherichia coli and found that it accumulates specifically in response to carbon starvation, thereby acting as a signal rather than a cofactor. We detected smaller amounts in yeast and in plant and animal tissues.	Univ Liege, Ctr Cellular & Mol Neurobiol, B-4000 Liege, Belgium; Univ Liege, Dept Phys Chem, B-4000 Liege, Belgium; Univ Liege, Drug Res Ctr, Lab Pharmacognosy, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege	Bettendorff, L (corresponding author), Univ Liege, Ctr Cellular & Mol Neurobiol, Ave Hop 1, B-4000 Liege, Belgium.	l.bettendorff@ulg.ac.be		Mazzucchelli, Gabriel/0000-0002-8757-8133; FREDERICH, Michel/0000-0002-0770-9990; De Pauw, Edwin/0000-0003-3475-1315				Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; BETTENDORFF L, 1991, ANAL BIOCHEM, V198, P52, DOI 10.1016/0003-2697(91)90505-N; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788	8	73	83	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2007	3	4					211	212		10.1038/nchembio867	http://dx.doi.org/10.1038/nchembio867			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148UW	17334376				2022-12-25	WOS:000245103000009
J	de Witte, L; Nabatov, A; Pion, M; Fluitsma, D; de Jong, MAWP; de Gruijl, T; Piguet, V; van Kooyk, Y; Geijtenbeek, TBH				de Witte, Lot; Nabatov, Alexey; Pion, Marjorie; Fluitsma, Donna; de Jong, Marein A. W. P.; de Gruijl, Tanja; Piguet, Vincent; van Kooyk, Yvette; Geijtenbeek, Teunis B. H.			Langerin is a natural barrier to HIV-1 transmission by Langerhans cells	NATURE MEDICINE			English	Article							EPIDERMAL DENDRITIC CELLS; INFECTION; BINDING; MICROBICIDES; RECEPTORS; MODEL	Human immunodeficiency virus-1 (HIV-1) is primarily transmitted sexually. Dendritic cells (DCs) in the subepithelium transmit HIV-1 to T cells through the C- type lectin DC-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin (DC-SIGN). However, the epithelial Langerhans cells (LCs) are the first DC subset to encounter HIV-1. It has generally been assumed that LCs mediate the transmission of HIV-1 to T cells through the C- type lectin Langerin, similarly to transmission by DC-SIGN on dendritic cells (DCs). Here we show that in stark contrast to DC-SIGN, Langerin prevents HIV-1 transmission by LCs. HIV-1 captured by Langerin was internalized into Birbeck granules and degraded. Langerin inhibited LC infection and this mechanism kept LCs refractory to HIV-1 transmission; inhibition of Langerin allowed LC infection and subsequent HIV-1 transmission. Notably, LCs also inhibited T-cell infection by viral clearance through Langerin. Thus Langerin is a natural barrier to HIV-1 infection, and strategies to combat infection must enhance, preserve or, at the very least, not interfere with Langerin expression and function.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; Univ Hosp Geneva, Dept Dermatol & Venerol, CH-1211 Geneva, Switzerland; Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Geneva; Vrije Universiteit Amsterdam	Geijtenbeek, TBH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Van De Boechorstr 7, NL-1081 BT Amsterdam, Netherlands.	t.geijtenbeek@vumc.nl	Nabatov, Alexey/R-5291-2016; Geijtenbeek, Teunis/C-2229-2009; Pion, Marjorie/D-8139-2012; Pion, Marjorie/AAB-5812-2022; de Witte, Lot/H-1499-2011; Pion, Marjorie/D-8139-2012	Nabatov, Alexey/0000-0001-7932-1445; Pion, Marjorie/0000-0003-1828-4745; Van Kooyk, Yvette/0000-0001-5997-3665; Pion, Marjorie/0000-0002-6406-747X				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cohn MA, 2001, J INFECT DIS, V184, P410, DOI 10.1086/322780; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kawamura T, 2001, EUR J IMMUNOL, V31, P360, DOI 10.1002/1521-4141(200102)31:2<360::AID-IMMU360>3.0.CO;2-X; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller CJ, 1999, J INFECT DIS, V179, pS413, DOI 10.1086/314795; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; PICUT CA, 1987, J HISTOCHEM CYTOCHEM, V35, P745, DOI 10.1177/35.7.2884251; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Reece JC, 1998, J EXP MED, V187, P1623, DOI 10.1084/jem.187.10.1623; RICHTERS CD, 1994, CLIN EXP IMMUNOL, V98, P330; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200	25	450	464	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2007	13	3					367	371		10.1038/nm1541	http://dx.doi.org/10.1038/nm1541			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17334373				2022-12-25	WOS:000244715700051
J	St Onge, RP; Mani, R; Oh, J; Proctor, M; Fung, E; Davis, RW; Nislow, C; Roth, FP; Giaever, G				St Onge, Robert P.; Mani, Ramamurthy; Oh, Julia; Proctor, Michael; Fung, Eula; Davis, Ronald W.; Nislow, Corey; Roth, Frederick P.; Giaever, Guri			Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; DELETERIOUS MUTATIONS; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; INTERACTION NETWORKS; YEAST; REPLICATION; PROTEINS; HELICASE; MUTANTS	Systematic genetic interaction studies have illuminated many cellular processes. Here we quantitatively examine genetic interactions among 26 Saccharomyces cerevisiae genes conferring resistance to the DNA- damaging agent methyl methanesulfonate ( MMS), as determined by chemogenomic fitness profiling of pooled deletion strains. We constructed 650 double- deletion strains, corresponding to all pairings of these 26 deletions. The fitness of single- and double- deletion strains were measured in the presence and absence of MMS. Genetic interactions were defined by combining principles from both statistical and classical genetics. The resulting network predicts that the Mph1 helicase has a role in resolving homologous recombination - derived DNA intermediates that is similar to ( but distinct from) that of the Sgs1 helicase. Our results emphasize the utility of small molecules and multifactorial deletion mutants in uncovering functional relationships and pathway order.	Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Univ Toronto, Dept Pharmaceut Chem, Leslie Dan Fac Pharm, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Ctr Canc Syst Biol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Stanford University; University of Toronto; Harvard University; Dana-Farber Cancer Institute	Roth, FP (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	froth@hms.harvard.edu; guri.giaever@utoronto.ca	Roth, Frederick P/H-6308-2011	Nislow, Corey/0000-0002-4016-8874; Roth, Frederick/0000-0002-6628-649X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003224-02, R01 HG003224-03, R01 HG003224-01A2, R01 HG003224] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JANA S, 1972, THEOR APPL GENET, V42, P119, DOI 10.1007/BF00583413; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Klein H, 2001, GENETICS, V157, P557; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Phillips PC, 1998, GENETICS, V149, P1167; PHILLIPS PC, 2000, AVERAGE EVOLUTIONARY, P20; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; PUNNETT RC, 1913, MENDELISM; Rose MD., 1990, METHODS YEAST GENETI; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong SL, 2005, TRENDS GENET, V21, P424, DOI 10.1016/j.tig.2005.06.006; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-270	48	231	234	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					199	206		10.1038/ng1948	http://dx.doi.org/10.1038/ng1948			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206143	Green Accepted			2022-12-25	WOS:000244063900017
J	Nguyen-Ngoc, T; Afshar, K; Gonczy, P				Nguyen-Ngoc, Tu; Afshar, Katayoun; Goenczy, Pierre			Coupling of cortical dynein and G alpha proteins mediates spindle positioning in Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEINS; MITOTIC SPINDLE; C-ELEGANS; CYTOPLASMIC DYNEIN; FORCE GENERATORS; EMBRYOS; ORIENTATION; NUMA; COMPLEX	Despite being essential for spatial cell division control, the mechanisms governing spindle positioning remain incompletely understood. In the Caenorhabditis elegans one-cell stage embryo, the spindle becomes asymmetrically positioned during anaphase through the action of as-yet unidentified cortical force generators that pull on astral microtubules and that depend on two G alpha proteins and associated proteins(1,2). We performed spindle-severing experiments following temporally restricted gene inactivation and drug exposure, and established that microtubule dynamics and dynein are both required for generating efficient pulling forces. We found that the G alpha-associated proteins GPR-1/2 and LIN-5 interact in vivo with LIS-1, a component of the dynein complex. Moreover, we discovered that the LIN-5, GPR-1/2 and the G alpha proteins promote the presence of the dynein complex at the cell cortex. Our findings suggest a mechanism by which the G alpha proteins enable GPR-1/2 and LIN-5 recruitment to the cortex, thus ensuring the presence of cortical dynein. Together with microtubule dynamics, this allows pulling forces to be exerted and proper cell division to be achieved.	Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Lausanne, Switzerland.	Pierre.Gonczy@isrec.unil.ch		Nguyen-Ngoc, Tu/0000-0001-7574-2947; Gonczy, Pierre/0000-0002-6305-6883				Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cockell MM, 2004, J CELL SCI, V117, P4571, DOI 10.1242/jcs.01344; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fink G, 2006, EMBO J, V25, P4897, DOI 10.1038/sj.emboj.7601354; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017	35	183	195	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1294	U158		10.1038/ncb1649	http://dx.doi.org/10.1038/ncb1649			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17922003				2022-12-25	WOS:000250659600015
J	Lanzuolo, C; Roure, V; Dekker, J; Bantignies, F; Orlando, V				Lanzuolo, Chiara; Roure, Virginie; Dekker, Job; Bantignies, Frederic; Orlando, Valerio			Polycomb response elements mediate the formation of chromosome higher-order structures in the bithorax complex	NATURE CELL BIOLOGY			English	Article							NUCLEAR REORGANIZATION; RNA INTERFERENCE; GENE-EXPRESSION; GROUP PROTEINS; TRANSCRIPTION; ORGANIZATION; ARCHITECTURE; TRITHORAX; HETEROCHROMATIN; EPIGENOME	In Drosophila, the function of the Polycomb group genes ( PcGs) and their target sequences ( Polycomb response elements ( PREs)) is to convey mitotic heritability of transcription programmes-in particular, gene silencing. As part of the mechanisms involved, PREs are thought to mediate this transcriptional memory function by building up higher-order structures in the nucleus. To address this question, we analysed in vivo the three-dimensional structure of the homeotic locus bithorax complex ( BX-C) by combining chromosome conformation capture (3C) with fluorescent in situ hybridization ( FISH) and FISH immunostaining ( FISH-I) analysis. We found that, in the repressed state, all major elements that have been shown to bind PcG proteins, including PREs and core promoters, interact at a distance, giving rise to a topologically complex structure. We show that this structure is important for epigenetic silencing of the BX-C, as we find that major changes in higher-order structures must occur to stably maintain alternative transcription states, whereas histone modification and reduced levels of PcG proteins determine an epigenetic switch that is only partially heritable.	Dulbecco Telethon Inst, CNR, IGB, I-80131 Naples, Italy; CNRS, Inst Human Genet, UPR 1142, Chromatin & Cell Biol Lab, F-34396 Montpellier, France; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Gene Funct & Expt, Worcester, MA 01605 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Massachusetts System; University of Massachusetts Worcester	Orlando, V (corresponding author), Dulbecco Telethon Inst, CNR, IGB, Via Pietro Castellino 111, I-80131 Naples, Italy.	orlando@igb.cnr.it	Lanzuolo, Chiara/AAB-1037-2019	Lanzuolo, Chiara/0000-0003-2649-6334	NHGRI NIH HHS [HG03143] Funding Source: Medline; Telethon [TCR05001] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lanzuolo C, 2007, CELL MOL LIFE SCI, V64, P1043, DOI 10.1007/s00018-007-6420-8; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	36	225	231	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1167	1174		10.1038/ncb1637	http://dx.doi.org/10.1038/ncb1637			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828248				2022-12-25	WOS:000249882300012
J	Martindill, DMJ; Risebro, CA; Smart, N; Franco-Viseras, MDM; Rosario, CO; Swallow, CJ; Dennis, JW; Riley, PR				Martindill, David M. J.; Risebro, Catherine A.; Smart, Nicola; Franco-Viseras, Maria Del Mar; Rosario, Carla O.; Swallow, Carol J.; Dennis, James W.; Riley, Paul R.			Nucleolar release of Hand1 acts as a molecular switch to determine cell fate	NATURE CELL BIOLOGY			English	Article							DOMAIN-CONTAINING PROTEIN; HELIX TRANSCRIPTION FACTOR; TROPHOBLAST STEM-CELLS; PLACENTAL DEVELOPMENT; MOUSE EMBRYOS; POLO KINASE; DIFFERENTIATION; LOCALIZATION; FAMILY; EXPRESSION	The bHLH transcription factor Hand1 is essential for placentation and cardiac morphogenesis in the developing embryo. Here we implicate Hand1 as a molecular switch that determines whether a trophoblast stem cell continues to proliferate or commits to differentiation. We identify a novel interaction of Hand1 with a protein that contains an I- mfa ( inhibitor of myogenic factor) domain that anchors Hand1 in the nucleolus where it negatively regulates Hand1 activity. In the trophoblast stem-cell line Rcho-1, nucleolar sequestration of Hand1 accompanies sustained cell proliferation and renewal, whereas release of Hand1 into the nucleus leads to its activation, thus committing cells to a differentiated giant-cell fate. Site-specific phosphorylation is required for nucleolar release of Hand1, for its dimerization and biological function, and this is mediated by the non-canonical polo-like kinase Plk4 ( Sak). Sak is co-expressed in Rcho-1 cells, localizes to the nucleolus during G2 and phosphorylates Hand1 as a requirement for trophoblast stem-cell commitment to a giant-cell fate. This study defines a novel cellular mechanism for regulating Hand1 that is a crucial step in the stem-cell differentiation pathway.	UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of London; University College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Riley, PR (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	P.Riley@ich.ucl.ac.uk	Smart, Nicola/AAN-4011-2020; Smart, Nicola/AAD-3874-2020; Dennis, James/E-7268-2013	Smart, Nicola/0000-0002-3501-7254; 				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Centonze Victoria E., 2004, Biol Proced Online, V6, P78, DOI 10.1251/bpo75; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390; Hill AA, 2004, MOL CELL BIOL, V24, P9835, DOI 10.1128/MCB.24.22.9835-9847.2004; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Leung GC, 2007, FEBS LETT, V581, P77, DOI 10.1016/j.febslet.2006.11.080; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Ma GT, 2000, BIOL REPROD, V63, P570, DOI 10.1095/biolreprod63.2.570; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Riley PR, 2000, DEV BIOL, V227, P156, DOI 10.1006/dbio.2000.9864; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sahgal N, 2005, DIFFERENTIATION, V73, P452, DOI 10.1111/j.1432-0436.2005.00044.x; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Thebault S, 2000, EUR J CELL BIOL, V79, P834, DOI 10.1078/0171-9335-00111; Thebault S, 2001, CURR PROTEIN PEPT SC, V2, P155, DOI 10.2174/1389203013381143; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	50	59	62	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1131	1141		10.1038/ncb1633	http://dx.doi.org/10.1038/ncb1633			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891141				2022-12-25	WOS:000249882300008
J	Shestopalov, IA; Sinha, S; Chen, JK				Shestopalov, Ilya A.; Sinha, Surajit; Chen, James K.			Light-controlled gene silencing in zebrafish embryos	NATURE CHEMICAL BIOLOGY			English	Article							FLOOR PLATE; NO-TAIL; NOTOCHORD; PROTEIN	Functional genomic studies in zebrafish frequently use synthetic oligonucleotides called morpholinos that block RNA splicing or translation. However, the constitutive activity of these reagents limits their experimental utility. We report here the synthesis of a photoactivatable morpholino targeting the no tail ( ntl) gene. This caged reagent permits spatiotemporal gene regulation in vivo and the photochemical generation of functionally mosaic organisms.	Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Chen, JK (corresponding author), Indian Assoc Cultivat Sci, Dept Organ Chem, 2A & 2B Mullick Rd, Kolkata 700032, W Bengal, India.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072600] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072600] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amacher SL, 2002, DEVELOPMENT, V129, P3311; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; Melby AE, 1996, DEVELOPMENT, V122, P2225; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; ORDOUKHANIAN P, 1995, J AM CHEM SOC, V117, P9570, DOI 10.1021/ja00142a028; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Tang XJ, 2006, ANGEW CHEM INT EDIT, V45, P3523, DOI 10.1002/anie.200600954	11	168	178	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					650	651		10.1038/nchembio.2007.30	http://dx.doi.org/10.1038/nchembio.2007.30			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17717538				2022-12-25	WOS:000249642700013
J	Balklava, Z; Pant, S; Fares, H; Grant, BD				Balklava, Zita; Pant, Saumya; Fares, Hanna; Grant, Barth D.			Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic	NATURE CELL BIOLOGY			English	Article							J-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; CELL-POLARITY; C-ELEGANS; N-WASP; VESICULAR TRANSPORT; SPINDLE ORIENTATION; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE	In a genome-wide RNA-mediated interference screen for genes required in membrane traffic-including endocytic uptake, recycling from endosomes to the plasma membrane, and secretion-we identified 168 candidate endocytosis regulators and 100 candidate secretion regulators. Many of these candidates are highly conserved among metazoans but have not been previously implicated in these processes. Among the positives from the screen, we identified PAR-3, PAR-6, PKC-3 and CDC-42, proteins that are well known for their importance in the generation of embryonic and epithelial-cell polarity. Further analysis showed that endocytic transport in Caenorhabditis elegans coelomocytes and human HeLa cells was also compromised after perturbation of CDC-42/Cdc42 or PAR-6/Par6 function, indicating a general requirement for these proteins in regulating endocytic traffic. Consistent with these results, we found that tagged CDC-42/Cdc42 is enriched on recycling endosomes in C. elegans and mammalian cells, suggesting a direct function in the regulation of transport.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Arizona, Dept Mol & Cell Biol, Tucson, AZ 85721 USA	Rutgers State University New Brunswick; University of Arizona	Grant, BD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	grant@biology.rutgers.edu	Balklava, Zita/AAU-6146-2021	Balklava, Zita/0000-0001-9039-9710; Grant, Barth/0000-0002-5943-8336	NIGMS NIH HHS [GM65235, R01 GM067237-05, R01 GM067237, R01 GM067237-06, GM67237] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237, R01GM065235] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; BRENNER S, 1974, GENETICS, V77, P71; BRODSKY FM, 1985, J CELL BIOL, V101, P2055, DOI 10.1083/jcb.101.6.2055; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chin WC, 2002, NOVART FDN SYMP, V248, P132; CHIN WC, 2002, NOVART FDN SYMP, V248, P277; CHIN WC, 2002, NOVART FDN SYMP, V248, P141; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cowan CR, 2007, DEVELOPMENT, V134, P1035, DOI 10.1242/dev.000513; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; KUGE O, 1993, J CELL BIOL, V123, P1727, DOI 10.1083/jcb.123.6.1727; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; POTENZA M, 1992, YEAST, V8, P549, DOI 10.1002/yea.320080706; Praitis V, 2001, GENETICS, V157, P1217; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; SATO M, 2005, NAT CELL BIOL; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Soroka CJ, 1999, J BIOL CHEM, V274, P26416, DOI 10.1074/jbc.274.37.26416; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; STENBECK G, 1992, FEBS LETT, V314, P195, DOI 10.1016/0014-5793(92)80973-K; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; Straight SW, 2001, MOL BIOL CELL, V12, P1329, DOI 10.1091/mbc.12.5.1329; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; Weigert R, 2005, METHOD ENZYMOL, V403, P243, DOI 10.1016/S0076-6879(05)03020-X; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011	91	202	217	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1066	U35		10.1038/ncb1627	http://dx.doi.org/10.1038/ncb1627			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704769				2022-12-25	WOS:000249256500014
J	Miyanari, Y; Atsuzawa, K; Usuda, N; Watashi, K; Hishiki, T; Zayas, M; Bartenschlager, R; Wakita, T; Hijikata, M; Shimotohno, K				Miyanari, Yusuke; Atsuzawa, Kimie; Usuda, Nobuteru; Watashi, Koichi; Hishiki, Takayuki; Zayas, Margarita; Bartenschlager, Ralf; Wakita, Takaji; Hijikata, Makoto; Shimotohno, Kunitada			The lipid droplet is an important organelle for hepatitis C virus production	NATURE CELL BIOLOGY			English	Article							CORE PROTEIN; CELL-LINES; REPLICATION; IDENTIFICATION; EXPRESSION; SURFACE; GENOME	The lipid droplet (LD) is an organelle that is used for the storage of neutral lipids. It dynamically moves through the cytoplasm, interacting with other organelles, including the endoplasmic reticulum ( ER)(1-3). These interactions are thought to facilitate the transport of lipids and proteins to other organelles. The hepatitis C virus (HCV) is a causative agent of chronic liver diseases(4). HCV capsid protein ( Core) associates with the LD5, envelope proteins E1 and E2 reside in the ER lumen(6), and the viral replicase is assumed to localize on ER- derived membranes. How and where HCV particles are assembled, however, is poorly understood. Here, we show that the LD is involved in the production of infectious virus particles. We demonstrate that Core recruits nonstructural (NS) proteins and replication complexes to LD-associated membranes, and that this recruitment is critical for producing infectious viruses. Furthermore, virus particles were observed in close proximity to LDs, indicating that some steps of virus assembly take place around LDs. This study reveals a novel function of LDs in the assembly of infectious HCV and provides a new perspective on how viruses usurp cellular functions.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068507, Japan; Fujita Hlth Univ, Dept Anat, Toyoake, Aichi 4701192, Japan; Heidelberg Univ, Dept Mol Biol, D-69120 Heidelberg, Germany; Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Kyoto University; Kyoto University; Fujita Health University; Ruprecht Karls University Heidelberg; National Institute of Infectious Diseases (NIID)	Shimotohno, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan.	shimkuni@z8.keio.jp	Bartenschlager, Ralf/L-2582-2015	Bartenschlager, Ralf/0000-0001-5601-9307				BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Hijikata M, 1993, Uirusu, V43, P293; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Vock R, 1996, J EXP BIOL, V199, P1689; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	28	916	944	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1089	U74		10.1038/ncb1631	http://dx.doi.org/10.1038/ncb1631			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721513				2022-12-25	WOS:000249256500017
J	Zheng, B; Cao, BH; Crisan, M; Sun, B; Li, GH; Logar, A; Yap, S; Pollett, JB; Drowley, L; Cassino, T; Gharaibeh, B; Deasy, BM; Huard, J; Peault, B				Zheng, Bo; Cao, Baohong; Crisan, Mihaela; Sun, Bin; Li, Guangheng; Logar, Alison; Yap, Solomon; Pollett, Jonathan B.; Drowley, Lauren; Cassino, Theresa; Gharaibeh, Burhan; Deasy, Bridget M.; Huard, Johnny; Peault, Bruno			Prospective identification of myogenic endothelial cells in human skeletal muscle	NATURE BIOTECHNOLOGY			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; MYOBLAST TRANSPLANTATION; CELLULAR TRANSPLANTATION; SATELLITE CELLS; DORSAL AORTA; IN-VITRO; REGENERATION; MULTIPOTENT	We document anatomic, molecular and developmental relationships between endothelial and myogenic cells within human skeletal muscle. Cells coexpressing myogenic and endothelial cell markers (CD56, CD34, CD144) were identified by immunohistochemistry and flow cytometry. These myoendothelial cells regenerate myofibers in the injured skeletal muscle of severe combined immunodeficiency mice more effectively than CD56(+) myogenic progenitors. They proliferate long term, retain a normal karyotype, are not tumorigenic and survive better under oxidative stress than CD56(+) myogenic cells. Clonally derived myoendothelial cells differentiate into myogenic, osteogenic and chondrogenic cells in culture. Myoendothelial cells are amenable to biotechnological handling, including purification by flow cytometry and long-term expansion in vitro, and may have potential for the treatment of human muscle disease.	Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Childrens Hosp, Dept Mol Genet & Biochem, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Childrens Hosp, Dept Bioengn, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Childrens Hosp, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Dept Orthopaed Surg, 4100 Rangos Res Ctr,3460 Fifth Ave, Pittsburgh, PA 15213 USA.	jhuard@pitt.edu	Gharaibeh, Burhan/A-7696-2017; Pollett, Jonathan/A-8778-2008		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049684, U54AR050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013420] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR 049684, 1U54 AR 050733-01] Funding Source: Medline; NIDCR NIH HHS [R01 DE 13420-06] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; BERESFORD JN, 1992, J CELL SCI, V102, P341; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Cao Baohong, 2005, Phys Med Rehabil Clin N Am, V16, P889, DOI 10.1016/j.pmr.2005.08.020; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jankowski RJ, 2004, PANMINERVA MED, V46, P81; Jankowski RJ, 2002, J CELL SCI, V115, P4361, DOI 10.1242/jcs.00110; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Menasche P, 2004, CURR OPIN CARDIOL, V19, P154, DOI 10.1097/00001573-200403000-00016; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Miller JB, 1999, CURR TOP DEV BIOL, V43, P191; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mueller GM, 2002, HUM GENE THER, V13, P1081, DOI 10.1089/104303402753812485; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Nomura T, 2007, BIOCHEM BIOPH RES CO, V352, P668, DOI 10.1016/j.bbrc.2006.11.097; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Partridge TA, 2004, ACTA NEUROL BELG, V104, P141; PARTRIDGE TA, 1991, MUSCLE NERVE, V14, P197, DOI 10.1002/mus.880140302; Payne TR, 2005, GENE THER, V12, P1264, DOI 10.1038/sj.gt.3302521; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PROCKOP DJ, 1997, SCIENCE, V276, P71, DOI [DOI 10.1126/SCIENCE.276.5309.71, 10.1126/science.276.5309.71]; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Skuk D, 2003, J MUSCLE RES CELL M, V24, P285; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087; Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	57	249	257	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1025	1034		10.1038/nbt1334	http://dx.doi.org/10.1038/nbt1334			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17767154				2022-12-25	WOS:000249444200026
J	Azuma, H; Paulk, N; Ranade, A; Dorrell, C; Al-Dhalimy, M; Ellis, E; Strom, S; Kay, MA; Finegold, M; Grompe, M				Azuma, Hisaya; Paulk, Nicole; Ranade, Aarati; Dorrell, Craig; Al-Dhalimy, Muhsen; Ellis, Ewa; Strom, Stephen; Kay, Mark A.; Finegold, Milton; Grompe, Markus			Robust expansion of human hepatocytes in Fah(-/-)/Rag2(-/-)/Il2rg(-/-) mice	NATURE BIOTECHNOLOGY			English	Article							DRUG-METABOLIZING-ENZYMES; TYROSINEMIA TYPE-I; HUMAN STEM-CELLS; CHIMERIC MICE; HEPATIC-DYSFUNCTION; LIVER-REGENERATION; CYTOCHROMES P450; NOD/SCID MICE; MURINE MODEL; SCID MOUSE	Mice that could be highly repopulated with human hepatocytes would have many potential uses in drug development and research applications. The best available model of liver humanization, the uroplasminogen-activator transgenic model, has major practical limitations. To provide a broadly useful hepatic xenorepopulation system, we generated severely immunodeficient, fumarylacetoacetate hydrolase ( Fah)-deficient mice. After pretreatment with a urokinase-expressing adenovirus, these animals could be highly engrafted ( up to 90%) with human hepatocytes from multiple sources, including liver biopsies. Furthermore, human cells could be serially transplanted from primary donors and repopulate the liver for at least four sequential rounds. The expanded cells displayed typical human drug metabolism. This system provides a robust platform to produce high-quality human hepatocytes for tissue culture. It may also be useful for testing the toxicity of drug metabolites and for evaluating pathogens dependent on human liver cells for replication.	Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15261 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Baylor Coll Med, Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Baylor College of Medicine	Grompe, M (corresponding author), Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA.	grompem@ohsu.edu	Ellis, Ewa C S/D-5370-2014	Ellis, Ewa C S/0000-0002-3057-5337; Grompe, Markus/0000-0002-6616-4345; Kay, Mark/0000-0002-2799-2615; Paulk, Nicole/0000-0002-5557-6280; Strom, Stephen/0000-0002-2889-3387	NATIONAL CANCER INSTITUTE [F31CA130116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092310, R01DK048252] Funding Source: NIH RePORTER; NCI NIH HHS [F31 CA130116] Funding Source: Medline; NIDDK NIH HHS [R01-DK48252, DK 92310, R01 DK048252] Funding Source: Medline; NIGMS NIH HHS [GM 06346] Funding Source: Medline; NLM NIH HHS [N01DK92310] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aoki K, 2006, DRUG METAB PHARMACOK, V21, P277, DOI 10.2133/dmpk.21.277; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Brandon EFA, 2003, TOXICOL APPL PHARM, V189, P233, DOI 10.1016/S0041-008X(03)00128-5; Cascio SM, 2001, ARTIF ORGANS, V25, P529, DOI 10.1046/j.1525-1594.2001.025007529.x; Dandri M, 2005, J HEPATOL, V42, P54, DOI 10.1016/j.jhep.2004.09.021; Dick JE, 1997, STEM CELLS, V15, P204; Dick JE, 1997, STEM CELLS, V15, P199, DOI 10.1002/stem.5530150826; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Katoh M, 2005, DRUG METAB DISPOS, V33, P754, DOI 10.1124/dmd.104.002600; Katoh M, 2004, DRUG METAB DISPOS, V32, P1402, DOI 10.1124/dmd.104.001347; Katoh M, 2007, J PHARM SCI-US, V96, P428, DOI 10.1002/jps.20783; KNOX WE, 1955, METHOD ENZYMOL, V2, P287, DOI 10.1016/S0076-6879(55)02202-7; Komoroski BJ, 2004, DRUG METAB DISPOS, V32, P512, DOI 10.1124/dmd.32.5.512; Kostrubsky SE, 2006, TOXICOL SCI, V90, P451, DOI 10.1093/toxsci/kfj095; Kostrubsky VE, 2000, DRUG METAB DISPOS, V28, P1192; Kostrubsky VE, 1999, DRUG METAB DISPOS, V27, P887; LIEBER A, 1995, HUM GENE THER, V6, P1029, DOI 10.1089/hum.1995.6.8-1029; LIEBER A, 1995, P NATL ACAD SCI USA, V92, P6210, DOI 10.1073/pnas.92.13.6210; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Nishimura M, 2005, XENOBIOTICA, V35, P877, DOI 10.1080/00498250500307251; Okamura K, 2006, HISTOCHEM CELL BIOL, V125, P247, DOI 10.1007/s00418-005-0065-1; Overturf K, 1997, AM J PATHOL, V151, P1273; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Runge D, 2000, BIOCHEM BIOPH RES CO, V274, P1, DOI 10.1006/bbrc.2000.2912; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Schiedner G, 2003, MOL THER, V7, P35, DOI 10.1016/S1525-0016(02)00017-5; Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Turrini P, 2006, TRANSPL P, V38, P1181, DOI 10.1016/j.transproceed.2006.02.149; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wen YH, 2002, DRUG METAB DISPOS, V30, P977, DOI 10.1124/dmd.30.9.977; Yamamoto N, 2006, HEPATOL RES, V35, P169, DOI 10.1016/j.hepres.2006.04.006; Yoshitsugu H, 2006, DRUG METAB PHARMACOK, V21, P465, DOI 10.2133/dmpk.21.465	43	573	619	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					903	910		10.1038/nbt1326	http://dx.doi.org/10.1038/nbt1326			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17664939	Green Accepted			2022-12-25	WOS:000248725800029
J	Jenkins, AH; Schyns, G; Potot, S; Sun, GX; Begley, TP				Jenkins, Amy Haas; Schyns, Ghislain; Potot, Sebastien; Sun, Guangxing; Begley, Tadhg P.			A new thiamin salvage pathway	NATURE CHEMICAL BIOLOGY			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS; KINASE; IDENTIFICATION; PYROPHOSPHATE; PYRIMIDINE; SYNTHASE; PROTEIN	The physiological function for thiaminase II, a thiamin-degrading enzyme, has eluded investigators for more than 50 years. Here, we demonstrate that this enzyme is involved in the regeneration of the thiamin pyrimidine rather than in thiamin degradation, and we identify a new pathway involved in the salvage of base-degraded forms of thiamin. This pathway is widely distributed among bacteria, archaea and eukaryotes. In this pathway, thiamin hydrolysis products such as N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine (formylaminopyrimidine; 15) are transported into the cell using the ThiXYZ transport system, deformylated by the ylmB-encoded amidohydrolase and hydrolyzed to 4-amino-5-hydroxymethyl-2methylpyrimidine (HMP; 6) - an intermediate on the de novo thiamin biosynthetic pathway. To our knowledge this is the first example of a thiamin salvage pathway involving thiamin analogs generated by degradation of one of the heterocyclic rings of the cofactor.	Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; DSM Nutr Prod, Biotechnol R&D, CH-4002 Basel, Switzerland	Cornell University; DSM NV	Begley, TP (corresponding author), Cornell Univ, Dept Chem & Biol Chem, 120 Baker Lab, Ithaca, NY 14853 USA.	tpb2@cornell.edu	Begley, Tadhg/B-5801-2015		NIDDK NIH HHS [DK44083] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044083, R37DK044083] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P1604, DOI 10.1021/bi00405a032; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; BEGLEY TP, 2004, OXID STRESS DIS, V11, P15; CHAHINE JME, 1983, J AM CHEM SOC, V105, P2335, DOI 10.1021/ja00346a037; Day N, 1999, ANAL BIOCHEM, V274, P141, DOI 10.1006/abio.1999.4255; DORNOW A, 1953, CHEM BER-RECL, V86, P1404; Dorrestein PC, 2004, CHEM BIOL, V11, P1373, DOI 10.1016/j.chembiol.2004.08.009; Haas AL, 2005, BIOORG CHEM, V33, P338, DOI 10.1016/j.bioorg.2005.04.001; Hanes JW, 2007, J AM CHEM SOC, V129, P4860, DOI 10.1021/ja0679634; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; IMAMURA N, 1981, EXPERIENTIA, V37, P1265, DOI 10.1007/BF01948350; IMAMURA N, 1982, J BACTERIOL, V151, P708, DOI 10.1128/JB.151.2.708-717.1982; KURATA G, 1968, BITAMIN, V37, P398; Lawhorn BG, 2004, ORG BIOMOL CHEM, V2, P2538, DOI 10.1039/b405429f; MAIER GD, 1957, J AM CHEM SOC, V79, P4386, DOI 10.1021/ja01573a040; Melnick J, 2004, J BACTERIOL, V186, P3660, DOI 10.1128/JB.186.11.3660-3662.2004; Miranda-Rios J, 2007, STRUCTURE, V15, P259, DOI 10.1016/j.str.2007.02.001; MIZOTE T, 1989, J BACTERIOL, V171, P3228, DOI 10.1128/jb.171.6.3228-3232.1989; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park JH, 2004, J BACTERIOL, V186, P1571, DOI 10.1128/JB.186.5.1571-1573.2004; Quayle J. R., 1966, METHODS ENZYMOL, V9, P360; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Schyns G, 2005, J BACTERIOL, V187, P8127, DOI 10.1128/JB.187.23.8127-8136.2005; Takami H, 1999, BIOSCI BIOTECH BIOCH, V63, P943, DOI 10.1271/bbb.63.943; Toms AV, 2005, BIOCHEMISTRY-US, V44, P2319, DOI 10.1021/bi0478648; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Xu JC, 2001, ENVIRON TOXICOL CHEM, V20, P2717, DOI [10.1002/etc.5620201210, 10.1897/1551-5028(2001)020&lt;2717:FOAAAI&gt;2.0.CO;2]	29	79	90	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2007	3	8					492	497		10.1038/nchembio.2007.13	http://dx.doi.org/10.1038/nchembio.2007.13			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	193VB	17618314				2022-12-25	WOS:000248302200016
J	Razzaque, MA; Nishizawa, T; Komoike, Y; Yagi, H; Furutani, M; Amo, R; Kamisago, M; Momma, K; Katayama, H; Nakagawa, M; Fujiwara, Y; Matsushima, M; Mizuno, K; Tokuyama, M; Hirota, H; Muneuchi, J; Higashinakagawa, T; Matsuoka, R				Razzaque, M. Abdur; Nishizawa, Tsutomu; Komoike, Yuta; Yagi, Hisato; Furutani, Michiko; Amo, Ryunosuke; Kamisago, Mitsuhiro; Momma, Kazuo; Katayama, Hiroshi; Nakagawa, Masao; Fujiwara, Yuko; Matsushima, Masaki; Mizuno, Katsumi; Tokuyama, Mika; Hirota, Hamao; Muneuchi, Jun; Higashinakagawa, Toru; Matsuoka, Rumiko			Germline gain-of-function mutations in RAF1 cause Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; PROTEIN-KINASE-A; CARDIAC-HYPERTROPHY; SIGNALING PATHWAY; C-RAF; B-RAF; DISORDERS; PHENOTYPE; KRAS; ACTIVATION	Noonan syndrome is characterized by short stature, facial dysmorphia and a wide spectrum of congenital heart defects1,2. Mutations of PTPN11, KRAS and SOS1 in the RAS- MAPK pathway cause similar to 60% of cases of Noonan syndrome3-9. However, the gene(s) responsible for the remainder are unknown. We have identified five different mutations in RAF1 in ten individuals with Noonan syndrome; those with any of four mutations causing changes in the CR2 domain of RAF1 had hypertrophic cardiomyopathy (HCM), whereas affected individuals with mutations leading to changes in the CR3 domain did not. Cells transfected with constructs containing Noonan syndrome - associated RAF1 mutations showed increased in vitro kinase and ERK activation, and zebrafish embryos with morpholino knockdown of raf1 demonstrated the need for raf1 for the development of normal myocardial structure and function. Thus, our findings implicate RAF1 gain-of-function mutations as a causative agent of a human developmental disorder, representing a new genetic mechanism for the activation of the MAPK pathway.	Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan; Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Div Pediat Cardiol, Tokyo 1628666, Japan; Osaka Med Coll, Dept Pediat, Osaka, Japan; Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; Jikei Univ, Dept Pediat, Tokyo, Japan; Social Insurance Chukyo Hosp, Dept Pediat Cardiol, Aichi, Japan; Chiba Childrens Hosp, Dept Neonatol, Chiba, Japan; Toho Univ, Dept Pediat, Tokyo, Japan; Kitasato Univ, Dept Pediat, Kanagawa, Japan; Kyushu Univ, Dept Pediat, Fukuoka 812, Japan	Tokyo Women's Medical University; Waseda University; Tokyo Women's Medical University; Tokyo Women's Medical University; Osaka Medical College; Shiga University of Medical Science; Jikei University; Chiba Children's Hospital; Toho University; Kitasato University; Kyushu University	Matsuoka, R (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan.	rumiko@imcir.twmu.ac.jp		Amo, Ryunosuke/0000-0001-8644-2296; Yagi, Hisato/0000-0003-1460-4043; Razzaque, Md Abdur/0000-0002-5932-3432				ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Chan EYW, 2002, MOL CARCINOGEN, V33, P189, DOI 10.1002/mc.10031; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komoike Y, 2005, BIOCHEM BIOPH RES CO, V328, P858, DOI 10.1016/j.bbrc.2005.01.031; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Yamazaki T, 1997, J MOL CELL CARDIOL, V29, P2491, DOI 10.1006/jmcc.1997.0488; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	28	340	357	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1013	1017		10.1038/ng2078	http://dx.doi.org/10.1038/ng2078			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603482				2022-12-25	WOS:000248446900020
J	Cartolano, M; Castillo, R; Efremova, N; Kuckenberg, M; Zethof, J; Gerats, T; Schwarz-Sommer, Z; Vandenbussche, M				Cartolano, Maria; Castillo, Rosa; Efremova, Nadia; Kuckenberg, Markus; Zethof, Jan; Gerats, Tom; Schwarz-Sommer, Zsuzsanna; Vandenbussche, Michiel			A conserved microRNA module exerts homeotic control over Petunia hybrida and Antirrhinum majus floral organ identity	NATURE GENETICS			English	Article							ARABIDOPSIS; FLOWER; GENES; EXPRESSION; MORPHOGENESIS; FIMBRIATA; ELEMENTS; STYLOSA	It is commonly thought that deep phylogenetic conservation of plant microRNAs ( miRNAs) and their targets(1,2) indicates conserved regulatory functions. We show that the blind ( bl) mutant of Petunia hybrida(3) and the fistulata ( fis) mutant of Antirrhinum majus(4,5), which have similar homeotic phenotypes, are recessive alleles of two homologous miRNA- encoding genes. The BL and FIS genes control the spatial restriction of homeotic class C genes(6,7) to the inner floral whorls, but their ubiquitous early floral expression patterns are in contradiction with a potential role in patterning C gene expression. We provide genetic evidence for the unexpected function of the MIRFIS and MIRBL genes in the center of the flower and propose a dynamic mechanism underlying their regulatory role. Notably, Arabidopsis thaliana, a more distantly related species, also contains this miRNA module but does not seem to use it to confine early C gene expression to the center of the flower.	Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, D-50829 Cologne, Germany; Radboud Univ Nijmegen, Inst Wetlands & Water Res, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Schwarz-Sommer, Z (corresponding author), Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schwarzs@mpiz-koeln.mpg.de	Gerats, Tom/A-3528-2012	VANDENBUSSCHE, Michiel/0000-0002-4192-7369; Cartolano, Maria/0000-0001-9830-988X				Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Ingram GC, 1997, EMBO J, V16, P6521, DOI 10.1093/emboj/16.21.6521; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kater MM, 1998, PLANT CELL, V10, P171, DOI 10.1105/tpc.10.2.171; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; Maes T, 2001, PLANT CELL, V13, P229, DOI 10.1105/tpc.13.2.229; McSteen PCM, 1998, DEVELOPMENT, V125, P2359; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Motte P, 1998, DEVELOPMENT, V125, P71; Navarro C, 2004, DEVELOPMENT, V131, P3649, DOI 10.1242/dev.01205; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; VALLADE J, 1987, CAN J BOT, V65, P761, DOI 10.1139/b87-101; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943	28	122	146	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					901	905		10.1038/ng2056	http://dx.doi.org/10.1038/ng2056			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17589508	Green Published			2022-12-25	WOS:000247619800022
J	Koul, A; Dendouga, N; Vergauwen, K; Molenberghs, B; Vranckx, L; Willebrords, R; Ristic, Z; Lill, H; Dorange, I; Guillemont, J; Bald, D; Andries, K				Koul, Anil; Dendouga, Najoua; Vergauwen, Karen; Molenberghs, Brenda; Vranckx, Luc; Willebrords, Rudy; Ristic, Zorica; Lill, Holger; Dorange, Ismet; Guillemont, Jerome; Bald, Dirk; Andries, Koen			Diarylquinolines target subunit c of mycobacterial ATP synthase	NATURE CHEMICAL BIOLOGY			English	Article							TUBERCULOSIS; RESISTANCE; SMEGMATIS; RIFAMPIN	The diarylquinoline R207910 (TMC207) is a promising candidate in clinical development for the treatment of tuberculosis. Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compound's precise target is not known. Here we establish by genetic, biochemical and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910. Thus targeting energy metabolism is a new, promising approach for antibacterial drug discovery.	Tibotec BVBA, Dept Antimicrobial Res, B-2340 Beerse, Belgium; Vrije Univ Amsterdam, Dept Biol Struct, Inst Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; Johnson & Johnson, F-27106 Val De Reuil, France	Johnson & Johnson; Vrije Universiteit Amsterdam; Johnson & Johnson	Koul, A (corresponding author), Tibotec BVBA, Dept Antimicrobial Res, Turnhoutseweg 30, B-2340 Beerse, Belgium.	akoul@prdbe.jnj.com		Lill, H./0000-0001-9336-5428				Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; DEJONGE MR, 2007, PROTEINS; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ferrandiz MJ, 2002, FEMS MICROBIOL LETT, V212, P133, DOI 10.1111/j.1574-6968.2002.tb11256.x; Ji BH, 2006, ANTIMICROB AGENTS CH, V50, P1558, DOI 10.1128/AAC.50.4.1558-1560.2006; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Tran SL, 2005, J BACTERIOL, V187, P5023, DOI 10.1128/JB.187.14.5023-5028.2005; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105	11	390	406	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2007	3	6					323	324		10.1038/nchembio884	http://dx.doi.org/10.1038/nchembio884			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172PN	17496888				2022-12-25	WOS:000246816400010
J	Toya, M; Sato, M; Haselmann, U; Asakawa, K; Brunner, D; Antony, C; Toda, T				Toya, Mika; Sato, Masamitsu; Haselmann, Uta; Asakawa, Kazuhide; Brunner, Damian; Antony, Claude; Toda, Takashi			gamma-Tubulin complex-mediated anchoring of spindle microtubules to spindle-pole bodies requires Msd1 in fission yeast	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; ORGANIZING CENTERS; MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; INTERPHASE MICROTUBULES; CENTROSOMAL PROTEINS; RING COMPLEX; CELL-CYCLE; BODY; CHECKPOINT	The anchoring of microtubules to subcellular structures is critical for cell polarity and motility. Although the process of anchoring cytoplasmic microtubules to the centrosome has been studied in some detail(1-4), it is not known how spindle microtubules are anchored to the mitotic centrosome and, particularly, whether anchoring and nucleation of mitotic spindles are functionally separate. Here, we show that a fission yeast coiled-coil protein, Msd1, is required for anchoring the minus end of spindle microtubules to the centrosome equivalent, the spindle-pole body (SPB). msd1 deletion causes spindle microtubules to abnormally extend beyond SPBs, which results in chromosome missegregation. Importantly, this protruding spindle is phenocopied by the amino-terminal deletion mutant of Alp4, a component of the gamma-tubulin complex(5) (gamma-TuC), which lacks the potential Msd1-interacting domain. We propose that Msd1 interacts with gamma-TuC, thereby specifically anchoring the minus end of microtubules to SPBs without affecting microtubule nucleation.	Canc Res UK, Lab Cell Regulat, London Res Inst, Lincolns Inn Field Lab, London WC2A 3PX, England; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	Cancer Research UK; European Molecular Biology Laboratory (EMBL)	Toda, T (corresponding author), Canc Res UK, Lab Cell Regulat, London Res Inst, Lincolns Inn Field Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	toda@cancer.org.uk	Asakawa, Kazuhide/ABD-2065-2020; antony, claude/K-5342-2013; Brunner, Damian/F-2024-2011	Asakawa, Kazuhide/0000-0003-0628-1176; Toya, Mika/0000-0003-0999-3021; Brunner, Damian/0000-0001-5250-492X				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hagan IM, 2000, CURR TOP DEV BIOL, V49, P133; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kilmartin JV, 1996, EMBO J, V15, P4592, DOI 10.1002/j.1460-2075.1996.tb00837.x; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Krien MJE, 1998, J CELL SCI, V111, P967; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Osmani AH, 2003, MOL BIOL CELL, V14, P3169, DOI 10.1091/mbc.E02-11-0715; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Saito TT, 2005, J CELL SCI, V118, P447, DOI 10.1242/jcs.01629; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2002, CURR BIOL, V12, P141, DOI 10.1016/S0960-9822(01)00654-6; Saunders William S., 1993, Trends in Cell Biology, V3, P432, DOI 10.1016/0962-8924(93)90032-V; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tanaka K, 2005, CURR BIOL, V15, P1479, DOI 10.1016/j.cub.2005.07.058; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yoder TJ, 2005, MOL BIOL CELL, V16, P141, DOI 10.1091/mbc.E04-08-0703; Zimmerman S, 2004, DEV CELL, V6, P497, DOI 10.1016/S1534-5807(04)00096-6	43	44	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					646	U55		10.1038/ncb1593	http://dx.doi.org/10.1038/ncb1593			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486116				2022-12-25	WOS:000246922700009
J	Nakai, A; Yamaguchi, O; Takeda, T; Higuchi, Y; Hikoso, S; Taniike, M; Omiya, S; Mizote, I; Matsumura, Y; Asahi, M; Nishida, K; Hori, M; Mizushima, N; Otsu, K				Nakai, Atsuko; Yamaguchi, Osamu; Takeda, Toshihiro; Higuchi, Yoshiharu; Hikoso, Shungo; Taniike, Masayuki; Omiya, Shigemiki; Mizote, Isamu; Matsumura, Yasushi; Asahi, Michio; Nishida, Kazuhiko; Hori, Masatsugu; Mizushima, Noboru; Otsu, Kinya			The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress	NATURE MEDICINE			English	Article							CELLULAR AUTOPHAGY; APOPTOSIS; MICE; DEATH; CARDIOMYOPATHY; INHIBITION; PROTEIN; CELLS; HYPERTROPHY; DISEASE	Autophagy, an evolutionarily conserved process for the bulk degradation of cytoplasmic components, serves as a cell survival mechanism in starving cells(1,2). Although altered autophagy has been observed in various heart diseases, including cardiac hypertrophy(3,4) and heart failure(5,6), it remains unclear whether autophagy plays a beneficial or detrimental role in the heart. Here, we report that the cardiac-specific loss of autophagy causes cardiomyopathy in mice. In adult mice, temporally controlled cardiac-specific deficiency of Atg5 (autophagy-related 5), a protein required for autophagy, led to cardiac hypertrophy, left ventricular dilatation and contractile dysfunction, accompanied by increased levels of ubiquitination. Furthermore, Atg5-deficient hearts showed disorganized sarcomere structure and mitochondrial misalignment and aggregation. On the other hand, cardiac-specific deficiency of Atg5 early in cardiogenesis showed no such cardiac phenotypes under baseline conditions, but developed cardiac dysfunction and left ventricular dilatation one week after treatment with pressure overload. These results indicate that constitutive autophagy in the heart under baseline conditions is a homeostatic mechanism for maintaining cardiomyocyte size and global cardiac structure and function, and that upregulation of autophagy in failing hearts is an adaptive response for protecting cells from hemodynamic stress.	Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Med Informat Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Otsu, K (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kotsu@medone.med.osaka-u.ac.jp	Hikoso, Shungo/R-4281-2018; Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Hikoso, Shungo/0000-0003-2284-1970; Yamaguchi, Osamu/0000-0002-7461-369X				Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962; DECKER RS, 1980, AM J PATHOL, V98, P425; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	30	1167	1225	2	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2007	13	5					619	624		10.1038/nm1574	http://dx.doi.org/10.1038/nm1574			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17450150				2022-12-25	WOS:000246302800030
J	Xiong, QJ; Sun, HY; Li, M				Xiong, Qiaojie; Sun, Haiyan; Li, Min			Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants	NATURE CHEMICAL BIOLOGY			English	Article							KCNQ2/KCNQ3 K+ CHANNELS; ANTICONVULSANT RETIGABINE; ION CHANNELS; GIANT AXONS; EPILEPSY; MUTATION; D-23129; SENSOR; GENE; CONDUCTANCE	KCNQ potassium channels are activated by changes in transmembrane voltage and play an important role in controlling electrical excitability. Human mutations of KCNQ2 and KCNQ3 potassium channel genes result in reduction or loss of channel activity and cause benign familial neonatal convulsions ( BFNCs). Thus, small molecules capable of augmenting KCNQ currents are essential both for understanding the mechanism of channel activity and for developing therapeutics. We performed a high- throughput screen in search for agonistic compounds potentiating KCNQ potassium channels. Here we report identification of a new opener, zinc pyrithione ( 1), which activates both recombinant and native KCNQ M currents. Interactions with the channel protein cause an increase of single- channel open probability that could fully account for the overall conductance increase. Separate point mutations have been identified that either shift the concentration dependence or affect potentiation efficacy, thereby providing evidence for residues influencing ligand binding and downstream events. Furthermore, zinc pyrithione is capable of rescuing the mutant channels causal to BFNCs.	Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA.	minli@jhmi.edu		Xiong, Qiaojie/0000-0002-9221-860X	NIGMS NIH HHS [GM70959] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070959] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; BARNETT BL, 1977, INORG CHEM, V16, P1834, DOI 10.1021/ic50174a002; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bond AD, 2001, MOL CRYST LIQ CRYST, V356, P305, DOI 10.1080/10587250108023710; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; Dedek K, 2001, P NATL ACAD SCI USA, V98, P12272, DOI 10.1073/pnas.211431298; FLISS H, 2002, Patent No. 6495538; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Huang CC, 1996, BIOCHEMISTRY-US, V35, P3439, DOI 10.1021/bi9526692; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; KIMURA E, 2004, SCI STKE; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; MARKS R, 1985, BRIT J DERMATOL, V112, P415, DOI 10.1111/j.1365-2133.1985.tb02314.x; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Rostock A, 1996, EPILEPSY RES, V23, P211, DOI 10.1016/0920-1211(95)00101-8; Rundfeldt C, 1997, EUR J PHARMACOL, V336, P243, DOI 10.1016/S0014-2999(97)01249-1; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Sun HY, 2004, P NATL ACAD SCI USA, V101, P16964, DOI 10.1073/pnas.0404178101; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Terstappen GC, 1999, ANAL BIOCHEM, V272, P149, DOI 10.1006/abio.1999.4179; Tober C, 1996, EUR J PHARMACOL, V303, P163, DOI 10.1016/0014-2999(96)00073-8; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; WANG DW, 2003, RYIONG HUAXUE GONGYE, V33, P340; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; XU J, 2004, TARGETS, V3, P32	55	87	90	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2007	3	5					287	296		10.1038/nchembio874	http://dx.doi.org/10.1038/nchembio874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159FP	17435769				2022-12-25	WOS:000245851100013
J	Liu, QYP; Sulzenbacher, G; Yuan, HP; Bennett, EP; Pietz, G; Saunders, K; Spence, J; Nudelman, E; Levery, SB; White, T; Neveu, JM; Lane, WS; Bourne, Y; Olsson, ML; Henrissat, B; Clausen, H				Liu, Qiyong P.; Sulzenbacher, Gerlind; Yuan, Huaiping; Bennett, Eric P.; Pietz, Greg; Saunders, Kristen; Spence, Jean; Nudelman, Edward; Levery, Steven B.; White, Thayer; Neveu, John M.; Lane, William S.; Bourne, Yves; Olsson, Martin L.; Henrissat, Bernard; Clausen, Henrik			Bacterial glycosidases for the production of universal red blood cells	NATURE BIOTECHNOLOGY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; GROUP-B ERYTHROCYTES; TYPE-3 CHAIN-H; GROUP-A; HYDROLYSIS; EXPRESSION; GALACTOSIDASE; ANTIGENS; CLONING; SEROCONVERSION	Enzymatic removal of blood group ABO antigens to develop universal red blood cells ( RBCs) was a pioneering vision originally proposed more than 25 years ago. Although the feasibility of this approach was demonstrated in clinical trials for group B RBCs, a major obstacle in translating this technology to clinical practice has been the lack of efficient glycosidase enzymes. Here we report two bacterial glycosidase gene families that provide enzymes capable of efficient removal of A and B antigens at neutral pH with low consumption of recombinant enzymes. The crystal structure of a member of the alpha-N-acetylgalactosaminidase family reveals an unusual catalytic mechanism involving NAD(+). The enzymatic conversion processes we describe hold promise for achieving the goal of producing universal RBCs, which would improve the blood supply while enhancing the safety of clinical transfusions.	Univ Aix Marseille 1, CNRS, UMR 6098, F-13288 Marseille 9, France; Univ Aix Marseille 2, F-13284 Marseille 9, France; ZymeQuest Inc, Beverly, MA 01915 USA; Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Dept Oral Diag, DK-2200 Copenhagen N, Denmark; Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Lund Univ, Dept Lab Med, Div Hemtol & Transfus Med, SE-221185 Lund, Sweden; Univ Lund Hosp, Blood Ctr, SE-221185 Lund, Sweden; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen; University of Copenhagen; University System Of New Hampshire; University of New Hampshire; Harvard University; Lund University; Lund University; Skane University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sulzenbacher, G (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6098, Case 932,163 Ave Luminy, F-13288 Marseille 9, France.	gerlind.sulzenbacher@afmb.univ-mrs.fr	clausen, henrik/AAD-8016-2021; Henrissat, Bernard/J-2475-2012; Sulzenbacher, Gerlind/A-6801-2018; Bennett, Eric/AAG-6120-2020; Bourne, Yves/AAC-4635-2022	Henrissat, Bernard/0000-0002-3434-8588; Sulzenbacher, Gerlind/0000-0003-4844-2820; Bennett, Eric/0000-0002-4976-0647; Bourne, Yves/0000-0003-3850-0548; Clausen, Henrik/0000-0002-0915-5055; Olsson, Martin L/0000-0003-1647-9610				AABB, 2005, TECHNICAL MANUAL, V15th, P535; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakunina IY, 2002, BIOCHEMISTRY-MOSCOW+, V67, P689, DOI 10.1023/A:1016106623655; Bakunina IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1209; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; CLAUSEN H, 1986, J BIOL CHEM, V261, P1380; CLAUSEN H, 1986, J BIOL CHEM, V261, P1388; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Davis MO, 1996, BIOCHEM MOL BIOL INT, V39, P471; GOLDSTEIN J, 1989, VOX SANG, V57, P142, DOI 10.1111/j.1423-0410.1989.tb01152.x; GOLDSTEIN J, 1982, SCIENCE, V215, P168, DOI 10.1126/science.6274021; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hsin-Yeh H, 2005, ARTIF CELL BLOOD SUB, V33, P187, DOI 10.1081/BIO-200055904; Ishikura H, 2003, J MED MICROBIOL, V52, P1101, DOI 10.1099/jmm.0.05349-0; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kruskall MS, 2000, TRANSFUSION, V40, P1290, DOI 10.1046/j.1537-2995.2000.40111290.x; LANDRY D, 2002, Patent No. 6458525; Landsteiner K, 2001, WIEN KLIN WOCHENSCHR, V113, P768; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsson ML, 2004, TRANSFUS CLIN BIOL, V11, P33, DOI 10.1016/j.tracli.2003.12.002; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pikis A, 2002, MICROBIOL-SGM, V148, P843, DOI 10.1099/00221287-148-3-843; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sazama K, 2003, Curr Hematol Rep, V2, P518; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Stainsby D, 2005, SERIOUS HAZARDS TRAN; Varrot A, 2005, J MOL BIOL, V346, P423, DOI 10.1016/j.jmb.2004.11.058; Vosnidou NC, 1998, BIOCHEM MOL BIOL INT, V46, P175; Watkins W M, 1980, Adv Hum Genet, V10, P1; Watkins W.M., 1980, ADV HUM GENET, V10, P379; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yip VLY, 2006, ANGEW CHEM INT EDIT, V45, P6179, DOI 10.1002/anie.200601421; Yip VLY, 2006, BIOCHEMISTRY-US, V45, P571, DOI 10.1021/bi052054x; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; Zhu A, 1996, PROTEIN EXPRES PURIF, V8, P456, DOI 10.1006/prep.1996.0124; Zhu A, 1996, ARCH BIOCHEM BIOPHYS, V327, P324, DOI 10.1006/abbi.1996.0129	47	183	230	4	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					454	464		10.1038/nbt1298	http://dx.doi.org/10.1038/nbt1298			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17401360				2022-12-25	WOS:000245651800027
J	Cohen, MS; Hadjivassiliou, H; Taunton, J				Cohen, Michael S.; Hadjivassiliou, Haralambos; Taunton, Jack			A clickable inhibitor reveals context-dependent autoactivation of p90 RSK	NATURE CHEMICAL BIOLOGY			English	Article							RIBOSOMAL S6 KINASE; IN-VIVO; PROTEIN-KINASE; DOCKING SITE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; CHEMISTRY; STRATEGY; DOMAINS	p90 ribosomal protein S6 kinases (RSKs) integrate upstream signals through two catalytic domains. Autophosphorylation of Ser386 by the regulatory C-terminal kinase domain (CTD) is thought to be essential for activation of the N-terminal kinase domain (NTD), which phosphorylates multiple downstream targets1. We recently reported fmk, an irreversible inhibitor of the CTD of RSK1 and RSK2(2). Here we describe fmk-pa, a propargylamine variant that has improved cellular potency and a 'clickable' tag for assessing the extent and selectivity of covalent RSK modification. Copper-catalyzed conjugation of an azidoalkyl reporter (the click reaction) revealed that fmk-pa achieves selective and saturable modification of endogenous RSK1 and RSK2 in mammalian cells. Saturating concentrations of fmk-pa inhibited Ser386 phosphorylation and downstream signaling in response to phorbol ester stimulation, but had no effect on RSK activation by lipopolysaccharide. RSK autoactivation by the CTD is therefore context dependent, which suggests that NTD and CTD inhibitors should have distinct physiological effects.	Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94158 USA; Cornell Univ, Weill Med Coll, Dept Mol & Cellular Pharmacol, New York, NY 10021 USA	Cornell University; University of California System; University of California San Francisco; Cornell University	Taunton, J (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	taunton@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071434-04, GM71434, R01 GM071434] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Itoh S, 2006, CIRCULATION, V113, P1787, DOI 10.1161/CIRCULATIONAHA.105.578278; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Ovaa H, 2003, ANGEW CHEM INT EDIT, V42, P3626, DOI 10.1002/anie.200351314; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Vocadlo DJ, 2004, ANGEW CHEM INT EDIT, V43, P5338, DOI 10.1002/anie.200454235; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370	30	126	128	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2007	3	3					156	160		10.1038/nchembio859	http://dx.doi.org/10.1038/nchembio859			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	138BD	17259979	Green Accepted			2022-12-25	WOS:000244336600011
J	Heintzman, ND; Stuart, RK; Hon, G; Fu, YT; Ching, CW; Hawkins, RD; Barrera, LO; Van Calcar, S; Qu, CX; Ching, KA; Wang, W; Weng, ZP; Green, RD; Crawford, GE; Ren, B				Heintzman, Nathaniel D.; Stuart, Rhona K.; Hon, Gary; Fu, Yutao; Ching, Christina W.; Hawkins, R. David; Barrera, Leah O.; Van Calcar, Sara; Qu, Chunxu; Ching, Keith A.; Wang, Wei; Weng, Zhiping; Green, Roland D.; Crawford, Gregory E.; Ren, Bing			Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome	NATURE GENETICS			English	Article							SYSTEMIC CARNITINE DEFICIENCY; HISTONE MODIFICATIONS; WIDE ANALYSIS; MOLECULAR-CLONING; TRANSPORTER OCTN2; GENE-EXPRESSION; CODE; ORGANIZATION; ACETYLATION; ACTIVATION	Eukaryotic gene transcription is accompanied by acetylation and methylation of nucleosomes near promoters, but the locations and roles of histone modifications elsewhere in the genome remain unclear. We determined the chromatin modification states in high resolution along 30 Mb of the human genome and found that active promoters are marked by trimethylation of Lys4 of histone H3 (H3K4), whereas enhancers are marked by monomethylation, but not trimethylation, of H3K4. We developed computational algorithms using these distinct chromatin signatures to identify new regulatory elements, predicting over 200 promoters and 400 enhancers within the 30-Mb region. This approach accurately predicted the location and function of independently identified regulatory elements with high sensitivity and specificity and uncovered a novel functional enhancer for the carnitine transporter SLC22A5 (OCTN2). Our results give insight into the connections between chromatin modifications and transcriptional regulatory activity and provide a new tool for the functional annotation of the human genome.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Program Bioinformat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Pediat, Durham, NC 27708 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; University of California System; University of California San Diego; Boston University; Roche Holding; Roche NimbleGen; Duke University; Duke University	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Stuart, Rhona/0000-0001-5916-9693; Soriaga, Leah/0000-0001-5852-741X				Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; Sekine T, 1998, BIOCHEM BIOPH RES CO, V251, P586, DOI 10.1006/bbrc.1998.9521; Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669	35	2325	2369	5	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					311	318		10.1038/ng1966	http://dx.doi.org/10.1038/ng1966			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277777				2022-12-25	WOS:000244480000012
J	Cortina, C; Palomo-Ponce, S; Iglesias, M; Fernandez-Masip, JL; Vivancos, A; Whissell, G; Huma, M; Peiro, N; Gallego, L; Jonkheer, S; Davy, A; Lloreta, J; Sancho, E; Batlle, E				Cortina, Carme; Palomo-Ponce, Sergio; Iglesias, Mar; Fernandez-Masip, Juan Luis; Vivancos, Ana; Whissell, Gavin; Huma, Mireia; Peiro, Nerea; Gallego, Lourdes; Jonkheer, Suzanne; Davy, Alice; Lloreta, Josep; Sancho, Elena; Batlle, Eduard			EphB ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells	NATURE GENETICS			English	Article							EXPRESSION; RECEPTORS; EPHB/EPHRINB; EPITHELIUM; MICE	The genes encoding tyrosine kinase receptors EphB2 and EphB3 are beta-catenin and Tcf4 target genes in colorectal cancer (CRC) and in normal intestinal cells(1,2). In the intestinal epithelium, EphB signaling controls the positioning of cell types along the crypt-villus axis(1). In CRC, EphB activity suppresses tumor progression beyond the earliest stages(3,4). Here we show that EphB receptors compartmentalize the expansion of CRC cells through a mechanism dependent on E-cadherin-mediated adhesion. We demonstrate that EphB-mediated compartmentalization restricts the spreading of EphB-expressing tumor cells into ephrin-B1-positive territories in vitro and in vivo. Our results indicate that CRC cells must silence EphB expression to avoid repulsive interactions imposed by normal ephrin-B1-expressing intestinal cells at the onset of tumorigenesis.	Inst Res Biomed IRB, Oncol Programme, Glassboro, NJ 08028 USA; Univ Autonoma Barcelona, Hosp Univ Mar, Dept Pathol, E-08193 Barcelona, Spain; UPS, CNRS, Ctr Dev Biol, F-31062 Toulouse, France	Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batlle, E (corresponding author), Inst Res Biomed IRB, Oncol Programme, Josep Samitier 1 5, Glassboro, NJ 08028 USA.	eduard.batlle@irbbarcelona.org	Lloreta-Trull, Josep/GRR-9682-2022; Vivancos, Ana/AAG-8331-2019; Lloreta-Trull, Josep/AAZ-1229-2020; Cortina Duran, Carme/K-7203-2017; Sancho, Elena/ABH-4867-2020; Batlle, Eduard/K-8080-2014; Palomo-Ponce, Sergio/L-2749-2017; Lloreta, J/I-2112-2014	Vivancos, Ana/0000-0003-2888-6512; Cortina Duran, Carme/0000-0003-3477-4322; Sancho, Elena/0000-0002-8182-513X; Batlle, Eduard/0000-0003-2422-0326; Palomo-Ponce, Sergio/0000-0002-3371-6457; Lloreta, J/0000-0003-1644-9470				Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Oshima H, 1997, CANCER RES, V57, P1644; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Taketo MM, 2006, CANCER SCI, V97, P355, DOI 10.1111/j.1349-7006.2006.00190.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yamada Y, 2002, CANCER RES, V62, P6367	21	208	212	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1376	1383		10.1038/ng.2007.11	http://dx.doi.org/10.1038/ng.2007.11			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906625				2022-12-25	WOS:000250575900022
J	Bi, YM; Ehirchiou, D; Kilts, TM; Inkson, CA; Embree, MC; Sonoyama, W; Li, L; Leet, AI; Seo, BM; Zhang, L; Shi, ST; Young, MF				Bi, Yanming; Ehirchiou, Driss; Kilts, Tina M.; Inkson, Colette A.; Embree, Mildred C.; Sonoyama, Wataru; Li, Li; Leet, Arabella I.; Seo, Byoung-Moo; Zhang, Li; Shi, Songtao; Young, Marian F.			Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche	NATURE MEDICINE			English	Article							MARROW STROMAL FIBROBLASTS; MESENCHYMAL STEM-CELLS; LABEL-RETAINING CELLS; HUMAN BONE-MARROW; IN-VITRO; PROGENITOR CELLS; MONOCLONAL-ANTIBODY; DEFICIENT MICE; TENASCIN-C; MOUSE	The repair of injured tendons remains a great challenge, largely owing to a lack of in- depth characterization of tendon cells and their precursors. We show that human and mouse tendons harbor a unique cell population, termed tendon stem/ progenitor cells ( TSPCs), that has universal stem cell characteristics such as clonogenicity, multipotency and self- renewal capacity. The isolated TSPCs could regenerate tendon- like tissues after extended expansion in vitro and transplantation in vivo. Moreover, we show that TSPCs reside within a unique niche predominantly comprised of an extracellular matrix, and we identify biglycan ( Bgn) and fibromodulin ( Fmod) as two critical components that organize this niche. Depletion of Bgn and Fmod affects the differentiation of TSPCs by modulating bone morphogenetic protein signaling and impairs tendon formation in vivo. Our results, while offering new insights into the biology of tendon cells, may assist in future strategies to treat tendon diseases.	Natl Inst Dental & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Dept Physiol, Baltimore, MD 21201 USA; Johns Hopkins Univ, Div Pediat Orthopaed, Baltimore, MD 21287 USA; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; University of Southern California	Young, MF (corresponding author), Natl Inst Dental & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, 30 Convent Dr 30-225 MSC 4320, Bethesda, MD 20892 USA.	songtaos@usc.edu; myoung@dir.nidcr.nih.gov	Mordwinkin, Nicholas M/A-4347-2010; Sonoyama, Wataru/B-2160-2011	Inkson, Colette/0000-0003-1215-312X; Young, Marian F/0000-0003-0929-8854	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL61589-01, R01 HL061589] Funding Source: Medline; NIAID NIH HHS [R21 AI078365] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000379] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Brandau O, 2001, DEV DYNAM, V221, P72, DOI 10.1002/dvdy.1126; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DEMOS M, 2007, DISORD, V8, P16; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Fenwick S, 2002, RHEUMATOLOGY, V41, pA474, DOI 10.1093/rheumatology/41.4.474; Filshie RJA, 1998, LEUKEMIA, V12, P414, DOI 10.1038/sj.leu.2400922; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Krause DS, 2002, ONCOGENE, V21, P3262, DOI 10.1038/sj.onc.1205316; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Ohta M, 1998, BLOOD, V91, P4074; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; SIMMONS PJ, 1991, BLOOD, V78, P55; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; VANVLASSELAER P, 1994, BLOOD, V84, P753, DOI 10.1182/blood.V84.3.753.bloodjournal843753; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	50	928	1002	10	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1219	1227		10.1038/nm1630	http://dx.doi.org/10.1038/nm1630			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17828274				2022-12-25	WOS:000249980200038
J	Mi, S; Hu, B; Hahm, KM; Luo, Y; Hui, ESK; Yuan, QJ; Wong, WM; Wang, L; Su, HX; Chu, TH; Guo, JS; Zhang, WM; So, KF; Pepinsky, B; Shao, ZH; Graff, C; Garber, E; Jung, V; Wu, EX; Wu, W				Mi, Sha; Hu, Bing; Hahm, Kyungmin; Luo, Yi; Hui, Edward Sai Kam; Yuan, Qiuju; Wong, Wai Man; Wang, Li; Su, Huanxing; Chu, Tak-Ho; Guo, Jiasong; Zhang, Wenming; So, Kwok-Fai; Pepinsky, Blake; Shao, Zhaohui; Graff, Christilyn; Garber, Ellen; Jung, Vincent; Wu, Ed Xuekui; Wu, Wutian			LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis	NATURE MEDICINE			English	Article							DIFFUSION-TENSOR MRI; MULTIPLE-SCLEROSIS; MODEL; DEMYELINATION; MYELINATION; RECOVERY; LESIONS	Demyelinating diseases, such as multiple sclerosis, are characterized by the loss of the myelin sheath around neurons, owing to inflammation and gliosis in the central nervous system ( CNS). Current treatments therefore target anti- inflammatory mechanisms to impede or slow disease progression. The identification of a means to enhance axon myelination would present new therapeutic approaches to inhibit and possibly reverse disease progression. Previously, LRR and Ig domain - containing, Nogo receptor interacting protein ( LINGO- 1) has been identified as an in vitro and in vivo negative regulator of oligodendrocyte differentiation and myelination. Here we show that loss of LINGO- 1 function by Lingo1 gene knockout or by treatment with an antibody antagonist of LINGO- 1 function leads to functional recovery from experimental autoimmune encephalomyelitis. This is reflected biologically by improved axonal integrity, as confirmed by magnetic resonance diffusion tensor imaging, and by newly formed myelin sheaths, as determined by electron microscopy. Antagonism of LINGO- 1 or its pathway is therefore a promising approach for the treatment of demyelinating diseases of the CNS.	Biogen Idec Inc, Cambridge, MA 02142 USA; Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, Fac Engn, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China	Biogen; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Mi, S (corresponding author), Biogen Idec Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com; wtwu@hkucc.hku.hk	Messier, Claude/A-2322-2008; Chu, Tak Ho/C-4153-2009; Wu, Ed/C-1579-2009; Yuan, Qiuju/AAJ-3101-2020; hu, bing/B-1030-2010; Su, Huanxing/X-3980-2019; Guo, Jiasong/I-2206-2019; Su, Huanxing/X-3954-2019; Hui, Edward/GQO-9176-2022; Chu, Tak-Ho/AAB-4608-2021	Messier, Claude/0000-0002-4791-1763; Wu, Ed/0000-0001-5581-1546; hu, bing/0000-0001-8627-5272; Su, Huanxing/0000-0002-0513-4943; Guo, Jiasong/0000-0002-7885-2903; Su, Huanxing/0000-0003-3254-825X; Chu, Tak-Ho/0000-0002-3123-207X; Hui, Sai Kam/0000-0002-1761-0169; So, Kwok-Fai/0000-0003-4039-4246				Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Diem R, 2005, BRAIN, V128, P375, DOI 10.1093/brain/awh365; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; EAGER KB, 1983, J IMMUNOL METHODS, V64, P157, DOI 10.1016/0022-1759(83)90394-0; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 1997, GLIA, V19, P104, DOI 10.1002/(SICI)1098-1136(199702)19:2<104::AID-GLIA2>3.3.CO;2-R; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lubetzki C, 2005, CURR OPIN NEUROL, V18, P237, DOI 10.1097/01.wco.0000169739.83793.e0; LUDWIN SK, 1981, ANN NEUROL, V9, P301; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Noseworthy JH, 1999, CURR OPIN NEUROL, V12, P279, DOI 10.1097/00019052-199906000-00007; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; WEKERLE H, 1994, ANN NEUROL, V36, P47; WU WT, 1993, EXP NEUROL, V122, P88, DOI 10.1006/exnr.1993.1110; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	24	389	416	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1228	1233		10.1038/nm1664	http://dx.doi.org/10.1038/nm1664			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17906634				2022-12-25	WOS:000249980200039
J	Gregory, SG; Schmidt, S; Seth, P; Oksenberg, JR; Hart, J; Prokop, A; Caillier, SJ; Ban, M; Goris, A; Barcellos, LF; Lincoln, R; McCauley, JL; Sawcer, SJ; Compston, DAS; Dubois, B; Hauser, SL; Garcia-Blanco, MA; Pericak-Vance, MA; Haines, JL				Gregory, Simon G.; Schmidt, Silke; Seth, Puneet; Oksenberg, Jorge R.; Hart, John; Prokop, Angela; Caillier, Stacy J.; Ban, Maria; Goris, An; Barcellos, Lisa F.; Lincoln, Robin; McCauley, Jacob L.; Sawcer, Stephen J.; Compston, D. A. S.; Dubois, Benedicte; Hauser, Stephen L.; Garcia-Blanco, Mariano A.; Pericak-Vance, Margaret A.; Haines, Jonathan L.		Multiple Sclerosis Genetics Grp	Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; THYMIC STROMAL LYMPHOPOIETIN; FAMILY-BASED TESTS; GENE-EXPRESSION; LINKAGE DISEQUILIBRIUM; DISEASE; IDENTIFICATION; RISK; SUSCEPTIBILITY; HOMEOSTASIS	Multiple sclerosis is a demyelinating neurodegenerative disease with a strong genetic component. Previous genetic risk studies have failed to identify consistently linked regions or genes outside of the major histocompatibility complex on chromosome 6p. We describe allelic association of a polymorphism in the gene encoding the interleukin 7 receptor a chain ( IL7R) as a significant risk factor for multiple sclerosis in four independent family- based or case- control data sets ( overall P 2.9 x 10(-7)). Further, the likely causal SNP, rs6897932, located within the alternatively spliced exon 6 of IL7R, has a functional effect on gene expression. The SNP influences the amount of soluble and membrane- bound isoforms of the protein by putatively disrupting an exonic splicing silencer.	Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Katholieke Univ Leuven, Sect Expt Neurol, B-3000 Louvain, Belgium; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Miami, Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA	Vanderbilt University; Duke University; Duke University; Duke University; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; KU Leuven; University of California System; University of California Berkeley; University of Miami	Haines, JL (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37232 USA.	MPericak@med.miami.edu; jonathan@chgr.mc.vanderbilt.edu	Goris, An/F-2943-2010; Haines, Jonathan/C-3374-2012; Goris, An/L-5852-2019; Hauser, Stephen L/J-2978-2016; Dubois, Benedicte/A-4338-2019	Goris, An/0000-0002-1276-6682; Haines, Jonathan/0000-0002-4351-4728; Goris, An/0000-0002-1276-6682; Gregory, Simon/0000-0002-7805-1743; Dubois, Benedicte/0000-0003-0604-8702	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477, R01NS032830] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Baraniak AP, 2003, MOL CELL BIOL, V23, P9327, DOI 10.1128/MCB.23.24.9327-9337.2003; Barcellos LF, 2004, ANN NEUROL, V55, P793, DOI 10.1002/ana.20092; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Fernald GH, 2005, J NEUROIMMUNOL, V167, P157, DOI 10.1016/j.jneuroim.2005.06.032; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Giedraitis V, 2003, GENES IMMUN, V4, P559, DOI 10.1038/sj.gene.6364024; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Huston DP, 2006, CURR ALLERGY ASTHM R, V6, P372, DOI 10.1007/s11882-996-0006-7; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Malmestrom C, 2006, J NEUROIMMUNOL, V175, P176, DOI 10.1016/j.jneuroim.2006.03.004; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Schmidt S, 2006, GENES IMMUN, V7, P384, DOI 10.1038/sj.gene.6364311; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Traggiai E, 2001, J NEUROIMMUNOL, V121, P111, DOI 10.1016/S0165-5728(01)00433-7; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	50	474	489	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1083	1091		10.1038/ng2103	http://dx.doi.org/10.1038/ng2103			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660817				2022-12-25	WOS:000249122400017
J	Tanno, T; Bhanu, NV; Oneal, PA; Goh, SH; Staker, P; Lee, YT; Moroney, JW; Reed, CH; Luban, NLC; Wang, RH; Eling, TE; Childs, R; Ganz, T; Leitman, SF; Fucharoen, S; Miller, JL				Tanno, Toshihiko; Bhanu, Natarajan V.; Oneal, Patricia A.; Goh, Sung-Ho; Staker, Pamela; Lee, Y. Terry; Moroney, John W.; Reed, Christopher H.; Luban, Naomi L. C.; Wang, Rui-Hong; Eling, Thomas E.; Childs, Richard; Ganz, Tomas; Leitman, Susan F.; Fucharoen, Suthat; Miller, Jeffery L.			High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin	NATURE MEDICINE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; FACTOR-BETA SUPERFAMILY; SERUM; ERYTHROPOIESIS; METABOLISM; ABSORPTION	In thalassemia, deficient globin-chain production during erythropoiesis results in anemia(1-3). Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death(4). Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism(5). To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.	NIDDK, Mol Med Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; Natl Naval Med Ctr, Dept Obstet & Gynecol, Bethesda, MD 20889 USA; Childrens Natl Med Ctr, Lab Med Pathol, Washington, DC 20010 USA; NIDDK, Genet Dev & Dis Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; NHLBI, Hematol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Pathol & Med, Los Angeles, CA 90095 USA; Natl Inst Hlth, Dept Transfus Med, Bethesda, MD 20892 USA; Mahidol Univ, Inst Sci & Technol Res & Dev, Thalassemia Res Ctr, Phuttamonthon 73170, Nakornpathom, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Walter Reed National Military Medical Center; Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; Mahidol University	Miller, JL (corresponding author), NIDDK, Mol Med Branch, Natl Inst Hlth, 10 Ctr Dr, Bethesda, MD 20892 USA.	jm7f@nih.gov	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Ganz, Tomas/0000-0002-2830-5469	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, Z01HL002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK025094, Z01DK025100, ZIADK025095, ZIADK025100, ZIADK025094, Z01DK025095, Z01DK025099, ZIADK025099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES010016, ZIAES010016] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kearney SL, 2007, PEDIATR BLOOD CANCER, V48, P57, DOI 10.1002/pbc.20616; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Millard KN, 2004, GUT, V53, P655, DOI 10.1136/gut.2003.031153; NATHAN DG, 1964, MEDICINE, V43, P779, DOI 10.1097/00005792-196411000-00021; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; RAO KRP, 1984, J LAB CLIN MED, V103, P792; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Sritippayawan S, 2005, ASIAN PAC J ALLERGY, V23, P121; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Weizer-Stern O, 2006, BRIT J HAEMATOL, V135, P129, DOI 10.1111/j.1365-2141.2006.06258.x; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yang H, 2003, MOL CANCER THER, V2, P1023	30	624	655	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1096	1101		10.1038/nm1629	http://dx.doi.org/10.1038/nm1629			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17721544				2022-12-25	WOS:000249353100037
J	Yang, H; Bell, TA; Churchill, GA; de Villena, FPM				Yang, Hyuna; Bell, Timothy A.; Churchill, Gary A.; de Villena, Fernando Pardo-Manuel			On the subspecific origin of the laboratory mouse	NATURE GENETICS			English	Article							MUS-MUSCULUS-MOLOSSINUS; INBRED STRAINS; HOUSE MOUSE; MITOCHONDRIAL-DNA; GENETIC-VARIATION; Y-CHROMOSOME; REPRODUCTIVE ISOLATION; INTELLECTUAL HISTORY; HAPLOTYPE DIVERSITY; COMPLEX TRAITS	The genome of the laboratory mouse is thought to be a mosaic of regions with distinct subspecific origins. We have developed a high- resolution map of the origin of the laboratory mouse by generating 25,400 phylogenetic trees at 100- kb intervals spanning the genome. On average, 92% of the genome is of Mus musculus domesticus origin, and the distribution of diversity is markedly nonrandom among the chromosomes. There are large regions of extremely low diversity, which represent blind spots for studies of natural variation and complex traits, and hot spots of diversity. In contrast with the mosaic model, we found that most of the genome has intermediate levels of variation of intrasubspecific origin. Finally, mouse strains derived from the wild that are supposed to represent different mouse subspecies show substantial intersubspecific introgression, which has strong implications for evolutionary studies that assume these are pure representatives of a given subspecies.	Univ N Carolina, Dept Genet, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA.	fernando@med.unc.edu	Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NIGMS NIH HHS [1P50 GM076468] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2004, GENOME RES, V14, P2439, DOI 10.1101/gr.2899304; AUFFRAY JC, 1990, BIOL J LINN SOC, V41, P13, DOI 10.1111/j.1095-8312.1990.tb00818.x; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; Boissinot S, 1997, GENETICS, V146, P1019; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Bonhomme F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r80; Boursot P, 2006, GENOME RES, V16, P1191, DOI 10.1101/gr.5541806; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920; Din W, 1996, J EVOLUTION BIOL, V9, P519, DOI 10.1046/j.1420-9101.1996.9050519.x; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Harr B, 2006, GENOME RES, V16, P1193, DOI 10.1101/gr.5787706; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; LYON MF, 1996, GENETIC VARIANTS STR; NAGAMINE CM, 1992, MAMM GENOME, V3, P84, DOI 10.1007/BF00431251; Oka A, 2007, GENETICS, V175, P185, DOI 10.1534/genetics.106.062976; Paigen K, 2003, GENETICS, V163, P1227; Paigen K, 2003, GENETICS, V163, P1; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Payseur BA, 2005, GENETICS, V171, P1905, DOI 10.1534/genetics.105.046193; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Prager EM, 1998, GENETICS, V150, P835; Sakai T, 2005, MAMM GENOME, V16, P11, DOI 10.1007/s00344-004-3013-9; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Trachtulec Z, 2005, BIOL J LINN SOC, V84, P637, DOI 10.1111/j.1095-8312.2005.00460.x; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	44	235	239	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1100	1107		10.1038/ng2087	http://dx.doi.org/10.1038/ng2087			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660819				2022-12-25	WOS:000249122400019
J	Song, H; Hollstein, M; Xu, Y				Song, Hoseok; Hollstein, Monica; Xu, Yang			P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; TARGETED DISRUPTION; THYMIC LYMPHOMA; HISTONE H2AX; MOUSE; ACTIVATION; MUTATIONS; RESPONSES	Tp53 is the most commonly mutated tumour- suppressor gene in human cancers(1). In addition to the loss of tumour-suppression function, some missense mutants gain novel oncogenic activities(2). To elucidate the nature of the gain of function, we introduced the most common p53 cancer mutations (R248W and R273H) independently into the humanized p53 knock-in (HUPKI) allele in mice. Tumour-suppressor functions of p53 are abolished in p53-mutant mice. Several lines of evidence further indicate gain-of-function of p53 mutants in promoting tumorigenesis. p53(R248W) mice rapidly succumb to certain types of cancers not commonly observed in p53(-/-) mice. Interchromosomal translocations, a type of genetic instability rarely observed in p53(-/-)-cells, are readily detectable in p53-mutant pre- tumor thymocytes. Although normal in p53(-/-) mouse cells, the G2-M checkpoint is impaired in p53-mutant cells after DNA damage. These acquired oncogenic properties of mutant p53 could be explained by the findings that these p53 mutants interact with the nuclease Mre11 and suppress the binding of the Mre11 Rad50-NBS1 ( MRN) complex to DNA double-stranded breaks ( DSBs), leading to impaired Ataxia-telangiectasia mutated ( ATM) activation. Therefore, p53 gain-of-function mutants promote tumorigenesis by a novel mechanism involving active disruption of critical DNA damage-response pathways.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; German Canc Res Ctr, Dept Genet Alterat Carcinogenesis, Heidelberg, Germany	University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ)	Xu, Y (corresponding author), Univ Leeds, Fac Med & Hlth, Light Labs, Leeds LS2 9JT, W Yorkshire, England.	yangxu@ucsd.edu		Xu, Yang/0000-0001-5574-921X	NCI NIH HHS [CA77563] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077563] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gudkov AV, 2003, CANCER BIOL THER, V2, P444, DOI 10.4161/cbt.2.4.480; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hergenhahn M, 2004, CELL CYCLE, V3, P738; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lista F, 1997, CANCER RES, V57, P4408; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Murphy ME, 2003, CANCER BIOL THER, V2, P381, DOI 10.4161/cbt.2.4.439; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sigal A, 2000, CANCER RES, V60, P6788; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804; Xu Y, 2005, CELL CYCLE, V4, P363, DOI 10.4161/cc.4.3.1529; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	30	306	321	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					573	U166		10.1038/ncb1571	http://dx.doi.org/10.1038/ncb1571			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417627				2022-12-25	WOS:000246181500016
J	Yeager, M; Orr, N; Hayes, RB; Jacobs, KB; Kraft, P; Wacholder, S; Minichiello, MJ; Fearnhead, P; Yu, K; Chatterjee, N; Wang, ZM; Welch, R; Staats, BJ; Calle, EE; Feigelson, HS; Thun, MJ; Rodriguez, C; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Giovannucci, E; Willett, WC; Cancel-Tassin, G; Cussenot, O; Valeri, A; Andriole, GL; Gelmann, EP; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, R; Hunter, DJ; Chanock, SJ; Thomas, G				Yeager, Meredith; Orr, Nick; Hayes, Richard B.; Jacobs, Kevin B.; Kraft, Peter; Wacholder, Sholom; Minichiello, Mark J.; Fearnhead, Paul; Yu, Kai; Chatterjee, Nilanjan; Wang, Zhaoming; Welch, Robert; Staats, Brian J.; Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Giovannucci, Edward; Willett, Walter C.; Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Gelmann, Edward P.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hunter, David J.; Chanock, Stephen J.; Thomas, Gilles			Genome-wide association study of prostate cancer identifies a second risk locus at 8q24	NATURE GENETICS			English	Article							GENETIC ALTERATIONS; ATTRIBUTABLE RISK	Recently, common variants on human chromosome 8q24 were found to be associated with prostate cancer risk. While conducting a genome-wide association study in the Cancer Genetic Markers of Susceptibility project with 550,000 SNPs in a nested case-control study ( 1,172 cases and 1,157 controls of European origin), we identified a new association at 8q24 with an independent effect on prostate cancer susceptibility. The most significant signal is 70 kb centromeric to the previously reported SNP, rs1447295, but shows little evidence of linkage disequilibrium with it. A combined analysis with four additional studies ( total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus ( P = 9.42 x 10(-13;) heterozygote odds ratio (OR): 1.26, 95% confidence interval ( c. i.): 1.13 - 1.41; homozygote OR: 1.58, 95% c. i.: 1.40 - 1.78). Each SNP remained significant in a joint analysis after adjusting for the other ( rs1447295 P = 1.41 x 10(-11); rs6983267 P = 6.62 x 10(-10)). These observations, combined with compelling evidence for a recombination hotspot between the two markers, indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry. We estimate that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked by rs1447295 ( 21% versus 9%).	NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA; NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Lancaster, Dept Math & Stat, Lancaster LA1 4YF, England; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Natl Inst Publ Hlth, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Hop Tenon, AP HP, CeRePP, F-75970 Paris, France; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA; Columbia Univ, Div Hematol & Oncol, New York, NY 10032 USA; NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Wellcome Trust Sanger Institute; Lancaster University; American Cancer Society; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Washington University (WUSTL); Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Weinstein, Stephanie J/P-1627-2017; Tucker, Margaret A/B-4297-2015; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020; Fearnhead, Paul/A-1653-2008; Schumacher, Fredrick/R-6043-2019; Fearnhead, Paul/A-5938-2015; Wang, Zhaoming/R-5527-2018	Weinstein, Stephanie J/0000-0002-3834-1535; Fearnhead, Paul/0000-0002-9386-2341; Schumacher, Fredrick/0000-0002-3073-7463; Fearnhead, Paul/0000-0002-9386-2341; Wang, Zhaoming/0000-0001-7556-3869; Hayes, Richard/0000-0002-0918-661X; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Jacobs, Kevin/0000-0002-4657-6473; cussenot, olivier/0000-0002-9912-0533; Staats, Brian/0000-0002-3818-3792	CCR NIH HHS [N01-RC-37004, N01-RC-45035] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA 09001, U01 CA098710, 5U01CA098233-04, CA55075, N01-CN-45165] Funding Source: Medline; Wellcome Trust Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009001, U01CA098710, U01CA098233, Z01SC010083] Funding Source: NIH RePORTER	CCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cher ML, 1996, CANCER RES, V56, P3091; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Parkin DM, 2002, CANC INCIDENCE 5 CON; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; SCHUMACHER FR, IN PRESS CANC RES; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valeri A, 2003, ANN HUM GENET, V67, P125, DOI 10.1046/j.1469-1809.2003.00022.x; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131	26	909	958	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					645	649		10.1038/ng2022	http://dx.doi.org/10.1038/ng2022			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401363				2022-12-25	WOS:000245971300020
J	Jeon, J; Park, SY; Chi, MH; Choi, J; Park, J; Rho, HS; Kim, S; Goh, J; Yoo, S; Choi, J; Park, JY; Yi, M; Yang, S; Kwon, MJ; Han, SS; Kim, BR; Khang, CH; Park, B; Lim, SE; Jung, K; Kong, S; Karunakaran, M; Oh, HS; Kim, H; Kim, S; Park, J; Kang, S; Choi, WB; Kang, S; Lee, YH				Jeon, Junhyun; Park, Sook-Young; Chi, Myoung-Hwan; Choi, Jaehyuk; Park, Jongsun; Rho, Hee-Sool; Kim, Soonok; Goh, Jaeduk; Yoo, Sungyong; Choi, Jinhee; Park, Ju-Young; Yi, Mihwa; Yang, Seonyoung; Kwon, Min-Jung; Han, Seong-Sook; Kim, Byeong Ryun; Khang, Chang Hyun; Park, Bongsoo; Lim, Se-Eun; Jung, Kyongyong; Kong, Sunghyung; Karunakaran, Maruthachalam; Oh, Hong-Sik; Kim, Hyojeong; Kim, Seryun; Park, Jaejin; Kang, Soyoung; Choi, Woo-Bong; Kang, Seogchan; Lee, Yong-Hwan			Genome-wide functional analysis of pathogenicity genes in the rice blast fungus	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MAGNAPORTHE-GRISEA; PLANT INFECTION; DRAFT SEQUENCE; RNAI; TRANSFORMATION; PENETRATION; ARABIDOPSIS; PATHWAY; BIOLOGY	Rapid translation of genome sequences into meaningful biological information hinges on the integration of multiple experimental and informatics methods into a cohesive platform. Despite the explosion in the number of genome sequences available(1), such a platform does not exist for filamentous fungi. Here we present the development and application of a functional genomics and informatics platform for a model plant pathogenic fungus, Magnaporthe oryzae(2). In total, we produced 21,070 mutants through large-scale insertional mutagenesis using Agrobacterium tumefaciens mediated transformation(3). We used a high-throughput phenotype screening pipeline to detect disruption of seven phenotypes encompassing the fungal life cycle and identified the mutated gene and the nature of mutation for each mutant. Comparative analysis of phenotypes and genotypes of the mutants uncovered 202 new pathogenicity loci. Our findings demonstrate the effectiveness of our platform and provide new insights on the molecular basis of fungal pathogenesis. Our approach promises comprehensive functional genomics in filamentous fungi and beyond.	Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources, Seoul 151921, South Korea; Seoul Natl Univ, Ctr Agr Biomat, Seoul 151921, South Korea; Rural Dev Adm, Natl Inst Crop Sci, Seoul 441857, South Korea; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; Dong Eui Univ, Dept Biotechnol & Bioengn, Pusan 614714, South Korea	Seoul National University (SNU); Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dong-Eui University	Lee, YH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources, Seoul 151921, South Korea.	yonglee@snu.ac.kr	Khang, Chang Hyun/ABH-5124-2020	Khang, Chang Hyun/0000-0001-7954-4841; Kang, Seogchan/0000-0003-2291-5634; Park, Jongsun/0000-0003-0786-4701				Andres AJ, 2004, TRENDS ENDOCRIN MET, V15, P243, DOI 10.1016/j.tem.2004.06.010; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker EJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-11; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Chen CB, 2004, MOL MICROBIOL, V51, P1493, DOI 10.1111/j.1365-2958.2003.03932.x; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Donofrio N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-94; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hirochika H, 2004, PLANT MOL BIOL, V54, P325, DOI 10.1023/B:PLAN.0000036368.74758.66; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kwon-Chung K.J., 1992, MED MYCOL; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Rho HS, 2001, MOL CELLS, V12, P407; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	30	180	193	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					561	565		10.1038/ng2002	http://dx.doi.org/10.1038/ng2002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353894				2022-12-25	WOS:000245271200030
J	Hoebe, RA; Van Oven, CH; Gadella, TWJ; Dhonukshe, PB; Van Noorden, CJF; Manders, EMM				Hoebe, R. A.; Van Oven, C. H.; Gadella, T. W. J., Jr.; Dhonukshe, P. B.; Van Noorden, C. J. F.; Manders, E. M. M.			Controlled light-exposure microscopy reduces photobleaching and phototoxicity in fluorescence live-cell imaging	NATURE BIOTECHNOLOGY			English	Article							CONFOCAL MICROSCOPY; LIVING CELLS; PHOTODYNAMIC THERAPY; 2-STEP PHOTOLYSIS; KINETICS; PHOTON; MITOSIS; STRESS; PLANTS; STATE	Fluorescence microscopy of living cells enables visualization of the dynamics and interactions of intracellular molecules. However, fluorescence live-cell imaging is limited by photobleaching and phototoxicity induced by the excitation light. Here we describe controlled light-exposure microscopy ( CLEM), a simple imaging approach that reduces photobleaching and phototoxicity two- to tenfold, depending on the fluorophore distribution in the object. By spatially controlling the light-exposure time, CLEM reduces the excitation-light dose without compromising image quality. We show that CLEM reduces photobleaching sevenfold in tobacco plant cells expressing microtubule-associated GFP-MAP4 and reduces production of reactive oxygen species eightfold and prolongs cell survival sixfold in HeLa cells expressing chromatin-associated H2B-GFP. In addition, CLEM increases the dynamic range of the fluorescence intensity at least twofold.	Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, NL-1098 SM Amsterdam, Netherlands; Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, NL-1098 SM Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Manders, EMM (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, Kruislaan 403, NL-1098 SM Amsterdam, Netherlands.	e.m.m.manders@uva.nl	Manders, Erik/D-1983-2009	Gadella, Theodorus/0000-0002-7639-219X				Bartosz G, 1997, ACTA PHYSIOL PLANT, V19, P47, DOI 10.1007/s11738-997-0022-9; Bernas T, 2004, J MICROSC-OXFORD, V215, P281, DOI 10.1111/j.0022-2720.2004.01377.x; Centonze Victoria, 1995, P549; Deschenes LA, 2002, CHEM PHYS LETT, V365, P387, DOI 10.1016/S0009-2614(02)01490-2; Dhonukshe P, 2003, PLANT CELL, V15, P597, DOI 10.1105/tpc.008961; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Eggeling C, 2005, CHEMPHYSCHEM, V6, P791, DOI 10.1002/cphc.200400509; Eggeling C, 1998, ANAL CHEM, V70, P2651, DOI 10.1021/ac980027p; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Houtsmuller AB, 2005, ADV BIOCHEM ENG BIOT, V95, P177, DOI 10.1007/b102214; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Hsi RA, 1999, DRUGS, V57, P725, DOI 10.2165/00003495-199957050-00005; Jou MJ, 2002, J BIOMED SCI, V9, P507; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Knight MM, 2003, AM J PHYSIOL-CELL PH, V284, pC1083, DOI 10.1152/ajpcell.00276.2002; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; MANDERS EM, 2004, Patent No. 2004102249; MANDERS EMM, 2003, Patent No. 1023440; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Molski A, 2001, J CHEM PHYS, V114, P1142, DOI 10.1063/1.1333760; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; RIGAUT JP, 1991, ANAL QUANT CYTOL, V13, P223; Shepherd Rebecca K., 1995, Microcirculation (New York), V2, P363, DOI 10.3109/10739689509148280; Song LL, 1997, CYTOMETRY, V27, P213, DOI 10.1002/(SICI)1097-0320(19970301)27:3<213::AID-CYTO2>3.3.CO;2-I; Song LL, 1996, BIOPHYS J, V70, P2959, DOI 10.1016/S0006-3495(96)79866-1; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sugden JK, 2004, BIOTECH HISTOCHEM, V79, P71, DOI 10.1080/10520290412331292400; Van Oostveldt P, 1998, CYTOMETRY, V32, P137; Vrouenraets MB, 2003, ANTICANCER RES, V23, P505; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2; Zwier JM, 2004, J MICROSC-OXFORD, V216, P15, DOI 10.1111/j.0022-2720.2004.01390.x	31	278	293	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					249	253		10.1038/nbt1278	http://dx.doi.org/10.1038/nbt1278			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17237770				2022-12-25	WOS:000244064000032
J	Kaidi, A; Williams, AC; Paraskeva, C				Kaidi, Abderrahmane; Williams, Ann Caroline; Paraskeva, Christos			Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia	NATURE CELL BIOLOGY			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; FACTOR-I; TUMOR; CANCER; APOPTOSIS; COMPLEX; INHIBITION; ACTIVATION	Aberrant activation of beta-catenin promotes cell proliferation(1) and initiates colorectal tumorigenesis(2,3). However, the expansion of tumours and the inadequacy of their local vasculature results in areas of hypoxia where cell growth is typically constrained(4,5). Here, we report a novel diversion in beta-catenin signalling triggered by hypoxia. We show that hypoxia inhibits beta-catenin T-cell factor-4 (TCF-4) complex formation and transcriptional activity, resulting in a G1 arrest that involves the c-Myc-p21 axis. Additionally, we find that hypoxia inducible factor-1 alpha (HIF-1 alpha) competes with TCF-4 for direct binding to beta-catenin. DNA-protein interaction studies reveal that beta-catenin-HIF-1 alpha interaction occurs at the promoter region of HIF-1 target genes. Furthermore, rigorous analyses indicate that beta-catenin can enhance HIF-1-mediated transcription, thereby promoting cell survival and adaptation to hypoxia. These findings demonstrate a dynamic role for beta-catenin in colorectal tumorigenesis, where a functional switch is instigated to meet the ever-changing needs of the tumour. This study highlights the importance of the microenvironment in transcriptional regulation.	Univ Bristol, Dept Cellular & Mol Med, Canc Res UK, Colorectal Tumour Biol Res Grp, Bristol BS8 1TD, Avon, England	Cancer Research UK; University of Bristol	Paraskeva, C (corresponding author), Univ Bristol, Dept Cellular & Mol Med, Canc Res UK, Colorectal Tumour Biol Res Grp, Bristol BS8 1TD, Avon, England.	c.paraskeva@bristol.ac.uk		Kaidi, Abderrahmane/0000-0001-9411-8912; Williams, Ann/0000-0002-6009-7137				Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Elder DJE, 1996, CANCER RES, V56, P2273; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Giles RH, 2006, ONCOGENE, V25, P3065, DOI 10.1038/sj.onc.1209330; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Goethals L, 2006, INT J RADIAT ONCOL, V65, P246, DOI 10.1016/j.ijrobp.2006.01.007; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vaupel P, 1998, ADV EXP MED BIOL, V454, P591; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong H, 1999, CANCER RES, V59, P5830	30	371	389	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					210	U113		10.1038/ncb1534	http://dx.doi.org/10.1038/ncb1534			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220880				2022-12-25	WOS:000243903000014
J	Rogaeva, E; Meng, Y; Lee, JH; Gu, Y; Kawarai, T; Zou, F; Katayama, T; Baldwin, CT; Cheng, R; Hasegawa, H; Chen, F; Shibata, N; Lunetta, KL; Pardossi-Piquard, R; Bohm, C; Wakutani, Y; Cupples, LA; Cuenco, KT; Green, RC; Pinessi, L; Rainero, I; Sorbi, S; Bruni, A; Duara, R; Friedland, RP; Inzelberg, R; Hampe, W; Bujo, H; Song, YQ; Andersen, OM; Willnow, TE; Graff-Radford, N; Petersen, RC; Dickson, D; Der, SD; Fraser, PE; Schmitt-Ulms, G; Younkin, S; Mayeux, R; Farrer, LA; St George-Hyslop, P				Rogaeva, Ekaterina; Meng, Yan; Lee, Joseph H.; Gu, Yongjun; Kawarai, Toshitaka; Zou, Fanggeng; Katayama, Taiichi; Baldwin, Clinton T.; Cheng, Rong; Hasegawa, Hiroshi; Chen, Fusheng; Shibata, Nobuto; Lunetta, Kathryn L.; Pardossi-Piquard, Raphaelle; Bohm, Christopher; Wakutani, Yosuke; Cupples, L. Adrienne; Cuenco, Karen T.; Green, Robert C.; Pinessi, Lorenzo; Rainero, Innocenzo; Sorbi, Sandro; Bruni, Amalia; Duara, Ranjan; Friedland, Robert P.; Inzelberg, Rivka; Hampe, Wolfgang; Bujo, Hideaki; Song, You-Qiang; Andersen, Olav M.; Willnow, Thomas E.; Graff-Radford, Neill; Petersen, Ronald C.; Dickson, Dennis; Der, Sandy D.; Fraser, Paul E.; Schmitt-Ulms, Gerold; Younkin, Steven; Mayeux, Richard; Farrer, Lindsay A.; St George-Hyslop, Peter			The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILY-BASED ASSOCIATION; APOLIPOPROTEIN-E GENOTYPE; MISSENSE MUTATIONS; BETA PRODUCTION; TESTS; GENE; COMPLEX; SUSCEPTIBILITY; INFORMATION	The recycling of the amyloid precursor protein ( APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid beta peptide ( A beta) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late- onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene ( also known as LR11 or SORLA) may regulate tissue- specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into A beta- generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.	Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY USA; Univ Toronto, Ctr Res Neurodegenerat Dis, Dept Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Toronto Western Hosp, Res Inst, Toronto, ON M5S 3H2, Canada; Boston Univ, Sch Med, Dept Epidemiol, Dept Med,Genet Program,Dept Neurol,Dept Genet & G, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA; Mayo Clin Rochester, Dept Neurol, Rochester, MN 55905 USA; Univ Turin, Dept Neurosci, I-10126 Turin, Italy; Univ Florence, Dept Neurol & Psychiat Sci, Ctr Res Transfer & High Educ Chron Inflammat Dege, I-50139 Florence, Italy; Reg Ctr Neurogenet, I-88046 Lamezia Terme, CZ, Italy; Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Mem Disorders, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Psychiat, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Behav Sci & Med, Miami Beach, FL 33140 USA; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Meir Hosp, Kfar Saba & Rappaport Fac Med, IL-47441 Haifa, Israel; Univ Med Ctr Hamburg Eppendorf, Dept Mol Cell Biol, D-20246 Hamburg, Germany; Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat M6, Chuo Ku, Chiba 2608670, Japan; Univ Hong Kong, Dept Biochem, Dept Orthopaed Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; Max Delbruck Ctr Mol Med, Dept Mol Cardiovasc Res, D-13125 Berlin, Germany	Columbia University; Columbia University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Boston University; Boston University; Columbia University; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Turin; University of Florence; Mount Sinai Medical Center; University of Miami; University of Miami; Case Western Reserve University; Tel Aviv University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Chiba University; University of Hong Kong; University of Hong Kong; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Mayeux, R (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA.	rpm2@columbia.edu; farrer@bu.edu; p.hyslop@utoronto.ca	Pardossi-Piquard, Raphaëlle/D-6263-2012; Kawarai, Toshitaka/C-2822-2013; Song, You-qiang/C-4401-2009; Lee, Joseph H/D-2441-2012; Farrer, Lindsay/AAS-1035-2020; Mayeux, Richard/E-9788-2013; Shibata, Nobuto/AAB-9366-2020; Song, You-Qiang/E-5207-2011; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Friedland, Robert/A-2834-2010; Inzelberg, Rivka/E-5861-2010; Andersen, Olav/N-2777-2017; Bruni, Amalia/K-5038-2016	Kawarai, Toshitaka/0000-0003-4547-8131; Lee, Joseph H/0000-0002-2000-4821; Mayeux, Richard/0000-0001-6519-9696; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Friedland, Robert/0000-0001-5721-1843; Inzelberg, Rivka/0000-0002-0720-0502; Cupples, L. Adrienne/0000-0003-0273-7965; Baldwin, Clinton/0000-0002-3275-9463; Song, You-Qiang/0000-0001-9407-2256; Andersen, Olav/0000-0003-4226-3354; St George-Hyslop, Peter/0000-0003-0796-7209; Lunetta, Kathryn/0000-0002-9268-810X; Bruni, Amalia/0000-0003-3471-3343; Dickson, Dennis W/0000-0001-7189-7917; Willnow, Thomas/0000-0001-9515-7921; Farrer, Lindsay/0000-0001-5533-4225; sorbi, sandro/0000-0002-0380-6670	NATIONAL INSTITUTE ON AGING [R37AG015473, P50AG016574, P30AG013846, R01AG017173, U01AG006786, R01AG009029, P01AG007232] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG006786, R01-HG/AG02213, R01-AG09029, R37 AG015473-10, R01 AG009029, P50 AG016574, P01-AG07232, R37 AG015473-09, R37 AG015473-08, P30 AG013846, R37 AG015473-06, P01 AG007232, P50-AG16574, R37 AG015473, R37-AG15473, R01 AG017173, R01-AG017173, P30-AG13846, R37 AG015473-07, U01-AG06786] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bayer TA, 2001, BRAIN PATHOL, V11, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bowirrat A, 2001, EUR J NEUROL, V8, P119, DOI 10.1046/j.1468-1331.2001.00183.x; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee JH, 2004, MOL PSYCHIATR, V9, P1042, DOI 10.1038/sj.mp.4001538; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Rogaeva EA, 1999, NAT GENET, V22, P19, DOI 10.1038/8729; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	49	853	889	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					168	177		10.1038/ng1943	http://dx.doi.org/10.1038/ng1943			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220890	Green Accepted			2022-12-25	WOS:000244063900014
J	Kanai, M; Hanashiro, K; Kim, SH; Hanai, S; Boulares, AH; Miwa, M; Fukasawa, K				Kanai, Masayuki; Hanashiro, Kazuhiko; Kim, Song-Hee; Hanai, Shuji; Boulares, A. Hamid; Miwa, Masanao; Fukasawa, Kenji			Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation	NATURE CELL BIOLOGY			English	Article							RING-FINGER DOMAIN; DNA-BINDING; PROTEIN; MDM2; POLYMERASE; ACTIVATION; CELLS; PARP; TRANSCRIPTION; LOCALIZATION	Poly( ADP- ribose) polymerase 1 (PARP- 1) and p53 are two key proteins in the DNA-damage response. Although PARP1 is known to poly( ADP- ribosyl) ate p53, the role of this modification remains elusive. Here, we identify the major poly( ADP- ribosyl) ated sites of p53 by PARP- 1 and find that PARP-1-mediated poly( ADP- ribosyl) ation blocks the interaction between p53 and the nuclear export receptor Crm1, resulting in nuclear accumulation of p53. These findings molecularly link PARP- 1 and p53 in the DNA-damage response, providing the mechanism for how p53 accumulates in the nucleus in response to DNA damage. PARP- 1 becomes super-activated by binding to damaged DNA, which in turn poly( ADP- ribosyl) ates p53. The nuclear export machinery is unable to target poly( ADP- ribosyl) ated p53, promoting accumulation of p53 in the nucleus where p53 exerts its transactivational function.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 305, Japan; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; Nagahama Inst Biosci & Technol, Fac Biosci, Shiga 526, Japan	H Lee Moffitt Cancer Center & Research Institute; University System of Ohio; University of Cincinnati; National Institute of Advanced Industrial Science & Technology (AIST); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fukasawa, K (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	kenji.fukasawa@uc.edu			NCI NIH HHS [CA90522, CA95925] Funding Source: Medline; NHLBI NIH HHS [HL072889] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090522, R01CA095925] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agarwal ML, 1997, ONCOGENE, V15, P1035, DOI 10.1038/sj.onc.1201274; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Burkle A, 2001, CANCER LETT, V163, P1, DOI 10.1016/S0304-3835(00)00694-7; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Kanai M, 2003, MOL CELL BIOL, V23, P2451, DOI 10.1128/MCB.23.7.2451-2462.2003; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Simbulan-Rosenthal CM, 1999, CANCER RES, V59, P2190; Simbulan-Rosenthal CM, 1998, BIOCHEM BIOPH RES CO, V253, P864, DOI 10.1006/bbrc.1998.9792; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wesierska-Gadek J, 2003, J CELL BIOCHEM, V89, P220, DOI 10.1002/jcb.10521; Wesierska-Gadek J, 2001, CELL MOL BIOL LETT, V6, P117; WesierskaGadek J, 1996, BIOCHEM BIOPH RES CO, V224, P96, DOI 10.1006/bbrc.1996.0990; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	34	158	161	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1175	1183		10.1038/ncb1638	http://dx.doi.org/10.1038/ncb1638			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891139				2022-12-25	WOS:000249882300013
J	Brault, AC; Huang, CYH; Langevin, SA; Kinney, RM; Bowen, RA; Ramey, WN; Panella, NA; Holmes, EC; Powers, AM; Miller, BR				Brault, Aaron C.; Huang, Claire Y-H; Langevin, Stanley A.; Kinney, Richard M.; Bowen, Richard A.; Ramey, Wanichaya N.; Panella, Nicholas A.; Holmes, Edward C.; Powers, Ann M.; Miller, Barry R.			A single positively selected West Nile viral mutation confers increased virogenesis in American crows	NATURE GENETICS			English	Article							VIRUS-STRAINS; NEW-YORK; VIRULENCE; BIRDS; TRANSMISSION; DISEASE; EUROPE; HOST; EPIDEMIOLOGY; ENCEPHALITIS	West Nile virus ( WNV), first recognized in North America in 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis in recorded history. Despite the well- described epidemiological patterns of WNV in North America, the basis for the emergence of WNV-associated avian pathology, particularly in the American crow ( AMCR) sentinel species, and the large scale of the North American epidemic and epiornitic is uncertain. We report here that the introduction of a T249P amino acid substitution in the NS3 helicase ( found in North American WNV) in a lowvirulence strain was sufficient to generate a phenotype highly virulent to AMCRs. Furthermore, comparative sequence analyses of full- length WNV genomes demonstrated that the same site ( NS3- 249) was subject to adaptive evolution. These phenotypic and evolutionary results provide compelling evidence for the positive selection of a mutation encoding increased viremia potential and virulence in the AMCR sentinel bird species.	Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; US Dept HHS, Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA; Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Brault, AC (corresponding author), Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA.	acbrault@ucdavis.edu	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; Pacific-Southwest, RCE/B-6155-2009	Holmes, Edward/0000-0001-9596-3552; 	NIAID NIH HHS [U54 AI065359-010001, R01 AI061822, U54 AI065359, R01 AI061822-01, AI061822] Funding Source: Medline; NCPDCID CDC HHS [R01 CI000235, CI000235] Funding Source: Medline; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061822, U54AI065359] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; DAY JF, 1983, J PARASITOL, V69, P163, DOI 10.2307/3281292; DAY JF, 1984, COMP BIOCHEM PHYS A, V77, P447, DOI 10.1016/0300-9629(84)90210-X; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Eidson M, 2001, ANN NY ACAD SCI, V951, P38; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2001, CURR OPIN INFECT DIS, V14, P519, DOI 10.1097/00001432-200110000-00004; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Langevin SA, 2003, AM J TROP MED HYG, V69, P78, DOI 10.4269/ajtmh.2003.69.78; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69; Solomon T, 2003, LANCET INFECT DIS, V3, P189, DOI 10.1016/S1473-3099(03)00574-7; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; SWOFFORD D, 2003, PHYLOGENETICS ANAL U; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; WORK TH, 1953, P SOC EXP BIOL MED, V84, P719, DOI 10.3181/00379727-84-20764	28	254	262	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1162	1166		10.1038/ng2097	http://dx.doi.org/10.1038/ng2097			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694056	Green Accepted			2022-12-25	WOS:000249122400029
J	Marshall, A				Marshall, Andrew			GM soybeans and health safety - a controversy reexamined	NATURE BIOTECHNOLOGY			English	Article							CONVENTIONAL SOYBEANS; ROUNDUP READY; RATS; MEAL; DNA	An unprecedented study claiming that transgenic soybeans compromise the fertility of rats and the survival and growth of their offspring has garnered widespread media and political attention but remains unpublished in the peer-reviewed literature. Here, an account of the work from the principal investigator, Irina Ermakova, is appended with comments from researchers in the field.										*ADV COMM NOV FOOD, 2005, ACNFP STAT EFF GM SO; [Anonymous], 1983, OECD GUID TEST CHEM; AOYA AH, 2005, J TOXICOL SCI, V30, P59; Beever D. E., 2000, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V70, P175; Brake DG, 2004, FOOD CHEM TOXICOL, V42, P29, DOI 10.1016/j.fct.2003.08.003; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Collas P, 2003, TRENDS BIOTECHNOL, V21, P354, DOI 10.1016/S0167-7799(03)00147-1; Cromwell GL, 2002, J ANIM SCI, V80, P708; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; ERMAKOVA IV, 2005, P C EP TRANSG PLANTS, P41; Hammond BG, 1996, J NUTR, V126, P717, DOI 10.1093/jn/126.3.717; Jonas DA, 2001, ANN NUTR METAB, V45, P235, DOI 10.1159/000046734; Kalaitzandonakes N, 2007, NAT BIOTECHNOL, V25, P509, DOI 10.1038/nbt0507-509; OECD (Organisation for Economic Co-operation and Development), 1998, REP DOS 90 DAY OR TO, DOI DOI 10.1787/9789264070707-EN; Stewart CN, 2003, NAT BIOTECHNOL, V21, P353, DOI 10.1038/nbt0403-353; Teshima R, 2000, J FOOD HYG SOC JPN, V41, P188, DOI 10.3358/shokueishi.41.188; *US EPA, 2006, US EPA SER 870 HLTH; *US EPA, 1998, HLTH EFF TEST GUID O; *US FDA, 2000, GUID REPROD STUD; Zhu YZ, 2004, ARCH ANIM NUTR, V58, P295, DOI 10.1080/00039420412331273277; 2005, GENETICALLY MODIFIED	21	22	25	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					981	987		10.1038/nbt0907-981	http://dx.doi.org/10.1038/nbt0907-981			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17846624				2022-12-25	WOS:000249444200018
J	Franco-Zorrilla, JM; Valli, A; Todesco, M; Mateos, I; Puga, MI; Rubio-Somoza, I; Leyva, A; Weigel, D; Garcia, JA; Paz-Ares, J				Franco-Zorrilla, Jose Manuel; Valli, Adrian; Todesco, Marco; Mateos, Isabel; Puga, Maria Isabel; Rubio-Somoza, Ignacio; Leyva, Antonio; Weigel, Detlef; Garcia, Juan Antonio; Paz-Ares, Javier			Target mimicry provides a new mechanism for regulation of microRNA activity	NATURE GENETICS			English	Article							PHOSPHATE-STARVATION; SIRNA BIOGENESIS; PLANTS; ARABIDOPSIS; EXPRESSION; GENE; PATHWAY; SHOOTS; ROOTS; ROLES	MicroRNAs (miRNA) regulate key aspects of development and physiology in animals and plants. These regulatory RNAs act as guides of effector complexes to recognize specific mRNA sequences based on sequence complementarity, resulting in translational repression or site-specific cleavage1,2. In plants, most miRNA targets are cleaved and show almost perfect complementarity with the miRNAs around the cleavage site3-8. Here, we examined the non -protein coding gene IPS1 (INDUCED BY PHOSPHATE STARVATION1) from Arabidopsis thaliana. IPS1 contains a motif with sequence complementarity to the phosphate (Pi) starvation -induced miRNA miR-399, but the pairing is interrupted by a mismatched loop at the expected miRNA cleavage site. We show that IPS1 RNA is not cleaved but instead sequesters miR-399. Thus, IPS1 overexpression results in increased accumulation of the miR-399 target PHO2 mRNA and, concomitantly, in reduced shoot P-i content5-8. Engineering of IPS1 to be cleavable abolishes its inhibitory activity on miR-399. We coin the term 'target mimicry' to define this mechanism of inhibition of miRNA activity. Target mimicry can be generalized beyond the control of Pi homeostasis, as demonstrated using artificial target mimics.	CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, E-28049 Madrid, Spain; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society	Paz-Ares, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Campus Cantoblanco, E-28049 Madrid, Spain.	jpazares@cnb.uam.es	Todesco, Marco/HCH-3494-2022; Franco-Zorrilla, Jose Manuel/ABD-5092-2021; Weigel, Detlef/AAR-3312-2021; Leyva, Antonio/C-9040-2013; Weigel, Detlef/GSJ-0799-2022; Somoza, Ignacio Rubio/L-6139-2014; Franco-Zorrilla, Jose/M-8361-2015; Weigel, Detlef/C-1418-2008; Mateos, Isabel/B-7127-2014; Valli, Adrian/H-6738-2012; Garcia, Juan Antonio/N-3723-2014	Franco-Zorrilla, Jose Manuel/0000-0001-6769-7349; Leyva, Antonio/0000-0001-7617-0418; Weigel, Detlef/0000-0002-2114-7963; Somoza, Ignacio Rubio/0000-0003-0754-816X; Franco-Zorrilla, Jose/0000-0001-6769-7349; Weigel, Detlef/0000-0002-2114-7963; Valli, Adrian/0000-0002-3266-7200; Garcia, Juan Antonio/0000-0002-4861-9609; puga, maria isabel/0000-0001-7498-2236; Paz-Ares, Javier/0000-0003-0553-9745; Todesco, Marco/0000-0002-6227-4096				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; BECHTOLD N, 1993, CR ACAD SCI PARIS LI, V316, P15; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Burleigh SH, 1997, PLANT MOL BIOL, V34, P199, DOI 10.1023/A:1005841119665; CHIROU TJ, 2006, PLANT CELL, V18, P412; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Liu CM, 1997, PLANT MOL BIOL, V33, P867, DOI 10.1023/A:1005729309569; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Poirier Y, 2002, ARABIDOPSIS BOOK; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521	28	1367	1487	17	347	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1033	1037		10.1038/ng2079	http://dx.doi.org/10.1038/ng2079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17643101				2022-12-25	WOS:000248446900023
J	Conrad, C; Boyman, O; Tonel, G; Tun-Kyi, A; Laggner, U; de Fougerolles, A; Kotelianski, V; Gardner, H; Nestle, FO				Conrad, Curdin; Boyman, Onur; Tonel, Giulia; Tun-Kyi, Adrian; Laggner, Ute; de Fougerolles, Antonin; Kotelianski, Victor; Gardner, Humphrey; Nestle, Frank O.			alpha(1)beta(1) integrin is crucial for accumulation of epidermal T cells and the development of psoriasis	NATURE MEDICINE			English	Article							ALPHA-1-BETA-1 INTEGRIN; EXPRESSION; RESIDENT; LYMPHOCYTES; INDUCTION; MAJORITY; LESIONS; MEMORY; ALPHA; VLA-1	Psoriasis is a common T cell-mediated autoimmune inflammatory disease. We show that blocking the interaction of alpha(1)beta(1) integrin (VLA-1) with collagen prevented accumulation of epidermal T cells and immunopathology of psoriasis. alpha(1)beta(1) integrin, a major collagen-binding surface receptor, was exclusively expressed by epidermal but not dermal T cells. alpha(1)beta(1)-positive T cells showed characteristic surface markers of effector memory cells and contained high levels of interferon-gamma but not interleukin-4. Blockade of alpha(1)beta(1) inhibited migration of T cells into the epidermis in a clinically relevant xenotransplantation model. This was paralleled by a complete inhibition of psoriasis development, comparable to that caused by tumor necrosis factor-alpha blockers. These results define a crucial role for alpha(1)beta(1) in controlling the accumulation of epidermal type 1 polarized effector memory T cells in a common human immunopathology and provide the basis for new strategies in psoriasis treatment focusing on T cell-extracellular matrix interactions.	Kings Coll London, Sch Med, Guys Hosp, St Johns Inst Dermatol,Div Genet & Mol Med, London SE1 9RT, England; Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; Biogen Inc, Cambridge Ctr, Cambridge, MA 02142 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Zurich; University Zurich Hospital; Biogen	Nestle, FO (corresponding author), Kings Coll London, Sch Med, Guys Hosp, St Johns Inst Dermatol,Div Genet & Mol Med, Floor 8 Guys Tower,St Thomas St, London SE1 9RT, England.	curdin.conrad@usz.ch; frank.nestle@kcl.ac.uk		Conrad, Curdin/0000-0002-2547-3440; Boyman, Onur/0000-0001-8279-5545	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; BAKER BS, 1984, BRIT J DERMATOL, V110, P555; Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007; BOEHNCKE WH, 1992, J AM ACAD DERMATOL, V26, P907, DOI 10.1016/0190-9622(92)70131-X; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Boyman O, 2005, BRIT J DERMATOL, V152, P1211, DOI 10.1111/j.1365-2133.2005.06701.x; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; CHANG JCC, 1994, P NATL ACAD SCI USA, V91, P9282, DOI 10.1073/pnas.91.20.9282; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; CHRISTOPHERS E, 1973, BRIT J DERMATOL, V89, P327; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; de Fougerolles AR, 2003, MOL B INT U, P165; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; FRAKI JE, 1983, J INVEST DERMATOL, V80, pS31, DOI 10.1111/1523-1747.ep12537053; Ghohestani RF, 2001, CLIN DERMATOL, V19, P551, DOI 10.1016/S0738-081X(00)00175-9; Goldstein I, 2003, J CLIN INVEST, V112, P1444, DOI 10.1172/JCI200319607; Gotwals PJ, 1999, BIOCHEMISTRY-US, V38, P8280, DOI 10.1021/bi982860m; Griffiths CEM, 1996, J ROY SOC MED, V89, P315, DOI 10.1177/014107689608900604; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; KRUEGER JG, 1995, J EXP MED, V182, P2057, DOI 10.1084/jem.182.6.2057; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Nestle FO, 2005, J INVEST DERMATOL, V125, pXIV, DOI 10.1111/j.0022-202X.2005.23923.x; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Pauls K, 2001, J INVEST DERMATOL, V117, P569, DOI 10.1046/j.0022-202x.2001.01481.x; Ragaz A, 1979, Am J Dermatopathol, V1, P199, DOI 10.1097/00000372-197900130-00002; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Selin LK, 2004, NAT MED, V10, P343, DOI 10.1038/nm0404-343; Teraki Y, 2002, BRIT J DERMATOL, V147, P1118, DOI 10.1046/j.1365-2133.2002.05005.x	39	187	193	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					836	842		10.1038/nm1605	http://dx.doi.org/10.1038/nm1605			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17603494				2022-12-25	WOS:000247902800030
J	Goodman, C				Goodman, Catherine			Natural products at the Hans Knoll Institute	NATURE CHEMICAL BIOLOGY			English	Editorial Material								Understanding the creation, induction and function of natural products that are important for microbial communication are central aims for scientists at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoll Institute.					Goodman, Catherine/AAO-6148-2020	Goodman, Catherine/0000-0003-3415-8554					0	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					367	367		10.1038/nchembio0707-367	http://dx.doi.org/10.1038/nchembio0707-367			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17576418	Bronze			2022-12-25	WOS:000247462800006
J	Parkes, M; Barrett, JC; Prescott, NJ; Tremelling, M; Anderson, CA; Fisher, SA; Roberts, RG; Nimmo, ER; Cummings, FR; Soars, D; Drummond, H; Lees, CW; Khawaja, SA; Bagnall, R; Burke, DA; Todhunter, CE; Ahmad, T; Onnie, CM; McArdle, W; Strachan, D; Bethel, G; Bryan, C; Lewis, CM; Deloukas, P; Forbes, A; Sanderson, J; Jewell, DP; Satsangi, J; Mansfield, JC; Cardon, L; Mathew, CG				Parkes, Miles; Barrett, Jeffrey C.; Prescott, Natalie J.; Tremelling, Mark; Anderson, Carl A.; Fisher, Sheila A.; Roberts, Roland G.; Nimmo, Elaine R.; Cummings, Fraser R.; Soars, Dianne; Drummond, Hazel; Lees, Charlie W.; Khawaja, Saud A.; Bagnall, Richard; Burke, Denis A.; Todhunter, Catherine E.; Ahmad, Tariq; Onnie, Clive M.; McArdle, Wendy; Strachan, David; Bethel, Graeme; Bryan, Claire; Lewis, Cathryn M.; Deloukas, Panos; Forbes, Alastair; Sanderson, Jeremy; Jewell, Derek P.; Satsangi, Jack; Mansfield, John C.; Cardon, Lon; Mathew, Christopher G.		Wellcome Trust Case Control Consor	Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RESISTANCE; EXPRESSION; IL23R	A genome- wide association scan in individuals with Crohn's disease by the Wellcome Trust Case Control Consortium detected strong association at four novel loci. We tested 37 SNPs from these and other loci for association in an independent case- control sample. We obtained replication for the autophagy- inducing IRGM gene on chromosome 5q33.1 ( replication P = 6.6 x 10(-4), combined P = 2.1 x 10(-10)) and for nine other loci, including NKX2- 3, PTPN2 and gene deserts on chromosomes 1q and 5p13.	Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Div Med Sci,Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; Univ Newcastle Upon Tyne, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Bristol, ALSPAC, Bristol BS8 1TQ, Avon, England; St Georges Univ London, Div Community Hlth Serv, London SW17 0RE, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; UCL, Hosp Trust, Inst Digest Dis, London NW1 2BU, England; Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Edinburgh; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Bristol; St Georges University London; Wellcome Trust Sanger Institute; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Parkes, M (corresponding author), Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Hills Rd, Cambridge CB2 2QQ, England.	miles.parkes@addenbrookes.nhs.uk	Anderson, Carl A/B-8327-2013; Prescott, Natalie J/F-6490-2011; Mathew, Christopher G/G-3434-2015; Brown, Matthew A/E-5749-2010; Roberts, Roland G/C-3596-2009; Lewis, Cathryn M/A-5225-2010; Deloukas, Panos/B-2922-2013; Lewis, Cathryn/M-8766-2019	Anderson, Carl A/0000-0003-1719-7009; Prescott, Natalie J/0000-0002-5901-7371; Mathew, Christopher G/0000-0003-4178-1838; Brown, Matthew A/0000-0003-0538-8211; Lewis, Cathryn M/0000-0002-8249-8476; Deloukas, Panos/0000-0001-9251-070X; Lewis, Cathryn/0000-0002-8249-8476; Khawaja, Saud Ahmed/0000-0001-5349-6087; Roberts, Roland/0000-0001-6636-1579; Bagnall, Richard/0000-0002-2476-9864; Parkes, Miles/0000-0002-6467-0631; Barrett, Jeffrey/0000-0002-1152-370X; Forbes, Alastair/0000-0001-7416-9843; Lees, Charlie/0000-0002-0732-8215; Cummings, Fraser/0000-0002-9659-3247; Morgan, Ann/0000-0003-1109-624X	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [072029, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Todd JA, 2007, NAT GENET; Zwiers A, 2004, GENES IMMUN, V5, P675, DOI 10.1038/sj.gene.6364131	15	897	926	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					830	832		10.1038/ng2061	http://dx.doi.org/10.1038/ng2061			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17554261	Green Accepted			2022-12-25	WOS:000247619800010
J	Wang, KH; Neumann, H; Peak-Chew, SY; Chin, JW				Wang, Kaihang; Neumann, Heinz; Peak-Chew, Sew Y.; Chin, Jason W.			Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion	NATURE BIOTECHNOLOGY			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; SUPPRESSOR TRANSFER-RNA; PHOTO-CROSS-LINKING; MESSENGER-RNA; ESCHERICHIA-COLI; MAMMALIAN-CELLS; IN-VITRO; PROTEINS; TRANSLATION	In vivo incorporation of unnatural amino acids by amber codon suppression is limited by release factor-1-mediated peptide chain termination. Orthogonal ribosome- mRNA pairs function in parallel with, but independent of, natural ribosomes and mRNAs. Here we show that an evolved orthogonal ribosome (ribo-X) improves tRNA(CUA)-dependent decoding of amber codons placed in orthogonal mRNA. By combining ribo-X, orthogonal mRNAs and orthogonal aminoacyl-tRNA synthetase/tRNA pairs in Escherichia coli, we increase the efficiency of site-specific unnatural amino acid incorporation from similar to 20% to > 60% on a single amber codon and from < 1% to > 20% on two amber codons. We hypothesize that these increases result from a decreased functional interaction of the orthogonal ribosome with release factor-1. This technology should minimize the functional and phenotypic effects of truncated proteins in experiments that use unnatural amino acid incorporation to probe protein function in vivo.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	chin@mrc-lmb.cam.ac.uk	Neumann, Heinz/ABC-7323-2021; Neumann, Heinz/F-7875-2014	Neumann, Heinz/0000-0001-9657-1913; Wang, Kaihang/0000-0001-7657-8755	Medical Research Council [MC_U105181009] Funding Source: Medline; MRC [MC_U105181009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOSSI L, 1983, J MOL BIOL, V164, P73, DOI 10.1016/0022-2836(83)90088-8; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CASKEY CT, 1968, SCIENCE, V162, P135, DOI 10.1126/science.162.3849.135; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DATTA K, 1985, MICROBIOLOGICA, V8, P73; Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4; Furter R, 1998, PROTEIN SCI, V7, P419; HECKLER TG, 1984, BIOCHEMISTRY-US, V23, P1468, DOI 10.1021/bi00302a020; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; KAUER JC, 1986, J BIOL CHEM, V261, P695; KLEINA LG, 1990, J MOL BIOL, V213, P705, DOI 10.1016/S0022-2836(05)80257-8; Kohrer C, 2003, CHEM BIOL, V10, P1095, DOI 10.1016/j.chembiol.2003.10.013; Kohrer C, 2001, P NATL ACAD SCI USA, V98, P14310, DOI 10.1073/pnas.251438898; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; MORI H, 2006, P NATL ACAD SCI US; Murakami Hiroshi, 2006, Nucleic Acids Symp Ser (Oxf), P35, DOI 10.1093/nass/nrl018; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rackham O, 2005, J AM CHEM SOC, V127, P17584, DOI 10.1021/ja055338d; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; RICE JB, 1984, J BIOL CHEM, V259, P6505; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Short GF, 1999, BIOCHEMISTRY-US, V38, P8808, DOI 10.1021/bi990281r; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; Triman KL, 1998, NUCLEIC ACIDS RES, V26, P280, DOI 10.1093/nar/26.1.280; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Youngman EM, 2006, COLD SPRING HARB SYM, V71, P545, DOI 10.1101/sqb.2006.71.036	50	213	233	0	65	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					770	777		10.1038/nbt1314	http://dx.doi.org/10.1038/nbt1314			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17592474				2022-12-25	WOS:000247994000028
J	Denecker, G; Hoste, E; Gilbert, B; Hochepied, T; Ovaere, P; Lippens, S; Van den Broecke, C; Van Damme, P; D'Herde, K; Hachem, JP; Borgonie, G; Presland, RB; Schoonjans, L; Libert, C; Vandekerckhove, J; Gevaert, K; Vandenabeele, P; Declercq, W				Denecker, Geertrui; Hoste, Esther; Gilbert, Barbara; Hochepied, Tino; Ovaere, Petra; Lippens, Saskia; Van den Broecke, Caroline; Van Damme, Petra; D'Herde, Katharina; Hachem, Jean-Pierre; Borgonie, Gaetan; Presland, Richard B.; Schoonjans, Luc; Libert, Claude; Vandekerckhove, Joel; Gevaert, Kris; Vandenabeele, Peter; Declercq, Wim			Caspase-14 protects against epidermal UVB photodamage and water loss	NATURE CELL BIOLOGY			English	Article							STRATUM-CORNEUM; INDUCED APOPTOSIS; ICHTHYOSIS VULGARIS; MICE LACKING; CELL-DEATH; DIFFERENTIATION; SKIN; KERATINOCYTES; FILAGGRIN; PROFILAGGRIN	Caspase-14 belongs to a conserved family of aspartate-specific proteinases. Its expression is restricted almost exclusively to the suprabasal layers of the epidermis and the hair follicles(1-4). Moreover, the proteolytic activation of caspase-14 is associated with stratum corneum formation, implicating caspase-14 in terminal keratinocyte differentiation and cornification(5,6). Here, we show that the skin of caspase-14-deficient mice was shiny and lichenified, indicating an altered stratum-corneum composition. Caspase-14-deficient epidermis contained significantly more alveolar keratohyalin F-granules, the profilaggrin stores. Accordingly, caspase-14-deficient epidermis is characterized by an altered profilaggrin processing pattern and we show that recombinant caspase-14 can directly cleave profilaggrin in vitro. Caspase-14-deficient epidermis is characterized by reduced skin-hydration levels and increased water loss. In view of the important role of filaggrin in the structure and moisturization of the skin, the knockout phenotype could be explained by an aberrant processing of filaggrin. Importantly, the skin of caspase-14-deficient mice was highly sensitive to the formation of cyclobutane pyrimidine dimers after UVB irradiation, leading to increased levels of UVB-induced apoptosis. Removal of the stratum corneum indicate that caspase-14 controls the UVB scavenging capacity of the stratum corneum.	VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; Univ Ghent, Dept Pathol, B-9000 Ghent, Belgium; VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; Univ Ghent, Dept Anat Embryol Histol Med Phys, B-9000 Ghent, Belgium; Free Univ Brussels, Dept Dermatol, B-1090 Brussels, Belgium; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; Univ Washington, Dept Oral Biol & Med Dermatol, Seattle, WA 98195 USA; Univ Leuven, Dept Mol & Cellular Med, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; University of Washington; University of Washington Seattle; KU Leuven	Vandenabeele, P (corresponding author), VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.ugent.be; wim.declercq@dmbr.ugent.be	Vandenabeele, Peter/C-8597-2009; Van Damme, Petra/C-7269-2008; Denecker, Geertrui/E-8134-2010; Gevaert, Kris/H-3637-2013; D'Herde, Katharina/AAM-4570-2020; Gevaert, Kris/D-6489-2017; Gevaert, Kris/AAE-4212-2019; Vandenabeele, Peter/AAD-5793-2022; Lippens, Saskia/C-1343-2009; Libert, Claude/A-6504-2010; Hoste, Esther/M-9926-2014	Van Damme, Petra/0000-0001-9090-027X; Gevaert, Kris/0000-0002-4237-0283; D'Herde, Katharina/0000-0001-6591-0476; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Vandenabeele, Peter/0000-0002-6669-8822; Lippens, Saskia/0000-0002-8261-3462; Presland, Richard/0000-0003-1440-7402; Denecker, Geertrui/0000-0002-2515-2911; Hoste, Esther/0000-0002-3181-431X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049183] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR49183] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alibardi L, 2004, J HISTOCHEM CYTOCHEM, V52, P1561, DOI 10.1369/jhc.4A6300.2004; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Chien AJ, 2002, BIOCHEM BIOPH RES CO, V296, P911, DOI 10.1016/S0006-291X(02)02015-6; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Fischer H, 2005, DIFFERENTIATION, V73, P406, DOI 10.1111/j.1432-0436.2005.00046.x; Fischer H, 2004, FEBS LETT, V577, P446, DOI 10.1016/j.febslet.2004.10.046; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lippens S, 2004, AM J PATHOL, V165, P833, DOI 10.1016/S0002-9440(10)63346-9; Lippens S, 2003, CELL DEATH DIFFER, V10, P257, DOI 10.1038/sj.cdd.4401141; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Lu YP, 2004, CANCER RES, V64, P5020, DOI 10.1158/0008-5472.CAN-04-0760; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mikolajczyk J, 2004, BIOCHEMISTRY-US, V43, P10560, DOI 10.1021/bi0498048; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings AV, 2005, J INVEST DERMATOL, V124, P1099, DOI 10.1111/j.1523-1747.2005.23726.x; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743	30	211	225	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					666	U101		10.1038/ncb1597	http://dx.doi.org/10.1038/ncb1597			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515931				2022-12-25	WOS:000246922700012
J	Masui, S; Nakatake, Y; Toyooka, Y; Shimosato, D; Yagi, R; Takahashi, K; Okochi, H; Okuda, A; Matoba, R; Sharov, AA; Ko, MSH; Niwa, H				Masui, Shinji; Nakatake, Yuhki; Toyooka, Yayoi; Shimosato, Daisuke; Yagi, Rika; Takahashi, Kazue; Okochi, Hitoshi; Okuda, Akihiko; Matoba, Ryo; Sharov, Alexei A.; Ko, Minoru S. H.; Niwa, Hitoshi			Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; ES CELLS; TRANSCRIPTIONAL REGULATION; GENE; OCT-3/4; NANOG; OCT4; DIFFERENTIATION; COMPLEX; IDENTIFICATION	The pluripotency of embryonic stem (ES) cells is thought to be maintained by a few key transcription factors, including Oct3/4 and Sox2. The function of Oct3/4 in ES cells has been extensively characterized, but that of Sox2 has yet to be determined. Sox2 can act synergistically with Oct3/4 in vitro to activate Oct-Sox enhancers, which regulate the expression of pluripotent stem cell-specific genes, including Nanog, Oct3/4 and Sox2 itself. These findings suggest that Sox2 is required by ES cells for its Oct-Sox enhancer activity. Using inducible Sox2-null mouse ES cells, we show that Sox2 is dispensable for the activation of these Oct-Sox enhancers. In contrast, we demonstrate that Sox2 is necessary for regulating multiple transcription factors that affect Oct3/4 expression and that the forced expression of Oct3/4 rescues the pluripotency of Sox2-null ES cells. These results indicate that the essential function of Sox2 is to stabilize ES cells in a pluripotent state by maintaining the requisite level of Oct3/4 expression.	RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Int Med Ctr Japan, Div Mol Biol & Cell Engn, Dept Regenerat Med, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; Kobe Univ, Lab Dev & Regenerat Med, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; Saitama Med Univ, Div Dev Biol, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; NIA, NIH, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA	RIKEN; Japan Science & Technology Agency (JST); National Center for Global Health & Medicine - Japan; Kobe University; Saitama Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Masui, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Minatojima Minamimachi 2-2-3, Kobe, Hyogo 6500047, Japan.	masui@ri.imcj.go.jp; niwa@cdb.riken.jp	Nakatake, Yuhki/K-5405-2013; Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Masui, Shinji/0000-0001-7417-0019	NATIONAL INSTITUTE ON AGING [Z01AG000662, ZIAAG000656, Z01AG000656, ZIAAG000662] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; DEROBERTIS EM, 1995, NATURE, V374, P407, DOI 10.1038/374407a0; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Rathjen J, 1999, J CELL SCI, V112, P601; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Wiebe MS, 2003, J BIOL CHEM, V278, P17901, DOI 10.1074/jbc.M212211200; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	50	836	897	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					625	U26		10.1038/ncb1589	http://dx.doi.org/10.1038/ncb1589			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515932				2022-12-25	WOS:000246922700007
J	Watanabe, K; Ueno, M; Kamiya, D; Nishiyama, A; Matsumura, M; Wataya, T; Takahashi, JB; Nishikawa, S; Nishikawa, S; Muguruma, K; Sasai, Y				Watanabe, Kiichi; Ueno, Morio; Kamiya, Daisuke; Nishiyama, Ayaka; Matsumura, Michiru; Wataya, Takafumi; Takahashi, Jun B.; Nishikawa, Satomi; Nishikawa, Shin-ichi; Muguruma, Keiko; Sasai, Yoshiki			A ROCK inhibitor permits survival of dissociated human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							ES CELLS; DIRECTED DIFFERENTIATION; EFFICIENT GENERATION; HUMAN BLASTOCYSTS; MOTOR-NEURONS; RHO-KINASE; LINES; MIDBRAIN; ESTABLISHMENT; SELECTION	Poor survival of human embryonic stem (hES) cells after cell dissociation is an obstacle to research, hindering manipulations such as subcloning. Here we show that application of a selective Rho-associated kinase (ROCK) inhibitor(1,2), Y-27632, to hES cells markedly diminishes dissociation- induced apoptosis, increases cloning efficiency (from similar to 1% to similar to 27%) and facilitates subcloning after gene transfer. Furthermore, dissociated hES cells treated with Y-27632 are protected from apoptosis even in serum-free suspension (SFEB) culture(3) and form floating aggregates. We demonstrate that the protective ability of Y-27632 enables SFEB-cultured hES cells to survive and differentiate into Bf1(+) cortical and basal telencephalic progenitors, as do SFEB-cultured mouse ES cells.	RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Stem Cell Biol Grp, Kobe, Hyogo 6500047, Japan; Natl Ctr Geriatr & Gerontol, Dept Ophthalmol, Oulu 4748511, Finland; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan	RIKEN; RIKEN; Kyoto University; Kyoto University	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Watanabe, Kiichi/ABA-4854-2020	Muguruma, Keiko/0000-0002-3149-4408				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Graczyk Piotr P, 2002, Prog Med Chem, V39, P1, DOI 10.1016/S0079-6468(08)70068-7; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Hu E, 2005, EXPERT OPIN THER TAR, V9, P715, DOI 10.1517/14728222.9.4.715; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pera MF, 2004, NAT BIOTECHNOL, V22, P42, DOI 10.1038/nbt0104-42; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7	30	1416	1635	9	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					681	686		10.1038/nbt1310	http://dx.doi.org/10.1038/nbt1310			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17529971				2022-12-25	WOS:000247077500026
J	Sandilands, A; Terron-Kwiatkowski, A; Hull, PR; O'Regan, GM; Clayton, TH; Watson, RM; Carrick, T; Evans, AT; Liao, HH; Zhao, YW; Campbell, LE; Schmuth, M; Gruber, R; Janecke, AR; Elias, PM; van Steensel, MAM; Nagtzaam, I; van Geel, M; Steijlen, PM; Munro, CS; Bradley, DG; Palmer, CNA; Smith, FJD; McLean, WHI; Irvine, AD				Sandilands, Aileen; Terron-Kwiatkowski, Ana; Hull, Peter R.; O'Regan, Grainne M.; Clayton, Timothy H.; Watson, Rosemarie M.; Carrick, Thomas; Evans, Alan T.; Liao, Haihui; Zhao, Yiwei; Campbell, Linda E.; Schmuth, Matthias; Gruber, Robert; Janecke, Andreas R.; Elias, Peter M.; van Steensel, Maurice A. M.; Nagtzaam, Ivo; van Geel, Michel; Steijlen, Peter M.; Munro, Colin S.; Bradley, Daniel G.; Palmer, Colin N. A.; Smith, Frances J. D.; McLean, W. H. Irwin; Irvine, Alan D.			Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; PREDISPOSE; DERMATITIS; POLYMORPHISMS; PROFILAGGRIN; BARRIER; COMPLEX	We recently reported two common filaggrin (FLG) null mutations that cause ichthyosis vulgaris(1) and predispose to eczema and secondary allergic diseases(2). We show here that these common European mutations are ancestral variants carried on conserved haplotypes. To facilitate comprehensive analysis of other populations, we report a strategy for full sequencing of this large, highly repetitive gene, and we describe 15 variants, including seven that are prevalent. All the variants are either nonsense or frameshift mutations that, in representative cases, resulted in loss of filaggrin production in the epidermis. In an Irish case-control study, the five most common European mutations showed a strong association with moderate-to-severe childhood eczema (chi(2) test: P = 2.12 x 10(-51); Fisher's exact test: heterozygote odds ratio (OR) = 7.44 (95% confidence interval (c. i.) = 4.9 - 11.3), and homozygote OR 151 (95% c. i. = 20 - 1,136)). We found three additional rare null mutations in this case series, suggesting that the genetic architecture of filaggrin-related atopic dermatitis consists of both prevalent and rare risk alleles.	Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Genet, Dundee DD1 9SY, Scotland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland; Innsbruck Med Univ, Dept Dermatol, Innsbruck, Austria; Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; Vet Affairs Med Ctr, Dermatol & Metab Med Serv, San Francisco, CA 94121 USA; Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands; So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	University of Dundee; Our Ladys Children Hospital Crumlin; University of Dundee; University of Dundee; Medical University of Innsbruck; Medical University of Innsbruck; US Department of Veterans Affairs; Veterans Health Administration (VHA); Maastricht University; Maastricht University Medical Centre (MUMC); University of Glasgow; Trinity College Dublin; University of Dundee; Trinity College Dublin	McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk; irvinea@tcd.ie	Bradley, Daniel G/A-3240-2012; McLean, William HI/C-6352-2009; Palmer, Colin NA/C-7053-2008; Janecke, Andreas/AAA-5227-2019; Irvine, Alan D/A-3982-2008; van Steensel, Maurice A.M./V-3852-2019; Steijlen, Peter/X-2729-2019	Palmer, Colin NA/0000-0002-6415-6560; Irvine, Alan D/0000-0002-9048-2044; van Steensel, Maurice/0000-0002-7507-2442; Schmuth, Matthias/0000-0002-4064-1334; Bradley, Daniel G/0000-0001-7335-7092; Janecke, Andreas/0000-0001-7155-0315; McLean, William Henry Irwin/0000-0001-5539-5757; Hull, Peter/0000-0002-3896-9373	MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gruber R, 2007, EUR J HUM GENET, V15, P179, DOI 10.1038/sj.ejhg.5201742; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Irvine AD, 2006, J INVEST DERMATOL, V126, P1200, DOI 10.1038/sj.jid.5700365; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V1; Katagiri C, 2003, J DERMATOL SCI, V31, P29, DOI 10.1016/S0923-1811(02)00137-8; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Ruether A, 2006, BRIT J DERMATOL, V155, P1093, DOI 10.1111/j.1365-2133.2006.07500.x; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630	24	447	469	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					650	654		10.1038/ng2020	http://dx.doi.org/10.1038/ng2020			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417636				2022-12-25	WOS:000245971300021
J	Weber, M; Hellmann, I; Stadler, MB; Ramos, L; Paabo, S; Rebhan, M; Schubeler, D				Weber, Michael; Hellmann, Ines; Stadler, Michael B.; Ramos, Liliana; Paabo, Svante; Rebhan, Michael; Schubeler, Dirk			Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome	NATURE GENETICS			English	Article							CPG-BINDING-PROTEIN; GENE-EXPRESSION; GERM-CELL; ISLANDS; WIDE; PATTERNS; PROFILE; CANCER; MOUSE; HYPOMETHYLATION	To gain insight into the function of DNA methylation at cis-regulatory regions and its impact on gene expression, we measured methylation, RNA polymerase occupancy and histone modifications at 16,000 promoters in primary human somatic and germline cells. We find CpG-poor promoters hypermethylated in somatic cells, which does not preclude their activity. This methylation is present in male gametes and results in evolutionary loss of CpG dinucleotides, as measured by divergence between humans and primates. In contrast, strong CpG island promoters are mostly unmethylated, even when inactive. Weak CpG island promoters are distinct, as they are preferential targets for de novo methylation in somatic cells. Notably, most germline-specific genes are methylated in somatic cells, suggesting additional functional selection. These results show that promoter sequence and gene function are major predictors of promoter methylation states. Moreover, we observe that inactive unmethylated CpG island promoters show elevated levels of dimethylation of Lys4 of histone H3, suggesting that this chromatin mark may protect DNA from methylation.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Copenhagen, DK-2100 Copenhagen, Denmark; Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands	Friedrich Miescher Institute for Biomedical Research; Max Planck Society; University of Copenhagen; Radboud University Nijmegen	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ramos, L./L-4590-2015; Weber, Michael/P-1914-2016	Weber, Michael/0000-0003-3484-5821				Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CHOI YC, 1991, J BIOL CHEM, V266, P20504; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singal R, 2000, BIOL REPROD, V63, P1237, DOI 10.1095/biolreprod63.5.1237; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	50	1563	1642	10	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					457	466		10.1038/ng1990	http://dx.doi.org/10.1038/ng1990			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334365				2022-12-25	WOS:000245271200015
J	Yang, ZF; Mott, S; Rosmarin, AG				Yang, Zhong-Fa; Mott, Stephanie; Rosmarin, Alan G.			The Ets transcription factor GABP is required for cell-cycle progression	NATURE CELL BIOLOGY			English	Article							MOUSE DNA-POLYMERASE; BINDING-PROTEIN; GENE-EXPRESSION; ALPHA; SKP2; E2F; ACTIVATION; SUBUNITS; PROMOTER; COMPLEX	The transition from cellular quiescence (G0) into S phase is regulated by the mitogenic-activation of D-type cyclins and cyclin-dependent kinases (Cdks), the sequestration of the Cdk inhibitors (CDKIs), p21 and p27, and the hyperphosphorylation of Rb with release of E2F transcription factors(1,2). However, fibroblasts that lack all D-type cyclins can still undergo serum-induced proliferation(3) and key E2F targets are expressed at stable levels despite cyclical Rb-E2F activity(1). Here, we show that serum induces expression of the Ets transcription factor, Gabp alpha, and that its ectopic expression induces quiescent cells to re-enter the cell cycle. Genetic disruption of Gabpa prevents entry into S phase, and selectively reduces expression of genes that are required for DNA synthesis and degradation of CDKIs, yet does not alter expression of D-type cyclins, Cdks, Rb or E2Fs. Thus, GABP is necessary and sufficient for re-entry into the cell cycle and it regulates a pathway that is distinct from that of D-type cyclins and CDKs.	Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; Brown Univ, Sch Med, Div Hematol Oncol, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Rosmarin, AG (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Rosmarin@Brown.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757, P20RR017695, P20RR015578] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073945] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20RR018757, P20 RR15578, 1P20RR017695] Funding Source: Medline; NHLBI NIH HHS [1R01HL073945] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CARTER RS, 1992, J BIOL CHEM, V267, P23418; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Genuario R. Robert, 1993, Gene Expression, V3, P279; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Imaki H, 2003, CANCER RES, V63, P4607; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Luo ML, 1999, GENE, V234, P119, DOI 10.1016/S0378-1119(99)00167-5; MIYAZAWA H, 1993, J BIOL CHEM, V268, P8111; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; Nishikawa NS, 2001, GENES CELLS, V6, P57, DOI 10.1046/j.1365-2443.2001.00395.x; Resendes KK, 2006, MOL CELL BIOL, V26, P3060, DOI 10.1128/MCB.26.8.3060-3070.2006; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rudge TL, 2002, EXP CELL RES, V274, P45, DOI 10.1006/excr.2001.5451; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sucharov C, 1995, GENE EXPRESSION, V5, P93; Villena JA, 1998, BIOCHEM J, V331, P121, DOI 10.1042/bj3310121; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	30	81	81	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					339	U164		10.1038/ncb1548	http://dx.doi.org/10.1038/ncb1548			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277770				2022-12-25	WOS:000244558600019
J	Buey, RM; Calvo, E; Barasoain, I; Pineda, O; Edler, MC; Matesanz, R; Cerezo, G; Vanderwal, CD; Day, BW; Sorensen, EJ; Lopez, JA; Andreu, JM; Hamel, E; Diaz, JF				Buey, Ruben M.; Calvo, Enrique; Barasoain, Isabel; Pineda, Oriol; Edler, Michael C.; Matesanz, Ruth; Cerezo, Gemma; Vanderwal, Christopher D.; Day, Billy W.; Sorensen, Erik J.; Lopez, Juan Antonio; Andreu, Jose Manuel; Hamel, Ernest; Diaz, J. Fernando			Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites	NATURE CHEMICAL BIOLOGY			English	Article							ANTIMITOTIC SUBSTANCE; BETA-TUBULIN; CANCER-CELLS; GDP-TUBULIN; THERMODYNAMICS; FR182877; CYTOTOXICITY; EPOTHILONE; RESISTANCE; INHIBITOR	Cyclostreptin ( 1), a natural product from Streptomyces sp. 9885, irreversibly stabilizes cellular microtubules, causes cell cycle arrest, evades drug resistance mediated by P- glycoprotein in a tumor cell line and potently inhibits paclitaxel binding to microtubules, yet it only weakly induces tubulin assembly. In trying to understand this paradox, we observed irreversible binding of synthetic cyclostreptin to tubulin. This results from formation of covalent crosslinks to beta- tubulin in cellular microtubules and microtubules formed from purified tubulin in a 1: 1 total stoichiometry distributed between Thr220 ( at the outer surface of a pore in the microtubule wall) and Asn228 ( at the lumenal paclitaxel site). Unpolymerized tubulin was only labeled at Thr220. Thus, the pore region of beta- tubulin is an undescribed binding site that ( i) elucidates the mechanism by which taxoid-site compounds reach the kinetically unfavorable lumenal site and ( ii) explains how taxoid-site drugs induce microtubule formation from dimeric and oligomeric tubulin.	CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; Ctr Nacl Invest Cardiovasc, Unidad Proteom, Madrid 28029, Spain; Univ Barcelona, Fac Quim, Dept Quim Organ, E-08028 Barcelona, Spain; NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; PharmaMar SA, Colmenar Viejo 28770, Spain; Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Irvine; PharmaMar; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Diaz, JF (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, E-28040 Madrid, Spain.	fer@cib.csic.es	Martinez-Buey, Ruben/K-4296-2014; Díaz, J. Fernando/U-3532-2017; Díaz, J. Fernando/M-6853-2019; Lopez, Juan Antonio/G-7750-2015	Martinez-Buey, Ruben/0000-0003-1263-0221; Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; Lopez, Juan Antonio/0000-0002-9097-6060; Day, Billy/0000-0001-6208-9950; Andreu, Jose M/0000-0001-8064-6933				Adam GC, 2003, ANGEW CHEM INT EDIT, V42, P5480, DOI 10.1002/anie.200352576; Andreu JM, 2001, BIOCHEMISTRY-US, V40, P11975, DOI 10.1021/bi010869+; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Buey RM, 2004, CHEM BIOL, V11, P225, DOI 10.1016/j.chembiol.2004.01.014; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Diaz JF, 2000, J BIOL CHEM, V275, P26265, DOI 10.1074/jbc.M003120200; Diaz JF, 1996, BIOPHYS J, V70, P2408, DOI 10.1016/S0006-3495(96)79809-0; Diaz JF, 2005, J BIOL CHEM, V280, P3928, DOI 10.1074/jbc.M407816200; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Edler MC, 2005, BIOCHEMISTRY-US, V44, P11525, DOI 10.1021/bi050660m; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Henness S, 2006, DRUGS, V66, P1625, DOI 10.2165/00003495-200666120-00012; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PARNESS J, 1981, J CELL BIOL, V91, P479, DOI 10.1083/jcb.91.2.479; Sato B, 2000, J ANTIBIOT, V53, P204, DOI 10.7164/antibiotics.53.204; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Vanderwal CD, 2003, J AM CHEM SOC, V125, P5393, DOI 10.1021/ja021472b; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; Yoshimura S, 2000, J ANTIBIOT, V53, P615, DOI 10.7164/antibiotics.53.615	31	115	119	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2007	3	2					117	125		10.1038/nchembio853	http://dx.doi.org/10.1038/nchembio853			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	128UZ	17206139	Green Submitted			2022-12-25	WOS:000243685800016
J	Suk, J; Bruce, A; Gertz, R; Warkup, C; Whitelaw, CBA; Braun, A; Oram, C; Rodriguez-Cerezo, E; Papatryfon, I				Suk, J.; Bruce, A.; Gertz, R.; Warkup, C.; Whitelaw, C. B. A.; Braun, A.; Oram, C.; Rodriguez-Cerezo, E.; Papatryfon, I.			Dolly for dinner? Assessing commercial and regulatory trends in cloned livestock	NATURE BIOTECHNOLOGY			English	Article							MEAT-PRODUCTS; MILK; CLONING; CATTLE; SHEEP	As cloning technologies become more widely established, will products enter the food chain sooner than regulatory agencies and the public might be prepared for?	Univ Edinburgh, ESRC Genom Policy & Res Forum, Edinburgh, Midlothian, Scotland; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Edinburgh, Old Coll, AHRC Ctr Studies Intellectual Property & Technol, Edinburgh, Midlothian, Scotland; Roslin BioCtr, Genesis Faraday Partnership, Roslin, Midlothian, Scotland; VDI Technol Zentrum GmbH, Ffuture Technol Div, Dusseldorf, Germany; IPTS, JRC, European Commiss, Seville, Spain	UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; European Commission Joint Research Centre; EC JRC Institute for Prospective Technological Studies (IPTS)	Suk, J (corresponding author), Univ Edinburgh, ESRC Genom Policy & Res Forum, St Johns Land, Edinburgh, Midlothian, Scotland.			Whitelaw, Bruce/0000-0002-2918-1605	Economic and Social Research Council [RES-145-28-1005, ES/F028180/1] Funding Source: researchfish; ESRC [ES/F028180/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2006, WTDS293R; Clark J, 2003, NAT REV GENET, V4, P825, DOI 10.1038/nrg1183; *DTI MORI, 2005, SCI SOC; Einsiedel EF, 2000, NAT BIOTECHNOL, V18, P943, DOI 10.1038/79419; *EUR COMM, 2005, ATT CONS WELF FARM A, V229; *EUR COMM I PROSP, 2007, IN PRESS AN CLON GEN; GAMBORG C, 2006, REGULATION FARM ANIM; Gaskell G., 2000, AgBioForum, V3, P87; GASKELL GSS, 2005, EUROPEANS BIOTECHNOL; Grove-White R., 2000, WISING PUBLIC NEW TE; Jasanoff S, 2003, MINERVA, V41, P223, DOI 10.1023/A:1025557512320; MACNAGHTEN P, 2001, ANIMAL FUTURES REPOR; MARRIS C, 2001, CR983844 FAIR; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; *NAT RES COUNC, 1996, UND RISK INF DEC DEM; Norman HD, 2004, CLONING STEM CELLS, V6, P157, DOI 10.1089/1536230041372346; *PEW IN FOOD BIOTE, 2004, OV FIND 2004 FOC GRO; Sagar A, 2000, NAT BIOTECHNOL, V18, P2, DOI 10.1038/71861; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; SUPPAN S, 2006, WTOS EC BIOTECH PROD; Takahashi S, 2004, CLONING STEM CELLS, V6, P165, DOI 10.1089/1536230041372265; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; Tome D, 2004, CLONING STEM CELLS, V6, P172, DOI 10.1089/1536230041372445; *US FDA, 2003, AN CLON RISK ASS DRA; WEISS R, 2006, WASHINGTON POST 1017; WILMUT I, 1997, NATURE, V385, P813; *WORLD TRAD ORG, 2006, WTDS292R; *WORLD TRAD ORG, 2006, WTDS291R; Zarrilli S., 2005, INT TRADE GMOS GM PR	29	21	21	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2007	25	1					47	53		10.1038/nbt0107-47	http://dx.doi.org/10.1038/nbt0107-47			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	126CY	17211395				2022-12-25	WOS:000243491000023
J	Buonomano, DV				Buonomano, Dean V.			The biology of time across different scales	NATURE CHEMICAL BIOLOGY			English	Editorial Material							TEMPORAL INFORMATION; CIRCADIAN-RHYTHMS; TIMING MECHANISMS; NEURAL-NETWORK; REPRESENTATION; SPEECH; MODEL	Animals time events on scales that span from microseconds to days. In contrast to the technologies devised by humans to keep track of time, biology has developed vastly different mechanisms for timing across these different scales.	Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Box 951761, Los Angeles, CA 90095 USA.	dbuono@ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER; NIMH NIH HHS [MH060163] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Schirmer A, 2004, COGNITIVE BRAIN RES, V21, P269, DOI 10.1016/j.cogbrainres.2004.04.003; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303	22	70	74	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2007	3	10					594	597		10.1038/nchembio1007-594	http://dx.doi.org/10.1038/nchembio1007-594			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	213CE	17876310				2022-12-25	WOS:000249642700002
J	Chakravarty, S; Cockburn, IA; Kuk, S; Overstreet, MG; Sacci, JB; Zavala, F				Chakravarty, Sumana; Cockburn, Ian A.; Kuk, Salih; Overstreet, Michael G.; Sacci, John B.; Zavala, Fidel			CD8(+) T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes	NATURE MEDICINE			English	Article							MARROW-DERIVED CELLS; CIRCUMSPOROZOITE PROTEIN; PLASMODIUM-YOELII; DENDRITIC CELLS; SPOROZOITE INFECTION; ANTIGEN PRESENTATION; KUPFFER CELLS; IMMUNITY; RESPONSES; MICE	The success of immunization with irradiated sporozoites is unparalleled among the current vaccination approaches against malaria, but its mechanistic underpinnings have yet to be fully elucidated. Using a model mimicking natural infection by Plasmodium yoelii, we delineated early events governing the development of protective CD8(+) T-cell responses to the circumsporozoite protein. We demonstrate that dendritic cells in cutaneous lymph nodes prime the first cohort of CD8+ T cells after an infectious mosquito bite. Ablation of these lymphoid sites greatly impairs subsequent development of protective immunity. Activated CD8+ T cells then travel to systemic sites, including the liver, in a sphingosine-1-phosphate(S1P)-dependent fashion. These effector cells, however, no longer require bone marrow-derived antigen-presenting cells for protection; instead, they recognize antigen on parenchymal cells-presumably parasitized hepatocytes. Therefore, we report an unexpected dichotomy in the tissue restriction of host responses during the development and execution of protective immunity to Plasmodium.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Zavala, F (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	fzavala@jhsph.edu	Kuk, Salih/ABA-7923-2020	Cockburn, Ian/0000-0001-8220-9294; Overstreet, Michael/0000-0001-7450-7929	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044375, R21AI044375] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44375] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Baer K, 2007, CELL MICROBIOL, V9, P397, DOI 10.1111/j.1462-5822.2006.00798.x; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Cantz T, 2004, CELL TRANSPLANT, V13, P659, DOI 10.3727/000000004783983521; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frevert U, 2006, CELL MICROBIOL, V8, P1537, DOI 10.1111/j.1462-5822.2006.00777.x; Hafalla JCR, 2003, J IMMUNOL, V171, P964, DOI 10.4049/jimmunol.171.2.964; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Hafalla JCR, 2006, EUR J IMMUNOL, V36, P1179, DOI 10.1002/eji.200535712; HAMILTON AJ, 1988, CELL BIOL INT REP, V12, P123, DOI 10.1016/0309-1651(88)90126-9; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Krzych U, 2000, IMMUNOL REV, V174, P123, DOI 10.1034/j.1600-0528.2002.00013h.x; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Milling SWF, 2006, NAT PROTOC, V1, P2263, DOI 10.1038/nprot.2006.315; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; PARADIS K, 1990, J PEDIATR GASTR NUTR, V11, P525, DOI 10.1097/00005176-199011000-00014; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Radhakrishnan S, 2005, P NATL ACAD SCI USA, V102, P11438, DOI 10.1073/pnas.0501420102; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; STEWART MJ, 1991, J PROTOZOOL, V38, P411, DOI 10.1111/j.1550-7408.1991.tb01379.x; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Waters AP, 2005, SCIENCE, V307, P528, DOI 10.1126/science.1108598; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x; Yrlid U, 2003, APMIS, V111, P756, DOI 10.1034/j.1600-0463.2003.11107807.x	48	196	205	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1035	1041		10.1038/nm1628	http://dx.doi.org/10.1038/nm1628			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17704784				2022-12-25	WOS:000249353100030
J	Lee-Kirsch, MA; Gong, M; Chowdhury, D; Senenko, L; Engel, K; Lee, YA; de Silva, U; Bailey, SL; Witte, T; Vyse, TJ; Kere, J; Pfeiffer, C; Harvey, S; Wong, A; Koskenmies, S; Hummel, O; Rohde, K; Schmidt, RE; Dominiczak, AF; Gahr, M; Hollis, T; Perrino, FW; Lieberman, J; Hubner, N				Lee-Kirsch, Min Ae; Gong, Maolian; Chowdhury, Dipanjan; Senenko, Lydia; Engel, Kerstin; Lee, Young-Ae; de Silva, Udesh; Bailey, Suzanna L.; Witte, Torsten; Vyse, Timothy J.; Kere, Juha; Pfeiffer, Christiane; Harvey, Scott; Wong, Andrew; Koskenmies, Sari; Hummel, Oliver; Rohde, Klaus; Schmidt, Reinhold E.; Dominiczak, Anna F.; Gahr, Manfred; Hollis, Thomas; Perrino, Fred W.; Lieberman, Judy; Huebner, Norbert			Mutations in the gene encoding the 3 '-5 ' DNA exonuclease TREX1 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							NUCLEAR-BODIES	TREX1 acts in concert with the SET complex in granzyme A - mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutieres syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/ 417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P= 4.1x10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.	Tech Univ Dresden, Klin Kinder & Jugendmed, D-01307 Dresden, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Harvard Univ, Sch Med, Dept Pediat, CBR Inst Biomed Res, Boston, MA 02125 USA; Charite Univ Med Berlin, D-13353 Berlin, Germany; Wake Forest Univ Hlth Sci, Dept Biochem, Ctr Struct Biol, Winston Salem, NC 27157 USA; Hannover Med Sch, Klin Immunol, D-30625 Hannover, Germany; Hammersmith Hosp, Imperial Coll, Fac Med, Sect Rheumatol & Mol Genet, London W12 0NN, England; Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; Clin Res Ctr, S-14157 Huddinge, Sweden; Tech Univ Dresden, Dermatol Klin, D-01307 Dresden, Germany; Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Dermatol, FIN-00014 Helsinki, Finland; Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland	Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wake Forest University; Wake Forest University School of Medicine; Hannover Medical School; Imperial College London; Karolinska Institutet; Technische Universitat Dresden; Wake Forest University; Wake Forest University School of Medicine; University of Helsinki; University of Helsinki; University of Glasgow	Lee-Kirsch, MA (corresponding author), Tech Univ Dresden, Klin Kinder & Jugendmed, D-01307 Dresden, Germany.	minae.lee-kirsch@uniklinikum-dresden.de; nhuebner@mdc-berlin.de	Dominiczak, Anna F/P-9390-2017; Kere, Juha/A-9179-2008; Wong, Andrew/AAE-6995-2019; Wong, Andrew/M-8899-2016; Witte, Torsten/B-5783-2016; Lieberman, Judy/A-2717-2015; Kere, Juha/AAX-9117-2021; Dominiczak, Anna F/D-2262-2009; Lee-Kirsch, Min Ae/C-5769-2018	Dominiczak, Anna F/0000-0003-4913-3608; Kere, Juha/0000-0003-1974-0271; Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Kere, Juha/0000-0003-1974-0271; 	NIAID NIH HHS [AI45587] Funding Source: Medline; NIGMS NIH HHS [GM069962] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045587, R56AI045587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	15	479	495	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1065	1067		10.1038/ng2091	http://dx.doi.org/10.1038/ng2091			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660818				2022-12-25	WOS:000249122400013
J	Bagnat, M; Cheung, ID; Mostov, KE; Stainier, DYR				Bagnat, Michel; Cheung, Isla D.; Mostov, Keith E.; Stainier, Didier Y. R.			Genetic control of single lumen formation in the zebrafish gut	NATURE CELL BIOLOGY			English	Article							TIGHT JUNCTIONS; TUBE MORPHOGENESIS; NAGIE-OKO; PROTEIN; DROSOPHILA; CLAUDINS; SYSTEM; FAMILY; CELL; SPECIFICATION	Most organs consist of networks of interconnected tubes that serve as conduits to transport fluid and cells and act as physiological barriers between compartments. Biological tubes are assembled through very diverse developmental processes that generate structures of different shapes and sizes. Nevertheless, all biological tubes invariably possess one single lumen. The mechanisms responsible for single lumen specification are not known. Here we show that zebrafish mutants for the MODY5 and familial GCKD gene tcf2 ( also known as vhnf1) fail to specify a single lumen in their gut tube and instead develop multiple lumens. We show that Tcf2 controls single lumen formation by regulating claudin15 and Na+/K+-ATPase expression. Our in vivo and in vitro results indicate that Claudin15 functions in paracellular ion transport to specify single lumen formation. This work shows that single lumen formation is genetically controlled and appears to be driven by the accumulation of fluid.	Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Genet & Human Genet, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94147 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bagnat, M (corresponding author), Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	michel.bagnat@ucsf.edu; dstainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026; mostov, keith/0000-0002-8123-6247; Bagnat, Michel/0000-0002-3829-0168				Barbacci E, 1999, DEVELOPMENT, V126, P4795; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GRANTHAM JJ, 1995, J CLIN INVEST, V95, P195, DOI 10.1172/JCI117638; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; Kubota K, 1999, CURR BIOL, V9, P1035, DOI 10.1016/S0960-9822(99)80452-7; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie Christina M, 2004, Proc Am Thorac Soc, V1, P38, DOI 10.1513/pats.2306013; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134	31	189	193	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					954	U119		10.1038/ncb1621	http://dx.doi.org/10.1038/ncb1621			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17632505				2022-12-25	WOS:000248486700017
J	Gudmundsson, J; Sulem, P; Steinthorsdottir, V; Bergthorsson, JT; Thorleifsson, G; Manolescu, A; Rafnar, T; Gudbjartsson, D; Agnarsson, BA; Baker, A; Sigurdsson, A; Benediktsdottir, KR; Jakobsdottir, M; Blondal, T; Stacey, SN; Helgason, A; Gunnarsdottir, S; Olafsdottir, A; Kristinsson, KT; Birgisdottir, B; Ghosh, S; Thorlacius, S; Magnusdottir, D; Stefansdottir, G; Kristjansson, K; Bagger, Y; Wilensky, RL; Reilly, MP; Morris, AD; Kimber, CH; Adeyemo, A; Chen, Y; Zhou, J; So, WY; Tong, PCY; Ng, MCY; Hansen, T; Andersen, G; Borch-Johnsen, K; Jorgensen, T; Tres, A; Fuertes, F; Ruiz-Echarri, M; Asin, L; Saez, B; van Boven, E; Klaver, S; Swinkels, DW; Aben, KK; Graif, T; Cashy, J; Suarez, BK; van Vierssen, O; Frigge, ML; Ober, C; Hofker, MH; Wijmenga, C; Christiansen, C; Rader, DJ; Palmer, CNA; Rotimi, C; Chan, JCN; Pedersen, O; Sigurdsson, G; Benediktsson, R; Jonsson, E; Einarsson, GV; Mayordomo, JI; Catalona, WJ; Kiemeney, LA; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Steinthorsdottir, Valgerdur; Bergthorsson, Jon T.; Thorleifsson, Gudmar; Manolescu, Andrei; Rafnar, Thorunn; Gudbjartsson, Daniel; Agnarsson, Bjarni A.; Baker, Adam; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Jakobsdottir, Margret; Blondal, Thorarinn; Stacey, Simon N.; Helgason, Agnar; Gunnarsdottir, Steinunn; Olafsdottir, Adalheidur; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Thorlacius, Steinunn; Magnusdottir, Dana; Stefansdottir, Gerdur; Kristjansson, Kristleifur; Bagger, Yu; Wilensky, Robert L.; Reilly, Muredach P.; Morris, Andrew D.; Kimber, Charlotte H.; Adeyemo, Adebowale; Chen, Yuanxiu; Zhou, Jie; So, Wing-Yee; Tong, Peter C. Y.; Ng, Maggie C. Y.; Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; Tres, Alejandro; Fuertes, Fernando; Ruiz-Echarri, Manuel; Asin, Laura; Saez, Berta; van Boven, Erica; Klaver, Siem; Swinkels, Dorine W.; Aben, Katja K.; Graif, Theresa; Cashy, John; Suarez, Brian K.; van Vierssen, Onco; Frigge, Michael L.; Ober, Carole; Hofker, Marten H.; Wijmenga, Cisca; Christiansen, Claus; Rader, Daniel J.; Palmer, Colin N. A.; Rotimi, Charles; Chan, Juliana C. N.; Pedersen, Oluf; Sigurdsson, Gunnar; Benediktsson, Rafn; Jonsson, Eirikur; Einarsson, Gudmundur V.; Mayordomo, Jose I.; Catalona, William J.; Kiemeney, Lambertus A.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes	NATURE GENETICS			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-BETA; LINKAGE; ASSOCIATION; FAMILIES; MUTATIONS; GENES; GENETICS; UNCOMMON; BRCA1; SCAN	We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer and 11,290 controls. Follow-up studies involving three additional case-control groups replicated an association of two variants on chromosome 17 with the disease. These two variants, 33 Mb apart, fall within a region previously implicated by family-based linkage studies on prostate cancer. The risks conferred by these variants are moderate individually ( allele odds ratio of about 1.20), but because they are common, their joint population attributable risk is substantial. One of the variants is in TCF2 ( HNF1 beta), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5. Results from eight case-control groups, including one West African and one Chinese, demonstrate that this variant confers protection against type 2 diabetes.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Howard Univ, Natl Human Genome Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; Glostrup Univ Hosp, Ctr Res Prevent & Hlth, DK-2600 Glostrup, Denmark; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; Nanotechnol Inst Aragon, Inst Hlth Sci, Zaragoza 50009, Spain; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Radiat Oncol, E-50009 Zaragoza, Spain; Maas Ziekenhuis, Dept Urol, NL-5830 AB Boxmeer, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Gelderse Vallei Hosp, Dept Urol, NL-6716 RP Ede, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands; Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Radboud Univ Nijmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Center Clinical & Basic Research; University of Pennsylvania; University of Dundee; University of Dundee; Howard University; Chinese University of Hong Kong; Prince of Wales Hospital; Steno Diabetes Center; Aarhus University; University of Copenhagen; Lozano Blesa University Clinical Hospital; University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza; Radboud University Nijmegen; Radboud University Nijmegen; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Gelderse Vallei Hospital; University of Chicago; University of Groningen; Maastricht University; University of Groningen; Utrecht University; Utrecht University Medical Center; Icelandic Heart Association; Landspitali National University Hospital; Radboud University Nijmegen	Gudmundsson, J (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	julius.gudmundsson@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Wijmenga, Cisca/D-2173-2009; Benediktsson, Rafn/R-2457-2018; Swinkels, Dorine W./H-8098-2014; Kiemeney, Lambertus A./D-3357-2009; Wijmenga, Cisca/AAE-7719-2019; Chan, Juliana/B-7918-2016; Aben, Katja KH/G-9686-2016; Mayordomo, Jose/K-3453-2013; Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Morris, Andrew D/C-2837-2009; Palmer, Colin NA/C-7053-2008; Study, GoDARTS/K-9448-2016; ASIN, LAURA/H-7276-2017; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Benediktsson, Rafn/0000-0002-2954-9801; Swinkels, Dorine W./0000-0002-1040-9446; Kiemeney, Lambertus A./0000-0002-2368-1326; Wijmenga, Cisca/0000-0002-5635-1614; Chan, Juliana/0000-0003-1325-1194; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Palmer, Colin NA/0000-0002-6415-6560; ASIN, LAURA/0000-0003-0641-3407; Pedersen, Oluf/0000-0002-3321-3972; Kong, Augustine/0000-0001-8193-5438; Ober, Carole/0000-0003-4626-9809; Adeyemo, Adebowale/0000-0002-3105-3231; Saez, Berta/0000-0003-0753-1165; Jorgensen, Torben/0000-0001-9453-2830; Bergthorsson, Jon Thor/0000-0002-0560-2639; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reilly, Muredach/0000-0002-3035-9386; Hansen, Torben/0000-0001-8748-3831	FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072128] Funding Source: NIH RePORTER; FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NCRR NIH HHS [RR03048] Funding Source: Medline; NIDDK NIH HHS [DK072128] Funding Source: Medline; Wellcome Trust Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hill-Harfe KL, 2005, AM J HUM GENET, V76, P663, DOI 10.1086/429254; KASPER JS, 2006, BIOMARKERS PREV, V15, P2056; Kraft P, 2005, PLOS GENET, V1, P603, DOI 10.1371/journal.pgen.0010068; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lange EM, 2007, HUM GENET, V121, P49, DOI 10.1007/s00439-006-0274-2; MANTEL N, 1959, J NATL CANCER I, V22, P719; RISCH N, 1990, AM J HUM GENET, V46, P222; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; White KA, 2006, PROSTATE CANCER P D, V9, P298, DOI 10.1038/sj.pcan.4500878; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	23	565	590	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					977	983		10.1038/ng2062	http://dx.doi.org/10.1038/ng2062			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603485				2022-12-25	WOS:000248446900014
J	Chen, CJ; Kono, H; Golenbock, D; Reed, G; Akira, S; Rock, KL				Chen, Chun-Jen; Kono, Hajime; Golenbock, Douglas; Reed, George; Akira, Shizuo; Rock, Kenneth L.			Identification of a key pathway required for the sterile inflammatory response triggered by dying cells	NATURE MEDICINE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HEPATIC ISCHEMIA-REPERFUSION; TUMOR-NECROSIS-FACTOR; ACTIVATE B-CELLS; NEUTROPHIL DEPLETION; INJURY; MECHANISMS; BLOCKADE; ANTIBODY; HMGB1	Dying cells stimulate inflammation, and this response is thought to contribute to the pathogenesis of many diseases. Very little has been known, however, about how cell death triggers inflammation. We found here that the acute neutrophilic inflammatory response to cell injury requires the signaling protein myeloid differentiation primary response gene 88 (Myd88). Analysis of the contribution of Myd88-dependent receptors to this response revealed only a minor reduction in mice doubly deficient in Toll-like receptor 2 (Tlr2) and Tlr4 and normal responses in mice lacking Tlr1, Tlr3, Tlr6, Tlr7, Tlr9, Tlr11 or the interleukin-18 receptor (IL-18R). However, mice lacking IL-1R showed a markedly reduced neutrophilic inflammatory response to dead cells and tissue injury in vivo as well as greatly decreased collateral damage from inflammation. This inflammatory response required IL-1 alpha, and IL-1R function was required on non-bone-marrow-derived cells. Notably, the acute monocyte response to cell death, which is thought to be important for tissue repair, was much less dependent on the IL-1R-Myd88 pathway. Also, this pathway was not required for the neutrophil response to a microbial stimulus. These findings suggest that inhibiting the IL-1R-Myd88 pathway in vivo could block the damage from acute inflammation that occurs in response to sterile cell death, and do so in a way that might not compromise tissue repair or host defense against pathogens.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Natl Taiwan Univ, Inst Microbiol & Biochem, Taipei 10617, Taiwan; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	University of Massachusetts System; University of Massachusetts Worcester; National Taiwan University; University of Massachusetts System; University of Massachusetts Worcester; Osaka University	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 55 Lake Ave N,Room S2-109, Worcester, MA 01655 USA.	kenneth.rock@umassmed.edu	Hsiao, Wei-Hung/B-9931-2013; Akira, Shizuo/C-3134-2009; Chen, Chun-Jen/D-9647-2013	Chen, Chun-Jen/0000-0002-9211-8641; Kono, Hajime/0000-0002-4578-8677	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ANTMAN EM, 2001, ACUTE MYOCARDIAL INF, P1114; Balding DJ, 2004, APPL LONGITUDINAL AN; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; FISHER CJ, 1994, CIRC SHOCK, V44, P1; FISHER TC, 1994, THROMB RES, V74, pS21, DOI 10.1016/S0049-3848(10)80004-0; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaeschke Hartmut, 2005, Expert Opin Drug Metab Toxicol, V1, P389, DOI 10.1517/17425255.1.3.389; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; MAJNO G, 1960, VIRCHOWS ARCH A, V333, P421, DOI 10.1007/BF00955327; Palmer G, 2003, EUR J IMMUNOL, V33, P434, DOI 10.1002/immu.200310018; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Sawa Y, 1996, CIRCULATION, V93, P1640, DOI 10.1161/01.CIR.93.9.1640; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Shito M, 1997, TRANSPLANTATION, V63, P143, DOI 10.1097/00007890-199701150-00026; Suzuki K, 2001, CIRCULATION, V104, pI308; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zingarelli B, 1999, GASTROENTEROLOGY, V116, P335, DOI 10.1016/S0016-5085(99)70130-7	30	650	685	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					851	856		10.1038/nm1603	http://dx.doi.org/10.1038/nm1603			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17572686	Green Published			2022-12-25	WOS:000247902800032
J	Mara, A; Schroeder, J; Chalouni, C; Holley, SA				Mara, Andrew; Schroeder, Joshua; Chalouni, Cecile; Holley, Scott A.			Priming, initiation and synchronization of the segmentation clock by deltaD and deltaC	NATURE CELL BIOLOGY			English	Article							ZEBRAFISH SOMITE-SEGMENTATION; GENE-EXPRESSION; LUNATIC-FRINGE; NOTCH; SOMITOGENESIS; HER1; CELL; OSCILLATOR; BOUNDARIES; ANTERIOR	Zebrafish somitogenesis is governed by a segmentation clock that generates oscillations in expression of several Notch pathway genes, including her1, her7 and deltaC(1-6). Using a combination of pharmacological inhibition and Mendelian genetics, we show that DeltaD and DeltaC, two Notch ligands, represent functionally distinct signals within the segmentation clock. Using high- resolution fluorescent in situ hybridization7, the oscillations were divided into phases based on eight distinct subcellular patterns of mRNA localization for 140,000 cells. her1, her7 and deltaC expression was examined in wild- type, deltaD(-/-) and deltaC(-/-) embryos. We identified areas within the tailbud where the clock is set up in the progenitor cells (priming), where the clock starts running (initiation), and where the clocks of neighbouring cells are entrained (synchronization). We find that the clocks of motile cells are primed by deltaD in a progenitor zone in the posterior tailbud and that deltaD is required for cells to initiate oscillations on exiting this zone. Oscillations of adjacent cells are synchronized and amplified by deltaC in the posterior presomitic mesoderm as cell movement subsides and cells maintain stable neighbour relationships.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Holley, SA (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	scott.holley@yale.edu			NICHD NIH HHS [R01 HD045738] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045738] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; COOKE I, 1981, PHILOS T R SOC B, V295, P509, DOI 10.1098/rstb.1981.0157; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Henry CA, 2002, DEVELOPMENT, V129, P3693; Henry CA, 2000, CURR BIOL, V10, P1063, DOI 10.1016/S0960-9822(00)00677-1; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kanki JP, 1997, DEVELOPMENT, V124, P881; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Takke C, 1999, DEVELOPMENT, V126, P3005; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153	38	76	77	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					523	U69		10.1038/ncb1578	http://dx.doi.org/10.1038/ncb1578			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417625				2022-12-25	WOS:000246181500010
J	Li, JY; Brieher, WM; Scimone, ML; Kang, SJ; Zhu, H; Yin, H; von Andrian, UH; Mitchison, T; Yuan, JY				Li, Juying; Brieher, William M.; Scimone, M. Lucila; Kang, Shin Jung; Zhu, Hong; Yin, Helen; von Andrian, Ulrich H.; Mitchison, Timothy; Yuan, Junying			Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN-1; FILAMENTS; COFILIN; FACTOR/COFILIN; IDENTIFICATION; REQUIREMENTS; ACTIVATION; DYNAMICS; EFFECTOR; MOTILITY	Coordinated regulation of cell migration, cytokine maturation and apoptosis is critical in inflammatory responses. Caspases, a family of cysteine proteases, are known to regulate cytokine maturation and apoptosis. Here, we show that caspase-11, a mammalian pro-inflammatory caspase, regulates cell migration during inflammation. Caspase-11-deficient lymphocytes exhibit a cell-autonomous migration defect in vitro and in vivo. We demonstrate that caspase-11 interacts physically and functionally with actin interacting protein 1 ( Aip1),an activator of cofilin-mediated actin depolymerization. The caspase-recruitment domain ( CARD) of caspase-11 interacts with the carboxy-terminal WD40 propeller domain of Aip1 to promote cofilin-mediated actin depolymerization. Cells with Aip1 or caspase-11 deficiency exhibit defects in actin dynamics. Using in vitro actin depolymerization assays, we found that caspase-11 and Aip1 work cooperatively to promote cofilin-mediated actin depolymerization. These data demonstrate a novel cell autonomous caspase-mediated mechanism that regulates actin dynamics and mammalian cell migration distinct from the receptor mediated Rho-Rac-Cdc42 pathway.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Li, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008	Brieher, William/0000-0002-3168-6688; Zhu, Hong/0000-0002-2575-4031	NIA NIH HHS [R37 AG12859] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Heyworth PG, 1997, HISTOCHEM CELL BIOL, V108, P221, DOI 10.1007/s004180050162; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Konzok A, 1999, J CELL BIOL, V146, P453, DOI 10.1083/jcb.146.2.453; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SOUTHWICK FS, 1989, J CELL BIOL, V109, P1561, DOI 10.1083/jcb.109.4.1561; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916	28	107	109	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					276	+		10.1038/ncb1541	http://dx.doi.org/10.1038/ncb1541			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293856				2022-12-25	WOS:000244558600012
J	Thomas, RK; Baker, AC; DeBiasi, RM; Winckler, W; LaFramboise, T; Lin, WM; Wang, M; Feng, W; Zander, T; MacConnaill, LE; Lee, JC; Nicoletti, R; Hatton, C; Goyette, M; Girard, L; Majmudar, K; Ziaugra, L; Wong, KK; Gabriel, S; Beroukhim, R; Peyton, M; Barretina, J; Dutt, A; Emery, C; Greulich, H; Shah, K; Sasaki, H; Gazdar, A; Minna, J; Armstrong, SA; Mellinghoff, IK; Hodi, FS; Dranoff, G; Mischel, PS; Cloughesy, TF; Nelson, SF; Liau, LM; Mertz, K; Rubin, MA; Moch, H; Loda, M; Catalona, W; Fletcher, J; Signoretti, S; Kaye, F; Anderson, KC; Demetri, GD; Dummer, R; Wagner, S; Herlyn, M; Sellers, WR; Meyerson, M; Garraway, LA				Thomas, Roman K.; Baker, Alissa C.; DeBiasi, Ralph M.; Winckler, Wendy; LaFramboise, Thomas; Lin, William M.; Wang, Meng; Feng, Whei; Zander, Thomas; MacConnaill, Laura E.; Lee, Jeffrey C.; Nicoletti, Rick; Hatton, Charlie; Goyette, Mary; Girard, Luc; Majmudar, Kuntal; Ziaugra, Liuda; Wong, Kwok-Kin; Gabriel, Stacey; Beroukhim, Rameen; Peyton, Michael; Barretina, Jordi; Dutt, Amit; Emery, Caroline; Greulich, Heidi; Shah, Kinjal; Sasaki, Hidefumi; Gazdar, Adi; Minna, John; Armstrong, Scott A.; Mellinghoff, Ingo K.; Hodi, F. Stephen; Dranoff, Glenn; Mischel, Paul S.; Cloughesy, Tim F.; Nelson, Stan F.; Liau, Linda M.; Mertz, Kirsten; Rubin, Mark A.; Moch, Holger; Loda, Massimo; Catalona, William; Fletcher, Jonathan; Signoretti, Sabina; Kaye, Frederic; Anderson, Kenneth C.; Demetri, George D.; Dummer, Reinhard; Wagner, Stephan; Herlyn, Meenhard; Sellers, William R.; Meyerson, Matthew; Garraway, Levi A.			High-throughput oncogene mutation profiling in human cancer	NATURE GENETICS			English	Article							GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE JAK2; OF-FUNCTION MUTATION; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATIONS; LUNG ADENOCARCINOMA; POLYCYTHEMIA-VERA; GENE; SENSITIVITY; GEFITINIB	Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression(1,2). However, widespread clinical application of this information is hampered by an inability to identify critical genetic events across the spectrum of human tumors with adequate sensitivity and scalability. Here, we have adapted high-throughput genotyping to query 238 known oncogene mutations across 1,000 human tumor samples. This approach established robust mutation distributions spanning 17 cancer types. Of 17 oncogenes analyzed, we found 14 to be mutated at least once, and 298 (30%) samples carried at least one mutation. Moreover, we identified previously unrecognized oncogene mutations in several tumor types and observed an unexpectedly high number of co-occurring mutations. These results offer a new dimension in tumor genetics, where mutations involving multiple cancer genes may be interrogated simultaneously and in 'real time' to guide cancer classification and rational therapeutic intervention.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol & Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60637 USA; NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; USN, Natl Med Ctr, Bethesda, MD 20084 USA; Dana Farber Canc Inst, Ludwig Ctr Canc Res, Boston, MA 02115 USA; Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; Med Univ Vienna, Austrian Acad Sci, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Novartis Inst BioMed Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Melanoma Program Med Oncol, Boston, MA 02115 USA; Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; Univ Cologne, Fac Med, D-50931 Cologne, Germany; Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Nagoya City University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Zurich; University Zurich Hospital; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; Harvard University; Dana-Farber Cancer Institute; University of Zurich; University Zurich Hospital; Austrian Academy of Sciences; Medical University of Vienna; Austrian Academy of Sciences; The Wistar Institute; Novartis; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Max Planck Society; University of Cologne; University of Cologne; University of Cologne	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Mertz, Kirsten/AAY-1660-2020; Cloughesy, Timothy Francis/AGV-1013-2022; kaye, frederic/E-2437-2011; Nelson, Stanley F/D-4771-2009; Dutt, Amit/I-1911-2013; Peyton, Michael/A-8728-2008; Barretina, Jordi/A-7192-2013	Mertz, Kirsten/0000-0002-3074-6925; Nelson, Stanley F/0000-0002-2082-3114; Dutt, Amit/0000-0002-1119-4774; Hatton, Charlie/0000-0001-9903-4291; Liau, Linda/0000-0002-4053-0052; Barretina, Jordi/0000-0002-3478-4080; wong, kwok kin/0000-0001-6323-235X; Wagner, Stephan/0000-0003-4941-7029; Rubin, Mark/0000-0002-8321-9950	NCI NIH HHS [P50CA70907, P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907, ZIASC007256, Z01SC007256] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JIANG J, 2004, BLOOD; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nakahara M, 1998, GASTROENTEROLOGY, V115, P1090, DOI 10.1016/S0016-5085(98)70079-4; Naoki K, 2002, CANCER RES, V62, P7001; *NAT HUM GEN RES I, 2006, CANC SEQ; National Cancer Institute National Human Genome Research Institute, 2006, CANC GEN ATL; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Thomas RK, 2005, COLD SH Q B, V70, P73, DOI 10.1101/sqb.2005.70.056; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Werner M, 2002, HUM MUTAT, V20, P57, DOI 10.1002/humu.10094	27	836	870	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					347	351		10.1038/ng1975	http://dx.doi.org/10.1038/ng1975			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293865				2022-12-25	WOS:000244480000016
J	Vander Haar, E; Lee, S; Bandhakavi, S; Griffin, TJ; Kim, DH				Vander Haar, Emilie; Lee, Seong-il; Bandhakavi, Sricharan; Griffin, Timothy J.; Kim, Do-Hyung			Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40	NATURE CELL BIOLOGY			English	Article							RICH AKT-SUBSTRATE; MAMMALIAN TARGET; BINDING PARTNER; RAPAMYCIN; TOR; RAPTOR; PATHWAY; GROWTH; PHOSPHORYLATION; IDENTIFICATION	Insulin stimulates protein synthesis and cell growth by activation of the protein kinases Akt ( also known as protein kinase B, PKB) and mammalian target of rapamycin ( mTOR). It was reported that Akt activates mTOR by phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2)(1-4). However, in recent studies the physiological requirement of Akt phosphorylation of TSC2 for mTOR activation has been questioned(5,6). Here, we identify PRAS40 ( proline-rich Akt/PKB substrate 40 kDa) as a novel mTOR binding partner that mediates Akt signals to mTOR. PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition. Binding of PRAS40 inhibits mTOR activity and suppresses constitutive activation of mTOR in cells lacking TSC2. PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of mTOR to Akt signals. Furthermore, PRAS40 phosphorylation by Akt and association with 14-3-3, a cytosolic anchor protein, are crucial for insulin to stimulate mTOR. These findings identify PRAS40 as an important regulator of insulin sensitivity of the Akt-mTOR pathway and a potential target for the treatment of cancers, insulin resistance and hamartoma syndromes.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kim, DH (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	dhkim@umn.edu		Kim, Do-Hyung/0000-0002-2924-4370; Griffin, Timothy/0000-0001-6801-2559	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072004, R56DK072004] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK072004] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Singh A, 2005, GENETICS, V171, P169, DOI 10.1534/genetics.105.044180; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	878	898	1	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					316	U126		10.1038/ncb1547	http://dx.doi.org/10.1038/ncb1547			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277771				2022-12-25	WOS:000244558600016
J	Andrew, N; Insall, RH				Andrew, Natalie; Insall, Robert H.			Chemotaxis in shallow gradients is mediated independently of PtdIns 3-kinase by biased choices between random protrusions	NATURE CELL BIOLOGY			English	Article							DICTYOSTELIUM-DISCOIDEUM AMEBAS; EUKARYOTIC CHEMOTAXIS; CELL POLARITY; COMPASS; MOTILITY; PLAYS; MODEL; TRANSDUCTION; PSEUDOPODIA; MECHANISMS	Current models of eukaryotic chemotaxis propose that directional sensing causes localized generation of new pseudopods(1). However, quantitative analysis of pseudopod generation suggests a fundamentally different mechanism for chemotaxis in shallow gradients: first, pseudopods in multiple cell types are usually generated when existing ones bifurcate and are rarely made de novo; second, in Dictyostelium cells in shallow chemoattractant gradients, pseudopods are made at the same rate whether cells are moving up or down gradients. The location and direction of new pseudopods are random within the range allowed by bifurcation and are not oriented by chemoattractants. Thus, pseudopod generation is controlled independently of chemotactic signalling. Third, directional sensing is mediated by maintaining the most accurate existing pseudopod, rather than through the generation of new ones. Finally, the phosphatidylinositol 3-kinase (PI(3) K) inhibitor LY294002 affects the frequency of pseudopod generation, but not the accuracy of selection, suggesting that PI(3) K regulates the underlying mechanism of cell movement, rather than control of direction.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Insall, RH (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	r.h.insall@bham.ac.uk	Insall, Robert/G-5611-2011	Insall, Robert/0000-0003-4898-040X				Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; GERISCH G, 1981, J CELL SCI, V52, P1; Laevsky G, 2001, BIOTECHNIQUES, V31, P1140, DOI 10.2144/01315rr03; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Meinhardt H, 1999, J CELL SCI, V112, P2867; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; Postma M, 2004, J CELL SCI, V117, P2925, DOI 10.1242/jcs.01143; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Sheikh S, 1996, BLOOD, V87, P5040, DOI 10.1182/blood.V87.12.5040.bloodjournal87125040; SHUTT DC, 1995, J CELL BIOL, V131, P1495, DOI 10.1083/jcb.131.6.1495; Stepanovic V, 2005, EUKARYOT CELL, V4, P775, DOI 10.1128/EC.4.4.775-786.2005; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Wang YQ, 2006, J CELL SCI, V119, P702, DOI 10.1242/jcs.02742; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	30	279	283	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					193	U91		10.1038/ncb1536	http://dx.doi.org/10.1038/ncb1536			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220879				2022-12-25	WOS:000243903000012
J	Stock, RP; Massougbodji, A; Alagon, A; Chippaux, JP				Stock, Roberto P.; Massougbodji, Achille; Alagon, Alejandro; Chippaux, Jean-Philippe			Bringing antivenoms to Sub-Saharan Africa	NATURE BIOTECHNOLOGY			English	Editorial Material								To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.	Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62210, Morelos, Mexico; Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; Inst Rech Dev, La Paz, Bolivia	Universidad Nacional Autonoma de Mexico; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD)	Stock, RP (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotechnol, Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	rstock@ibt.unam.mx		Chippaux, Jean-Philippe/0000-0002-1976-8568				Chippaux J P, 2005, Bull Soc Pathol Exot, V98, P263; Chippaux Jean-Philippe, 2005, Toxicon, V46, P115, DOI 10.1016/j.toxicon.2005.03.004; Chippaux JP, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P457; Chippaux JP, 1998, TOXICON, V36, P1503, DOI 10.1016/S0041-0101(98)00140-8; Chippaux JP, 1999, AM J TROP MED HYG, V61, P1017, DOI 10.4269/ajtmh.1999.61.1017; Chippaux JP, 2002, VENINS SERPENT ENVEN; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; Nkinin SW, 1997, B SOC PATHOL EXOT, V90, P277	10	69	77	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					173	177		10.1038/nbt0207-173	http://dx.doi.org/10.1038/nbt0207-173			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17287747				2022-12-25	WOS:000244064000018
J	Popp, MW; Antos, JM; Grotenbreg, GM; Spooner, E; Ploegh, HL				Popp, Maximilian W.; Antos, John M.; Grotenbreg, Gijsbert M.; Spooner, Eric; Ploegh, Hidde L.			Sortagging: a versatile method for protein labeling	NATURE CHEMICAL BIOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; LIVING CELLS; TRANSPEPTIDASE; LIGATION	Genetically encoded reporter constructs that yield fluorescently labeled fusion proteins are a powerful tool for observing cell biological phenomena, but they have limitations. Sortagging (sortase-mediated transpeptidation) is a versatile chemoenzymatic system for site-specific labeling of proteins with small (< 2 kDa) probes. Sortagging combines the precision of a genetically encoded tag with the specificity of an enzymatic reaction and the ease and chemical versatility of peptide synthesis. Here we apply this technique to proteins in vitro and on the surface of living cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Aulabaugh A, 2007, ANAL BIOCHEM, V360, P14, DOI 10.1016/j.ab.2006.10.021; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	15	373	413	2	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					707	708		10.1038/nchembio.2007.31	http://dx.doi.org/10.1038/nchembio.2007.31			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17891153				2022-12-25	WOS:000250311500010
J	Long, XT; Deng, S; Mattner, JC; Zang, Z; Zhou, D; McNary, N; Goff, RD; Teyton, L; Bendelac, A; Savage, PB				Long, Xiangtian; Deng, Shenglou; Mattner, Jochen; Zang, Zhuo; Zhou, Dapeng; McNary, Nathan; Goff, Randal D.; Teyton, Luc; Bendelac, Albert; Savage, Paul B.			Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids	NATURE CHEMICAL BIOLOGY			English	Article							KILLER T-CELLS; NKT CELLS; GLYCOSYL DONORS; GLYCOSPHINGOLIPIDS; ANTIGENS; MICE; THERAPY	Glycosphingolipids (GSLs) from the Sphingomonadaceae family of bacteria have been reported to be potent stimulators of natural killer T cells. These glycolipids include mono-, tri- and tetraglycosylceramides. Here we have prepared the GSL-1 to GSL-4 series of glycolipids and tested their abilities to stimulate natural killer T cells. Among these glycolipids, only GSL-1 ( 1) is a potent stimulator. Using a series of synthetic diglycosylceramides, we show that oligoglycosylceramides from Sphingomonadaceae are not effectively truncated to GSL-1 in lysosomes in antigenpresenting cells, possibly because the higher-order GSLs are poor substrates for lysosomal acyltransfer enzymes.	Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Texas, Dept Melanorma Med Oncol, Houston, TX 77054 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Brigham Young University; University of Chicago; University of Texas System; Scripps Research Institute	Savage, PB (corresponding author), Brigham Young Univ, Dept Chem & Biochem, C100 BNSN, Provo, UT 84602 USA.	paul_savage@byu.edu	zhou, dapeng/GXG-9715-2022; Mattner, Jochen/AAT-7866-2021; Savage, Paul B/E-1448-2011; Zhou, Dapeng/A-6446-2019; Savage, Paul B/HGB-3414-2022	Savage, Paul B/0000-0002-4642-6109; Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053725] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053725] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMANO K, 1987, INFECT IMMUN, V55, P2290, DOI 10.1128/IAI.55.9.2290-2292.1987; ANDERSSON F, 1986, TETRAHEDRON LETT, V27, P3919, DOI 10.1016/S0040-4039(00)83917-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Garcia BA, 1997, J AM CHEM SOC, V119, P7597, DOI 10.1021/ja971067y; Kawahara K, 1999, J IND MICROBIOL BIOT, V23, P408, DOI 10.1038/sj.jim.2900708; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; LUSIS AJ, 1976, BIOCHIM BIOPHYS ACTA, V437, P487, DOI 10.1016/0304-4165(76)90017-9; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MEIKLE PJ, 1995, BIOCHEM J, V308, P327, DOI 10.1042/bj3080327; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Naka T, 2000, J BACTERIOL, V182, P2660, DOI 10.1128/JB.182.9.2660-2663.2000; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Roces DP, 2004, HUM MOL GENET, V13, P1979, DOI 10.1093/hmg/ddh220; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Savage PB, 2006, CHEM SOC REV, V35, P771, DOI 10.1039/b510638a; SCHMIDT RR, 1980, ANGEW CHEM INT EDIT, V19, P731, DOI 10.1002/anie.198007311; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zhou XT, 2002, ORG LETT, V4, P1267, DOI 10.1021/ol025565+	29	47	53	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					559	564		10.1038/nchembio.2007.19	http://dx.doi.org/10.1038/nchembio.2007.19			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17660835				2022-12-25	WOS:000248968000013
J	Zhang, LM; Lee, KC; Bhojani, MS; Khan, AP; Shilman, A; Holland, EC; Ross, BD; Rehemtulla, A				Zhang, Limin; Lee, Kuei C.; Bhojani, Mahaveer S.; Khan, Amjad P.; Shilman, Alla; Holland, Eric C.; Ross, Brian D.; Rehemtulla, Alnawaz			Molecular imaging of Akt kinase activity	NATURE MEDICINE			English	Article							PHOSPHOINOSITIDE 3-KINASE INHIBITORS; ENCODED FLUORESCENT REPORTER; PROTEIN-PROTEIN INTERACTIONS; NF-KAPPA-B; CANCER; CELLS; TUMOR; PHOSPHORYLATION; LY294002; PATHWAY	The serine/threonine kinase Akt mediates mitogenic and antiapoptotic responses that result from activation of multiple signaling cascades. It is considered a key determinant of tumor aggressiveness and is a major target for anticancer drug development. Here, we describe a new reporter molecule whose bioluminescence activity within live cells and in mice can be used to measure Akt activity. Akt activity in cultured cells and tumor xenografts was monitored quantitatively and dynamically in response to activation or inhibition of receptor tyrosine kinase, inhibition of phosphoinositide 3-kinase, or direct inhibition of Akt. The results provide unique insights into the pharmacokinetics and pharmacodynamics of agents that modulate Akt activity, revealing the usefulness of this reporter for rapid dose and schedule optimization in the drug development process.	Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	Rehemtulla, A (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	alnawaz@umich.edu	Lee, Kuei/AAF-9272-2021		NATIONAL CANCER INSTITUTE [P01CA085878, R24CA083099, P50CA093990] Funding Source: NIH RePORTER; NCI NIH HHS [R24CA83099, P50CA01014, P01CA85878, P50 CA093990, R24 CA083099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amann J, 2005, CANCER RES, V65, P226; Beckmann N, 2001, ANAT RECORD, V265, P85, DOI 10.1002/ar.1059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu LM, 2000, CLIN CANCER RES, V6, P880; Knight ZA, 2004, BIOORGAN MED CHEM, V12, P4749, DOI 10.1016/j.bmc.2004.06.022; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moffat BA, 2004, MAGN RESON MATER PHY, V17, P249, DOI 10.1007/s10334-004-0079-z; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Vink SR, 2005, INVEST NEW DRUG, V23, P279, DOI 10.1007/s10637-005-1436-0; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	30	107	112	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1114	1119		10.1038/nm1608	http://dx.doi.org/10.1038/nm1608			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17694068				2022-12-25	WOS:000249353100040
J	Orinska, Z; Maurer, M; Mirghomizadeh, F; Bulanova, E; Metz, M; Nashkevich, N; Schiemann, F; Schulmistrat, J; Budagian, V; Giron-Michel, J; Brandt, E; Paus, R; Bulfone-Paus, S				Orinska, Zane; Maurer, Marcus; Mirghomizadeh, Farhad; Bulanova, Elena; Metz, Martin; Nashkevich, Natalia; Schiemann, Florian; Schulmistrat, Jan; Budagian, Vadim; Giron-Michel, Julien; Brandt, Ernst; Paus, Ralf; Bulfone-Paus, Silvia			IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities	NATURE MEDICINE			English	Article							INTERLEUKIN-15 PROTECTS; BACTERIAL CLEARANCE; SEPTIC PERITONITIS; PROTEASES; RECEPTOR; EXPRESSION; GRANULE; ALPHA; ACTIVATION; MODEL	Sepsis remains a global clinical problem. By using the mouse cecal ligation and puncture model of sepsis, here we identify an important aspect of mast cell (MC)-dependent, innate immune defenses against Gram-negative bacteria by demonstrating that MC protease activity is regulated by interleukin- 15 (IL-15). Mouse MCs express both constitutive and lipopolysaccharide-inducible IL-15 and store it intracellularly. Deletion of parallel to 15 in mice markedly increases chymase activities, leading to greater MC bactericidal responses, increased processing and activation of neutrophil-recruiting chemokines, and significantly higher survival rates of mice after septic peritonitis. By showing that intracellular IL-15 acts as a specific negative transcriptional regulator of a mouse MC chymase (mast cell protease-2), we provide evidence that defined MC protease activity is transcriptionally regulated by an intracellularly retained cytokine. Our results identify an unexpected breach in MC-dependent innate immune defenses against sepsis and suggest that inhibiting intracellular IL-15 in MCs may improve survival from sepsis.	Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany; Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, D-10117 Berlin, Germany; Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Hop Paul Brousse, INSERM, U542, F-94807 Villejuif, France; Univ Hosp Schleswig Holstein, Dept Dermatol, D-23538 Lubeck, Germany	Forschungszentrum Borstel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Kiel; Schleswig Holstein University Hospital	Bulfone-Paus, S (corresponding author), Res Ctr Borstel, Dept Immunol & Cell Biol, Pk Allee 22, D-23845 Borstel, Germany.	sbulfone@fz-borstel.de	Giron-michel, Julien/GNP-7299-2022; Giron-Michel, Julien/Q-4503-2018; Metz, Martin/B-8799-2009; Metz, Martin/M-5237-2013; Paus, Ralf/F-6243-2011; Maurer, Marcus/ABG-2174-2020	Giron-michel, Julien/0000-0001-6613-6099; Giron-Michel, Julien/0000-0001-6613-6099; Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X				Abu Nabah YN, 2004, CIRCULATION, V110, P3581, DOI 10.1161/01.CIR.0000148824.93600.F3; Bone-Larson CL, 2000, AM J PATHOL, V157, P1177, DOI 10.1016/S0002-9440(10)64633-0; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Dvorak Ann M, 2005, Chem Immunol Allergy, V85, P72; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Feger F, 2002, TRENDS IMMUNOL, V23, P151, DOI 10.1016/S1471-4906(01)02156-1; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GHILDYAL N, 1992, J BIOL CHEM, V267, P8473; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Hiromatsu T, 2003, J INFECT DIS, V187, P1442, DOI 10.1086/374643; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; Ilangumaran S, 2003, J BIOL CHEM, V278, P41871, DOI 10.1074/jbc.M308382200; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KINGHT PA, 2000, MAST CELLS BASOPHILS, P257; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Miller HRP, 1999, BLOOD, V93, P3473, DOI 10.1182/blood.V93.10.3473.410k01_3473_3486; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Moreno SE, 2006, J IMMUNOL, V177, P3218, DOI 10.4049/jimmunol.177.5.3218; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Schiemann F, 2006, BLOOD, V107, P2234, DOI 10.1182/blood-2005-06-2424; Solivan S, 2002, FEBS LETT, V512, P133, DOI 10.1016/S0014-5793(02)02242-1; Strik MCM, 2004, BLOOD, V103, P2710, DOI 10.1182/blood-2003-08-2981; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	49	93	97	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2007	13	8					927	934		10.1038/nm1615	http://dx.doi.org/10.1038/nm1615			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	199CU	17643110				2022-12-25	WOS:000248674600023
J	Winkelmann, J; Schormair, B; Lichtner, P; Ripke, S; Xiong, L; Jalilzadeh, S; Fulda, S; Putz, B; Eckstein, G; Hauk, S; Trenkwalder, C; Zimprich, A; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Peglau, I; Eisensehr, I; Montplaisir, J; Turecki, G; Rouleau, G; Gieger, C; Illig, T; Wichmann, E; Holsboer, F; Muller-Myhsok, B; Meitinger, T				Winkelmann, Juliane; Schormair, Barbara; Lichtner, Peter; Ripke, Stephan; Xiong, Lan; Jalilzadeh, Shapour; Fulda, Stephany; Putz, Benno; Eckstein, Gertrud; Hauk, Stephanie; Trenkwalder, Claudia; Zimprich, Alexander; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Peglau, Ines; Eisensehr, Ilonka; Montplaisir, Jacques; Turecki, Gustavo; Rouleau, Guy; Gieger, Christian; Illig, Thomas; Wichmann, Erich; Holsboer, Florian; Muller-Myhsok, Bertram; Meitinger, Thomas			Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions	NATURE GENETICS			English	Article							POPULATION; ERK5	Restless legs syndrome (RLS) is a frequent neurological disorder characterized by an imperative urge to move the legs during night, unpleasant sensation in the lower limbs, disturbed sleep and increased cardiovascular morbidity. In a genome- wide association study we found highly significant associations between RLS and intronic variants in the homeobox gene MEIS1, the BTBD9 gene encoding a BTB(POZ) domain as well as variants in a third locus containing the genes encoding mitogen- activated protein kinase MAP2K5 and the transcription factor LBXCOR1 on chromosomes 2p, 6p and 15q, respectively. Two independent replications confirmed these association signals. Each genetic variant was associated with a more than 50% increase in risk for RLS, with the combined allelic variants conferring more than half of the risk. MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.	GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; Univ Montreal, Notre Dame Hosp, Ctr Rech CHUM, Lab Etude Maladies Cerveau, Montreal, PQ H2L 4M1, Canada; Paracelsus Elena Hosp, D-34128 Kassel, Germany; Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-37070 Gottingen, Germany; Neurol Praxis, D-10969 Berlin, Germany; Neurol Praxis, D-80331 Munich, Germany; Hop Sacre Coeur, Ctr Etud Sommeil, Montreal, PQ H4J 1C5, Canada; Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H4J 1C5, Canada; McGill Univ, Dept Psychiat, Douglas Hosp, Verdun, PQ H4H 1R3, Canada; McGill Univ, Dept Human Genet, Douglas Hosp, Verdun, PQ H4H 1R3, Canada; GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Technical University of Munich; Universite de Montreal; Medical University of Vienna; Philipps University Marburg; University of Gottingen; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Winkelmann, J (corresponding author), GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany.	janew@mpipsykl.mpg.de; meitinger@gsf.de	Trenkwalder, Claudia/ABD-6559-2021; Ripke, Stephan/AAK-5486-2021; Meitinger, Thomas/O-1318-2015; Paulus, Walter/A-3544-2009; Müller-Myhsok, Bertram/A-3289-2013; Zimprich, Alexander/A-5232-2017; Trenkwalder, Claudia/AHD-1232-2022; Pütz, Benno/P-2630-2016; Turecki, Gustavo/K-5100-2015; Fulda, Stephany/C-6867-2013	Paulus, Walter/0000-0001-5549-8377; Zimprich, Alexander/0000-0002-1668-5177; Trenkwalder, Claudia/0000-0001-6407-1199; Pütz, Benno/0000-0002-2208-209X; Meitinger, Thomas/0000-0002-8838-8403; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Turecki, Gustavo/0000-0003-4075-2736; ripke, stephan/0000-0003-3622-835X; Fulda, Stephany/0000-0001-8416-2610				*ALL I BRAINSCI, 2004, ALL BRAIN ATL; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bara-Jimenez W, 2000, NEUROLOGY, V54, P1609, DOI 10.1212/WNL.54.8.1609; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barriere G, 2005, PROG NEUROBIOL, V77, P139, DOI 10.1016/j.pneurobio.2005.10.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; DUBDRIDGE F, 2006, 20065 MRC BIOST UN C; GODT D, 1993, DEVELOPMENT, V119, P799; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Kemlink D, 2007, MOVEMENT DISORD, V22, P207, DOI 10.1002/mds.21254; Maeda R, 2001, ONCOGENE, V20, P1329, DOI 10.1038/sj.onc.1204250; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rajaram SS, 2004, SLEEP, V27, P767; RAO S, 2007, RESTLESS LEGS SYNDRO, P111; Rowe AK, 2004, AM J PREV MED, V26, P243, DOI 10.1016/j.amepre.2003.12.007; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Walters AS, 1996, NEUROLOGY, V46, P92, DOI 10.1212/WNL.46.1.92; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; WINKELMANN J, 2007, MOV DISORD	30	474	488	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					1000	1006		10.1038/ng2099	http://dx.doi.org/10.1038/ng2099			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17637780				2022-12-25	WOS:000248446900018
J	Loudet, O; Saliba-Colombani, V; Camilleri, C; Calenge, F; Gaudon, V; Koprivova, A; North, KA; Kopriva, S; Daniel-Vedele, F				Loudet, Olivier; Saliba-Colombani, Vera; Camilleri, Christine; Calenge, Fanny; Gaudon, Virginie; Koprivova, Anna; North, Kathryn A.; Kopriva, Stanislav; Daniel-Vedele, Francoise			Natural variation for sulfate content in Arabidopsis thaliana is highly controlled by APR2	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; HETEROGENEOUS INBRED FAMILY; SULFUR METABOLISM; NITROGEN; GLUTATHIONE; PLANTS; TRANSFORMATION; BIOSYNTHESIS; ASSIMILATION	Most agronomic traits of importance, whether physiological ( such as nutrient use efficiency) or developmental ( such as flowering time), are controlled simultaneously by multiple genes and their interactions with the environment. Here, we show that variation in sulfate content between wild Arabidopsis thaliana accessions Bay- 0 and Shahdara is controlled by a major quantitative trait locus that results in a strong interaction with nitrogen availability in the soil. Combining genetic and biochemical results and using a candidate gene approach, we have cloned the underlying gene, showing how a single - amino acid substitution in a key enzyme of the assimilatory sulfate reduction pathway, adenosine 5'- phosphosulfate reductase, is responsible for a decrease in enzyme activity, leading to sulfate accumulation in the plant. This work illustrates the potential of natural variation as a source of new alleles of known genes, which can aid in the study of gene function and metabolic pathway regulation. Our new insights on sulfate assimilation may have an impact on sulfur fertilizer use and stress defense improvement.	INRA, SGAP, F-78026 Versailles, France; INRA, Lab Nutr Azotee Plantes, NAP, F-78026 Versailles, France; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Loudet, O (corresponding author), INRA, SGAP, Rte St Cyr, F-78026 Versailles, France.	loudet@versailles.inra.fr	Kopriva, Stanislav/C-7401-2013; Loudet, Olivier/CAF-7559-2022; Loudet, Olivier/K-8266-2012	Kopriva, Stanislav/0000-0002-7416-6551; Loudet, Olivier/0000-0003-3717-0137; CALENGE, Fanny/0000-0003-3529-3387				Brunold C., 1990, METHODS PLANT BIOCH, P339; CHURCHILL GA, 1994, GENETICS, V138, P963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creissen G, 1999, PLANT CELL, V11, P1277, DOI 10.1105/tpc.11.7.1277; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hesse H, 2004, J EXP BOT, V55, P1283, DOI 10.1093/jxb/erh136; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2003, GENETICS, V163, P711; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145; McGrath SP, 1996, J AGR SCI, V126, P53, DOI 10.1017/S0021859600088808; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mejlhede N, 2006, PLANT BREEDING, V125, P461, DOI 10.1111/j.1439-0523.2006.01226.x; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; STROHM M, 1995, PLANT J, V7, P141, DOI 10.1046/j.1365-313X.1995.07010141.x; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157	28	116	121	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					896	900		10.1038/ng2050	http://dx.doi.org/10.1038/ng2050			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17589509				2022-12-25	WOS:000247619800021
J	Bourdon, A; Minai, L; Serre, V; Jais, JP; Sarzi, E; Aubert, S; Chretien, D; de Lonlay, P; Paquis-Flucklinger, V; Arakawa, H; Nakamura, Y; Munnich, A; Rotig, A				Bourdon, Alice; Minai, Limor; Serre, Valerie; Jais, Jean-Philippe; Sarzi, Emmanuelle; Aubert, Sophie; Chretien, Dominique; de Lonlay, Pascale; Paquis-Flucklinger, Veronique; Arakawa, Hirofumi; Nakamura, Yusuke; Munnich, Arnold; Rotig, Agnes			Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion	NATURE GENETICS			English	Article							SWISS-MODEL; R2 PROTEIN; DNTP POOLS; GENE; ENCEPHALOMYOPATHY; CLUSPRO; DOCKING; KINASE; DAMAGE; CELLS	Mitochondrial DNA (mtDNA) depletion syndrome (MDS; MIM 251880) is a prevalent cause of oxidative phosphorylation disorders characterized by a reduction in mtDNA copy number. The hitherto recognized disease mechanisms alter either mtDNA replication (POLG (ref. 1)) or the salvage pathway of mitochondrial deoxyribonucleosides 5'- triphosphates (dNTPs) for mtDNA synthesis (DGUOK (ref. 2), TK2 (ref. 3) and SUCLA2 (ref. 4)). A last gene, MPV17 ( ref. 5), has no known function. Yet the majority of cases remain unexplained. Studying seven cases of profound mtDNA depletion (1-2% residual mtDNA in muscle) in four unrelated families, we have found nonsense, missense and splice-site mutations and in-frame deletions of the RRM2B gene, encoding the cytosolic p53-inducible ribonucleotide reductase small subunit. Accordingly, severe mtDNA depletion was found in various tissues of the Rrm2b(-/-) mouse. The mtDNA depletion triggered by p53R2 alterations in both human and mouse implies that p53R2 has a crucial role in dNTP supply for mtDNA synthesis.	Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France; Univ Paris 07, F-75005 Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Serv Biostat & Informat, F-75015 Paris, France; Archet 2 Hosp, Dept Med Genet, F-06107 Nice, France; Univ Tokyo, Inst Med Sci, Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; University of Tokyo	Rotig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	roetig@necker.fr	Rötig, Agnès/G-9592-2017; Arakawa, Hirofumi/L-3459-2013; JAIS, Jean-Philippe/B-2993-2009	Rötig, Agnès/0000-0003-0589-0703; Arakawa, Hirofumi/0000-0001-6077-0638; JAIS, Jean-Philippe/0000-0002-0708-8776; Sarzi, Emmanuelle/0000-0002-7623-6699				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PAQUISFLUCKLINGER V, 1995, EUR J PEDIATR, V154, P557, DOI 10.1007/BF02074834; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SARZI E, IN PRESS J PEDIATR; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Zhou BS, 2003, CANCER RES, V63, P6583	26	418	433	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					776	780		10.1038/ng2040	http://dx.doi.org/10.1038/ng2040			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486094				2022-12-25	WOS:000246859100022
J	Svistoonoff, S; Creff, A; Reymond, M; Sigoillot-Claude, C; Ricaud, L; Blanchet, A; Nussaume, L; Desnos, T				Svistoonoff, Sergio; Creff, Audrey; Reymond, Matthieu; Sigoillot-Claude, Cecile; Ricaud, Lilian; Blanchet, Aline; Nussaume, Laurent; Desnos, Thierry			Root tip contact with low-phosphate media reprograms plant root architecture	NATURE GENETICS			English	Article							SYSTEM ARCHITECTURE; ARABIDOPSIS; AVAILABILITY; STARVATION; ADAPTATION; COMPONENT; OXIDASES; LACCASE	Plant roots are able to sense soil nutrient availability. In order to acquire heterogeneously distributed water and minerals(1-3), they optimize their root architecture. One poorly understood plant response to soil phosphate ( Pi) deficiency is a reduction in primary root growth with an increase in the number and length of lateral roots(4-12). Here we show that physical contact of the Arabidopsis thaliana primary root tip with low-P-i medium is necessary and sufficient to arrest root growth. We further show that loss-of-function mutations in Low Phosphate Root1 (LPR1) and its close paralog LPR2 strongly reduce this inhibition. LPR1 was previously mapped as a major quantitative trait locus (QTL)(12); the molecular origin of this QTL is explained by the differential allelic expression of LPR1 in the root cap. These results provide strong evidence for the involvement of the root cap in sensing nutrient deficiency, responding to it, or both. LPR1 and LPR2 encode multicopper oxidases (MCOs), highlighting the essential role of MCOs for plant development.	Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Desnos, T (corresponding author), Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France.	thierry.desnos@cea.fr	SVISTOONOFF, Sergio/X-9659-2019; NUSSAUME, Laurent/AAA-5980-2022; NUSSAUME, Laurent/AAB-8312-2020	SVISTOONOFF, Sergio/0000-0001-8554-2922; NUSSAUME, Laurent/0000-0002-9445-2563; DESNOS, Thierry/0000-0002-6585-1362				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURZON G, 1960, BIOCHEM J, V77, P66, DOI 10.1042/bj0770066; DECAMPILLO E, 2004, PLANT MOL BIOL, V56, P309; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y	30	416	448	3	150	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					792	796		10.1038/ng2041	http://dx.doi.org/10.1038/ng2041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496893				2022-12-25	WOS:000246859100025
J	Ieda, M; Kanazawa, H; Kimura, K; Hattori, F; Ieda, Y; Taniguchi, M; Lee, JK; Matsumura, K; Tomita, Y; Miyoshi, S; Shimoda, K; Makino, S; Sano, M; Kodama, I; Ogawa, S; Fukuda, K				Ieda, Masaki; Kanazawa, Hideaki; Kimura, Kensuke; Hattori, Fumiyuki; Ieda, Yasuyo; Taniguchi, Masahiko; Lee, Jong-Kook; Matsumura, Keisuke; Tomita, Yuichi; Miyoshi, Shunichiro; Shimoda, Kouji; Makino, Shinji; Sano, Motoaki; Kodama, Itsuo; Ogawa, Satoshi; Fukuda, Keiichi			Sema3a maintains normal heart rhythm through sympathetic innervation patterning	NATURE MEDICINE			English	Article							CARDIAC CONDUCTION SYSTEM; SEMAPHORIN-III; SUDDEN; EXPRESSION; GENE; ARRHYTHMIA; GROWTH; RAT; SUSCEPTIBILITY; AFFERENTS	Sympathetic innervation is critical for effective cardiac function. However, the developmental and regulatory mechanisms determining the density and patterning of cardiac sympathetic innervation remain unclear, as does the role of this innervation in arrhythmogenesis. Here we show that a neural chemorepellent, Sema3a, establishes cardiac sympathetic innervation patterning. Sema3a is abundantly expressed in the trabecular layer in early-stage embryos but is restricted to Purkinje fibers after birth, forming an epicardial-to-endocardial transmural sympathetic innervation patterning. Sema3a(-/-) mice lacked a cardiac sympathetic innervation gradient and exhibited stellate ganglia malformation, which led to marked sinus bradycardia due to sympathetic dysfunction. Cardiac-specific overexpression of Sema3a in transgenic mice (SemaTG) was associated with reduced sympathetic innervation and attenuation of the epicardial-to-endocardial innervation gradient. SemaTG mice demonstrated sudden death and susceptibility to ventricular tachycardia, due to catecholamine supersensitivity and prolongation of the action potential duration. We conclude that appropriate cardiac Sema3a expression is needed for sympathetic innervation patterning and is critical for heart rate control.	Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Med, Cardiol Div,Shinjuku Ku, Tokyo 1608582, Japan; Sapporo Med Univ, Sch Med, Canc Res Inst, Dept Biochem,Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Nagoya Univ, Environm Med Res Inst, Dept Cardiovasc Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Keio Univ, Sch Med, Lab Anim Ctr, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Sapporo Medical University; Nagoya University; Keio University	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kfukuda@sc.itc.keio.ac.jp	Shimoda, Kouji/V-2280-2017; Kanazawa, Hideaki/A-2874-2014; Sano, Motoaki/L-3405-2013; Fukuda, Keiichi/L-3777-2013					Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chantranuwat C, 2004, J HEART LUNG TRANSPL, V23, P683, DOI 10.1016/S1053-2498(03)00295-X; CHOW LTC, 1993, BRIT HEART J, V69, P430; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Crick SJ, 1999, J ANAT, V195, P341, DOI 10.1046/j.1469-7580.1999.19530341.x; CRICK SJ, 1994, CIRCULATION, V89, P1697, DOI 10.1161/01.CIR.89.4.1697; Dae MW, 1997, CIRCULATION, V96, P1337, DOI 10.1161/01.CIR.96.4.1337; Ecker PM, 2006, AM J PHYSIOL-HEART C, V290, pH192, DOI 10.1152/ajpheart.00032.2005; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hansson M, 1998, J MOL CELL CARDIOL, V30, P2047, DOI 10.1006/jmcc.1998.0767; Heart rate variability: standards of measurement physiological interpretation and clinical use, 1996, AQUACULTURE, V93, P1043, DOI [10.1111/j.1542-474X.1996.tb00275.x, DOI 10.1161/STR.0b013e3182587839]; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; ITO M, 1994, CIRCULATION, V90, P1459, DOI 10.1161/01.CIR.90.3.1459; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; Kawasaki T, 2002, DEVELOPMENT, V129, P671; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; OPTHOF T, 1991, CIRC RES, V68, P1204, DOI 10.1161/01.RES.68.5.1204; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Qu JH, 2004, J MOL CELL CARDIOL, V37, P439, DOI 10.1016/j.yjmcc.2004.05.009; RANDALL WC, 1968, CIRC RES, V22, P315, DOI 10.1161/01.RES.22.3.315; Saba S, 2003, J CARDIOVASC ELECTR, V14, P191, DOI 10.1046/j.1540-8167.2003.02454.x; Shusterman V, 2002, AM J PHYSIOL-HEART C, V282, pH2076, DOI 10.1152/ajpheart.00917.2001; Sosunov EA, 2001, CARDIOVASC RES, V51, P659, DOI 10.1016/S0008-6363(01)00333-9; STRAMBABADIALE M, 1992, AM J PHYSIOL, V263, pH1514, DOI 10.1152/ajpheart.1992.263.5.H1514; TAGO H, 1986, J HISTOCHEM CYTOCHEM, V34, P1431, DOI 10.1177/34.11.2430009; Takahashi T, 2006, CIRCULATION, V114, P388, DOI 10.1161/CIRCULATIONAHA.106.632513; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xu XM, 2000, J NEUROSCI, V20, P2638	44	141	149	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					604	612		10.1038/nm1570	http://dx.doi.org/10.1038/nm1570			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17417650				2022-12-25	WOS:000246302800028
J	Myers, GSA; Parker, D; Al-Hasani, K; Kennan, RM; Seemann, T; Ren, QH; Badger, JH; Selengut, JD; DeBoy, RT; Tettelin, H; Boyce, JD; McCarl, VP; Han, XY; Nelson, WC; Madupu, R; Mohamoud, Y; Holley, T; Fedorova, N; Khouri, H; Bottomley, SP; Whittington, RJ; Adler, B; Songer, JG; Rood, JI; Paulsen, IT				Myers, Garry S. A.; Parker, Dane; Al-Hasani, Keith; Kennan, Ruth M.; Seemann, Torsten; Ren, Qinghu; Badger, Jonathan H.; Selengut, Jeremy D.; DeBoy, Robert T.; Tettelin, Herve; Boyce, John D.; McCarl, Victoria P.; Han, Xiaoyan; Nelson, William C.; Madupu, Ramana; Mohamoud, Yasmin; Holley, Tara; Fedorova, Nadia; Khouri, Hoda; Bottomley, Steven P.; Whittington, Richard J.; Adler, Ben; Songer, J. Glenn; Rood, Julian I.; Paulsen, Ian T.			Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus	NATURE BIOTECHNOLOGY			English	Article							GRAM-NEGATIVE BACTERIA; OVINE FOOTROT PATHOGEN; BACTEROIDES-NODOSUS; PSEUDOMONAS-AERUGINOSA; SIGNAL PEPTIDES; HIGH-THROUGHPUT; VIRULENCE; PREDICTION; STRAINS; SHEEP	Dichelobacter nodosus causes ovine footrot, a disease that leads to severe economic losses in the wool and meat industries. We sequenced its 1.4-Mb genome, the smallest known genome of an anaerobe. It differs markedly from small genomes of intracellular bacteria, retaining greater biosynthetic capabilities and lacking any evidence of extensive ongoing genome reduction. Comparative genomic microarray studies and bioinformatic analysis suggested that, despite its small size, almost 20% of the genome is derived from lateral gene transfer. Most of these regions seem to be associated with virulence. Metabolic reconstruction indicated unsuspected capabilities, including carbohydrate utilization, electron transfer and several aerobic pathways. Global transcriptional profiling and bioinformatic analysis enabled the prediction of virulence factors and cell surface proteins. Screening of these proteins against ovine antisera identified eight immunogenic proteins that are candidate antigens for a cross-protective vaccine.	Inst Genom Res, Rockville, MD 20850 USA; Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Med Genom, Melbourne, Vic 3800, Australia; Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3800, Australia; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia; Univ Arizona, Dept Vet Sci, Tucson, AZ 85721 USA	J. Craig Venter Institute; Monash University; Monash University; Monash University; Monash University; University of Sydney; University of Arizona	Paulsen, IT (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	ipaulsen@tigr.org	Parker, Dane/AAX-7001-2021; han, xiao/HDN-9782-2022; Nelson, William C/E-9263-2016; Seemann, Torsten/B-2318-2010; Paulsen, Ian T/K-3832-2012; Rood, Julian I/A-4858-2008; Boyce, John D/F-5058-2012; Myers, Garry/E-7708-2011	Parker, Dane/0000-0001-7304-3392; Nelson, William C/0000-0002-1873-3929; Seemann, Torsten/0000-0001-6046-610X; Paulsen, Ian T/0000-0001-9015-9418; Rood, Julian I/0000-0003-2126-7209; Boyce, John D/0000-0002-8614-3074; Myers, Garry/0000-0002-4756-4810; Al-Hasani, Keith/0000-0001-6109-5603				Adler B, 1999, J BIOTECHNOL, V73, P83, DOI 10.1016/S0168-1656(99)00111-X; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Calza L, 2004, EXPERT OPIN PHARMACO, V5, P1899, DOI 10.1517/14656566.5.9.1899; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; CLAXTON PD, 1983, AUST VET J, V60, P331, DOI 10.1111/j.1751-0813.1983.tb02834.x; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGERTON JR, 1970, AUST VET J, V46, P517, DOI 10.1111/j.1751-0813.1970.tb06636.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Frey J, 2002, INT J MED MICROBIOL, V292, P149, DOI 10.1078/1438-4221-00200; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; HARING V, 1995, MICROBIOL-SGM, V141, P2081, DOI 10.1099/13500872-141-9-2081; HESS J, 1995, INFECT IMMUN, V63, P2047, DOI 10.1128/IAI.63.5.2047-2053.1995; HOBBS M, 1991, MOL MICROBIOL, V5, P543, DOI 10.1111/j.1365-2958.1991.tb00726.x; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kennan RM, 1998, FEMS MICROBIOL LETT, V169, P383, DOI 10.1111/j.1574-6968.1998.tb13344.x; Kennan RM, 2003, VET MICROBIOL, V92, P169, DOI 10.1016/S0378-1135(02)00359-0; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; Kirkwood JK, 2006, VET REC, V158, P203, DOI 10.1136/vr.158.6.203; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; MOSES EK, 1995, MOL MICROBIOL, V17, P183, DOI 10.1111/j.1365-2958.1995.mmi_17010183.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Parker D, 2005, J BACTERIOL, V187, P366, DOI 10.1128/JB.187.1.366-375.2005; Parker D, 2006, J BACTERIOL, V188, P4801, DOI 10.1128/JB.00255-06; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Riffkin MC, 1995, GENE, V167, P279, DOI 10.1016/0378-1119(95)00664-8; Rood JI, 2002, CURR TOP MICROBIOL, V264, P47; ROOD JI, 2005, BERGEYS MANUAL SYSTE, V2, P124; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHWARTZKOFF CL, 1993, AUST VET J, V70, P123, DOI 10.1111/j.1751-0813.1993.tb06101.x; Stewart D. J., 1989, Footrot and foot abscess of ruminants., P5; STEWART DJ, 1983, AUST VET J, V60, P83, DOI 10.1111/j.1751-0813.1983.tb05877.x; STEWART DJ, 1985, AUST VET J, V62, P153, DOI 10.1111/j.1751-0813.1985.tb07277.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; THOMAS J. H., 1958, AUSTRALIAN VET JOUR, V34, P411, DOI 10.1111/j.1751-0813.1958.tb05811.x; THOMAS JH, 1964, AUST J AGR RES, V15, P1001, DOI 10.1071/AR9641001; Yorgey P, 2001, MOL MICROBIOL, V41, P1063, DOI 10.1046/j.1365-2958.2001.02580.x; Zhou H, 2000, VET MICROBIOL, V71, P113, DOI 10.1016/S0378-1135(99)00155-8	48	57	289	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					569	575		10.1038/nbt1302	http://dx.doi.org/10.1038/nbt1302			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17468768				2022-12-25	WOS:000246369400025
J	Netz, DJA; Pierik, AJ; Stuempfig, M; Muhlenhoff, U; Lill, R				Netz, Daili J. A.; Pierik, Antonio J.; Stuempfig, Martin; Muehlenhoff, Ulrich; Lill, Roland			The Cfd1-Nbp35 complex acts as a scaffold for iron-sulfur protein assembly in the yeast cytosol	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; 4FE-4S CLUSTERS; 2FE-2S CLUSTER; BIOGENESIS; MATURATION; MITOCHONDRIA; FERREDOXIN; FRATAXIN; GENE; ISCU	Biogenesis of iron- sulfur ([Fe- S]) proteins in eukaryotes requires the function of complex proteinaceous machineries in both mitochondria and cytosol. In contrast to the mitochondrial pathway, little is known about [ Fe- S] protein assembly in the cytosol. So far, four highly conserved proteins ( Cfd1, Nbp35, Nar1 and Cia1) have been identified as members of the cytosolic [ Fe- S] protein assembly machinery, but their molecular function is unresolved. Using in vivo and in vitro approaches, we found that the soluble P -loop NTPases Cfd1 and Nbp35 form a complex and bind up to three [ 4Fe- 4S] clusters, one at the N terminus of Nbp35 and one each at a new C- terminal cysteine- rich motif present in both proteins. These labile [ Fe- S] clusters can be rapidly transferred and incorporated into target [ Fe- S] apoproteins in a Nar1- and Cia1- dependent fashion. Our data suggest that the Cfd1 - Nbp35 complex functions as a novel scaffold for [ Fe- S] cluster assembly in the eukaryotic cytosol.	Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany	Philipps University Marburg	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol, Robert Koch Str 6, D-35033 Marburg, Germany.	lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518				Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 2004, ENCY BIOL CHEM, P482; Bekri S, 2000, BLOOD, V96, P3256; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Floss B, 1997, PHOTOSYNTH RES, V54, P63, DOI 10.1023/A:1005823620291; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JUNGERMANN K, 1969, FEBS LETT, V3, P144, DOI 10.1016/0014-5793(69)80119-5; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Orme-Johnson W H, 1978, Methods Enzymol, V53, P259; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Skovran E, 2003, J BACTERIOL, V185, P98, DOI 10.1128/JB.185.1.98-106.2003; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	51	137	142	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2007	3	5					278	286		10.1038/nchembio872	http://dx.doi.org/10.1038/nchembio872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159FP	17401378				2022-12-25	WOS:000245851100012
J	Julien, SG; Dube, N; Read, M; Penney, J; Paquet, M; Han, YX; Kennedy, BP; Muller, WJ; Tremblay, ML				Julien, Sofi G.; Dube, Nadia; Read, Michelle; Penney, Janice; Paquet, Marilene; Han, Yongxin; Kennedy, Brian P.; Muller, William J.; Tremblay, Michel L.			Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; TRANSGENIC MICE; NEU ONCOGENE; CYCLIN D1; SIGNALING PATHWAY; EPITHELIAL-CELLS; POINT MUTATION; ERBB RECEPTORS; TRANSFORMATION; KINASE	We investigated the role of protein tyrosine phosphatase 1B (PTP1B) in mammary tumorigenesis using both genetic and pharmacological approaches. It has been previously shown that transgenic mice with a deletion mutation in the region of Erbb2 encoding its extracellular domain (referred to as NDL2 mice, for 'Neu deletion in extracellular domain 2') develop mammary tumors that progress to lung metastasis. However, deletion of PTP1B activity in the NDL2 transgenic mice either by breeding with Ptpn1-deficient mice or by treatment with a specific PTP1B inhibitor results in significant mammary tumor latency and resistance to lung metastasis. In contrast, specific overexpression of PTP1B in the mammary gland leads to spontaneous breast cancer development. The regulation of ErbB2-induced mammary tumorigenesis by PTB1B occurs through the attenuation of both the MAP kinase (MAPK) and Akt pathways. This report provides a rationale for the development of PTP1B as a new therapeutic target in breast cancer.	McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Vet Pathol Serv, Montreal, PQ H3G 1Y6, Canada; Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada; McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; Merck & Company; McGill University; Royal Victoria Hospital; McGill University	Tremblay, ML (corresponding author), McGill Univ, Ctr Canc, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.	michel.tremblay@mcgill.ca	Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Julien, Sophie/0000-0003-2694-7211				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrechek ER, 2003, CANCER RES, V63, P4920; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Dube N, 2004, CELL CYCLE, V3, P550; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaminski R, 2006, CANCER RES, V66, P5757, DOI 10.1158/0008-5472.CAN-05-3536; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lenferink AEG, 2001, CANCER RES, V61, P6583; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Perez-Nadales E, 2004, BREAST CANCER RES, V6, P137, DOI 10.1186/bcr792; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2004, ONCOLOGIST, V9, P1, DOI 10.1634/theoncologist.9-suppl_3-1; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; ZHAI YF, 1993, CANCER RES, V53, P2272; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	44	258	270	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					338	346		10.1038/ng1963	http://dx.doi.org/10.1038/ng1963			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259984				2022-12-25	WOS:000244480000015
J	Oh, P; Borgstrom, P; Witkiewicz, H; Li, Y; Borgstrom, BJ; Chrastina, A; Iwata, K; Zinn, KR; Baldwin, R; Testa, JE; Schnitzer, JE				Oh, Phil; Borgstrom, Per; Witkiewicz, Halina; Li, Yan; Borgstrom, Bengt J.; Chrastina, Adrian; Iwata, Koji; Zinn, Kurt R.; Baldwin, Richard; Testa, Jacqueline E.; Schnitzer, Jan E.			Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; PLASMA-MEMBRANE; CELL-SURFACE; GENE-THERAPY; SOLID TUMORS; CAPILLARY-PERMEABILITY; DELIVERY SYSTEMS; TRANSPORT; CANCER; DRUG	How effectively and quickly endothelial caveolae can transcytose in vivo is unknown, yet critical for understanding their function and potential clinical utility. Here we use quantitative proteomics to identify aminopeptidase P (APP) concentrated in caveolae of lung endothelium. Electron microscopy confirms this and shows that APP antibody targets nanoparticles to caveolae. Dynamic intravital fluorescence microscopy reveals that targeted caveolae operate effectively as pumps, moving antibody within seconds from blood across endothelium into lung tissue, even against a concentration gradient. This active transcytosis requires normal caveolin-1 expression. Whole body gamma-scintigraphic imaging shows rapid, specific delivery into lung well beyond that achieved by standard vascular targeting. This caveolar trafficking in vivo may underscore a key physiological mechanism for selective transvascular exchange and may provide an enhanced delivery system for imaging agents, drugs, gene-therapy vectors and nanomedicines. 'In vivo proteomic imaging' as described here integrates organellar proteomics with multiple imaging techniques to identify an accessible target space that includes the transvascular pumping space of the caveola.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calif Los Angeles, EE Dept, Los Angeles, CA 90095 USA; Gamma Med Inc, Northridge, CA 91324 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Schnitzer, JE (corresponding author), Sidney Kimmel Canc Ctr, 10905 Rd Cure, San Diego, CA 92121 USA.	jschnitzer@skcc.org	Chrastina, Adrian/AHE-3296-2022	Chrastina, Adrian/0000-0002-4097-9773; Zinn, Kurt/0000-0001-7463-4741	NCI NIH HHS [R01 CA119378-02, R01CA104898, R24CA95893, R24 CA095893, R01 CA119378, P01 CA104898] Funding Source: Medline; NHLBI NIH HHS [R01 HL074063, R01 HL058216, R01 HL58216, R01 HL52766, R01 HL052766] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119378, P01CA104898, R24CA095893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058216, R01HL074063, R01HL052766] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALGER GH, 1943, J NATL CANCER I, V4, P1; Bilbao G, 1998, ADV EXP MED BIOL, V451, P365; BUNDGAARD M, 1979, P NATL ACAD SCI USA, V76, P6439, DOI 10.1073/pnas.76.12.6439; BURROWS FJ, 1994, PHARMACOL THERAPEUT, V64, P155, DOI 10.1016/0163-7258(94)90037-X; Carver LA, 2002, BIOMEDICAL ASPECTS OF DRUG TARGETING, P107; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chaurand P, 2004, AM J PATHOL, V165, P1057, DOI 10.1016/S0002-9440(10)63367-6; Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40; DENEKAMP J, 1984, PROG APPLIED MICROCI, V4, P28; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77; Frost GI, 2005, MICROVASC RES, V69, P1, DOI 10.1016/j.mvr.2004.10.001; Frost Gregory I, 2003, Methods Mol Med, V85, P65; Galanis E, 2001, CRIT REV ONCOL HEMAT, V38, P177, DOI 10.1016/S1040-8428(01)00103-2; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; HUGHES BJ, 1989, CANCER RES, V49, P6214; Jain RK, 1998, NAT MED, V4, P655, DOI 10.1038/nm0698-655; Jenkins R G, 2003, Monaldi Arch Chest Dis, V59, P17; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; LEHR HA, 1993, AM J PATHOL, V143, P1055; McElroy DP, 2002, IEEE T NUCL SCI, V49, P2139, DOI 10.1109/TNS.2002.803801; McIntosh DP, 1999, AM J PHYSIOL-HEART C, V277, pH2222, DOI 10.1152/ajpheart.1999.277.6.H2222; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; MILLER N, 1995, FASEB J, V9, P190, DOI 10.1096/fasebj.9.2.7781922; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MURO H, 1987, GASTROENTEROLOGY, V93, P1078, DOI 10.1016/0016-5085(87)90572-5; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Oh P, 1999, J BIOL CHEM, V274, P23144, DOI 10.1074/jbc.274.33.23144; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oh P, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P34; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PORTER GA, 1987, AM J ANAT, V178, P116, DOI 10.1002/aja.1001780203; Razani B, 2001, J BIOL CHEM, V276, P38121; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Russell J, 2002, J NUCL MED, V43, P671; Schnitzer J. E., 1997, VASCULAR ENDOTHELIUM, P77; Schnitzer JE, 1998, NEW ENGL J MED, V339, P472, DOI 10.1056/NEJM199808133390711; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SCHNITZER JE, 1993, TRENDS CARDIOVAS MED, V3, P124, DOI 10.1016/1050-1738(93)90012-U; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; SCHNITZER JE, 1988, AM J PHYSIOL, V254, pH425, DOI 10.1152/ajpheart.1988.254.3.H425; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SEVERS NJ, 1988, J CELL SCI, V90, P341; SIMIONESCU M, 1974, J CELL BIOL, V60, P128, DOI 10.1083/jcb.60.1.128; SIMIONESCU M, 1991, CELL BIOL REV, V25, P5; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TOMLINSON E, 1987, Advanced Drug Delivery Reviews, V1, P87, DOI 10.1016/0169-409X(87)90001-9	54	240	252	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					327	337		10.1038/nbt1292	http://dx.doi.org/10.1038/nbt1292			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17334358	Green Accepted			2022-12-25	WOS:000244748300025
J	Rinner, O; Mueller, LN; Hubalek, M; Muller, M; Gstaiger, M; Aebersold, R				Rinner, Oliver; Mueller, Lukas N.; Hubalek, Martin; Mueller, Markus; Gstaiger, Matthias; Aebersold, Ruedi			An integrated mass spectrometric and computational framework for the analysis of protein interaction networks	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; STATISTICAL-MODEL; COMPLEXES; PROTEOMICS; IDENTIFICATION; STRATEGY; EXPRESSION	Biological systems are controlled by protein complexes that associate into dynamic protein interaction networks. We describe a strategy that analyzes protein complexes through the integration of label-free, quantitative mass spectrometry and computational analysis. By evaluating peptide intensity profiles throughout the sequential dilution of samples, the MasterMap system identifies specific interaction partners, detects changes in the composition of protein complexes and reveals variations in the phosphorylation states of components of protein complexes. We use the complexes containing the human forkhead transcription factor FoxO3A to demonstrate the validity and performance of this technology. Our analysis identifies previously known and unknown interactions of FoxO3A with 14-3-3 proteins, in addition to identifying FoxO3A phosphorylation sites and detecting reduced 14-3-3 binding following inhibition of phosphoinositide-3 kinase. By improving specificity and sensitivity of interaction networks, assessing post-translational modifications and providing dynamic interaction profiles, the MasterMap system addresses several limitations of current approaches for protein complexes.	ETH, Inst Mol Syst Biol, Zurich, Switzerland; Natl Def Univ, Fac Mil Hlth Sci, Inst Mol Pathol, Hradec Kralove, Czech Republic; Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Defence - Czech Republic; University of Zurich	Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	markus.mueller@imsb.biol.ethz.ch; matthias.gstaiger@imsb.biol.ethz.ch; aebersold@imsb.biol.ethz.ch	Muller, Markus/B-4974-2011; quandt, andreas/B-6582-2009; Hubalek, Martin/H-1400-2014	Hubalek, Martin/0000-0003-0247-7956; Muller, Markus/0000-0003-0907-3583	DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28179] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chen SS, 2005, J CHROMATOGR B, V829, P107, DOI 10.1016/j.jchromb.2005.09.039; Colinge J, 2006, J PROTEOME RES, V5, P619, DOI 10.1021/pr0504236; Duda R. O., 2000, PATTERN CLASSIFICATI, V1; Figeys D, 2002, CURR OPIN MOL THER, V4, P210; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin IM, 2005, BIOTECHNIQUES, V39, P99, DOI 10.2144/05391RR02; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, Tanpakushitsu Kakusan Koso, V46, P2407; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li XJ, 2005, MOL CELL PROTEOMICS, V4, P1328, DOI 10.1074/mcp.M500141-MCP200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Nesvizhskii AI, 2004, DRUG DISCOV TODAY, V9, P173, DOI 10.1016/S1359-6446(03)02978-7; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schmidt A, 2005, PROTEOMICS, V5, P4, DOI 10.1002/pmic.200400873; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Uetz P, 2000, CURR OPIN MICROBIOL, V3, P303, DOI 10.1016/S1369-5274(00)00094-1; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425	42	141	144	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					345	352		10.1038/nbt1289	http://dx.doi.org/10.1038/nbt1289			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17322870				2022-12-25	WOS:000244748300027
J	Wissmann, M; Yin, N; Muller, JM; Greschik, H; Fodor, BD; Jenuwein, T; Vogler, C; Schneider, R; Gunther, T; Buettner, R; Metzger, E; Schule, R				Wissmann, Melanie; Yin, Na; Mueller, Judith M.; Greschik, Holger; Fodor, Barna D.; Jenuwein, Thomas; Vogler, Christine; Schneider, Robert; Guenther, Thomas; Buettner, Reinhard; Metzger, Eric; Schuele, Roland			Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression	NATURE CELL BIOLOGY			English	Article							HISTONE; TRIMETHYLATION; COACTIVATOR; METHYLATION; LYSINE-9; SIGNALS; DOMAIN; FHL2	Posttranslational modifications of histones, such as methylation, regulate chromatin structure and gene expression(1). Recently, lysine-specific demethylase 1 (LSD1(2), the first histone demethylase, was identified. LSD1 interacts with the androgen receptor and promotes androgen-dependent transcription of target genes by ligand-induced demethylation of mono- and dimethylated histone H3 at Lys 9 (H3K9)(3) only. Here, we identify the Jumonji C ( JMJC)(4) domain-containing protein JMJD2C(5,6) as the first histone tridemethylase regulating androgen receptor function. JMJD2C interacts with androgen receptor in vitro and in vivo. Assembly of ligand-bound androgen receptor and JMJD2C on androgen receptor-target genes results in demethylation of trimethyl H3K9 and in stimulation of androgen receptor-dependent transcription. Conversely, knockdown of JMJD2C inhibits androgen-induced removal of trimethyl H3K9, transcriptional activation and tumour cell proliferation. Importantly, JMJD2C colocalizes with androgen receptor and LSD1 in normal prostate and in prostate carcinomas. JMJD2C and LSD1 interact and both demethylases cooperatively stimulate androgen receptor-dependent gene transcription. In addition, androgen receptor, JMJD2C and LSD1 assemble on chromatin to remove methyl groups from mono, di and trimethylated H3K9. Thus, our data suggest that specific gene regulation requires the assembly and coordinate action of demethylases with distinct substrate specificities.	Univ Freiburg Klinikum, Univ Frauenklin, D-79106 Freiburg, Germany; Univ Freiburg Klinikum, Zentrum Klin Forsch, D-79106 Freiburg, Germany; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Univ Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de		Gunther, Thomas/0000-0003-3903-9490; Fodor, Barna/0000-0003-1653-4376				Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	24	464	504	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					347	U176		10.1038/ncb1546	http://dx.doi.org/10.1038/ncb1546			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277772				2022-12-25	WOS:000244558600020
J	Schlesinger, Y; Straussman, R; Keshet, I; Farkash, S; Hecht, M; Zimmerman, J; Eden, E; Yakhini, Z; Ben-Shushan, E; Reubinoff, BE; Bergman, Y; Simon, I; Cedar, H				Schlesinger, Yeshayahu; Straussman, Ravid; Keshet, Ilana; Farkash, Shlomit; Hecht, Merav; Zimmerman, Joseph; Eden, Eran; Yakhini, Zohar; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Bergman, Yehudit; Simon, Itamar; Cedar, Howard			Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer	NATURE GENETICS			English	Article							DNA METHYLATION; CPG ISLAND; DEVELOPMENTAL REGULATORS; METHYLTRANSFERASES; INACTIVATION; EXPRESSION; LYSINE-27; OCT-3/4; GENOME; SUZ12	Many genes associated with CpG islands undergo de novo methylation in cancer. Studies have suggested that the pattern of this modification may be partially determined by an instructive mechanism that recognizes specifically marked regions of the genome(1). Using chromatin immunoprecipitation analysis, here we show that genes methylated in cancer cells are specifically packaged with nucleosomes containing histone H3 trimethylated on Lys27. This chromatin mark is established on these unmethylated CpG island genes early in development and then maintained in differentiated cell types by the presence of an EZH2- containing Polycomb complex(2,3). In cancer cells(4), as opposed to normal cells, the presence of this complex brings about the recruitment of DNA methyl transferases, leading to de novo methylation. These results suggest that tumor-specific targeting of de novo methylation is pre-programmed by an established epigenetic system that normally has a role in marking embryonic genes for repression(2).	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Gastroenterol, IL-91120 Jerusalem, Israel; Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; Agilent Technol, IL-43527 Tel Aviv, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Goldyn Savad Inst Genet Therapy, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Expt Med, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Agilent Technologies; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel.	cedar@md.huji.ac.il		Yakhini, Zohar/0000-0002-0420-5412; Simon, Itamar/0000-0002-8517-1903; Reubinoff, Benjamin/0000-0003-0353-1299				Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; De Marzo AM, 1999, CANCER RES, V59, P3855; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Nguyen C, 2001, J NATL CANCER I, V93, P1465, DOI 10.1093/jnci/93.19.1465; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rush LJ, 2002, ANAL BIOCHEM, V307, P191, DOI 10.1016/S0003-2697(02)00033-7; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007	30	897	945	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					232	236		10.1038/ng1950	http://dx.doi.org/10.1038/ng1950			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200670				2022-12-25	WOS:000244063900022
J	Meissner, A; Wernig, M; Jaenisch, R				Meissner, Alexander; Wernig, Marius; Jaenisch, Rudolf			Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SOMATIC-CELLS; ES CELLS; MOUSE; COMPLEMENTATION; GENERATION; CLONING; MICE	In vitro reprogramming of somatic cells into a pluripotent embryonic stem cell-like state has been achieved through retroviral transduction of murine fibroblasts with Oct4, Sox2, c-myc and Klf4 (refs. 1-4). In these experiments, the rare 'induced pluripotent stem' (iPS) cells were isolated by stringent selection for activation of a neomycin-resistance gene inserted into the endogenous Oct4 (also known as Pou5f1) or Nanog loci(2-4). Direct isolation of pluripotent cells from cultured somatic cells is of potential therapeutic interest, but translation to human systems would be hindered by the requirement for transgenic donors in the present iPS isolation protocol. Here we demonstrate that reprogrammed pluripotent cells can be isolated from genetically unmodified somatic donor cells solely based upon morphological criteria.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu						Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; LENGNER C, IN PRESS CELL STEM C; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; NAGY A, 1990, DEVELOPMENT, V110, P815; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Scheffler B, 2006, BRAIN PATHOL, V16, P155, DOI 10.1111/j.1750-3639.2006.00010.x; Sonntag KC, 2005, MOL BRAIN RES, V134, P34, DOI 10.1016/j.molbrainres.2004.09.002; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	19	594	696	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1177	1181		10.1038/nbt1335	http://dx.doi.org/10.1038/nbt1335			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17724450				2022-12-25	WOS:000250226600030
J	Shukla, V; Coumoul, X; Wang, RH; Kim, HS; Deng, CX				Shukla, Vivek; Coumoul, Xavier; Wang, Rui-Hong; Kim, Hyun-Seok; Deng, Chu-Xia			RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis	NATURE GENETICS			English	Article							MUTATIONS; FGFR2; ACTIVATION; EXPRESSION; RECEPTORS; PATHWAY; ROLES; CELLS; FGF-2	Premature fusion of one or more of the cranial sutures ( craniosynostosis) in humans causes over 100 skeletal diseases, which occur in 1 of approximate to 2,500 live births(1-3). Among them is Apert syndrome, one of the most severe forms of craniosynostosis, primarily caused by missense mutations leading to amino acid changes S252W or P253R in fibroblast growth factor receptor 2 ( FGFR2)(4-6). Here we show that a small hairpin RNA targeting the dominant mutant form of Fgfr2 ( Fgfr2(S252W)) completely prevents Apert- like syndrome in mice. Restoration of normal FGFR2 signaling is manifested by an alteration of the activity of extracellular signal- regulated kinases 1 and 2 ( ERK1/ 2), implicating the gene encoding ERK and the genes downstream of it in disease expressivity. Furthermore, treatment of the mutant mice with U0126, an inhibitor of mitogen- activated protein ( MAP) kinase kinase 1 and 2 ( MEK1/ 2) that blocks phosphorylation and activation of ERK1/ 2, significantly inhibits craniosynostosis. These results illustrate a pathogenic role for ERK activation in craniosynostosis resulting from FGFR2 with the S252W substitution and introduce a new concept of small- molecule inhibitor - mediated prevention and therapy for diseases caused by gain- of- function mutations in the human genome.	NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, 10 Ctr Dr, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; COUMOUL, Xavier/AAR-3649-2020	COUMOUL, Xavier/0000-0003-2928-9648	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056004, ZIADK056004] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cabrita MA, 2003, THROMB HAEMOSTASIS, V90, P586, DOI 10.1160/TH03-04-0217; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Coumoul X, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh083; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Eswarakumar VP, 2006, P NATL ACAD SCI USA, V103, P18603, DOI 10.1073/pnas.0609157103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Ibrahimi OA, 2005, PLAST RECONSTR SURG, V115, P264, DOI 10.1097/01.PRS.0000146703.08958.95; Katzen JT, 2000, OTOLARYNG CLIN N AM, V33, P1257, DOI 10.1016/S0030-6665(05)70280-2; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Ornitz DM, 2001, GENOME BIOL, V2; PARK WJ, 1995, AM J HUM GENET, V57, P321; Perlyn CA, 2006, NEUROSURGERY, V59, P210, DOI 10.1227/01.NEU.0000224323.53866.1E; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Spector JA, 2005, PLAST RECONSTR SURG, V115, P838, DOI 10.1097/01.PRS.0000153035.73507.7B; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	30	147	163	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1145	1150		10.1038/ng2096	http://dx.doi.org/10.1038/ng2096			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694057				2022-12-25	WOS:000249122400026
J	Zhang, L; Anglesio, MS; O'Sullivan, M; Zhang, F; Yang, G; Sarao, R; Nghiem, MP; Cronin, S; Hara, H; Melnyk, N; Li, LH; Wada, T; Liu, PP; Farrar, J; Arceci, RJ; Sorensen, PH; Penninger, JM				Zhang, Liyong; Anglesio, Michael S.; O'Sullivan, Maureen; Zhang, Fan; Yang, Ge; Sarao, Renu; Nghiem, Mai P.; Cronin, Shane; Hara, Hiromitsu; Melnyk, Nataliya; Li, Liheng; Wada, Teiji; Liu, Peter P.; Farrar, Jason; Arceci, Robert J.; Sorensen, Poul H.; Penninger, Josef M.			The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers	NATURE MEDICINE			English	Article							UBIQUITIN-PROTEIN LIGASE; WILMS-TUMOR; ALLELIC LOSS; OVARIAN-TUMORS; BREAST-CANCER; CYCLIN D1; IN-SITU; TUMORIGENESIS; CARCINOMA; MICE	Transformation and cancer growth are regulated by the coordinate actions of oncogenes and tumor suppressors. Here, we show that the novel E3 ubiquitin ligase HACE1 is frequently downregulated in human tumors and maps to a region of chromosome 6q21 implicated in multiple human cancers. Genetic inactivation of HACE1 in mice results in the development of spontaneous, late-onset cancer. A second hit from either environmental triggers or genetic heterozygosity of another tumor suppressor, p53, markedly increased tumor incidence in a Hace1-deficient background. Re-expression of HACE1 in human tumor cells directly abrogates in vitro and in vivo tumor growth, whereas downregulation of HACE1 via siRNA allows non-tumorigenic human cells to form tumors in vivo. Mechanistically, the tumor-suppressor function of HACE1 is dependent on its E3 ligase activity and HACE1 controls adhesion-dependent growth and cell cycle progression during cell stress through degradation of cyclin D1. Thus, HACE1 is a candidate chromosome 6q21 tumor-suppressor gene involved in multiple cancers.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Lab Med, Vancouver, BC V5Z 1L3, Canada; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Johns Hopkins University; Johns Hopkins Medicine	Sorensen, PH (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	psor@interchange.ubc.ca; josef.penninger@imba.oeaw.ac.at	Farrar, Jason/G-8451-2017; Penninger, Josef M/I-6860-2013	Farrar, Jason/0000-0003-2148-5839; Penninger, Josef M/0000-0002-8194-3777; O'Sullivan, Maureen/0000-0001-5838-1609; Anglesio, Michael/0000-0003-1639-5003				Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Barghorn A, 2001, AM J PATHOL, V158, P1903, DOI 10.1016/S0002-9440(10)64658-5; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bruce CK, 2003, CANCER GENET CYTOGEN, V141, P106, DOI 10.1016/S0165-4608(02)00669-6; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fernandez CV, 2001, CANCER GENET CYTOGEN, V129, P165, DOI 10.1016/S0165-4608(01)00445-9; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fujii H, 1996, GENE CHROMOSOME CANC, V16, P35, DOI 10.1002/(SICI)1098-2264(199605)16:1<35::AID-GCC5>3.0.CO;2-4; Fujii H, 2002, BREAST CANCER RES TR, V76, P255, DOI 10.1023/A:1020808020873; Fujii Satoshi, 1998, Hiroshima Journal of Medical Sciences, V47, P89; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Herzog CR, 1999, MOL CARCINOGEN, V25, P92, DOI 10.1002/(SICI)1098-2744(199906)25:2<92::AID-MC3>3.0.CO;2-2; Hoban PR, 1997, J MED GENET, V34, P343, DOI 10.1136/jmg.34.4.343; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hyytinen ER, 2002, GENE CHROMOSOME CANC, V34, P306, DOI 10.1002/gcc.10065; Inoue M, 2002, AM J PATHOL, V161, P1507, DOI 10.1016/S0002-9440(10)64426-4; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Konishi N, 2003, CANCER SCI, V94, P764, DOI 10.1111/j.1349-7006.2003.tb01516.x; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Li BCY, 2003, DIAGN MOL PATHOL, V12, P193, DOI 10.1097/00019606-200312000-00003; Lovvorn HN, 2000, J PEDIATR SURG, V35, P1070, DOI 10.1053/jpsu.2000.7774; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Morelli C, 2002, ONCOGENE, V21, P7266, DOI 10.1038/sj.onc.1205573; Nakamura M, 2003, CANCER RES, V63, P737; ORPHANOS V, 1995, BRIT J CANCER, V71, P666, DOI 10.1038/bjc.1995.132; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2002, CANCER RES, V62, P2761; Smeds J, 2005, ACTA ONCOL, V44, P41, DOI 10.1080/02841860410002842; SOLIS V, 1988, CANCER GENET CYTOGEN, V34, P223, DOI 10.1016/0165-4608(88)90264-6; Takeuchi S, 2003, ONCOGENE, V22, P6970, DOI 10.1038/sj.onc.1206974; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; Thomas NA, 2003, INT J CANCER, V105, P499, DOI 10.1002/ijc.11107; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Trink B, 1998, ONCOGENE, V16, P2815, DOI 10.1038/sj.onc.1201795; Utada Y, 2000, JPN J CANCER RES, V91, P293, DOI 10.1111/j.1349-7006.2000.tb00944.x; Yatsuoka T, 2000, AM J GASTROENTEROL, V95, P2080; Yoon J, 2003, LEUKEMIA LYMPHOMA, V44, P2077, DOI 10.1080/1042819031000123410; Zhang YM, 2000, GENE CHROMOSOME CANC, V27, P52, DOI 10.1002/(SICI)1098-2264(200001)27:1<52::AID-GCC7>3.0.CO;2-X	45	106	109	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2007	13	9					1060	1069		10.1038/nm1621	http://dx.doi.org/10.1038/nm1621			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17694067				2022-12-25	WOS:000249353100033
J	Soutoglou, E; Dorn, JF; Sengupta, K; Jasin, M; Nussenzweig, A; Ried, T; Danuser, G; Misteli, T				Soutoglou, Evi; Dorn, Jonas F.; Sengupta, Kundan; Jasin, Maria; Nussenzweig, Andre; Ried, Thomas; Danuser, Gaudenz; Misteli, Tom			Positional stability of single double-strand breaks in mammalian cells	NATURE CELL BIOLOGY			English	Article							LIVING CELLS; DNA BREAKS; HISTONE H2AX; TRANSLOCATIONS; REPAIR; VISUALIZATION; ORGANIZATION; CANCER; SITES; ENDONUCLEASE	Formation of cancerous translocations requires the illegitimate joining of chromosomes containing double-strand breaks (DSBs). It is unknown how broken chromosome ends find their translocation partners within the cell nucleus. Here, we have visualized and quantitatively analysed the dynamics of single DSBs in living mammalian cells. We demonstrate that broken ends are positionally stable and unable to roam the cell nucleus. Immobilization of broken chromosome ends requires the DNA-end binding protein Ku80, but is independent of DNA repair factors, H2AX, the MRN complex and the cohesion complex. DSBs preferentially undergo translocations with neighbouring chromosomes and loss of local positional constraint correlates with elevated genomic instability. These results support a contact-first model in which chromosome translocations predominantly form among spatially proximal DSBs.	NCI, NIH, Genet Branch, Bethesda, MD 20892 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Genet Branch, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov		Soutoglou, Evi/0000-0002-3724-5613; Sengupta, Kundan/0000-0002-9936-2284; Dorn, Jonas/0000-0001-6696-0117; Danuser, Gaudenz/0000-0001-8583-2014	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NIGMS NIH HHS [GM68956, R01 GM068956] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010837, Z01BC010283, Z01BC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068956] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2004, CELL CYCLE, V3, P149; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fugunaga K., 1990, INTRO STAT PATTERN R; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Martinez ED, 2005, J STEROID BIOCHEM, V97, P307, DOI 10.1016/j.jsbmb.2005.06.033; MCNEIL N, 2000, EXPERT REV MOL MED, P1; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Villalobos Michael J, 2006, Methods Mol Biol, V314, P109; Wyman C, 2002, CURR BIOL, V12, pR446, DOI 10.1016/S0960-9822(02)00941-7	41	387	398	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					675	U121		10.1038/ncb1591	http://dx.doi.org/10.1038/ncb1591			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486118	Green Accepted			2022-12-25	WOS:000246922700013
J	Courtine, G; Bunge, MB; Fawcett, JW; Grossman, RG; Kaas, JH; Lemon, R; Maier, I; Martin, J; Nudo, RJ; Ramon-Cueto, A; Rouiller, EM; Schnell, L; Wannier, T; Schwab, ME; Edgerton, VR				Courtine, Gregoire; Bunge, Mary Bartlett; Fawcett, James W.; Grossman, Robert G.; Kaas, Jon H.; Lemon, Roger; Maier, Irin; Martin, John; Nudo, Randolph J.; Ramon-Cueto, Almudena; Rouiller, Eric M.; Schnell, Lisa; Wannier, Thierry; Schwab, Martin E.; Edgerton, V. Reggie			Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?	NATURE MEDICINE			English	Editorial Material							UPPER-LIMB MOTONEURONS; CORTICOSPINAL TRACT; UNILATERAL SECTION; CERVICAL LEVEL; MOTOR CORTEX; HAND REPRESENTATION; PYRAMIDAL TRACT; CELL GRAFTS; RECOVERY; LOCOMOTION		Univ Calif Los Angeles, Dept Physiol Sci & Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Dept Cell Biol & Anat, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33101 USA; Univ Cambridge, Brain Repair Ctr, Cambridge CB2 2PY, England; Methodist Hosp, Inst Neurol, Dept Neurosurg, Houston, TX 77030 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; UCL, Inst Neurol, London WC1N 3BG, England; Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Kansas, Med Ctr, Landon Ctr Aging, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; Spanish Council Sci Res, Lab Neural Regenerat, Inst Biomed, Valencia 46010, Spain; Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Miami; University of Miami; University of Cambridge; The Methodist Hospital System; The Methodist Hospital - Houston; Vanderbilt University; University of London; University College London; University of Zurich; Columbia University; University of Kansas; University of Kansas Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Fribourg	Edgerton, VR (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci & Neurobiol, Los Angeles, CA 90095 USA.	vre@ucla.edu	Schwab, Martin E/B-6818-2016; Nudo, Randolph/B-1623-2009; courtine, gregoire/AAJ-1694-2020	courtine, gregoire/0000-0002-5744-4142; Rouiller, Eric/0000-0003-1355-6019; Fawcett, James/0000-0002-7990-4568	NINDS NIH HHS [R01 NS016446, R37 NS030853-16A1, R37 NS030853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030853, R01NS016446] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Belci M, 2004, SPINAL CORD, V42, P417, DOI 10.1038/sj.sc.3101613; BORTOFF GA, 1993, J NEUROSCI, V13, P5105, DOI 10.1523/JNEUROSCI.13-12-05105.1993; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Darian-Smith C, 2005, J COMP NEUROL, V491, P27, DOI 10.1002/cne.20686; Fawcett J, 2002, SPINAL CORD, V40, P615, DOI 10.1038/sj.sc.3101328; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; KUYPERS H. G. J. M., 1964, PROGR BRAIN RES, V11, P178; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lemon RN, 2004, PROG BRAIN RES, V143, P263, DOI 10.1016/S0079-6123(03)43026-4; *MED RES COUNC, 2006, PRIM MED RES; Muir GD, 1999, BEHAV BRAIN RES, V103, P45, DOI 10.1016/S0166-4328(99)00018-2; Nakajima K, 2004, PROG BRAIN RES, V143, P183, DOI 10.1016/S0079-6123(03)43018-5; Nakajima K, 2000, J NEUROPHYSIOL, V84, P698, DOI 10.1152/jn.2000.84.2.698; NATHAN PW, 1994, BRAIN, V117, P337, DOI 10.1093/brain/117.2.337; Rouiller EM, 1996, EUR J NEUROSCI, V8, P1055, DOI 10.1111/j.1460-9568.1996.tb01592.x; Schmidlin E, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-56; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tuszynski MH, 2002, J COMP NEUROL, V449, P88, DOI 10.1002/cne.10266; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6	31	271	281	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2007	13	5					561	566		10.1038/nm1595	http://dx.doi.org/10.1038/nm1595			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	165JW	17479102	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000246302800022
J	Diamandis, P; Wildenhain, J; Clarke, ID; Sacher, AG; Graham, J; Bellows, DS; Ling, EKM; Ward, RJ; Jamieson, LG; Tyers, M; Dirks, PB				Diamandis, Phedias; Wildenhain, Jan; Clarke, Ian D.; Sacher, Adrian G.; Graham, Jeremy; Bellows, David S.; Ling, Erick K. M.; Ward, Ryan J.; Jamieson, Leanne G.; Tyers, Mike; Dirks, Peter B.			Chemical genetics reveals a complex functional ground state of neural stem cells	NATURE CHEMICAL BIOLOGY			English	Article							SELF-RENEWAL; ADULT NEUROGENESIS; BRAIN-TUMORS; MEDULLOBLASTOMA; IDENTIFICATION; MOLECULES; HEDGEHOG; DISEASE; CANCER; EGF	The identification of self- renewing and multipotent neural stem cells ( NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain cancer(1 - 3). However, the complete repertoire of signaling pathways that governs the proliferation and self-renewal of NSCs, which we refer to as the 'ground state', remains largely uncharacterized. Although the candidate gene approach has uncovered vital pathways in NSC biology(4 - 8), so far only a few highly studied pathways have been investigated. Based on the intimate relationship between NSC self- renewal and neurosphere proliferation(8), we undertook a chemical genetic screen for inhibitors of neurosphere proliferation in order to probe the operational circuitry of the NSC. The screen recovered small molecules known to affect neurotransmission pathways previously thought to operate primarily in the mature central nervous system; these compounds also had potent inhibitory effects on cultures enriched for brain cancer stem cells. These results suggest that clinically approved neuromodulators may remodel the mature central nervous system and find application in the treatment of brain cancer.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Banting Inst, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON M5G 1L5, Canada; Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca; peter.dirks@sickkids.ca	Wildenhain, Jan/Q-6596-2019; Tyers, Michael/ABE-3194-2021; Sacher, Adrian/I-8080-2016; Wildenhain, Jan/E-5597-2011	Wildenhain, Jan/0000-0002-5461-3828; Sacher, Adrian/0000-0001-7865-2701; Wildenhain, Jan/0000-0002-5461-3828; Diamandis, Phedias/0000-0001-5291-9068				Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; BUTTERWORTH RF, 1975, CAN J BIOCHEM CELL B, V53, P308, DOI 10.1139/o75-043; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Gritti A, 1999, J NEUROSCI, V19, P3287; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Kevorkov D, 2005, J BIOMOL SCREEN, V10, P557, DOI 10.1177/1087057105276989; Lalonde FM, 2003, BREAST, V12, P280, DOI 10.1016/S0960-9776(03)00061-4; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	31	121	125	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2007	3	5					268	273		10.1038/nchembio873	http://dx.doi.org/10.1038/nchembio873			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159FP	17417631				2022-12-25	WOS:000245851100010
J	Thoma, CR; Frew, IJ; Hoerner, CR; Montani, M; Moch, H; Krek, W				Thoma, Claudio R.; Frew, Ian J.; Hoerner, Christian R.; Montani, Matteo; Moch, Holger; Krek, Wilhelm			pVHL and GSK3 beta are components of a primary cilium-maintenance signalling network	NATURE CELL BIOLOGY			English	Article							LINDAU TUMOR-SUPPRESSOR; GLYCOGEN-SYNTHASE KINASE-3; POLYCYSTIC KIDNEY-DISEASE; PROTEIN; INACTIVATION; GENE; CILIOGENESIS; ACTIVATION; STABILITY; LESIONS	Defects in the structure or function of the primary cilium, an antennae-like structure whose functional integrity has been linked to the suppression of uncontrolled kidney epithelial cell proliferation, are a common feature of genetic disorders characterized by kidney cysts(1,2). However, the mechanisms by which primary cilia are maintained remain poorly defined. von Hippel-Lindau (VHL) disease is characterized by the development of premalignant renal cysts and arises because of functional inactivation of the VHL tumour suppressor gene product, pVHL(3,4). Here, we show that pVHL and glycogen synthase kinase (GSK)3 beta are key components of an interlinked signalling pathway that maintains the primary cilium. Although inactivation of either pVHL or GSK3 beta alone did not affect cilia maintenance, their combined inactivation leads to loss of cilia. In VHL patients, GSK3 beta is subjected to inhibitory phosphorylation in renal cysts, but not in early VHL mutant lesions, and these cysts exhibit reduced frequencies of primary cilia. We propose that pVHL and GSK3 beta function together in a ciliary-maintenance signalling network, disruption of which enhances the vulnerability of cells to lose their cilia, thereby promoting cyst formation.	ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; Univ Zurich, PHD Programme Mol Life Sci, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Krek, W (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	wilhelm.krek@cell.biol.ethz.ch		Frew, Ian/0000-0003-2735-5509; Hoerner, Christian/0000-0002-8685-1126				Alieva I B, 1999, Membr Cell Biol, V12, P895; BRAUCH H, 1995, HUM GENET, V95, P551, DOI 10.1007/BF00223868; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; CHOYKE PL, 1992, AM J ROENTGENOL, V159, P1229, DOI 10.2214/ajr.159.6.1442389; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Lutz MS, 2006, CANCER RES, V66, P6903, DOI 10.1158/0008-5472.CAN-06-0501; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2004, AM J PHYSIOL-RENAL, V287, pF969, DOI 10.1152/ajprenal.00096.2004; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; SOLOMON D, 1988, HUM PATHOL, V19, P1072, DOI 10.1016/S0046-8177(88)80089-3; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	34	178	180	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					588	U191		10.1038/ncb1579	http://dx.doi.org/10.1038/ncb1579			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450132				2022-12-25	WOS:000246181500018
J	Jasnos, L; Korona, R				Jasnos, Lukasz; Korona, Ryszard			Epistatic buffering of fitness loss in yeast double deletion strains	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; DELETERIOUS MUTATIONS; SEXUAL REPRODUCTION; METABOLIC NETWORK; RECOMBINATION; EVOLUTION; GENOME; SELECTION; GENES	Interactions between deleterious mutations have been insufficiently studied(1,2), despite the fact that their strength and direction are critical for understanding the evolution of genetic recombination(3,4) and the buildup of mutational load in populations(5,6). We compiled a list of 758 yeast gene deletions causing growth defects ( from the Munich Information Center for Protein Sequences database and ref. 7). Using BY4741 and BY4742 single- deletion strains, we carried out 639 random crosses and assayed growth curves of the resulting progeny. We show that the maximum growth rate averaged over strains lacking deletions and those with double deletions is higher than that of strains with single deletions, indicating a positive epistatic effect. This tendency is shared by genes belonging to a variety of functional classes. Based on our data and former theoretical work(8-10), we suggest that epistasis is likely to diminish the negative effects of mutations when the ability to produce biomass at high rates contributes significantly to fitness.	Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland	Jagiellonian University	Korona, R (corresponding author), Jagiellonian Univ, Inst Environm Sci, Gronostajowa 7, PL-30387 Krakow, Poland.	korona@eko.uj.edu.pl	Korona, Ryszard/J-7154-2015	Korona, Ryszard/0000-0002-4329-5908				Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; FELDMAN MW, 1980, P NATL ACAD SCI-BIOL, V77, P4838, DOI 10.1073/pnas.77.8.4838; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jasnos L, 2005, ANAL BIOCHEM, V344, P138, DOI 10.1016/j.ab.2005.04.034; Keightley PD, 1996, J THEOR BIOL, V182, P311, DOI 10.1006/jtbi.1996.0169; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sliwa P, 2005, P NATL ACAD SCI USA, V102, P17670, DOI 10.1073/pnas.0505517102; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SZATHMARY E, 1993, GENETICS, V133, P127; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931	30	93	94	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					550	554		10.1038/ng1986	http://dx.doi.org/10.1038/ng1986			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322879				2022-12-25	WOS:000245271200028
J	Oliynyk, M; Samborskyy, M; Lester, JB; Mironenko, T; Scott, N; Dickens, S; Haydock, SF; Leadlay, PF				Oliynyk, Markiyan; Samborskyy, Markiyan; Lester, John B.; Mironenko, Tatiana; Scott, Nataliya; Dickens, Shilo; Haydock, Stephen F.; Leadlay, Peter F.			Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338	NATURE BIOTECHNOLOGY			English	Article							SITE-SPECIFIC INTEGRATION; STREPTOMYCES-LIVIDANS 66; MYCOBACTERIUM-TUBERCULOSIS; POLYKETIDE BIOSYNTHESIS; ADENYLATION DOMAINS; IDENTIFICATION; GENES; RECOGNITION; CHROMOSOMES; SYNTHASE	Saccharopolyspora erythraea is used for the industrial- scale production of the antibiotic erythromycin A, derivatives of which play a vital role in medicine. The sequenced chromosome of this soil bacterium comprises 8,212,805 base pairs, predicted to encode 7,264 genes. It is circular, like those of the pathogenic actinomycetes Mycobacterium tuberculosis and Corynebacterium diphtheriae, but unlike the linear chromosomes of the model actinomycete Streptomyces coelicolor A3( 2) and the closely related Streptomyces avermitilis. The S. erythraea genome contains at least 25 gene clusters for production of known or predicted secondary metabolites, at least 72 genes predicted to confer resistance to a range of common antibiotic classes and many sets of duplicated genes to support its saprophytic lifestyle. The availability of the genome sequence of S. erythraea will improve insight into its biology and facilitate rational development of strains to generate high- titer producers of clinically important antibiotics.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Leadlay, PF (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	leadlay@mole.bio.cam.ac.uk		Samborskyy, Dr. Markiyan/0000-0002-6946-0385; Leadlay, Peter/0000-0002-3247-509X	Biotechnology and Biological Sciences Research Council [BB/C519597/1, CFB17699] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao K, 2003, GENE DEV, V17, P774, DOI 10.1101/gad.1060303; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Boakes S, 2004, J MOL MICROB BIOTECH, V8, P73, DOI 10.1159/000084562; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BROWN DP, 1994, MOL GEN GENET, V242, P185, DOI 10.1007/BF00391012; BROWN DP, 1990, J BACTERIOL, V172, P1877, DOI 10.1128/jb.172.4.1877-1888.1990; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen CW, 2002, TRENDS GENET, V18, P522, DOI 10.1016/S0168-9525(02)02752-X; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cortes J, 2002, MOL MICROBIOL, V44, P1213, DOI 10.1046/j.1365-2958.2002.02975.x; Diacovich L, 2002, J BIOL CHEM, V277, P31228, DOI 10.1074/jbc.M203263200; Donadio S, 1996, MOL MICROBIOL, V19, P977, DOI 10.1046/j.1365-2958.1996.439969.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gaitatzis N, 2005, CHEMBIOCHEM, V6, P365, DOI 10.1002/cbic.200400206; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hessler PE, 1997, APPL MICROBIOL BIOT, V47, P398, DOI 10.1007/s002530050947; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jakimowicz D, 1998, MICROBIOL-SGM, V144, P1281, DOI 10.1099/00221287-144-5-1281; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; LABEDA DP, 1987, INT J SYST BACTERIOL, V37, P19, DOI 10.1099/00207713-37-1-19; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; LEADLAY PF, 1981, BIOCHEM J, V197, P413, DOI 10.1042/bj1970413; LEBLOND P, 1993, J BACTERIOL, V175, P3422, DOI 10.1128/jb.175.11.3422-3429.1993; LIN YS, 1993, MOL MICROBIOL, V10, P923, DOI 10.1111/j.1365-2958.1993.tb00964.x; Liu HB, 2001, METAB ENG, V3, P40, DOI 10.1006/mben.2000.0169; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Merkl R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-22; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Oliveira PH, 2006, LETT APPL MICROBIOL, V42, P375, DOI 10.1111/j.1472-765X.2006.01849.x; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reeves AR, 2004, METAB ENG, V6, P300, DOI 10.1016/j.ymben.2004.03.003; Reeves AR, 1998, MICROBIOL-UK, V144, P2151, DOI 10.1099/00221287-144-8-2151; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stassi DL, 1998, P NATL ACAD SCI USA, V95, P7305, DOI 10.1073/pnas.95.13.7305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Staunton J, 1997, CHEM REV, V97, P2611, DOI 10.1021/cr9600316; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Volff JN, 2000, FEMS MICROBIOL LETT, V186, P143, DOI 10.1016/S0378-1097(00)00118-X; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang WW, 2001, J BACTERIOL, V183, P2071, DOI 10.1128/JB.183.6.2071-2080.2001	50	297	597	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					447	453		10.1038/nbt1297	http://dx.doi.org/10.1038/nbt1297			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17369815	hybrid			2022-12-25	WOS:000245651800026
J	Yang, BF; Lin, HX; Xiao, JN; Lu, YJ; Luo, XB; Li, BX; Zhang, Y; Xu, CQ; Bai, YL; Wang, HZ; Chen, GH; Wang, ZG				Yang, Baofeng; Lin, Huixian; Xiao, Jiening; Lu, Yanjie; Luo, Xiaobin; Li, Baoxin; Zhang, Ying; Xu, Chaoqian; Bai, Yunlong; Wang, Huizhen; Chen, Guohao; Wang, Zhiguo			The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2	NATURE MEDICINE			English	Article							RAT-HEART; IN-VIVO; VENTRICULAR-ARRHYTHMIAS; EXPRESSION; ISCHEMIA; DISEASE; CARDIOMYOCYTES; HYPERTROPHY; INHIBITION; CONNEXIN43	MicroRNAs (miRNAs) are endogenous noncoding RNAs, about 22 nucleotides in length, that mediate post-transcriptional gene silencing by annealing to inexactly complementary sequences in the 3'-untranslated regions of target mRNAs1-3. Our current understanding of the functions of miRNAs relies mainly on their tissue-specific or developmental stage-dependent expression and their evolutionary conservation, and therefore is primarily limited to their involvement in developmental regulation and oncogenesis(2). Of more than 300 miRNAs that have been identified, miR-1 and miR-133 are considered to be muscle specific(4-6). Here we show that miR-1 is overexpressed in individuals with coronary artery disease, and that when overexpressed in normal or infarcted rat hearts, it exacerbates arrhythmogenesis. Elimination of miR-1 by an antisense inhibitor in infarcted rat hearts relieved arrhythmogenesis. miR-1 overexpression slowed conduction and depolarized the cytoplasmic membrane by post-transcriptionally repressing KCNJ2 (which encodes the K+ channel subunit Kir2.1) and GJA1 (which encodes connexin 43), and this likely accounts at least in part for its arrhythmogenic potential. Thus, miR-1 may have important pathophysiological functions in the heart, and is a potential antiarrhythmic target.	Harbin Med Coll, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin 150086, Heilongjiang, Peoples R China; Harbin Med Coll, Cardiovasc Res Inst, Harbin 150086, Heilongjiang, Peoples R China; Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Harbin Medical University; Harbin Medical University; Universite de Montreal; Universite de Montreal	Wang, ZG (corresponding author), Harbin Med Coll, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin 150086, Heilongjiang, Peoples R China.	yangbf@ems.hrbmu.edu.cn; wz.email@gmail.com	wang, zhiguo/AAN-4182-2021; Wang, Zhiguo/GRS-4339-2022	Wang, Zhiguo/0000-0002-0811-2045				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Clements-Jewery H, 2005, BRIT J PHARMACOL, V145, P551, DOI 10.1038/sj.bjp.0706231; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Diaz RJ, 2004, CIRC RES, V95, P325, DOI 10.1161/01.RES.0000137727.34938.35; Ghuran AV, 2001, BRIT MED BULL, V59, P193, DOI 10.1093/bmb/59.1.193; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Jongsma HJ, 2000, CIRC RES, V86, P1193, DOI 10.1161/01.RES.86.12.1193; KITSIS RN, 1991, P NATL ACAD SCI USA, V88, P4138, DOI 10.1073/pnas.88.10.4138; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lerner DL, 2000, CIRCULATION, V101, P547, DOI 10.1161/01.CIR.101.5.547; McLerie M, 2003, J MOL CELL CARDIOL, V35, P367, DOI 10.1016/S0022-2828(03)00014-2; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Rajan S, 2003, BASIC RES CARDIOL, V98, P39, DOI 10.1007/s00395-003-0382-2; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Salameh A, 2004, EUR J PHARMACOL, V503, P9, DOI 10.1016/j.ejphar.2004.09.024; Sarkar N, 2002, J CARDIOVASC PHARM, V39, P215, DOI 10.1097/00005344-200202000-00008; SAYED D, 2007, CIRC RES; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Yang BF, 2005, CELL PHYSIOL BIOCHEM, V16, P163, DOI 10.1159/000089842; Yue P, 2006, CELL PHYSIOL BIOCHEM, V17, P129, DOI 10.1159/000092074; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	24	892	1041	4	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2007	13	4					486	491		10.1038/nm1569	http://dx.doi.org/10.1038/nm1569			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	154YG	17401374				2022-12-25	WOS:000245543900038
J	Park, M; Yong, YY; Choi, SW; Kim, JH; Lee, JE; Kim, DW				Park, Minsun; Yong, Yeryoung; Choi, Seung-Won; Kim, Jae Hwan; Lee, Jong Eun; Kim, Dae-Won			Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; SOMITIC CHONDROGENESIS; TRANSCRIPTION FACTORS; SKELETAL DYSPLASIA; AXIAL SKELETON; BAPX1; BONE; GENE; DIFFERENTIATION; EXPRESSION	During endochondral ossification, a process that accounts for the majority of bone formation in vertebrates, hypertrophic chondrocytes display a greater susceptibility to apoptosis when compared to proliferating chondrocytes. However, the molecular mechanisms underlying this phenomenon remain unclear. Nkx3.2, a member of the NK class of homeoproteins, is initially expressed in chondrogenic precursor cells, and later, during cartilage maturation, its expression is restricted to proliferating chondrocytes. Here, we show that the nuclear factor kappa B (NF-kappa B) pathway is required for chondrocyte viability and that Nkx3.2 supports chondrocyte survival by constitutively activating RelA. Although signal-dependent NF-kappa B activation has been intensively studied, ligand-independent NF-kappa B activation is poorly understood. The data presented here support a novel ligand-independent mechanism of NF-kappa B activation, whereby Nkx3.2 recruits the ReIA-I kappa B alpha heteromeric complex into the nucleus by direct protein-protein interactions and activates RelA through proteasome-dependent I kappa B alpha degradation in the nucleus. Furthermore, we demonstrate that stage-specific NF-kappa B activation, mediated by Nkx3.2, regulates chondrocyte viability during cartilage maturation.	Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Anat, Seoul 120752, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Kim, DW (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	kimdw@yonsei.ac.kr		Lee, Jong Eun/0000-0001-6203-7413				Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Church V, 2005, ANAT EMBRYOL, V209, P461, DOI 10.1007/s00429-005-0464-z; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tribioli C, 1997, GENE, V203, P225, DOI 10.1016/S0378-1119(97)00520-9; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Vortkamp A, 2001, OSTEOARTHR CARTILAGE, V9, pS109, DOI 10.1053/joca.2001.0452; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Yoshiura KI, 1997, GENOMICS, V45, P425, DOI 10.1006/geno.1997.4926; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002	32	39	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					287	U87		10.1038/ncb1538	http://dx.doi.org/10.1038/ncb1538			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310243				2022-12-25	WOS:000244558600013
J	Benetti, R; Garcia-Cao, M; Blasco, MA				Benetti, Roberta; Garcia-Cao, Marta; Blasco, Maria A.			Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres	NATURE GENETICS			English	Article							CONSTITUTIVE HETEROCHROMATIN; HISTONE METHYLTRANSFERASES; CHROMOSOMAL INSTABILITY; DNA-DAMAGE; CELLS; MICE; STABILITY/; PROTEINS; COMPLEX; FAMILY	Mammalian telomeres have epigenetic marks of constitutive heterochromatin. Here, we study the impact of telomere length on the maintenance of heterochromatin domains at telomeres. Telomerase-deficient Terc(-/-) mice with short telomeres show decreased trimethylation of histone 3 at Lys9 ( H3K9) and histone 4 at Lys20 ( H4K20) in telomeric and subtelomeric chromatin as well as decreased CBX3 binding accompanied by increased H3 and H4 acetylation at these regions. Subtelomeric DNA methylation is also decreased in conjunction with telomere shortening in Terc(-/-) mice. In contrast, telomere repeat factors 1 and 2 show normal binding to telomeres independent of telomere length. These results indicate that loss of telomeric repeats leads to a change in the architecture of telomeric and subtelomeric chromatin consisting of loss of heterochromatic features leading to a more 'open' chromatin state. These observations highlight the importance of telomere repeats in the establishment of constitutive heterochromatin at mammalian telomeres and subtelomeres and point to histone modifications as important in counting telomere repeats.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; BENETTI, Roberta/0000-0001-8863-0821				Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4	29	274	288	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					243	250		10.1038/ng1952	http://dx.doi.org/10.1038/ng1952			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237781				2022-12-25	WOS:000244063900024
J	Ozsolak, F; Song, JS; Liu, XS; Fisher, DE				Ozsolak, Fatih; Song, Jun S.; Liu, X. Shirley; Fisher, David E.			High-throughput mapping of the chromatin structure of human promoters	NATURE BIOTECHNOLOGY			English	Article							TRANSCRIPTIONAL REGULATION; NUCLEOSOME POSITIONS; LINEAGE SURVIVAL; GENE-REGULATION; GENOME-WIDE; DNA; MELANOMA; YEAST; MITF; CHROMOSOME	Our understanding of how chromatin structure influences cellular processes such as transcription and replication has been limited by a lack of nucleosome-positioning data in human cells. We describe a high-resolution microarray approach combined with an analysis algorithm to examine nucleosome positioning in 3,692 promoters within seven human cell lines. Unlike unexpressed genes without transcription-preinitiation complexes at their promoters, expressed genes or genes containing preinitiation complexes exhibit characteristic nucleosome-free regions at their transcription start sites. The combination of these nucleosome data with chromatin immunoprecipitation-chip analyses reveals that the melanocyte master regulator microphthalmia-associated transcription factor ( MITF) predominantly binds nucleosome-free regions, supporting the model that nucleosomes limit sequence accessibility. This study presents a global view of human nucleosome positioning and provides a high-throughput tool for analyzing chromatin structure in development and disease.	Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Melanoma Program Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Liu, XS (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Melanoma Program Med Oncol, 44 Binney St, Boston, MA 02115 USA.	xsliu@jimmy.harvard.edu; david_fisher@dfci.harvard.edu	Song, Jun S/E-2526-2016	Song, Jun S/0000-0002-0422-2175	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004069-02, R01 HG004069-01, R01 HG004069] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen C, 2001, MOL CELL BIOL, V21, P7682, DOI 10.1128/MCB.21.22.7682-7695.2001; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fivaz J, 2000, GENE, V255, P169, DOI 10.1016/S0378-1119(00)00339-5; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hoffmann A, 1997, P NATL ACAD SCI USA, V94, P8928, DOI 10.1073/pnas.94.17.8928; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LU Q, 1994, J CELL BIOCHEM, V55, P83, DOI 10.1002/jcb.240550110; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mucha M, 2000, J BIOL CHEM, V275, P1275, DOI 10.1074/jbc.275.2.1275; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; REID DG, 1985, BIOCHEMISTRY-US, V24, P4325, DOI 10.1021/bi00337a011; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2001, Nucleic Acids Res, V29, pE66, DOI 10.1093/nar/29.13.e66	30	266	280	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					244	248		10.1038/nbt1279	http://dx.doi.org/10.1038/nbt1279			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17220878				2022-12-25	WOS:000244064000031
J	Tao, R; de Zoeten, EF; Ozkaynak, E; Chen, CX; Wang, LQ; Porrett, PM; Li, B; Turka, LA; Olson, EN; Greene, MI; Wells, AD; Hancock, WW				Tao, Ran; de Zoeten, Edwin F.; Oezkaynak, Engin; Chen, Chunxia; Wang, Liqing; Porrett, Paige M.; Li, Bin; Turka, Laurence A.; Olson, Eric N.; Greene, Mark I.; Wells, Andrew D.; Hancock, Wayne W.			Deacetylase inhibition promotes the generation and function of regulatory T cells	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXP3; HISTONE-DEACETYLASE; TRICHOSTATIN-A; EXPERIMENTAL COLITIS; CHEMOKINE RECEPTOR; PROGRAMMED DEATH-1; PERMANENT SURVIVAL; ISLET ALLOGRAFTS; GENE-EXPRESSION; DNA-BINDING	Histone/protein deacetylases (HDACs) regulate chromatin remodeling and gene expression as well as the functions of more than 50 transcription factors and nonhistone proteins. We found that administration of an HDAC inhibitor (HDACi) in vivo increased Foxp3 gene expression, as well as the production and suppressive function of regulatory T cells (T-reg cells). Although T-reg cells express multiple HDACs, HDAC9 proved particularly important in regulating Foxp3-dependent suppression. Optimal Treg function required acetylation of several lysines in the forkhead domain of Foxp3, and Foxp3 acetylation enhanced binding of Foxp3 to the II2 promoter and suppressed endogenous IL-2 production. HDACi therapy in vivo enhanced T-reg-mediated suppression of homeostatic proliferation, decreased inflammatory bowel disease through T-reg-dependent effects, and, in conjunction with a short course of low-dose rapamycin, induced permanent, Treg-dependent cardiac and islet allograft survival and donor-specific allograft tolerance. Our data show that use of HDACi allows the beneficial pharmacologic enhancement of both the numbers and suppressive function of Foxp3+ T-reg cells.	Childrens Hosp Philadelphia, Div Transplantat Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Biesecker Ctr Studies Pediat Liver Dis, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hancock, WW (corresponding author), Childrens Hosp Philadelphia, Div Transplantat Immunol, Dept Pathol & Lab Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu	Porrett, Paige/AAU-8992-2020; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884; de Zoeten, Edwin/0000-0002-0946-9759	NIAID NIH HHS [R01 AI 54720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054720] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida ARM, 2006, INT IMMUNOL, V18, P1607, DOI 10.1093/intimm/dxl093; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fukuzaki T, 1998, TRANSPLANTATION, V65, P1036, DOI 10.1097/00007890-199804270-00005; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hancock WW, 1998, NAT MED, V4, P1392, DOI 10.1038/3982; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lam AL, 2005, CHROMOSOMA, V114, P242, DOI 10.1007/s00412-005-0001-0; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lee I, 2003, J IMMUNOL, V171, P6929, DOI 10.4049/jimmunol.171.12.6929; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Shintani N, 1998, GEN PHARMACOL-VASC S, V31, P477, DOI 10.1016/S0306-3623(98)00004-4; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Wang LQ, 2005, J IMMUNOL, V175, P6311, DOI 10.4049/jimmunol.175.10.6311; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	50	682	726	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1299	1307		10.1038/nm1652	http://dx.doi.org/10.1038/nm1652			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17922010				2022-12-25	WOS:000250736900022
J	Maller, JB; Fagerness, JA; Reynolds, RC; Neale, BM; Daly, MJ; Seddon, JM				Maller, Julian B.; Fagerness, Jesen A.; Reynolds, Robyn C.; Neale, Benjamin M.; Daly, Mark J.; Seddon, Johanna M.			Variation in complement factor 3 is associated with risk of age-related macular degeneration	NATURE GENETICS			English	Article							FACTOR-H POLYMORPHISM; VARIANT; CFH; GENES; Y402H	The association of variants in complement factors H and B with age-related macular degeneration has led to more intense genetic and functional analysis of the complement pathway. We identify a nonsynonymous coding change in complement factor 3 that is strongly associated with risk of age-related macular degeneration in a large case-control sample.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Tufts Univ New England Med Ctr, New England Eye Ctr, Ophthal Epidemiol & Genet Serv, Boston, MA 02111 USA; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AP, England; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts Medical Center; University of London; King's College London; Harvard University; Harvard Medical School	Seddon, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; jseddon@tufts-nemc.org	maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [N01EY002127, R01EY011309] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [EY11309, R01 EY011309, N01-EY-0-2127] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; WYATT RJ, 1987, RECENT DEV MUCOSAL I; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	14	335	364	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1200	1201		10.1038/ng2131	http://dx.doi.org/10.1038/ng2131			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767156				2022-12-25	WOS:000249737400014
J	Menzel, S; Garner, C; Gut, I; Matsuda, F; Yamaguchi, M; Heath, S; Foglio, M; Zelenika, D; Boland, A; Rooks, H; Best, S; Spector, TD; Farrall, M; Lathrop, M; Thein, SL				Menzel, Stephan; Garner, Chad; Gut, Ivo; Matsuda, Fumihiko; Yamaguchi, Masao; Heath, Simon; Foglio, Mario; Zelenika, Diana; Boland, Anne; Rooks, Helen; Best, Steve; Spector, Tim D.; Farrall, Martin; Lathrop, Mark; Thein, Swee Lay			A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15	NATURE GENETICS			English	Article							FETAL-HEMOGLOBIN; ASSOCIATION; ADULTS	F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.	Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London SE5 9PJ, England; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91006 Evry, France; St Thomas Hosp, Univ London Kings Coll, Sch Med, Div Genet & Mol Med, London SE1 7EH, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Kings Coll Hosp London, Dept Haematol Med, London SE5 9RS, England	University of London; King's College London; University of California System; University of California Irvine; CEA; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; King's College Hospital NHS Foundation Trust; King's College Hospital	Thein, SL (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, Kings Denmark Hill Campus, London SE5 9PJ, England.	sl.thein@kcl.ac.uk	Menzel, Stephan/U-6906-2019; Matsuda, Fumihiko/B-9893-2009; Spector, Tim D/F-6533-2012; Gut, Ivo/ABF-3188-2020; Best, Steve/A-7531-2012; Foglio, mary A./B-9149-2012; Heath, Simon C/J-4138-2012	Gut, Ivo/0000-0001-7219-632X; Foglio, mary A./0000-0001-7715-4452; Heath, Simon C/0000-0002-9550-0897; Menzel, Stephan/0000-0002-1590-9108	Medical Research Council [G0000111] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000111] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Tenesa A, 2005, BEHAV GENET, V35, P219, DOI 10.1007/s10519-004-0811-5; Thein SL, 1998, HEMOGLOBIN, V22, P401, DOI 10.3109/03630269809071538; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104	15	384	408	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1197	1199		10.1038/ng2108	http://dx.doi.org/10.1038/ng2108			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767159				2022-12-25	WOS:000249737400013
J	Brems, H; Chmara, M; Sahbatou, M; Denayer, E; Taniguchi, K; Kato, R; Somers, R; Messiaen, L; De Schepper, S; Fryns, JP; Cools, J; Marynen, P; Thomas, G; Yoshimura, A; Legius, E				Brems, Hilde; Chmara, Magdalena; Sahbatou, Mourad; Denayer, Ellen; Taniguchi, Koji; Kato, Reiko; Somers, Riet; Messiaen, Ludwine; De Schepper, Sofie; Fryns, Jean-Pierre; Cools, Jan; Marynen, Peter; Thomas, Gilles; Yoshimura, Akihiko; Legius, Eric			Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype	NATURE GENETICS			English	Article							SPROUTY DOMAIN; SUPPRESSOR; PTPN11; GENE; IDENTIFICATION; PATHWAY; PROTEIN; TYPE-1	We report germline loss- of- function mutations in SPRED1 in a newly identified autosomal dominant human disorder. SPRED1 is a member of the SPROUTY/ SPRED family(1) of proteins that act as negative regulators of RAS- RAF interaction and mitogen-activated protein kinase ( MAPK) signaling(2). The clinical features of the reported disorder resemble those of neurofibromatosis type 1 and consist of multiple cafe - au- lait spots, axillary freckling and macrocephaly. Melanocytes from a cafe - au- lait spot showed, in addition to the germline SPRED1 mutation, an acquired somatic mutation in the wild- type SPRED1 allele, indicating that complete SPRED1 inactivation is needed to generate a cafe - au- lait spot in this syndrome. This disorder is yet another member of the recently characterized group of phenotypically overlapping syndromes caused by mutations in the genes encoding key components of the RAS- MAPK pathway(3,4). To our knowledge, this is the first report of mutations in the SPRY ( SPROUTY)/ SPRED family of genes in human disease.	Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; CEPH, Fdn Jean Dausset, F-75010 Paris, France; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; VIB, Flanders Inst Biotechnol, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL USA; Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; NCI, Dept Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Universite Catholique Louvain; Fahrenheit Universities; Medical University Gdansk; Foundation Jean Dausset-CEPH; Kyushu University; Flanders Institute for Biotechnology (VIB); University of Alabama System; University of Alabama Birmingham; Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Legius, E (corresponding author), Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium.	Eric.Legius@uz.kuleuven.be	Yoshimura, Akihiko/K-5515-2013; Brems, Hilde/AAN-4075-2020; Legius, Eric/H-1735-2011	Cools, Jan/0000-0001-6626-5843; Chmara, Magdalena/0000-0003-1430-8367				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bundschu K, 2006, J BIOL CHEM, V281, P36477, DOI 10.1074/jbc.R600023200; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; De Schepper S, 2006, ARCH DERMATOL RES, V297, P439, DOI 10.1007/s00403-006-0644-6; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maertens O, 2007, AM J HUM GENET, V81, P243, DOI 10.1086/519562; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; NILHORI T, 2006, NAT GENET, V38, P294; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shannon K, 2007, NAT GENET, V39, P8, DOI 10.1038/ng0107-8; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	26	286	304	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1120	1126		10.1038/ng2113	http://dx.doi.org/10.1038/ng2113			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704776				2022-12-25	WOS:000249122400022
J	Kotake, Y; Sagane, K; Owa, T; Mimori-Kiyosue, Y; Shimizu, H; Uesugi, M; Ishihama, Y; Iwata, M; Mizui, Y				Kotake, Yoshihiko; Sagane, Koji; Owa, Takashi; Mimori-Kiyosue, Yuko; Shimizu, Hajime; Uesugi, Mai; Ishihama, Yasushi; Iwata, Masao; Mizui, Yoshiharu			Splicing factor SF3b as a target of the antitumor natural product pladienolide	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; RNA; SUBSTANCES; CULTURE; PROTEIN; U2	Pladienolide is a naturally occurring antitumor macrolide that was discovered by using a cell-based reporter gene expression assay controlled by the human vascular endothelial growth factor promoter(1,2). Despite the unique mechanisms of action(3) and prominent antitumor activities of pladienolides B and D in diverse in vitro and in vivo systems(3), their target protein has remained unclear. We used H-3-labeled, fluorescence-tagged and photoaffinity/biotin (PB)-tagged 'chemical probes' to identify a 140-kDa protein in splicing factor SF3b as the binding target of pladienolide. Immunoblotting of an enhanced green fluorescent protein fusion protein of SF3b subunit 3 (SAP130) revealed direct interaction between the PB probe and SAP130. The binding affinities of pladienolide derivatives to the SF3b complex were highly correlated with their inhibitory activities against reporter gene expression and cell proliferation. Furthermore, pladienolide B impaired in vivo splicing in a dose-dependent manner. Our results demonstrate that the SF3b complex is a pharmacologically relevant protein target of pladienolide and suggest that this splicing factor is a potential antitumor drug target.	Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 36002635, Japan; KAN Res Inst Inc, Chuo Ku, Kobe, Hyogo 6500047, Japan	Eisai Co Ltd; KAN Research Institute	Mizui, Y (corresponding author), Eisai & Co Ltd, Tsukuba Res Labs, 5-1-3 Tokodai, Tsukuba, Ibaraki 36002635, Japan.	y-mizui@hhc.eisai.co.jp	Mimori-Kiyosue, Yuko/K-9158-2015; Ishihama, Yasushi/B-3101-2016	Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Ishihama, Yasushi/0000-0001-7714-203X; Sagane, Koji/0000-0001-5814-3037				Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Iwata Masao, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P691; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KOTAKE Y, 2003, AACR NCI EORTC INT C; Loyer P, 1998, J CELL SCI, V111, P1495; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sakai T, 2004, J ANTIBIOT, V57, P173, DOI 10.7164/antibiotics.57.173; Sakai T, 2004, J ANTIBIOT, V57, P180, DOI 10.7164/antibiotics.57.180; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Taunton J, 1996, J AM CHEM SOC, V118, P10412, DOI 10.1021/ja9615841; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	23	435	457	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2007	3	9					570	575		10.1038/nchembio.2007.16	http://dx.doi.org/10.1038/nchembio.2007.16			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	203IJ	17643112				2022-12-25	WOS:000248968000015
J	Podrez, EA; Byzova, TV; Febbraio, M; Salomon, RG; Ma, Y; Valiyaveettil, M; Poliakov, E; Sun, M; Finton, PJ; Curtis, BR; Chen, J; Zhang, R; Silverstein, RL; Hazen, SL				Podrez, Eugene A.; Byzova, Tatiana V.; Febbraio, Maria; Salomon, Robert G.; Ma, Yi; Valiyaveettil, Manojkumar; Poliakov, Eugenia; Sun, Mingjiang; Finton, Paula J.; Curtis, Brian R.; Chen, Juhua; Zhang, Renliang; Silverstein, Roy L.; Hazen, Stanley L.			Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype	NATURE MEDICINE			English	Article							SCAVENGER RECEPTOR CD36; LOW-DENSITY-LIPOPROTEIN; GLYCOPROTEIN-IV CD36; PERCUTANEOUS CORONARY INTERVENTION; OXIDIZED PHOSPHOLIPIDS; ANTIOXIDANT STATUS; TYROSINE KINASES; APOLIPOPROTEIN-E; MICE; ATHEROSCLEROSIS	Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.	Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; Blood Ctr SE Wisconsin Inc, Platelet & Neutrophil Immunol Lab, Milwaukee, WI 53233 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Versiti Blood Center of Wisconsin; Cleveland Clinic Foundation	Podrez, EA (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	podreze@ccf.org	Salomon, Robert G/C-3463-2008; Curtis, Brian R/AAT-7861-2020; Hazen, Stanley L/ABD-5845-2021	Byzova, Tatiana/0000-0002-2615-875X; Salomon, Robert/0000-0001-9456-3557	NCRR NIH HHS [M01 RR018390] Funding Source: Medline; NHLBI NIH HHS [P01 HL072942, R01 HL070621, HL072942, HL46403, HL053315, R01 HL071625-05, R01 HL071625, P01 HL046403, P50 HL81011, P01 HL077107, P50 HL077107, HL077107, HL073311, R01 HL077213, HL071625, P50 HL081011, P01 HL073311, R01 HL070083, HL077213, P01 HL073311-050004, R01 HL077213-05, P01 HL076491, HL70621, HL076491, R01 HL053315, HL 70083] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070083, P01HL076491, R01HL070621, R01HL053315, P01HL072942, P01HL046403, R01HL071625, R01HL077213, P50HL081011, P01HL073311, P50HL077107] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; CARVALHO AC, 1974, NEW ENGL J MED, V290, P434, DOI 10.1056/NEJM197402212900805; Cipollone F, 2002, CIRCULATION, V106, P399, DOI 10.1161/01.CIR.0000025419.95769.F0; DAVI G, 1992, CIRCULATION, V85, P1792, DOI 10.1161/01.CIR.85.5.1792; Davi G, 1998, CIRCULATION, V97, P953; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Englyst NA, 2003, DIABETES, V52, P1248, DOI 10.2337/diabetes.52.5.1248; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Kabbani SS, 2003, AM J CARDIOL, V91, P876, DOI 10.1016/S0002-9149(03)00025-0; Kabbani SS, 2001, CIRCULATION, V104, P181, DOI 10.1161/01.CIR.104.2.181; KIEFFER N, 1989, BIOCHEM J, V262, P835, DOI 10.1042/bj2620835; LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172; Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199; MORITOKI H, 1994, J MATER PROCESS TECH, V45, P589, DOI 10.1016/0924-0136(94)90403-0; Pearce SFA, 1998, J BIOL CHEM, V273, P34875, DOI 10.1074/jbc.273.52.34875; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; PLOW EF, 1985, BLOOD, V66, P724; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; SALONEN JT, 1991, AM J CLIN NUTR, V53, P1222, DOI 10.1093/ajcn/53.5.1222; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Schafer K, 2003, ARTERIOSCL THROM VAS, V23, P2097, DOI 10.1161/01.ATV.0000097766.36623.DF; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; STUART MJ, 1980, NEW ENGL J MED, V302, P6, DOI 10.1056/NEJM198001033020102; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; TANDON NN, 1989, J BIOL CHEM, V264, P7570; TANDON NN, 1991, BLOOD, V78, P2809; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Vanschoonbeek K, 2002, THROMB HAEMOSTASIS, V88, P931, DOI 10.1055/s-0037-1613336; Vericel E, 2004, DIABETES, V53, P1046, DOI 10.2337/diabetes.53.4.1046; WANG TH, 2005, EUR HEART J; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597	45	337	347	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1086	1095		10.1038/nm1626	http://dx.doi.org/10.1038/nm1626			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17721545	Green Accepted			2022-12-25	WOS:000249353100036
J	Sun, MG; Williams, J; Munoz-Pinedo, C; Perkins, GA; Brown, JM; Ellisman, MH; Green, DR; Frey, TG				Sun, Mei G.; Williams, James; Munoz-Pinedo, Cristina; Perkins, Guy A.; Brown, Joshua M.; Ellisman, Mark H.; Green, Douglas R.; Frey, Terrence G.			Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis	NATURE CELL BIOLOGY			English	Article							CYTOCHROME-C; FUSION; CRISTAE; TOMOGRAPHY; ORGANELLES; DYNAMICS; RELEASE; OPA1	In addition to their role in cellular bioenergetics, mitochondria also initiate common forms of programmed cell death ( apoptosis) through the release of proteins such as cytochrome c from the intermembrane and intracristal spaces(1,2). the release of these proteins is studied in populations of cells by western blotting mitochondrial and cytoplasmic fractions of cellular extracts, and in single cells by fluorescence microscopy using fluorescent indicators and fusion proteins(3,4). However, studying the changes in ultrastructure associated with release of proteins requires the higher resolution provided by transmission electron microscopy(5-7). Here, we have used fluorescence microscopy to characterize the state of apoptosis in Hela cells treated with etoposide followed by electron microscopy and three-dimensional electron microscope tomography of the identical cells to study the sequence of structural changes. We have identified a remodelling of the inner mitochondrial membrane into many separate vesicular matrix compartments that accompanies release of proteins; however, this remodelling is not required for efficient release of cytochrome c. swelling occurs only late in apoptosis after release of cytochrome c and loss of the mitochondrial membrane potential.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; St Jude Childrens Hosp, Memphis, TN 38105 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA	California State University System; San Diego State University; St Jude Children's Research Hospital; University of California System; University of California San Diego	Frey, TG (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tfrey@sunstroke.sdsu.edu	Green, Douglas R/N-8083-2018; Munoz-Pinedo, Cristina/B-6118-2008	Green, Douglas R/0000-0002-7332-1417; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Perkins, Guy/0000-0002-1834-6646	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072033] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NCRR NIH HHS [P41 RR004050] Funding Source: Medline; NIAID NIH HHS [AI52735, AI40646] Funding Source: Medline; NIGMS NIH HHS [GM72033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; HEALTHENGEL HM, 2006, BIOCHIM BIOPHYS ACTA, V1763, P1277; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MANOR JC, 2006, INT C BIOINF COMP BI, P310; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003	23	186	191	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1057	U21		10.1038/ncb1630	http://dx.doi.org/10.1038/ncb1630			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721514				2022-12-25	WOS:000249256500013
J	Tian, TH; Harding, A; Inder, K; Plowman, S; Parton, RG; Hancock, JF				Tian, Tianhai; Harding, Angus; Inder, Kerry; Plowman, Sarah; Parton, Robert G.; Hancock, John F.			Plasma membrane nanoswitches generate high-fidelity Ras signal transduction	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; IMAGING MICROSCOPY DATA; H-RAS; K-RAS; LIPID RAFTS; SINGLE-MOLECULE; PHOSPHOINOSITIDE 3-KINASE; SCAFFOLD PROTEINS; CELL-MEMBRANES; LIVING CELLS	Ras proteins occupy dynamic plasma membrane nanodomains called nanoclusters. The significance of this spatial organization is unknown. Here we show, using in silico and in vivo analyses of mitogen-activated protein ( MAP) kinase signalling, that Ras nanoclusters operate as sensitive switches, converting graded ligand inputs into fixed outputs of activated extracellular signal-regulated kinase ( ERK). By generating Ras nanoclusters in direct proportion to ligand input, cells build an analogue-digital analogue circuit relay that transmits a signal across the plasma membrane with high fidelity. Signal transmission is completely dependent on Ras spatial organization and fails if nanoclustering is abrogated. A requirement for high-fidelity signalling may explain the non-random distribution of other plasma membrane signalling complexes.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Hancock, JF (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.hancock@imb.uq.edu.au	Parton, Robert G/C-5673-2009; Harding, Angus/B-4120-2012; Inder, Kerry/K-3769-2012; Tian, Tianhai/AAU-2335-2021	Parton, Robert G/0000-0002-7494-5248; Inder, Kerry/0000-0002-7648-2398; Hancock, John/0000-0003-0542-4710; Tian, Tianhai/0000-0001-6191-0209				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Batada NN, 2004, P NATL ACAD SCI USA, V101, P6445, DOI 10.1073/pnas.0401314101; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Esposito A, 2005, BIOPHYS J, V89, P4286, DOI 10.1529/biophysj.104.053397; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2003, J BIOL CHEM, V278, P45519, DOI 10.1074/jbc.M303106200; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kim Y, 2003, BIOCHEMISTRY-US, V42, P15197, DOI 10.1021/bi035346b; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2000, GENE DEV, V14, P895; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Roix J, 2002, HISTOCHEM CELL BIOL, V118, P105, DOI 10.1007/s00418-002-0446-7; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Verveer PJ, 2003, J MICROSC-OXFORD, V209, P1, DOI 10.1046/j.1365-2818.2003.01093.x; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	52	282	284	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					905	U60		10.1038/ncb1615	http://dx.doi.org/10.1038/ncb1615			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618274				2022-12-25	WOS:000248486700012
J	Wolf, K; Wu, YI; Liu, Y; Geiger, J; Tam, E; Overall, C; Stack, MS; Friedl, P				Wolf, Katarina; Wu, Yi I.; Liu, Yueying; Geiger, Joerg; Tam, Eric; Overall, Christopher; Stack, M. Sharon; Friedl, Peter			Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion	NATURE CELL BIOLOGY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; HEMOPEXIN-C DOMAIN; I COLLAGEN; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; TUMOR INVASION; MEMBRANE; MIGRATION; MT1-MMP	Invasive cell migration through tissue barriers requires pericellular remodelling of extracellular matrix (ECM) executed by cell-surface proteases, particularly membrane-type-1 matrix metalloproteinase (MT1-MMP/MMP-14). Using time-resolved multimodal microscopy, we show how invasive HT-1080 fibrosarcoma and MDA-MB-231 breast cancer cells coordinate mechanotransduction and fibrillar collagen remodelling by segregating the anterior force-generating leading edge containing beta(1) integrin, MT1-MMP and F-actin from a posterior proteolytic zone executing fibre breakdown. During forward movement, sterically impeding fibres are selectively realigned into microtracks of single-cell calibre. Microtracks become expanded by multiple following cells by means of the large-scale degradation of lateral ECM interfaces, ultimately prompting transition towards collective invasion similar to that in vivo. Both ECM track widening and transition to multicellular invasion are dependent on MT1-MMP-mediated collagenolysis, shown by broad-spectrum protease inhibition and RNA interference. Thus, invasive migration and proteolytic ECM remodelling are interdependent processes that control tissue micropatterning and macropatterning and, consequently, individual and collective cell migration.	Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; Northwestern Univ, Feinberg Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; Northwestern University; Feinberg School of Medicine; University of Wurzburg; University of British Columbia	Friedl, P (corresponding author), Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	peter.fr@mail.uni-wuerzburg.de	Friedl, Peter/A-8961-2010; Geiger, Joerg/I-6661-2013; Wolf, Katarina/A-7787-2010	Friedl, Peter/0000-0002-0119-4041; Geiger, Joerg/0000-0002-7689-531X; Wolf, Katarina/0000-0003-0616-2708	NCI NIH HHS [R01 CA86984] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086984] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BELL CD, 1986, INVAS METAST, V6, P11; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Deryugina EI, 1997, ANTICANCER RES, V17, P3201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Filla Michael B, 2004, Birth Defects Res C Embryo Today, V72, P267, DOI 10.1002/bdrc.20020; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McNiff JM, 2005, J CUTAN PATHOL, V32, P413, DOI 10.1111/j.0303-6987.2005.00358.x; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Nabeshima K, 2000, CANCER RES, V60, P3364; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Petroll WM, 2004, SCANNING, V26, P1, DOI 10.1002/sca.4950260102; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434, DOI 10.1096/fasebj.7.15.8262328; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMADA KM, 1990, CANCER RES, V50, P4485; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	51	722	738	10	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					893	U39		10.1038/ncb1616	http://dx.doi.org/10.1038/ncb1616			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618273				2022-12-25	WOS:000248486700011
J	Szczepek, M; Brondani, V; Buchel, J; Serrano, L; Segal, DJ; Cathomen, T				Szczepek, Michal; Brondani, Vincent; Buechel, Janine; Serrano, Luis; Segal, David J.; Cathomen, Toni			Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAKS; ARTIFICIAL TRANSCRIPTION FACTORS; HISTONE H2AX PHOSPHORYLATION; HOMOLOGOUS RECOMBINATION; ADENOASSOCIATED VIRUS; RESTRICTION ENZYMES; CHIMERIC NUCLEASES; DNA-SEQUENCES; HUMAN-CELLS; CLEAVAGE	Artificial endonucleases consisting of a Fokl cleavage domain tethered to engineered zinc-finger DNA-binding proteins have proven useful for stimulating homologous recombination in a variety of cell types. Because the catalytic domain of zinc-finger nucleases (ZFNs) must dimerize to become active, two subunits are typically assembled as heterodimers at the cleavage site. The use of ZFNs is often associated with significant cytotoxicity, presumably due to cleavage at off- target sites. Here we describe a structure- based approach to reducing off- target cleavage. Using in silico protein modeling and energy calculations, we increased the specificity of target site cleavage by preventing homodimerization and lowering the dimerization energy. Cell-based recombination assays confirmed that the modified ZFNs were as active as the original ZFNs but elicit significantly less genotoxicity. The improved safety profile may facilitate therapeutic application of the ZFN technology.	Charite Univ Med Berlin, Inst Virol, D-12203 Berlin, Germany; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; CRG, EMBL Syst Biol Unit, Barcelona 08003, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Davis; University of California System; University of California Davis; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Cathomen, T (corresponding author), Charite Univ Med Berlin, Inst Virol, D-12203 Berlin, Germany.	djsegal@ucdavis.edu; toni.cathomen@charite.de	Brondani, Vincent/AAB-8394-2021; Cathomen, Toni/GZL-2702-2022; Segal, David/B-6646-2013; Serrano, Luis/B-3355-2013; Segal, David/V-9126-2019; Cathomen, Toni/ABG-8410-2021	Cathomen, Toni/0000-0002-7757-4630; Segal, David/0000-0001-8962-3105; Serrano, Luis/0000-0002-5276-1392; Segal, David/0000-0001-8962-3105; Cathomen, Toni/0000-0002-7757-4630; Serrano Cantador, Luis/0000-0002-2785-7704	NATIONAL CANCER INSTITUTE [R21CA103651] Funding Source: NIH RePORTER; NCI NIH HHS [CA103651, R21 CA103651-03, R21 CA103651] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Banath JP, 2003, CANCER RES, V63, P4347; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Cathomen T, 2000, J VIROL, V74, P11407, DOI 10.1128/JVI.74.23.11407-11412.2000; Catto LE, 2006, NUCLEIC ACIDS RES, V34, P1711, DOI 10.1093/nar/gkl076; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Fernandez-Ballester Gregorio, 2006, V340, P207; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Han JX, 2006, RADIAT RES, V165, P283, DOI 10.1667/RR3516.1; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Miller DG, 2003, MOL CELL BIOL, V23, P3550, DOI 10.1128/MCB.23.10.3550-3557.2003; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2003, MOL CELL BIOL, V23, P3558, DOI 10.1128/MCB.23.10.3558-3565.2003; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Silva GH, 2006, J MOL BIOL, V361, P744, DOI 10.1016/j.jmb.2006.06.063; Sims PA, 2006, J MOL BIOL, V355, P422, DOI 10.1016/j.jmb.2005.10.050; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564	42	390	448	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					786	793		10.1038/nbt1317	http://dx.doi.org/10.1038/nbt1317			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17603476	Green Submitted			2022-12-25	WOS:000247994000030
J	Srinivas, BP; Woo, J; Leong, WY; Roy, S				Srinivas, Bhylahalli P.; Woo, Jennifer; Leong, Wan Ying; Roy, Sudipto			A conserved molecular pathway mediates myoblast fusion in insects and vertebrates	NATURE GENETICS			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MYOSIN EXPRESSION; SKELETAL-MUSCLE; IN-VIVO; ZEBRAFISH; CELLS; DROSOPHILA; HEDGEHOG; SLOW; GENE	Skeletal muscles arise by fusion of precursor cells, myoblasts, into multinucleated fibers. In vertebrates, mechanisms controlling this essential step in myogenesis remain poorly understood1,2. Here we provide evidence that Kirrel, a homolog of receptor proteins that organize myoblast fusion in Drosophila melanogaster(3,4), is necessary for muscle precursor fusion in zebrafish. Within developing somites, Kirrel expression localized to membranes of fusion-competent myoblasts of the fast-twitch lineage. Unlike wild-type myoblasts that form spatially arrayed syncytial ( multinucleated) fast myofibers, those deficient in Kirrel showed a significant reduction in fusion capacity. Inhibition of Rac, a GTPase and the most downstream intracellular transducer of the fusion signal in D. melanogaster(1,5,6), also compromised fast-muscle precursor fusion in zebrafish. However, unlike in D. melanogaster(6), constitutive Rac activation in zebrafish led to hyperfused giant syncytia, highlighting an entirely new function for this protein in zebrafish for gating the number and polarity of fusion events. These findings uncover a substantial degree of evolutionary conservation in the genetic regulation of myoblast fusion.	Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Roy, S (corresponding author), Inst Mol & Cell Biol, Proteos 61 Biopolis Dr, Singapore 138673, Singapore.	sudipto@imcb.a-star.edu.sg						Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bour BA, 2000, GENE DEV, V14, P1498; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; DANGOOR M, 1990, J MUSCLE RES CELL M, V11, P216, DOI 10.1007/BF01843575; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Du SJ, 2003, COMP BIOCHEM PHYS B, V134, P123, DOI 10.1016/S1096-4959(02)00194-X; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; GARDAHAUT MF, 1992, DEVELOPMENT, V115, P1121; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Koprunner M, 2001, GENE DEV, V15, P2877; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mann CJ, 2006, GENE EXPR PATTERNS, V6, P952, DOI 10.1016/j.modgep.2006.03.010; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Weinberg ES, 1996, DEVELOPMENT, V122, P271	27	107	109	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					781	786		10.1038/ng2055	http://dx.doi.org/10.1038/ng2055			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529975				2022-12-25	WOS:000246859100023
J	Adams, GB; Martin, RP; Alley, IR; Chabner, KT; Cohen, KS; Calvi, LM; Kronenberg, HM; Scadden, DT				Adams, Gregor B.; Martin, Roderick P.; Alley, Ian R.; Chabner, Karissa T.; Cohen, Kenneth S.; Calvi, Laura M.; Kronenberg, Henry M.; Scadden, David T.			Therapeutic targeting of a stem cell niche	NATURE BIOTECHNOLOGY			English	Article							UMBILICAL-CORD BLOOD; HEMATOPOIETIC STEM; COMPETITIVE REPOPULATION; PARATHYROID-HORMONE; PROGENITOR CELLS; G-CSF; MARROW; CYCLOPHOSPHAMIDE; DIFFERENTIATION; QUIESCENCE	The specialized microenvironment or niche where stem cells reside provides regulatory input governing stem cell function. We tested the hypothesis that targeting the niche might improve stem cell-based therapies using three mouse models that are relevant to clinical uses of hematopoietic stem ( HS) cells. We and others previously identified the osteoblast as a component of the adult HS cell niche and established that activation of the parathyroid hormone ( PTH) receptor on osteoblasts increases stem cell number(1-3). Here we show that pharmacologic use of PTH increases the number of HS cells mobilized into the peripheral blood for stem cell harvests, protects stem cells from repeated exposure to cytotoxic chemotherapy and expands stem cells in transplant recipients. These data provide evidence that the niche may be an attractive target for drug-based stem cell therapeutics.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Rochester; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu	Calvi, Laura/P-6988-2019	Calvi, Laura/0000-0001-6969-239X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069563] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK069563, R21 DK069563-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ballen KK, 2005, BLOOD, V105, P3786, DOI 10.1182/blood-2004-10-4125; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450; Freedman A, 1997, BLOOD, V90, P4996, DOI 10.1182/blood.V90.12.4996.4996_4996_5001; Gazitt Y, 1999, J HEMATOTHER, V8, P173, DOI 10.1089/106161299320442; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1980, BLOOD, V55, P77; HORNUNG RL, 1992, BLOOD, V80, P77; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; LORD BI, 1975, BLOOD, V46, P65; Matrosova VY, 2004, STEM CELLS, V22, P544, DOI 10.1634/stemcells.22-4-544; MOORE MAS, 1992, BLOOD, V80, P3; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; SONNENBERG FA, 1989, BLOOD, V74, P2569; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; van Os R, 1998, BLOOD, V92, P1950, DOI 10.1182/blood.V92.6.1950.418k21_1950_1956; van Os R, 2000, STEM CELLS, V18, P120, DOI 10.1634/stemcells.18-2-120; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Whitfield JF, 2006, CANCER LETT, V244, P8, DOI 10.1016/j.canlet.2006.02.006; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	29	226	230	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					238	243		10.1038/nbt1281	http://dx.doi.org/10.1038/nbt1281			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17237769				2022-12-25	WOS:000244064000030
J	Lim, HN; van Oudenaarden, A				Lim, Han N.; van Oudenaarden, Alexander			A multistep epigenetic switch enables the stable inheritance of DNA methylation states	NATURE GENETICS			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; DEPENDENT PHASE VARIATION; MU MOM OPERON; ADENINE METHYLATION; COLONY MORPHOLOGY; GENE-EXPRESSION; DAM; OXYR; MECHANISM	In many prokaryotes and eukaryotes, DNA methylation at cis-regulatory sequences determines whether gene expression is on or off. Stable inheritance of these expression states is required in bacterial pathogenesis, cancer and developmental pathways(1,2). Here we delineate the factors that control the stability of these states by using the agn43 gene in Escherichia coli as a model system. Systematic disruption of this system shows that a functional switch requires the presence of several, rarely occupied, intermediate states that separate the 'on' and 'off' states. Cells that leave the on and off state enter different intermediate states, where there is a strong bias that drives cells back to their original state. The intermediate states therefore act as buffers that prevent back and forth switching. This mechanism of generating multiple states is an alternative to feedback regulation(3-5), and its general principle should be applicable to the analysis of other epigenetic switches and the design of synthetic circuits.	MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Lim, HN (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hanlim@berkeley.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM077183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMPBELL JL, 1988, GENE, V74, P189, DOI 10.1016/0378-1119(88)90283-1; Correnti J, 2002, MOL MICROBIOL, V44, P521, DOI 10.1046/j.1365-2958.2002.02918.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Haagmans W, 2000, MOL MICROBIOL, V35, P877, DOI 10.1046/j.1365-2958.2000.01762.x; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Henderson IR, 1997, ADV EXP MED BIOL, V412, P349; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KLOSE RJ, 2006, TRENDS BIOCH SCI; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Oehler S, 2006, NUCLEIC ACIDS RES, V34, P606, DOI 10.1093/nar/gkj453; OWEN P, 1987, J BACTERIOL, V169, P3770, DOI 10.1128/jb.169.8.3770-3777.1987; Owen P, 1996, FEMS IMMUNOL MED MIC, V16, P63; Stancheva I, 1999, EMBO J, V18, P6542, DOI 10.1093/emboj/18.22.6542; Sun WY, 1996, NUCLEIC ACIDS RES, V24, P4042, DOI 10.1093/nar/24.20.4042; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	76	78	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					269	275		10.1038/ng1956	http://dx.doi.org/10.1038/ng1956			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220888				2022-12-25	WOS:000244063900028
J	Storozhenko, S; De Brouwer, V; Volckaert, M; Navarrete, O; Blancquaert, D; Zhang, GF; Lambert, W; Van Der Straeten, D				Storozhenko, Sergei; De Brouwer, Veerle; Volckaert, Maarten; Navarrete, Oscar; Blancquaert, Dieter; Zhang, Guo-Fang; Lambert, Willy; Van Der Straeten, Dominique			Folate fortification of rice by metabolic engineering	NATURE BIOTECHNOLOGY			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; BIOFORTIFICATION; SEQUENCE; GENES	Rice, the world's major staple crop, is a poor source of essential micronutrients, including folates (vitamin B9). We report folate biofortification of rice seeds achieved by overexpressing two Arabidopsis thaliana genes of the pterin and para-aminobenzoate branches of the folate biosynthetic pathway from a single locus. We obtained a maximal enhancement as high as 100 times above wild type, with 100 g of polished raw grains containing up to four times the adult daily folate requirement.	Univ Ghent, Dept Mol Genet, Unit Plant Hormone Signalling & Bio Imaging, B-9000 Ghent, Belgium; Univ Ghent, Toxicol Lab, B-9000 Ghent, Belgium; Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Ghent University; Ghent University; Case Western Reserve University	Van Der Straeten, D (corresponding author), Univ Ghent, Dept Mol Genet, Unit Plant Hormone Signalling & Bio Imaging, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	dominique.vanderstraeten@ugent.be	Van Der Straeten, Dominique/E-7385-2016	Van Der Straeten, Dominique/0000-0002-7755-1420				Berry RJ, 2002, EPIDEMIOLOGY, V13, P114, DOI 10.1097/00001648-200201000-00021; de la Garza RD, 2004, P NATL ACAD SCI USA, V101, P13720, DOI 10.1073/pnas.0404208101; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Geisel J, 2003, J PERINAT NEONAT NUR, V17, P268, DOI 10.1097/00005237-200310000-00005; GUTSTEIN S, 1973, DIG DIS, V18, P142; Li GM, 2003, J NUTR BIOCHEM, V14, P568, DOI 10.1016/S0955-2863(03)00115-3; Melse-Boonstra A, 2004, AM J CLIN NUTR, V79, P424; Nakase M, 1996, GENE, V170, P223, DOI 10.1016/0378-1119(95)00887-X; Oakley GP, 2002, TERATOLOGY, V66, P44, DOI 10.1002/tera.10079; Patarca Roberto, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P117, DOI 10.1615/JEnvPathToxOncol.v22.i2.50; SAUBERLICH HE, 1987, AM J CLIN NUTR, V46, P1016, DOI 10.1093/ajcn/46.6.1016; Sohta Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1081, DOI 10.1271/bbb.61.1081; Storozhenko S, 2005, TRENDS FOOD SCI TECH, V16, P271, DOI 10.1016/j.tifs.2005.03.007; TAKAIWA F, 1991, PLANT MOL BIOL, V17, P875, DOI 10.1007/BF00037068; Zhang GF, 2005, RAPID COMMUN MASS SP, V19, P963, DOI 10.1002/rcm.1878	15	186	204	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1277	1279		10.1038/nbt1351	http://dx.doi.org/10.1038/nbt1351			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17934451				2022-12-25	WOS:000251086500028
J	Choi, HS; Liu, W; Misra, P; Tanaka, E; Zimmer, JP; Ipe, BI; Bawendi, MG; Frangioni, JV				Choi, Hak Soo; Liu, Wenhao; Misra, Preeti; Tanaka, Eiichi; Zimmer, John P.; Ipe, Binil Itty; Bawendi, Moungi G.; Frangioni, John V.			Renal clearance of quantum dots	NATURE BIOTECHNOLOGY			English	Article							DEPENDENCE; CDSE	The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by > 15 nm and prevented renal excretion. A final hydrodynamic diameter <5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.	Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT)	Frangioni, JV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, 330 Brookline Ave,Room SL-BO5, Boston, MA 02215 USA.	mgb@mit.edu; jfrangio@bidmc.harvard.edu	Choi, Hak Soo/C-9954-2011		NCI NIH HHS [U54 CA119349, 1U54-CA119349] Funding Source: Medline; NIBIB NIH HHS [R21 EB000673, R21 EB000673-01, R33 EB000673-04, R33 EB000673] Funding Source: Medline; NIGMS NIH HHS [P50 GM068762, GM68762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA119349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB000673, R21EB000673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; De Grand AM, 2003, TECHNOL CANCER RES T, V2, P553, DOI 10.1177/153303460300200607; Fisher BR, 2004, J PHYS CHEM B, V108, P143, DOI 10.1021/jp035756+; Frangioni John V, 2007, Methods Mol Biol, V374, P147; Fu AH, 2007, NANO LETT, V7, P179, DOI 10.1021/nl0626434; Goel A, 2000, CANCER RES, V60, P6964; HANSEN NE, 1971, J CLIN INVEST, V50, P1473, DOI 10.1172/JCI106632; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Humblet V, 2006, CONTRAST MEDIA MOL I, V1, P196, DOI 10.1002/cmmi.106; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Lund U, 2003, AM J PHYSIOL-RENAL, V284, pF1226, DOI 10.1152/ajprenal.00316.2002; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; Misra P, 2007, J NUCL MED, V48, P1379, DOI 10.2967/jnumed.107.040303; Nakayama Akira, 2002, Mol Imaging, V1, P365, DOI 10.1162/153535002321093972; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; PAPPENHEIMER JR, 1951, AM J PHYSIOL, V167, P13, DOI 10.1152/ajplegacy.1951.167.1.13; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; PRESCOTT LF, 1991, EUR J CLIN PHARMACOL, V40, P619; SOLOMON A, 1964, J CLIN INVEST, V43, P103, DOI 10.1172/JCI104884; Uyeda HT, 2005, J AM CHEM SOC, V127, P3870, DOI 10.1021/ja044031w	24	3224	3302	31	912	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1165	1170		10.1038/nbt1340	http://dx.doi.org/10.1038/nbt1340			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17891134	Green Accepted			2022-12-25	WOS:000250226600028
J	Jakobovits, A; Amad, RG; Yang, X; RoskoS, L; Schwab, G				Jakobovits, Aya; Amad, Rafael G.; Yang, Xiaodong; RoskoS, Lorin; Schwab, Gisela			From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN MONOCLONAL-ANTIBODIES; SQUAMOUS-CELL CARCINOMA; PHASE-II MULTICENTER; COLORECTAL-CANCER; EGF RECEPTOR; TUMOR-GROWTH; ABX-EGF; CETUXIMAB; EXPRESSION	Therapeutic monoclonal antibodies have shown limited efficacy and safety owing to immunogenicity of mouse sequences in humans. Among the approaches developed to overcome these hurdles were transgenic mice genetically engineered with a 'humanized' humoral immune system. One such transgenic system, the XenoMouse, has succeeded in recapitulating the human antibody response in mice, by introducing nearly the entire human immunoglobulin loci into the germ line of mice with inactivated mouse antibody machinery. XenoMouse strains have been used to generate numerous high-affinity, fully human antibodies to targets in multiple disease indications, many of which are progressing in clinical development. However, validation of the technology has awaited the recent regulatory approval of panitumumab (Vectibix), a fully human antibody directed against epidermal growth factor receptor (EGFR), as treatment for people with advanced colorectal cancer. The successful development of panitumumab represents a milestone for mice engineered with a human humoral immune system and their future applications.	Agensys Inc, Santa Monica, CA 90404 USA; Amgen Inc, Thousand Oaks, CA 91320 USA; Intradigm Corp, Palo Alto, CA 94303 USA; AstraZeneca Pharmaceut LP, Hayward, CA 94545 USA; Exelixis Inc, San Francisco, CA 94083 USA	Amgen; AstraZeneca; Exelixis, Inc.	Jakobovits, A (corresponding author), Agensys Inc, 2225 Colorado Blvd, Santa Monica, CA 90404 USA.	ajakobovits@agensys.com						Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BERLIN J, 2006, J CLIN ONCOL S18, V24; Berlin J, 2007, CLIN COLORECTAL CANC, V6, P427, DOI 10.3816/CCC.2007.n.011; Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Burton D.R., 1993, PROTEIN ENG ANTIBODY, P65; BUSH T, 2005, CLIN CANC RES, V11; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DEBUIRE B, 1984, SCIENCE, V224, P1456, DOI 10.1126/science.6328658; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FOLTZ IN, 2006, DRUGS, V66, P2005; Ford Shirin Khambata, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P950; Francoual M, 2006, ANN ONCOL, V17, P962, DOI 10.1093/annonc/mdl037; Gallo ML, 2000, EUR J IMMUNOL, V30, P534, DOI 10.1002/1521-4141(200002)30:2<534::AID-IMMU534>3.3.CO;2-G; Gladue R.P., 2006, P AM ASS CANC RES, V47; Green LL, 1998, J EXP MED, V188, P483, DOI 10.1084/jem.188.3.483; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; Hecht JR, 2007, CANCER-AM CANCER SOC, V110, P980, DOI 10.1002/cncr.22915; HECHT JR, 2007, 9 WORLD C GASTR CANC; HELBLING D, 2006, ANN ONCOL, V24, P4914; HENZENLOGMANS SC, 1992, J CANCER RES CLIN, V118, P303, DOI 10.1007/BF01208620; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; Heun J, 2007, CLIN COLORECTAL CANC, V6, P529, DOI 10.3816/CCC.2007.n.019; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Jakobovits A, 2005, J CLIN ONCOL, V23, p433S; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; Kellermann SA, 2002, CURR OPIN BIOTECH, V13, P593, DOI 10.1016/S0958-1669(02)00354-3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; LOFGREN J, 2007, IN PRESS J IMMUNOL; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Long L., 2004, BLOOD, V104; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Matsuda F, 1996, ADV IMMUNOL, V62, P1, DOI 10.1016/S0065-2776(08)60426-5; Max EE, 1993, IMMUNOGLOBULINS MOL; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McGary EC, 2003, CLIN CANCER RES, V9, P6560; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146; MENDEZ MJ, 1995, GENOMICS, V26, P294, DOI 10.1016/0888-7543(95)80214-7; MITCHELL EP, 2007, J CLIN ONCOL S18, V25; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; MORRISON SL, 1989, IMMUNOGLOBULIN GENES, P260; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; OGISO Y, 1988, J INVEST DERMATOL, V90, P841, DOI 10.1111/1523-1747.ep12462078; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; Patton A, 2005, J IMMUNOL METHODS, V304, P189, DOI 10.1016/j.jim.2005.06.014; Pendley C, 2003, CURR OPIN MOL THER, V5, P172; Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; Rowinsky EK, 2004, J CLIN ONCOL, V22, P3003, DOI 10.1200/JCO.2004.11.061; SAKAI K, 1986, J NATL CANCER I, V77, P1047; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; SARGENT ER, 1989, J UROLOGY, V142, P1364, DOI 10.1016/S0022-5347(17)39100-0; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; TERADA T, 1994, VIRCHOWS ARCH, V424, P669, DOI 10.1007/BF01069749; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; VANDERLAAN BFAM, 1995, THYROID, V5, P67, DOI 10.1089/thy.1995.5.67; Wang Y, 2007, DRUG FUTURE, V32, P337, DOI 10.1358/dof.2007.032.04.1089088; WEICHHOLD GM, 1993, GENOMICS, V16, P503, DOI 10.1006/geno.1993.1217; Weiner L.M., 2005, J CLIN ONCOL S16, V23; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Yang XD, 2001, CRIT REV ONCOL HEMAT, V38, P17, DOI 10.1016/S1040-8428(00)00134-7; Yang XD, 1999, CANCER RES, V59, P1236; YANG XD, 2005, CANC DRUG DISCOVERY; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	83	139	207	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1134	1143		10.1038/nbt1337	http://dx.doi.org/10.1038/nbt1337			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17921999				2022-12-25	WOS:000250226600024
J	Neuenschwander, M; Butz, M; Heintz, C; Kast, P; Hilvert, D				Neuenschwander, Martin; Butz, Maren; Heintz, Caroline; Kast, Peter; Hilvert, Donald			A simple selection strategy for evolving highly efficient enzymes	NATURE BIOTECHNOLOGY			English	Article							DIRECTED EVOLUTION; CHORISMATE MUTASE; EXPRESSION; CATALYSIS; SYSTEM	Combining tunable transcription with an enzyme-degradation tag affords an effective means to reduce intracellular enzyme concentrations from high to very low levels. Such fine-tuned control allows selection pressure to be systematically increased in directed-evolution experiments. This facilitates identification of mutants with wild-type activity, as shown here for an engineered chorismate mutase. Numerous selection formats and cell-based screening methodologies may benefit from the large dynamic range afforded by this easily implemented strategy.	ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, Honggerberg HCI F 339, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Heintz, Caroline/R-3272-2017					Burton SG, 2002, NAT BIOTECHNOL, V20, P37, DOI 10.1038/nbt0102-37; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; Hansen LH, 2001, APPL ENVIRON MICROB, V67, P239, DOI 10.1128/AEM.67.1.239-244.2001; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Jestin JL, 2004, J BIOTECHNOL, V113, P85, DOI 10.1016/j.jbiotec.2004.03.032; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MacBeath G, 1998, PROTEIN SCI, V7, P325; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Turner NJ, 2006, ENZYME ASSAYS HIGH T, P139; Vamvaca K, 2005, PROTEIN SCI, V14, P2103, DOI 10.1110/ps.051431605; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511	14	41	46	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2007	25	10					1145	1147		10.1038/nbt1341	http://dx.doi.org/10.1038/nbt1341			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	221KQ	17873865				2022-12-25	WOS:000250226600025
J	Kim, S; Plagnol, V; Hu, TT; Toomajian, C; Clark, RM; Ossowski, S; Ecker, JR; Weigel, D; Nordborg, M				Kim, Sung; Plagnol, Vincent; Hu, Tina T.; Toomajian, Christopher; Clark, Richard M.; Ossowski, Stephan; Ecker, Joseph R.; Weigel, Detlef; Nordborg, Magnus			Recombination and linkage disequilibrium in Arabidopsis thaliana	NATURE GENETICS			English	Article							GENE CONVERSION; HUMAN GENOME; HISTORY; DNA; POLYMORPHISM; POPULATIONS; ASSOCIATION; DROSOPHILA; PATTERNS; RATES	Linkage disequilibrium ( LD) is a major aspect of the organization of genetic variation in natural populations. Here we describe the genome- wide pattern of LD in a sample of 19 Arabidopsis thaliana accessions using 341,602 non- singleton SNPs. LD decays within 10 kb on average, considerably faster than previously estimated. Tag SNP selection algorithms and ' hide- the- SNP' simulations suggest that genome- wide association mapping will require only 40% - 50% of the observed SNPs, a reduction similar to estimates in a sample of African Americans. An Affymetrix genotyping array containing 250,000 SNPs has been designed based on these results; we demonstrate that it should have more than adequate coverage for genome- wide association mapping. The extent of LD is highly variable, and we find clear evidence of recombination hotspots, which seem to occur preferentially in intergenic regions. LD also reflects the action of selection, and it is more extensive between nonsynonymous polymorphisms than between synonymous polymorphisms.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Salk Inst Genome Anal Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; University of Cambridge; Max Planck Society; Salk Institute; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Weigel, Detlef/C-1418-2008; Ecker, Joseph R/B-9144-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/GSJ-0799-2022; Plagnol, Vincent/A-5667-2011; Weigel, Detlef/AAR-3312-2021; Toomajian, Christopher/ABA-2615-2021	Weigel, Detlef/0000-0002-2114-7963; Ecker, Joseph R/0000-0001-5799-5895; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963; Toomajian, Christopher/0000-0002-6763-0678; Plagnol, Vincent/0000-0002-5597-9215; Nordborg, Magnus/0000-0001-7178-9748	NHGRI NIH HHS [HG002790] Funding Source: Medline; NIGMS NIH HHS [R01 GM062932, GM62932] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 1998, GENETICS, V148, P1397; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hagenblad J, 2002, GENETICS, V161, P289; Haubold B, 2002, GENETICS, V161, P1269; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Li N, 2003, GENETICS, V165, P2213; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2000, GENETICS, V154, P923; Padhukasahasram B, 2006, GENETICS, V174, P1517, DOI 10.1534/genetics.106.060723; Pagnol V, 2006, GENETICS, V172, P2441, DOI 10.1534/genetics.104.040311; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	27	388	397	0	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1151	1155		10.1038/ng2115	http://dx.doi.org/10.1038/ng2115			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676040				2022-12-25	WOS:000249122400027
J	Lowe, CE; Cooper, JD; Brusko, T; Walker, NM; Smyth, DJ; Bailey, R; Bourget, K; Plagnol, V; Field, S; Atkinson, M; Clayton, DG; Wicker, LS; Todd, JA				Lowe, Christopher E.; Cooper, Jason D.; Brusko, Todd; Walker, Neil M.; Smyth, Deborah J.; Bailey, Rebecca; Bourget, Kirsi; Plagnol, Vincent; Field, Sarah; Atkinson, Mark; Clayton, David G.; Wicker, Linda S.; Todd, John A.			Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; INSULIN GENE; T-CELLS; INTERLEUKIN-2; SEQUENCE; RECEPTOR; LOCUS; HLA; SUSCEPTIBILITY	Genome- wide association studies are now identifying disease- associated chromosome regions. However, even after convincing replication, the localization of the causal variant( s) requires comprehensive resequencing, extensive genotyping and statistical analyses in large sample sets leading to targeted functional studies. Here, we have localized the type 1 diabetes ( T1D) association in the interleukin 2 receptor alpha ( IL2RA) gene region to two independent groups of SNPs, spanning overlapping regions of 14 and 40 kb, encompassing IL2RA intron 1 and the 5' regions of IL2RA and RBM17 ( odds ratio 2.04, 95% confidence interval 1.70 - 2.45; P 1.92 x 10(-28); control frequency 0.635). Furthermore, we have associated IL2RA T1D susceptibility genotypes with lower circulating levels of the biomarker, soluble IL- 2RA ( P 6.28 x 10(-28)), suggesting that an inherited lower immune responsiveness predisposes to T1D.	Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; Univ Florida, Coll Med, Gainesville, FL 32610 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; State University System of Florida; University of Florida	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Brusko, Todd/0000-0003-2878-9296; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688; Plagnol, Vincent/0000-0002-5597-9215	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [061859, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Burren Oliver S., 2004, Human Genomics, V1, P98; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Ionescu-Tirgoviste C, 2001, DIABETOLOGIA, V44, pB60, DOI 10.1007/PL00002956; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KLOSE RJ, 1993, TRENDS BIOCHEM SCI, V52, P506; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; ROBB RJ, 1987, J IMMUNOL, V139, P855; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	49	314	323	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1074	1082		10.1038/ng2102	http://dx.doi.org/10.1038/ng2102			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676041				2022-12-25	WOS:000249122400016
J	Wilkinson, IR; Ferrandis, E; Artymiuk, PJ; Teillot, M; Soulard, C; Touvay, C; Pradhananga, SL; Justice, S; Wu, Z; Leung, KC; Strasburger, CJ; Sayers, JR; Ross, RJ				Wilkinson, Ian R.; Ferrandis, Eric; Artymiuk, Peter J.; Teillot, Marc; Soulard, Chantal; Touvay, Caroline; Pradhananga, Sarbendra L.; Justice, Sue; Wu, Zida; Leung, Kin C.; Strasburger, Christian J.; Sayers, Jon R.; Ross, Richard J.			A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist	NATURE MEDICINE			English	Article							GH-DEFICIENT ADULTS; BINDING-PROTEIN; EXTRACELLULAR DOMAIN; METABOLIC-CLEARANCE; INJECTIONS; INFUSION; KINETICS; COMPLEX; HEALTH; SAFETY	Cytokine hormones have a short plasma half-life and require frequent administration. For example, growth hormone replacement involves daily injections. In common with other cytokines, the extracellular domain of the growth hormone receptor circulates as a binding protein, which naturally prolongs the biological half-life of growth hormone. Here we have studied the biological actions of a ligand-receptor fusion of growth hormone and the extracellular domain of its receptor. The genetically engineered ligand-receptor fusion protein was purified from mammalian cell culture. In rats, the ligandreceptor fusion had a 300-times reduced clearance as compared to native growth hormone, and a single injection promoted growth for 10 d, far exceeding the growth seen after administration of native growth hormone. The ligand-receptor fusion forms a reciprocal, head-to-tail dimer that provides a reservoir of inactive hormone similar to the natural reservoir of growth hormone and its binding protein. In conclusion, a ligand-receptor fusion of cytokine to its extracellular receptor generates a potent, long-acting agonist with exceptionally slow absorption and elimination. This approach could be easily applied to other cytokines.	Univ Sheffield, Royal Hallamshire Hosp, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; Inst Henri Beaufour, Ipsen, F-91966 Les Ulis, France; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2JF, S Yorkshire, England; Campus Mitte Charite Univ Med, Dept Med, D-10117 Berlin, Germany; Garvan Inst Med Res, Pituitary Res Unit, Sydney, NSW 2010, Australia; Univ Sheffield, Royal Hallamshire Hosp, Unit Infect & Immun, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Garvan Institute of Medical Research; University of Sheffield	Ross, RJ (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England.	r.j.ross@sheffield.ac.uk	Ross, Richard/B-2672-2012; Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020	Ross, Richard/0000-0001-9222-9678; Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443; Wilkinson, Ian/0000-0001-6236-2419				Ayling RM, 1997, NAT GENET, V16, P13, DOI 10.1038/ng0597-13; BAUMANN G, 1991, ENDOCR REV, V12, P424, DOI 10.1210/edrv-12-4-424; BAUMANN G, 1995, ENDOCRINOLOGY, V136, P377, DOI 10.1210/en.136.2.377; BAUMANN G, 1987, J CLIN ENDOCR METAB, V64, P657, DOI 10.1210/jcem-64-4-657; BAUMANN G, 1989, METABOLISM, V38, P330, DOI 10.1016/0026-0495(89)90119-4; Clark R, 1996, J BIOL CHEM, V271, P21969, DOI 10.1074/jbc.271.36.21969; Clark RG, 1996, ENDOCRINOLOGY, V137, P4308, DOI 10.1210/en.137.10.4308; Cook DM, 2002, J CLIN ENDOCR METAB, V87, P4508, DOI 10.1210/jc.2002-020480; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Frick GP, 1998, ENDOCRINOLOGY, V139, P2824, DOI 10.1210/en.139.6.2824; HAFFNER D, 1994, J CLIN INVEST, V93, P1163, DOI 10.1172/JCI117069; HERINGTON AC, 1987, MOL CELL ENDOCRINOL, V53, P203, DOI 10.1016/0303-7207(87)90175-4; Huston J S, 1993, Cell Biophys, V22, P189; JOHNSON V, 1977, AM J PHYSIOL, V233, P185; Jostel A, 2005, CLIN ENDOCRINOL, V62, P623, DOI 10.1111/j.1365-2265.2005.02271.x; LAURSEN T, 1995, J CLIN ENDOCR METAB, V80, P2410, DOI 10.1210/jc.80.8.2410; Laursen T, 2001, J CLIN ENDOCR METAB, V86, P1222, DOI 10.1210/jc.86.3.1222; LIM L, 1990, ENDOCRINOLOGY, V127, P1287, DOI 10.1210/endo-127-3-1287; MANNOR DA, 1991, J CLIN ENDOCR METAB, V73, P30, DOI 10.1210/jcem-73-1-30; MullerNewen G, 1996, INT ARCH ALLERGY IMM, V111, P99, DOI 10.1159/000237353; Osborn BL, 2002, EUR J PHARMACOL, V456, P149, DOI 10.1016/S0014-2999(02)02644-4; Reiter EO, 2001, J CLIN ENDOCR METAB, V86, P4700, DOI 10.1210/jc.86.10.4700; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Veldhuis JD, 2002, J CLIN ENDOCR METAB, V87, P5737, DOI 10.1210/jc.2001-011885; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022	27	26	43	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2007	13	9					1108	1113		10.1038/nm1610	http://dx.doi.org/10.1038/nm1610			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	208XS	17721547				2022-12-25	WOS:000249353100039
J	Kassmann, CM; Lappe-Siefke, C; Baes, M; Brugger, B; Mildner, A; Werner, HB; Natt, O; Michaelis, T; Prinz, M; Frahm, J; Nave, KA				Kassmann, Celia M.; Lappe-Siefke, Corinna; Baes, Myriam; Bruegger, Britta; Mildner, Alexander; Werner, Hauke B.; Natt, Oliver; Michaelis, Thomas; Prinz, Marco; Frahm, Jens; Nave, Klaus-Armin			Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes	NATURE GENETICS			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; MOUSE MODEL; MULTIPLE-SCLEROSIS; PROTEOLIPID PROTEIN; NERVOUS-SYSTEM; MICE; DEGENERATION; MYELIN; CELLS; GENE	Oligodendrocytes myelinate axons for rapid impulse conduction and contribute to normal axonal functions in the central nervous system. In multiple sclerosis, demyelination is caused by autoimmune attacks, but the role of oligodendroglial cells in disease progression and axon degeneration is unclear. Here we show that oligodendrocytes harbor peroxisomes whose function is essential for maintaining white matter tracts throughout adult life. By selectively inactivating the import factor PEX5 in myelinating glia, we generated mutant mice that developed normally, but within several months showed ataxia, tremor and premature death. Absence of functional peroxisomes from oligodendrocytes caused widespread axonal degeneration and progressive subcortical demyelination, but did not interfere with glial survival. Moreover, it caused a strong proinflammatory milieu and, unexpectedly, the infiltration of B and activated CD8(+) T cells into brain lesions. We conclude that peroxisomes provide oligodendrocytes with an essential neuroprotective function against axon degeneration and neuroinflammation, which is relevant for human demyelinating diseases.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Katholieke Univ Leuven, Fac Pharm, Lab Cell Metab, B-3000 Louvain, Belgium; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany; Biomed NMR Forsch GmbH, Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; KU Leuven; Ruprecht Karls University Heidelberg; University of Gottingen; Max Planck Society	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	nave@em.mpg.de	mildner, alexander/AFK-2161-2022; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Nave, Klaus-Armin/C-8883-2011; mildner, alexander/AAF-9451-2022	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Werner, Hauke/0000-0002-7710-5738; Baes, Myriam/0000-0002-2525-2269				Baes M, 2002, GENESIS, V32, P177, DOI 10.1002/gene.10047; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Barnett FH, 2004, NEUROSURGERY, V55, P468, DOI 10.1227/00006123-200408000-00083; Barth PG, 2001, NEUROLOGY, V57, P1949, DOI 10.1212/WNL.57.11.1949; Baumgartner MR, 1998, ANN NEUROL, V44, P720, DOI 10.1002/ana.410440505; Bielschowsky M, 1904, J PSYCHOL NEUROL, V3, P169; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang CC, 1999, J CELL SCI, V112, P1579; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Gallyas F, 1979, Neurol Res, V1, P203; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; GOVERMAN J, 2005, ALLERGY, V4, P239; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hirrlinger J, 2002, J NEUROCHEM, V82, P635, DOI 10.1046/j.1471-4159.2002.00999.x; Hudspeth MP, 2007, J NEUROIMMUNOL, V182, P5, DOI 10.1016/j.jneuroim.2006.10.009; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Jung M, 1996, J NEUROSCI, V16, P7920; Kemp S, 2007, MOL GENET METAB, V90, P268, DOI 10.1016/j.ymgme.2006.10.001; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; Koivusalo M, 2001, J LIPID RES, V42, P663; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; Loers G, 2004, MOL CELL NEUROSCI, V27, P175, DOI 10.1016/j.mcn.2004.06.006; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; MOSER HW, 1991, BIOCHEM CELL BIOL, V69, P463, DOI 10.1139/o91-070; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Raivich G, 1998, J NEUROSCI, V18, P5804; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wilken B, 2003, NEUROPEDIATRICS, V34, P237; ZOELLER RA, 1986, P NATL ACAD SCI USA, V83, P5170, DOI 10.1073/pnas.83.14.5170	50	234	238	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					969	976		10.1038/ng2070	http://dx.doi.org/10.1038/ng2070			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17643102				2022-12-25	WOS:000248446900013
J	Sobacchi, C; Frattini, A; Guerrini, MM; Abinun, M; Pangrazio, A; Susani, L; Bredius, R; Mancini, G; Cant, A; Bishop, N; Grabowski, P; Del Fattore, A; Messina, C; Errigo, G; Coxon, FP; Scott, DI; Teti, A; Rogers, MJ; Vezzoni, P; Villa, A; Helfrich, MH				Sobacchi, Cristina; Frattini, Annalisa; Guerrini, Matteo M.; Abinun, Mario; Pangrazio, Alessandra; Susani, Lucia; Bredius, Robbert; Mancini, Grazia; Cant, Andrew; Bishop, Nick; Grabowski, Peter; Del Fattore, Andrea; Messina, Chiara; Errigo, Gabriella; Coxon, Fraser P.; Scott, Debbie I.; Teti, Anna; Rogers, Michael J.; Vezzoni, Paolo; Villa, Anna; Helfrich, Miep H.			Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL	NATURE GENETICS			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; MICE; DEFICIENCY; REGULATOR; DEFECTS; RESCUE; MOUSE	Autosomal recessive osteopetrosis is usually associated with normal or elevated numbers of nonfunctional osteoclasts. Here we report mutations in the gene encoding RANKL ( receptor activator of nuclear factor - KB ligand) in six individuals with autosomal recessive osteopetrosis whose bone biopsy specimens lacked osteoclasts. These individuals did not show any obvious defects in immunological parameters and could not be cured by hematopoietic stem cell transplantation; however, exogenous RANKL induced formation of functional osteoclasts from their monocytes, suggesting that they could, theoretically, benefit from exogenous RANKL administration.	CNR, Inst Biomed Technol, I-20090 Segrate, Italy; Ist Clin Humanitas, I-20089 Rozzano, Italy; Newcastle Gen Hosp, Childrens Bone Marrow Transplant Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Fac Med, Inst Cellular Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Univ Sheffield, Acad Unit Child Hlth, Sheffield S1O 2TH, S Yorkshire, England; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; Univ Padua, Pediat Hematol & Oncol Unit, I-35122 Padua, Italy; Univ Aberdeen, Bone & Musculoskeletal Programme, Aberdeen AB25 2ZD, Scotland; Univ Vita & Salute San Raffaele, Telethon Inst GeneTherapy, I-20090 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Humanitas Research Hospital; Newcastle General Hospital; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Sheffield; University of L'Aquila; University of Padua; University of Aberdeen; Vita-Salute San Raffaele University	Frattini, A (corresponding author), CNR, Inst Biomed Technol, Via F Cervi 93, I-20090 Segrate, Italy.	annalisa.frattini@itb.cnr.it	Bredius, Robbert/AAF-2592-2019; Grabowski, Peter S/G-2345-2010; Vezzoni, Paolo/K-3197-2018; SOBACCHI, CRISTINA/J-9345-2018; Susani, Lucia/HHM-4185-2022; Frattini, Annalisa/B-7684-2015; Del Fattore, Andrea/AAP-2045-2020; Del Fattore, Andrea/H-4409-2015; Vezzoni, Paolo/R-3416-2019	Grabowski, Peter S/0000-0001-5924-1587; SOBACCHI, CRISTINA/0000-0002-2684-7184; Susani, Lucia/0000-0003-3368-2135; Frattini, Annalisa/0000-0002-1166-3091; Del Fattore, Andrea/0000-0003-3848-412X; Del Fattore, Andrea/0000-0003-3848-412X; Teti, Anna Maria/0000-0002-5887-4419; Villa, Anna/0000-0003-4428-9013; Vezzoni, Paolo/0000-0002-6382-3923; Bredius, Robbert/0000-0001-8151-1539; Rogers, Michael/0000-0002-1818-9249; Wilkinson, Debbie/0000-0003-0237-3807	Telethon [TGT06S01, TGT06A04] Funding Source: Medline; Chief Scientist Office [CZB/4/495] Funding Source: Medline	Telethon(Fondazione Telethon); Chief Scientist Office		Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Susani L, 2004, HUM MUTAT, V24, P225, DOI 10.1002/humu.20076	15	288	299	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					960	962		10.1038/ng2076	http://dx.doi.org/10.1038/ng2076			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632511				2022-12-25	WOS:000248446900010
J	Rinaudo, K; Bleris, L; Maddamsetti, R; Subramanian, S; Weiss, R; Benenson, Y				Rinaudo, Keller; Bleris, Leonidas; Maddamsetti, Rohan; Subramanian, Sairam; Weiss, Ron; Benenson, Yaakov			A universal RNAi-based logic evaluator that operates in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; RIBOREGULATORS; INTERFERENCE; GATES	Molecular automata(1-3) that combine sensing(4-6), computation(7-12) and actuation(13,14) enable programmable manipulation of biological systems. We use RNA interference (RNAi)(15) in human kidney cells to construct a molecular computing core that implements general Boolean logic(1,3,8-12,16) to make decisions based on endogenous molecular inputs. The state of an endogenous input is encoded by the presence or absence of 'mediator' small interfering RNAs (siRNAs). The encoding rules, combined with a specific arrangement of the siRNA targets in a synthetic gene network(17), allow direct evaluation of any Boolean expression in standard forms using siRNAs and indirect evaluation using endogenous inputs. We demonstrate direct evaluation of expressions with up to five logic variables. Implementation of the encoding rules through sensory up- and down-regulatory links between the inputs and siRNA mediators will allow arbitrary Boolean decision-making using these inputs.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Benenson, Y (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	rweiss@princeton.edu; kbenenson@cgr.harvard.edu	Benenson, Yaakov/B-1433-2009; Bleris, Leonidas/A-6761-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM068763-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; Balzani V, 2003, CHEMPHYSCHEM, V4, P49, DOI 10.1002/cphc.200390007; Baron R, 2006, ANGEW CHEM INT EDIT, V45, P1572, DOI 10.1002/anie.200503314; BASU S, 2002, 1 WORKSH NONS COMP B; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Beyer S, 2006, NUCLEIC ACIDS RES, V34, P1581, DOI 10.1093/nar/gkl075; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Caron L, 2005, CELL MOL LIFE SCI, V62, P1605, DOI 10.1007/s00018-005-5123-2; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eckstein F, 2005, TRENDS BIOCHEM SCI, V30, P445, DOI 10.1016/j.tibs.2005.06.008; Ezziane Z, 2006, NANOTECHNOLOGY, V17, pR27, DOI 10.1088/0957-4484/17/2/R01; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Kolpashchikov DM, 2005, J AM CHEM SOC, V127, P11348, DOI 10.1021/ja051362f; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Macdonald J, 2006, NANO LETT, V6, P2598, DOI 10.1021/nl0620864; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Soloveichik D, 2005, THEOR COMPUT SCI, V344, P279, DOI 10.1016/j.tcs.2005.07.027; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Weiss R, 2002, NAT COMPUT SER, P275; Wiener N, 1948, CYBERNETICS; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	30	354	388	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					795	801		10.1038/nbt1307	http://dx.doi.org/10.1038/nbt1307			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17515909				2022-12-25	WOS:000247994000031
J	Matzen, K; Elzaouk, L; Matskevich, AA; Nitzsche, A; Heinrich, J; Moelling, K				Matzen, Kathrin; Elzaouk, Lina; Matskevich, Alexey A.; Nitzsche, Anja; Heinrich, Jochen; Moelling, Karin			RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides	NATURE BIOTECHNOLOGY			English	Article							REVERSE-TRANSCRIPTASE; CRYSTAL-STRUCTURE; HIV-1; REPLICATION; INHIBITION; ARGONAUTE; CLEAVAGE; DOMAIN	The HIV-1 RNase H can be prematurely activated by oligodeoxynucleotides targeting the highly conserved polypurine tract required for second strand DNA synthesis(1-5). This inhibits retroviral replication in cell-free HIV particles and newly infected cells(1-4). Here we extend these studies to an in vivo model of retroviral replication. Mice that are chronically infected with the spleen focus-forming virus and treated with oligodeoxynucleotides that target the polypurine tract, exhibit either transient or long-term reductions in plasma virus titer, depending on the therapeutic regimen. Treatment prior to, during or shortly after infection can delay disease progression, increase survival rates and prevent viral infection. This strategy destroys viral RNA template in virus particles in serum as well as early retroviral replication intermediates in infected cells. As it targets events common to the replication cycle of all retroviruses, this approach may be broadly applicable to retroviruses of medical and agricultural importance.	Univ Zurich, Inst Med Virol, CH-8006 Zurich, Switzerland	University of Zurich	Moelling, K (corresponding author), Elswigstr 68, D-23562 Lubeck, Germany.	moelling@immv.unizh.ch						Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Coffin J, 1997, RETROVIRUSES; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jekerle V, 2005, J PHARM PHARM SCI, V8, P516; Jendis J, 1998, AIDS RES HUM RETROV, V14, P999, DOI 10.1089/aid.1998.14.999; Jendis J, 1996, AIDS RES HUM RETROV, V12, P1161, DOI 10.1089/aid.1996.12.1161; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Matskevich AA, 2006, AIDS RES HUM RETROV, V22, P1220, DOI 10.1089/aid.2006.22.1220; MOELLING K, 1974, COLD SPRING HARB SYM, V39, P969, DOI 10.1101/SQB.1974.039.01.111; Moelling K, 2006, COLD SPRING HARB SYM, V71, P365, DOI 10.1101/sqb.2006.71.010; MOELLING K, 1974, VIROLOGY, V62, P46, DOI 10.1016/0042-6822(74)90302-X; Moelling K, 2006, FEBS LETT, V580, P3545, DOI 10.1016/j.febslet.2006.05.033; MOLLING K, 1971, NATURE-NEW BIOL, V234, P240, DOI 10.1038/newbio234240a0; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Ruscetti SK, 1999, INT J BIOCHEM CELL B, V31, P1089, DOI 10.1016/S1357-2725(99)00074-6; SCHULZE T, 1991, ARCH VIROL, V118, P179, DOI 10.1007/BF01314028; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Westerhout EM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-57; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	24	26	30	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2007	25	6					669	674		10.1038/nbt1311	http://dx.doi.org/10.1038/nbt1311			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	176IF	17546028				2022-12-25	WOS:000247077500024
J	Mor, A; Campi, G; Du, GW; Zheng, Y; Foster, DA; Dustin, ML; Philips, MR				Mor, Adam; Campi, Gabriele; Du, Guangwei; Zheng, Yang; Foster, David A.; Dustin, Michael L.; Philips, Mark R.			The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2	NATURE CELL BIOLOGY			English	Article							T-CELL-RECEPTOR; PHOSPHATIDIC-ACID; GOLGI-APPARATUS; ACTIVATION; LFA-1; PHAGOCYTOSIS; CYTOHESIN-1; MIGRATION; ADHESION; COMPLEX	Ras activation as a consequence of antigen receptor (T-cell receptor; TCR) engagement on T lymphocytes is required for T-cell development, selection and function. Lymphocyte function-associated antigen-1 (LFA-1) mediates lymphocyte adhesion, stabilization of the immune synapse and bidirectional signalling. Using a fluorescent biosensor we found that TCR activation with or without costimulation of CD28 led to activation of Ras only on the Golgi apparatus, whereas costimulation with LFA-1 induced Ras activation on both the Golgi and the plasma membrane. Ras activation on both compartments required RasGRP1, an exchange factor regulated by calcium and diacylglycerol (DAG), but phospholipase C ( PLC) activity was required only for activation on the Golgi. Engagement of LFA-1 increased DAG levels at the plasma membrane by stimulating phospholipase D (PLD). PLD2 and phosphatidic acid phosphatase (PAP) were required for Ras activation on the plasma membrane. Thus, LFA-1 acts through PLD2 to reshape the pattern of Ras activation downstream of the TCR.	NYU, Dept Med, Sch Med, New York, NY 10016 USA; NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Philips, MR (corresponding author), NYU, Dept Med, Sch Med, 550 1St Ave, New York, NY 10016 USA.	philim01@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Du, Guangwei/0000-0003-4193-6975; Mark, Philips/0000-0002-1179-8156				Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bankaitis VA, 2002, SCIENCE, V295, P290, DOI 10.1126/science.1068446; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOER A, 1994, N-S ARCH PHARMACOL, V350, P653; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	30	109	112	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					713	U182		10.1038/ncb1592	http://dx.doi.org/10.1038/ncb1592			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486117				2022-12-25	WOS:000246922700018
J	Pennington, JM; Rosenberg, SM				Pennington, Jeanine M.; Rosenberg, Susan M.			Spontaneous DNA breakage in single living Escherichia coli cells	NATURE GENETICS			English	Article							STALLED REPLICATION FORKS; RECOMBINATIONAL REPAIR; CHROMOSOME; FIDELITY; MUTANTS; CANCER; DAMAGE; AMPLIFICATION; DYNAMICS; BACTERIA	Spontaneous DNA breakage is predicted to be a frequent, inevitable consequence of DNA replication and is thought to underlie much of the genomic change that fuels cancer and evolution(1-3). Despite its importance, there has been little direct measurement of the amounts, types, sources and fates of spontaneous DNA lesions in living cells. We present a direct, sensitive flow cytometric assay in single living Escherichia coli cells for DNA lesions capable of inducing the SOS DNA damage response, and we report its use in quantification of spontaneous DNA double-strand breaks (DSBs). We report efficient detection of single chromosomal DSBs and rates of spontaneous breakage similar to 20- to 100-fold lower than predicted. In addition, we implicate DNA replication in the origin of spontaneous DSBs with the finding of fewer spontaneous DSBs in a mutant with altered DNA polymerase III. The data imply that spontaneous DSBs induce genomic changes and instability 20-100 times more potently than previously appreciated. Finally, FACS demonstrated two main cell fates after spontaneous DNA damage: viability with or without resumption of proliferation.	Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	smr@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA85777, R01 CA085777] Funding Source: Medline; NIGMS NIH HHS [R01-GM53158, R01 GM053158-11A1, R01 GM053158-10, R01 GM053158] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Nystrom T, 2002, CURR OPIN MICROBIOL, V5, P596, DOI 10.1016/S1369-5274(02)00367-3; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rothstein R, 2000, GENE DEV, V14, P1; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	30	148	150	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					797	802		10.1038/ng2051	http://dx.doi.org/10.1038/ng2051			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529976	Green Accepted			2022-12-25	WOS:000246859100026
J	Baala, L; Briault, S; Etchevers, HC; Laumonnier, F; Natiq, A; Amiel, J; Boddaert, N; Picard, C; Sbiti, A; Asermouh, A; Attie-Bitach, T; Encha-Razavi, F; Munnich, A; Sefiani, A; Lyonnet, S				Baala, Lekbir; Briault, Sylvain; Etchevers, Heather C.; Laumonnier, Frederic; Natiq, Abdelhafid; Amiel, Jeanne; Boddaert, Nathalie; Picard, Capucine; Sbiti, Aziza; Asermouh, Abdellah; Attie-Bitach, Tania; Encha-Razavi, Ferechte; Munnich, Arnold; Sefiani, Abdelaziz; Lyonnet, Stanislas			Homozygous silencing of T-box transcription factor EOMES leads to microcephaly with polymicrogyria and corpus callosum agenesis	NATURE GENETICS			English	Article							RADIAL GLIA; EOMESODERMIN; MOUSE; DIFFERENTIATION; EXPRESSION; NEOCORTEX; TBR2	Neural progenitor proliferation and migration influence brain size during neurogenesis. We report an autosomal recessive microcephaly syndrome cosegregating with a homozygous balanced translocation between chromosomes 3p and 10q, and we show that a position effect at the breakpoint on chromosome 3 silences the eomesodermin transcript (EOMES), also known as T-box-brain2 (TBR2). Together with the expression pattern of EOMES in the developing human brain, our data suggest that EOMES is involved in neuronal division and/or migration. Thus, mutations in genes encoding not only mitotic and apoptotic proteins but also transcription factors may be responsible for malformative microcephaly syndromes.	Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France; Inst Natl Hyg, Dept Med Genet, Rabat, Morocco; INSERM, Fac Med, U619, Tours, France; Hop Necker Enfants Malad, Serv Radiol Pediat, Paris, France; Ctr Etud Deficits Immunitaires, Paris, France; CHU Avicenne, Hop Enfants, Rabat, Morocco; Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; UDICE-French Research Universities; Universite Paris Cite	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France.	lyonnet@necker.fr	Laumonnier, Frederic/N-1165-2016; ATTIE-BITACH, Tania/K-1453-2017; Picard, Capucine/H-3914-2017; amiel, jeanne/AGX-1124-2022; boddaert, nathalie/GWV-2865-2022; Lyonnet, Stanislas/H-5483-2017; Etchevers, Heather C./B-5813-2012; amiel, jeanne/H-3501-2017	Laumonnier, Frederic/0000-0003-2567-0708; ATTIE-BITACH, Tania/0000-0002-1155-3626; Picard, Capucine/0000-0001-8788-5056; Lyonnet, Stanislas/0000-0001-5426-9417; Etchevers, Heather C./0000-0003-0201-3799; amiel, jeanne/0000-0001-5973-4728; boddaert, nathalie/0000-0003-0991-7774				Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fernandez BA, 2005, CLIN GENET, V68, P349, DOI 10.1111/j.1399-0004.2005.00498.x; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Kimura N, 1999, DEV BRAIN RES, V115, P183, DOI 10.1016/S0165-3806(99)00064-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515	14	140	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					454	456		10.1038/ng1993	http://dx.doi.org/10.1038/ng1993			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353897				2022-12-25	WOS:000245271200014
J	Janiesch, PC; Kim, J; Mouysset, J; Barikbin, R; Lochmuller, H; Cassata, G; Krause, S; Hoppe, T				Janiesch, Philipp Christoph; Kim, Johnny; Mouysset, Julien; Barikbin, Roja; Lochmueller, Hanns; Cassata, Giuseppe; Krause, Sabine; Hoppe, Thorsten			The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; AAA-ATPASE; PROTEASOME PATHWAY; PROTEIN; UNC-45; ER; MUTATIONS; GENE; MULTIUBIQUITYLATION; POLYUBIQUITINATION	Protein degradation in eukaryotes often requires the ubiquitin-selective chaperone p97 for substrate recruitment and ubiquitin-chain assembly. However, the physiological relevance of p97, and its role in developmental processes, remain unclear. Here, we discover an unanticipated function for CDC-48/p97 in myosin assembly and myofibril organization, both in Caenorhabditis elegans and humans. The developmentally regulated assembly of a CDC-48 -UFD-2 -CHN-1 complex links turnover of the myosin-directed chaperone UNC-45 to functional muscle formation. Our data suggest a similarly conserved pathway regulating myosin assembly in humans. Remarkably, mutations in human p97, known to cause hereditary inclusion-body myopathy, abrogate UNC-45 degradation and result in severely disorganized myofibrils, detrimental towards sarcomeric function. These results identify a key role for CDC-48/p97 in the process of myofibre differentiation and maintenance, which is abolished during pathological conditions leading to protein aggregation and inclusion-body formation in human skeletal muscle.	Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; Univ Munich, Friedrich Baur Inst, D-81377 Munich, Germany; Univ Munich, Dept Neurol, D-81377 Munich, Germany; IFOM, FIRC, Inst Mol Oncol, I-20139 Milan, Italy	University of Hamburg; University of Munich; University of Munich; IFOM - FIRC Institute of Molecular Oncology	Hoppe, T (corresponding author), Univ Hamburg, ZMNH, Falkenried 94, D-20251 Hamburg, Germany.	thorsten.hoppe@zmnh.uni-hamburg.de	Krause, Sabine/AAJ-1163-2020; Hoppe, Thorsten/AAC-7880-2020; Kim, Johnny/AAY-2149-2020	Krause, Sabine/0000-0002-3141-886X; Lochmuller, Hanns/0000-0003-2324-8001; Hoppe, Thorsten/0000-0002-4734-9352; Kim, Johnny/0000-0002-5226-5460				Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; SLUSTON J, 1988, NEMATODE CAENORHABDI, P587; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tajsharghi H, 2005, EUR J HUM GENET, V13, P617, DOI 10.1038/sj.ejhg.5201375; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; VENOLIA L, 1990, GENETICS, V126, P345; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Yamanaka K, 2004, J STRUCT BIOL, V146, P242, DOI 10.1016/j.jsb.2003.11.017; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	44	115	128	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					379	U46		10.1038/ncb1554	http://dx.doi.org/10.1038/ncb1554			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369820				2022-12-25	WOS:000245359400009
J	Korn, T; Reddy, J; Gao, WD; Bettelli, E; Awasthi, A; Petersen, TR; Backstrom, BT; Sobel, RA; Wucherpfennig, KW; Strom, TB; Oukka, M; Kuchroo, VK				Korn, Thomas; Reddy, Jayagopala; Gao, Wenda; Bettelli, Estelle; Awasthi, Amit; Petersen, Troels R.; Backstrom, B. Thomas; Sobel, Raymond A.; Wucherpfennig, Kai W.; Strom, Terry B.; Oukka, Mohamed; Kuchroo, Vijay K.			Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR TRANSGENIC MICE; IN-VIVO; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; OLIGODENDROCYTE GLYCOPROTEIN; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; ENCEPHALOMYELITIS; FOXP3	Treatment with ex vivo-generated regulatory T cells (T-reg) has been regarded as a potentially attractive therapeutic approach for autoimmune diseases. However, the dynamics and function of T-reg in autoimmunity are not well understood. Thus, we developed Foxp3gfp knock-in (Foxp3gfp.KI) mice and myelin oligodendrocyte glycoprotein (MOG)(35-55)/IA(b) (MHC class II) tetramers to track autoantigen-specific effector T cells (T-eff) and T-reg in vivo during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. MOG tetramer-reactive, Foxp3(+) T-reg expanded in the peripheral lymphoid compartment and readily accumulated in the central nervous system (CNS), but did not prevent the onset of disease. Foxp3(+) T cells isolated from the CNS were effective in suppressing naive MOG-specific T cells, but failed to control CNS-derived encephalitogenic T-eff that secreted interleukin (IL)-6 and tumor necrosis factor (TNF). Our data suggest that in order for CD4(+)Foxp3(+) T-reg to effectively control autoimmune reactions in the target organ, it may also be necessary to control tissue inflammation.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Res Ctr, Boston, MA 02115 USA; Malaghan Inst Med Res, Wellington, New Zealand; Vet Affairs Hlth Care Syst, Lab Serv, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Malaghan Institute; Victoria University Wellington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Oukka, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Strom, Terry B./E-9268-2010; Reddy, Jay/K-7200-2014; Korn, Thomas/AAE-6960-2019	Strom, Terry B./0000-0002-7570-0736; Reddy, Jay/0000-0003-4082-9254; Korn, Thomas/0000-0002-3633-0955; Petersen, Troels/0000-0002-6378-352X; Sobel, Raymond/0000-0002-0477-9002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, R01AI044880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035685, P01NS038037, R37NS030843, R01NS045937, R01NS046414] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044880, P01 AI039671] Funding Source: Medline; NINDS NIH HHS [R37 NS030843, R01 NS045937, P01 NS038037, 1R01NS046414, R01 NS035685, 2R37NS30843-11, 2R01NS35685-06, 1R01NS045937-01, R01 NS046414, 1P01NS38037-04] Funding Source: Medline; PHS HHS [1R01A144880-03, 2P01A139671-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bagaeva LV, 2003, J NEUROIMMUNOL, V137, P109, DOI 10.1016/S0165-5728(03)00079-1; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Cao D, 2006, SCAND J IMMUNOL, V63, P444, DOI 10.1111/j.1365-3083.2006.001755.x; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Di Marco R, 2001, J NEUROIMMUNOL, V116, P168, DOI 10.1016/S0165-5728(01)00301-0; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Glabinski AR, 2002, J AUTOIMMUN, V19, P175, DOI 10.1006/jaut.2002.0613; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Piccirillo CA, 2005, ANN NY ACAD SCI, V1051, P72, DOI 10.1196/annals.1361.048; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Tanchot C, 2004, J IMMUNOL, V172, P4285, DOI 10.4049/jimmunol.172.7.4285; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	47	636	662	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2007	13	4					423	431		10.1038/nm1564	http://dx.doi.org/10.1038/nm1564			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	154YG	17384649	Green Accepted			2022-12-25	WOS:000245543900030
J	Baker, DEC; Harrison, NJ; Maltby, E; Smith, K; Moore, HD; Shaw, PJ; Heath, PR; Holden, H; Andrews, PW				Baker, Duncan E. C.; Harrison, Neil J.; Maltby, Edna; Smith, Kath; Moore, Harry D.; Shaw, Pamela J.; Heath, Paul R.; Holden, Hazel; Andrews, Peter W.			Adaptation to culture of human embryonic stem cells and oncogenesis in vivo	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FIBROBLAST-GROWTH-FACTOR; ES CELLS; CHROMOSOMAL-ABNORMALITIES; X-CHROMOSOME; GENE; TUMORS; LINES; DIFFERENTIATION; EXPRESSION	The application of human embryonic stem cells ( HESCs) to provide differentiated cells for regenerative medicine will require the continuous maintenance of the undifferentiated stem cells for long periods in culture. However, chromosomal stability during extended passaging cannot be guaranteed, as recent cytogenetic studies of HESCs have shown karyotypic aberrations. The observed karyotypic aberrations probably reflect the progressive adaptation of self-renewing cells to their culture conditions. Genetic change that increases the capacity of cells to proliferate has obvious parallels with malignant transformation, and we propose that the changes observed in HESCs in culture reflect tumorigenic events that occur in vivo, particularly in testicular germ cell tumors. Further supporting a link between culture adaptation and malignancy, we have observed the formation of a chromosomal homogeneous staining region in one HESC line, a genetic feature almost a hallmark of cancer cells. Identifying the genes critical for culture adaptation may thus reveal key players for both stem cell maintenance in vitro and germ cell tumorigenesis in vivo.	Univ Sheffield, Ctr Stem Cell Biol, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; Sheffield Reg Cytogenet Serv, Sheffield Childrens Trust, Sheffield S10 2TH, S Yorkshire, England; Univ Sheffield, Sch Med & Biomed Sci, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield; Sheffield Children's NHS Foundation Trust; University of Sheffield	Andrews, PW (corresponding author), Univ Sheffield, Ctr Stem Cell Biol, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	p.w.andrews@sheffield.ac.uk	Shaw, Pamela J/A-7620-2010; Heath, Paul/B-4778-2009; Shaw, Pamela J/A-5215-2009; Shaw, Pamela/E-6193-2010	Shaw, Pamela/0000-0002-8925-2567; Andrews, Peter/0000-0001-7215-4410	MRC [G0300268] Funding Source: UKRI; Medical Research Council [G0801059, G0300268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBRECHT S, 1993, GENE CHROMOSOME CANC, V6, P61, DOI 10.1002/gcc.2870060112; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, LAB INVEST, V50, P147; Azuhata T, 2001, J PEDIATR SURG, V36, P1785, DOI 10.1053/jpsu.2001.28839; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; BIEDLER JL, 1976, J NATL CANCER I, V57, P683, DOI 10.1093/jnci/57.3.683; Boveri T, 1914, ORIGIN MALIGNANT TUM; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; Caisander G, 2006, CHROMOSOME RES, V14, P131, DOI 10.1007/s10577-006-1019-8; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; DAMJANOV I, 1990, CANCER SURV, V9, P303; DAMJANOV I, 1993, EUR UROL, V23, P2; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Ishitani K, 2003, BIOCHEM BIOPH RES CO, V306, P660, DOI 10.1016/S0006-291X(03)01021-0; Josephson R, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-28; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Kim SJ, 2005, MOL CELLS, V19, P46; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kraggerud SM, 2002, GENE CHROMOSOME CANC, V34, P168, DOI 10.1002/gcc.10058; Lastowska M, 2002, GENE CHROMOSOME CANC, V34, P428, DOI 10.1002/gcc.10089; Liu X, 1997, DEV DYNAM, V209, P85; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Looijenga LHJ, 2000, J PATHOL, V191, P187, DOI 10.1002/(SICI)1096-9896(200006)191:2<187::AID-PATH584>3.0.CO;2-T; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; MOLLER H, 1993, EUR UROL, V23, P8; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Roelofs H, 2000, AM J PATHOL, V157, P1155, DOI 10.1016/S0002-9440(10)64631-7; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; SAMANIEGO F, 1990, GENE CHROMOSOME CANC, V1, P289, DOI 10.1002/gcc.2870010406; Sandberg AA, 1996, J UROLOGY, V155, P1531, DOI 10.1016/S0022-5347(01)66124-X; Skotheim RI, 2006, CELL ONCOL, V28, P315; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Sugawara A, 2006, COMPARATIVE MED, V56, P31; Summersgill BM, 2001, CANCER GENET CYTOGEN, V128, P120, DOI 10.1016/S0165-4608(01)00414-9; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; van Dartel M, 2004, CANCER GENET CYTOGEN, V153, P77, DOI 10.1016/j.cancergencyto.2004.03.007; von Eyben FE, 2004, CANCER GENET CYTOGEN, V151, P93, DOI 10.1016/j.cancergencyto.2003.09.008; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; WANG N, 1980, CANCER RES, V40, P796; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Wu XY, 1996, J BIOL CHEM, V271, P3265, DOI 10.1074/jbc.271.6.3265; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zafarana G, 2003, ONCOGENE, V22, P7695, DOI 10.1038/sj.onc.1207011	77	468	497	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					207	215		10.1038/nbt1285	http://dx.doi.org/10.1038/nbt1285			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17287758				2022-12-25	WOS:000244064000026
J	MacArthur, DG; Seto, JT; Raftery, JM; Quinlan, KG; Huttley, GA; Hook, JW; Lemckert, FA; Kee, AJ; Edwards, MR; Berman, Y; Hardeman, EC; Gunning, PW; Easteal, S; Yang, N; North, KN				MacArthur, Daniel G.; Seto, Jane T.; Raftery, Joanna M.; Quinlan, Kate G.; Huttley, Gavin A.; Hook, Jeff W.; Lemckert, Frances A.; Kee, Anthony J.; Edwards, Michael R.; Berman, Yemima; Hardeman, Edna C.; Gunning, Peter W.; Easteal, Simon; Yang, Nan; North, Kathryn N.			Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans	NATURE GENETICS			English	Article							ALPHA-ACTININ-3; PERFORMANCE; DEFICIENCY; ENDURANCE; GENOTYPE	More than a billion humans worldwide are predicted to be completely deficient in the fast skeletal muscle fiber protein alpha-actinin-3 owing to homozygosity for a premature stop codon polymorphism, R577X, in the ACTN3 gene. The R577X polymorphism is associated with elite athlete status and human muscle performance, suggesting that alpha-actinin-3 deficiency influences the function of fast muscle fibers. Here we show that loss of alpha-actinin-3 expression in a knockout mouse model results in a shift in muscle metabolism toward the more efficient aerobic pathway and an increase in intrinsic endurance performance. In addition, we demonstrate that the genomic region surrounding the 577X null allele shows low levels of genetic variation and recombination in individuals of European and East Asian descent, consistent with strong, recent positive selection. We propose that the 577X allele has been positively selected in some human populations owing to its effect on skeletal muscle metabolism.	Childrens Hosp Westmead, Inst Neuromascular Res, Sydney, NSW 2145, Australia; Univ Sydney, Fac Med, Discipline Paediatric & Child Hlth, Sydney, NSW 2006, Australia; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; Childrens Hosp Westmead, Oncol Res Unit, Sydney, NSW 2145, Australia; Childrens Med Res Inst, Muscle Dev Unit, Sydney, NSW 2145, Australia; Univ New S Wales, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; Australian National University; John Curtin School of Medical Research; University of Sydney; Children's Medical Research Institute - Australia; University of Sydney; University of New South Wales Sydney	North, KN (corresponding author), Childrens Hosp Westmead, Inst Neuromascular Res, Sydney, NSW 2145, Australia.	kathryn@chw.edu.au	Seto, Jane/AAN-4581-2021; Hardeman, Edna C/F-8872-2012; Huttley, Gavin A/G-5169-2015; Gunning, Peter W/E-9058-2010; North, Kathryn N/K-6476-2012; MacArthur, Daniel/E-3275-2010	Huttley, Gavin A/0000-0001-7224-2074; North, Kathryn N/0000-0003-0841-8009; Gunning, Peter/0000-0003-0833-3128; Berman, Yemima/0000-0003-2495-4928; Easteal, Simon/0000-0002-0462-502X; Seto, Jane/0000-0003-2864-6199; MacArthur, Daniel/0000-0002-5771-2290; Quinlan, Kate/0000-0002-5722-8183; Hardeman, Edna/0000-0003-1649-7712				Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; REICHMANN H, 1983, PFLUG ARCH EUR J PHY, V397, P202, DOI 10.1007/BF00584358; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	16	224	226	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1261	1265		10.1038/ng2122	http://dx.doi.org/10.1038/ng2122			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828264	Green Published			2022-12-25	WOS:000249737400023
J	Davidovich-Rikanati, R; Sitrit, Y; Tadmor, Y; Iijima, Y; Bilenko, N; Bar, E; Carmona, B; Fallik, E; Dudai, N; Simon, JE; Pichersky, E; Lewinsohn, E				Davidovich-Rikanati, Rachel; Sitrit, Yaron; Tadmor, Yaakov; Iijima, Yoko; Bilenko, Natalya; Bar, Einat; Carmona, Bentsi; Fallik, Elazar; Dudai, Nativ; Simon, James E.; Pichersky, Eran; Lewinsohn, Efraim			Enrichment of tomato flavor by diversion of the early plastidial terpenoid pathway	NATURE BIOTECHNOLOGY			English	Article							ALCOHOL-DEHYDROGENASE; VOLATILES; FRUITS; AROMA; BIOSYNTHESIS; EXPRESSION; GENE	We have modified the flavor and aroma of tomatoes by expressing the Ocimum basilicum geraniol synthase gene under the control of the tomato ripening-specific polygalacturonase promoter. A majority of untrained taste panelists preferred the transgenic fruits over controls. Monoterpene accumulation was at the expense of reduced lycopene accumulation. Similar approaches may be applicable for carotenoid-accumulating fruits and flowers of other species.	Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84105 Beer Sheva, Israel; Agr Res Org, Newe Yaar Res Ctr, Dept Vegetable Crops, IL-30095 Ramat Yishay, Israel; Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Ben Gurion Univ Negev, Dept Evaluat, Epidemiol & Hlth Serv, S Daniel Abraham Int Ctr Hlth & Nutr, IL-84105 Beer Sheva, Israel; Agr Res Org, Volcani Ctr, Dept Postharvest Sci, IL-50250 Bet Dagan, Israel; Rutgers State Univ, Dept Plant Biol & Plant Pathol, New Use Agr & Nat Plant Prod Program, New Brunswick, NJ 08901 USA	Ben Gurion University; Ben Gurion University; University of Michigan System; University of Michigan; Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Rutgers State University New Brunswick	Sitrit, Y (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, POB 653, IL-84105 Beer Sheva, Israel.	sitrit@bgu.ac.il; twefraim@agri.gov.il						Antonelli A, 1997, J AGR FOOD CHEM, V45, P4435, DOI 10.1021/jf9702407; Baldwin EA, 2000, HORTSCIENCE, V35, P1013, DOI 10.21273/HORTSCI.35.6.1013; BICSAK TA, 1982, ARCH BIOCHEM BIOPHYS, V216, P605, DOI 10.1016/0003-9861(82)90250-8; BUTTERY RG, 1987, J AGR FOOD CHEM, V35, P540, DOI 10.1021/jf00076a025; DUNPHY PJ, 1972, PHYTOCHEMISTRY, V11, P1887, DOI 10.1016/S0031-9422(00)90148-1; Galili G, 2002, CRIT REV PLANT SCI, V21, P167, DOI 10.1080/0735-260291044232; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Speirs J, 1998, PLANT PHYSIOL, V117, P1047, DOI 10.1104/pp.117.3.1047; THOMSON DMH, 1987, DEV FOOD FLAVOURS, P1; Tieman DM, 2006, J EXP BOT, V57, P887, DOI 10.1093/jxb/erj074	16	142	149	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					899	901		10.1038/nbt1312	http://dx.doi.org/10.1038/nbt1312			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17592476				2022-12-25	WOS:000248725800028
J	Qiu, XQ; Wang, H; Cai, B; Wang, LL; Yue, ST				Qiu, Xiao-Qing; Wang, He; Cai, Bei; Wang, Lan-Lan; Yue, Shi-Tao			Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting	NATURE BIOTECHNOLOGY			English	Article							EPSTEIN-BARR-VIRUS; CHANNEL-FORMING COLICINS; SINGLE-CHAIN FV; MONOCLONAL-ANTIBODIES; VARIABLE DOMAINS; PEPTIDE; IA; RECOMBINANT; PROTEINS; GLYCOPROTEIN	Here we show that fusion of two complementarity-determining regions ( CDRs), V(H)CDR1 and V(L)CDR3, through a cognate framework region ( V(H)FR2) yields mimetics that retain the antigen recognition of their parent molecules, but have a superior capacity to penetrate tumors. The antigen-recognition abilities of these similar to 3 kDa mimetics surpass those of comparable fragments lacking the framework region. In vivo activities of the mimetics suggests that the structural orientation of their CDRs approximates the conformation of the CDRs in the complex of the parent antibody with antigen. We linked the antibody mimetics to the bacterial toxin colicin la to create fusion proteins called "pheromonicins,'' which enable targeted inhibition of tumor growth. In mice bearing human malignant tumors, pheromonicins directed against tumor-specific surface markers show greater capacity to target and penetrate tumors than their parent antibodies. Rational recombination of selected V-H/ V-L binding sites and their framework regions might provide useful targeting moieties for cytotoxic cancer therapies.	Sichuan Univ, Minist Hlth, State Key Lab Biotherapy, Key Lab Transplant Immunol, Chengdu 610041, Peoples R China; Sichuan Univ, W China Hosp, Div Clin Immunol, Dept Lab Med, Chengdu 610041, Peoples R China; Sichuan Univ, W China Sch Med, W China Univ Hosp 2, Genet Lab, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Qiu, XQ (corresponding author), Sichuan Univ, Minist Hlth, State Key Lab Biotherapy, Key Lab Transplant Immunol, 37 Wai Nan Guo Xue Xiang, Chengdu 610041, Peoples R China.	xqqiu@tfol.com						Aburatani T, 2002, J BIOCHEM, V132, P775, DOI 10.1093/oxfordjournals.jbchem.a003286; Adams GP, 2001, CANCER RES, V61, P4750; Bang S, 2005, CLIN CANCER RES, V11, P1545, DOI 10.1158/1078-0432.CCR-04-1939; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; CRAMER WA, 1995, ANNU REV BIOPH BIOM, V24, P611, DOI 10.1146/annurev.biophys.24.1.611; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FUJIMORI K, 1989, CANCER RES, V49, P5656; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; GONG M, 1990, J VIROL, V64, P1507, DOI 10.1128/JVI.64.4.1507-1516.1990; HARLOW E, 2002, USING ANTIBODIES LAB, P93; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; HELLSTROM I, 1986, CANCER RES, V46, P3917; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; JAKES KS, 1990, J BIOL CHEM, V265, P6984; Jakes KS, 1999, Q REV BIOPHYS, V32, P189, DOI 10.1017/S0033583599003492; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Krauss J, 2005, BRIT J HAEMATOL, V128, P602, DOI 10.1111/j.1365-2141.2005.05356.x; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; MATTES MJ, 1984, P NATL ACAD SCI-BIOL, V81, P568, DOI 10.1073/pnas.81.2.568; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Qin WS, 2006, MOL IMMUNOL, V43, P660, DOI 10.1016/j.molimm.2005.04.009; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; QIU XQ, 1994, J BIOL CHEM, V269, P7483; Qiu XQ, 2003, NAT BIOTECHNOL, V21, P1480, DOI 10.1038/nbt913; Qiu XQ, 2005, ANTIMICROB AGENTS CH, V49, P1184, DOI 10.1128/AAC.49.3.1184-1189.2005; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Souriau C, 2005, BIOCHEMISTRY-US, V44, P7143, DOI 10.1021/bi0481592; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; THORLEYLAWSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P5307, DOI 10.1073/pnas.77.9.5307; Vallera DA, 2005, LEUKEMIA RES, V29, P331, DOI 10.1016/j.leukres.2004.08.006; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937	38	65	112	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					921	929		10.1038/nbt1320	http://dx.doi.org/10.1038/nbt1320			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17676038				2022-12-25	WOS:000248725800031
J	Butcher, RA; Fujita, M; Schroeder, FC; Clardy, J				Butcher, Rebecca A.; Fujita, Masaki; Schroeder, Frank C.; Clardy, Jon			Small-molecule pheromones that control dauer development in Caenorhabditis elegans	NATURE CHEMICAL BIOLOGY			English	Article							LARVAL DEVELOPMENT; C-ELEGANS; TEMPERATURE; VARIANT; GENE; FOOD	In response to high population density or low food supply, the nematode Caenorhabditis elegans enters an alternative larval stage, known as the dauer, that can withstand adverse conditions for prolonged periods. C. elegans senses its population density through a small-molecule signal, traditionally called the dauer pheromone, that it secretes into its surroundings. Here we show that the dauer pheromone consists of several structurally related ascarosides - derivatives of the dideoxysugar ascarylose - and that two of these ascarosides ( 1 and 2) are roughly two orders of magnitude more potent at inducing dauer formation than a previously reported dauer pheromone component ( 3) and constitute a physiologically relevant signal. The identification of dauer pheromone components 1 and 2 will facilitate the identification of target receptors and downstream signaling proteins.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu	Fujita, Masaki/A-8464-2012; Schroeder, Frank/H-5026-2012	Schroeder, Frank/0000-0002-4420-0237	NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NCI NIH HHS [CA24487] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Birnby DA, 2000, GENETICS, V155, P85; Braeckman BP, 2001, MECH AGEING DEV, V122, P673, DOI 10.1016/S0047-6374(01)00222-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; LAW JH, 1971, ANNU REV BIOCHEM, V40, P533, DOI 10.1146/annurev.bi.40.070171.002533; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1992, GENETICS, V130, P105; Zwaal RR, 1997, GENETICS, V145, P715	25	250	263	3	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2007	3	7					420	422		10.1038/nchembio.2007.3	http://dx.doi.org/10.1038/nchembio.2007.3			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181UY	17558398				2022-12-25	WOS:000247462800017
J	Kuo, LE; Kitlinska, JB; Tilan, JU; Li, LJ; Baker, SB; Johnson, MD; Lee, EW; Burnett, MS; Fricke, ST; Kvetnansky, R; Herzog, H; Zukowska, Z				Kuo, Lydia E.; Kitlinska, Joanna B.; Tilan, Jason U.; Li, Lijun; Baker, Stephen B.; Johnson, Michael D.; Lee, Edward W.; Burnett, Mary Susan; Fricke, Stanley T.; Kvetnansky, Richard; Herzog, Herbert; Zukowska, Zofia			Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome	NATURE MEDICINE			English	Article							WHITE ADIPOSE-TISSUE; RAT CAROTID-ARTERY; SYMPATHETIC ACTIVATION; ISCHEMIC ANGIOGENESIS; GENE-EXPRESSION; OB/OB MICE; NPY; RESPONSES; EXERCISE; DIET	The relationship between stress and obesity remains elusive. In response to stress, some people lose weight, whereas others gain. Here we report that stress exaggerates diet-induced obesity through a peripheral mechanism in the abdominal white adipose tissue that is mediated by neuropeptide Y (NPY). Stressors such as exposure to cold or aggression lead to the release of NPY from sympathetic nerves, which in turn upregulates NPY and its Y2 receptors (NPY2R) in a glucocorticoid-dependent manner in the abdominal fat. This positive feedback response by NPY leads to the growth of abdominal fat. Release of NPY and activation of NPY2R stimulates fat angiogenesis, macrophage infiltration, and the proliferation and differentiation of new adipocytes, resulting in abdominal obesity and a metabolic syndrome-like condition. NPY, like stress, stimulates mouse and human fat growth, whereas pharmacological inhibition or fat-targeted knockdown of NPY2R is anti-angiogenic and anti-adipogenic, while reducing abdominal obesity and metabolic abnormalities. Thus, manipulations of NPY2R activity within fat tissue offer new ways to remodel fat and treat obesity and metabolic syndrome.	Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA; Georgetown Univ, Med Ctr, Dept Plast Surg, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; MedStar Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Slovak Acad Sci, Inst Expt Endocrinol, Bratislava 83306, Slovakia; Gaven Inst Med Res, Sydney, NSW 2010, Australia	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Slovak Academy of Sciences	Zukowska, Z (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, 3900 Reservoir Rd NW,BSB 234, Washington, DC 20057 USA.	zzukow01@georgetown.edu	Herzog, Herbert/B-8294-2008	, Herbert/0000-0002-1713-1029; Lee, Edward/0000-0003-0418-1454	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067357, R37HL055310, R01HL055310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016050] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL067357, HL055310] Funding Source: Medline; NIDCR NIH HHS [DE016050] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALLEN JM, 1987, MOL BRAIN RES, V3, P39, DOI 10.1016/0169-328X(87)90042-8; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Boehm S, 1997, PROG NEUROBIOL, V51, P225, DOI 10.1016/S0301-0082(96)00056-1; BOSWELL T, 1993, BRAIN RES BULL, V32, P379, DOI 10.1016/0361-9230(93)90203-N; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Bradley RL, 2005, OBES RES, V13, P653, DOI 10.1038/oby.2005.73; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; BRAY GA, 1993, ANN NY ACAD SCI, V676, P223; Bujalska IJ, 2002, ENDOCR RES, V28, P449, DOI 10.1081/ERC-120016822; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; Ghersi G, 2001, PEPTIDES, V22, P453, DOI 10.1016/S0196-9781(01)00340-0; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hjemdahl P, 2002, CIRCULATION, V106, P2634, DOI 10.1161/01.CIR.0000041502.43564.79; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Kallio J, 2001, J CLIN ENDOCR METAB, V86, P5348, DOI 10.1210/jc.86.11.5348; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; KOZLOWSKI S, 1983, PFLUG ARCH EUR J PHY, V399, P63, DOI 10.1007/BF00652523; Lavebratt C, 2006, INT J OBESITY, V30, P453, DOI 10.1038/sj.ijo.0803188; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Levenson CW, 1998, NEUROSCI LETT, V242, P177, DOI 10.1016/S0304-3940(98)00064-0; Li LJ, 2005, ARTERIOSCL THROM VAS, V25, P2075, DOI 10.1161/01.ATV.0000179601.19888.19; Li LJ, 2003, ARTERIOSCL THROM VAS, V23, P1204, DOI 10.1161/01.ATV.0000071349.30914.25; Mark AL, 2002, J HYPERTENS, V20, P1245, DOI 10.1097/00004872-200207000-00001; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Mikurube Hajime, 2005, Nihon Koshu Eisei Zasshi, V52, P987; MORRIS MJ, 1986, J AUTONOM NERV SYST, V17, P143, DOI 10.1016/0165-1838(86)90089-5; Nankova B, 1996, ENDOCRINOLOGY, V137, P5597, DOI 10.1210/en.137.12.5597; Naveilhan P, 2002, PEPTIDES, V23, P1087, DOI 10.1016/S0196-9781(02)00042-6; Prod'homme T, 2006, TRENDS IMMUNOL, V27, P164, DOI 10.1016/J.IT.2006.02.003; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Rotunda AM, 2006, DERMATOL SURG, V32, P465, DOI 10.1111/j.1524-4725.2006.32100.x; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Sainsbury A, 2002, DIABETES, V51, P3420, DOI 10.2337/diabetes.51.12.3420; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669; Turtzo LC, 2002, HORM METAB RES, V34, P607, DOI 10.1055/s-2002-38245; van Rossum CTM, 2006, INT J OBESITY, V30, P1522, DOI 10.1038/sj.ijo.0803314; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Zukowska Z, 2003, TRENDS CARDIOVAS MED, V13, P86, DOI 10.1016/S1050-1738(02)00232-3; ZUKOWSKAGROJEC Z, 1988, LIFE SCI, V42, P1615, DOI 10.1016/0024-3205(88)90440-7; ZUKOWSKAGROJEC Z, 1987, AM J PHYSIOL, V253, pH1234, DOI 10.1152/ajpheart.1987.253.5.H1234; ZUKOWSKAGROJEC Z, 1988, SYNAPSE, V2, P293, DOI 10.1002/syn.890020319; ZukowskaGrojec Z, 1995, ANN NY ACAD SCI, V771, P219, DOI 10.1111/j.1749-6632.1995.tb44683.x	49	461	485	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					803	811		10.1038/nm1611	http://dx.doi.org/10.1038/nm1611			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17603492				2022-12-25	WOS:000247902800026
J	Roberts, JN; Buck, CB; Thompson, CD; Kines, R; Bernardo, M; Choyke, PL; Lowy, DR; Schiller, JT				Roberts, Jeffrey N.; Buck, Christopher B.; Thompson, Cynthia D.; Kines, Rhonda; Bernardo, Marcelino; Choyke, Peter L.; Lowy, Douglas R.; Schiller, John T.			Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan	NATURE MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MINOR CAPSID PROTEIN; PREVENTION; NEUTRALIZATION; SPERMICIDE; EFFICACY; SERA; HIV; L2	Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection, and virtually all cases of cervical cancer are attributable to infection by a subset of HPVs (reviewed in ref. 1). Despite the high incidence of HPV infection and the recent development of a prophylactic vaccine that confers protection against some HPV types, many features of HPV infection are poorly understood. It remains worthwhile to consider other interventions against genital HPVs, particularly those that target infections not prevented by the current vaccine. However, productive papillomavirus infection is species- and tissue-restricted, and traditional models use animal papillomaviruses that infect the skin or oral mucosa. Here we report the development of a mouse model of cervicovaginal infection with HPV16 that recapitulates the establishment phase of papillomavirus infection. Transduction of a reporter gene by an HPV16 pseudovirus was characterized by histology and quantified by whole-organ, multispectral imaging. Disruption of the integrity of the stratified or columnar genital epithelium was required for infection, which occurred after deposition of the virus on the basement membrane underlying basal keratinocytes. A widely used vaginal spermicide, nonoxynol-9 (N-9), greatly increased susceptibility to infection. In contrast, carrageenan, a polysaccharide present in some vaginal lubricants, prevented infection even in the presence of N-9, suggesting that carrageenan might serve as an effective topical HPV microbicide.	NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; SAIC Frederick, Frederick, MD 21702 USA; NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schiller, JT (corresponding author), NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA.	schillej@mail.nih.gov	Buck, Christopher/G-8358-2017; Schiller, John/ABK-8287-2022	Buck, Christopher/0000-0003-3165-8094; 	NATIONAL CANCER INSTITUTE [ZIABC010657, Z01BC009052, ZIABC010579, Z01BC010657, ZIABC009052, Z01BC010579] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; GIMENEZCONTI IB, 1994, DIFFERENTIATION, V56, P143, DOI 10.1007/s002580050031; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; HERMONAT PL, 1992, SEX TRANSM DIS, V19, P203, DOI 10.1097/00007435-199207000-00004; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Maguire RA, 1998, SEX TRANSM DIS, V25, P494, DOI 10.1097/00007435-199810000-00010; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Patton DL, 1999, AM J OBSTET GYNECOL, V180, P1080, DOI 10.1016/S0002-9378(99)70598-3; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Reuter JD, 2001, J VIROL METHODS, V98, P127, DOI 10.1016/S0166-0934(01)00370-6; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts J.N, 2007, NAT PROTOC, DOI [10.1038/nprot.2007.235, DOI 10.1038/NPROT.2007.235]; Roden RBS, 2001, J VIROL, V75, P10493, DOI 10.1128/JVI.75.21.10493-10497.2001; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spieler R, 2002, LANCET, V359, P1675, DOI 10.1016/S0140-6736(02)08605-1; TROTTIER H, 2005, VACCINE; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1	26	369	399	3	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					857	861		10.1038/nm1598	http://dx.doi.org/10.1038/nm1598			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17603495	Green Published			2022-12-25	WOS:000247902800033
J	Zhao, C; Du, GW; Skowronek, K; Frohman, MA; Bar-Sagi, D				Zhao, Chen; Du, Guangwei; Skowronek, Karl; Frohman, Michael A.; Bar-Sagi, Dafna			Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos	NATURE CELL BIOLOGY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; EXCHANGE FACTOR SON; PLASMA-MEMBRANE; BINDING DOMAIN; D ISOFORM; RECEPTOR; TRANSLOCATION; ASSOCIATION; EXPRESSION; ROLES	The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways. A prerequisite for the function of Sos in this context is its ligand-dependent membrane recruitment, and the prevailing model implicates both the Sos carboxy-terminal proline-rich motifs and amino-terminal pleckstrin homology (PH) domain in this process. Here, we describe a previously unrecognized pathway for the PH domain-dependent membrane recruitment of Sos that is initiated by the growth factor-induced generation of phosphatidic acid via the signalling enzyme phospholipase D2 (PLD2). Phosphatidic acid interacts with a defined site in the Sos PH domain with high affinity and specificity. This interaction is essential for epidermal growth factor (EGF)-induced Sos membrane recruitment and Ras activation. Our findings establish a crucial role for PLD2 in the coupling of extracellular signals to Sos-mediated Ras activation, and provide new insights into the spatial coordination of this activation event.	SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	Dafna.Bar-Sagi@med.nyu.edu	zhao, chen/C-7358-2011	Du, Guangwei/0000-0003-4193-6975; Bar-Sagi, Dafna/0000-0003-2597-8948	NCI NIH HHS [CA55360, CA28146] Funding Source: Medline; NIDDK NIH HHS [DK64166] Funding Source: Medline; NIGMS NIH HHS [GM71520, GM071475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146, R37CA055360, R01CA055360, R56CA055360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071520, R01GM071475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Byrne JL, 1996, ONCOGENE, V13, P2055; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Foster DA, 2003, MOL CANCER RES, V1, P789; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; Kubiseski TJ, 1997, J BIOL CHEM, V272, P1799, DOI 10.1074/jbc.272.3.1799; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MCCOLLAM L, 1995, J BIOL CHEM, V270, P15954, DOI 10.1074/jbc.270.27.15954; Park JW, 1996, BIOCHEM BIOPH RES CO, V229, P758, DOI 10.1006/bbrc.1996.1877; Qian XL, 1998, MOL CELL BIOL, V18, P771, DOI 10.1128/MCB.18.2.771; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12748, DOI 10.1021/bi00166a006; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WELSH CJ, 1994, BIOCHEM BIOPH RES CO, V202, P211, DOI 10.1006/bbrc.1994.1914; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719; Zheng J, 1997, J BIOL CHEM, V272, P30340, DOI 10.1074/jbc.272.48.30340	33	251	260	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					706	U171		10.1038/ncb1594	http://dx.doi.org/10.1038/ncb1594			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486115				2022-12-25	WOS:000246922700017
J	Neef, R; Gruneberg, U; Kopajtich, R; Li, XL; Nigg, EA; Sillje, H; Barr, FA				Neef, Ruediger; Gruneberg, Ulrike; Kopajtich, Robert; Li, Xiuling; Nigg, Erich A.; Sillje, Herman; Barr, Francis A.			Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE; CENTRAL-SPINDLE; CELL-CYCLE; MITOTIC SPINDLE; MIDZONE FORMATION; BOX DOMAIN; PRC1; BINDING; PLX1; PHOSPHORYLATION	Spatial and temporal coordination of polo-like kinase 1 (Plk1) activity is necessary for mitosis and cytokinesis, and this is achieved through binding to phosphorylated docking proteins with distinct subcellular localizations(1-4). Although cyclin-dependent kinase 1 (Cdk1) creates these phosphorylated docking sites in metaphase(1,2), a general principle that explains how Plk1 activity is controlled in anaphase after Cdk1 inactivation is lacking. Here, we show that the microtubule-associated protein regulating cytokinesis (PRC1) is an anaphase-specific binding partner for Plk1, and that this interaction is required for cytokinesis. In anaphase, Plk1 creates its own docking site on PRC1, whereas in metaphase Cdk1 phosphorylates PRC1 adjacent to this docking site and thereby prevents binding of Plk1. Mutation of these Cdk1-sites results in a form of PRC1 that prematurely recruits Plk1 to the spindle during prometaphase and blocks mitotic progression. The activation state of Cdk1, therefore, controls the switch of Plk1 localization from centrosomes and kinetochores during metaphase, to the central spindle during anaphase.	Max Planck Inst Biochem, Independent Jr Res Grp, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Kiadis Pharma, NL-9747 AN Groningen, Netherlands; Univ Liverpool, Canc Studies Ctr, Liverpool L3 9TA, Merseyside, England	Max Planck Society; Max Planck Society; University of Liverpool	Barr, FA (corresponding author), Max Planck Inst Biochem, Independent Jr Res Grp, D-82152 Martinsried, Germany.	barr@biochem.mpg.de	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Barr, Francis/0000-0001-7518-253X; nigg, erich/0000-0003-4835-5719				Abrieu A, 1998, J CELL SCI, V111, P1751; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Doree M, 2002, J CELL SCI, V115, P2461; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lowery DM, 2004, CELL CYCLE, V3, P128; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PINES J, 1999, NATL CELL BIOL, V1, P73; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; ZIEVE G, 1982, CELL, V28, P233, DOI 10.1016/0092-8674(82)90341-5	34	188	194	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					436	U132		10.1038/ncb1557	http://dx.doi.org/10.1038/ncb1557			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351640				2022-12-25	WOS:000245359400015
J	Nobuta, K; Venu, RC; Lu, C; Belo, A; Vemaraju, K; Kulkarni, K; Wang, WZ; Pillay, M; Green, PJ; Wang, GL; Meyers, BC				Nobuta, Kan; Venu, R. C.; Lu, Cheng; Belo, Andre; Vemaraju, Kalyan; Kulkarni, Karthik; Wang, Wenzhong; Pillay, Manoj; Green, Pamela J.; Wang, Guo-liang; Meyers, Blake C.			An expression atlas of rice mRNAs and small RNAs	NATURE BIOTECHNOLOGY			English	Article							TRANSPOSABLE ELEMENTS; ANTISENSE TRANSCRIPTS; ARABIDOPSIS; GENOME; HETEROCHROMATIN; CENTROMERE; RESOLUTION; PLANTS	Identification of all expressed transcripts in a sequenced genome is essential both for genome analysis and for realization of the goals of systems biology. We used the transcriptional profiling technology called ` massively parallel signature sequencing' to develop a comprehensive expression atlas of rice ( Oryza sativa cv Nipponbare). We sequenced 46,971,553 mRNA transcripts from 22 libraries, and 2,953,855 small RNAs from 3 libraries. The data demonstrate widespread transcription throughout the genome, including sense expression of at least 25,500 annotated genes and antisense expression of nearly 9,000 annotated genes. An additional set of similar to 15,000 mRNA signatures mapped to unannotated genomic regions. The majority of the small RNA data represented lower abundance short interfering RNAs that match repetitive sequences, intergenic regions and genes. Among these, numerous clusters of highly regulated small RNAs were readily observed. We developed a genome browser ( http:// mpss. udel. edu/ rice) for public access to the transcriptional profiling data for this important crop.	Univ Delaware, Coll Marine & Earth Studies, Delaware Biotechnol Inst, Newark, DE 19711 USA; Univ Delaware, Coll Marine & Earth Studies, Dept Plant & Soil Sci, Newark, DE 19711 USA; Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	University of Delaware; University of Delaware; University System of Ohio; Ohio State University	Meyers, BC (corresponding author), Univ Delaware, Coll Marine & Earth Studies, Delaware Biotechnol Inst, Newark, DE 19711 USA.	meyers@dbi.udel.edu	Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Wang, Guo-Liang/0000-0001-8877-3064				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Britten R, 2006, P NATL ACAD SCI USA, V103, P1798, DOI 10.1073/pnas.0510007103; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Lipatov M, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-24; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	21	205	214	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2007	25	4					473	477		10.1038/nbt1291	http://dx.doi.org/10.1038/nbt1291			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	156MD	17351617				2022-12-25	WOS:000245651800029
J	Risheg, H; Graham, JM; Clark, RD; Rogers, RC; Opitz, JM; Moeschler, JB; Peiffer, AP; May, M; Joseph, SM; Jones, JR; Stevenson, RE; Schwartz, CE; Friez, MJ				Risheg, Hiba; Graham, John M., Jr.; Clark, Robin D.; Rogers, R. Curtis; Opitz, John M.; Moeschler, John B.; Peiffer, Andreas P.; May, Melanie; Joseph, Sumy M.; Jones, Julie R.; Stevenson, Roger E.; Schwartz, Charles E.; Friez, Michael J.			A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome	NATURE GENETICS			English	Article							MENTAL-RETARDATION; FG-SYNDROME; DODECAMER DUPLICATION; NEURAL CREST; MEDIATOR; GENE; ASSOCIATION; VARIANT; HOPA	Opitz-Kaveggia syndrome (also known as FG syndrome) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation. We report here that the original family for whom the condition is named and five other families have a recurrent mutation (2881C > T, leading to R961W) in MED12 (also called TRAP230 or HOPA), a gene located at Xq13 that functions as a thyroid receptor associated protein in the Mediator complex.	Greenwood Genet Ctr, Greenwood, SC 29646 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Med Genet Inst, David Geffen Sch Med, Los Angeles, CA 90048 USA; Loma Linda Univ, Dept Pediat, Childrens Hosp, Loma Linda, CA 92354 USA; Univ Utah, Sch Med, Dept Pediat Med Genet Human Genet Pathol Obstet &, Salt Lake City, UT 84112 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA	Greenwood Genetic Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; Loma Linda University; Utah System of Higher Education; University of Utah; Dartmouth College	Friez, MJ (corresponding author), Greenwood Genet Ctr, Greenwood, SC 29646 USA.	friez@ggc.org	Graham, John M./J-1429-2019	joseph, sumy/0000-0001-8586-2109	NICHD NIH HHS [HD 26202] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Beyer KS, 2002, AM J MED GENET, V114, P110, DOI 10.1002/ajmg.1613; Briault S, 1997, AM J MED GENET, V73, P87; Friez MJ, 2000, HUM GENET, V106, P36, DOI 10.1007/s004390051006; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kleefstra T, 2005, CLIN GENET, V67, P451, DOI 10.1111/j.1399-0004.2005.00434.x; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Philibert RA, 1998, MOL PSYCHIATR, V3, P303, DOI 10.1038/sj.mp.4000442; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	15	153	157	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					451	453		10.1038/ng1992	http://dx.doi.org/10.1038/ng1992			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334363				2022-12-25	WOS:000245271200013
J	Ercan, S; Giresi, PG; Whittle, CM; Zhang, XM; Green, RD; Lieb, JD				Ercan, Sevinc; Giresi, Paul G.; Whittle, Christina M.; Zhang, Xinmin; Green, Roland D.; Lieb, Jason D.			X chromosome repression by localization of the C-elegans dosage compensation machinery to sites of transcription initiation	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; COMPLEX; GENOME; GENE; SEX; BINDING; ARRAY; TOOL	Among organisms with chromosome-based mechanisms of sex determination, failure to equalize expression of X-linked genes between the sexes is typically lethal. In C. elegans, XX hermaphrodites halve transcription from each X chromosome to match the output of XO males(1). Here, we mapped the binding location of the condensin homolog DPY-27 and the zinc finger protein SDC-3, two components of the C. elegans dosage compensation complex (DCC)(2,3). We observed strong foci of DCC binding on X, surrounded by broader regions of localization. Binding foci, but not adjacent regions of localization, were distinguished by clusters of a 10-bp DNA motif, suggesting a recruitment-and-spreading mechanism for X recognition. The DCC was preferentially bound upstream of genes, suggesting modulation of transcriptional initiation and polymerase-coupled spreading. Stronger DCC binding upstream of genes with high transcriptional activity indicated a mechanism for tuning DCC activity at specific loci. These data aid in understanding how proteins involved in higherorder chromosome dynamics can regulate transcription at individual loci.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carloina Ctr Genome Sci, Chapel Hill, NC 27599 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roche Holding; Roche NimbleGen	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, 202 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu		Lieb, Jason/0000-0001-7601-8061	NHGRI NIH HHS [U01 HG004270-01, U01 HG004270] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Davis TL, 1997, DEVELOPMENT, V124, P1019; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HODGKIN J, 1994, DEVELOPMENT, V120, P3681; HSU DR, 1995, DEVELOPMENT, V121, P3323; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li WQ, 1999, GENETICS, V152, P237; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; MEYER BJ, 2005, X CHROMOSOME DOSAGE; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nicoll M, 1997, NATURE, V388, P200, DOI 10.1038/40645; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439	30	91	94	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					403	408		10.1038/ng1983	http://dx.doi.org/10.1038/ng1983			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293863	Green Accepted, Green Submitted			2022-12-25	WOS:000244480000025
J	Huq, MDM; Tsai, NP; Lin, YP; Higgins, L; Wei, LN				Huq, M. D. Mostaqul; Tsai, Nien-Pei; Lin, Ya-Ping; Higgins, LeeAnn; Wei, Li-Na			Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation	NATURE CHEMICAL BIOLOGY			English	Article							RECEPTOR-INTERACTING PROTEIN-140; MODULATES TRANSCRIPTIONAL ACTIVATION; PYRIDOXAL 5'-PHOSPHATE; GLUCOCORTICOID-RECEPTOR; BINDING-SITE; EXPRESSION; ADIPOCYTES	Pyridoxal 5'-phosphate (PLP), the biologically active form of vitamin B6, is an important cofactor in amino acid metabolism(1), and supplementary vitamin B6 has protective effects in many disorders(2-5). Other than serving as a cofactor, it can also modulate the activities of steroid hormone receptors(6-9) and transcription factors(10). However, the molecular basis of this modulation is unclear. Here, we report that mouse nuclear receptor interacting protein 140 (RIP140) can be modified by PLP conjugation. We mapped the modification site to Lys613 by LC-ESI-MS/MS analysis. This modification enhanced its transcriptional corepressive activity and its physiological function in adipocyte differentiation. We attribute this effect to increased interaction of RIP140 with histone deacetylases and nuclear retention of RIP140. This study uncovers a new physiological role of vitamin B6 in gene regulation by PLP conjugation to a transcriptional coregulator, which represents a new function of an old form(11) of protein post-translational modification that has important biological consequences.	Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wei, LN (corresponding author), Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	weixx009@umn.edu			NIDA NIH HHS [K02-DA13926, DA11806, DA11190] Funding Source: Medline; NIDDK NIH HHS [DK60521, DK54733] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054733, R01DK060521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806, R01DA011190, K02DA013926] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agnihotri G, 2001, BIOORG CHEM, V29, P234, DOI 10.1006/bioo.2001.1211; ALLGOOD VE, 1993, J BIOL CHEM, V268, P20870; ALLGOOD VE, 1992, J BIOL CHEM, V267, P3819; ALLGOOD VE, 1990, J BIOL CHEM, V265, P12424; Bender DA, 1999, BRIT J NUTR, V81, P7, DOI 10.1017/S0007114599000082; BOHNEY JP, 1992, FEBS LETT, V298, P266, DOI 10.1016/0014-5793(92)80073-P; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Christian M, 2004, J BIOL CHEM, V279, P15645, DOI 10.1074/jbc.M313906200; CORTIJO M, 1988, J BIOL CHEM, V263, P17960; Farooqui M, 2003, BIOCHEMISTRY-US, V42, P971, DOI 10.1021/bi020497k; Golinelli-Pimpaneau B, 2006, J BIOL CHEM, V281, P23969, DOI 10.1074/jbc.M602184200; Hu XL, 2004, J BIOL CHEM, V279, P319, DOI 10.1074/jbc.M307621200; Huq MDM, 2005, PROTEOMICS, V5, P2157, DOI 10.1002/pmic.200401090; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAWADA T, 1990, COMP BIOCHEM PHYS A, V96, P323, DOI 10.1016/0300-9629(90)90699-S; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Oka T, 2001, BBA-GEN SUBJECTS, V1568, P189, DOI 10.1016/S0304-4165(01)00221-5; Okada M, 1999, DIABETES OBES METAB, V1, P221, DOI 10.1046/j.1463-1326.1999.00028.x; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Ristila M, 2006, J PHYS CHEM B, V110, P16774, DOI 10.1021/jp062800n; SYMES EK, 1984, J STEROID BIOCHEM, V20, P1089, DOI 10.1016/0022-4731(84)90348-0; TULLY DB, 1994, FASEB J, V8, P343, DOI 10.1096/fasebj.8.3.8143940; Tunnicliff G, 1998, CELL PHYSIOL BIOCHEM, V8, P117, DOI 10.1159/000016275; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; Williams KL, 2005, J BIOL CHEM, V280, P7949, DOI 10.1074/jbc.M413579200	30	57	58	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2007	3	3					161	165		10.1038/nchembio861	http://dx.doi.org/10.1038/nchembio861			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	138BD	17277785				2022-12-25	WOS:000244336600012
J	McClean, MN; Mody, A; Broach, JR; Ramanathan, S				McClean, Megan N.; Mody, Areez; Broach, James R.; Ramanathan, Sharad			Cross-talk and decision making in MAP kinase pathways	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; PROTEIN-KINASES; FLUORESCENT PROTEIN; MATING PATHWAY; BUDDING YEAST; CASCADE; HOG; ACTIVATION; STE5	Cells must respond specifically to different environmental stimuli in order to survive. The signal transduction pathways involved in sensing these stimuli often share the same or homologous proteins. Despite potential cross-wiring, cells show specificity of response. We show, through modeling, that the physiological response of such pathways exposed to simultaneous and temporally ordered inputs can demonstrate system-level mechanisms by which pathways achieve specificity. We apply these results to the hyperosmolar and pheromone mitogen-activated protein (MAP) kinase pathways in the yeast Saccharomyces cerevisiae. These two pathways specifically sense osmolar and pheromone signals(1-3), despite sharing a MAPKKK, Ste11, and having homologous MAPKs (Fus3 and Hog1). We show that in a single cell, the pathways are bistable over a range of inputs, and the cell responds to only one stimulus even when exposed to both. Our results imply that these pathways achieve specificity by filtering out spurious cross-talk through mutual inhibition. The variability between cells allows for heterogeneity of the decisions.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Harvard University; Harvard University; Princeton University; Alcatel-Lucent; Lucent Technologies; AT&T	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	sharadr@alcatel-lucent.com	McClean, Megan/D-4108-2013; McClean, Megan N./D-9211-2018	McClean, Megan/0000-0002-1141-4802; McClean, Megan N./0000-0002-1141-4802; Broach, James/0000-0003-1197-0312				Banuett F, 1998, MICROBIOL MOL BIOL R, V62, P249, DOI 10.1128/MMBR.62.2.249-274.1998; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHOI KY, 1994, CELL, V78, P499; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; HAGEN DC, 1991, MOL CELL BIOL, V11, P2952, DOI 10.1128/MCB.11.6.2952; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Murray J.D., 2002, MATH BIOL; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	27	117	119	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					409	414		10.1038/ng1957	http://dx.doi.org/10.1038/ng1957			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259986				2022-12-25	WOS:000244480000026
J	Chan, J; Calder, G; Fox, S; Lloyd, C				Chan, Jordi; Calder, Grant; Fox, Samantha; Lloyd, Clive			Cortical microtubule arrays undergo rotary movements in Arabidopsis hypocotyl epidermal cells	NATURE CELL BIOLOGY			English	Article							CYCLIC REORIENTATION; MAIZE COLEOPTILES; LIVING CELLS; GROWTH-RATE; ORIENTATION; WALL; REVEALS; VISUALIZATION; ESTABLISHMENT; GIBBERELLIN	Plant-cell expansion is controlled by cellulose microfibrils in the wall(1) with microtubules providing tracks for cellulose synthesizing enzymes(2). Microtubules can be reoriented experimentally(3-11) and are hypothesized to reorient cyclically in aerial organs(12-14), but the mechanism is unclear. Here, Arabidopsis hypocotyl microtubules were labelled with AtEB1a-GFP (Arabidopsis microtubule end-binding protein 1a) or GFP-TUA6 (Arabidopsis alpha-tubulin 6) to record long cycles of reorientation. This revealed microtubules undergoing previously unseen clockwise or counter-clockwise rotations. Existing models emphasize selective shrinkage and regrowth(15) or the outcome of individual microtubule encounters to explain realignment(16). Our higher-order view emphasizes microtubule group behaviour over time. Successive microtubules move in the same direction along self-sustaining tracks. Significantly, the tracks themselves migrate, always in the direction of the individual fast-growing ends, but twentyfold slower. Spontaneous sorting of tracks into groups with common polarities generates a mosaic of domains. Domains slowly migrate around the cell in skewed paths, generating rotations whose progressive nature is interrupted when one domain is displaced by collision with another. Rotary movements could explain how the angle of cellulose microfibrils can change from layer to layer in the polylamellate cell wall.	John Innes Ctr, Dept Dev & Cell Biol, Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Chan, J (corresponding author), John Innes Ctr, Dept Dev & Cell Biol, Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	jordi.chan@bbsrc.ac.uk		Fox, Samantha/0000-0003-1271-6412				Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Chan J, 2005, PLANT CELL, V17, P1737, DOI 10.1105/tpc.105.032615; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Costa MMR, 2005, DEVELOPMENT, V132, P5093, DOI 10.1242/dev.02085; Dhonukshe P, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-11; Dixit R, 2006, MOL BIOL CELL, V17, P1298, DOI 10.1091/mbc.E05-09-0864; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GIDDINGS TH, 1991, MICROTUBULE MEDIATED; Hejnowicz Z, 2005, PROTOPLASMA, V225, P243, DOI 10.1007/s00709-005-0091-9; HUSH JM, 1994, J CELL SCI, V107, P775; IGDDINGS TH, 1991, MICROTUBULE MEDIATED; ISHIDA K, 1992, INT J PLANT SCI, V153, P155, DOI 10.1086/297017; ISHIDA K, 1991, PLANT CELL PHYSIOL, V32, P409, DOI 10.1093/oxfordjournals.pcp.a078095; IWATA K, 1989, PLANT CELL PHYSIOL, V30, P1011; LASKOWSKI MJ, 1990, PLANTA, V181, P44, DOI 10.1007/BF00202323; Le J, 2005, J PLANT GROWTH REGUL, V24, P166, DOI 10.1007/s00344-005-0044-8; Lloyd CW, 1996, J MICROSC-OXFORD, V181, P140, DOI 10.1046/j.1365-2818.1996.100380.x; Mayumi K, 1996, PROTOPLASMA, V195, P112, DOI 10.1007/BF01279190; Nakajima K, 2006, PLANT CELL PHYSIOL, V47, P513, DOI 10.1093/pcp/pcj020; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Penfold R, 2006, LANGMUIR, V22, P2005, DOI 10.1021/la052719w; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Takesue K, 1998, PLANTA, V205, P539, DOI 10.1007/s004250050353; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; YUAN M, 1995, PLANT J, V7, P17, DOI 10.1046/j.1365-313X.1995.07010017.x; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	32	122	125	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					171	U57		10.1038/ncb1533	http://dx.doi.org/10.1038/ncb1533			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220881				2022-12-25	WOS:000243903000009
J	Lee, W; Tillo, D; Bray, N; Morse, RH; Davis, RW; Hughes, TR; Nislow, C				Lee, William; Tillo, Desiree; Bray, Nicolas; Morse, Randall H.; Davis, Ronald W.; Hughes, Timothy R.; Nislow, Corey			A high- resolution atlas of nucleosome occupancy in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC GENOME; RNA-POLYMERASE; BUDDING YEAST; Z-DNA; CHROMATIN; TRANSCRIPTION; BINDING; PROMOTER	We present the first complete high-resolution map of nucleosome occupancy across the whole Saccharomyces cerevisiae genome, identifying over 70,000 positioned nucleosomes occupying 81% of the genome. On a genome-wide scale, the persistent nucleosome-depleted region identified previously in a subset of genes demarcates the transcription start site. Both nucleosome occupancy signatures and overall occupancy correlate with transcript abundance and transcription rate. In addition, functionally related genes can be clustered on the basis of the nucleosome occupancy patterns observed at their promoters. A quantitative model of nucleosome occupancy indicates that DNA structural features may account for much of the global nucleosome occupancy.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Genome Technol, Palo Alto, CA 94304 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Banting & Best Dept Med Res, Toronto, ON M5S 1L6, Canada	Stanford University; University of Toronto; State University of New York (SUNY) System; Wadsworth Center; University of Toronto; University of Toronto	Nislow, C (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	corey.nislow@utoronto.ca		Nislow, Corey/0000-0002-4016-8874; Morse, Randall/0000-0003-0000-8718; Lee, William/0000-0001-9582-4413				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Champ PC, 2004, NUCLEIC ACIDS RES, V32, P6501, DOI 10.1093/nar/gkh988; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; LOHR D, 1995, J BIOL CHEM, V270, P27671, DOI 10.1074/jbc.270.46.27671; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ponomarenko JV, 1999, BIOINFORMATICS, V15, P654, DOI 10.1093/bioinformatics/15.7.654; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Sivolob A, 2000, J MOL BIOL, V295, P55, DOI 10.1006/jmbi.1999.3302; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wong B, 2007, P NATL ACAD SCI USA, V104, P2229, DOI 10.1073/pnas.0611447104; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	49	648	666	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1235	1244		10.1038/ng2117	http://dx.doi.org/10.1038/ng2117			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873876				2022-12-25	WOS:000249737400019
J	Perry, GH; Dominy, NJ; Claw, KG; Lee, AS; Fiegler, H; Redon, R; Werner, J; Villanea, FA; Mountain, JL; Misra, R; Carter, NP; Lee, C; Stone, AC				Perry, George H.; Dominy, Nathaniel J.; Claw, Katrina G.; Lee, Arthur S.; Fiegler, Heike; Redon, Richard; Werner, John; Villanea, Fernando A.; Mountain, Joanna L.; Misra, Rajeev; Carter, Nigel P.; Lee, Charles; Stone, Anne C.			Diet and the evolution of human amylase gene copy number variation	NATURE GENETICS			English	Article							SALIVARY AMYLASE; PLANT; CHIMPANZEE; DIGESTION; LINEAGE; ORIGINS; GENOME; FOODS	Starch consumption is a prominent characteristic of agricultural societies and hunter-gatherers in arid environments. In contrast, rainforest and circum-arctic hunter-gatherers and some pastoralists consume much less starch(1-3). This behavioral variation raises the possibility that different selective pressures have acted on amylase, the enzyme responsible for starch hydrolysis(4). We found that copy number of the salivary amylase gene (AMY1) is correlated positively with salivary amylase protein level and that individuals from populations with high-starch diets have, on average, more AMY1 copies than those with traditionally low-starch diets. Comparisons with other loci in a subset of these populations suggest that the extent of AMY1 copy number differentiation is highly unusual. This example of positive selection on a copy number-variable gene is, to our knowledge, one of the first discovered in the human genome. Higher AMY1 copy numbers and protein levels probably improve the digestion of starchy foods and may buffer against the fitness-reducing effects of intestinal disease.	Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Arizona State University; Arizona State University-Tempe; Harvard University; Brigham & Women's Hospital; University of California System; University of California Santa Cruz; Arizona State University; Arizona State University-Tempe; Wellcome Trust Sanger Institute; Stanford University; Harvard University; Harvard Medical School	Dominy, NJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	njdominy@ucsc.edu	Dominy, Nathaniel Jay/A-6151-2013; Martinez, Octavio/B-7375-2009; Stone, Anne C/B-5719-2009; Redon, Richard/F-3303-2014	Dominy, Nathaniel Jay/0000-0001-5916-418X; Redon, Richard/0000-0001-7751-2280; Stone, Anne/0000-0001-8021-8314; Claw, Katrina/0000-0003-2239-5018	NCRR NIH HHS [RR016483, RR014491, U42 RR015087, C06 RR016483, U42 RR015087-01, C06 RR014491, C06 RR016483-01, C06 RR014491-01, RR015087] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR015087, C06RR014491, C06RR016483] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; COURSEY DG, 1973, MAN, V8, P634; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DRAPER HH, 1977, AM ANTHROPOL, V79, P309, DOI 10.1525/aa.1977.79.2.02a00070; FIEGLER H, 2002, GENOME RES, V16, P156; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; FRIED M, 1987, DIGEST DIS SCI, V32, P1097, DOI 10.1007/BF01300195; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; HOHMAN G, 2006, FEEDING ECOLOGY APES; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lambert JE, 2005, AM J PHYS ANTHROPOL, V126, P183, DOI 10.1002/ajpa.10440; LEBENTHAL E, 1987, DIGEST DIS SCI, V32, P1155, DOI 10.1007/BF01300204; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MCGEACHIN RL, 1982, COMP BIOCHEM PHYS A, V72, P267, DOI 10.1016/0300-9629(82)90045-7; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; READ NW, 1986, BRIT J NUTR, V55, P43, DOI 10.1079/BJN19860008; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TOKAREV SA, 1956, PEOPLES SIBERIA, P243; VALDEZ IH, 1991, DIGEST DIS, V9, P125, DOI 10.1159/000171298; Vincent A. S., 1984, WORLD ARCHAEOL, V17, P131; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	30	902	924	57	572	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1256	1260		10.1038/ng2123	http://dx.doi.org/10.1038/ng2123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828263	Green Accepted			2022-12-25	WOS:000249737400022
J	Haiman, CA; Le Marchand, L; Yamamato, J; Stram, DO; Sheng, X; Kolonel, LN; Wu, AH; Reich, D; Henderson, BE				Haiman, Christopher A.; Le Marchand, Loic; Yamamato, Jennifer; Stram, Daniel O.; Sheng, Xin; Kolonel, Laurence N.; Wu, Anna H.; Reich, David; Henderson, Brian E.			A common genetic risk factor for colorectal and prostate cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; WIDE ASSOCIATION; LOCUS; OCT4; 8Q24	Variants on chromosome 8q24 contribute risk for prostate cancer; here, we tested whether they also modulate risk for colorectal cancer. We studied 1,807 affected individuals and 5,511 controls and found that one variant, rs6983267, is also significantly associated with colorectal cancer ( odds ratio = 1.22; P = 4.4 x 10(-6)) and that the apportionment of risk among the variants differs significantly between the two cancers. Comprehensive testing in the region uncovered variants capturing significant additional risk. Our results show that variants at 8q24 have different effects on cancer development that depend on the tissue type.	Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA.	haiman@usc.edu			NATIONAL CANCER INSTITUTE [U01CA063464, R01CA060987, R01CA063464, P01CA017054, R37CA054281, R01CA072520, R01CA054281] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054281, R37 CA054281, P01 CA17054, CA72520, CA54281, U01 CA063464, R01 CA072520, R01 CA063464, R01 CA060987, R01 CA063464-09S1, CA60987, CA63464, P01 CA017054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; VISAKORPI T, 1995, CANCER RES, V55, P342; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	301	312	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					954	956		10.1038/ng2098	http://dx.doi.org/10.1038/ng2098			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618282	Green Accepted			2022-12-25	WOS:000248446900008
J	Sandhu, MS; Weedon, MN; Fawcett, KA; Wasson, J; Debenham, SL; Daly, A; Lango, H; Frayling, TM; Neumann, RJ; Sherva, R; Blech, I; Pharoah, PD; Palmer, CNA; Kimber, C; Tavendale, R; Morris, AD; McCarthy, MI; Walker, M; Hitman, G; Glaser, B; Permutt, MA; Hattersley, AT; Wareham, NJ; Barroso, I				Sandhu, Manjinder S.; Weedon, Michael N.; Fawcett, Katherine A.; Wasson, Jon; Debenham, Sally L.; Daly, Allan; Lango, Hana; Frayling, Timothy M.; Neumann, Rosalind J.; Sherva, Richard; Blech, Ilana; Pharoah, Paul D.; Palmer, Colin N. A.; Kimber, Charlotte; Tavendale, Roger; Morris, Andrew D.; McCarthy, Mark I.; Walker, Mark; Hitman, Graham; Glaser, Benjamin; Permutt, M. Alan; Hattersley, Andrew T.; Wareham, Nicholas J.; Barroso, Ines			Common variants in WFS1 confer risk of type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; NUCLEAR FACTOR-4-ALPHA GENE; BETA-CELL LOSS; TRANSMEMBRANE PROTEIN; OPTIC ATROPHY; E23K VARIANT; POLYMORPHISM; ASSOCIATION; MELLITUS	We studied genes involved in pancreatic beta cell function and survival, identifying associations between SNPs in WFS1 and diabetes risk in UK populations that we replicated in an Ashkenazi population and in additional UK studies. In a pooled analysis comprising 9,533 cases and 11,389 controls, SNPs in WFS1 were strongly associated with diabetes risk. Rare mutations in WFS1 cause Wolfram syndrome; using a gene-centric approach, we show that variation in WFS1 also predisposes to common type 2 diabetes.	UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge CB10 1SA, England; Washington Univ, Sch Med, St Louis, MO 63110 USA; Hadassah Hebrew Univ, Med Ctr, Endocrine & Metab Serv, IL-91120 Jerusalem, Israel; Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge CB1 8RN, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London, Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London E1 1BB, England	University of Cambridge; University of Cambridge; University of Exeter; Wellcome Trust Sanger Institute; Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Dundee; University of Dundee; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; University of London; Queen Mary University London	Sandhu, MS (corresponding author), UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk; ib1@sanger.ac.uk	Study, GoDARTS/K-9448-2016; Allen, Hana Lango/G-9026-2012; Palmer, Colin NA/C-7053-2008; Morris, Andrew D/C-2837-2009; Glaser, Benjamin/F-8411-2017; Pharoah, Paul/V-6658-2019; McCarthy, Mark/M-3763-2015	Allen, Hana Lango/0000-0002-7803-8688; Palmer, Colin NA/0000-0002-6415-6560; Glaser, Benjamin/0000-0003-4711-5000; Pharoah, Paul/0000-0001-8494-732X; Weedon, Michael/0000-0002-6174-6135; Sherva, Richard/0000-0003-2133-1493; Fawcett, Katherine/0000-0002-6675-2112; Barroso, Ines/0000-0001-5800-4520; McCarthy, Mark/0000-0002-4393-0510; Ricketts, Sally/0000-0002-5644-7958; Hattersley, Andrew/0000-0001-5620-473X	MRC [G0500070] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0500070] Funding Source: Medline; Wellcome Trust [068545/z/02, 077016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; KARASIK A, 1989, DIABETES CARE, V12, P135, DOI 10.2337/diacare.12.2.135; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	14	272	281	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					951	953		10.1038/ng2067	http://dx.doi.org/10.1038/ng2067			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603484	Green Accepted			2022-12-25	WOS:000248446900007
J	den Hollander, AI; Koenekoop, RK; Mohamed, MD; Arts, HH; Boldt, K; Towns, KV; Sedmak, T; Beer, M; Nagel-Wolfrum, K; McKibbin, M; Dharmaraj, S; Lopez, I; Ivings, L; Williams, GA; Springell, K; Woods, CG; Jafri, H; Rashid, Y; Strom, TM; van der Zwaag, B; Gosens, I; Kersten, FFJ; van Wijk, E; Veltman, JA; Zonneveld, MN; van Beersum, SEC; Maumenee, IH; Wolfrum, U; Cheetham, ME; Ueffing, M; Cremers, FPM; Inglehearn, CF; Roepman, R				den Hollander, Anneke I.; Koenekoop, Robert K.; Mohamed, Moin D.; Arts, Heleen H.; Boldt, Karsten; Towns, Katherine V.; Sedmak, Tina; Beer, Monika; Nagel-Wolfrum, Kerstin; McKibbin, Martin; Dharmaraj, Sharola; Lopez, Irma; Ivings, Lenka; Williams, Grange A.; Springell, Kelly; Woods, C. Geoff; Jafri, Hussain; Rashid, Yasmin; Strom, Tim M.; van der Zwaag, Bert; Gosens, Ilse; Kersten, Ferry F. J.; van Wijk, Erwin; Veltman, Joris A.; Zonneveld, Marijke N.; van Beersum, Sylvia E. C.; Maumenee, Irene H.; Wolfrum, Uwe; Cheetham, Michael E.; Ueffing, Marius; Cremers, Frans P. M.; Inglehearn, Chris F.; Roepman, Ronald			Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis	NATURE GENETICS			English	Article							CASEIN KINASE-II; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; ASSOCIATION; NUCLEOLIN; INTERACTS; NUCLEOPHOSMIN/B23; PHOSPHORYLATION; LOCALIZATION; CENTRIOLES	Leber congenital amaurosis ( LCA) causes blindness or severe visual impairment at or within a few months of birth. Here we show, using homozygosity mapping, that the LCA5 gene on chromosome 6q14, which encodes the previously unknown ciliary protein lebercilin, is associated with this disease. We detected homozygous nonsense and frameshift mutations in LCA5 in five families affected with LCA. In a sixth family, the LCA5 transcript was completely absent. LCA5 is expressed widely throughout development, although the phenotype in affected individuals is limited to the eye. Lebercilin localizes to the connecting cilia of photoreceptors and to the microtubules, centrioles and primary cilia of cultured mammalian cells. Using tandem affinity purification, we identified 24 proteins that link lebercilin to centrosomal and ciliary functions. Members of this interactome represent candidate genes for LCA and other ciliopathies. Our findings emphasize the emerging role of disrupted ciliary processes in the molecular pathogenesis of LCA.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; McGill Univ, Hlth Sci Ctr, McGill Ocular Genet Ctr, Montreal, PQ H3A 2T5, Canada; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; St Thomas Hosp, Dept Ophthalmol, London, England; GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany; Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; St James Univ Hosp, Eye Dept, Leeds, W Yorkshire, England; INRA, FLAVIC, Eye & Nutr Res Grp, Dijon, France; Addenbrookes Hosp, Cambridge Inst Med Tes, Dept Med Genet, Cambridge, England; Gene Tech Lab 146 1, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; Univ Utrecht, Med Ctr, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3508 TC Utrecht, Netherlands; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; UCL, Inst Ophthalmol, Div Mol & Cellular Neurosci, London WC1E 6BT, England	Radboud University Nijmegen; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Saint James's University Hospital; University of Leeds; Guy's & St Thomas' NHS Foundation Trust; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Saint James's University Hospital; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl	van Wijk, Erwin/J-8913-2014; Veltman, Joris A/F-5128-2010; Cheetham, Michael/B-4672-2011; woods, christopher g/A-1361-2010; Koenekoop, Robert/AAT-6676-2021; Nagel-Wolfrum, Kerstin/AAX-6477-2020; arts, heleen/ACL-6040-2022; Cremers, Frans/A-5625-2014; Boldt, Karsten/B-7538-2014; Kersten, Ferry F.J./ABC-7666-2020; Roepman, Ronald/B-1339-2014; van Beersum, Sylvia E.C./P-8653-2015; Hollander, Anneke den/N-4911-2014; Inglehearn, Chris/GYD-9783-2022	van Wijk, Erwin/0000-0002-5702-3460; Veltman, Joris A/0000-0002-3218-8250; Cremers, Frans/0000-0002-4954-5592; Roepman, Ronald/0000-0002-5178-8163; van Beersum, Sylvia E.C./0000-0002-4552-2908; Cheetham, Michael/0000-0001-6429-654X; Arts, Heleen/0000-0002-9860-3744	Wellcome Trust [073477, 061682, 068579] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chen CY, 2006, BIOCHEM BIOPH RES CO, V342, P1203, DOI 10.1016/j.bbrc.2006.02.089; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dharmaraj S, 2000, AM J HUM GENET, V66, P319, DOI 10.1086/302719; Faust M, 2002, CELL MOL LIFE SCI, V59, P2155, DOI 10.1007/s000180200022; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Ginisty H, 1999, J CELL SCI, V112, P761; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	30	141	146	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					889	895		10.1038/ng2066	http://dx.doi.org/10.1038/ng2066			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546029				2022-12-25	WOS:000247619800020
J	Zhang, X; Zhu, J; Yang, GY; Wang, QJ; Qian, L; Chen, YM; Chen, F; Tao, Y; Hu, HS; Wang, T; Luo, ZG				Zhang, Xian; Zhu, Ji; Yang, Guo-Ying; Wang, Qing-Jie; Qian, Lei; Chen, Yan-Min; Chen, Fei; Tao, Yu; Hu, Han-Song; Wang, Tong; Luo, Zhen-Ge			Dishevelled promotes axon differentiation by regulating atypical protein kinase C	NATURE CELL BIOLOGY			English	Article							HIPPOCAMPAL NEURONAL POLARITY; WNT SIGNALING PATHWAY; CELL-POLARITY; ESTABLISHMENT; GSK-3-BETA; PAR-1; GUIDANCE; ELEGANS; COMPLEX; CDC42	The atypical protein kinase C (aPKC) in complex with PAR3 and PAR6 is required for axon-dendrite differentiation, but the upstream factors responsible for regulating its activity are largely unknown. Here, we report that in cultured hippocampal neurons aPKC is directly regulated by Dishevelled (Dvl), an immediate downstream effector of Wnt. We found that downregulation of Dvl abrogated axon differentiation, whereas Dvl overexpression resulted in multiple axon formation. Interestingly, Dvl was associated with aPKC and this interaction resulted in aPKC stabilization and activation. Furthermore, the multiple axon formation resulting from Dvl overexpression was attenuated by expressing a dominant-negative aPKC in these neurons and overexpression of aPKC prevented the loss of axon caused by Dvl downregulation. Finally, Wnt5a, a noncanonical Wnt, activated aPKC and promoted axon differentiation. The Wnt5a effect on axon differentiation was attenuated by downregulating Dvl or inhibiting aPKC. Thus, Dvl-aPKC interaction can promote axon differentiation mediated by the PAR3-PAR6-aPKC complex.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Qian, Lei/H-1977-2013; CHEN, YANMIN/H-6124-2011; Wang, Tong/AAJ-9949-2020; Qian, Lei/N-1796-2019; Luo, Zhen-Ge/GNM-7635-2022	Qian, Lei/0000-0002-3480-4248; Wang, Tong/0000-0002-3680-8189; Qian, Lei/0000-0002-3480-4248; Luo, Zhen-Ge/0000-0001-5037-0542				Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salinas PC, 2003, CURR BIOL, V13, pR60, DOI 10.1016/S0960-9822(02)01429-X; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	43	168	175	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					743	U27		10.1038/ncb1603	http://dx.doi.org/10.1038/ncb1603			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558396				2022-12-25	WOS:000247760700010
J	Mullican, SE; Zhang, S; Konopleva, M; Ruvolo, V; Andreeff, M; Milbrandt, J; Conneely, OM				Mullican, Shannon E.; Zhang, Shuo; Konopleva, Marina; Ruvolo, Vivian; Andreeff, Michael; Milbrandt, Jeffrey; Conneely, Orla M.			Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia	NATURE MEDICINE			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; ORPHAN RECEPTOR; MICE LACKING; C/EBP-ALPHA; NGFI-B; NUR77; IDENTIFICATION; PROGENITORS; EXPRESSION	Nur77 (NR4A1) and Nor-1 (NR4A3) are highly homologous orphan nuclear receptors(1,2) that regulate the transcription of overlapping target genes(2),(3). The transcriptional activity of both proteins is regulated in a ligand-independent manner by cell-and stimulus-specific gene induction and protein phosphorylation(4,5). Nor-1 and Nur77 have been implicated in a variety of cellular processes, including the transduction of hormonal, inflammatory, mitogenic, apoptotic and differentiative signals(4,6,7). Cellular responses to these proteins suggest that they may function as homeostatic regulators of proliferation, apoptosis and differentiation, and thus may regulate cellular susceptibility to tumorigenesis. Their physiological functions, however, remain poorly understood. Here we describe a previously unsuspected function of Nor-1 and Nur77-as critical tumor suppressors of myeloid leukemogenesis. The abrogation of these proteins in mice led to rapidly lethal acute myeloid leukemia (AML), involving abnormal expansion of hematopoietic stem cells (HSCs) and myeloid progenitors, decreased expression of the AP-1 transcription factors JunB and c-Jun and defective extrinsic apoptotic (Fas-L and TRAIL) signaling. We found that downregulation of NR4A3 (NOR-1) and NR4A1 (NUR77) was a common feature in leukemic blasts from human AML patients, irrespective of karyotype. Thus Nor-1 and Nur77 may provide potential targets for therapeutic intervention in AML.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL)	Conneely, OM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	orlac@bcm.tmc.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA111411, P01CA055164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA55164, CA16672, CA111411] Funding Source: Medline; NIDDK NIH HHS [U19DK62434] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Castilla LH, 2004, P NATL ACAD SCI USA, V101, P4924, DOI 10.1073/pnas.0400930101; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DAVIS IJ, 1994, MOL CELL BIOL, V14, P3469, DOI 10.1128/MCB.14.5.3469; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Lee JM, 2002, P NATL ACAD SCI USA, V99, P11878, DOI 10.1073/pnas.182552499; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; NUCIFORA G, 1993, BLOOD, V81, P883; Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Ponnio T, 2002, MOL CELL BIOL, V22, P935, DOI 10.1128/MCB.22.3.935-945.2002; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	30	229	238	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					730	735		10.1038/nm1579	http://dx.doi.org/10.1038/nm1579			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17515897				2022-12-25	WOS:000247084300037
J	Radhika, V; Proikas-Cezanne, T; Jayaraman, M; Onesime, D; Ha, JH; Dhanasekaran, DN				Radhika, Venkat; Proikas-Cezanne, Tassula; Jayaraman, Muralidharan; Onesime, Djamila; Ha, Ji Hee; Dhanasekaran, Danny N.			Chemical sensing of DNT by engineered olfactory yeast strain	NATURE CHEMICAL BIOLOGY			English	Article							ADULT-RAT BRAIN; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; RECEPTORS; ODORANT; IDENTIFICATION; LOCALIZATION; SUBUNIT	With the increasing threat of environmental toxicants including biological and chemical warfare agents, fabricating innovative biomimetic systems to detect these harmful agents is critically important. With the broad objective of developing such a biosensor, here we report the construction of a Saccharomyces cerevisiae strain containing the primary components of the mammalian olfactory signaling pathway. In this engineered yeast strain, WIF-1 alpha, olfactory receptor signaling is coupled to green fluorescent protein expression. Using this 'olfactory yeast', we screened for olfactory receptors that could report the presence of the odorant 2,4-dinitrotoluene, an explosive residue mimic. With this approach, we have identified the novel rat olfactory receptor Olfr226, which is closely related to the mouse olfactory receptors Olfr2 and MOR226-1, as a 2,4-dinitrotoluene-responsive receptor.	Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Dhanasekaran, DN (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St, Philadelphia, PA 19140 USA.	danny.dhanasekaran@temple.edu	Jayaraman, Muralidharan/H-8563-2019	Jayaraman, Muralidharan/0000-0003-3274-877X; HA, Ji Hee/0000-0002-6281-1904; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X				Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JOHNSON GL, 1989, ENDOCR REV, V10, P317, DOI 10.1210/edrv-10-3-317; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; LALLI E, 1994, J BIOL CHEM, V269, P17359; Liang JJ, 1998, J NEUROCHEM, V71, P345; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Miret JJ, 2002, J BIOL CHEM, V277, P6881, DOI 10.1074/jbc.M107384200; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Radhika V, 2005, BIOTECHNOL BIOENG, V90, P29, DOI 10.1002/bit.20344; RUSSELL M, 1993, MOL BIOL CELL, V4, P757, DOI 10.1091/mbc.4.7.757; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	30	101	110	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2007	3	6					325	330		10.1038/nchembio882	http://dx.doi.org/10.1038/nchembio882			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172PN	17486045				2022-12-25	WOS:000246816400011
J	Valadi, H; Ekstrom, K; Bossios, A; Sjostrand, M; Lee, JJ; Lotvall, JO				Valadi, Hadi; Ekstrom, Karin; Bossios, Apostolos; Sjostrand, Margareta; Lee, James J.; Lotvall, Jan O.			Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells	NATURE CELL BIOLOGY			English	Article							MAST-CELL; PROTEOMIC ANALYSIS; DENDRITIC CELLS; ANIMAL DEVELOPMENT; MICROVESICLES; VESICLES; ACCUMULATION; ACTIVATION; COMPLEX; SURFACE	Exosomes are vesicles of endocytic origin released by many cells. These vesicles can mediate communication between cells, facilitating processes such as antigen presentation. Here, we show that exosomes from a mouse and a human mast cell line (MC/9 and HMC-1, respectively), as well as primary bone marrow-derived mouse mast cells, contain RNA. Microarray assessments revealed the presence of mRNA from approximately 1300 genes, many of which are not present in the cytoplasm of the donor cell. In vitro translation proved that the exosome mRNAs were functional. Quality control RNA analysis of total RNA derived from exosomes also revealed presence of small RNAs, including microRNAs. The RNA from mast cell exosomes is transferable to other mouse and human mast cells. After transfer of mouse exosomal RNA to human mast cells, new mouse proteins were found in the recipient cells, indicating that transferred exosomal mRNA can be translated after entering another cell. In summary, we show that exosomes contain both mRNA and microRNA, which can be delivered to another cell, and can be functional in this new location. We propose that this RNA is called "exosomal shuttle RNA" (esRNA).	Univ Gothenburg, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden; Univ Gothenburg, Dept Resp Med & Allergol, Sahlgrenska Acad, Gothenburg, Sweden; Mayo Clin, Scottsdale, AZ 85259 USA	University of Gothenburg; University of Gothenburg; Mayo Clinic; Mayo Clinic Phoenix	Lotvall, JO (corresponding author), Univ Gothenburg, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden.	jan.lotvall@gu.se	Bossios, Apostolos/A-1720-2008; Bossios, Apostolos/ABH-8262-2020; Ekström, Karin/M-7501-2013; Valadi, Hadi/ABH-9766-2020	Bossios, Apostolos/0000-0002-0494-2690; Ekström, Karin/0000-0001-7808-4572; Valadi, Hadi/0000-0003-3482-2451; Lotvall, Jan/0000-0001-9195-9249				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bess JW, 1997, VIROLOGY, V230, P134, DOI 10.1006/viro.1997.8499; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; RAZIN E, 1984, J IMMUNOL, V132, P1479; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	28	8330	8808	71	1806	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					654	U72		10.1038/ncb1596	http://dx.doi.org/10.1038/ncb1596			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486113				2022-12-25	WOS:000246922700010
J	Lim, CJ; Han, J; Yousefi, N; Ma, YL; Amieux, PS; McKnight, GS; Taylor, SS; Ginsberg, MH				Lim, Chinten James; Han, Jaewon; Yousefi, Nima; Ma, Yuliang; Amieux, Paul S.; McKnight, G. Stanley; Taylor, Susan S.; Ginsberg, Mark H.			alpha 4 integrins are Type I cAMP-dependent protein kinase-anchoring proteins	NATURE CELL BIOLOGY			English	Article							REGULATORY SUBUNIT; RI-ALPHA; ACTIVATION; BINDING; PAXILLIN; PHOSPHORYLATION; CONSEQUENCES; MUTATIONS; STABILITY; COMPLEX	A-kinase anchoring proteins (AKAPs) control the localization and substrate specificity of cAMP-dependent protein kinase (PKA), tetramers of regulatory (PKA-R) and catalytic (PKA-C) subunits, by binding to PKA-R subunits(1). Most mammalian AKAPs bind Type II PKA through PKA-RII (ref. 2), whereas dual specificity AKAPs bind both PKA-RI and PKA-RII (ref. 3). Inhibition of PKA-AKAP interactions modulates PKA signalling(2). Localized PKA activation in pseudopodia of migrating cells(4) phosphorylates alpha 4 integrins to provide spatial cues governing cell motility(5). Here, we report that the alpha 4 cytoplasmic domain is a Type I PKA-specific AKAP that is distinct from canonical AKAPs in two ways: the a4 interaction requires the PKA holoenzyme, and is insensitive to amphipathic peptides that disrupt most PKA-AKAP interactions. We exploited type-specific PKA anchoring peptides to create genetically encoded baits that sequester specific PKA isoforms to the mitochondria and found that mislocalization of Type I, but not Type II, PKA disrupts alpha 4 phosphorylation and markedly inhibits the velocity and directional persistence of cell migration.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Lim, Chinten James/G-3777-2013; Amieux, Paul/AAG-4102-2021	Lim, Chinten James/0000-0001-6381-7585; 				Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Carlson CR, 2003, J MOL BIOL, V327, P609, DOI 10.1016/S0022-2836(03)00093-7; CARR DW, 1991, J BIOL CHEM, V266, P14188; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; MANDEVILLE JTH, 1995, BIOPHYS J, V68, P1207, DOI 10.1016/S0006-3495(95)80336-X; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	29	69	70	6	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					415	U96		10.1038/ncb1561	http://dx.doi.org/10.1038/ncb1561			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369818				2022-12-25	WOS:000245359400012
J	Venkatraman, P; Nguyen, TT; Sainlos, M; Bilsel, O; Chitta, S; Imperiali, B; Stern, LJ				Venkatraman, Prasanna; Nguyen, Tina T.; Sainlos, Matthieu; Bilsel, Osman; Chitta, Sriram; Imperiali, Barbara; Stern, Lawrence J.			Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cells	NATURE CHEMICAL BIOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FLUORESCENT AMINO-ACID; HIGH-AFFINITY BINDING; DENDRITIC CELLS; INFLAMMATORY STIMULI; ANTIGEN PRESENTATION; IN-VIVO; HLA-DR; HLA-DR1; 6-N,N-DIMETHYLAMINO-2,3-NAPHTHALIMIDE	A crucial step in the immune response is the binding of antigenic peptides to major histocompatibility complex (MHC) proteins. Class II MHC proteins present their bound peptides to CD4(+) T cells, thereby helping to activate both the humoral and the cellular arms of the adaptive immune response. Peptide loading onto class II MHC proteins is regulated temporally, spatially and developmentally in antigen-presenting cells(1). To help visualize these processes, we have developed a series of novel fluorogenic probes that incorporate the environment-sensitive amino acid analogs 6-N, N-dimethylamino-2-3- naphthalimidoalanine and 4-N, N-dimethylaminophthalimidoalanine. Upon binding to class II MHC proteins these fluorophores show large changes in emission spectra, quantum yield and fluorescence lifetime. Peptides incorporating these fluorophores bind specifically to class II MHC proteins on antigen-presenting cells and can be used to follow peptide binding in vivo. Using these probes we have tracked a developmentally regulated cell-surface peptide-binding activity in primary human monocyte-derived dendritic cells.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Imperiali, B (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	imper@mit.edu; lawrence.stern@umassmed.edu	Sainlos, Matthieu/H-4253-2013	Sainlos, Matthieu/0000-0001-5465-5641; Bilsel, Osman/0000-0003-0414-3060; Imperiali, Barbara/0000-0002-5749-7869	NIAID NIH HHS [R01 AI048833-11, R37 AI038996, R37 AI038996-11A1, AI38996, R56 AI038996, R01 AI048833, R01 AI038996] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048833, R56AI038996, R01AI038996, R37AI038996] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTI S, 1987, CYTOMETRY, V8, P114, DOI 10.1002/cyto.990080203; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chen HR, 2005, BIOPOLYMERS, V80, P325, DOI 10.1002/bip.20200; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Colledge L, 2002, EUR J IMMUNOL, V32, P3246, DOI 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Nitz M, 2002, CHEM COMMUN, P1912, DOI 10.1039/b205224e; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Saroja G, 1998, J FLUORESC, V8, P405, DOI 10.1023/A:1020536918438; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Vazquez ME, 2006, J MED CHEM, V49, P3653, DOI 10.1021/jm060343t; Vazquez ME, 2005, J AM CHEM SOC, V127, P1300, DOI 10.1021/ja0449168; Vazquez ME, 2004, ORG BIOMOL CHEM, V2, P1965, DOI 10.1039/b408001g; Vazquez ME, 2003, J AM CHEM SOC, V125, P10150, DOI 10.1021/ja0351847; Veeraswamy RK, 2003, J IMMUNOL, V170, P5367, DOI 10.4049/jimmunol.170.11.5367; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729	30	80	84	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2007	3	4					222	228		10.1038/nchembio868	http://dx.doi.org/10.1038/nchembio868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148UW	17351628	Green Accepted			2022-12-25	WOS:000245103000012
J	Dong, PDS; Munson, CA; Norton, W; Crosnier, C; Pan, XF; Gong, ZY; Neumann, CJ; Stainier, DYR				Dong, P. Duc Si; Munson, Chantilly A.; Norton, William; Crosnier, Cecile; Pan, Xiufang; Gong, Zhiyuan; Neumann, Carl J.; Stainier, Didier Y. R.			Fgf10 regulates hepatopancreatic ductal system patterning and differentiation	NATURE GENETICS			English	Article							TRANSGENIC ZEBRAFISH; PANCREAS DEVELOPMENT; DIGESTIVE-SYSTEM; ENDOCRINE-CELLS; MORPHOGENESIS; EPITHELIUM; MAINTAINS; EXOCRINE; REQUIRES; GROWTH	During organogenesis, the foregut endoderm gives rise to the many different cell types that comprise the hepatopancreatic system, including hepatic, pancreatic and gallbladder cells, as well as the epithelial cells of the hepatopancreatic ductal system that connects these organs together and with the intestine. However, the mechanisms responsible for demarcating ducts versus organs are poorly understood. Here, we show that Fgf10 signaling from the adjacent mesenchyme is responsible for refining the boundaries between the hepatopancreatic duct and organs. In zebrafish fgf10 mutants, the hepatopancreatic ductal epithelium is severely dysmorphic, and cells of the hepatopancreatic ductal system and adjacent intestine misdifferentiate toward hepatic and pancreatic fates. Furthermore, Fgf10 also functions to prevent the differentiation of the proximal pancreas and liver into hepatic and pancreatic cells, respectively. These data shed light onto how the multipotent cells of the foregut endoderm, and subsequently those of the hepatopancreatic duct, are directed toward different organ fates.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94158 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94158 USA; European Mol Biol Lab, Dev Biol Program, D-60117 Heidelberg, Germany; Canc Res UK, Vertebrate Dev Lab, London WC2A 3PX, England; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pulm Biol, Cincinnati, OH 45229 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; European Molecular Biology Laboratory (EMBL); Cancer Research UK; National University of Singapore; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	didier_stainier@biochem.ucsf.edu	Gong, Zhiyuan/H-8794-2012; Norton, William/E-9924-2012	Gong, Zhiyuan/0000-0002-9660-5260; Stainier, Didier/0000-0002-0382-0026; Norton, William/0000-0002-3244-0145				Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Li JX, 2000, GENE DEV, V14, P464; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Pulkkinen MA, 2003, MECH DEVELOP, V120, P167, DOI 10.1016/S0925-4773(02)00440-9; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021	21	146	152	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					397	402		10.1038/ng1961	http://dx.doi.org/10.1038/ng1961			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259985				2022-12-25	WOS:000244480000024
J	Okada, Y; Ueshin, Y; Isotani, A; Saito-Fujita, T; Nakashima, H; Kimura, K; Mizoguchi, A; Oh-hora, M; Mori, Y; Ogata, M; Oshima, RG; Okabe, M; Ikawa, M				Okada, Yuka; Ueshin, Yuko; Isotani, Ayako; Saito-Fujita, Tomoko; Nakashima, Hisako; Kimura, Kazushi; Mizoguchi, Akira; Oh-hora, Masatsugu; Mori, Yoshiko; Ogata, Masato; Oshima, Robert G.; Okabe, Masaru; Ikawa, Masahito			Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer	NATURE BIOTECHNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; PREIMPLANTATION EMBRYOS; EXPRESSION; VECTORS; P38-ALPHA; MICE; BLASTOCYSTS; CELLS; ERK2	Placental dysfunction underlies many complications during pregnancy, and better understanding of gene function during placentation could have considerable clinical relevance. However, the lack of a facile method for placenta-specific gene manipulation has hampered investigation of placental organogenesis and the treatment of placental dysfunction. We showed previously that transduction of fertilized mouse eggs with lentiviral vectors leads to transgene expression in both ;the fetus and the placenta(1,2). Here we report placenta-specific gene incorporation by lentiviral transduction of mouse blastocysts after removal of the zona pellucida. All of the placentas analyzed, but none of the fetuses, were transgenic. Application of this method substantially rescued mice deficient in Ets2, Mapk14 ( also known as p38 alpha) and Mapk1 ( also known as Erk2) from embryonic lethality caused by placental defects. Ectopic expression of Mapk11 also complemented Mapk14 deficiency during placentation.	Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Mie Univ, Sch Med, Tsu, Mie 5148507, Japan; Burnham Inst Med Res, La Jolla, CA 92037 USA	Osaka University; Osaka University; Mie University; Sanford Burnham Prebys Medical Discovery Institute	Ikawa, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ikawa@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Kimura, Kazushi/ABB-4007-2020; morioka, yuka/A-9926-2009; Isotani, Ayako/A-9929-2009; Isotani, Ayako/D-4564-2017; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Isotani, Ayako/0000-0002-4720-2318; Isotani, Ayako/0000-0002-4720-2318; Okabe, Masaru/0000-0002-0803-9044				Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Cros C, 2005, NEW ENGL REV-MIDDLEB, V26, P9; Curnow EC, 2000, MOL REPROD DEV, V56, P372, DOI 10.1002/1098-2795(200007)56:3&lt;372::AID-MRD7&gt;3.0.CO;2-W; Federspiel MJ, 1996, P NATL ACAD SCI USA, V93, P4931, DOI 10.1073/pnas.93.10.4931; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nagy A, 2003, MANIPULATING MOUSE E, P453; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Prochazka R, 2004, THERIOGENOLOGY, V62, P155, DOI 10.1016/j.theriogenology.2003.08.017; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rygaard K, 1998, HUM GENET, V102, P87, DOI 10.1007/s004390050658; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Senut MC, 1998, J CLIN INVEST, V101, P1565, DOI 10.1172/JCI1959; SHOZU M, 1992, FERTIL STERIL, V58, P1084; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	30	87	90	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2007	25	2					233	237		10.1038/nbt1280	http://dx.doi.org/10.1038/nbt1280			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	134DV	17220877				2022-12-25	WOS:000244064000029
J	Reid, S; Schindler, D; Hanenberg, H; Barker, K; Hanks, S; Kalb, R; Neveling, K; Kelly, P; Seal, S; Freund, M; Wurm, M; Batish, SD; Lach, FP; Yetgin, S; Neitzel, H; Ariffin, H; Tischkowitz, M; Mathew, CG; D Auerbach, A; Rahman, N				Reid, Sarah; Schindler, Detlev; Hanenberg, Helmut; Barker, Karen; Hanks, Sandra; Kalb, Reinhard; Neveling, Kornelia; Kelly, Patrick; Seal, Sheila; Freund, Marcel; Wurm, Melanie; Batish, Sat Dev; Lach, Francis P.; Yetgin, Sevgi; Neitzel, Heidemarie; Ariffin, Hany; Tischkowitz, Marc; Mathew, Christopher G.; D Auerbach, Arleen; Rahman, Nazneen			Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer	NATURE GENETICS			English	Article							SHARED GENETIC SUSCEPTIBILITY; COMPLEMENTATION GROUPS; BREAST-CANCER; BRCA2; TUMORS	PALB2 was recently identified as a nuclear binding partner of BRCA2. Biallelic BRCA2 mutations cause Fanconi anemia subtype FA- D1 and predispose to childhood malignancies. We identified pathogenic mutations in PALB2 ( also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N, and, similar to biallelic BRCA2 mutations, confer a high risk of childhood cancer.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Hacettepe Univ, Div Pediat Hematol, Ihsan Dooramacy Children Hosp, TR-06100 Ankara, Turkey; Charite Univ Med Berlin, Dept Human Genet, D-13353 Berlin, Germany; Univ Malaya, Med Ctr, Paediat Haematol Oncol Unit, Kuala Lumpur, Malaysia; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England	University of London; Institute of Cancer Research - UK; University of Wurzburg; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University-Purdue University Indianapolis; Rockefeller University; Cornell University; Hacettepe University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universiti Malaya; McGill University; McGill University; McGill University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Tischkowitz, Marc/O-4452-2018; ARIFFIN, HANY/B-8590-2010; Mathew, Christopher G/G-3434-2015; Rahman, Nazneen/B-8890-2012; Kalb, Reinhard/AAR-3249-2021; Rahman, Nazneen/D-2802-2013	Tischkowitz, Marc/0000-0002-7880-0628; ARIFFIN, HANY/0000-0002-4607-8837; Mathew, Christopher G/0000-0003-4178-1838; Kalb, Reinhard/0000-0003-3906-6907; Rahman, Nazneen/0000-0003-4376-0440; Auerbach, Arleen/0000-0002-6911-8379; Lach, Francis/0000-0003-3708-7122	NCI NIH HHS [R01CA82678] Funding Source: Medline; NHLBI NIH HHS [R37HL32987] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2003:592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; DECHADAREVIAN JP, 1985, ARCH PATHOL LAB MED, V109, P367; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V594, P39, DOI 10.1016/j.mrfmmm.2005.07.008; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	449	460	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					162	164		10.1038/ng1947	http://dx.doi.org/10.1038/ng1947			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200671				2022-12-25	WOS:000244063900012
J	Bostrom, P; Andersson, L; Rutberg, M; Perman, J; Lidberg, U; Johansson, BR; Fernandez-Rodriguez, J; Ericson, J; Nilsson, T; Boren, J; Olofsson, SO				Bostrom, Pontus; Andersson, Linda; Rutberg, Mikael; Perman, Jeanna; Lidberg, Ulf; Johansson, Bengt R.; Fernandez-Rodriguez, Julia; Ericson, Johanna; Nilsson, Tommy; Boren, Jan; Olofsson, Sven-Olof			SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity	NATURE CELL BIOLOGY			English	Article							MEMBRANE-FUSION; CELL-LINE; MECHANISMS; TRANSPORT; HL-1; PLD1	The accumulation of cytosolic lipid droplets in muscle and liver cells has been linked to the development of insulin resistance and type 2 diabetes(1). such droplets are formed as small structures(2) that increase in size through fusion(3), a process that is dependent on intact microtubules and the motor protein dynein(3,4). Approximately 15% of all droplets are involved in fusion processes at a given time(3). Here, we show that lipid droplets are associated with proteins involved in fusion processes in the cell: NSF (N-ethylmaleimide-sensitive-factor), alpha-SNAP ( soluble NSF attachment protein) and the SNAREs (SNAP receptors), SNAP23 (synaptosomal-associated protein of 23 kDa), syntaxin-5 and VAMP4 ( vesicle-associated membrane protein 4). Knockdown of the genes for SNAP23, syntaxin-5 or VAMP4, or microinjection of a dominant-negative mutant of alpha-SNAP, decreases the rate of fusion and the size of the lipid droplets. thus, the SNARE system seems to have an important role in lipid droplet fusion. We also show that oleic acid treatment decreases the insulin sensitivity of heart muscle cells, and this sensitivity is completely restored by transfection with SNAP23. thus, SNAP23 might be a link between insulin sensitivity and the inflow of fatty acids to the cell.	Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, SE-41345 Gothenburg, Sweden; Univ Gothenburg, Dept Biomed, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Olofsson, SO (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, SE-41345 Gothenburg, Sweden.	Sven-Olof.Olofsson@wlab.gu.se	Adiels, Martin/C-9278-2011	Fernandez-Rodriguez, Julia/0000-0003-4522-0966; Andersson, Linda/0000-0003-3230-5397				Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Asp L, 2005, ARTERIOSCL THROM VAS, V25, P566, DOI 10.1161/01.ATV.0000154135.21689.47; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; FOSTER J, 1999, AM J PHYSIOL, V276, pC1108; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Short B, 2004, CURR BIOL, V14, pR187, DOI 10.1016/j.cub.2004.02.017; Shuralyova I, 2004, AM J PHYSIOL-HEART C, V286, pH627, DOI 10.1152/ajpheart.00639.2003; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y	30	263	264	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1286	U139		10.1038/ncb1648	http://dx.doi.org/10.1038/ncb1648			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17922004				2022-12-25	WOS:000250659600014
J	Jiang, JY; He, XF; Cane, DE				Jiang, Jiaoyang; He, Xiaofei; Cane, David E.			Biosynthesis of the earthy odorant geosmin by a bifunctional Streptomyces coelicolor enzyme	NATURE CHEMICAL BIOLOGY			English	Article							SITE-DIRECTED MUTAGENESIS; ENT-KAURENE SYNTHASE; TRICHODIENE SYNTHASE; MECHANISTIC ANALYSIS; FUNCTIONAL-ANALYSIS; VOLATILES; CYCLASE; METHYLISOBORNEOL; AVERMITILIS; EXPRESSION	Geosmin (1) is responsible for the characteristic odor of moist soil, as well as off-flavors in drinking water and foodstuffs(1),(2).Geosmin is generated from farnesyl diphosphate (FPP, 2) by an enzyme that is encoded by the SCO6073 gene in the soil organism Streptomyces coelicolor A3 (2) (ref. 3). We have now shown that the recombinant N-terminal half of this protein catalyzes the Mg2+- dependent cyclization of FPP to germacradienol (3) and germacrene D (4), while the highly homologous C-terminal domain, previously thought to be catalytically silent, catalyzes the Mg2+ -dependent conversion of germacradienol to geosmin. Site-directed mutagenesis confirmed that the N- and C-terminal domains each harbor a distinct, independently functioning active site. A mutation in the N- terminal domain of germacradienol-geosmin synthase of a catalytically essential serine to alanine results in the conversion of FPP to a mixture of sesquiterpenes that includes an aberrant product identified as isolepidozene (6), which was previously suggested to be an enzyme-bound intermediate in the cyclization of FPP to germacradienol.	Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Cane, DE (corresponding author), Brown Univ, Dept Chem, Box H, Providence, RI 02912 USA.	david_cane@brown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030301, R01GM030301] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030301, R01 GM030301-28, R01 GM030301-27, R01 GM030301, R01 GM030301-26, GM30301] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENTLEY R, 1981, FEBS LETT, V125, P220, DOI 10.1016/0014-5793(81)80723-5; Berthelot M., 1891, CR HEBD ACAD SCI, V112, P598; BUTTERY RG, 1976, J AGR FOOD CHEM, V24, P1246, DOI 10.1021/jf60208a041; Cane DE, 2006, J ANTIBIOT, V59, P471, DOI 10.1038/ja.2006.66; Cane DE, 2003, P NATL ACAD SCI USA, V100, P1547, DOI 10.1073/pnas.0337625100; Cane DE, 1997, BIOCHEMISTRY-US, V36, P8332, DOI 10.1021/bi963018o; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Dickschat JS, 2005, CHEMBIOCHEM, V6, P2023, DOI 10.1002/cbic.200500174; Dickschat JS, 2005, J ORG CHEM, V70, P5174, DOI 10.1021/jo050449g; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Feil C, 1996, EUR J BIOCHEM, V242, P51, DOI 10.1111/j.1432-1033.1996.0051r.x; Felicetti B, 2004, J AM CHEM SOC, V126, P7212, DOI 10.1021/ja0499593; GERBER NN, 1979, CRC CR REV MICROBIOL, V7, P191, DOI 10.3109/10408417909082014; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Gerber NN, 1968, TETRAHEDRON LETT, V25, P2971; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HARDT IH, 1995, PHYTOCHEMISTRY, V40, P605, DOI 10.1016/0031-9422(95)00324-Z; He XF, 2004, J AM CHEM SOC, V126, P2678, DOI 10.1021/ja039929k; HEIL TP, 1988, J ENVIRON SCI HEAL B, V23, P489, DOI 10.1080/03601238809372621; Jiang JY, 2006, J AM CHEM SOC, V128, P8128, DOI 10.1021/ja062669x; Kawaide H, 2000, J BIOL CHEM, V275, P2276, DOI 10.1074/jbc.275.4.2276; La Guerche S, 2005, ANTON LEEUW INT J G, V88, P131, DOI 10.1007/s10482-005-3872-4; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295, DOI 10.1128/AEM.62.4.1295-1299.1996; Rynkiewicz MJ, 2002, BIOCHEMISTRY-US, V41, P1732, DOI 10.1021/bi011960g; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Spiteller D, 2002, PHYTOCHEMISTRY, V61, P827, DOI 10.1016/S0031-9422(02)00282-0; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Tetzlaff CN, 2006, BIOCHEMISTRY-US, V45, P6179, DOI 10.1021/bi060419n; Toyomasu T, 2000, BIOSCI BIOTECH BIOCH, V64, P660, DOI 10.1271/bbb.64.660	30	161	168	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					711	715		10.1038/nchembio.2007.29	http://dx.doi.org/10.1038/nchembio.2007.29			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17873868	Green Accepted			2022-12-25	WOS:000250311500012
J	Reis, A; Madgwick, S; Chang, HY; Nabti, I; Levasseur, M; Jones, KT				Reis, Alexandra; Madgwick, Suzanne; Chang, Heng-Yu; Nabti, Ibtissem; Levasseur, Mark; Jones, Keith T.			Prometaphase APC(cdh1) activity prevents non-disjunction in mammalian oocytes	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; 1ST MEIOTIC DIVISION; METAPHASE-I ARREST; MOUSE OOCYTES; MEIOSIS-I; SPINDLE CHECKPOINT; XENOPUS-OOCYTES; CYCLIN-B; DEGRADATION; SECURIN	The first female meiotic division ( meiosis I, MI) is uniquely prone to chromosome segregation errors through nondisjunction, resulting in trisomies and early pregnancy loss(1). Here, we show a fundamental difference in the control of mammalian meiosis that may underlie such susceptibility. It involves a reversal in the well-established timing of activation of the anaphase-promoting complex (APC) (2,3) by its co-activators cdc20 and cdh1. APC(cdh1) was active first, during prometaphase I, and was needed in order to allow homologue congression, as loss of cdh1 speeded up MI, leading to premature chromosome segregation and a non-disjunction phenotype. APCcdh1 targeted cdc20 for degradation, but did not target securin or cyclin B1. These were degraded later in MI through APC(cdc20), making cdc20 re-synthesis essential for successful meiotic progression. The switch from APCcdh1 to APCcdc20 activity was controlled by increasing CDK1 and cdh1 loss. These findings demonstrate a fundamentally different mechanism of control for the first meiotic division in mammalian oocytes that is not observed in meioses of other species.	Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Jones, KT (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	k.t.jones@ncl.ac.uk	Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851	Wellcome Trust [075744] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HAMPL A, 1995, DEVELOPMENT, V121, P925; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	31	80	82	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1192	1198		10.1038/ncb1640	http://dx.doi.org/10.1038/ncb1640			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891138	Green Accepted			2022-12-25	WOS:000249882300015
J	Soucek, L; Lawlor, ER; Soto, D; Shchors, K; Swigart, LB; Evan, GI				Soucek, Laura; Lawlor, Elizabeth R.; Soto, Darya; Shchors, Ksenya; Swigart, Lamorna Brown; Evan, Gerard I.			Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors	NATURE MEDICINE			English	Article							GASTROINTESTINAL STROMAL TUMORS; C-KIT CD117; BETA-CELLS; IN-VIVO; GENE-EXPRESSION; CANCER; INFLAMMATION; MICE; ACTIVATION; INDUCTION	An association between inflammation and cancer has long been recognized, but the cause and effect relationship linking the two remains unclear. Myc is a pleiotropic transcription factor that is overexpressed in many human cancers and instructs many extracellular aspects of the tumor tissue phenotype, including remodeling of tumor stroma and angiogenesis. Here we show in a beta-cell tumor model that activation of Myc in vivo triggers rapid recruitment of mast cells to the tumor site - a recruitment that is absolutely required for macroscopic tumor expansion. In addition, treatment of established beta-cell tumors with a mast cell inhibitor rapidly triggers hypoxia and cell death of tumor and endothelial cells. Inhibitors of mast cell function may therefore prove therapeutically useful in restraining expansion and survival of pancreatic and other cancers.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu	Soucek, Laura/AAG-7393-2019; Soucek, Laura/AAG-8377-2019	Soucek, Laura/0000-0002-4750-7971; 	NCI NIH HHS [F32 CA106039, CA098018] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098018, F32CA106039] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amann B, 1998, BRIT J UROL, V82, P118; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Belo AV, 2005, MICROCIRCULATION, V12, P597, DOI 10.1080/10739680500253535; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Escribano L, 1998, LEUKEMIA LYMPHOMA, V30, P459, DOI 10.3109/10428199809057558; Fischer M, 2003, INT J CANCER, V107, P197, DOI 10.1002/ijc.11370; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Kanbe N, 1999, EUR J IMMUNOL, V29, P2645; Kaneto H, 2002, J BIOL CHEM, V277, P12998, DOI 10.1074/jbc.M111148200; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; NAGLE DL, 1995, HUM MOL GENET, V4, P2073, DOI 10.1093/hmg/4.11.2073; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Robinson SC, 2005, ADV CANCER RES, V93, P159, DOI 10.1016/S0065-230X(05)93005-4; Rubin BP, 2001, CANCER RES, V61, P8118; Sawatsubashi M, 2000, VIRCHOWS ARCH, V436, P243, DOI 10.1007/s004280050037; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Sperling C, 1997, HAEMATOLOGICA, V82, P617; THOMPSON PJ, 1983, LANCET, V2, P848; Toth T, 2000, MODERN PATHOL, V13, P1020, DOI 10.1038/modpathol.3880184; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zhang R, 1997, ONCOGENE, V14, P1607, DOI 10.1038/sj.onc.1200957	41	375	392	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2007	13	10					1211	1218		10.1038/nm1649	http://dx.doi.org/10.1038/nm1649			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17906636				2022-12-25	WOS:000249980200037
J	Zaidel-Bar, R; Itzkovitz, S; Ma'ayan, A; Iyengar, R; Geiger, B				Zaidel-Bar, Ronen; Itzkovitz, Shalev; Ma'ayan, Avi; Iyengar, Ravi; Geiger, Benjamin			Functional atlas of the integrin adhesome	NATURE CELL BIOLOGY			English	Article							EXTRACELLULAR-MATRIX; INTERACTION NETWORK; CELL; ADHESIONS; DATABASE; MODELS; MOTIFS		Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai	Zaidel-Bar, R (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017; Zaidel-Bar, Ronen/0000-0002-1374-5007	NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, U54GM064346, P50GM071558] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY016586, PN2 EY016586-05] Funding Source: Medline; NIGMS NIH HHS [U54 GM64346, P50 GM071558-01A20007, P50 GM071558-030007, P50 GM071558-020007, GM-54508, U54 GM064346, P50 GM071558, R01 GM054508, R01 GM054508-20] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Caldarelli G, 2004, EUR PHYS J B, V38, P183, DOI 10.1140/epjb/e2004-00020-6; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; GOUGH NR, 2002, SCI STKE, V135, pEG8; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; Iragne F, 2005, BIOINFORMATICS, V21, P272, DOI 10.1093/bioinformatics/bth494; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	38	813	825	2	100	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					858	868		10.1038/ncb0807-858	http://dx.doi.org/10.1038/ncb0807-858			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17671451	Green Accepted			2022-12-25	WOS:000248486700003
J	Kim, DY; Carey, BW; Wang, HB; Ingano, LAM; Binshtok, AM; Wertz, MH; Pettingell, WH; He, P; Lee, VMY; Woolf, CJ; Kovacs, DM				Kim, Doo Yeon; Carey, Bryce W.; Wang, Haibin; Ingano, Laura A. M.; Binshtok, Alexander M.; Wertz, Mary H.; Pettingell, Warren H.; He, Ping; Lee, Virginia M. -Y.; Woolf, Clifford J.; Kovacs, Dora M.			BACE1 regulates voltage-gated sodium channels and neuronal activity	NATURE CELL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; ALZHEIMERS-DISEASE; ALPHA-SUBUNIT; CELL-ADHESION; MOLECULAR-MECHANISMS; MESSENGER-RNAS; RAT-BRAIN; IN-VIVO; SEIZURES	BACE1 activity is significantly increased in the brains of Alzheimer's disease patients, potentially contributing to neurodegeneration. The voltage-gated sodium channel ( Na(v)1) beta 2-subunit (beta 2), a type I membrane protein that covalently binds to Nav1 alpha-subunits, is a substrate for BACE1 and gamma-secretase. Here, we find that BACE1-gamma-secretase cleavages release the intracellular domain of beta 2, which increases mRNA and protein levels of the pore-forming Na v 1.1 a-subunit in neuroblastoma cells. Similarly, endogenous beta 2 processing and Na(v) 1.1 protein levels are elevated in brains of BACE1-transgenic mice and Alzheimer's disease patients with high BACE1 levels. However, Na(v) 1.1 is retained inside the cells and cell surface expression of the Na(v) 1 alpha-subunits and sodium current densities are markedly reduced in both neuroblastoma cells and adult hippocampal neurons from BACE1-transgenic mice. BACE1, by cleaving beta 2, thus regulates Na(v)1 alpha-subunit levels and controls cell-surface sodium current densities. BACE1 inhibitors may normalize membrane excitability in Alzheimer's disease patients with elevated BACE1 activity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat Dis,Neurobiol Dis Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Anaesthesia & Crit Care, Neural Plastic Res Grp, Boston, MA 02129 USA; Sun Hlth Res Inst, Haldeman Lab Mol & Cellular Neurobiol, Sun City, AZ 85351 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Pennsylvania; Pennsylvania Medicine	Kovacs, DM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat Dis,Neurobiol Dis Lab, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Binshtok, Alexander/0000-0002-3620-8116	NIA NIH HHS [P01 AG015379, P01 AG015379-100006, R01 AG014713, R01 AG014713-11] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG014713] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; DibHajj SD, 1996, FEBS LETT, V384, P78, DOI 10.1016/0014-5793(96)00273-6; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 1999, J COMP NEUROL, V412, P342; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhou JS, 2000, CIRC RES, V87, P33, DOI 10.1161/01.RES.87.1.33; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703	44	236	253	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					755	U43		10.1038/ncb1602	http://dx.doi.org/10.1038/ncb1602			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17576410	Green Accepted			2022-12-25	WOS:000247760700011
J	McHughen, A				McHughen, Alan			Fatal flaws in agbiotech regulatory policies	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	McHughen, A (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	alanmc@ucr.edu	McHughen, Alan/AAM-9215-2021; McHughen, Alan/HII-3301-2022					Friebe B, 1999, CROP SCI, V39, P1692, DOI 10.2135/cropsci1999.3961692x; Kessler C, 2001, EC SPONSORED RES SAF; *NAT RES COUNC, 2002, ENV EFF TRANSG PLANT; *NAT RES COUNC, 2004, SAF GEN ENG FOODS; National Research Council, 1987, INTR REC DNA ENG ORG; Organisation for Economic Cooperation and Development (OECD), 1986, REC DNA SAF CONS SAF; ZITNAK A, 1970, AM POTATO J, V47, P256, DOI 10.1007/BF02864825	7	21	22	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					725	727		10.1038/nbt0707-725	http://dx.doi.org/10.1038/nbt0707-725			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17621292				2022-12-25	WOS:000247994000016
J	Xiang, YY; Wang, SH; Liu, MY; Hirota, JA; Li, JX; Ju, W; Fan, YJ; Kelly, MM; Ye, B; Orser, B; O'Byrne, PM; Inman, MD; Yang, X; Lu, WY				Xiang, Yun-Yan; Wang, Shuhe; Liu, Mingyao; Hirota, Jeremy A.; Li, Jingxin; Ju, William; Fan, Yijun; Kelly, Margaret M.; Ye, Bin; Orser, Beverley; O'Byrne, Paul M.; Inman, Mark D.; Yang, Xi; Lu, Wei-Yang			A GABAergic system in airway epithelium is essential for mucus overproduction in asthma	NATURE MEDICINE			English	Article							HIPPOCAMPAL-NEURONS; GOBLET CELL; MOUSE MODEL; RECEPTOR; EXPRESSION; INFLAMMATION; INHIBITION; RESPONSES; GROWTH; MICE	gamma-aminobutyric acid (GABA) is an important neurotransmitter that, through the subtype A GABA receptor (GABA(A)R), induces inhibition in the adult brain. Here we show that an excitatory, rather than inhibitory, GABAergic system exists in airway epithelial cells. Both GABA(A)Rs and the GABA synthetic enzyme glutamic acid decarboxylase (GAD) are expressed in pulmonary epithelial cells. Activation of GABA(A)Rs depolarized these cells. The expression of GAD in the cytosol and GABA(A)Rs in the apical membranes of airway epithelial cells increased markedly when mice were sensitized and then challenged with ovalbumin, an approach for inducing allergic asthmatic reactions. Similarly, GAD and GABA(A)Rs in airway epithelial cells of humans with asthma increased after allergen inhalation challenge. Intranasal application of selective GABA(A)R inhibitors suppressed the hyperplasia of goblet cells and the overproduction of mucus induced by ovalbumin or interleukin-13 in mice. These findings show that a previously unknown epithelial GABAergic system has an essential role in asthma.	Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Manitoba, Dept Med Microbiol, Immune Regulat Allergy Grp, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Microbiol & Immunol, Winnipeg, MB R3E 0W3, Canada; Univ Toronto, Dept Surg, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Michael G DeGroot Sch Med, Hamilton, ON L8N 3Z5, Canada; Shandong Univ, Sch Med, Inst Physiol, Jinan 250012, Shandong, Peoples R China; Univ Toronto, Dept Anesthesia, Toronto, ON M5S 3E2, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; University of Manitoba; University of Toronto; University of Toronto; McMaster University; Shandong University; University of Toronto	Lu, WY (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	yangxi@cc.umanitoba.ca; wlu@sten.sunnybrook.utoronto.ca	Kelly, Margaret M/G-4128-2012; Lu, Wei-Yang/K-4404-2013	Kelly, Margaret M/0000-0002-1629-3210; O'Byrne, Paul/0000-0003-0979-281X; Yang, Xi/0000-0002-8831-7488; Liu, Mingyao/0000-0002-9188-8417				Baufreton J, 2005, J NEUROSCI, V25, P8505, DOI 10.1523/JNEUROSCI.1163-05.2005; COCKCROFT DW, 1977, THORAX, V32, P429, DOI 10.1136/thx.32.4.429; Dong HH, 2004, J NEUROSCI, V24, P8950, DOI 10.1523/JNEUROSCI.2106-04.2004; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Gauvreau GM, 1999, J ALLERGY CLIN IMMUN, V104, P66, DOI 10.1016/S0091-6749(99)70115-6; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Han XB, 2006, J IMMUNOL, V176, P5232, DOI 10.4049/jimmunol.176.9.5232; Hirota JA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-120; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; INMAN MD, 1995, J ALLERGY CLIN IMMUN, V95, P1191, DOI 10.1016/S0091-6749(95)70075-7; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rogers DF, 2002, CLIN EXP ALLERGY, V32, P1124, DOI 10.1046/j.1365-2745.2002.01474.x; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Wang SH, 2001, J IMMUNOL, V166, P2741, DOI 10.4049/jimmunol.166.4.2741; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; YANG X, 1993, J EXP MED, V178, P349, DOI 10.1084/jem.178.1.349	29	147	158	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2007	13	7					862	867		10.1038/nm1604	http://dx.doi.org/10.1038/nm1604			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	188EU	17589520				2022-12-25	WOS:000247902800034
J	McGrath, PT; Lee, H; Zhang, L; Iniesta, AA; Hottes, AK; Tan, MH; Hillson, NJ; Hu, P; Shapiro, L; McAdams, HH				McGrath, Patrick T.; Lee, Honglak; Zhang, Li; Iniesta, Antonio A.; Hottes, Alison K.; Tan, Meng How; Hillson, Nathan J.; Hu, Ping; Shapiro, Lucy; McAdams, Harley H.			High-throughput identification of transcription start sites, conserved promoter motifs and predicted regulons	NATURE BIOTECHNOLOGY			English	Article							BACTERIAL-CELL-CYCLE; CAULOBACTER-CRESCENTUS; DNA-REPLICATION; MASTER REGULATOR; NETWORK; SEQUENCE; PROGRESSION; EXPRESSION; PROTEASE; GENE	Using 62 probe-level datasets obtained with a custom-designed Caulobacter crescentus microarray chip, we identify transcriptional start sites of 769 genes, 53 of which are transcribed from multiple start sites. Transcriptional start sites are identified by analyzing probe signal cross-correlation matrices created from probe pairs tiled every 5 bp upstream of the genes. Signals from probes binding the same message are correlated. The contribution of each promoter for genes transcribed from multiple promoters is identified. Knowing the transcription start site enables targeted searching for regulatory-protein binding motifs in the promoter regions of genes with similar expression patterns. We identified 27 motifs, 17 of which share no similarity to the characterized motifs of other C. crescentus transcriptional regulators. Using these motifs, we predict coregulated genes. We verified novel promoter motifs that regulate stress-response genes, including those responding to uranium challenge, a stress-response sigma factor and a stress-response noncoding RNA.	Stanford Univ, Dept Dev Biol, Becmkan Ctr B300, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl C Icahn Lab L206, Princeton, NJ 08544 USA; Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA 94720 USA	Stanford University; Stanford University; Stanford University; Stanford University; Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	McAdams, HH (corresponding author), Stanford Univ, Dept Dev Biol, Becmkan Ctr B300, 279 Campus Dr, Stanford, CA 94305 USA.	hmcadams@stanford.edu	Tan, Meng How/M-8605-2015; Hu, Ping/G-2384-2015; Hillson, Nathan/F-9957-2012; Iniesta, Antonio A/G-7798-2015	Tan, Meng How/0000-0003-3627-5586; Hillson, Nathan/0000-0002-9169-3978; Iniesta, Antonio A/0000-0002-7629-1057	NHGRI NIH HHS [T32 HG00044] Funding Source: Medline; NIGMS NIH HHS [5R24GM73011-2, GM32506] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506, R24GM073011] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BRUN YV, 1992, GENE DEV, V6, P2395, DOI 10.1101/gad.6.12a.2395; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Craven M, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P116; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; GOBER JW, 1992, MOL BIOL CELL, V3, P913, DOI 10.1091/mbc.3.8.913; GOMES SL, 1990, J BACTERIOL, V172, P3051, DOI 10.1128/jb.172.6.3051-3059.1990; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Liu X, 2001, Pac Symp Biocomput, P127; MALAKOOTI J, 1995, J BACTERIOL, V177, P4372, DOI 10.1128/jb.177.15.4372-4376.1995; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; MULLIN DA, 1989, J BACTERIOL, V171, P3218, DOI 10.1128/jb.171.6.3218-3227.1989; Osteras M, 1999, J BACTERIOL, V181, P3039; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Reisenauer A, 1996, J BACTERIOL, V178, P1919, DOI 10.1128/jb.178.7.1919-1927.1996; Roberts RC, 1997, J BACTERIOL, V179, P2319, DOI 10.1128/jb.179.7.2319-2330.1997; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tjaden Brian, 2002, Bioinformatics, V18 Suppl 1, pS337; Viollier PH, 2004, CURR OPIN MICROBIOL, V7, P572, DOI 10.1016/j.mib.2004.10.005	30	127	129	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2007	25	5					584	592		10.1038/nbt1294	http://dx.doi.org/10.1038/nbt1294			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	166HK	17401361				2022-12-25	WOS:000246369400027
J	Bergmann, S; Schumann, J; Scherlach, K; Lange, C; Brakhage, AA; Hertweck, C				Bergmann, Sebastian; Schuemann, Julia; Scherlach, Kirstin; Lange, Corinna; Brakhage, Axel A.; Hertweck, Christian			Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans	NATURE CHEMICAL BIOLOGY			English	Article							POLYKETIDE SYNTHASE GENES; NATURAL-PRODUCT; RELATIVE CONFIGURATION; PAECILOMYCES-FARINOSUS; FUNCTIONAL-ANALYSIS; MICROBIAL GENOMICS; MAGNAPORTHE-GRISEA; BEAUVERIA-BASSIANA; DRUG DISCOVERY; BIOSYNTHESIS	In the postgenomic era it has become increasingly apparent that the vast number of predicted biosynthesis genes of microorganisms is not reflected by the metabolic profile observed under standard fermentation conditions. In the absence of a particular (in most cases unknown) trigger these gene loci remain silent. Because these cryptic gene clusters may code for the biosynthesis of important virulence factors, toxins, or even drug candidates, new strategies for their activation are urgently needed to make use of this largely untapped reservoir of potentially bioactive compounds(1,2). The discovery of new microbial metabolites through genome mining has proven to be a very promising approach 3-15. Even so, the investigation of silent gene clusters is still a substantial challenge, particularly in fungi(16). Here we report a new strategy for the successful induction of a silent metabolic pathway in the important model organism Aspergillus nidulans, which led to the discovery of novel PKS-NRPS hybrid metabolites.	Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, D-07745 Jena, Germany; Univ Jena, D-07737 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hertweck, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Beutenbergstr 11A, D-07745 Jena, Germany.	christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Scherlach, Kirstin/0000-0002-1326-3761				Banskota AH, 2006, J ANTIBIOT, V59, P168, DOI 10.1038/ja.2006.24; Banskota AH, 2006, J ANTIBIOT, V59, P533, DOI 10.1038/ja.2006.74; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Cheng YX, 2004, J NAT PROD, V67, P1854, DOI 10.1021/np049761w; Clark AJ, 1998, TETRAHEDRON LETT, V39, P6033, DOI 10.1016/S0040-4039(98)01190-3; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Eley KL, 2007, CHEMBIOCHEM, V8, P289, DOI 10.1002/cbic.200600398; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Fujita Y, 2005, TETRAHEDRON LETT, V46, P5885, DOI 10.1016/j.tetlet.2005.06.115; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Lang G, 2005, J NAT PROD, V68, P810, DOI 10.1021/np0500979; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; McAlpine JB, 2005, J NAT PROD, V68, P493, DOI 10.1021/np0401664; MCINNES AG, 1974, J CHEM SOC CHEM COMM, P281, DOI 10.1039/c39740000281; Moore MC, 1998, TETRAHEDRON, V54, P9195, DOI 10.1016/S0040-4020(98)00557-2; Peric-Concha N, 2003, DRUG DISCOV TODAY, V8, P1078, DOI 10.1016/S1359-6446(03)02901-5; Ricke DO, 2006, CURR OPIN CHEM BIOL, V10, P303, DOI 10.1016/j.cbpa.2006.06.024; Scherlach K, 2006, ORG BIOMOL CHEM, V4, P3517, DOI 10.1039/b607011f; Schmidt K, 2003, J NAT PROD, V66, P378, DOI 10.1021/np020430y; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Sims JW, 2005, CHEM COMMUN, P186, DOI 10.1039/b413523g; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Stahl M, 1996, J ORG CHEM, V61, P8083, DOI 10.1021/jo960809n; Sudek S, 2006, APPL ENVIRON MICROB, V72, P4382, DOI 10.1128/AEM.00380-06; Tohyama S, 2004, TETRAHEDRON, V60, P3999, DOI 10.1016/j.tet.2004.03.027; Van Lanen SG, 2006, CURR OPIN MICROBIOL, V9, P252, DOI 10.1016/j.mib.2006.04.002; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Wenzel SC, 2005, CHEMBIOCHEM, V6, P375, DOI 10.1002/cbic.200400282	34	430	480	12	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2007	3	4					213	217		10.1038/nchembio869	http://dx.doi.org/10.1038/nchembio869			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148UW	17369821				2022-12-25	WOS:000245103000010
J	Lage, K; Karlberg, EO; Storling, ZM; Olason, PI; Pedersen, AG; Rigina, O; Hinsby, AM; Tumer, Z; Pociot, F; Tommerup, N; Moreau, Y; Brunak, S				Lage, Kasper; Karlberg, E. Olof; Storling, Zenia M.; Olason, Pall I.; Pedersen, Anders G.; Rigina, Olga; Hinsby, Anders M.; Tumer, Zeynep; Pociot, Flemming; Tommerup, Niels; Moreau, Yves; Brunak, Soren			A human phenome-interactome network of protein complexes implicated in genetic disorders	NATURE BIOTECHNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERACTION MAP; LINKAGE; ASSOCIATION; MUTATIONS; GENOME; PRIORITIZATION; KNOWLEDGEBASE; INTEGRATION; PHENOTYPES	We performed a systematic, large-scale analysis of human protein complexes comprising gene products implicated in many different categories of human disease to create a phenome-interactome network. This was done by integrating quality-controlled interactions of human proteins with a validated, computationally derived phenotype similarity score, permitting identification of previously unknown complexes likely to be associated with disease. Using a phenomic ranking of protein complexes linked to human disease, we developed a Bayesian predictor that in 298 of 669 linkage intervals correctly ranks the known disease-causing protein as the top candidate, and in 870 intervals with no identified disease-causing gene, provides novel candidates implicated in disorders such as retinitis pigmentosa, epithelial ovarian cancer, inflammatory bowel disease, amyotrophic lateral sclerosis, Alzheimer disease, type 2 diabetes and coronary heart disease. Our publicly available draft of protein complexes associated with pathology comprises 506 complexes, which reveal functional relationships between disease-promoting genes that will inform future experimentation.	Tech Univ Denmark, Ctr Biol Sequence Anal, BioCtr STU, DK-2800 Lyngby, Denmark; Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark; Lund Univ, Inst Clin Sci, SE-22100 Lund, Sweden; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Katholieke Univ Leuven, Fac Engn, Dept Elect Engn, B-3001 Heverlee, Belgium	Technical University of Denmark; University of Copenhagen; Lund University; Steno Diabetes Center; KU Leuven	Brunak, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, BioCtr STU, Bldg 208, DK-2800 Lyngby, Denmark.	brunak@cbs.dtu.dk	Tommerup, Niels/T-8776-2017; Tümer, Zeynep/C-4235-2014; Tumer, Zeynep/AAF-8501-2019; Brunak, Soren/O-6621-2016	Tommerup, Niels/0000-0003-2304-0112; Tumer, Zeynep/0000-0002-4777-5802; Brunak, Soren/0000-0003-0316-5866; Pedersen, Anders Gorm/0000-0001-9650-8965; Pociot, Flemming/0000-0003-3274-5448; Moreau, Yves/0000-0002-4647-6560				Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Dechairo B, 2001, EUR J HUM GENET, V9, P627, DOI 10.1038/sj.ejhg.5200687; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Divita G, 2004, STUD HEALTH TECHNOL, V107, P763; Franke L, 2004, EUR J HUM GENET, V12, P633, DOI 10.1038/sj.ejhg.5201215; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gu SM, 1999, J MED GENET, V36, P705; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Masseroli M, 2005, NUCLEIC ACIDS RES, V33, pW717, DOI 10.1093/nar/gki454; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; OTI M, 2006, J MED GENET; Perez-Iratxeta C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-45; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Polavarapu N, 2005, 2005 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P366, DOI 10.1109/CSB.2005.36; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salton G, 1983, INTRO MODERN INFORM; Schijvenaars BJA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-149; Sekine M, 2001, HUM MOL GENET, V10, P1421, DOI 10.1093/hmg/10.13.1421; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Thompson LH, 2005, NAT GENET, V37, P921, DOI 10.1038/ng0905-921; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; van Driel MA, 2005, NUCLEIC ACIDS RES, V33, pW758, DOI 10.1093/nar/gki435; van Driel MA, 2003, EUR J HUM GENET, V11, P57, DOI 10.1038/sj.ejhg.5200918; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	56	688	703	0	61	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2007	25	3					309	316		10.1038/nbt1295	http://dx.doi.org/10.1038/nbt1295			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	143TP	17344885	Green Published			2022-12-25	WOS:000244748300022
J	Medarova, Z; Pham, W; Farrar, C; Petkova, V; Moore, A				Medarova, Zdravka; Pham, Wellington; Farrar, Christian; Petkova, Victoria; Moore, Anna			In vivo imaging of siRNA delivery and silencing in tumors	NATURE MEDICINE			English	Article							SMALL INTERFERING RNA; FAS PROTECTS MICE; GENE-EXPRESSION; EFFICIENT DELIVERY; LENTIVIRAL VECTORS; SEQUENCE; MODEL; INHIBITION; KNOCKDOWN; POTENT	With the increased potential of RNA interference (RNAi) as a therapeutic strategy, new noninvasive methods for detection of siRNA delivery and silencing are urgently needed. Here we describe the development of dual-purpose probes for in vivo transfer of siRNA and the simultaneous imaging of its accumulation in tumors by high-resolution magnetic resonance imaging (MRI) and near-infrared in vivo optical imaging (NIRF). These probes consisted of magnetic nanoparticles labeled with a near-infrared dye and covalently linked to siRNA molecules specific for model or therapeutic targets. Additionally, these nanoparticles were modified with a membrane translocation peptide for intracellular delivery. We show the feasibility of in vivo tracking of tumor uptake of these probes by MRI and optical imaging in two separate tumor models. We also used proof-of-principle optical imaging to corroborate the efficiency of the silencing process. These studies represent the first step toward the advancement of siRNA delivery and imaging strategies, essential for cancer therapeutic product development and optimization.	Harvard Univ, Sch Med, MIT,Athinoula A Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp,Dept Radiol, Boston, MA 02129 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Moore, A (corresponding author), Harvard Univ, Sch Med, MIT,Athinoula A Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp,Dept Radiol, Room 2301,Bldg 149,13th St, Boston, MA 02129 USA.	amoore@helix.mgh.harvard.edu		Pham, Wellington/0000-0002-8408-7611; Farrar, Christian/0000-0001-6623-8220	NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER; NIA NIH HHS [K25 AG029415-03, K25 AG029415-01A1, K25 AG029415-02, K25 AG029415-04, K25 AG029415, K25 AG029415-05] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Moore A, 2004, CANCER RES, V64, P1821, DOI 10.1158/0008-5472.CAN-03-3230; Moore A, 1998, MICROVASC RES, V56, P145, DOI 10.1006/mvre.1998.2102; Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; Zimmer C, 1997, EXP NEUROL, V143, P61, DOI 10.1006/exnr.1996.6350; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	35	565	619	1	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					372	377		10.1038/nm1486	http://dx.doi.org/10.1038/nm1486			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17322898				2022-12-25	WOS:000244715700052
J	Yamauchi, T; Nio, Y; Maki, T; Kobayashi, M; Takazawa, T; Iwabu, M; Okada-Iwabu, M; Kawamoto, S; Kubota, N; Kubota, T; Ito, Y; Kamon, J; Tsuchida, A; Kumagai, K; Kozono, H; Hada, Y; Ogata, H; Tokuyama, K; Tsunoda, M; Ide, T; Murakami, K; Awazawa, M; Takamoto, I; Froguel, P; Hara, K; Tobe, K; Nagai, R; Ueki, K; Kadowaki, T				Yamauchi, Toshimasa; Nio, Yasunori; Maki, Toshiyuki; Kobayashi, Masaki; Takazawa, Takeshi; Iwabu, Masato; Okada-Iwabu, Miki; Kawamoto, Sachiko; Kubota, Naoto; Kubota, Tetsuya; Ito, Yusuke; Kamon, Junji; Tsuchida, Atsushi; Kumagai, Katsuyoshi; Kozono, Hideki; Hada, Yusuke; Ogata, Hitomi; Tokuyama, Kumpei; Tsunoda, Masaki; Ide, Tomohiro; Murakami, Kouji; Awazawa, Motoharu; Takamoto, Iseki; Froguel, Philippe; Hara, Kazuo; Tobe, Kazuyuki; Nagai, Ryozo; Ueki, Kohjiro; Kadowaki, Takashi			Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED INSULIN-RESISTANCE; FATTY-ACID OXIDATION; PPAR-ALPHA; HORMONE ADIPONECTIN; MUSCLE-CELLS; WEIGHT-LOSS; OBESITY; RECEPTOR; EXPRESSION	Adiponectin plays a central role as an antidiabetic and antiatherogenic adipokine. AdipoR1 and AdipoR2 serve as receptors for adiponectin in vitro, and their reduction in obesity seems to be correlated with reduced adiponectin sensitivity. Here we show that adenovirus-mediated expression of AdipoR1 and R2 in the liver of Lepr(-/-) mice increased AMP-activated protein kinase (AMPK) activation and peroxisome proliferator-activated receptor (PPAR)-alpha signaling pathways, respectively. Activation of AMPK reduced gluconeogenesis, whereas expression of the receptors in both cases increased fatty acid oxidation and lead to an amelioration of diabetes. Alternatively, targeted disruption of AdipoR1 resulted in the abrogation of adiponectin-induced AMPK activation, whereas that of AdipoR2 resulted in decreased activity of PPAR-alpha signaling pathways. Simultaneous disruption of both AdipoR1 and R2 abolished adiponectin binding and actions, resulting in increased tissue triglyceride content, inflammation and oxidative stress, and thus leading to insulin resistance and marked glucose intolerance. Therefore, AdipoR1 and R2 serve as the predominant receptors for adiponectin in vivo and play important roles in the regulation of glucose and lipid metabolism, inflammation and oxidative stress in vivo.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan; Univ Tokyo, 22nd Century Med & Res Ctr, Dept Integrated Mol Sci Metab Dis, Tokyo 1138655, Japan; Japan Sci & Technol, Core Res Evolut Sci & Technol, Tokyo 3320012, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; Kyorin Pharmaceut Co Ltd, Biosci Div 1, Metab Discovery Res Labs, Shimotsuga 3290114, Japan; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London W12 0NN, England	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tsukuba; Imperial College London	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp	Nio, Yasunori/AFE-2456-2022; FROGUEL, Philippe/O-6799-2017; Kubota, Naoto/N-7892-2015	FROGUEL, Philippe/0000-0003-2972-0784; Kumagai, Katsuyoshi/0000-0003-4072-9907				Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hug C, 2005, CURR OPIN PHARMACOL, V5, P129, DOI 10.1016/j.coph.2005.01.001; Inoue I, 2001, METABOLISM, V50, P3, DOI 10.1053/meta.2001.19415; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matschinsky FM, 2006, DIABETES, V55, P1; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	40	986	1049	1	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2007	13	3					332	339		10.1038/nm1557	http://dx.doi.org/10.1038/nm1557			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	143JC	17268472				2022-12-25	WOS:000244715700046
J	Helgason, A; Palsson, S; Thorleifsson, G; Grant, SFA; Emilsson, V; Gunnarsdottir, S; Adeyemo, A; Chen, YX; Chen, GJ; Reynisdottir, I; Benediktsson, R; Hinney, A; Hansen, T; Andersen, G; Borch-Johnsen, K; Jorgensen, T; Schafer, H; Faruque, M; Doumatey, A; Zhou, J; Wilensky, RL; Reilly, MP; Rader, DJ; Bagger, Y; Christiansen, C; Sigurdsson, G; Hebebrand, J; Pedersen, O; Thorsteinsdottir, U; Gulcher, JR; Kong, A; Rotimi, C; Stefansson, K				Helgason, Agnar; Palsson, Snaebjorn; Thorleifsson, Gudmar; Grant, Struan F. A.; Emilsson, Valur; Gunnarsdottir, Steinunn; Adeyemo, Adebowale; Chen, Yuanxiu; Chen, Guanjie; Reynisdottir, Inga; Benediktsson, Rafn; Hinney, Anke; Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; Schaefer, Helmut; Faruque, Mezbah; Doumatey, Ayo; Zhou, Jie; Wilensky, Robert L.; Reilly, Muredach P.; Rader, Daniel J.; Bagger, Yu; Christiansen, Claus; Sigurdsson, Gunnar; Hebebrand, Johannes; Pedersen, Oluf; Thorsteinsdottir, Unnur; Gulcher, Jeffrey R.; Kong, Augustine; Rotimi, Charles; Stefansson, Kari			Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution	NATURE GENETICS			English	Article							HUMAN GENOME; CONFERS RISK; POPULATION; ASSOCIATION; RECOMBINATION; PROGRAM; OBESITY; MAP	We recently described an association between risk of type 2 diabetes and variants in the transcription factor 7- like 2 gene ( TCF7L2; formerly TCF4), with a population attributable risk ( PAR) of 17% - 28% in three populations of European ancestry(1). Here, we refine the definition of the TCF7L2 type 2 diabetes risk variant, HapB(T2D), to the ancestral T allele of a SNP, rs7903146, through replication in West African and Danish type 2 diabetes case-control studies and an expanded Icelandic study. We also identify another variant of the same gene, HapA, that shows evidence of positive selection in East Asian, European and West African populations. Notably, HapA shows a suggestive association with body mass index and altered concentrations of the hunger-satiety hormones ghrelin and leptin in males, indicating that the selective advantage of HapA may have been mediated through effects on energy metabolism.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, IS-101 Reykjavik, Iceland; Howard Univ, Natl Human Gen Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Natl Univ Hosp Reykjavik, IS-101 Reykjavik, Iceland; Univ Duisburg Essen, Rhein Klin Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Aarhus, DK-8000 Aarhus, Denmark; Univ Hosp Glostrup, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark	University of Iceland; Howard University; Icelandic Heart Association; Landspitali National University Hospital; University of Duisburg Essen; Steno Diabetes Center; Aarhus University; University of Copenhagen; Philipps University Marburg; University of Pennsylvania; Center Clinical & Basic Research	Helgason, A (corresponding author), DeCODE Genet, IS-101 Reykjavik, Iceland.	agnar@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Jørgensen, Torben/Z-1335-2018; Palsson, Snaebjorn/J-9113-2012; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Benediktsson, Rafn/R-2457-2018; Hinney, Anke/D-6953-2011	Pedersen, Oluf/0000-0002-3321-3972; Benediktsson, Rafn/0000-0002-2954-9801; Hinney, Anke/0000-0001-5659-0706; Reilly, Muredach/0000-0002-3035-9386; Palsson, Snaebjorn/0000-0002-4297-3500; Hansen, Torben/0000-0001-8748-3831; Adeyemo, Adebowale/0000-0002-3105-3231; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767; Jorgensen, Torben/0000-0001-9453-2830; Grant, Struan/0000-0003-2025-5302; Reynisdottir, Inga/0000-0002-9730-7476; Emilsson, Valur/0000-0001-9982-0524	FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NIDDK NIH HHS [DK-54001] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andersen G, 2006, DIABETOLOGIA, V49, P75, DOI 10.1007/s00125-005-0049-7; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Erdmann J, 2005, DIABETES, V54, P1371, DOI 10.2337/diabetes.54.5.1371; EXCOFFIER L, 1992, GENETICS, V131, P491; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean G, 2002, GENETICS, V160, P1231; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Slatkin M, 2001, GENETICS, V158, P865; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	30	389	406	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					218	225		10.1038/ng1960	http://dx.doi.org/10.1038/ng1960			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206141				2022-12-25	WOS:000244063900020
J	Cheng, AC; Coleman, RG; Smyth, KT; Cao, Q; Soulard, P; Caffrey, DR; Salzberg, AC; Huang, ES				Cheng, Alan C.; Coleman, Ryan G.; Smyth, Kathleen T.; Cao, Qing; Soulard, Patricia; Caffrey, Daniel R.; Salzberg, Anna C.; Huang, Enoch S.			Structure-based maximal affinity model predicts small-molecule druggability	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; INHIBITORS; MECHANISM; CAVITIES	Lead generation is a major hurdle in small-molecule drug discovery, with an estimated 60% of projects failing from lack of lead matter or difficulty in optimizing leads for drug-like properties. It would be valuable to identify these less-druggable targets before incurring substantial expenditure and effort. Here we show that a model-based approach using basic biophysical principles yields good prediction of druggability based solely on the crystal structure of the target binding site. We quantitatively estimate the maximal affinity achievable by a drug-like molecule, and we show that these calculated values correlate with drug discovery outcomes. We experimentally test two predictions using high-throughput screening of a diverse compound collection. The collective results highlight the utility of our approach as well as strategies for tackling difficult targets.	Amgen Inc, Cambridge, MA 02139 USA; Pfizer Global Res & Dev, Res Technol Ctr, Dept Biol Sci, Cambridge, MA 02139 USA; Pfizer Global Res & Dev, Res Technol Ctr, Dept Mol Informat, Cambridge, MA 02139 USA	Amgen; Pfizer; Pfizer	Cheng, AC (corresponding author), Amgen Inc, 1 Kendall Sq,Bldg 1000, Cambridge, MA 02139 USA.	alan.cheng@amgen.com	Coleman, Ryan G/A-1038-2009	Cheng, Alan/0000-0003-3645-172X; Coleman, Ryan/0000-0003-4093-4281				Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Armstrong KA, 2006, J MED CHEM, V49, P2470, DOI 10.1021/jm051105l; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Coleman RG, 2005, PROTEINS, V61, P1068, DOI 10.1002/prot.20680; Davis AM, 1999, ANGEW CHEM INT EDIT, V38, P737, DOI 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; DEYOUNG LR, 1990, J PHYS CHEM-US, V94, P801, DOI 10.1021/j100365a054; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; FAUMAN EB, 2003, STRUCTURAL BIOINFORM, P447; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jacques SL, 2001, BBA-PROTEIN STRUCT M, V1544, P28, DOI 10.1016/S0167-4838(00)00203-X; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Palm K, 1997, PHARMACEUT RES, V14, P568, DOI 10.1023/A:1012188625088; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Southall NT, 2000, J PHYS CHEM B, V104, P1326, DOI 10.1021/jp992860b; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wermuth C.G., 2003, PRACTICE MED CHEM, V2nd	31	500	518	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2007	25	1					71	75		10.1038/nbt1273	http://dx.doi.org/10.1038/nbt1273			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	126CY	17211405				2022-12-25	WOS:000243491000031
J	Huang, JL; Wang, FX; Argyris, E; Chen, KY; Liang, ZH; Tian, H; Huang, WL; Squires, K; Verlinghieri, G; Zhang, H				Huang, Jialing; Wang, Fengxiang; Argyris, Elias; Chen, Keyang; Liang, Zhihui; Tian, Heng; Huang, Wenlin; Squires, Kathleen; Verlinghieri, Gwen; Zhang, Hui			Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; IN-VIVO; RNA; CELLS; REPLICATION; IDENTIFICATION; RECRUITMENT; SUPPRESSION	The latency of human immunodeficiency virus type 1 ( HIV- 1) in resting primary CD4(+) T cells is the major barrier for the eradication of the virus in patients on suppressive highly active antiretroviral therapy ( HAART). Even with optimal HAART treatment, replication- competent HIV- 1 still exists in resting primary CD4(+) T cells(1-4). Multiple restriction factors that act upon various steps of the viral life cycle could contribute to viral latency. Here we show that cellular microRNAs ( miRNAs) potently inhibit HIV- 1 production in resting primary CD4(+) T cells. We have found that the 3' ends of HIV-1 messenger RNAs are targeted by a cluster of cellular miRNAs including miR- 28, miR-125b, miR- 150, miR- 223 and miR- 382, which are enriched in resting CD4(+) T cells as compared to activated CD4(+) T cells. Specific inhibitors of these miRNAs substantially counteracted their effects on the target mRNAs, measured either as HIV- 1 protein translation in resting CD4(+) T cells transfected with HIV- 1 infectious clones, or as HIV- 1 virus production from resting CD4(+) T cells isolated from HIV-1 infected individuals on suppressive HAART. Our data indicate that cellular miRNAs are pivotal in HIV-1 latency and suggest that manipulation of cellular miRNAs could be a novel approach for purging the HIV-1 reservoir.	Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA; Sun Yat Sen Univ, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China	Jefferson University; Sun Yat Sen University	Zhang, H (corresponding author), Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA.	hui.zhang@jefferson.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052732, R01AI058798] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Patterson BK, 2001, AIDS, V15, P1635, DOI 10.1097/00002030-200109070-00005; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	29	595	640	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2007	13	10					1241	1247		10.1038/nm1639	http://dx.doi.org/10.1038/nm1639			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17906637				2022-12-25	WOS:000249980200041
J	McAteer, MA; Sibson, NR; von zur Muhlen, C; Schneider, JE; Lowe, AS; Warrick, N; Channon, KM; Anthony, DC; Choudhury, RP				McAteer, Martina A.; Sibson, Nicola R.; von zur Muhlen, Constantin; Schneider, Jurgen E.; Lowe, Andrew S.; Warrick, Nicholas; Channon, Keith M.; Anthony, Daniel C.; Choudhury, Robin P.			In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; ADHESION MOLECULES; ENDOTHELIAL-CELLS; MRI DETECTION; VCAM-1; ICAM-1; ATHEROSCLEROSIS; ACTIVATION	Multiple sclerosis is a disease of the central nervous system that is associated with leukocyte recruitment and subsequent inflammation, demyelination and axonal loss. Endothelial vascular cell adhesion molecule- 1 ( VCAM- 1) and its ligand, alpha(4)beta(1) integrin, are key mediators of leukocyte recruitment, and selective inhibitors that bind to the alpha(4) subunit of alpha(4)beta(1) substantially reduce clinical relapse in multiple sclerosis. Urgently needed is a molecular imaging technique to accelerate diagnosis, to quantify disease activity and to guide specific therapy. Here we report in vivo detection of VCAM- 1 in acute brain inflammation, by magnetic resonance imaging in a mouse model, at a time when pathology is otherwise undetectable. Antibody- conjugated microparticles carrying a large amount of iron oxide provide potent, quantifiable contrast effects that delineate the architecture of activated cerebral blood vessels. Their rapid clearance from blood results in minimal background contrast. This technology is adaptable to monitor the expression of endovascular molecules in vivo in various pathologies.	Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; Dept Physiol Anat & Genet, Expt Neuroimaging Grp, Oxford OX1 3PT, England; Dept Pharmacol, Oxford OX1 3QX, England	University of Oxford; University of Oxford	Choudhury, RP (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	robin.choudhury@cardiov.ox.ac.uk	McAteer, Martina/AAD-8628-2022; Lowe, Andrew S/J-4801-2013; Anthony, Daniel/F-7765-2010	Lowe, Andrew S/0000-0001-6650-7486; Anthony, Daniel/0000-0003-1380-6655; McAteer (Duric), Martina/0000-0002-7350-4651; channon, keith/0000-0002-1043-4342	MRC [G0300456, G9900989] Funding Source: UKRI; Medical Research Council [G9900989, G0300456] Funding Source: Medline; Wellcome Trust [076994, 088291] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aime S, 2002, J MAGN RESON IMAGING, V16, P394, DOI 10.1002/jmri.10180; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Briley-Saebo K, 2004, CELL TISSUE RES, V316, P315, DOI 10.1007/s00441-004-0884-8; CARLOS TM, 1990, BLOOD, V76, P965; Chen HH, 2005, MAGN RESON MED, V53, P614, DOI 10.1002/mrm.20395; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dedrick RL, 2003, EXPERT OPIN BIOL TH, V3, P85, DOI 10.1517/eobt.3.1.85.20954; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Gosk S, 2005, Int J Clin Pharmacol Ther, V43, P581; Guttmann CRG, 2006, MAGN RESON IMAGING, V24, P475, DOI 10.1016/j.mri.2005.12.038; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; OROSZ CG, 1992, IMMUNOL LETT, V32, P7, DOI 10.1016/0165-2478(92)90191-P; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reinhardt M, 2005, NEUROIMAGE, V27, P267, DOI 10.1016/j.neuroimage.2005.04.019; Ropele S, 2000, AM J NEURORADIOL, V21, P1885; Sakhalkar HS, 2003, P NATL ACAD SCI USA, V100, P15895, DOI 10.1073/pnas.2631433100; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; Sipkins DA, 2000, J NEUROIMMUNOL, V104, P1, DOI 10.1016/S0165-5728(99)00248-9; Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1; Will O, 2006, LANCET ONCOL, V7, P52, DOI 10.1016/S1470-2045(05)70537-4; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	28	220	225	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2007	13	10					1253	1258		10.1038/nm1631	http://dx.doi.org/10.1038/nm1631			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	217XI	17891147	Green Accepted			2022-12-25	WOS:000249980200043
J	Kawahara, M; Wu, Q; Takahashi, N; Morita, S; Yamada, K; Ito, M; Ferguson-Smith, AC; Kono, T				Kawahara, Manabu; Wu, Qiong; Takahashi, Nozomi; Morita, Shinnosuke; Yamada, Kaori; Ito, Mitsuteru; Ferguson-Smith, Anne C.; Kono, Tomohiro			High-frequency generation of viable mice from engineered bi-maternal embryos	NATURE BIOTECHNOLOGY			English	Article							OOCYTE GROWTH; PARTHENOGENETIC DEVELOPMENT; IMPRINTED GENES; H19 GENE; MOUSE; EXPRESSION; EMBRYOGENESIS; RETARDATION; DISRUPTION; RASGRF1	Mammalian development to adulthood typically requires both maternal and paternal genomes, because genomic imprinting places stringent limitations on mammalian development, strictly precluding parthenogenesis(1,2). Here we report the generation of bi-maternal embryos that develop at a high success rate equivalent to the rate obtained with in vitro fertilization of normal embryos. These bi-maternal mice developed into viable and fertile female adults. The bi-maternal embryos, distinct from parthenogenetic or gynogenetic conceptuses, were produced by the construction of oocytes from fully grown oocytes and nongrowing oocytes that contain double deletions in the H19 differentially methylated region (DMR) and the Dlk1-Dio3 intergenic germline-derived DMR. The results provide conclusive evidence that imprinted genes regulated by these two paternally methylated imprinting-control regions are the only paternal barrier that prevents the normal development of bi-maternal mouse fetuses to term.	Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 156, Japan; Bio Oriented Technol Res Adv Inst, Minato Ku, Tokyo 105, Japan; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Harbin Inst Technol, Dept Life Sci & Engn, Harbin, Peoples R China	Tokyo University of Agriculture; University of Cambridge; Harbin Institute of Technology	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 156, Japan.	tomohiro@nodai.ac.jp	Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0400156] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; Medical Research Council [G0400156] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Clapcott SJ, 2003, MAMM GENOME, V14, P495, DOI 10.1007/s00335-002-2258-4; Delany AM, 1996, ENDOCRINOLOGY, V137, P4665, DOI 10.1210/en.137.11.4665; FIELDER PJ, 1992, ENDOCRINOLOGY, V131, P261, DOI 10.1210/en.131.1.261; Kawahara M, 2006, HUM MOL GENET, V15, P2869, DOI 10.1093/hmg/ddl228; Kono T, 2002, DEV BIOL, V243, P294, DOI 10.1006/dbio.2001.0561; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 1998, DEVELOPMENT, V125, P1553; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Wu Q, 2006, REPRODUCTION, V131, P481, DOI 10.1530/rep.1.00933; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	24	106	116	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2007	25	9					1045	1050		10.1038/nbt1331	http://dx.doi.org/10.1038/nbt1331			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	210GH	17704765				2022-12-25	WOS:000249444200028
J	Shi, JR; Wang, HY; Schellin, K; Li, BL; Faller, M; Stoop, JM; Meeley, RB; Ertl, DS; Ranch, JP; Glassman, K				Shi, Jinrui; Wang, Hongyu; Schellin, Kathleen; Li, Bailin; Faller, Marianna; Stoop, Johan M.; Meeley, Robert B.; Ertl, David S.; Ranch, Jerry P.; Glassman, Kimberly			Embryo-specific silencing of a transporter reduces phytic acid content of maize and soybean seeds	NATURE BIOTECHNOLOGY			English	Article							LOW-PHYTATE CORN; PHOSPHORUS BIOAVAILABILITY; WILD-TYPE; PROTEIN; DIGESTIBILITY; ARABIDOPSIS; ABSORPTION; EXPRESSION; BARLEY; GENES	Phytic acid in cereal grains and oilseeds is poorly digested by monogastric animals and negatively affects animal nutrition and the environment. However, breeding programs involving mutants with less phytic acid and more inorganic phosphate ( Pi) have been frustrated by undesirable agronomic characteristics associated with the phytic acid-reducing mutations. We show that maize lpa1 mutants are defective in a multidrug resistance-associated protein ( MRP) ATP-binding cassette ( ABC) transporter that is expressed most highly in embryos, but also in immature endosperm, germinating seed and vegetative tissues. Silencing expression of this transporter in an embryo-specific manner produced low-phytic-acid, high-P-i transgenic maize seeds that germinate normally and do not show any significant reduction in seed dry weight. This dominant transgenic approach obviates the need for incorporating recessive lpa1 mutations to create maize hybrids with reduced phytic acid. Suppressing the homologous soybean MRP gene also generated low-phytic-acid seed, suggesting that the strategy might be feasible for many crops.	Pioneer HiBred Int Inc, A DuPont Co, Crop Genet Res & Dev, Johnston, IA 50131 USA	DuPont	Shi, JR (corresponding author), Pioneer HiBred Int Inc, A DuPont Co, Crop Genet Res & Dev, Johnston, IA 50131 USA.	Jinrui.shi@Pioneer.com	li, bz/GVR-7133-2022; Ertl, David/J-4962-2019	Ertl, David/0000-0003-1374-2970; Shi, Jinrui/0000-0002-0428-6777				AALEN RB, 1995, PLANT MOL BIOL, V28, P583, DOI 10.1007/BF00020404; AN GH, 1989, PLANT CELL, V1, P115, DOI 10.1105/tpc.1.1.115; BELANGER FC, 1991, GENETICS, V129, P863; BELANGER FC, 1989, PLANT PHYSIOL, V91, P636, DOI 10.1104/pp.91.2.636; Bohlke RA, 2005, J ANIM SCI, V83, P2396; Bregitzer P, 2006, CROP SCI, V46, P1318, DOI 10.2135/cropsci2005.09-0301; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Ertl DS, 1998, J ENVIRON QUAL, V27, P299, DOI 10.2134/jeq1998.00472425002700020008x; Finer JJ., 1991, IN VITRO CELL DEV-PL, V27, P175, DOI [10.1007/bf02632213, DOI 10.1007/BF02632213, 10.2307/4292952]; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; GREENWOOD JS, 1984, PLANTA, V160, P113, DOI 10.1007/BF00392859; Hambidge KM, 2005, AM J CLIN NUTR, V82, P84, DOI 10.1093/ajcn/82.1.84; Hambidge KM, 2004, AM J CLIN NUTR, V79, P1053; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jang DA, 2003, POULTRY SCI, V82, P1914, DOI 10.1093/ps/82.12.1914; JOFUKU KD, 1989, PLANT CELL, V1, P1079, DOI 10.1105/tpc.1.11.1079; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Li YC, 2000, POULTRY SCI, V79, P1444, DOI 10.1093/ps/79.10.1444; Lin L, 2005, CAN J BOT, V83, P131, DOI [10.1139/B04-146, 10.1139/b04-146]; Lott JNA, 2000, SEED SCI RES, V10, P11, DOI 10.1017/S0960258500000039; Lyons TP, 1991, BIOTECHNOLOGY FEED I, P133; Meis SJ, 2003, CROP SCI, V43, P1336, DOI 10.2135/cropsci2003.1336; Mendoza C, 1998, AM J CLIN NUTR, V68, P1123, DOI 10.1093/ajcn/68.5.1123; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; NELSON TS, 1968, POULTRY SCI, V47, P1842, DOI 10.3382/ps.0471842; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Pilu R, 2005, CROP SCI, V45, P2096, DOI 10.2135/cropsci2004.0651; PREISS J, 1997, MOL APPROACH PRIMARY, P81; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Reddy N.R., 1989, PHYTATES CEREALS LEG, P81; Sands JS, 2001, J ANIM SCI, V79, P2134; Selle Peter H., 2006, Journal of Poultry Science, V43, P89, DOI 10.2141/jpsa.43.89; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Spencer JD, 2000, J ANIM SCI, V78, P675; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Sugiura SH, 1999, AQUACULTURE, V170, P285, DOI 10.1016/S0044-8486(98)00414-1; Zhao ZY, 2002, MOL BREEDING, V8, P323, DOI 10.1023/A:1015243600325; [No title captured]	46	216	233	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					930	937		10.1038/nbt1322	http://dx.doi.org/10.1038/nbt1322			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17676037				2022-12-25	WOS:000248725800032
J	Shojaei, F; Wu, XM; Malik, AK; Zhong, CL; Baldwin, ME; Schanz, S; Fuh, G; Gerber, HP; Ferrara, N				Shojaei, Farbod; Wu, Xiumin; Malik, Ajay K.; Zhong, Cuiling; Baldwin, Megan E.; Schanz, Stefanie; Fuh, Germaine; Gerber, Hans-Peter; Ferrara, Napoleone			Tumor refractoriness to anti-VEGF treatment is mediated by CD11b(+)Gr1(+) myeloid cells	NATURE BIOTECHNOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNAL-TRANSDUCTION; PROGENITOR CELLS; TYROSINE KINASE; DENDRITIC CELLS; HUMAN MONOCYTES; GM-CSF; ANGIOGENESIS; MICE; COMBINATION	Vascular endothelial growth factor ( VEGF) is an essential regulator of normal and abnormal blood vessel growth. A monoclonal antibody ( mAb) that targets VEGF suppresses tumor growth in murine cancer models and human patients. We investigated cellular and molecular events that mediate refractoriness of tumors to anti-angiogenic therapy. Inherent anti-VEGF refractoriness is associated with infiltration of the tumor tissue by CD11b(+)Gr1(+) myeloid cells. Recruitment of these myeloid cells is also sufficient to confer refractoriness. Combining anti-VEGF treatment with a mAb that targets myeloid cells inhibits growth of refractory tumors more effectively than anti-VEGF alone. Gene expression analysis in CD11b(+)Gr1(+) cells isolated from the bone marrow of mice bearing refractory tumors reveals higher expression of a distinct set of genes known to be implicated in active mobilization and recruitment of myeloid cells. These findings indicate that, in our models, refractoriness to anti-VEGF treatment is determined by the ability of tumors to prime and recruit CD11b(+)Gr1(+) cells.	Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Shojaei, F (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	farbod@gene.com; nf@gene.com		MALIK, AJAY/0000-0002-4831-3597				Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bobek V, 2004, CLIN EXP METASTAS, V21, P705, DOI 10.1007/s10585-004-8118-8; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Di Maio M, 2005, LANCET ONCOL, V6, P669, DOI 10.1016/S1470-2045(05)70255-2; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 2000, CANCER RES, V60, P6253; Gerber HP, 2005, CANCER RES, V65, P671; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; HESTDAL K, 1991, J IMMUNOL, V147, P22; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; HO RLX, 1993, ONCOL RES, V5, P363; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lazarovici P, 2006, ENDOTHELIUM-J ENDOTH, V13, P51, DOI 10.1080/10623320600669053; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; LEMOLI RM, 1991, LEUKEMIA, V5, P386; LEONARD EJ, 1993, ADV EXP MED BIOL, V351, P55; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Liu YQ, 2002, LEUKEMIA RES, V26, P757, DOI 10.1016/S0145-2126(02)00002-4; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Malik AK, 2006, BLOOD, V107, P550, DOI 10.1182/blood-2005-05-2047; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Onai N, 2000, BLOOD, V96, P2074; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PalmerCrocker RL, 1996, J CLIN INVEST, V98, P604, DOI 10.1172/JCI118829; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; RAPOPORT AP, 1992, BLOOD REV, V6, P43, DOI 10.1016/0268-960X(92)90007-D; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Wald M, 2001, CANCER CHEMOTH PHARM, V47, pS16, DOI 10.1007/s002800170004; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	50	675	703	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2007	25	8					911	920		10.1038/nbt1323	http://dx.doi.org/10.1038/nbt1323			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	199WL	17664940				2022-12-25	WOS:000248725800030
J	Duchaud, E; Boussaha, M; Loux, V; Bernardet, JF; Michel, C; Kerouault, B; Mondot, S; Nicolas, P; Bossy, R; Caron, C; Bessieres, P; Gibrat, JF; Claverol, S; Dumetz, F; Le Henaff, M; Benmansour, A				Duchaud, Eric; Boussaha, Mekki; Loux, Valentin; Bernardet, Jean-Francois; Michel, Christian; Kerouault, Brigitte; Mondot, Stanislas; Nicolas, Pierre; Bossy, Robert; Caron, Christophe; Bessieres, Philippe; Gibrat, Jean-Francois; Claverol, Stephane; Dumetz, Fabien; Le Henaff, Michel; Benmansour, Abdenour			Complete genome sequence of the fish pathogen Flavobacterium psychrophilum	NATURE BIOTECHNOLOGY			English	Article							RAINBOW-TROUT; PORPHYROMONAS-GINGIVALIS; ONCORHYNCHUS-MYKISS; GLIDING MOTILITY; SURFACE-ANTIGEN; PURIFICATION; METALLOPROTEASE; EXPRESSION; VIRULENCE; OPERON	We report here the complete genome sequence of the virulent strain JIP02/86 (ATCC 49511) of Flavobacterium psychrophilum, a widely distributed pathogen of wild and cultured salmonid fish. The genome consists of a 2,861,988-base pair (bp) circular chromosome with 2,432 predicted protein-coding genes. Among these predicted proteins, stress response mediators, gliding motility proteins, adhesins and many putative secreted proteases are probably involved in colonization, invasion and destruction of the host tissues. The genome sequence provides the basis for explaining the relationships of the pathogen to the host and opens new perspectives for the development of more efficient disease control strategies. It also allows for a better understanding of the physiology and evolution of a significant representative of the family Flavobacteriaceae, whose members are associated with an interesting diversity of lifestyles and habitats.	INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France; INRA, Unite Math Informat & Genome, UR1077, F-78350 Jouy En Josas, France; Univ Bordeaux 2, F-33076 Bordeaux, France; Ecole natl Ingenieurs Travaux Agr Bordeaux, Lab Microbiol & Biochim Appl, F-33175 Gradignan, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux	Duchaud, E (corresponding author), INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France.	eric.duchaud@jouy.inra.fr	Loux, Valentin/C-6270-2008	boussaha, mekki/0000-0002-5432-4604; Loux, Valentin/0000-0002-8268-915X; Bossy, Robert/0000-0001-6652-9319; Le Henaff, Michel/0000-0002-8897-252X; Mondot, Stanislas/0000-0003-3668-3168				Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004; Baba H, 2002, INFECT IMMUN, V70, P107, DOI 10.1128/IAI.70.1.107-113.2002; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796, DOI 10.1128/AEM.55.7.1796-1800.1989; BERNARDET JF, 2003, PROKARYOTES EVOLVING; Bernardet JF, 2006, PROKARYOTES EVOLVING; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BOVO G, 2005, WORK PACAKGE 1 REPOR; Brouta F, 2001, MED MYCOL, V39, P269, DOI 10.1080/mmy.39.3.269.275; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; Cosseau C, 2004, ARCH MICROBIOL, V181, P89, DOI 10.1007/s00203-003-0641-5; Crump EM, 2005, MICROBIOL-SGM, V151, P3127, DOI 10.1099/mic.0.28140-0; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Dumetz F, 2006, APPL ENVIRON MICROB, V72, P4845, DOI 10.1128/AEM.00279-06; Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996; Gustafson RH, 1997, J APPL MICROBIOL, V83, P531, DOI 10.1046/j.1365-2672.1997.00280.x; Holt R. A., 1993, P3; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3; Krehenbrink M, 2002, ARCH MICROBIOL, V177, P371, DOI 10.1007/s00203-001-0396-9; Lim J, 2000, J MOL BIOL, V297, P553, DOI 10.1006/jmbi.2000.3585; Madetoja J, 2003, FEMS MICROBIOL ECOL, V43, P217, DOI 10.1111/j.1574-6941.2003.tb01061.x; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Merle C, 2003, J APPL MICROBIOL, V94, P1120, DOI 10.1046/j.1365-2672.2003.01946.x; MURATA N, 1995, BIOCHEM J, V308, P1; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nelson SS, 2006, J BACTERIOL, V188, P348, DOI 10.1128/JB.188.1.348-351.2006; Nematollahi A, 2005, DIS AQUAT ORGAN, V64, P23, DOI 10.3354/dao064023; Oikawa T, 2005, BIOSCI BIOTECH BIOCH, V69, P2146, DOI 10.1271/bbb.69.2146; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; PACHA RE, 1968, APPL MICROBIOL, V16, P1901, DOI 10.1128/AEM.16.12.1901-1906.1968; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; REDDY AS, 1993, PLANT MOL BIOL, V22, P293, DOI 10.1007/BF00014936; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rodkhum C, 2005, MICROB PATHOGENESIS, V39, P109, DOI 10.1016/j.micpath.2005.06.004; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Schuijffel DF, 2005, INFECT IMMUN, V73, P6812, DOI 10.1128/IAI.73.10.6812-6821.2005; Secades P, 2003, FEMS MICROBIOL LETT, V226, P273, DOI 10.1016/S0378-1097(03)00599-8; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Secombes C. J., 1996, The fish immune system: organism, pathogen, and environment, P63; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Tang YXP, 1999, MOL MICROBIOL, V32, P139, DOI 10.1046/j.1365-2958.1999.01337.x	50	163	389	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2007	25	7					763	769		10.1038/nbt1313	http://dx.doi.org/10.1038/nbt1313			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	189MW	17592475	hybrid			2022-12-25	WOS:000247994000027
J	Medyouf, H; Alcalde, H; Berthier, C; Guillemin, MC; dos Santos, NR; Janin, A; Decaudin, D; de The, H; Ghysdael, J				Medyouf, Hind; Alcalde, Helene; Berthier, Caroline; Guillemin, Marie Claude; dos Santos, Nuno R.; Janin, Anne; Decaudin, Didier; de The, Hugues; Ghysdael, Jacques			Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR; DEFICIENT MICE; NFAT; LYMPHOMA; TEL-JAK2; INDUCTION; PROTEINS; NOTCH1; VIRUS; MYC	Calcineurin is a calcium-activated serine/threonine phosphatase critical to a number of developmental processes in the cardiovascular, nervous and immune systems. In the T-cell lineage, calcineurin activation is important for pre-T-cell receptor (TCR) signaling, TCR-mediated positive selection of thymocytes into mature T cells, and many aspects of the immune response 1,2. The critical role of calcineurin in the immune response is underscored by the fact that calcineurin inhibitors, such as cyclosporin A (CsA) and FK506, are powerful immunosuppressants in wide clinical use. We observed sustained calcineurin activation in human B-and T-cell lymphomas and in all mouse models of lymphoid malignancies analyzed. In intracellular NOTCH1 (ICN1)-and TEL-JAK2-induced T-cell lymphoblastic leukemia3-5, two mouse models relevant to human malignancies6-8, in vivo inhibition of calcineurin activity by CsA or FK506 induced apoptosis of leukemic cells and rapid tumor clearance, and substantially prolonged mouse survival. In contrast, ectopic expression of a constitutively activated mutant of calcineurin favored leukemia progression. Moreover, CsA treatment induced apoptosis in human lymphoma and leukemia cell lines. Thus, calcineurin activation is critical for the maintenance of the leukemic phenotype in vivo, identifying this pathway as a relevant therapeutic target in lymphoid malignancies.	Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France; Ctr Univ, Unite Mixt Rech 146, CNRS, F-91405 Orsay, France; Univ Paris 07, CNRS, Unite Mixte Rech 7151, Hop St Louis, F-75475 Paris, France; Univ Paris 07, Inst Natl Sante & Rech Med, Unite 728, Hop St Louis, F-75475 Paris, France; Inst Curie, Dept Clin Hematol, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Ghysdael, J (corresponding author), Ctr Univ Orsay, Inst Curie, Batiment 110, F-91405 Orsay, France.	Jacques.Ghysdael@curie.u-psud.fr	GHYSDAEL, Jacques/F-3377-2013; dos Santos, Nuno Rodrigues/F-4411-2012	dos Santos, Nuno Rodrigues/0000-0001-7347-2592; Medyouf, Hind/0000-0003-4652-9455				Abramson JS, 2005, BLOOD, V106, P1164, DOI 10.1182/blood-2005-02-0687; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Blyth K, 2000, ONCOGENE, V19, P773, DOI 10.1038/sj.onc.1203321; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Carron C, 2000, BLOOD, V95, P3891; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Decaudin D, 2006, ANTI-CANCER DRUG, V17, P685, DOI 10.1097/01.cad.0000215061.78189.4e; dos Santos NR, 2007, BLOOD, V109, P3972, DOI 10.1182/blood-2006-09-048801; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marafiot T, 2005, BRIT J HAEMATOL, V128, P333, DOI 10.1111/j.1365-2141.2004.05313.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhao WL, 2004, LAB INVEST, V84, P1512, DOI 10.1038/labinvest.3700145	30	120	126	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2007	13	6					736	741		10.1038/nm1588	http://dx.doi.org/10.1038/nm1588			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	176KQ	17515895				2022-12-25	WOS:000247084300038
J	Trenker, M; Malli, R; Fertschai, I; Levak-Frank, S; Graier, WF				Trenker, Michael; Malli, Roland; Fertschai, Ismene; Levak-Frank, Sanja; Graier, Wolfgang F.			Uncoupling proteins 2 and 3 are fundamental for mitochondrial Ca2+ uniport	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; YEAST MITOCHONDRIA; PROTEIN HOMOLOGS; SKELETAL-MUSCLE; CALCIUM; ACTIVATION; CELLS; SUPEROXIDE; EXPRESSION; CHANNEL	Mitochondrial Ca2+ uptake is crucial for the regulation of the rate of oxidative phosphorylation(1), the modulation of spatiotemporal cytosolic Ca2+ signals(2,3,4) and apoptosis(5). Although the phenomenon of mitochondrial Ca2+ sequestration, its characteristics and physiological consequences have been convincingly reported(6,7), the actual protein(s) involved in this process are unknown. Here, we show that the uncoupling proteins 2 and 3 (UCP2 and UCP3) are essential for mitochondrial Ca2+ uptake. Using overexpression, knockdown (small interfering RNA) and mutagenesis experiments, we demonstrate that UCP2 and UCP3 are elementary for mitochondrial Ca2+ sequestration in response to cell stimulation under physiological conditions - observations supported by isolated liver mitochondria of Ucp2(-/)-mice lacking ruthenium red-sensitive Ca2+ uptake. Our results reveal a novel molecular function for UCP2 and UCP3, and may provide the molecular mechanism for their reported effects(8-10). Moreover, the identification of proteins fundemental for mitochondrial Ca2+ uptake expands our knowledge of the physiological role for mitochondrial Ca2+ sequestration.	Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria	Medical University of Graz	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Harrachgasse 21-11, A-8010 Graz, Austria.	wolfgang.graier@meduni-graz.at	Graier, Wolfgang F./B-7052-2008; Malli, Roland/B-7369-2008	Graier, Wolfgang F./0000-0003-1871-3298; Malli, Roland/0000-0001-6327-8729	Austrian Science Fund FWF [F 3010, P 16860] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dejean L, 2004, J CELL PHYSIOL, V201, P294, DOI 10.1002/jcp.20048; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Harper JA, 2002, BIOCHEM J, V361, P49, DOI 10.1042/0264-6021:3610049; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jezek P, 2004, PHYSIOL RES, V53, pS199; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Osibow K, 2006, J BIOL CHEM, V281, P5017, DOI 10.1074/jbc.M508583200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Schaeffer G, 2003, DIABETOLOGIA, V46, P773, DOI 10.1007/s00125-003-1091-y; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Szilagyi G, 2006, NEUROSCI LETT, V399, P206, DOI 10.1016/j.neulet.2006.01.071; Vergun O, 2004, BIOPHYS J, V87, P3585, DOI 10.1529/biophysj.104.042671; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Yoshitomi H, 1998, GENE, V215, P77, DOI 10.1016/S0378-1119(98)00279-0; Zoratti C, 2003, BRIT J PHARMACOL, V140, P1351, DOI 10.1038/sj.bjp.0705529	35	272	278	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					445	U156		10.1038/ncb1556	http://dx.doi.org/10.1038/ncb1556			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351641	Green Accepted			2022-12-25	WOS:000245359400016
J	Kubo, M; Hata, J; Ninomiya, T; Matsuda, K; Yonemoto, K; Nakano, T; Matsushita, T; Yamazaki, K; Ohnishi, Y; Saito, S; Kitazono, T; Ibayashi, S; Sueishi, K; Iida, M; Nakamura, Y; Kiyohara, Y				Kubo, Michiaki; Hata, Jun; Ninomiya, Toshiharu; Matsuda, Koichi; Yonemoto, Koji; Nakano, Toshiaki; Matsushita, Tomonaga; Yamazaki, Keiko; Ohnishi, Yozo; Saito, Susumu; Kitazono, Takanari; Ibayashi, Setsuro; Sueishi, Katsuo; Iida, Mitsuo; Nakamura, Yusuke; Kiyohara, Yutaka			A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction	NATURE GENETICS			English	Article							PKC-ETA; JAPANESE COMMUNITY; NPKC-ETA; EXPRESSION; ISOFORM; GENE; CELL; CLASSIFICATION; SUSCEPTIBILITY; ASSOCIATION	Cerebral infarction is the most common type of stroke an often causes long-term disability. To investigate the genetic contribution to cerebral infarction, we conducted a case-control study using 52,608 gene-based tag SNPs selected from the JSNP database. Here we report that a nonsynonymous SNP in a member of protein kinase C ( PKC) family, PRKCH, was significantly associated with lacunar infarction in two independent Japanese samples ( P =5.1 X 10(-7), crude odds ratio of 1.40). This SNP is likely to affect PKC activity. Furthermore, a 14- year follow- up cohort study in Hisayama ( Fukuoka, Japan) supported involvement of this SNP in the development of cerebral infarction ( P =0.03, age- and sex-adjusted hazard ratio of 2.83). We also found that PKC eta was expressed mainly in vascular endothelial cells and foamy macrophages in human atherosclerotic lesions, and its expression increased as the lesion type progressed. Our results support a role for PRKCH in the pathogenesis of cerebral infarction.	Kyushu Univ, Dept Environm Med, Fukuoka 8128582, Japan; Kyushu Univ, Dept Med & Clin Sci, Fukuoka 8128582, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genet, Tokyo 1088639, Japan; Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; RIKEN, Lab Genotyping, SNP Res Ctr, Inst Phys & Chem Res, Yokohama, Kanagawa 2300045, Japan	Kyushu University; Kyushu University; University of Tokyo; Kyushu University; RIKEN	Kubo, M (corresponding author), Kyushu Univ, Dept Environm Med, Fukuoka 8128582, Japan.	mkubo@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; [Anonymous], 1986, Arch Neurol, V43, P71; Chen CC, 1998, J BIOL CHEM, V273, P19424, DOI 10.1074/jbc.273.31.19424; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; IKUTA T, 1994, CELL GROWTH DIFFER, V5, P943; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kubo M, 2006, NEUROLOGY, V66, P1539, DOI 10.1212/01.wnl.0000216132.95207.b4; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Masso-Welch PA, 2001, BREAST CANCER RES TR, V68, P211, DOI 10.1023/A:1012265703669; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OSADA S, 1993, CELL GROWTH DIFFER, V4, P167; OSADA S, 1990, J BIOL CHEM, V265, P22434; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pham TNQ, 2003, NITRIC OXIDE-BIOL CH, V9, P123, DOI 10.1016/j.niox.2003.09.006; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379	30	165	183	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					212	217		10.1038/ng1945	http://dx.doi.org/10.1038/ng1945			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206144				2022-12-25	WOS:000244063900019
J	Fanciulli, M; Norsworthy, PJ; Petretto, E; Dong, R; Harper, L; Kamesh, L; Heward, JM; Gough, SCL; de Smith, A; Blakemore, AIF; Owen, CJ; Pearce, SHS; Teixeira, L; Guillevin, L; Graham, DSC; Pusey, CD; Cook, HT; Vyse, TJ; Aitman, TJ				Fanciulli, Manuela; Norsworthy, Penny J.; Petretto, Enrico; Dong, Rong; Harper, Lorraine; Kamesh, Lavanya; Heward, Joanne M.; Gough, Stephen C. L.; de Smith, Adam; Blakemore, Alexandra I. F.; Owen, Catherine J.; Pearce, Simon H. S.; Teixeira, Luis; Guillevin, Loic; Graham, Deborah S. Cunninghame; Pusey, Charles D.; Cook, H. Terence; Vyse, Timothy J.; Aitman, Timothy J.			FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; RECEPTORS; PATHOGENESIS; POLYMORPHISM; DISEASE; GENE	Naturally occurring variation in gene copy number is increasingly recognized as a heritable source of susceptibility to genetically complex diseases. Here we report strong association between FCGR3B copy number and risk of systemic lupus erythematosus (P = 2.7 x 10(-8)), microscopic polyangiitis (P = 2.9 x 10(-4)) and Wegener's granulomatosis in two independent cohorts from the UK ( P = 3 x 10(-3)) and France ( P = 1.1 x 10(-4)). We did not observe this association in the organ- specific Graves' disease or Addison's disease. Our findings suggest that low FCGR3B copy number, and in particular complete FCGR3B deficiency, has a key role in the development of systemic autoimmunity.	Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England; Univ Birmingham, Sch Med, Div Med Sci, Birmingham B15 277, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 277, W Midlands, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, Div Med, London W12 0NN, England; Inst Pasteur, Inst Biol, CNRS, UMR 8090, F-59800 Lille, France; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 EBZ, Tyne & Wear, England; Paris Descartes Univ, AP HP, Cochin Hosp, Dept Internal Med,Reference Ctr Vascul & System S, F-75679 Paris 14, France; Univ London Imperial Coll Sci Technol & Med, Sect Mol Genet & Rheumatol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Sect Renal Med, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W12 0NN, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham; University of Birmingham; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Teixeira, Luis/C-3694-2013; Pearce, Simon/AAB-3692-2019; Blakemore, Alexandra I F/D-2253-2009; FROGUEL, Philippe/O-6799-2017	Pearce, Simon/0000-0001-8384-8063; Blakemore, Alexandra I F/0000-0003-0661-564X; FROGUEL, Philippe/0000-0003-2972-0784; Aitman, Timothy/0000-0002-7875-4502; de Smith, Adam/0000-0003-4880-7543; Teixeira, Luis/0000-0003-1049-9661; Norsworthy, Penny/0000-0002-5572-8491	MRC [G0000934, G84/5959, MC_U120061454, G0400116] Funding Source: UKRI; Medical Research Council [G84/5959, G0000934, MC_U120097112, MC_U120061454, G0400116] Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline; Wellcome Trust [068545/Z/02, 066780] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; CLARK MR, 1990, J CLIN INVEST, V86, P341, DOI 10.1172/JCI114706; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Harper L, 2000, J PATHOL, V190, P349, DOI 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	15	398	418	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					721	723		10.1038/ng2046	http://dx.doi.org/10.1038/ng2046			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17968342	Green Accepted			2022-12-25	WOS:000246859100013
